data_2lss_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lss _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 108.473 -0.936 . . . . 71.12 108.473 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -129.56 153.73 47.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.267 0.469 . . . . 73.24 112.267 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 m120 58.07 42.04 23.1 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.985 0.914 . . . . 73.44 110.739 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 42.1 mt -75.68 150.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.428 -0.806 . . . . 73.22 112.14 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.8 t -96.43 138.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-N 114.854 -1.067 . . . . 73.15 109.777 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.71 171.01 43.94 Favored Glycine 0 N--CA 1.403 -3.524 0 C-N-CA 120.808 -0.71 . . . . 73.03 112.555 168.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -119.5 143.61 47.46 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.742 -0.836 . . . . 75.23 108.742 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.7 107.77 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.429 -0.952 . . . . 73.11 108.429 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 64.5 tttp -69.18 -43.07 74.96 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.823 -1.08 . . . . 74.23 108.57 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -171.85 155.34 3.84 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 114.729 -1.123 . . . . 72.32 108.346 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -159.99 121.77 3.24 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.624 0.577 . . . . 74.31 109.557 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -111.21 108.34 17.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.866 -0.42 . . . . 75.41 109.866 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 p -58.23 -23.64 56.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.215 -0.902 . . . . 63.14 112.709 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 m -57.46 -36.16 71.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.872 0.469 . . . . 72.35 110.941 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -114.73 -9.05 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.346 -0.542 . . . . 75.23 110.346 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 63.52 25.04 14.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.774 0.83 . . . . 73.1 111.837 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.41 158.34 23.67 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 116.035 -0.53 . . . . 73.41 109.966 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.51 -167.69 38.87 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.355 -1.098 . . . . 74.03 110.355 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -134.67 168.69 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.17 0.51 . . . . 73.25 110.981 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.413 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 66.4 mt -140.69 138.69 35.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.3 -0.863 . . . . 74.44 108.672 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 10' ' ' LYS . 11.7 pt-20 -143.03 141.7 31.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.829 -1.545 . . . . 70.33 106.829 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.1 pt20 -83.8 151.17 25.32 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 117.603 -1.639 . . . . 75.12 108.835 173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.27 -19.75 48.58 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 123.95 0.782 . . . . 72.43 111.926 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.16 1.14 51.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.157 -0.474 . . . . 73.22 111.872 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 45.88 1.13 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.579 -1.295 . . . . 65.01 112.569 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.69 154.67 36.3 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.888 -1.285 . . . . 63.24 109.888 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.77 169.69 14.95 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.788 0.662 . . . . 71.45 112.788 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD2' ' HE2' ' A' ' 10' ' ' LYS . 3.1 m-20 -70.87 90.44 0.8 Allowed 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.233 -0.894 . . . . 72.24 112.619 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -105.34 123.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.309 -0.997 . . . . 73.34 108.309 173.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 48.5 p90 -83.5 141.94 31.27 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.058 0.456 . . . . 74.31 111.539 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.96 130.46 46.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.671 -0.695 . . . . 73.51 109.624 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -109.36 148.41 31.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.557 -0.905 . . . . 75.35 108.557 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -57.54 -30.14 64.96 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 114.075 1.139 . . . . 73.11 114.075 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -54.44 -27.8 39.77 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.998 0.363 . . . . 75.42 111.325 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -74.26 -39.52 62.95 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.013 0.435 . . . . 54.21 109.959 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 42' ' ' LEU . 79.1 t -61.97 -50.65 79.23 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.889 0 N-CA-C 108.217 -1.031 . . . . 74.1 108.217 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.84 -22.63 67.03 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.178 0.924 . . . . 74.45 111.935 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.66 72.48 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.245 0.545 . . . . 75.52 110.741 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.89 -13.92 10.68 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.528 -0.76 . . . . 71.34 110.115 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.28 55.18 22.63 Favored Glycine 0 CA--C 1.486 -1.778 0 N-CA-C 109.743 -1.343 . . . . 51.43 109.743 -173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.406 ' HB3' HG11 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -64.18 125.99 26.3 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.592 -1.633 . . . . 75.35 106.592 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -73.81 -34.45 64.61 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 114.042 1.127 . . . . 75.01 114.042 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -161.4 143.68 12.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.873 0.368 . . . . 70.22 111.218 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.54 144.5 37.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.544 -0.753 . . . . 75.31 109.038 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.18 171.29 20.48 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.533 -1.284 . . . . 74.11 107.533 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 133.4 51.23 Favored 'General case' 0 N--CA 1.417 -2.095 0 C-N-CA 123.875 0.87 . . . . 75.11 110.096 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.44 -32.84 5.54 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.615 -0.721 . . . . 53.03 113.51 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.527 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.0 126.74 28.64 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.741 1.015 . . . . 63.41 113.741 -178.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.79 133.38 43.25 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 106.389 -1.708 . . . . 72.41 106.389 169.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 141.44 38.89 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 CA-C-O 122.125 0.964 . . . . 70.34 110.25 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 54.3 mt -114.92 124.18 71.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 N-CA-C 106.27 -1.752 . . . . 74.12 106.27 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 41.4 p90 -143.36 179.39 7.12 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.609 -0.437 . . . . 74.32 111.497 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -117.42 158.8 23.84 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 105.649 -1.982 . . . . 64.14 105.649 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 62' ' ' ALA . 17.2 tp -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 121.864 0.84 . . . . 74.34 112.577 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.21 157.28 30.59 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.674 -1.603 . . . . 75.33 108.755 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -100.19 155.22 17.87 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-O 122.082 0.944 . . . . 73.32 112.9 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.8 tptt -118.78 85.1 2.3 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.308 -1.738 . . . . 75.41 106.308 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 65.8 -76.04 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.063 0.852 . . . . 75.13 109.483 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.28 -4.69 3.17 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.378 -0.689 . . . . 70.24 111.378 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 55.3 mtpt -89.06 165.7 14.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 122.807 0.443 . . . . 74.11 110.934 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -122.97 123.16 40.28 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.757 0.28 . . . . 73.43 111.757 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.472 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 41.0 p90 -125.65 132.94 52.36 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.364 0.602 . . . . 73.42 111.695 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.45 134.99 37.29 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.038 -0.983 . . . . 71.4 110.446 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.515 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 28.3 m -137.65 165.92 25.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.205 -0.907 . . . . 63.43 108.864 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.52 64.07 1.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.648 0.593 . . . . 52.43 111.383 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 24.7 mt -80.2 142.67 34.47 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.463 -0.895 . . . . 72.42 112.443 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -138.79 131.56 29.22 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.151 -1.796 . . . . 73.44 106.151 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.34 1.8 pp -90.59 96.56 6.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 116.065 1.876 . . . . 62.51 116.065 -177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.6 tttp . . . . . 0 C--O 1.259 1.585 0 C-N-CA 125.703 1.601 . . . . 52.34 113.744 173.762 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 105.582 -2.007 . . . . 64.41 105.582 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.3 p -108.84 148.98 29.77 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.242 0.83 . . . . 60.34 113.242 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 52.48 76.16 0.2 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.36 -1.291 . . . . 72.3 112.111 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 36.6 mt -102.76 143.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.653 -1.158 . . . . 74.45 110.182 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 58.8 t -91.47 133.55 32.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.018 -0.992 . . . . 72.01 109.522 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.85 172.26 38.84 Favored Glycine 0 N--CA 1.396 -3.984 0 CA-C-N 115.45 -0.795 . . . . 73.35 112.166 171.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.7 ttmt -123.53 143.06 50.43 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.373 -0.973 . . . . 73.52 108.373 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.84 111.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 108.39 -0.967 . . . . 71.13 108.39 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.1 tttp -76.99 -40.57 46.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.549 -1.205 . . . . 73.4 108.786 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.401 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 68.5 p-90 -177.65 160.58 1.58 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 124.265 1.026 . . . . 75.24 109.1 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -155.35 134.61 12.36 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.007 0.432 . . . . 75.24 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.71 106.05 10.97 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.757 -0.656 . . . . 72.35 109.386 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.4 p -61.04 -32.62 72.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.612 -0.722 . . . . 73.33 112.439 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.0 m -61.88 -28.71 69.7 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.988 0.423 . . . . 64.4 110.686 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.21 -9.0 18.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.43 -0.508 . . . . 75.41 111.812 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 17' ' ' ASN . 0.7 OUTLIER 63.76 25.99 14.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 120.924 0.392 . . . . 75.23 110.077 -176.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -137.64 165.87 25.31 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.4 0.68 . . . . 71.12 112.318 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.53 44.38 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.507 -1.837 . . . . 53.31 108.507 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.454 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 39.0 m-85 -133.19 160.24 37.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 117.465 0.633 . . . . 74.12 111.534 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -145.47 130.11 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.092 -0.958 . . . . 74.13 108.465 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.88 149.65 37.23 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.363 -1.717 . . . . 74.31 106.363 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -74.87 146.85 41.58 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 117.708 -1.597 . . . . 72.31 109.24 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.47 -21.09 35.09 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.292 -1.322 . . . . 72.3 111.0 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.69 5.26 11.55 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.124 -0.944 . . . . 75.1 111.14 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.54 50.39 2.75 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 111.529 -0.629 . . . . 71.24 111.529 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.33 172.47 54.62 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.477 -0.868 . . . . 73.21 112.498 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.75 151.99 43.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.149 -0.525 . . . . 72.35 110.447 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.26 116.71 20.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.081 0.943 . . . . 74.03 111.144 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 55' ' ' LEU . 2.5 p -133.17 133.48 58.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.722 -1.127 . . . . 74.5 108.776 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 52.9 p90 -88.91 152.32 21.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 120.251 -0.58 . . . . 71.21 111.331 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.457 HG21 HD12 ' A' ' 67' ' ' LEU . 7.1 p -109.34 128.04 65.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.516 0.674 . . . . 74.43 109.409 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -109.63 156.73 19.84 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.396 -0.965 . . . . 74.32 108.396 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -22.48 65.99 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 113.265 0.839 . . . . 74.3 113.265 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -55.86 -27.41 51.52 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.988 0.423 . . . . 73.03 110.575 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.48 -34.14 58.66 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.912 0.387 . . . . 72.23 110.169 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 -47.85 78.91 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.625 0 N-CA-C 107.917 -1.142 . . . . 73.15 107.917 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.24 -22.79 67.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.68 0.622 . . . . 75.31 112.68 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.19 69.44 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.825 0.305 . . . . 72.25 111.825 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -21.78 2.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.286 0.565 . . . . 73.11 112.429 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.85 51.91 5.23 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.483 -1.047 . . . . 52.14 110.483 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.94 129.19 38.92 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -62.44 -39.04 92.05 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.68 0.622 . . . . 72.41 112.68 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.5 t -171.06 156.56 4.86 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 110.096 -0.335 . . . . 74.53 110.096 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.4 mt -135.72 132.28 36.68 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.215 -0.661 . . . . 72.44 109.215 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.88 160.78 34.03 Favored 'General case' 0 C--N 1.266 -3.039 0 C-N-CA 125.547 1.539 . . . . 73.42 107.023 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 155.12 37.09 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.368 0.877 . . . . 70.11 113.368 -172.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.37 -19.97 48.85 Favored Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.815 -1.084 . . . . 73.1 112.02 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -89.4 132.29 35.06 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 122.557 0.343 . . . . 74.13 111.422 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.6 m-20 -87.32 138.62 31.33 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.465 -0.939 . . . . 75.22 108.465 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.77 149.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-O 121.807 0.813 . . . . 75.25 110.893 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 63.2 mt -111.72 135.79 49.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 106.482 -1.673 . . . . 73.35 106.482 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.442 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.1 p90 -148.52 178.4 8.65 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.8 -0.36 . . . . 75.12 110.161 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -119.81 154.54 34.12 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 105.077 -2.194 . . . . 74.55 105.077 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 30' ' ' VAL . 27.4 tp -121.07 130.69 53.87 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 113.324 0.861 . . . . 74.14 113.324 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -124.6 150.16 46.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.481 -1.69 . . . . 75.32 111.131 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -100.83 127.09 47.43 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.068 -0.969 . . . . 73.41 110.251 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 58' ' ' LYS . 28.1 tptp -93.76 28.76 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.396 1.078 . . . . 73.52 108.543 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.84 90.86 0.08 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.7 -1.136 . . . . 74.31 107.981 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.37 -44.78 2.61 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.401 -0.818 . . . . 61.33 111.741 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -95.95 153.07 17.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.975 -0.38 . . . . 74.1 109.975 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -126.24 122.6 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.797 -0.446 . . . . 63.03 109.797 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.7 p90 -130.84 140.31 50.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 72.13 111.963 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.34 136.33 44.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.435 -1.257 . . . . 51.41 109.812 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 35.8 m -136.9 163.02 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.362 -0.835 . . . . 72.3 109.708 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.72 63.56 1.91 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.012 0.82 . . . . 72.14 111.034 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD12 HG21 ' A' ' 32' ' ' VAL . 28.7 mt -75.59 149.56 38.25 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.715 -0.794 . . . . 72.44 112.336 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -148.89 130.97 15.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.558 HD12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -74.73 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 118.2 0.455 . . . . 62.13 111.441 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.177 -0.919 . . . . 74.42 109.83 177.104 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.351 -0.611 . . . . 64.45 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -95.87 140.51 30.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.675 0.61 . . . . 75.13 112.411 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 49.51 72.15 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.819 1.044 . . . . 71.13 113.819 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 57.0 mt -92.66 151.13 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.146 -0.934 . . . . 72.15 110.081 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 55.9 t -92.28 139.35 18.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.509 -0.768 . . . . 74.32 110.377 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -174.42 179.13 45.95 Favored Glycine 1 N--CA 1.395 -4.039 0 CA-C-N 115.274 -0.875 . . . . 61.23 112.239 169.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -132.69 142.76 49.22 Favored 'General case' 0 C--N 1.259 -3.339 0 C-N-CA 124.017 0.927 . . . . 74.3 108.713 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.36 109.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.667 0.746 . . . . 64.32 109.072 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 22' ' ' GLU . 59.5 tttp -68.38 -40.73 81.28 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.495 1.518 . . . . 73.22 108.613 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -177.76 160.51 1.53 Allowed 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.267 1.427 . . . . 75.43 108.504 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -161.25 133.6 5.96 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.227 0.33 . . . . 74.41 110.227 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -122.29 103.94 9.09 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.629 -0.714 . . . . 53.44 109.368 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -57.11 -32.25 66.12 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.294 -0.866 . . . . 62.24 112.504 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.8 m -60.75 -34.64 74.74 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 112.126 0.417 . . . . 73.34 112.126 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -101.05 -7.01 23.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.522 -0.471 . . . . 71.4 111.009 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.9 m120 66.93 21.45 10.35 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.243 1.017 . . . . 73.01 110.765 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -125.47 152.0 45.52 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.517 0.675 . . . . 73.23 112.398 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.99 -175.62 38.49 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.528 -1.429 . . . . 74.13 109.528 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 m-85 -131.45 165.16 24.14 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 117.05 0.425 . . . . 74.32 110.751 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 65.8 mt -139.44 139.22 39.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.781 -0.822 . . . . 71.24 108.781 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.2 pt-20 -143.1 144.38 32.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.542 -1.651 . . . . 74.53 106.542 175.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.2 pt20 -84.49 151.91 24.3 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 117.451 -1.7 . . . . 73.44 109.633 174.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.91 -18.54 23.76 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.925 -1.034 . . . . 62.33 111.648 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -87.13 -0.93 57.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 73.34 111.41 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.14 51.02 1.1 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.689 -1.243 . . . . 75.24 112.782 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.47 150.08 26.67 Favored Glycine 0 C--N 1.318 -0.46 0 C-N-CA 119.948 -1.12 . . . . 75.2 110.819 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -66.91 171.99 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.572 0.952 . . . . 75.13 113.572 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.01 99.11 2.65 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.915 -0.584 . . . . 72.0 111.781 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 129.45 74.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.028 -0.73 . . . . 72.43 109.028 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 38.6 p90 -92.44 142.5 27.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.092 -0.643 . . . . 74.4 111.345 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.47 122.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-O 121.589 0.709 . . . . 73.2 109.747 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.19 140.76 31.2 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.212 -1.033 . . . . 74.45 108.212 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -76.3 -11.42 59.9 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.917 1.08 . . . . 75.41 113.917 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -61.59 -21.79 64.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 120.623 -0.431 . . . . 65.24 109.846 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.17 68.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.808 0.337 . . . . 71.11 110.197 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.35 -35.53 73.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.085 0 N-CA-C 108.007 -1.109 . . . . 74.11 108.007 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -66.28 -30.5 70.94 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.747 -0.66 . . . . 74.45 111.06 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.79 77.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.617 0.599 . . . . 73.44 112.617 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 -9.18 6.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.178 0.807 . . . . 75.44 113.178 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.99 57.71 7.47 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.49 -1.044 . . . . 63.13 110.49 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.38 131.28 46.78 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -50.83 -58.85 4.93 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.65 0.982 . . . . 64.0 113.65 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 p -170.62 147.25 2.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.199 0.444 . . . . 74.5 112.199 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -124.83 148.92 47.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.304 0.573 . . . . 72.45 110.109 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -166.69 162.13 16.14 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.226 -2.138 . . . . 61.24 105.226 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 149.94 48.14 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.907 -0.717 . . . . 75.02 111.295 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.77 -15.36 63.25 Favored Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.334 -0.848 . . . . 73.32 112.095 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.02 121.16 26.65 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 122.556 0.343 . . . . 64.0 111.476 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 m-20 -72.28 135.21 45.92 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.729 -1.212 . . . . 75.25 107.729 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.49 147.33 19.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 121.968 0.889 . . . . 75.14 111.514 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 60.0 mt -110.67 133.66 55.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 N-CA-C 107.073 -1.455 . . . . 74.12 107.073 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.1 p90 -148.14 174.78 11.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.187 0.518 . . . . 73.21 111.405 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.8 146.09 39.45 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.025 -1.472 . . . . 64.25 107.025 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 HD11 ' H ' ' A' ' 56' ' ' GLU . 25.1 tp -129.13 136.9 50.81 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.646 0.736 . . . . 63.22 111.585 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' H ' HD11 ' A' ' 55' ' ' LEU . 30.6 tt0 -153.15 143.98 22.82 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.473 -2.047 . . . . 71.3 105.473 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -85.67 140.65 30.37 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.892 1.071 . . . . 74.34 113.892 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 84.9 tttt -95.18 80.28 3.57 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.068 -1.827 . . . . 72.41 106.068 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 64.62 -81.6 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.252 1.021 . . . . 72.34 110.452 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.33 -6.83 7.96 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.364 -0.694 . . . . 74.12 111.364 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 9.5 mmpt? -92.49 164.79 13.33 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.293 -0.632 . . . . 74.31 109.293 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.13 118.53 24.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.774 -0.454 . . . . 70.51 109.774 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.524 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.2 p90 -126.78 136.03 51.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.375 0.607 . . . . 74.23 112.271 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 132.5 35.2 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.605 -1.18 . . . . 64.42 110.738 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.59 177.11 6.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 CA-C-N 115.167 -0.924 . . . . 72.52 109.337 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.25 63.16 2.35 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.92 0.762 . . . . 74.11 110.328 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 45.1 mt -81.93 147.46 29.25 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.319 0.859 . . . . 74.14 113.319 -174.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 22.7 tpp180 -151.33 130.64 12.82 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.315 -2.106 . . . . 74.43 105.315 175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -93.78 145.9 7.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 113.239 0.829 . . . . 75.53 113.239 -177.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 58.2 mtpt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 114.986 -1.006 . . . . 72.13 108.672 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 113.498 0.925 . . . . 72.13 113.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.0 p -141.01 140.95 34.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.478 -1.304 . . . . 73.33 107.478 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 58.81 74.2 0.45 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 106.833 -1.543 . . . . 65.1 106.833 -168.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.2 mt -101.47 147.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 113.852 -1.522 . . . . 75.33 111.65 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.4 t -91.27 140.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.502 -1.227 . . . . 73.52 109.384 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -179.91 161.08 26.59 Favored Glycine 0 N--CA 1.414 -2.785 0 C-N-CA 120.232 -0.985 . . . . 73.23 113.416 167.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 4.8 ttmp? -106.44 139.98 40.07 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.561 -0.903 . . . . 74.52 108.561 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.54 109.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.483 -0.932 . . . . 74.31 108.483 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.47 ' H ' ' HA ' ' A' ' 21' ' ' ILE . 55.2 tttp -67.59 -42.31 82.67 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.592 -1.64 . . . . 74.23 108.471 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -176.04 160.93 2.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 124.891 1.277 . . . . 71.02 107.783 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 81.3 t80 -163.35 131.97 3.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.043 0.449 . . . . 75.04 110.777 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -112.46 105.01 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.045 -1.094 . . . . 73.4 108.045 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.0 p -61.94 -36.2 80.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.951 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.6 m -63.51 -34.23 77.32 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.843 -0.617 . . . . 71.31 110.812 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 96.6 mttt -93.62 -8.13 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 71.53 111.052 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 m120 67.07 23.61 9.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.943 0.897 . . . . 72.25 112.51 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 46.5 p90 -153.19 168.18 26.84 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 112.883 0.697 . . . . 74.03 112.883 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -177.66 -154.84 12.78 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 109.923 -1.271 . . . . 71.51 109.923 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 35.4 m-85 -140.03 169.48 17.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.513 0.656 . . . . 74.24 111.24 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.47 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 62.9 mt -145.27 140.38 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.163 -1.051 . . . . 73.41 108.163 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.1 139.68 30.55 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.013 -1.477 . . . . 63.33 107.013 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.5 pt20 -84.41 146.5 27.63 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 117.765 -1.574 . . . . 74.1 109.05 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.09 -13.98 20.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 124.632 1.208 . . . . 72.31 110.627 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.44 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 14.1 m120 -87.34 -5.11 59.02 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.772 -0.649 . . . . 73.33 110.592 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.98 0.67 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 118.324 -1.893 . . . . 74.43 113.681 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.2 146.37 19.61 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 119.838 -1.172 . . . . 74.11 110.428 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.66 -175.86 4.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.293 0.849 . . . . 72.53 113.293 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.89 99.11 1.01 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.692 -0.685 . . . . 75.14 111.878 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.33 123.21 59.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.361 -0.978 . . . . 71.4 108.361 173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -92.41 147.49 22.87 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 119.559 -0.856 . . . . 74.3 111.16 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 67' ' ' LEU . 7.2 p -104.0 124.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 109.06 -0.719 . . . . 62.41 109.06 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -108.71 149.92 28.31 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.412 -0.959 . . . . 74.33 108.412 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.19 -22.64 61.31 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 113.502 0.927 . . . . 75.52 113.502 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.2 m -56.32 -23.38 36.64 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 120.388 -0.525 . . . . 74.03 111.102 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.92 -36.22 49.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.871 -0.418 . . . . 74.34 109.871 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 42' ' ' LEU . 60.8 t -61.9 -49.8 82.73 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.868 0 N-CA-C 107.416 -1.327 . . . . 75.31 107.416 172.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.93 -33.03 68.38 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.435 1.084 . . . . 72.53 111.73 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -30.12 68.84 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.998 0.427 . . . . 74.15 112.135 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.74 0.08 4.87 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.601 -0.44 . . . . 70.15 111.706 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.05 55.52 27.72 Favored Glycine 0 C--N 1.313 -0.746 0 N-CA-C 110.434 -1.066 . . . . 63.42 110.434 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -64.94 137.5 57.78 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.728 -1.582 . . . . 72.21 106.728 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -61.88 -61.14 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.895 0.331 . . . . 75.41 111.895 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -159.88 151.42 19.92 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.778 -0.453 . . . . 74.33 109.778 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 88.2 mt -123.87 146.59 48.3 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.545 -0.539 . . . . 73.23 109.545 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -160.51 162.12 32.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 106.058 -1.83 . . . . 73.33 106.058 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 148.86 50.12 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.744 -0.782 . . . . 72.52 110.627 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.58 -16.85 60.32 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.492 -0.776 . . . . 75.04 112.484 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.34 128.37 33.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 122.789 -0.242 . . . . 73.23 110.425 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 26.6 m-20 -88.01 138.56 31.35 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.991 -0.744 . . . . 63.13 108.991 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.64 154.23 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.712 -0.676 . . . . 62.04 110.656 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.2 mt -119.97 131.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.841 -1.54 . . . . 71.34 106.841 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.467 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 45.5 p90 -144.38 -179.98 6.88 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.795 0.331 . . . . 75.41 111.426 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -117.37 159.88 22.05 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.674 -1.232 . . . . 75.52 107.674 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 62' ' ' ALA . 22.3 tp -136.79 132.95 35.43 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 121.31 0.576 . . . . 75.51 110.958 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.53 145.39 51.47 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.828 -1.078 . . . . 73.53 108.156 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.86 112.2 20.91 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.45 0.643 . . . . 73.24 111.955 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -84.11 85.68 7.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.518 -1.29 . . . . 72.21 107.518 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 66.85 -71.54 0.1 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.562 1.145 . . . . 72.42 110.703 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 -6.72 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.654 -0.978 . . . . 37.59 110.654 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -92.09 165.65 13.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.076 0.55 . . . . 75.43 109.667 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -133.4 125.59 29.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.332 0.253 . . . . 71.14 110.627 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -136.46 139.88 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.063 0.459 . . . . 75.54 110.921 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 136.58 39.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.698 -1.137 . . . . 75.35 111.282 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.24 165.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.266 -0.879 . . . . 74.55 109.614 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 56.04 65.21 1.5 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.43 0.692 . . . . 75.21 111.06 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 27.9 mt -78.69 140.73 38.32 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.5 -0.88 . . . . 72.22 113.115 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.528 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 8.4 mpt_? -127.97 135.73 50.33 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.168 -1.79 . . . . 73.11 106.168 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -78.69 133.08 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 119.576 -0.85 . . . . 70.32 109.641 172.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.532 -0.758 . . . . 72.33 109.219 176.123 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 107.769 -1.197 . . . . 71.3 107.769 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -111.58 147.41 35.51 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.804 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 m120 59.34 75.87 0.38 Allowed 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.13 0.894 . . . . 74.0 110.977 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 23.9 mt -104.33 146.41 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.535 -0.757 . . . . 72.12 111.134 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.65 134.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.865 -1.061 . . . . 73.22 109.819 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 23' ' ' GLN . . . 179.09 163.19 29.7 Favored Glycine 0 CA--C 1.454 -3.774 0 C-N-CA 120.325 -0.94 . . . . 65.11 113.493 168.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.2 ttmt -101.81 142.27 33.39 Favored 'General case' 0 C--N 1.252 -3.644 0 CA-C-N 114.622 -0.789 . . . . 73.42 109.241 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.1 108.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.358 -0.979 . . . . 75.44 108.358 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.53 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 57.5 tttp -68.07 -38.84 82.88 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.419 -1.264 . . . . 73.31 108.19 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 177.78 157.5 0.39 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 125.272 1.429 . . . . 75.33 108.616 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -146.12 119.52 9.02 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.317 0.58 . . . . 75.11 110.541 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -88.05 107.11 18.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.893 -1.521 . . . . 74.13 106.893 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -11.88 60.01 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.107 0.41 . . . . 61.32 112.107 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 m -79.52 -46.47 17.33 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.27 -0.641 . . . . 73.15 109.27 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -97.41 -7.68 31.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.564 0.579 . . . . 71.3 112.564 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 66.76 27.67 9.18 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.577 0.584 . . . . 73.33 112.577 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -122.79 157.68 31.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.89 -0.595 . . . . 75.41 109.594 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.96 29.57 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.794 -1.323 . . . . 64.33 109.794 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 60.4 m-85 -141.24 167.64 21.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 117.396 0.598 . . . . 75.02 110.768 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -145.4 134.16 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.123 -0.695 . . . . 75.21 109.123 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -144.11 148.54 35.24 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.949 -1.5 . . . . 64.43 106.949 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HB3' ' HA2' ' A' ' 7' ' ' GLY 0.272 0.0 OUTLIER -91.83 158.8 16.12 Favored 'General case' 0 CA--C 1.462 -2.442 0 C-N-CA 115.245 -2.582 . . . . 71.1 109.849 172.714 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.15 -15.52 5.76 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 124.301 1.001 . . . . 72.14 113.027 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -84.36 -2.1 56.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.671 -0.24 . . . . 72.54 111.313 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.22 50.75 0.7 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.871 -0.68 . . . . 61.25 112.8 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.91 52.13 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.494 -0.86 . . . . 72.34 113.461 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -74.88 -178.63 3.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.142 0.496 . . . . 73.2 112.223 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.77 101.3 12.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.898 0.38 . . . . 65.3 110.598 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -128.3 123.76 60.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.411 -0.959 . . . . 73.54 108.411 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 52.6 p90 -87.69 147.14 25.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 120.119 -0.632 . . . . 61.04 111.661 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' CG2' HD12 ' A' ' 67' ' ' LEU . 9.2 p -109.28 141.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.0 -0.741 . . . . 73.34 109.0 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -131.66 155.81 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.235 -0.654 . . . . 72.44 109.235 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -63.47 -18.44 63.77 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 113.151 0.797 . . . . 72.42 113.151 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -57.97 -27.18 63.22 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 120.961 0.41 . . . . 73.4 110.639 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.63 -35.77 45.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.833 -0.432 . . . . 62.32 109.833 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 42' ' ' LEU . 71.9 t -61.98 -48.38 88.83 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.308 0 N-CA-C 107.715 -1.216 . . . . 71.51 107.715 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.84 -33.04 66.39 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.303 1.041 . . . . 74.13 111.241 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.34 68.32 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.112 0.782 . . . . 70.21 113.112 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.99 -2.49 4.62 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.6 52.52 50.45 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 123.65 0.643 . . . . 43.54 112.969 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.406 ' HB3' HG11 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -67.65 142.86 56.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.328 -1.73 . . . . 70.42 106.328 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -64.39 -62.42 1.62 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.6 0.593 . . . . 71.05 112.6 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.9 m -167.54 162.68 14.47 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.116 -1.068 . . . . 75.11 108.116 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.68 154.73 45.53 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.729 0.776 . . . . 74.34 112.006 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 174.97 14.6 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.531 -1.655 . . . . 71.53 106.531 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 157.8 28.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.28 0.562 . . . . 63.23 112.225 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.64 14.43 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.584 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.56 126.43 30.78 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 112.229 0.455 . . . . 62.54 112.229 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -81.95 134.46 35.38 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.222 -1.399 . . . . 71.21 107.222 173.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.88 150.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 CA-C-O 121.926 0.87 . . . . 73.34 110.463 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 78.4 mt -115.28 131.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 N-CA-C 106.888 -1.523 . . . . 73.44 106.888 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.0 p90 -146.48 -178.78 6.34 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.49 -0.559 . . . . 75.14 109.49 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.76 158.63 28.39 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.236 -1.764 . . . . 71.44 106.236 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.19 123.18 31.4 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.287 1.041 . . . . 64.12 112.744 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.02 143.78 46.9 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.311 -1.768 . . . . 75.3 107.561 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.41 141.67 28.35 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.766 -0.774 . . . . 74.4 110.38 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 58' ' ' LYS . 1.1 tpmt? -86.24 -61.32 1.77 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.966 -1.494 . . . . 71.41 106.966 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' A' ' 61' ' ' LYS . 6.5 tp-100 170.46 86.21 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.349 -2.093 . . . . 73.42 105.349 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.74 -29.94 2.61 Favored Glycine 0 C--N 1.307 -1.078 0 N-CA-C 111.089 -0.804 . . . . 62.4 111.089 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -92.71 144.75 24.99 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.161 -1.052 . . . . 71.2 108.161 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.71 120.24 26.1 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.968 -0.752 . . . . 74.12 108.968 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 4.2 p90 -129.16 137.12 50.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.381 0.61 . . . . 75.11 112.472 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.0 129.15 38.7 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.46 -1.245 . . . . 75.31 110.224 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.7 166.01 29.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.158 -0.928 . . . . 71.33 109.047 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.77 63.3 2.09 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.871 0.732 . . . . 73.5 110.604 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 32' ' ' VAL . 21.4 mt -76.4 133.62 39.86 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 119.219 -0.992 . . . . 70.14 112.898 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -137.71 131.27 31.11 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 113.899 -1.5 . . . . 72.35 107.858 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 69' ' ' ILE . 2.4 pp -75.3 146.14 9.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.908 -1.117 . . . . 74.41 110.634 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 4.2 ttpm? . . . . . 0 C--O 1.259 1.581 0 CA-C-O 118.115 -0.945 . . . . 72.42 108.873 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 108.643 -0.873 . . . . 63.41 108.643 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -111.8 143.31 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.413 -0.812 . . . . 74.41 112.243 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.1 t30 49.62 75.22 0.17 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.905 1.282 . . . . 74.34 110.376 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.8 mt -99.43 148.98 5.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.773 -1.103 . . . . 74.54 111.192 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.3 p -90.35 139.14 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 115.565 -0.743 . . . . 71.44 109.197 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -164.14 170.49 39.39 Favored Glycine 1 N--CA 1.395 -4.055 0 C-N-CA 120.334 -0.936 . . . . 74.32 112.102 172.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -126.12 138.48 53.68 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 108.533 -0.914 . . . . 71.44 108.533 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.03 107.53 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 109.135 -0.691 . . . . 70.34 109.135 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 27.2 mtpp -65.71 -46.67 78.1 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.149 -0.932 . . . . 74.54 109.241 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -172.7 160.1 4.46 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 114.894 -1.048 . . . . 74.35 108.504 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 90.3 t80 -160.5 108.47 1.61 Allowed 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.264 -1.013 . . . . 75.12 108.264 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -84.85 106.19 16.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.82 -0.807 . . . . 73.14 108.82 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 p -64.42 -17.49 63.84 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.487 0.715 . . . . 72.52 112.648 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 m -80.56 -43.5 20.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 120.935 0.398 . . . . 73.4 110.59 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -96.86 -8.15 31.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.9 0.333 . . . . 71.14 111.9 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 12.6 m120 67.68 24.44 8.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.023 0.929 . . . . 65.44 112.076 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.51 152.6 49.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 122.099 -0.376 . . . . 74.31 111.241 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.67 -168.63 33.5 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 111.178 -0.769 . . . . 73.44 111.178 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 40.4 m-85 -135.52 153.77 51.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.009 0.524 . . . . 61.13 111.529 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -137.23 134.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.718 -0.845 . . . . 73.33 108.718 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 12.7 pt-20 -143.63 150.62 39.04 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.222 -1.769 . . . . 73.2 106.222 173.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.268 0.5 OUTLIER -70.52 144.65 51.26 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 117.981 -1.488 . . . . 71.04 111.215 174.144 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.8 -39.39 11.77 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.671 -1.604 . . . . 70.05 112.686 -172.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.02 -9.4 30.16 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.64 0.776 . . . . 70.0 113.011 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 50.54 2.53 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.702 -0.761 . . . . 74.33 111.222 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.66 -99.66 0.33 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.083 -0.579 . . . . 75.21 113.179 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.621 0.248 . . . . 74.33 110.718 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.62 97.77 10.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.936 -0.575 . . . . 73.0 109.48 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.443 HG22 HD13 ' A' ' 55' ' ' LEU . 2.6 p -116.4 139.54 42.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.889 -0.596 . . . . 72.42 109.549 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 50.1 p90 -88.53 145.19 25.87 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.839 -0.744 . . . . 75.42 111.334 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.4 131.28 42.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.384 -0.598 . . . . 72.03 109.384 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -107.91 146.87 31.78 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.108 -1.441 . . . . 75.31 107.108 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HD3' ' HB3' ' A' ' 17' ' ' ASN . 27.1 ttpp -68.14 -17.46 64.36 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.684 0.624 . . . . 71.41 112.684 -171.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.6 t -54.92 -23.85 20.82 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 116.191 -0.459 . . . . 74.24 110.381 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -70.62 -41.68 71.91 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.571 0.224 . . . . 74.14 111.237 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.29 -41.49 83.76 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.837 0 N-CA-C 108.05 -1.093 . . . . 75.22 108.05 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.65 -24.38 67.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.947 -0.569 . . . . 73.5 110.889 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.9 45.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.265 0.839 . . . . 61.0 113.265 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.45 -23.37 2.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.813 0.671 . . . . 74.41 112.813 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.9 62.58 2.21 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.79 -0.641 . . . . 51.52 112.088 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 142.69 33.71 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.963 -1.866 . . . . 74.1 105.963 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -58.96 -59.34 5.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 117.737 0.244 . . . . 74.11 111.59 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 p -162.35 161.23 27.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.211 -0.663 . . . . 65.14 109.211 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 74.0 mt -124.02 134.28 53.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.859 -1.163 . . . . 62.42 107.859 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 150.1 34.3 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.08 -0.964 . . . . 74.45 108.479 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.88 151.02 43.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.156 0.799 . . . . 74.23 113.156 -175.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 -23.2 36.1 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.668 -1.151 . . . . 74.53 112.763 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.92 136.05 41.42 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 112.506 0.558 . . . . 74.0 112.506 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -85.97 135.67 33.57 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.665 -1.235 . . . . 74.11 107.665 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.05 151.58 20.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-O 121.49 0.662 . . . . 73.03 111.081 -172.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -116.09 134.21 60.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.9 p90 -144.86 -178.11 5.86 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.942 -0.392 . . . . 73.41 109.942 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.36 145.07 49.04 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.818 -1.549 . . . . 64.42 106.818 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD13 HG22 ' A' ' 30' ' ' VAL . 28.3 tp -116.5 109.37 17.18 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 122.374 1.083 . . . . 73.51 110.578 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -122.06 136.96 54.97 Favored 'General case' 0 C--N 1.258 -3.391 0 N-CA-C 105.07 -2.196 . . . . 74.43 105.07 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.9 136.9 33.1 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 114.693 1.368 . . . . 73.13 114.693 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 60.8 tptt -82.47 79.78 8.81 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.774 -1.936 . . . . 71.45 105.774 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 67.37 -80.0 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.946 0.898 . . . . 74.44 109.69 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.05 7.3 4.42 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.718 -0.953 . . . . 51.51 110.718 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -102.45 155.89 17.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.835 -1.543 . . . . 72.04 106.835 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.54 122.05 42.63 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.864 -0.522 . . . . 71.32 111.107 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -135.53 142.66 45.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.026 0.441 . . . . 75.02 109.986 178.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.62 33.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.233 -0.894 . . . . 74.35 109.953 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -133.54 169.38 21.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 73.04 111.019 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 57.2 63.13 1.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.218 0.949 . . . . 73.42 110.49 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 33.2 mt -81.91 140.29 34.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.299 1.222 . . . . 75.22 114.299 -172.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -140.28 139.54 35.53 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 125.829 1.651 . . . . 75.21 106.923 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.42 147.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 117.207 -1.797 . . . . 73.53 110.944 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.254 1.33 0 O-C-N 124.239 0.962 . . . . 73.21 110.898 179.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 107.977 -1.12 . . . . 75.22 107.977 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.5 p -117.14 140.79 49.09 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 111.378 0.14 . . . . 75.32 111.378 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 76.26 0.37 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.873 0.844 . . . . 63.32 112.022 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 47.1 mt -106.33 148.45 10.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 114.679 -1.146 . . . . 73.2 110.099 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.6 p -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 O-C-N 124.06 0.85 . . . . 71.21 109.794 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -166.47 171.15 41.36 Favored Glycine 1 N--CA 1.396 -4.009 0 C-N-CA 120.393 -0.908 . . . . 71.21 112.306 170.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.9 ttmt -123.89 137.22 54.67 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.123 -1.065 . . . . 74.34 108.123 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.44 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.366 -0.975 . . . . 74.55 108.366 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.8 tttp -75.94 -44.58 39.35 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.12 -1.4 . . . . 65.32 109.386 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -169.54 157.83 7.44 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.632 -0.713 . . . . 74.52 110.269 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -147.45 133.17 18.91 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.598 -0.728 . . . . 71.25 109.437 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -106.08 118.0 35.48 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.506 -0.924 . . . . 72.13 108.506 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 t -68.26 -33.85 75.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.157 -0.474 . . . . 75.31 111.464 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 m -73.57 -49.29 27.07 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.822 0.344 . . . . 71.43 111.534 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 64.4 mttp -82.25 -8.26 59.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.198 0.444 . . . . 72.23 112.198 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 13.4 m120 63.76 22.25 13.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.102 0.778 . . . . 75.41 113.102 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 42.0 p90 -142.37 174.25 10.79 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.544 -0.863 . . . . 75.03 110.804 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.63 -155.29 13.62 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.615 -0.994 . . . . 65.12 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 30.4 m-85 -132.65 163.54 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.404 0.621 . . . . 72.43 112.023 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.8 mt -145.84 138.51 20.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.105 -1.443 . . . . 73.22 107.105 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.07 148.64 35.43 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.761 -1.57 . . . . 74.14 106.761 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.538 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.279 0.2 OUTLIER -72.17 147.58 46.45 Favored 'General case' 0 CA--C 1.47 -2.115 0 C-N-CA 117.464 -1.694 . . . . 73.11 109.971 172.071 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -49.25 -35.15 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.0 1.438 . . . . 74.44 112.443 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -70.01 -0.85 8.25 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.458 0.91 . . . . 74.01 113.458 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 51.52 4.05 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 120.304 -0.95 . . . . 61.21 111.085 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' OE1' ' A' ' 23' ' ' GLN . . . -75.39 -110.55 0.1 Allowed Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.983 -0.627 . . . . 74.52 114.369 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.13 174.55 5.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.981 0.42 . . . . 73.33 112.1 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -102.27 92.87 4.91 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.319 -0.993 . . . . 64.32 108.319 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -116.74 124.45 72.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.633 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.4 p90 -91.19 149.16 21.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.009 -0.541 . . . . 72.03 110.189 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 67' ' ' LEU . 8.8 p -107.63 132.39 55.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 109.335 -0.617 . . . . 75.04 109.335 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -111.93 145.1 40.17 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.077 -1.083 . . . . 71.13 108.077 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 35.9 ttpt -62.54 -22.96 66.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -54.17 -24.07 16.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.34 112.144 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.77 -39.25 70.11 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 122.127 -0.358 . . . . 55.44 110.643 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.56 -36.52 71.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 107.86 -1.163 . . . . 74.25 107.86 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.38 -29.54 70.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.069 -0.969 . . . . 75.43 110.87 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.14 -47.7 9.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.584 0.587 . . . . 75.24 112.584 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -9.87 28.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.019 0.748 . . . . 71.1 113.019 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.48 55.61 29.06 Favored Glycine 0 CA--C 1.498 -1.022 0 O-C-N 123.459 0.475 . . . . 74.43 112.224 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.5 tm? -69.49 141.5 53.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.255 -1.017 . . . . 73.4 108.255 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' N ' HD11 ' A' ' 42' ' ' LEU . 58.7 t-80 -51.75 -60.67 2.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.867 . . . . 72.33 112.334 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -172.51 162.43 5.25 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -124.82 121.08 33.54 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.852 0.834 . . . . 72.14 109.657 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.54 144.85 36.14 Favored 'General case' 0 C--N 1.245 -3.95 0 CA-C-N 113.962 -1.472 . . . . 60.41 108.463 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.65 147.13 53.1 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.605 0.717 . . . . 70.53 112.253 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.21 -16.9 59.41 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.001 -0.999 . . . . 55.34 111.891 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.28 137.47 35.8 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 122.496 0.318 . . . . 74.31 110.659 177.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 9.4 m-20 -88.53 137.48 32.29 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.018 -1.105 . . . . 74.31 108.018 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.65 149.52 23.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 121.704 0.764 . . . . 73.41 110.969 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.1 mt -111.75 137.62 43.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.182 -1.784 . . . . 72.33 106.182 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.1 p90 -152.09 178.87 9.01 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.708 -0.397 . . . . 75.23 110.705 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -114.43 160.52 19.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.843 -2.28 . . . . 74.23 104.843 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 62' ' ' ALA . 18.7 tp -129.81 127.74 40.91 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 113.593 0.96 . . . . 74.41 113.593 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD11 ' A' ' 55' ' ' LEU . 47.0 mt-10 -114.08 134.67 54.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.275 -1.784 . . . . 74.51 107.981 174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -93.41 134.18 35.91 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.284 0.564 . . . . 72.35 110.818 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 58.4 tptt -102.29 76.9 1.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.11 -1.441 . . . . 73.41 107.11 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 67.71 -70.43 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.647 1.179 . . . . 73.1 110.67 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 -15.56 1.45 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.22 -0.752 . . . . 75.42 111.22 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 54.7 mtpt -84.43 165.04 18.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.57 -0.53 . . . . 75.32 109.57 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -127.94 129.47 46.87 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.619 -0.433 . . . . 53.15 110.499 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.4 p90 -127.65 128.38 45.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 113.167 0.803 . . . . 72.51 113.167 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.48 133.29 43.62 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.264 -1.335 . . . . 73.33 110.688 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.64 164.41 30.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.015 -1.106 . . . . 71.34 108.015 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.71 63.33 2.28 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.733 0.646 . . . . 65.35 110.959 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 38.4 mt -78.46 149.47 33.22 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.775 -0.648 . . . . 64.32 111.937 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -150.81 131.66 14.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.772 -1.936 . . . . 74.23 105.772 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 2.6 pp -80.33 140.57 16.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.366 -1.333 . . . . 74.25 112.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.088 -0.96 . . . . 74.33 109.214 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 109.576 -0.527 . . . . 72.31 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.8 p -115.87 142.56 46.61 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.65 -0.705 . . . . 64.31 110.983 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.35 78.09 0.2 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.035 0.921 . . . . 65.21 111.334 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.45 147.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 114.154 -1.384 . . . . 73.42 109.965 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 73.8 t -92.19 134.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 115.223 -0.899 . . . . 64.21 108.643 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.41 172.73 38.57 Favored Glycine 1 N--CA 1.392 -4.265 0 C-N-CA 120.27 -0.967 . . . . 72.34 112.154 171.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 27.5 ttpp -130.48 132.67 45.77 Favored 'General case' 0 C--N 1.257 -3.42 0 C-N-CA 125.204 1.402 . . . . 75.01 108.412 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.8 115.85 2.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.933 -0.576 . . . . 75.12 110.162 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HD2' ' CB ' ' A' ' 20' ' ' PHE . 66.7 mttm -66.94 -49.43 65.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.413 -0.958 . . . . 73.3 108.413 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -173.78 165.43 4.42 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.246 -1.343 . . . . 74.23 108.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -153.79 121.25 5.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.4 0.438 . . . . 74.43 110.368 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -96.36 98.81 10.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.088 0.471 . . . . 71.04 109.946 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 m -58.93 -35.08 72.51 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.113 -0.949 . . . . 62.31 111.427 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 m -65.32 -31.12 72.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.236 0.541 . . . . 74.21 110.525 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -97.98 -9.01 26.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.1 -0.375 . . . . 73.34 111.997 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.82 23.36 11.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.973 0.509 . . . . 72.2 112.346 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 37.4 p90 -151.06 161.12 43.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.445 0.64 . . . . 72.41 112.539 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.95 -162.27 18.18 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.156 -1.578 . . . . 75.1 109.156 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.486 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . 46.9 m-85 -135.71 154.84 51.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.938 0.869 . . . . 75.21 111.711 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.72 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.224 -0.658 . . . . 74.11 109.224 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 14.0 pt-20 -143.54 147.65 34.78 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 105.755 -1.942 . . . . 65.31 105.755 173.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.0 pt20 -80.73 151.3 28.93 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 116.786 -1.966 . . . . 72.52 109.44 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.74 -29.02 24.76 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.251 -1.34 . . . . 71.34 111.913 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -75.71 1.08 15.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.775 -0.648 . . . . 73.12 111.851 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.41 50.87 1.79 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.54 -0.838 . . . . 74.42 111.207 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.81 172.2 54.96 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.639 -0.791 . . . . 64.12 112.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.33 162.96 28.59 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.771 0.656 . . . . 75.41 112.771 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.14 97.67 10.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.398 -0.819 . . . . 72.34 110.604 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 55' ' ' LEU . 3.2 p -117.81 134.87 60.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.118 -0.947 . . . . 74.51 109.062 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -90.6 150.15 21.83 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.032 -0.667 . . . . 74.12 111.221 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 67' ' ' LEU . 7.5 p -110.11 125.46 67.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.583 -0.525 . . . . 63.13 109.583 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -108.43 152.93 24.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.298 -1.001 . . . . 73.33 108.298 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.06 -16.04 39.23 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 113.073 0.768 . . . . 74.11 113.073 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -58.76 -26.42 63.99 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.228 0.537 . . . . 54.43 110.03 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.94 -36.44 56.56 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.983 0.42 . . . . 73.41 109.973 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.68 -48.85 84.76 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.091 0 N-CA-C 107.647 -1.242 . . . . 71.13 107.647 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.37 -28.23 58.55 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 124.816 1.246 . . . . 64.12 111.292 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.13 -23.32 67.1 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.458 0.54 . . . . 53.23 112.458 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.44 -24.15 2.29 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.712 0.634 . . . . 72.12 112.712 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.16 48.74 5.57 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.454 -1.059 . . . . 50.03 110.454 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 130.37 41.09 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.435 -1.32 . . . . 75.51 107.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.35 -47.78 75.26 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.128 1.158 . . . . 74.41 114.128 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.4 p -159.06 160.49 35.85 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.53 -0.468 . . . . 74.43 111.064 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.11 142.78 48.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.249 -1.019 . . . . 73.44 108.249 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.86 162.77 40.51 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 123.73 0.812 . . . . 71.54 109.319 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -67.49 153.33 43.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.445 0.641 . . . . 65.24 112.466 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -16.08 59.27 Favored Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.881 -1.054 . . . . 72.35 112.198 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -83.84 124.93 31.46 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.244 0.218 . . . . 72.21 111.122 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 15.4 m-20 -78.33 133.57 37.59 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 107.185 -1.413 . . . . 64.02 107.185 174.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.74 147.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.138 0 CA-C-O 121.913 0.863 . . . . 72.51 110.51 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -109.98 132.28 58.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 N-CA-C 107.002 -1.481 . . . . 73.55 107.002 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -147.62 178.67 8.27 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.764 -0.458 . . . . 72.1 109.764 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -119.67 155.27 32.7 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.671 -1.974 . . . . 74.02 105.671 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 30' ' ' VAL . 26.3 tp -124.4 111.26 15.55 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.452 1.12 . . . . 75.23 112.649 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.74 141.51 45.26 Favored 'General case' 0 C--N 1.268 -2.953 0 CA-C-N 113.062 -1.881 . . . . 62.14 107.425 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 59' ' ' GLN . 33.0 tt0 -87.06 142.14 28.14 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.276 -0.638 . . . . 74.45 109.276 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -90.41 22.31 3.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.298 -1.371 . . . . 73.15 107.298 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 57' ' ' GLU . 29.4 tt0 65.09 87.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 75.14 108.333 -172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.21 -58.41 0.6 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.692 -1.14 . . . . 74.45 111.24 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.1 mmmt -86.19 154.12 21.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.177 -0.305 . . . . 63.13 110.177 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.69 118.11 27.33 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.215 0.206 . . . . 70.44 110.574 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -131.89 140.41 49.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.367 0.603 . . . . 73.21 111.509 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.97 135.14 46.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.675 -1.148 . . . . 64.24 109.527 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 34.8 m -133.96 164.71 33.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.364 -0.835 . . . . 64.15 109.959 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.53 64.23 1.74 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.962 0.789 . . . . 55.35 111.593 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 32' ' ' VAL . 28.9 mt -74.67 140.14 44.02 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.671 0.989 . . . . 75.53 113.671 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -143.51 131.35 21.5 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.36 -1.718 . . . . 75.4 106.36 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.9 148.72 4.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.346 -0.942 . . . . 73.34 111.536 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 3.7 ttpm? . . . . . 0 C--O 1.256 1.412 0 CA-C-O 118.758 -0.639 . . . . 73.23 109.498 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.248 0 N-CA-C 107.144 -1.428 . . . . 73.31 107.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.5 p -100.43 140.29 34.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 123.357 0.411 . . . . 74.41 111.812 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 56.5 77.79 0.24 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.774 1.23 . . . . 60.03 110.701 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.3 mt -100.42 148.4 6.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 114.627 -1.17 . . . . 72.32 109.564 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 87.8 t -92.81 132.84 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-N 115.369 -0.832 . . . . 74.13 109.522 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -161.99 163.93 35.08 Favored Glycine 1 N--CA 1.395 -4.087 0 CA-C-N 115.272 -0.877 . . . . 75.41 111.576 171.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -119.28 136.42 54.24 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.898 -1.149 . . . . 74.02 107.898 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.83 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.329 0.585 . . . . 75.45 109.572 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 49.1 tttp -70.18 -47.26 62.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.826 -1.079 . . . . 61.24 108.109 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 68.9 p-90 -173.66 165.75 4.52 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.16 0.984 . . . . 63.15 108.641 175.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.02 132.78 4.31 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.376 0.422 . . . . 74.45 110.596 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -125.39 107.81 11.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.463 -0.569 . . . . 73.33 109.463 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 m -57.55 -33.86 68.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.85 -0.614 . . . . 71.41 110.902 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.9 m -61.44 -33.17 73.28 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 115.951 -0.568 . . . . 73.21 111.219 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -97.62 -8.72 28.27 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 122.021 -0.424 . . . . 72.42 111.049 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 m120 61.26 21.48 11.97 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.784 0.834 . . . . 71.13 110.622 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -137.5 163.62 30.68 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.387 0.675 . . . . 73.3 110.894 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -175.02 -172.55 40.06 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 107.836 -2.106 . . . . 63.34 107.836 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 21.3 m-85 -136.05 162.93 31.52 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 117.749 0.775 . . . . 75.23 111.794 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.5 134.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.669 -1.151 . . . . 75.22 107.924 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.3 pt-20 -135.98 141.79 44.46 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.01 -2.219 . . . . 75.5 105.01 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.8 pt20 -78.53 143.29 36.7 Favored 'General case' 0 CA--C 1.464 -2.353 0 C-N-CA 116.135 -2.226 . . . . 71.53 108.922 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.63 -18.01 4.02 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.793 1.308 . . . . 61.55 112.07 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.36 -0.32 28.53 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.603 -0.726 . . . . 73.43 111.428 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.4 41.91 35.78 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 110.995 -0.842 . . . . 75.34 110.995 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 -132.35 4.26 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.933 -0.651 . . . . 63.44 113.371 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -86.64 152.49 22.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.149 0.426 . . . . 73.33 112.149 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.2 130.25 47.26 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 116.073 -0.512 . . . . 75.25 110.126 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 55' ' ' LEU . 2.7 p -138.66 143.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.823 -0.806 . . . . 74.35 108.823 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 51.5 p90 -93.53 148.99 21.58 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.696 -0.802 . . . . 74.43 111.603 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.498 ' CG2' HD12 ' A' ' 67' ' ' LEU . 7.1 p -105.74 128.85 59.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 CA-C-N 115.75 -0.659 . . . . 73.33 109.316 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -110.02 150.34 28.68 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.015 -0.735 . . . . 74.42 109.015 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.7 -18.82 64.39 Favored 'General case' 0 C--O 1.203 -1.395 0 N-CA-C 113.671 0.989 . . . . 71.4 113.671 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -57.22 -27.5 62.06 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.942 0.401 . . . . 74.52 110.314 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.73 59.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 120.986 0.422 . . . . 75.13 110.38 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.84 -37.77 77.83 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.286 0 N-CA-C 108.292 -1.003 . . . . 73.41 108.292 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.88 -32.58 73.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.053 0.541 . . . . 74.41 110.722 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.96 66.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.35 112.72 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -23.3 2.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.21 0.819 . . . . 61.11 113.21 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 53.93 3.57 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 109.954 -1.258 . . . . 74.12 109.954 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -75.58 127.0 32.11 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.89 -0.655 . . . . 75.41 111.396 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -104.61 -0.4 27.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.816 -0.629 . . . . 72.3 111.391 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 m -123.32 79.3 1.66 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.151 1.167 . . . . 62.33 114.151 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.16 114.1 19.2 Favored 'General case' 0 C--N 1.251 -3.683 0 N-CA-C 108.108 -1.071 . . . . 74.21 108.108 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -151.79 158.19 42.97 Favored 'General case' 1 C--N 1.243 -4.035 0 CA-C-N 113.94 -1.482 . . . . 70.55 107.239 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.12 148.83 49.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.695 0.759 . . . . 74.51 112.344 -174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.29 -18.61 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 CA-C-N 114.82 -1.082 . . . . 63.24 113.993 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -71.03 135.05 47.59 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 117.546 0.673 . . . . 63.41 111.644 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.07 135.11 34.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.426 -1.324 . . . . 75.44 107.426 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.56 145.28 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-O 121.981 0.896 . . . . 72.43 110.989 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.99 130.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.483 -1.673 . . . . 74.31 106.483 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.477 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.3 p90 -146.62 179.62 7.43 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.153 -0.619 . . . . 73.41 110.995 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -120.36 158.29 27.45 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 105.532 -2.025 . . . . 64.44 105.532 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 30' ' ' VAL . 26.1 tp -129.69 129.54 44.36 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.099 1.148 . . . . 74.1 114.099 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD11 ' A' ' 55' ' ' LEU . 5.2 mm-40 -125.63 139.46 53.55 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 113.088 -1.869 . . . . 64.1 109.567 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.94 142.79 32.68 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.825 -1.08 . . . . 75.31 111.688 -174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -90.76 31.92 1.02 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.271 -1.011 . . . . 75.32 108.271 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 62.34 22.72 13.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.197 -0.911 . . . . 70.01 111.715 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.08 -49.08 0.13 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 109.526 -1.43 . . . . 75.31 109.526 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -93.01 164.71 13.17 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.338 -0.431 . . . . 73.22 110.787 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -132.76 119.08 19.84 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.406 -0.59 . . . . 61.4 109.406 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.481 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 44.0 p90 -124.59 133.28 53.32 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.519 0.676 . . . . 71.4 112.423 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.19 134.05 42.75 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.631 -1.168 . . . . 75.23 110.534 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.77 169.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.937 -1.028 . . . . 71.34 109.517 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 53.77 63.06 2.33 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 123.246 0.619 . . . . 53.31 111.384 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.498 HD12 ' CG2' ' A' ' 32' ' ' VAL . 21.9 mt -82.36 135.77 35.12 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.617 0.723 . . . . 72.03 112.869 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -145.95 130.13 17.52 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 114.059 -1.428 . . . . 71.03 107.997 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -80.69 148.79 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 C-N-CA 121.057 -0.257 . . . . 73.5 110.717 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 124.387 1.054 . . . . 75.44 109.152 176.201 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.981 0 N-CA-C 109.094 -0.706 . . . . 73.22 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 p -131.54 153.18 50.11 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.246 0.461 . . . . 71.23 112.246 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 62.68 40.52 10.11 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.022 0.929 . . . . 72.45 111.633 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 mt -75.25 152.94 6.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.772 -0.649 . . . . 75.44 111.229 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 85.9 t -106.83 136.75 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 115.3 -0.863 . . . . 75.32 109.053 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.3 168.73 41.02 Favored Glycine 0 N--CA 1.404 -3.456 0 C-N-CA 119.128 -1.511 . . . . 72.43 113.77 167.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -113.72 136.24 53.07 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 114.411 -0.894 . . . . 72.22 108.969 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.57 107.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.965 -0.754 . . . . 71.51 108.965 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -63.81 -52.99 57.72 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.699 -1.137 . . . . 75.34 109.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 64.4 p-90 -160.64 160.01 31.08 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 108.859 -0.793 . . . . 72.41 108.859 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -157.61 125.31 5.3 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 124.053 0.845 . . . . 73.1 109.272 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.08 115.99 31.06 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 70.2 107.293 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 t -73.0 -25.96 61.17 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.698 0.285 . . . . 74.0 111.261 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 m -68.55 -55.21 12.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.116 0.484 . . . . 71.34 110.356 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.49 -8.49 52.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.498 . . . . 75.42 111.709 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.17 26.17 13.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.194 0.813 . . . . 72.01 113.194 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.83 157.98 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.869 -0.419 . . . . 75.33 109.869 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.96 -174.14 45.56 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.135 -0.786 . . . . 54.01 111.135 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -134.35 159.86 39.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.117 0.567 . . . . 71.15 111.132 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -143.08 135.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 123.737 0.648 . . . . 75.42 109.372 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.84 153.27 42.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.133 -1.432 . . . . 65.54 107.133 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.3 pt20 -84.84 154.69 22.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.382 -1.327 . . . . 73.23 109.386 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.55 -22.41 61.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.159 0.912 . . . . 72.22 113.116 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -77.82 -2.96 39.08 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.763 -0.375 . . . . 72.24 111.771 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.46 51.19 1.23 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 110.256 -1.138 . . . . 61.2 110.256 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -77.14 164.41 52.73 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.365 -0.921 . . . . 71.33 112.128 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.71 155.76 40.03 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 123.806 0.357 . . . . 74.33 111.816 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.09 120.93 25.93 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.83 0.824 . . . . 75.21 111.567 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.471 HG22 HD13 ' A' ' 55' ' ' LEU . 2.7 p -135.9 135.2 50.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.489 -1.232 . . . . 75.34 107.915 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.6 p90 -90.12 150.36 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.43 -0.908 . . . . 70.3 110.84 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.415 ' CG2' HD12 ' A' ' 67' ' ' LEU . 7.3 p -95.29 126.47 47.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-O 121.456 0.646 . . . . 61.21 109.606 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -113.33 148.0 36.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.731 -0.84 . . . . 71.45 108.731 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.72 -21.99 66.88 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.664 0.987 . . . . 72.02 113.664 -173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -54.19 -22.16 10.74 Favored 'General case' 0 C--O 1.208 -1.09 0 C-N-CA 120.627 -0.429 . . . . 37.27 111.315 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -74.21 -42.51 59.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.069 0.461 . . . . 74.02 110.853 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 57.3 t -70.45 -30.31 42.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.51 0 N-CA-C 108.215 -1.031 . . . . 75.02 108.215 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.63 -36.12 65.39 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.036 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.98 24.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.422 0.527 . . . . 73.23 112.422 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.07 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.43 0.53 . . . . 73.25 112.43 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 77.75 62.96 2.28 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 121.454 -0.403 . . . . 72.34 112.224 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.83 130.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.817 -1.549 . . . . 72.14 106.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.45 -49.27 78.24 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.525 0.565 . . . . 74.15 112.525 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -175.09 137.99 0.43 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.097 0.559 . . . . 72.21 110.918 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.82 164.31 12.69 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.195 0.521 . . . . 74.31 110.62 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -169.49 162.83 10.26 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.257 -1.757 . . . . 63.13 106.257 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.5 OUTLIER -75.17 152.84 38.4 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.207 0.527 . . . . 54.13 111.928 -177.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.25 69.81 Favored Glycine 0 C--N 1.306 -1.119 0 CA-C-N 115.386 -0.824 . . . . 72.21 112.478 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -77.42 136.26 38.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 122.503 0.321 . . . . 73.01 111.581 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.56 134.19 33.67 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.227 -1.397 . . . . 72.31 107.227 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.21 147.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-O 121.869 0.842 . . . . 72.23 110.773 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.03 129.34 71.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 106.41 -1.7 . . . . 73.31 106.41 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.5 p90 -147.52 -177.53 5.75 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 120.043 -0.663 . . . . 74.13 110.873 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -124.0 161.81 24.72 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 105.501 -2.037 . . . . 72.4 105.501 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.471 HD13 HG22 ' A' ' 30' ' ' VAL . 23.2 tp -130.18 129.83 43.93 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-O 121.899 0.857 . . . . 71.41 112.946 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.1 137.81 54.83 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.629 -1.623 . . . . 70.02 107.432 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.79 155.77 18.1 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.118 0.961 . . . . 73.0 110.308 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.0 tttp -116.88 24.66 11.07 Favored 'General case' 0 C--N 1.252 -3.643 0 N-CA-C 107.094 -1.447 . . . . 73.51 107.094 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 70.68 -59.99 0.51 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.5 1.52 . . . . 75.33 111.809 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.52 -23.34 36.96 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.098 -0.801 . . . . 62.2 111.098 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.1 mmtt -123.03 164.98 17.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.585 0.231 . . . . 64.23 111.11 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.34 116.42 11.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.192 -1.04 . . . . 71.52 108.192 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p90 -130.39 137.48 49.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.452 0.644 . . . . 73.35 112.442 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 137.52 51.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.666 -1.152 . . . . 51.11 110.181 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 29.0 m -135.42 161.6 38.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 75.04 109.986 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 56.27 63.88 1.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.03 0.831 . . . . 75.03 109.83 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 32.6 mt -79.24 137.43 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.968 0.729 . . . . 75.23 112.968 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.98 135.02 39.19 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-N 114.729 -1.123 . . . . 74.14 109.119 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -72.41 134.19 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 109.408 -0.589 . . . . 74.44 109.408 173.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.307 -1.265 0 O-C-N 123.849 0.718 . . . . 75.21 110.117 179.641 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 108.782 -0.822 . . . . 62.53 108.782 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.2 p -107.68 145.6 33.18 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.624 -0.262 . . . . 74.12 111.079 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 58.37 78.39 0.25 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.46 1.104 . . . . 61.3 109.78 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 50.7 mt -108.33 149.53 11.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.314 -1.312 . . . . 71.35 110.245 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 88.5 t -93.26 132.98 35.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.269 -0.878 . . . . 73.31 109.79 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.488 ' HA2' ' CA ' ' A' ' 23' ' ' GLN . . . -158.58 164.89 33.77 Favored Glycine 0 N--CA 1.405 -3.404 0 C-N-CA 120.522 -0.846 . . . . 74.21 111.944 171.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.05 134.31 53.68 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 107.234 -1.395 . . . . 72.34 107.234 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.45 110.41 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.725 -1.213 . . . . 75.02 107.725 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.3 tttp -75.2 -49.88 17.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.286 -1.325 . . . . 75.42 109.36 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -167.72 160.91 13.04 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.618 -0.882 . . . . 73.51 108.618 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -161.39 116.59 2.07 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.738 0.649 . . . . 75.22 110.18 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -92.08 105.76 17.92 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.03 -1.1 . . . . 63.42 108.03 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -53.95 -45.48 71.31 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 124.259 1.024 . . . . 71.5 111.8 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -58.1 -37.44 74.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.131 0.572 . . . . 74.52 111.635 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -99.22 -5.72 29.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.769 -0.372 . . . . 75.34 111.958 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.68 27.33 17.06 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.475 0.484 . . . . 73.43 111.897 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -134.83 152.13 51.5 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.598 -0.519 . . . . 74.3 109.598 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.89 -165.95 33.14 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.826 -0.909 . . . . 70.32 110.826 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 34.8 m-85 -137.26 165.01 27.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.209 0.528 . . . . 73.44 112.023 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -147.28 135.77 15.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.949 -1.13 . . . . 65.45 107.949 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.09 147.34 33.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.02 -2.215 . . . . 72.14 105.02 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.0 pt20 -77.35 144.15 38.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 C-N-CA 116.216 -2.194 . . . . 74.52 109.444 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.02 -29.1 27.5 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.971 1.419 . . . . 73.01 112.471 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.08 -11.77 61.13 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 62.25 111.847 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.89 50.85 0.76 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.42 -0.895 . . . . 72.33 111.199 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.59 171.2 36.07 Favored Glycine 0 C--N 1.318 -0.447 0 N-CA-C 110.602 -0.999 . . . . 75.03 110.602 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.81 147.82 33.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.353 0.577 . . . . 74.22 111.327 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 122.81 18.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.941 -1.027 . . . . 63.02 110.695 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 139.96 49.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -92.64 142.95 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 119.413 -0.915 . . . . 75.14 112.62 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 67' ' ' LEU . 10.8 p -112.83 142.02 26.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.303 -0.862 . . . . 73.35 109.023 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -136.64 162.5 32.97 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.017 -1.105 . . . . 74.15 108.017 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.11 -18.68 59.28 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 112.281 0.474 . . . . 75.51 112.281 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -52.89 -30.2 32.69 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.084 0.469 . . . . 73.15 110.302 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.95 -35.08 57.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.355 -0.384 . . . . 74.12 110.42 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -41.45 89.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.316 0 N-CA-C 107.786 -1.19 . . . . 75.03 107.786 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.07 -36.86 82.93 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.93 -0.577 . . . . 62.24 110.219 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.54 75.66 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.557 0.947 . . . . 74.52 113.557 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.23 -10.79 4.18 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.626 0.973 . . . . 61.43 113.626 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 55.0 5.61 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.21 -0.756 . . . . 45.01 111.21 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' N ' ' A' ' 43' ' ' HIS . 2.4 tm? -71.6 149.82 45.26 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.929 -1.508 . . . . 74.11 106.929 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.56 ' N ' HD11 ' A' ' 42' ' ' LEU . 60.7 m80 -83.04 -60.98 1.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.536 -0.727 . . . . 73.21 111.912 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.5 p -165.87 145.01 6.14 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 122.914 0.485 . . . . 75.42 109.919 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.8 mt -109.9 146.65 34.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.541 0.686 . . . . 74.43 111.669 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.49 153.04 41.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.607 -1.627 . . . . 63.14 106.607 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 155.3 38.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.905 0.383 . . . . 75.1 111.182 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 4.84 79.22 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 121.113 -0.565 . . . . 52.4 112.574 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.43 135.96 34.17 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 122.659 0.384 . . . . 74.11 110.352 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -86.0 120.14 27.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.25 -1.389 . . . . 74.04 107.25 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.37 152.7 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 CA-C-O 121.655 0.741 . . . . 75.44 111.044 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.5 mt -114.47 136.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.028 -1.471 . . . . 75.1 107.028 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -151.19 177.55 10.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.136 -0.32 . . . . 72.41 110.136 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.4 147.7 40.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.54 -1.652 . . . . 72.3 106.54 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 27.3 tp -134.41 133.4 40.49 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.249 1.023 . . . . 73.01 112.056 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -135.71 137.11 41.41 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 113.287 -1.779 . . . . 64.0 107.033 173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.94 138.81 32.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.69 0.757 . . . . 75.12 112.102 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.4 tttm -99.21 72.55 1.86 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 75.34 107.214 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.82 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.548 1.539 . . . . 71.41 109.339 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 -18.4 5.01 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.449 -0.405 . . . . 53.33 112.183 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 8.3 mmpt? -89.19 164.69 14.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.397 -0.594 . . . . 72.01 109.397 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.78 118.54 16.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.803 -0.443 . . . . 63.14 109.803 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -121.93 134.21 54.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.434 0.635 . . . . 73.14 111.976 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.41 131.85 35.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.817 -1.083 . . . . 52.24 109.559 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.0 m -139.64 168.31 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.484 -0.78 . . . . 74.25 110.036 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.73 63.21 1.87 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.956 0.785 . . . . 72.41 109.944 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 34.3 mt -81.41 143.33 32.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.342 -0.844 . . . . 75.3 111.912 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -145.68 129.87 17.57 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.807 -1.923 . . . . 64.41 105.807 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.574 HD12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.68 141.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 118.057 0.389 . . . . 73.2 111.764 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt . . . . . 0 C--N 1.298 -1.652 0 CA-C-N 115.274 -0.875 . . . . 65.22 109.723 176.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.123 -0.325 . . . . 71.23 110.123 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.1 p -120.99 146.12 47.02 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.384 0.513 . . . . 71.43 112.384 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 59.16 78.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.804 1.242 . . . . 64.44 112.266 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 33.4 mt -106.88 147.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.217 -0.901 . . . . 75.01 110.555 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 69.6 t -107.78 135.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.422 -0.808 . . . . 75.4 110.219 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.61 160.93 27.12 Favored Glycine 0 N--CA 1.408 -3.2 0 CA-C-N 115.246 -0.888 . . . . 74.2 112.95 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.2 ttmt -98.88 135.56 40.14 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.782 -0.709 . . . . 73.35 109.483 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.23 109.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.306 -0.998 . . . . 74.23 108.306 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.2 tttp -72.42 -42.22 65.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.371 -1.286 . . . . 74.35 108.954 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -174.79 160.53 2.95 Favored 'General case' 0 CA--C 1.486 -1.518 0 C-N-CA 123.949 0.9 . . . . 72.03 108.821 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -161.72 126.87 3.5 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.978 0.799 . . . . 73.21 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -99.05 118.4 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.711 -1.218 . . . . 73.21 107.711 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -70.04 -23.91 63.18 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.26 0.467 . . . . 62.3 112.26 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 m -86.46 -46.29 10.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.087 0.47 . . . . 75.51 111.216 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.43 -8.68 58.89 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.738 -0.385 . . . . 73.53 111.942 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 60.63 31.36 20.18 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 112.374 0.509 . . . . 70.04 112.374 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.83 153.08 43.09 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.272 -0.422 . . . . 73.55 109.872 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.62 -169.59 39.54 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.68 -0.968 . . . . 62.05 110.68 175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.425 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 53.1 m-85 -140.06 166.62 24.18 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.337 0.655 . . . . 73.34 110.588 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -145.17 133.67 17.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.061 -0.718 . . . . 74.45 109.061 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.44 143.01 31.43 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.488 -1.301 . . . . 72.41 107.488 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.6 pt20 -83.27 156.16 23.25 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 118.035 -1.466 . . . . 63.41 109.26 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.31 -25.06 21.7 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 124.628 1.205 . . . . 72.44 113.554 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -78.41 -0.39 28.98 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 122.256 -0.277 . . . . 71.52 111.591 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 51.48 3.03 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 109.896 -1.282 . . . . 74.51 109.896 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -66.43 -104.77 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 116.651 1.42 . . . . 51.24 116.651 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.69 176.48 7.49 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.301 0.572 . . . . 75.11 111.525 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -116.46 83.32 1.94 Allowed 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 107.816 -1.179 . . . . 62.23 107.816 172.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 HG22 HD13 ' A' ' 55' ' ' LEU . 4.2 p -119.46 129.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 CA-C-N 115.382 -0.827 . . . . 75.21 109.638 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 39.6 p90 -86.23 139.07 31.38 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.289 0.566 . . . . 75.32 111.681 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 67' ' ' LEU . 7.2 p -103.39 119.8 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.289 -0.869 . . . . 74.51 109.81 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -110.24 161.75 15.29 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.952 -1.129 . . . . 65.13 107.952 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.72 -22.31 63.85 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.83 0.678 . . . . 72.53 112.83 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -53.74 -24.58 15.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.178 0.513 . . . . 38.57 111.41 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 64' ' ' ALA . . . -75.33 -39.07 59.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.979 0.418 . . . . 63.1 110.597 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.89 -44.73 88.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 N-CA-C 108.089 -1.078 . . . . 72.41 108.089 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.35 -26.22 67.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.351 0.407 . . . . 70.32 110.634 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.74 66.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.707 0.632 . . . . 71.31 112.707 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.86 -0.59 4.23 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.161 0.8 . . . . 74.12 113.161 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.87 39.57 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 123.251 0.453 . . . . 71.35 112.463 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.43 142.72 51.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.306 -1.739 . . . . 63.41 106.306 178.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.423 ' N ' HD11 ' A' ' 42' ' ' LEU . 40.2 t60 -71.15 -61.51 1.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.637 -0.825 . . . . 75.43 111.829 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -164.37 157.15 17.18 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.077 -0.712 . . . . 63.0 109.077 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.03 153.93 42.72 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.682 0.754 . . . . 44.44 112.425 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.92 172.32 13.86 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.171 -1.377 . . . . 72.2 107.693 173.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.33 156.1 39.9 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.697 0.761 . . . . 75.11 112.607 -177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 -18.5 57.35 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.133 -0.939 . . . . 43.5 112.005 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -82.35 139.38 34.14 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 122.687 0.395 . . . . 64.4 111.657 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 11.1 m-20 -89.12 134.49 33.99 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.274 -1.009 . . . . 73.54 108.274 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.04 152.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.816 0.817 . . . . 75.31 111.142 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.6 mt -116.69 128.92 73.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.631 -1.618 . . . . 75.41 106.631 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.446 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.5 p90 -145.95 -180.0 7.09 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.75 -0.38 . . . . 74.24 110.299 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -119.98 157.23 29.27 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 105.379 -2.082 . . . . 64.24 105.379 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 62' ' ' ALA . 16.2 tp -123.93 128.51 49.54 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 121.581 0.705 . . . . 74.14 111.329 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' HD11 ' A' ' 55' ' ' LEU . 7.7 tp10 -122.85 142.47 50.74 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.43 -1.693 . . . . 74.03 106.43 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.05 143.83 26.01 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.586 -0.846 . . . . 73.44 112.551 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -103.7 35.48 2.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.288 -1.375 . . . . 73.41 107.288 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 63.52 88.81 0.09 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.634 -1.167 . . . . 75.14 109.324 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.82 -47.87 3.62 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.585 -0.817 . . . . 53.53 111.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 73.5 mmtt -83.73 153.11 24.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.519 -0.549 . . . . 74.33 109.519 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.425 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -123.82 122.37 37.85 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.829 -0.168 . . . . 73.11 111.183 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.507 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 23.1 p90 -126.49 133.22 51.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.459 0.647 . . . . 73.41 111.777 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -74.39 140.38 44.71 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.736 -1.12 . . . . 72.21 109.709 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -139.5 164.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.469 -0.787 . . . . 71.51 109.314 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.72 63.91 1.56 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.075 0.859 . . . . 70.33 111.147 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 36' ' ' ALA . 24.9 mt -78.98 138.07 37.88 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.611 -1.236 . . . . 75.25 112.929 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -141.92 131.67 24.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.187 -2.153 . . . . 74.23 105.187 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.254 2.3 pp -77.92 146.92 7.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 118.79 -1.164 . . . . 74.13 112.006 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.9 tttt . . . . . 0 C--O 1.262 1.74 0 CA-C-N 115.687 -0.688 . . . . 74.05 109.559 178.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . . . . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 107.713 -1.217 . . . . 70.43 107.713 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.503 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 27.7 p -101.0 142.94 31.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.52 0.933 . . . . 64.31 113.52 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 62.75 77.84 0.31 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 124.595 1.158 . . . . 62.5 111.785 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.5 mt -110.02 145.71 16.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.34 -0.845 . . . . 74.13 111.127 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 57.2 t -99.57 137.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.257 -0.883 . . . . 73.41 110.641 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 23' ' ' GLN . . . -172.45 177.99 44.79 Favored Glycine 0 N--CA 1.4 -3.71 0 CA-C-N 115.007 -0.997 . . . . 44.14 112.349 167.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -121.98 141.28 51.49 Favored 'General case' 0 C--N 1.256 -3.467 0 C-N-CA 123.813 0.845 . . . . 72.41 108.978 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.75 111.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 109.045 -0.724 . . . . 74.22 109.045 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 53.4 tttm -72.41 -48.12 43.88 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.393 -1.336 . . . . 73.44 107.393 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.478 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 67.4 p-90 -176.43 160.96 2.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.83 1.252 . . . . 73.21 108.494 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 81.0 t80 -151.35 126.08 9.63 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.943 -0.391 . . . . 73.43 109.943 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.79 101.74 11.56 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.478 -0.934 . . . . 74.12 108.478 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.4 m -63.85 -21.41 66.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.98 -0.554 . . . . 64.43 111.19 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.7 p -65.81 -37.54 86.54 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 123.33 0.652 . . . . 74.41 111.396 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.14 -6.13 22.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.936 -0.574 . . . . 72.25 111.862 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 69.43 22.38 6.48 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.533 0.733 . . . . 75.24 112.226 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -147.59 165.08 31.48 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.169 0.509 . . . . 62.34 111.748 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -167.95 -157.3 10.89 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.999 -1.241 . . . . 71.22 109.999 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.478 ' HD1' ' CZ2' ' A' ' 11' ' ' TRP . 46.4 m-85 -137.72 165.75 25.64 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 117.417 0.608 . . . . 75.31 112.168 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -143.92 139.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.09 -1.078 . . . . 72.32 108.09 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 12.4 pt-20 -142.84 144.54 32.55 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.519 -1.66 . . . . 73.14 106.519 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.4 pt20 -86.94 150.33 24.15 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 117.512 -1.675 . . . . 64.02 108.221 174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.59 -14.31 12.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 124.241 0.963 . . . . 75.34 112.597 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -88.64 5.39 43.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.539 -0.301 . . . . 74.05 111.183 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.7 50.97 2.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.691 -1.242 . . . . 63.22 112.259 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.4 55.15 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.359 -0.924 . . . . 72.42 111.399 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.55 162.99 27.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.449 0.537 . . . . 71.24 112.449 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.95 95.55 5.49 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.91 -0.586 . . . . 70.12 110.722 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' HD13 ' A' ' 55' ' ' LEU . 3.9 p -112.7 130.05 67.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.496 -0.775 . . . . 72.24 109.096 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.7 p90 -90.07 136.62 32.94 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.779 -0.768 . . . . 74.23 110.574 -178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.44 127.14 51.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.753 -0.832 . . . . 74.44 108.753 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -115.96 156.44 26.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.316 -0.624 . . . . 72.31 109.316 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.58 -18.65 12.59 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.631 0.974 . . . . 75.21 113.631 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -61.07 -22.94 65.09 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.22 0.533 . . . . 63.24 110.649 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -77.52 -33.42 54.29 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.433 -0.58 . . . . 62.04 109.433 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.04 -42.64 88.77 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 N-CA-C 107.704 -1.221 . . . . 71.25 107.704 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -53.75 -35.34 61.14 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.915 0.886 . . . . 64.45 110.866 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 -18.51 59.73 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.821 1.045 . . . . 74.12 113.821 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.59 -20.16 2.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.089 . . . . 74.3 113.939 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.12 38.01 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-O 121.689 0.605 . . . . 74.12 111.615 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.446 HD21 ' HG ' ' A' ' 45' ' ' LEU . 26.1 tp -64.72 141.31 58.82 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.681 -0.759 . . . . 74.24 110.292 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.22 -57.35 13.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.303 -0.628 . . . . 73.51 109.303 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -175.69 174.96 2.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.173 -1.418 . . . . 74.14 107.173 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.0 mp -111.95 145.19 40.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.094 0.473 . . . . 75.1 110.703 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.81 146.31 45.52 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.224 -0.898 . . . . 71.55 109.012 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.81 154.57 40.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.13 0.491 . . . . 51.34 111.387 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 -26.24 19.25 Favored Glycine 0 C--N 1.303 -1.259 0 C-N-CA 120.687 -0.768 . . . . 62.23 112.188 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 132.22 45.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 123.359 0.664 . . . . 74.22 111.647 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.67 132.91 35.31 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 108.125 -1.065 . . . . 74.32 108.125 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.84 147.27 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.915 0 CA-C-O 121.888 0.851 . . . . 74.1 110.457 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 68.9 mt -117.55 136.9 53.24 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 106.374 -1.713 . . . . 75.31 106.374 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 36.8 p90 -153.11 -178.53 7.0 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.836 -0.346 . . . . 74.01 110.476 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 37.1 m-20 -119.62 156.17 30.91 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.934 -1.876 . . . . 75.24 105.934 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 62' ' ' ALA . 13.6 tp -121.18 116.48 25.02 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-O 122.707 1.241 . . . . 72.33 114.332 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' N ' HD11 ' A' ' 55' ' ' LEU . 7.7 mm-40 -103.51 151.04 23.32 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.813 -1.994 . . . . 74.21 111.288 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -105.76 131.34 53.23 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 114.298 -1.319 . . . . 64.24 111.066 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 86.6 tttt -109.67 78.78 1.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.381 -0.827 . . . . 73.24 109.536 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 60.36 14.12 4.49 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.883 0.849 . . . . 74.54 111.64 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.03 -25.14 3.55 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.328 -0.709 . . . . 62.04 111.328 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.2 mmmt -83.87 164.92 19.16 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.601 -0.889 . . . . 74.14 108.601 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -122.51 119.81 32.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 119.835 -0.126 . . . . 71.02 111.121 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 40.4 p90 -125.22 133.75 52.6 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.549 0.69 . . . . 74.41 112.443 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 137.34 38.23 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.704 -1.135 . . . . 64.1 110.829 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 28.7 m -140.68 168.61 16.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.351 -0.84 . . . . 74.23 109.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.1 t30 54.32 63.43 2.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.079 0.862 . . . . 62.44 110.701 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 36' ' ' ALA . 23.6 mt -74.41 136.1 42.38 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.694 0.998 . . . . 74.43 113.694 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 41.6 mmt180 -122.59 131.17 53.7 Favored 'General case' 0 N--CA 1.405 -2.678 0 N-CA-C 106.177 -1.786 . . . . 64.01 106.177 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.38 131.24 56.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 114.354 1.242 . . . . 73.03 114.354 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.258 1.54 0 CA-C-N 115.209 -0.905 . . . . 72.53 109.345 173.646 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 107.64 -1.244 . . . . 75.31 107.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.5 p -127.18 161.83 27.58 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 60.79 39.85 16.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.0 110.874 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.3 mt -76.79 147.23 7.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.397 -0.819 . . . . 74.43 111.788 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 64.5 t -102.34 136.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.003 -0.999 . . . . 71.53 110.162 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -177.75 160.65 27.32 Favored Glycine 0 N--CA 1.413 -2.849 0 C-N-CA 120.685 -0.769 . . . . 64.42 113.503 168.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -97.63 143.75 27.99 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.661 -0.866 . . . . 64.03 108.661 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.06 107.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.226 -1.027 . . . . 72.31 108.226 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.45 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 65.9 tttp -67.87 -48.35 66.35 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.44 -1.255 . . . . 72.22 109.155 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -166.8 155.55 10.39 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.231 -1.026 . . . . 74.22 108.231 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -160.46 108.43 1.62 Allowed 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.724 0.64 . . . . 72.11 109.67 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -84.97 106.47 16.5 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.735 -1.58 . . . . 63.23 106.735 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 p -62.62 -26.02 68.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.267 0.84 . . . . 63.42 113.267 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -71.49 -32.22 67.99 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.09 0.471 . . . . 72.23 110.081 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.04 -9.8 30.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.004 -0.369 . . . . 70.0 110.004 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 52.37 34.67 15.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.701 0.801 . . . . 75.5 110.074 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.69 156.11 46.99 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.596 -0.52 . . . . 75.44 109.596 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.02 -153.61 17.39 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.296 -0.722 . . . . 63.51 111.296 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.45 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.3 m-85 -137.14 169.18 18.22 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.519 0.728 . . . . 74.52 110.9 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -145.61 130.6 12.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 123.505 0.722 . . . . 74.31 109.147 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.34 146.84 32.8 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.52 -0.918 . . . . 74.41 108.52 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.6 pt20 -79.74 148.15 31.61 Favored 'General case' 0 CA--C 1.483 -1.625 0 C-N-CA 118.838 -1.145 . . . . 72.43 108.38 175.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -53.72 -25.32 17.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 124.528 1.143 . . . . 64.1 112.065 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -76.93 -3.94 41.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.191 -0.459 . . . . 61.34 112.138 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.14 50.76 0.76 Allowed Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.393 -1.384 . . . . 61.24 112.542 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.33 150.69 32.08 Favored Glycine 0 C--N 1.313 -0.733 0 C-N-CA 119.753 -1.213 . . . . 43.33 110.167 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.19 163.58 26.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 117.264 0.532 . . . . 74.11 112.262 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.97 105.1 1.54 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-N 115.845 -0.616 . . . . 75.2 111.299 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 55' ' ' LEU . 4.3 p -126.81 123.71 63.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 108.585 -0.894 . . . . 74.12 108.585 172.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 47.2 p90 -87.17 149.73 24.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.041 -0.527 . . . . 74.13 112.397 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.27 126.72 61.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.381 0.61 . . . . 73.41 109.57 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -111.78 156.93 21.17 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.036 -1.468 . . . . 72.43 107.036 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.29 -13.7 61.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.381 -0.928 . . . . 75.4 112.077 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -59.0 -22.54 60.75 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.239 0.542 . . . . 72.11 109.716 171.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -75.51 -38.79 59.18 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.519 -0.549 . . . . 75.02 109.519 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.66 -43.68 96.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.672 0 N-CA-C 107.891 -1.152 . . . . 75.15 107.891 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.15 -37.15 69.14 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.107 0.563 . . . . 64.15 111.623 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.83 -27.45 69.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.22 0.822 . . . . 64.13 113.22 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.55 -14.88 3.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.498 0.925 . . . . 51.24 113.498 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.29 47.74 16.56 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 109.731 -1.347 . . . . 74.2 109.731 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.28 128.95 38.01 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.865 0.866 . . . . 75.31 108.669 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -46.55 -61.55 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.77 0.656 . . . . 71.43 112.77 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 p -178.51 162.98 1.49 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.452 -0.944 . . . . 75.52 108.452 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.9 mt -123.04 149.48 44.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.306 -0.627 . . . . 73.3 109.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.57 149.35 26.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.145 -1.057 . . . . 74.1 108.145 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.0 126.45 27.58 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.472 -0.936 . . . . 72.3 108.472 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.52 -14.91 27.38 Favored Glycine 0 C--N 1.288 -2.094 0 CA-C-N 115.589 -0.732 . . . . 75.34 113.266 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.44 130.04 34.89 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.282 -0.54 . . . . 74.21 111.18 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.86 131.07 34.56 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 107.198 -1.408 . . . . 73.43 107.198 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.1 145.95 31.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-O 121.854 0.835 . . . . 72.21 110.642 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 70.3 mt -113.37 132.67 61.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 107.063 -1.458 . . . . 70.13 107.063 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 34.6 p90 -147.39 -177.01 5.46 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 121.0 0.429 . . . . 61.13 110.968 -175.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -123.78 149.34 45.76 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 105.68 -1.97 . . . . 73.45 105.68 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 30' ' ' VAL . 16.2 tp -114.34 119.91 38.57 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 122.088 0.947 . . . . 75.34 111.473 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -126.25 159.14 33.89 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 113.67 -1.604 . . . . 71.35 107.977 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.31 143.02 26.75 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.368 0.604 . . . . 74.53 111.987 -173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 84.7 tttt -100.86 81.52 2.28 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.245 -1.761 . . . . 63.12 106.245 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 66.82 -68.77 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.724 1.21 . . . . 75.04 110.238 -174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.73 -2.19 1.99 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.577 -0.609 . . . . 72.41 111.577 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.9 mmmt -97.01 165.24 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.15 -0.685 . . . . 72.54 109.15 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -116.35 116.43 27.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 110.14 -0.319 . . . . 63.54 110.14 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -129.99 140.74 50.84 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.493 0.663 . . . . 73.42 111.6 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -72.28 133.55 45.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.552 -1.203 . . . . 64.24 109.227 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 32.5 m -138.3 161.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.69 -0.686 . . . . 73.22 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 59.96 63.23 1.49 Allowed 'General case' 0 C--O 1.216 -0.658 0 O-C-N 124.392 1.057 . . . . 73.14 109.294 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 28.4 mt -80.37 143.61 33.38 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.893 -0.723 . . . . 73.34 112.8 -173.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.07 133.48 41.2 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.187 1.395 . . . . 71.32 107.948 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 69' ' ' ILE . 2.3 mp -82.14 140.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.889 -1.522 . . . . 75.25 106.889 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.258 1.536 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 174.545 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.46 0 N-CA-C 110.288 -0.264 . . . . 65.32 110.288 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.9 p -102.36 147.31 26.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.377 -0.374 . . . . 73.23 111.539 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 52.27 77.37 0.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.537 1.135 . . . . 75.43 113.059 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 46.6 mt -103.93 148.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.183 -0.917 . . . . 73.33 110.484 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.3 t -91.48 132.72 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 115.242 -0.89 . . . . 64.13 109.134 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.87 167.45 37.95 Favored Glycine 1 N--CA 1.394 -4.123 0 C-N-CA 120.317 -0.945 . . . . 70.44 111.781 171.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -123.04 135.74 54.55 Favored 'General case' 0 C--N 1.261 -3.267 0 N-CA-C 107.569 -1.271 . . . . 74.1 107.569 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.86 116.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.68 0.752 . . . . 74.12 109.16 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 65.4 tttp -75.85 -43.62 44.84 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.03 -1.441 . . . . 71.44 109.109 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -175.02 159.65 2.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 123.917 0.887 . . . . 73.41 109.182 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -163.44 126.85 2.73 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.878 0.736 . . . . 74.05 109.236 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -115.71 122.57 45.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.672 -0.862 . . . . 74.5 108.672 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 m -65.14 -19.15 65.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.087 0.47 . . . . 65.31 110.063 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.6 m -62.28 -34.13 75.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.721 -0.672 . . . . 64.23 110.668 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.36 -10.2 11.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.061 -0.656 . . . . 74.41 111.88 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 54.27 29.66 11.09 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 113.405 0.891 . . . . 63.42 113.405 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -129.8 156.41 44.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 114.672 -1.149 . . . . 75.35 108.534 173.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.44 -172.78 38.54 Favored Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 109.087 -1.605 . . . . 73.44 109.087 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 50.3 m-85 -134.24 165.9 24.03 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 117.036 0.418 . . . . 74.44 111.123 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.6 mt -147.16 136.26 16.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.111 -1.07 . . . . 64.54 108.111 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.39 148.47 34.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.525 -2.028 . . . . 74.53 105.525 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.5 pt20 -74.84 142.5 44.16 Favored 'General case' 0 CA--C 1.473 -2.019 0 C-N-CA 116.655 -2.018 . . . . 75.24 108.68 175.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -49.62 -33.04 14.24 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.122 -1.399 . . . . 75.32 111.594 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -87.75 11.31 15.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.902 0.705 . . . . 64.31 112.902 -173.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.39 51.2 0.67 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.405 -1.379 . . . . 60.31 113.471 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -96.26 157.59 21.51 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 119.774 -1.203 . . . . 74.21 110.989 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -72.06 152.73 42.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.831 0.315 . . . . 73.12 110.522 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 120.79 24.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.19 0.995 . . . . 74.24 111.724 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 55' ' ' LEU . 3.0 p -121.87 139.01 50.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 114.365 -1.289 . . . . 75.23 108.223 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 40.7 p90 -88.15 142.67 27.58 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.428 -0.909 . . . . 74.33 111.45 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 67' ' ' LEU . 13.3 p -110.67 144.21 19.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.605 -0.887 . . . . 74.44 108.605 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -131.66 158.4 41.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.56 -16.44 63.87 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 112.505 0.557 . . . . 75.21 112.505 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -56.67 -26.24 55.87 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.235 0.541 . . . . 70.34 110.357 172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.85 -37.71 55.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.117 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.6 t -66.57 -40.6 86.71 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 N-CA-C 107.844 -1.169 . . . . 75.32 107.844 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.26 -32.6 72.42 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.78 0.832 . . . . 63.4 110.755 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.37 82.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.721 0.638 . . . . 71.43 112.721 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.68 -8.79 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.478 0.918 . . . . 71.52 113.478 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.63 58.36 7.83 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.47 -1.052 . . . . 74.22 110.47 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.02 145.46 51.75 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.435 -1.32 . . . . 75.32 107.435 -179.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.468 ' N ' HD11 ' A' ' 42' ' ' LEU . 62.7 t-80 -54.5 -61.7 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.58 0.352 . . . . 73.31 110.981 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -175.62 150.66 1.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.547 -0.538 . . . . 54.41 109.547 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.96 143.84 36.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.261 -0.644 . . . . 75.14 109.261 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.13 160.15 16.0 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.932 -1.136 . . . . 61.2 107.932 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 150.41 45.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.819 0.819 . . . . 74.1 112.374 -176.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.68 -14.73 62.21 Favored Glycine 0 C--N 1.298 -1.569 0 CA-C-N 114.991 -1.004 . . . . 55.01 112.677 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.41 116.65 19.77 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 122.519 -0.4 . . . . 75.11 111.152 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.91 129.92 38.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.998 -1.482 . . . . 71.03 106.998 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 147.83 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-O 122.034 0.921 . . . . 75.44 110.976 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.6 mt -110.03 127.76 66.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.199 -1.778 . . . . 74.42 106.199 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.4 p90 -142.47 176.45 9.0 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.948 -0.701 . . . . 73.43 111.311 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.46 140.39 52.23 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.107 -1.812 . . . . 62.13 106.107 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 30' ' ' VAL . 20.7 tp -121.36 122.06 39.01 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.728 0.775 . . . . 74.5 111.898 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -109.92 166.22 11.1 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.885 -1.507 . . . . 74.41 109.469 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.1 125.72 51.43 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.587 -1.264 . . . . 74.41 107.587 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -126.16 75.16 1.5 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.457 0.54 . . . . 74.31 112.457 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 26.7 tt0 58.12 32.91 22.61 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.857 0.837 . . . . 64.41 111.202 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.37 31.5 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 120.505 -0.855 . . . . 61.14 111.641 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.0 mmtt -96.87 162.04 13.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.803 -0.443 . . . . 74.22 109.803 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.11 112.01 8.91 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.585 -1.265 . . . . 75.15 107.585 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.6 p90 -124.96 135.51 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.418 0.628 . . . . 73.24 111.5 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 123.66 32.75 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.639 -1.164 . . . . 74.14 109.838 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.456 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 18.4 m -137.22 176.29 7.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.588 -0.733 . . . . 60.54 111.62 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.39 40.11 27.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.492 1.12 . . . . 74.32 108.361 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 36.3 mt -62.63 142.07 58.22 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.617 -1.174 . . . . 74.31 113.016 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -143.68 130.39 20.26 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.546 -1.65 . . . . 75.33 106.546 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.23 141.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.567 -0.853 . . . . 75.53 110.891 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.25 1.109 0 O-C-N 123.858 0.724 . . . . 73.03 110.798 178.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 108.044 -1.095 . . . . 75.41 108.044 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p -101.69 150.32 23.24 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.45 0.469 . . . . 53.21 111.492 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 61.84 76.07 0.38 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.681 0.792 . . . . 74.35 111.319 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 34.1 mt -108.36 150.65 10.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.193 -0.912 . . . . 74.34 110.462 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 93.9 t -96.11 132.46 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 115.629 -0.714 . . . . 65.45 110.182 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.44 171.07 39.04 Favored Glycine 0 N--CA 1.399 -3.819 0 CA-C-N 115.109 -0.95 . . . . 74.31 111.676 170.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -128.35 133.28 48.63 Favored 'General case' 0 C--N 1.26 -3.299 0 C-N-CA 124.472 1.109 . . . . 72.41 108.879 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.91 113.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 116.061 -0.518 . . . . 63.24 109.987 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.506 ' HD2' ' CB ' ' A' ' 20' ' ' PHE . 64.4 mttm -62.58 -49.0 76.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.615 -0.721 . . . . 71.15 109.276 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -175.81 166.67 3.1 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.805 1.242 . . . . 72.23 108.661 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -145.06 140.35 28.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.626 0.579 . . . . 73.4 109.442 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -112.25 121.53 45.18 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.501 -0.926 . . . . 73.43 108.501 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -75.99 -28.94 58.03 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.4 m -69.03 -48.64 62.4 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.975 0.417 . . . . 74.43 111.264 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -95.28 -8.56 35.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.681 0.622 . . . . 74.0 112.681 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 62.43 30.68 17.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.945 0.403 . . . . 71.24 111.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.65 163.41 21.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.128 -0.487 . . . . 62.2 109.939 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.18 -172.47 43.46 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 107.939 -2.064 . . . . 71.34 107.939 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . 55.8 m-85 -136.82 155.98 49.09 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 118.125 0.963 . . . . 74.34 111.372 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -134.94 140.93 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.499 -0.926 . . . . 74.44 108.499 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 13.8 pt-20 -143.05 147.4 35.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.25 -2.13 . . . . 72.11 105.25 175.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.2 pt20 -79.87 144.45 33.43 Favored 'General case' 0 CA--C 1.483 -1.613 0 C-N-CA 115.305 -2.558 . . . . 72.14 109.315 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.79 -29.21 11.01 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 124.992 1.433 . . . . 62.33 111.357 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.86 4.0 43.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.179 0.807 . . . . 64.13 113.179 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.25 53.62 0.88 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 117.744 -2.17 . . . . 75.11 112.332 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' A' ' 23' ' ' GLN . . . -83.09 -121.91 0.76 Allowed Glycine 0 C--N 1.312 -0.803 0 C-N-CA 120.576 -0.821 . . . . 51.53 114.23 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.95 168.66 15.68 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 122.726 0.41 . . . . 72.53 110.359 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.71 92.19 6.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.186 -0.672 . . . . 54.54 109.186 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.44 132.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.523 -0.762 . . . . 75.21 109.148 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 44.0 p90 -90.09 149.14 22.62 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 118.92 -1.112 . . . . 75.11 110.884 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG21 HD12 ' A' ' 67' ' ' LEU . 8.8 p -105.99 137.12 37.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -125.25 157.17 37.25 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.697 -1.223 . . . . 73.31 107.697 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -62.38 -24.23 67.26 Favored 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 113.022 0.749 . . . . 74.24 113.022 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -52.51 -26.06 12.02 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 120.981 0.419 . . . . 74.04 111.399 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -39.61 61.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.198 0.523 . . . . 73.33 109.823 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.89 -46.34 88.82 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.373 0 CA-C-N 115.06 -0.973 . . . . 64.03 108.404 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.69 -23.79 65.12 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.402 0.439 . . . . 74.02 111.14 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.74 69.16 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.301 0.482 . . . . 70.51 112.301 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.8 -4.8 4.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.229 0.826 . . . . 60.52 113.229 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.05 52.48 44.32 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.295 -0.722 . . . . 71.31 111.295 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.24 125.56 27.27 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.074 -1.825 . . . . 65.11 106.074 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -74.51 -37.79 63.0 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 114.833 1.419 . . . . 75.44 114.833 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -155.63 138.3 15.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.104 -0.638 . . . . 74.12 112.257 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.19 149.3 43.03 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.471 -0.786 . . . . 74.44 109.035 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.46 169.56 22.3 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.42 155.28 36.51 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.58 -0.448 . . . . 71.52 110.966 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.09 1.27 89.67 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.923 -0.656 . . . . 36.84 113.09 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.457 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -86.22 121.08 28.31 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 111.902 0.334 . . . . 74.25 111.902 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -71.78 127.51 32.8 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.144 -1.058 . . . . 74.42 108.144 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.49 147.58 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 CA-C-O 121.976 0.893 . . . . 70.45 110.686 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 71.9 mt -112.69 135.11 53.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 N-CA-C 106.893 -1.521 . . . . 75.52 106.893 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.465 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -150.13 179.28 8.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 121.076 -0.25 . . . . 72.12 110.566 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -114.86 154.35 28.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.035 -1.839 . . . . 73.35 106.035 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 37.1 tp -140.53 136.67 33.13 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.901 0.857 . . . . 75.21 112.755 -176.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -131.54 132.42 44.14 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.226 -1.768 . . . . 74.23 106.226 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.77 116.41 23.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.846 0.832 . . . . 70.12 111.04 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -81.26 79.14 7.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.154 -1.384 . . . . 75.01 109.785 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 57.52 20.62 6.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.061 0.945 . . . . 64.51 112.374 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.16 -30.11 3.56 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.413 -0.675 . . . . 72.05 111.413 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -84.13 164.12 19.38 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.377 -1.342 . . . . 75.54 107.377 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.15 129.04 26.97 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 118.652 0.66 . . . . 73.42 110.784 -176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 6.9 p90 -133.93 133.91 41.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.467 0.651 . . . . 75.21 111.175 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.58 133.37 36.44 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.537 -1.21 . . . . 74.35 110.297 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.508 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 26.9 m -135.24 161.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.976 -1.011 . . . . 75.33 109.29 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 t30 59.63 64.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.848 0.718 . . . . 64.24 110.817 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 21.8 mt -78.14 139.9 39.01 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.976 -1.09 . . . . 73.54 112.132 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 16.6 tpp180 -137.45 130.77 30.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.111 -2.551 . . . . 65.23 104.111 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.58 143.22 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.944 -1.102 . . . . 72.33 113.055 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.914 -1.041 . . . . 75.1 108.945 173.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 107.106 -1.442 . . . . 73.22 107.106 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.415 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 41.5 p -120.49 142.0 49.69 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.137 0.421 . . . . 73.34 112.137 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 55.86 74.54 0.38 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.308 1.043 . . . . 62.44 112.31 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mt -99.58 152.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.643 -1.162 . . . . 74.33 110.818 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.2 t -102.62 135.97 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 115.419 -0.81 . . . . 64.42 109.548 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.14 175.42 47.12 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 115.103 -0.953 . . . . 72.14 111.98 168.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 38.3 ttmt -123.91 143.02 50.62 Favored 'General case' 0 C--N 1.253 -3.627 0 C-N-CA 123.973 0.909 . . . . 74.14 108.801 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.02 109.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.136 -0.69 . . . . 62.42 109.136 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 58.2 tttp -68.53 -49.1 62.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.886 -1.524 . . . . 64.21 106.886 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -169.11 156.18 7.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 114.951 -1.022 . . . . 72.54 108.829 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -157.16 111.39 2.68 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 123.638 0.586 . . . . 71.11 109.668 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -99.49 118.63 36.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.822 -0.626 . . . . 71.42 109.932 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 m -64.36 -22.92 67.11 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.059 -0.973 . . . . 73.04 110.2 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -55.08 -44.99 75.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.537 -0.756 . . . . 64.44 111.212 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.8 mttt -106.21 -6.09 18.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.437 0.532 . . . . 74.14 112.437 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 68.86 22.65 7.11 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.073 0.549 . . . . 73.34 110.928 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.467 ' HB3' ' HD1' ' A' ' 33' ' ' HIS . 36.5 p90 -148.47 166.86 26.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.06 0.457 . . . . 75.21 111.965 176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.85 -153.06 8.56 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.757 -1.337 . . . . 64.53 109.757 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.522 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.4 m-85 -137.05 167.81 20.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 122.857 0.463 . . . . 75.53 111.419 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 64.0 mt -142.35 138.29 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.573 -0.899 . . . . 72.41 108.573 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -143.18 147.25 34.59 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 106.545 -1.65 . . . . 72.21 106.545 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.1 pt20 -86.29 156.79 20.1 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 117.599 -1.64 . . . . 73.0 108.78 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -53.99 -27.12 29.59 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.232 0.957 . . . . 74.12 112.368 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.41 5.45 17.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.079 0.4 . . . . 64.14 112.079 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.01 51.72 4.09 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.433 -1.365 . . . . 61.45 110.807 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.5 -168.12 32.99 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.877 -0.678 . . . . 75.11 112.459 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.02 144.71 55.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.044 -0.354 . . . . 73.04 110.044 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.29 87.39 7.11 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.494 -0.928 . . . . 73.21 108.494 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 62' ' ' ALA . 3.8 p -100.52 138.41 24.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.441 -1.254 . . . . 74.01 110.055 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.0 p90 -88.98 145.18 25.67 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 119.061 -1.055 . . . . 74.44 110.034 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' CG2' HD12 ' A' ' 67' ' ' LEU . 8.1 p -115.57 136.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 108.748 -0.834 . . . . 74.32 108.748 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' HD1' ' HB3' ' A' ' 18' ' ' PHE . 34.1 t60 -124.67 159.94 29.66 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.136 -0.691 . . . . 74.43 109.136 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.32 -15.69 60.77 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 112.647 0.61 . . . . 74.21 112.647 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.6 m -61.45 -26.93 68.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.963 0.411 . . . . 72.34 110.495 172.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -75.31 -34.9 61.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.7 -0.482 . . . . 71.52 109.7 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.57 -46.29 93.01 Favored 'Isoleucine or valine' 0 C--O 1.181 -2.524 0 N-CA-C 107.721 -1.214 . . . . 75.44 107.721 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.52 -31.24 63.93 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.124 0.97 . . . . 74.35 110.866 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.4 63.84 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.121 0.786 . . . . 74.51 113.121 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.63 -5.62 4.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.654 0.983 . . . . 62.4 113.654 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.09 49.43 75.17 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 111.117 -0.793 . . . . 71.1 111.117 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.1 tm? -66.86 138.16 57.11 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.154 -1.424 . . . . 65.23 107.154 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.401 ' N ' HD11 ' A' ' 42' ' ' LEU . 29.9 m-70 -65.15 -53.58 42.89 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.0 1.111 . . . . 72.04 114.0 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -165.83 153.84 10.84 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.527 -0.469 . . . . 61.34 110.575 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.6 mt -124.01 143.78 50.22 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.119 -0.697 . . . . 73.23 109.119 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.16 162.38 20.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.132 -1.432 . . . . 62.1 107.132 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.1 153.4 43.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.591 . . . . 73.24 111.501 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.58 84.66 Favored Glycine 0 C--N 1.3 -1.465 0 CA-C-N 115.262 -0.881 . . . . 73.5 112.803 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -93.58 119.08 32.19 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.268 0.47 . . . . 73.25 112.268 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 22.4 m-20 -71.91 136.38 46.87 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.171 -0.612 . . . . 71.41 109.745 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.29 153.41 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-O 121.876 0.846 . . . . 74.31 110.815 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 65.9 mt -115.2 135.36 55.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 N-CA-C 106.58 -1.637 . . . . 75.3 106.58 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -153.06 177.59 10.64 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.947 -0.701 . . . . 74.42 110.624 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 44.5 m-20 -118.93 157.53 27.5 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.013 -1.847 . . . . 75.44 106.013 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -134.9 138.18 43.88 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 120.879 0.371 . . . . 75.32 111.883 -174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -127.56 151.57 48.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.49 -1.3 . . . . 64.14 107.49 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.42 120.82 31.85 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 121.243 0.544 . . . . 71.33 111.018 -175.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 87.0 tttt -90.49 74.31 6.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.528 -0.76 . . . . 73.42 108.956 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 61.14 8.32 1.95 Allowed 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.85 -1.068 . . . . 73.03 113.178 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.53 -24.28 2.49 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.803 -0.919 . . . . 64.21 110.803 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -88.7 162.41 16.29 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.09 -1.078 . . . . 71.45 108.09 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 30' ' ' VAL . . . -120.99 127.73 52.05 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.975 -0.453 . . . . 71.33 111.495 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 36.4 p90 -127.81 132.6 49.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.367 0.603 . . . . 73.22 111.63 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.2 136.8 33.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.147 -0.933 . . . . 63.21 110.755 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 30.6 m -139.64 167.85 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.162 -0.926 . . . . 65.12 109.765 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.08 63.43 2.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.623 0.769 . . . . 62.34 110.472 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.456 HD12 ' CG2' ' A' ' 32' ' ' VAL . 30.1 mt -78.9 141.01 37.99 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.129 -1.029 . . . . 75.33 113.022 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 18.4 tpp180 -141.72 130.58 23.0 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 105.929 -1.878 . . . . 74.25 105.929 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.02 149.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.03 -1.068 . . . . 73.12 111.989 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt . . . . . 0 C--O 1.251 1.17 0 O-C-N 124.049 0.843 . . . . 74.24 110.755 175.555 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 109.327 -0.62 . . . . 74.34 109.327 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 p -100.22 146.0 27.4 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.847 -0.615 . . . . 71.41 111.662 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 t30 54.68 77.18 0.21 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.908 1.283 . . . . 54.41 110.656 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 45.3 mt -103.93 142.84 16.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.422 -0.808 . . . . 74.4 110.416 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 76.4 t -95.96 140.82 16.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.257 -0.883 . . . . 75.13 109.45 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.94 161.87 29.85 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.312 -0.947 . . . . 72.44 113.593 168.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -96.09 137.41 35.19 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.785 -0.821 . . . . 73.4 108.785 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.32 102.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 107.674 -1.232 . . . . 73.43 107.674 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.71 -45.36 92.37 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.499 -1.228 . . . . 72.42 110.417 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -172.53 162.81 5.31 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 124.072 0.949 . . . . 73.25 108.723 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.461 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 88.5 t80 -160.77 116.02 2.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.887 0.742 . . . . 74.33 109.934 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.71 106.28 18.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.374 -0.973 . . . . 64.32 108.374 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 p -59.76 -32.47 70.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.176 0.806 . . . . 72.35 113.176 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 m -76.71 -21.97 54.57 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.204 0.526 . . . . 73.22 110.725 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -101.45 -8.87 21.59 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 119.979 -0.688 . . . . 74.41 110.769 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 91.7 m-20 54.68 29.8 12.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.394 0.678 . . . . 71.31 112.809 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.03 154.32 51.75 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.195 0.598 . . . . 73.0 110.346 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.35 -171.78 39.65 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.787 -1.325 . . . . 72.23 109.787 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -132.39 157.42 44.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.272 0.536 . . . . 74.02 111.297 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -147.02 128.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.482 -0.781 . . . . 75.11 109.23 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.94 148.6 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.308 -0.997 . . . . 74.23 108.308 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 9.9 pt20 -80.41 151.82 29.16 Favored 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 119.567 -0.853 . . . . 74.42 109.971 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.9 -15.22 19.82 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.62 1.2 . . . . 74.53 110.997 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 71.0 m-20 -88.14 6.6 35.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.735 -0.666 . . . . 74.23 110.295 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.81 51.2 2.52 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.988 -1.101 . . . . 74.34 113.111 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.42 41.84 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 119.911 -1.138 . . . . 64.13 111.074 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 157.93 28.47 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.392 0.596 . . . . 75.32 112.055 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.71 90.95 4.63 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.342 0.592 . . . . 71.43 109.984 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 62' ' ' ALA . 5.4 p -106.0 135.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.972 -1.013 . . . . 73.45 108.873 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -91.95 142.84 27.1 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.353 -0.939 . . . . 70.12 110.566 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.44 145.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.535 -0.913 . . . . 70.3 108.535 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 32.8 t60 -135.52 161.37 35.66 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.296 -1.002 . . . . 71.52 108.296 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -68.06 -18.53 64.7 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 112.644 0.609 . . . . 72.5 112.644 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -56.85 -21.99 33.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.28 0.562 . . . . 74.22 110.373 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -81.14 -34.76 32.25 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.168 -0.469 . . . . 63.23 110.227 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.0 t -64.41 -52.26 57.62 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.424 0 N-CA-C 108.112 -1.07 . . . . 72.42 108.112 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.89 -22.61 64.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 123.436 0.46 . . . . 75.21 112.146 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.42 75.88 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 120.974 -0.29 . . . . 65.45 111.599 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.14 0.6 4.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.802 0.667 . . . . 71.53 112.802 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.08 50.26 65.64 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 111.092 -0.803 . . . . 72.33 111.092 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.8 138.58 58.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.753 -1.573 . . . . 75.02 106.753 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.55 -56.0 19.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.203 0.456 . . . . 71.32 111.968 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.1 p -167.81 152.46 6.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.389 -0.369 . . . . 63.22 110.323 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 90.2 mt -115.11 152.76 31.98 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.825 -0.435 . . . . 73.34 109.825 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.23 163.97 39.29 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.804 -1.554 . . . . 75.24 106.804 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 151.03 39.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.125 -0.63 . . . . 54.02 109.721 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.9 70.69 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.877 -0.678 . . . . 72.41 112.513 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.5 135.41 36.63 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 122.814 -0.227 . . . . 75.43 110.596 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.58 127.78 38.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.749 -1.574 . . . . 72.01 106.749 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.0 153.85 36.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.727 0 CA-C-O 121.485 0.66 . . . . 73.34 111.147 -173.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 67.0 mt -117.92 133.41 64.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 N-CA-C 106.821 -1.548 . . . . 73.11 106.821 177.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.8 p90 -144.76 -178.89 6.25 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.832 -0.432 . . . . 72.43 109.832 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -123.94 143.57 50.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.244 -1.391 . . . . 53.34 107.244 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 62' ' ' ALA . 22.9 tp -117.72 116.88 27.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.445 1.116 . . . . 74.44 112.973 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.94 123.96 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.471 -2.048 . . . . 72.11 105.471 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.57 132.98 36.4 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.783 0.801 . . . . 75.23 111.608 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -102.05 81.09 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.613 -1.176 . . . . 74.31 108.744 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 63.63 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.314 1.046 . . . . 62.23 111.484 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.62 5.35 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.876 -0.89 . . . . 70.25 110.876 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD3' ' H ' ' A' ' 62' ' ' ALA . 16.0 tppt? -110.91 154.73 23.67 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.789 -0.819 . . . . 72.54 108.789 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -134.08 128.63 34.62 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 110.063 -0.347 . . . . 60.12 110.063 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.32 134.54 45.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.35 0.595 . . . . 64.22 110.749 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.97 130.73 35.16 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.798 -1.092 . . . . 72.42 110.898 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 24.1 m -139.39 167.98 19.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.225 -0.898 . . . . 75.42 110.288 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 59.66 63.14 1.57 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.449 1.093 . . . . 74.31 110.056 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 36' ' ' ALA . 23.9 mt -79.47 139.47 37.62 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.932 0.872 . . . . 73.42 113.239 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -139.53 131.79 28.28 Favored 'General case' 0 N--CA 1.41 -2.425 0 C-N-CA 125.822 1.649 . . . . 71.22 107.101 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.8 mt -80.22 138.35 19.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 118.739 -1.185 . . . . 64.34 109.127 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 115.454 -0.794 . . . . 74.4 110.005 -177.163 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 105.872 -1.899 . . . . 73.45 105.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 p -97.09 140.74 31.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.149 1.166 . . . . 75.41 114.149 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 59.01 77.06 0.32 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.705 1.602 . . . . 74.44 110.869 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.4 mt -103.01 150.28 6.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.96 -1.018 . . . . 73.21 110.57 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.5 t -98.84 136.24 30.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.389 -0.823 . . . . 73.23 109.778 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.96 157.2 23.06 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.843 -0.694 . . . . 75.13 113.117 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.7 ttmt -99.69 139.75 34.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 123.231 0.612 . . . . 74.54 110.133 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.18 107.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.709 -0.678 . . . . 75.25 109.326 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -65.7 -46.6 78.4 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.243 -0.89 . . . . 72.11 109.74 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -174.29 161.68 3.5 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 123.736 0.815 . . . . 72.31 109.52 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -154.14 121.77 5.86 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.503 0.502 . . . . 75.2 111.181 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -117.85 106.77 13.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 115.69 -0.686 . . . . 75.2 110.036 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -56.42 -29.61 61.79 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.719 -1.128 . . . . 63.01 111.028 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 m -61.62 -34.57 75.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 65.03 110.614 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.35 -7.26 35.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 74.14 110.18 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.37 22.06 11.97 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.531 1.132 . . . . 74.02 110.983 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -157.2 174.91 14.76 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.493 0.663 . . . . 75.13 111.307 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.41 -164.63 24.43 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 108.834 -1.706 . . . . 70.4 108.834 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -131.95 152.53 51.03 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 117.6 0.7 . . . . 72.45 111.16 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -142.79 134.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 123.522 0.729 . . . . 52.33 109.143 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.99 151.53 38.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.319 -1.363 . . . . 72.24 107.319 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.4 pt20 -85.12 151.76 23.89 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.805 -1.558 . . . . 73.55 109.267 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.42 -27.75 57.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 124.282 0.989 . . . . 62.43 111.678 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -76.3 2.51 13.15 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.325 -0.398 . . . . 72.22 111.711 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 51.44 1.53 Allowed Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 119.804 -1.188 . . . . 71.44 111.965 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 170.32 53.28 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 119.758 -1.21 . . . . 72.23 111.047 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.93 154.55 39.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.882 0.341 . . . . 75.04 111.584 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.5 89.17 4.46 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.433 -0.951 . . . . 75.23 108.433 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 136.24 39.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.516 -0.766 . . . . 74.03 109.736 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 53.4 p90 -94.45 139.74 30.73 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.944 -0.702 . . . . 71.31 109.88 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 67' ' ' LEU . 7.4 p -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 109.722 -0.473 . . . . 71.2 109.722 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -98.12 138.61 35.16 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.679 -0.489 . . . . 71.12 109.679 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -57.21 -28.06 62.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.393 1.627 . . . . 73.54 115.393 -173.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 m -54.47 -25.79 27.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 120.624 -0.43 . . . . 72.14 111.244 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.86 63.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.53 0.205 . . . . 73.55 110.595 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.99 -52.64 58.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 108.263 -1.014 . . . . 75.02 108.263 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.91 -22.32 65.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 113.337 0.866 . . . . 72.14 113.337 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.16 -30.83 71.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.995 0.426 . . . . 72.55 110.981 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.98 -7.49 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.459 0.647 . . . . 65.54 110.437 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.59 24.3 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 109.886 -1.286 . . . . 62.5 109.886 -171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.04 130.49 44.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.981 -1.489 . . . . 74.34 106.981 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -53.53 -56.44 17.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.73 1.011 . . . . 74.24 113.73 -172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m -163.94 151.39 12.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 110.351 -0.24 . . . . 71.2 110.351 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -123.59 141.49 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.204 -1.036 . . . . 74.55 108.204 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.22 153.41 33.75 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.031 -0.531 . . . . 74.12 110.229 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.79 134.73 57.09 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.25 -1.018 . . . . 72.3 108.25 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.87 -14.56 49.17 Favored Glycine 0 C--N 1.295 -1.717 0 C-N-CA 120.993 -0.622 . . . . 73.21 111.947 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 134.09 34.09 Favored 'General case' 0 CA--C 1.495 -1.143 0 O-C-N 122.708 -0.289 . . . . 72.21 110.586 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -89.66 136.74 32.86 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.026 -1.472 . . . . 73.31 107.026 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.73 151.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-O 121.918 0.866 . . . . 75.31 111.378 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -113.07 133.32 59.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.918 -1.512 . . . . 74.12 106.918 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 43.5 p90 -149.54 177.48 9.69 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.297 -0.26 . . . . 75.01 110.297 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -115.34 155.56 27.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.349 -1.723 . . . . 71.35 106.349 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -141.03 136.9 32.53 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.772 0.796 . . . . 74.3 111.536 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.21 145.26 27.04 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.661 -1.977 . . . . 72.53 105.661 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.24 128.17 34.58 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 113.699 1.0 . . . . 74.42 113.699 -170.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 64.8 tttp -83.43 70.82 10.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.27 -1.332 . . . . 64.41 109.268 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 55.65 24.46 7.12 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.249 1.02 . . . . 74.52 111.325 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.81 -35.5 1.99 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.306 -0.718 . . . . 75.43 111.306 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 10.9 mptt -84.32 164.79 18.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.84 -0.429 . . . . 74.02 109.84 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.88 113.68 13.16 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.895 -0.409 . . . . 74.32 109.895 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 2.8 p90 -126.88 137.75 53.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.338 0.589 . . . . 72.33 111.569 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.9 35.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.588 -1.187 . . . . 64.04 110.392 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.88 168.08 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.156 -0.929 . . . . 72.05 109.935 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 55.39 63.55 2.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.492 0.717 . . . . 72.0 110.529 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 37.9 mt -81.95 145.93 30.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.274 -0.875 . . . . 74.41 112.461 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -150.53 130.86 13.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.241 -2.133 . . . . 72.23 105.241 174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.38 145.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 C-N-CA 119.545 -0.862 . . . . 73.33 110.148 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.903 -1.147 . . . . 72.42 107.903 174.124 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 N-CA-C 107.449 -1.315 . . . . 71.41 107.449 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 p -118.58 148.63 42.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 111.983 0.364 . . . . 74.15 111.983 -175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 58.15 76.93 0.31 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.128 0.971 . . . . 71.21 111.435 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mt -108.35 154.41 9.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.983 -1.008 . . . . 70.35 110.51 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.9 t -103.46 129.5 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.665 -0.698 . . . . 63.43 109.505 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 23' ' ' GLN . . . -158.79 171.62 35.48 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 110.658 -0.977 . . . . 63.41 110.658 171.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.8 ttmt -125.94 140.35 52.7 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 108.433 -0.951 . . . . 73.31 108.433 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 73.0 t -57.37 112.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.573 -0.528 . . . . 71.2 109.573 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.4 tttp -79.15 -43.09 24.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.582 -1.19 . . . . 74.3 109.112 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -176.2 160.01 2.14 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 124.139 0.976 . . . . 73.4 109.173 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -155.65 121.99 5.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.498 0.499 . . . . 74.12 110.089 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -105.15 104.18 13.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.733 -0.84 . . . . 75.12 108.733 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 p -63.75 -23.13 67.24 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 123.689 0.795 . . . . 72.43 112.469 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 m -67.84 -28.86 67.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.218 -0.447 . . . . 74.5 110.357 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -110.43 -8.24 14.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.834 -0.346 . . . . 75.43 110.347 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.07 27.2 14.57 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.648 0.779 . . . . 74.43 113.011 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.45 153.72 41.55 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.608 -0.723 . . . . 73.33 109.949 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.22 -168.73 32.47 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.608 -1.397 . . . . 54.23 109.608 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 57.5 m-85 -135.65 164.18 28.44 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.216 0.531 . . . . 74.01 111.597 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.8 mt -144.67 135.23 20.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 114.799 -1.091 . . . . 72.14 108.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.5 146.35 33.32 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.634 -1.987 . . . . 71.5 105.634 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.528 ' CA ' ' HA2' ' A' ' 7' ' ' GLY . 3.4 pt20 -72.17 144.81 48.43 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 117.809 -1.556 . . . . 72.15 109.398 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.81 -25.56 19.99 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.406 -1.27 . . . . 74.42 111.001 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.26 3.27 13.31 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.486 -0.779 . . . . 64.31 112.233 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.85 51.59 3.56 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.184 -1.007 . . . . 72.43 112.204 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.27 -143.5 9.84 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.349 -0.929 . . . . 45.22 113.098 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.38 164.16 13.32 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 110.259 -0.274 . . . . 74.11 110.259 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -101.25 112.53 25.05 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.712 -0.847 . . . . 70.1 108.712 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 55' ' ' LEU . 2.7 p -119.38 138.48 49.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.865 -0.791 . . . . 75.1 108.865 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.2 p90 -90.55 148.16 22.89 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.196 -1.002 . . . . 73.42 110.44 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 67' ' ' LEU . 11.7 p -113.98 142.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 109.078 -0.712 . . . . 74.43 109.078 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -130.12 160.14 34.65 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.426 -0.953 . . . . 74.4 108.426 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.2 -14.73 62.35 Favored 'General case' 0 C--O 1.197 -1.696 0 N-CA-C 111.802 0.297 . . . . 73.02 111.802 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -53.38 -33.32 53.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.702 0.286 . . . . 73.13 110.454 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -37.81 62.29 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.848 0.356 . . . . 73.35 110.894 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.23 -35.0 69.46 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 N-CA-C 108.205 -1.035 . . . . 74.43 108.205 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.2 -35.37 80.85 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.468 -0.787 . . . . 74.1 110.725 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.49 -49.09 12.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.247 0.462 . . . . 64.42 112.247 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.73 -23.27 19.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.492 0.923 . . . . 72.0 113.492 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.93 62.58 3.51 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 111.59 -0.604 . . . . 53.21 111.59 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.8 148.06 24.86 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.906 -1.516 . . . . 73.14 106.906 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -68.42 -60.85 2.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.208 0.458 . . . . 73.51 111.9 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.8 p -163.11 165.22 24.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.023 -0.362 . . . . 74.25 110.023 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.28 137.28 52.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.901 -0.778 . . . . 73.43 108.901 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.64 145.43 22.47 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.065 -0.97 . . . . 70.32 110.051 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -54.87 131.33 44.01 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 124.201 1.0 . . . . 73.02 109.893 -177.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.28 -26.1 8.38 Favored Glycine 0 C--N 1.301 -1.369 0 CA-C-N 115.486 -0.779 . . . . 63.53 111.653 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -80.69 117.51 21.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.676 0.991 . . . . 70.24 113.676 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.3 m-20 -70.4 132.19 45.23 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.431 -1.692 . . . . 73.2 106.431 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -133.26 146.6 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 CA-C-O 121.951 0.882 . . . . 74.14 110.981 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.6 mt -111.68 126.6 69.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 107.027 -1.472 . . . . 74.13 107.027 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 41.9 p90 -147.83 178.42 8.51 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.808 -0.357 . . . . 73.44 110.634 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -115.12 162.0 17.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.341 -2.096 . . . . 65.41 105.341 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 62' ' ' ALA . 16.4 tp -130.69 128.37 40.75 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.948 0.88 . . . . 72.12 112.841 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' N ' HD11 ' A' ' 55' ' ' LEU . 44.0 mt-10 -116.9 146.48 42.92 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.395 -1.73 . . . . 75.41 108.55 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.63 137.3 33.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.277 0.561 . . . . 65.52 111.873 -172.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -116.94 74.25 0.9 Allowed 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.585 -0.894 . . . . 75.45 108.585 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 65.58 -72.28 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.931 1.292 . . . . 74.22 111.838 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 -1.38 4.79 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.062 -0.815 . . . . 70.14 111.062 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 7.3 mmpt? -104.12 164.97 11.35 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.059 -0.719 . . . . 71.11 109.059 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -129.23 127.22 40.81 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.463 -0.569 . . . . 75.0 109.463 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.9 p90 -122.58 128.7 51.05 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.699 0.761 . . . . 74.11 112.831 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.83 130.98 37.34 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.382 -1.281 . . . . 74.51 110.218 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.9 m -135.36 168.77 22.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.938 -1.028 . . . . 61.0 108.871 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.7 t30 53.18 63.92 2.05 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.724 0.64 . . . . 64.4 111.138 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 44.5 mt -82.47 146.79 29.08 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.538 0.685 . . . . 73.31 112.528 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -148.77 130.72 15.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.016 -2.216 . . . . 75.31 105.016 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.82 148.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.176 -1.01 . . . . 74.3 112.784 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.34 -0.845 . . . . 75.13 109.769 172.507 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.404 0.621 . . . . 75.03 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.79 136.59 6.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.473 -0.936 . . . . 71.12 108.473 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -129.56 153.73 47.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.267 0.469 . . . . 73.24 112.267 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 m120 58.07 42.04 23.1 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.985 0.914 . . . . 73.44 110.739 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 42.1 mt -75.68 150.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.428 -0.806 . . . . 73.22 112.14 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.8 t -96.43 138.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-N 114.854 -1.067 . . . . 73.15 109.777 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.71 171.01 43.94 Favored Glycine 0 N--CA 1.403 -3.524 0 C-N-CA 120.808 -0.71 . . . . 73.03 112.555 168.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -119.5 143.61 47.46 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.742 -0.836 . . . . 75.23 108.742 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.7 107.77 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.429 -0.952 . . . . 73.11 108.429 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 64.5 tttp -69.18 -43.07 74.96 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.823 -1.08 . . . . 74.23 108.57 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -171.85 155.34 3.84 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 114.729 -1.123 . . . . 72.32 108.346 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -159.99 121.77 3.24 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.624 0.577 . . . . 74.31 109.557 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -111.21 108.34 17.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.866 -0.42 . . . . 75.41 109.866 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 p -58.23 -23.64 56.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.215 -0.902 . . . . 63.14 112.709 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 m -57.46 -36.16 71.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.872 0.469 . . . . 72.35 110.941 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -114.73 -9.05 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.346 -0.542 . . . . 75.23 110.346 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 63.52 25.04 14.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.774 0.83 . . . . 73.1 111.837 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.41 158.34 23.67 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 116.035 -0.53 . . . . 73.41 109.966 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.51 -167.69 38.87 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.355 -1.098 . . . . 74.03 110.355 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -134.67 168.69 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.17 0.51 . . . . 73.25 110.981 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.413 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 66.4 mt -140.69 138.69 35.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.3 -0.863 . . . . 74.44 108.672 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 10' ' ' LYS . 11.7 pt-20 -143.03 141.7 31.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.829 -1.545 . . . . 70.33 106.829 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.1 pt20 -83.8 151.17 25.32 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 117.603 -1.639 . . . . 75.12 108.835 173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.27 -19.75 48.58 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 123.95 0.782 . . . . 72.43 111.926 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.16 1.14 51.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.157 -0.474 . . . . 73.22 111.872 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 45.88 1.13 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.579 -1.295 . . . . 65.01 112.569 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.69 154.67 36.3 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.888 -1.285 . . . . 63.24 109.888 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.77 169.69 14.95 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.788 0.662 . . . . 71.45 112.788 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.512 ' OD2' ' HE2' ' A' ' 10' ' ' LYS . 3.1 m-20 -70.87 90.44 0.8 Allowed 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.233 -0.894 . . . . 72.24 112.619 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -105.34 123.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.309 -0.997 . . . . 73.34 108.309 173.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 48.5 p90 -83.5 141.94 31.27 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.058 0.456 . . . . 74.31 111.539 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -97.96 130.46 46.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.671 -0.695 . . . . 73.51 109.624 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -109.36 148.41 31.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.557 -0.905 . . . . 75.35 108.557 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -57.54 -30.14 64.96 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 114.075 1.139 . . . . 73.11 114.075 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -54.44 -27.8 39.77 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.998 0.363 . . . . 75.42 111.325 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -74.26 -39.52 62.95 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.013 0.435 . . . . 54.21 109.959 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 42' ' ' LEU . 79.1 t -61.97 -50.65 79.23 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.889 0 N-CA-C 108.217 -1.031 . . . . 74.1 108.217 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.84 -22.63 67.03 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.178 0.924 . . . . 74.45 111.935 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.66 72.48 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.245 0.545 . . . . 75.52 110.741 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.89 -13.92 10.68 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.528 -0.76 . . . . 71.34 110.115 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.28 55.18 22.63 Favored Glycine 0 CA--C 1.486 -1.778 0 N-CA-C 109.743 -1.343 . . . . 51.43 109.743 -173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' HB3' HG11 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -64.18 125.99 26.3 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.592 -1.633 . . . . 75.35 106.592 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -73.81 -34.45 64.61 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 114.042 1.127 . . . . 75.01 114.042 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -161.4 143.68 12.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.873 0.368 . . . . 70.22 111.218 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.54 144.5 37.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.544 -0.753 . . . . 75.31 109.038 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.18 171.29 20.48 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.533 -1.284 . . . . 74.11 107.533 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 133.4 51.23 Favored 'General case' 0 N--CA 1.417 -2.095 0 C-N-CA 123.875 0.87 . . . . 75.11 110.096 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.44 -32.84 5.54 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.615 -0.721 . . . . 53.03 113.51 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.527 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.0 126.74 28.64 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.741 1.015 . . . . 63.41 113.741 -178.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.79 133.38 43.25 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 106.389 -1.708 . . . . 72.41 106.389 169.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 141.44 38.89 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 CA-C-O 122.125 0.964 . . . . 70.34 110.25 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 54.3 mt -114.92 124.18 71.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 N-CA-C 106.27 -1.752 . . . . 74.12 106.27 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 41.4 p90 -143.36 179.39 7.12 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.609 -0.437 . . . . 74.32 111.497 -174.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -117.42 158.8 23.84 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 105.649 -1.982 . . . . 64.14 105.649 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 62' ' ' ALA . 17.2 tp -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 121.864 0.84 . . . . 74.34 112.577 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.21 157.28 30.59 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.674 -1.603 . . . . 75.33 108.755 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -100.19 155.22 17.87 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-O 122.082 0.944 . . . . 73.32 112.9 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.8 tptt -118.78 85.1 2.3 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.308 -1.738 . . . . 75.41 106.308 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 65.8 -76.04 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.063 0.852 . . . . 75.13 109.483 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.28 -4.69 3.17 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.378 -0.689 . . . . 70.24 111.378 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 55.3 mtpt -89.06 165.7 14.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 122.807 0.443 . . . . 74.11 110.934 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -122.97 123.16 40.28 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.757 0.28 . . . . 73.43 111.757 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.472 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 41.0 p90 -125.65 132.94 52.36 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.364 0.602 . . . . 73.42 111.695 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.45 134.99 37.29 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.038 -0.983 . . . . 71.4 110.446 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.515 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 28.3 m -137.65 165.92 25.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.205 -0.907 . . . . 63.43 108.864 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.52 64.07 1.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.648 0.593 . . . . 52.43 111.383 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 24.7 mt -80.2 142.67 34.47 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.463 -0.895 . . . . 72.42 112.443 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -138.79 131.56 29.22 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.151 -1.796 . . . . 73.44 106.151 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.34 1.8 pp -90.59 96.56 6.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 116.065 1.876 . . . . 62.51 116.065 -177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.6 tttp . . . . . 0 C--O 1.259 1.585 0 C-N-CA 125.703 1.601 . . . . 52.34 113.744 173.762 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 122.168 0.985 . . . . 64.32 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.87 18.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.582 -2.007 . . . . 64.41 105.582 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.3 p -108.84 148.98 29.77 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.242 0.83 . . . . 60.34 113.242 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 52.48 76.16 0.2 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.36 -1.291 . . . . 72.3 112.111 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 36.6 mt -102.76 143.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.653 -1.158 . . . . 74.45 110.182 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 58.8 t -91.47 133.55 32.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.018 -0.992 . . . . 72.01 109.522 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.85 172.26 38.84 Favored Glycine 0 N--CA 1.396 -3.984 0 CA-C-N 115.45 -0.795 . . . . 73.35 112.166 171.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.7 ttmt -123.53 143.06 50.43 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.373 -0.973 . . . . 73.52 108.373 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.84 111.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 108.39 -0.967 . . . . 71.13 108.39 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.1 tttp -76.99 -40.57 46.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.549 -1.205 . . . . 73.4 108.786 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.401 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 68.5 p-90 -177.65 160.58 1.58 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 124.265 1.026 . . . . 75.24 109.1 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -155.35 134.61 12.36 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.007 0.432 . . . . 75.24 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.71 106.05 10.97 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.757 -0.656 . . . . 72.35 109.386 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.4 p -61.04 -32.62 72.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.612 -0.722 . . . . 73.33 112.439 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.0 m -61.88 -28.71 69.7 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.988 0.423 . . . . 64.4 110.686 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.21 -9.0 18.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.43 -0.508 . . . . 75.41 111.812 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 17' ' ' ASN . 0.7 OUTLIER 63.76 25.99 14.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 120.924 0.392 . . . . 75.23 110.077 -176.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -137.64 165.87 25.31 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.4 0.68 . . . . 71.12 112.318 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.53 44.38 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.507 -1.837 . . . . 53.31 108.507 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.454 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 39.0 m-85 -133.19 160.24 37.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 117.465 0.633 . . . . 74.12 111.534 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -145.47 130.11 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.092 -0.958 . . . . 74.13 108.465 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.88 149.65 37.23 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.363 -1.717 . . . . 74.31 106.363 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.511 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -74.87 146.85 41.58 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 117.708 -1.597 . . . . 72.31 109.24 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.47 -21.09 35.09 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.292 -1.322 . . . . 72.3 111.0 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.69 5.26 11.55 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.124 -0.944 . . . . 75.1 111.14 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.54 50.39 2.75 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 111.529 -0.629 . . . . 71.24 111.529 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.33 172.47 54.62 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.477 -0.868 . . . . 73.21 112.498 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.75 151.99 43.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.149 -0.525 . . . . 72.35 110.447 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.26 116.71 20.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.081 0.943 . . . . 74.03 111.144 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.465 HG22 HD13 ' A' ' 55' ' ' LEU . 2.5 p -133.17 133.48 58.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.722 -1.127 . . . . 74.5 108.776 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 52.9 p90 -88.91 152.32 21.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 120.251 -0.58 . . . . 71.21 111.331 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.457 HG21 HD12 ' A' ' 67' ' ' LEU . 7.1 p -109.34 128.04 65.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.516 0.674 . . . . 74.43 109.409 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -109.63 156.73 19.84 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.396 -0.965 . . . . 74.32 108.396 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -22.48 65.99 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 113.265 0.839 . . . . 74.3 113.265 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -55.86 -27.41 51.52 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.988 0.423 . . . . 73.03 110.575 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.48 -34.14 58.66 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.912 0.387 . . . . 72.23 110.169 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 -47.85 78.91 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.625 0 N-CA-C 107.917 -1.142 . . . . 73.15 107.917 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.24 -22.79 67.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.68 0.622 . . . . 75.31 112.68 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.19 69.44 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.825 0.305 . . . . 72.25 111.825 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -21.78 2.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.286 0.565 . . . . 73.11 112.429 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.85 51.91 5.23 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.483 -1.047 . . . . 52.14 110.483 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.94 129.19 38.92 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -62.44 -39.04 92.05 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.68 0.622 . . . . 72.41 112.68 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.5 t -171.06 156.56 4.86 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 110.096 -0.335 . . . . 74.53 110.096 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.4 mt -135.72 132.28 36.68 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.215 -0.661 . . . . 72.44 109.215 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.88 160.78 34.03 Favored 'General case' 0 C--N 1.266 -3.039 0 C-N-CA 125.547 1.539 . . . . 73.42 107.023 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 155.12 37.09 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.368 0.877 . . . . 70.11 113.368 -172.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.37 -19.97 48.85 Favored Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.815 -1.084 . . . . 73.1 112.02 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -89.4 132.29 35.06 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 122.557 0.343 . . . . 74.13 111.422 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.6 m-20 -87.32 138.62 31.33 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.465 -0.939 . . . . 75.22 108.465 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.77 149.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-O 121.807 0.813 . . . . 75.25 110.893 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 63.2 mt -111.72 135.79 49.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 106.482 -1.673 . . . . 73.35 106.482 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.442 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.1 p90 -148.52 178.4 8.65 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.8 -0.36 . . . . 75.12 110.161 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -119.81 154.54 34.12 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 105.077 -2.194 . . . . 74.55 105.077 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 30' ' ' VAL . 27.4 tp -121.07 130.69 53.87 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 113.324 0.861 . . . . 74.14 113.324 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -124.6 150.16 46.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.481 -1.69 . . . . 75.32 111.131 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -100.83 127.09 47.43 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.068 -0.969 . . . . 73.41 110.251 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 58' ' ' LYS . 28.1 tptp -93.76 28.76 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.396 1.078 . . . . 73.52 108.543 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.84 90.86 0.08 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.7 -1.136 . . . . 74.31 107.981 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.37 -44.78 2.61 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.401 -0.818 . . . . 61.33 111.741 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -95.95 153.07 17.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.975 -0.38 . . . . 74.1 109.975 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -126.24 122.6 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.797 -0.446 . . . . 63.03 109.797 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.7 p90 -130.84 140.31 50.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 72.13 111.963 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.34 136.33 44.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.435 -1.257 . . . . 51.41 109.812 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 35.8 m -136.9 163.02 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.362 -0.835 . . . . 72.3 109.708 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.72 63.56 1.91 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.012 0.82 . . . . 72.14 111.034 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD12 HG21 ' A' ' 32' ' ' VAL . 28.7 mt -75.59 149.56 38.25 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.715 -0.794 . . . . 72.44 112.336 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -148.89 130.97 15.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.558 HD12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -74.73 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 118.2 0.455 . . . . 62.13 111.441 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.177 -0.919 . . . . 74.42 109.83 177.104 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 25.8 ttt . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.426 0.155 . . . . 74.22 111.031 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.5 119.67 35.41 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.351 -0.611 . . . . 64.45 109.351 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -95.87 140.51 30.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.675 0.61 . . . . 75.13 112.411 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 49.51 72.15 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.819 1.044 . . . . 71.13 113.819 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 57.0 mt -92.66 151.13 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.146 -0.934 . . . . 72.15 110.081 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 55.9 t -92.28 139.35 18.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.509 -0.768 . . . . 74.32 110.377 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -174.42 179.13 45.95 Favored Glycine 1 N--CA 1.395 -4.039 0 CA-C-N 115.274 -0.875 . . . . 61.23 112.239 169.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -132.69 142.76 49.22 Favored 'General case' 0 C--N 1.259 -3.339 0 C-N-CA 124.017 0.927 . . . . 74.3 108.713 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.36 109.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.667 0.746 . . . . 64.32 109.072 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 22' ' ' GLU . 59.5 tttp -68.38 -40.73 81.28 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.495 1.518 . . . . 73.22 108.613 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -177.76 160.51 1.53 Allowed 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.267 1.427 . . . . 75.43 108.504 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -161.25 133.6 5.96 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.227 0.33 . . . . 74.41 110.227 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -122.29 103.94 9.09 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.629 -0.714 . . . . 53.44 109.368 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -57.11 -32.25 66.12 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.294 -0.866 . . . . 62.24 112.504 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.8 m -60.75 -34.64 74.74 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 112.126 0.417 . . . . 73.34 112.126 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -101.05 -7.01 23.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.522 -0.471 . . . . 71.4 111.009 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.9 m120 66.93 21.45 10.35 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.243 1.017 . . . . 73.01 110.765 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -125.47 152.0 45.52 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.517 0.675 . . . . 73.23 112.398 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.99 -175.62 38.49 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.528 -1.429 . . . . 74.13 109.528 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 m-85 -131.45 165.16 24.14 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 117.05 0.425 . . . . 74.32 110.751 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 65.8 mt -139.44 139.22 39.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.781 -0.822 . . . . 71.24 108.781 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.2 pt-20 -143.1 144.38 32.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.542 -1.651 . . . . 74.53 106.542 175.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.2 pt20 -84.49 151.91 24.3 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 117.451 -1.7 . . . . 73.44 109.633 174.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.91 -18.54 23.76 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.925 -1.034 . . . . 62.33 111.648 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -87.13 -0.93 57.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 73.34 111.41 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.14 51.02 1.1 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.689 -1.243 . . . . 75.24 112.782 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.47 150.08 26.67 Favored Glycine 0 C--N 1.318 -0.46 0 C-N-CA 119.948 -1.12 . . . . 75.2 110.819 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -66.91 171.99 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.572 0.952 . . . . 75.13 113.572 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.01 99.11 2.65 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.915 -0.584 . . . . 72.0 111.781 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 129.45 74.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.028 -0.73 . . . . 72.43 109.028 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 38.6 p90 -92.44 142.5 27.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.092 -0.643 . . . . 74.4 111.345 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.47 122.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-O 121.589 0.709 . . . . 73.2 109.747 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.19 140.76 31.2 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.212 -1.033 . . . . 74.45 108.212 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -76.3 -11.42 59.9 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.917 1.08 . . . . 75.41 113.917 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -61.59 -21.79 64.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 120.623 -0.431 . . . . 65.24 109.846 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.17 68.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.808 0.337 . . . . 71.11 110.197 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.35 -35.53 73.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.085 0 N-CA-C 108.007 -1.109 . . . . 74.11 108.007 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -66.28 -30.5 70.94 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.747 -0.66 . . . . 74.45 111.06 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.79 77.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.617 0.599 . . . . 73.44 112.617 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 -9.18 6.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.178 0.807 . . . . 75.44 113.178 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.99 57.71 7.47 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.49 -1.044 . . . . 63.13 110.49 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.38 131.28 46.78 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -50.83 -58.85 4.93 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.65 0.982 . . . . 64.0 113.65 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 p -170.62 147.25 2.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.199 0.444 . . . . 74.5 112.199 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -124.83 148.92 47.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.304 0.573 . . . . 72.45 110.109 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -166.69 162.13 16.14 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.226 -2.138 . . . . 61.24 105.226 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 149.94 48.14 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.907 -0.717 . . . . 75.02 111.295 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.77 -15.36 63.25 Favored Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.334 -0.848 . . . . 73.32 112.095 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.02 121.16 26.65 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 122.556 0.343 . . . . 64.0 111.476 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 m-20 -72.28 135.21 45.92 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.729 -1.212 . . . . 75.25 107.729 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.49 147.33 19.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 121.968 0.889 . . . . 75.14 111.514 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 60.0 mt -110.67 133.66 55.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 N-CA-C 107.073 -1.455 . . . . 74.12 107.073 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.1 p90 -148.14 174.78 11.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.187 0.518 . . . . 73.21 111.405 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.8 146.09 39.45 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.025 -1.472 . . . . 64.25 107.025 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 HD11 ' H ' ' A' ' 56' ' ' GLU . 25.1 tp -129.13 136.9 50.81 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.646 0.736 . . . . 63.22 111.585 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' H ' HD11 ' A' ' 55' ' ' LEU . 30.6 tt0 -153.15 143.98 22.82 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.473 -2.047 . . . . 71.3 105.473 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -85.67 140.65 30.37 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.892 1.071 . . . . 74.34 113.892 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 84.9 tttt -95.18 80.28 3.57 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.068 -1.827 . . . . 72.41 106.068 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 64.62 -81.6 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.252 1.021 . . . . 72.34 110.452 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.33 -6.83 7.96 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.364 -0.694 . . . . 74.12 111.364 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 9.5 mmpt? -92.49 164.79 13.33 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.293 -0.632 . . . . 74.31 109.293 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.13 118.53 24.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.774 -0.454 . . . . 70.51 109.774 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.524 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.2 p90 -126.78 136.03 51.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.375 0.607 . . . . 74.23 112.271 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 132.5 35.2 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.605 -1.18 . . . . 64.42 110.738 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.59 177.11 6.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 CA-C-N 115.167 -0.924 . . . . 72.52 109.337 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.25 63.16 2.35 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.92 0.762 . . . . 74.11 110.328 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 45.1 mt -81.93 147.46 29.25 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.319 0.859 . . . . 74.14 113.319 -174.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 22.7 tpp180 -151.33 130.64 12.82 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.315 -2.106 . . . . 74.43 105.315 175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -93.78 145.9 7.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 113.239 0.829 . . . . 75.53 113.239 -177.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 58.2 mtpt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 114.986 -1.006 . . . . 72.13 108.672 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 108.589 -0.893 . . . . 73.23 108.589 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.02 89.67 3.06 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.498 0.925 . . . . 72.13 113.498 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.0 p -141.01 140.95 34.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.478 -1.304 . . . . 73.33 107.478 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 58.81 74.2 0.45 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 106.833 -1.543 . . . . 65.1 106.833 -168.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.2 mt -101.47 147.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 113.852 -1.522 . . . . 75.33 111.65 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.4 t -91.27 140.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.502 -1.227 . . . . 73.52 109.384 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -179.91 161.08 26.59 Favored Glycine 0 N--CA 1.414 -2.785 0 C-N-CA 120.232 -0.985 . . . . 73.23 113.416 167.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 4.8 ttmp? -106.44 139.98 40.07 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.561 -0.903 . . . . 74.52 108.561 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.54 109.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.483 -0.932 . . . . 74.31 108.483 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' H ' ' HA ' ' A' ' 21' ' ' ILE . 55.2 tttp -67.59 -42.31 82.67 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.592 -1.64 . . . . 74.23 108.471 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -176.04 160.93 2.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 124.891 1.277 . . . . 71.02 107.783 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 81.3 t80 -163.35 131.97 3.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.043 0.449 . . . . 75.04 110.777 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -112.46 105.01 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.045 -1.094 . . . . 73.4 108.045 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.0 p -61.94 -36.2 80.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.951 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.6 m -63.51 -34.23 77.32 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.843 -0.617 . . . . 71.31 110.812 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 96.6 mttt -93.62 -8.13 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 71.53 111.052 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 m120 67.07 23.61 9.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.943 0.897 . . . . 72.25 112.51 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 46.5 p90 -153.19 168.18 26.84 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 112.883 0.697 . . . . 74.03 112.883 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -177.66 -154.84 12.78 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 109.923 -1.271 . . . . 71.51 109.923 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 35.4 m-85 -140.03 169.48 17.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.513 0.656 . . . . 74.24 111.24 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.47 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 62.9 mt -145.27 140.38 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.163 -1.051 . . . . 73.41 108.163 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.1 139.68 30.55 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.013 -1.477 . . . . 63.33 107.013 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.5 pt20 -84.41 146.5 27.63 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 117.765 -1.574 . . . . 74.1 109.05 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.09 -13.98 20.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 124.632 1.208 . . . . 72.31 110.627 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.44 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 14.1 m120 -87.34 -5.11 59.02 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.772 -0.649 . . . . 73.33 110.592 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.98 0.67 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 118.324 -1.893 . . . . 74.43 113.681 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.2 146.37 19.61 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 119.838 -1.172 . . . . 74.11 110.428 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.66 -175.86 4.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.293 0.849 . . . . 72.53 113.293 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.89 99.11 1.01 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.692 -0.685 . . . . 75.14 111.878 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.33 123.21 59.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.361 -0.978 . . . . 71.4 108.361 173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -92.41 147.49 22.87 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 119.559 -0.856 . . . . 74.3 111.16 -176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 67' ' ' LEU . 7.2 p -104.0 124.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 109.06 -0.719 . . . . 62.41 109.06 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -108.71 149.92 28.31 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.412 -0.959 . . . . 74.33 108.412 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.19 -22.64 61.31 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 113.502 0.927 . . . . 75.52 113.502 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.2 m -56.32 -23.38 36.64 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 120.388 -0.525 . . . . 74.03 111.102 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.92 -36.22 49.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.871 -0.418 . . . . 74.34 109.871 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 42' ' ' LEU . 60.8 t -61.9 -49.8 82.73 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.868 0 N-CA-C 107.416 -1.327 . . . . 75.31 107.416 172.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.93 -33.03 68.38 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.435 1.084 . . . . 72.53 111.73 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -30.12 68.84 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.998 0.427 . . . . 74.15 112.135 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.74 0.08 4.87 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.601 -0.44 . . . . 70.15 111.706 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.05 55.52 27.72 Favored Glycine 0 C--N 1.313 -0.746 0 N-CA-C 110.434 -1.066 . . . . 63.42 110.434 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -64.94 137.5 57.78 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.728 -1.582 . . . . 72.21 106.728 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -61.88 -61.14 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.895 0.331 . . . . 75.41 111.895 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -159.88 151.42 19.92 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.778 -0.453 . . . . 74.33 109.778 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 88.2 mt -123.87 146.59 48.3 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.545 -0.539 . . . . 73.23 109.545 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -160.51 162.12 32.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 106.058 -1.83 . . . . 73.33 106.058 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 148.86 50.12 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.744 -0.782 . . . . 72.52 110.627 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.58 -16.85 60.32 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.492 -0.776 . . . . 75.04 112.484 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.34 128.37 33.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 122.789 -0.242 . . . . 73.23 110.425 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 26.6 m-20 -88.01 138.56 31.35 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.991 -0.744 . . . . 63.13 108.991 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.64 154.23 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.712 -0.676 . . . . 62.04 110.656 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.2 mt -119.97 131.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.841 -1.54 . . . . 71.34 106.841 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.467 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 45.5 p90 -144.38 -179.98 6.88 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.795 0.331 . . . . 75.41 111.426 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -117.37 159.88 22.05 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.674 -1.232 . . . . 75.52 107.674 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 62' ' ' ALA . 22.3 tp -136.79 132.95 35.43 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 121.31 0.576 . . . . 75.51 110.958 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.53 145.39 51.47 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.828 -1.078 . . . . 73.53 108.156 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.86 112.2 20.91 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.45 0.643 . . . . 73.24 111.955 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -84.11 85.68 7.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.518 -1.29 . . . . 72.21 107.518 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 66.85 -71.54 0.1 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.562 1.145 . . . . 72.42 110.703 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 -6.72 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.654 -0.978 . . . . 37.59 110.654 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -92.09 165.65 13.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.076 0.55 . . . . 75.43 109.667 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -133.4 125.59 29.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.332 0.253 . . . . 71.14 110.627 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -136.46 139.88 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.063 0.459 . . . . 75.54 110.921 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 136.58 39.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.698 -1.137 . . . . 75.35 111.282 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.24 165.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.266 -0.879 . . . . 74.55 109.614 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 56.04 65.21 1.5 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.43 0.692 . . . . 75.21 111.06 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 27.9 mt -78.69 140.73 38.32 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.5 -0.88 . . . . 72.22 113.115 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.528 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 8.4 mpt_? -127.97 135.73 50.33 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.168 -1.79 . . . . 73.11 106.168 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -78.69 133.08 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 119.576 -0.85 . . . . 70.32 109.641 172.357 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.532 -0.758 . . . . 72.33 109.219 176.123 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 9.8 mmt . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.844 0.354 . . . . 75.12 110.156 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.52 109.98 9.63 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.769 -1.197 . . . . 71.3 107.769 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -111.58 147.41 35.51 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.804 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 m120 59.34 75.87 0.38 Allowed 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.13 0.894 . . . . 74.0 110.977 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 23.9 mt -104.33 146.41 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.535 -0.757 . . . . 72.12 111.134 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.65 134.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.865 -1.061 . . . . 73.22 109.819 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 23' ' ' GLN . . . 179.09 163.19 29.7 Favored Glycine 0 CA--C 1.454 -3.774 0 C-N-CA 120.325 -0.94 . . . . 65.11 113.493 168.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.2 ttmt -101.81 142.27 33.39 Favored 'General case' 0 C--N 1.252 -3.644 0 CA-C-N 114.622 -0.789 . . . . 73.42 109.241 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.1 108.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.358 -0.979 . . . . 75.44 108.358 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 57.5 tttp -68.07 -38.84 82.88 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.419 -1.264 . . . . 73.31 108.19 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 177.78 157.5 0.39 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 125.272 1.429 . . . . 75.33 108.616 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -146.12 119.52 9.02 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.317 0.58 . . . . 75.11 110.541 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -88.05 107.11 18.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.893 -1.521 . . . . 74.13 106.893 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -11.88 60.01 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.107 0.41 . . . . 61.32 112.107 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 m -79.52 -46.47 17.33 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.27 -0.641 . . . . 73.15 109.27 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -97.41 -7.68 31.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.564 0.579 . . . . 71.3 112.564 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 66.76 27.67 9.18 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.577 0.584 . . . . 73.33 112.577 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -122.79 157.68 31.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.89 -0.595 . . . . 75.41 109.594 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.96 29.57 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.794 -1.323 . . . . 64.33 109.794 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 60.4 m-85 -141.24 167.64 21.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 117.396 0.598 . . . . 75.02 110.768 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -145.4 134.16 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.123 -0.695 . . . . 75.21 109.123 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -144.11 148.54 35.24 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.949 -1.5 . . . . 64.43 106.949 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HB3' ' HA2' ' A' ' 7' ' ' GLY 0.272 0.0 OUTLIER -91.83 158.8 16.12 Favored 'General case' 0 CA--C 1.462 -2.442 0 C-N-CA 115.245 -2.582 . . . . 71.1 109.849 172.714 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.15 -15.52 5.76 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 124.301 1.001 . . . . 72.14 113.027 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -84.36 -2.1 56.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.671 -0.24 . . . . 72.54 111.313 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.22 50.75 0.7 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.871 -0.68 . . . . 61.25 112.8 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.91 52.13 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.494 -0.86 . . . . 72.34 113.461 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -74.88 -178.63 3.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.142 0.496 . . . . 73.2 112.223 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.77 101.3 12.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.898 0.38 . . . . 65.3 110.598 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -128.3 123.76 60.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.411 -0.959 . . . . 73.54 108.411 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 52.6 p90 -87.69 147.14 25.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 120.119 -0.632 . . . . 61.04 111.661 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' CG2' HD12 ' A' ' 67' ' ' LEU . 9.2 p -109.28 141.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.0 -0.741 . . . . 73.34 109.0 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -131.66 155.81 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.235 -0.654 . . . . 72.44 109.235 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -63.47 -18.44 63.77 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 113.151 0.797 . . . . 72.42 113.151 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -57.97 -27.18 63.22 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 120.961 0.41 . . . . 73.4 110.639 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.63 -35.77 45.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.833 -0.432 . . . . 62.32 109.833 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 42' ' ' LEU . 71.9 t -61.98 -48.38 88.83 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.308 0 N-CA-C 107.715 -1.216 . . . . 71.51 107.715 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.84 -33.04 66.39 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.303 1.041 . . . . 74.13 111.241 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.34 68.32 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.112 0.782 . . . . 70.21 113.112 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.99 -2.49 4.62 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.6 52.52 50.45 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 123.65 0.643 . . . . 43.54 112.969 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' HB3' HG11 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -67.65 142.86 56.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.328 -1.73 . . . . 70.42 106.328 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -64.39 -62.42 1.62 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.6 0.593 . . . . 71.05 112.6 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.9 m -167.54 162.68 14.47 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.116 -1.068 . . . . 75.11 108.116 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.68 154.73 45.53 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.729 0.776 . . . . 74.34 112.006 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 174.97 14.6 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.531 -1.655 . . . . 71.53 106.531 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 157.8 28.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.28 0.562 . . . . 63.23 112.225 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.64 14.43 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.584 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.56 126.43 30.78 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 112.229 0.455 . . . . 62.54 112.229 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -81.95 134.46 35.38 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.222 -1.399 . . . . 71.21 107.222 173.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.88 150.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 CA-C-O 121.926 0.87 . . . . 73.34 110.463 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 78.4 mt -115.28 131.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 N-CA-C 106.888 -1.523 . . . . 73.44 106.888 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.0 p90 -146.48 -178.78 6.34 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.49 -0.559 . . . . 75.14 109.49 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.76 158.63 28.39 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.236 -1.764 . . . . 71.44 106.236 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.19 123.18 31.4 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.287 1.041 . . . . 64.12 112.744 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.02 143.78 46.9 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.311 -1.768 . . . . 75.3 107.561 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.41 141.67 28.35 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.766 -0.774 . . . . 74.4 110.38 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 58' ' ' LYS . 1.1 tpmt? -86.24 -61.32 1.77 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.966 -1.494 . . . . 71.41 106.966 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' A' ' 61' ' ' LYS . 6.5 tp-100 170.46 86.21 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.349 -2.093 . . . . 73.42 105.349 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.74 -29.94 2.61 Favored Glycine 0 C--N 1.307 -1.078 0 N-CA-C 111.089 -0.804 . . . . 62.4 111.089 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -92.71 144.75 24.99 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.161 -1.052 . . . . 71.2 108.161 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.71 120.24 26.1 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.968 -0.752 . . . . 74.12 108.968 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 4.2 p90 -129.16 137.12 50.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.381 0.61 . . . . 75.11 112.472 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.0 129.15 38.7 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.46 -1.245 . . . . 75.31 110.224 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.7 166.01 29.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.158 -0.928 . . . . 71.33 109.047 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.77 63.3 2.09 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.871 0.732 . . . . 73.5 110.604 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 32' ' ' VAL . 21.4 mt -76.4 133.62 39.86 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 119.219 -0.992 . . . . 70.14 112.898 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -137.71 131.27 31.11 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 113.899 -1.5 . . . . 72.35 107.858 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 69' ' ' ILE . 2.4 pp -75.3 146.14 9.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.908 -1.117 . . . . 74.41 110.634 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 4.2 ttpm? . . . . . 0 C--O 1.259 1.581 0 CA-C-O 118.115 -0.945 . . . . 72.42 108.873 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 109.923 -0.399 . . . . 74.41 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.14 98.85 3.46 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.643 -0.873 . . . . 63.41 108.643 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -111.8 143.31 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.413 -0.812 . . . . 74.41 112.243 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.1 t30 49.62 75.22 0.17 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.905 1.282 . . . . 74.34 110.376 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.8 mt -99.43 148.98 5.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.773 -1.103 . . . . 74.54 111.192 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.3 p -90.35 139.14 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 115.565 -0.743 . . . . 71.44 109.197 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -164.14 170.49 39.39 Favored Glycine 1 N--CA 1.395 -4.055 0 C-N-CA 120.334 -0.936 . . . . 74.32 112.102 172.252 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -126.12 138.48 53.68 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 108.533 -0.914 . . . . 71.44 108.533 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.03 107.53 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 109.135 -0.691 . . . . 70.34 109.135 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 27.2 mtpp -65.71 -46.67 78.1 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.149 -0.932 . . . . 74.54 109.241 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 58.9 p-90 -172.7 160.1 4.46 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 114.894 -1.048 . . . . 74.35 108.504 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 90.3 t80 -160.5 108.47 1.61 Allowed 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.264 -1.013 . . . . 75.12 108.264 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -84.85 106.19 16.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.82 -0.807 . . . . 73.14 108.82 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 p -64.42 -17.49 63.84 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.487 0.715 . . . . 72.52 112.648 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 m -80.56 -43.5 20.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 120.935 0.398 . . . . 73.4 110.59 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -96.86 -8.15 31.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.9 0.333 . . . . 71.14 111.9 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . 12.6 m120 67.68 24.44 8.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.023 0.929 . . . . 65.44 112.076 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.51 152.6 49.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 122.099 -0.376 . . . . 74.31 111.241 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.67 -168.63 33.5 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 111.178 -0.769 . . . . 73.44 111.178 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 40.4 m-85 -135.52 153.77 51.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.009 0.524 . . . . 61.13 111.529 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -137.23 134.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.718 -0.845 . . . . 73.33 108.718 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 12.7 pt-20 -143.63 150.62 39.04 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.222 -1.769 . . . . 73.2 106.222 173.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.567 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.268 0.5 OUTLIER -70.52 144.65 51.26 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 117.981 -1.488 . . . . 71.04 111.215 174.144 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.8 -39.39 11.77 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.671 -1.604 . . . . 70.05 112.686 -172.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.02 -9.4 30.16 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.64 0.776 . . . . 70.0 113.011 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 50.54 2.53 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.702 -0.761 . . . . 74.33 111.222 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.66 -99.66 0.33 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.083 -0.579 . . . . 75.21 113.179 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.621 0.248 . . . . 74.33 110.718 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.62 97.77 10.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.936 -0.575 . . . . 73.0 109.48 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.443 HG22 HD13 ' A' ' 55' ' ' LEU . 2.6 p -116.4 139.54 42.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.889 -0.596 . . . . 72.42 109.549 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 50.1 p90 -88.53 145.19 25.87 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.839 -0.744 . . . . 75.42 111.334 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.4 131.28 42.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.384 -0.598 . . . . 72.03 109.384 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -107.91 146.87 31.78 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.108 -1.441 . . . . 75.31 107.108 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HD3' ' HB3' ' A' ' 17' ' ' ASN . 27.1 ttpp -68.14 -17.46 64.36 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.684 0.624 . . . . 71.41 112.684 -171.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.6 t -54.92 -23.85 20.82 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 116.191 -0.459 . . . . 74.24 110.381 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -70.62 -41.68 71.91 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.571 0.224 . . . . 74.14 111.237 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.29 -41.49 83.76 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.837 0 N-CA-C 108.05 -1.093 . . . . 75.22 108.05 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.65 -24.38 67.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.947 -0.569 . . . . 73.5 110.889 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.9 45.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.265 0.839 . . . . 61.0 113.265 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.45 -23.37 2.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.813 0.671 . . . . 74.41 112.813 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.9 62.58 2.21 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.79 -0.641 . . . . 51.52 112.088 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 142.69 33.71 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.963 -1.866 . . . . 74.1 105.963 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -58.96 -59.34 5.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 117.737 0.244 . . . . 74.11 111.59 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 p -162.35 161.23 27.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.211 -0.663 . . . . 65.14 109.211 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 74.0 mt -124.02 134.28 53.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.859 -1.163 . . . . 62.42 107.859 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 150.1 34.3 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.08 -0.964 . . . . 74.45 108.479 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.88 151.02 43.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.156 0.799 . . . . 74.23 113.156 -175.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 -23.2 36.1 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.668 -1.151 . . . . 74.53 112.763 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.92 136.05 41.42 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 112.506 0.558 . . . . 74.0 112.506 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -85.97 135.67 33.57 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.665 -1.235 . . . . 74.11 107.665 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.05 151.58 20.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-O 121.49 0.662 . . . . 73.03 111.081 -172.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -116.09 134.21 60.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.9 p90 -144.86 -178.11 5.86 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.942 -0.392 . . . . 73.41 109.942 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.36 145.07 49.04 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.818 -1.549 . . . . 64.42 106.818 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD13 HG22 ' A' ' 30' ' ' VAL . 28.3 tp -116.5 109.37 17.18 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 122.374 1.083 . . . . 73.51 110.578 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -122.06 136.96 54.97 Favored 'General case' 0 C--N 1.258 -3.391 0 N-CA-C 105.07 -2.196 . . . . 74.43 105.07 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.9 136.9 33.1 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 114.693 1.368 . . . . 73.13 114.693 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 60.8 tptt -82.47 79.78 8.81 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.774 -1.936 . . . . 71.45 105.774 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 67.37 -80.0 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.946 0.898 . . . . 74.44 109.69 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.05 7.3 4.42 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.718 -0.953 . . . . 51.51 110.718 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -102.45 155.89 17.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.835 -1.543 . . . . 72.04 106.835 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.54 122.05 42.63 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.864 -0.522 . . . . 71.32 111.107 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -135.53 142.66 45.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.026 0.441 . . . . 75.02 109.986 178.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.62 33.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.233 -0.894 . . . . 74.35 109.953 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -133.54 169.38 21.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 73.04 111.019 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 57.2 63.13 1.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.218 0.949 . . . . 73.42 110.49 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 33.2 mt -81.91 140.29 34.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.299 1.222 . . . . 75.22 114.299 -172.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -140.28 139.54 35.53 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 125.829 1.651 . . . . 75.21 106.923 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.42 147.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 117.207 -1.797 . . . . 73.53 110.944 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.254 1.33 0 O-C-N 124.239 0.962 . . . . 73.21 110.898 179.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtm . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.943 -0.762 . . . . 62.34 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.99 134.98 49.3 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.977 -1.12 . . . . 75.22 107.977 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.5 p -117.14 140.79 49.09 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 111.378 0.14 . . . . 75.32 111.378 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 76.26 0.37 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.873 0.844 . . . . 63.32 112.022 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 47.1 mt -106.33 148.45 10.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 114.679 -1.146 . . . . 73.2 110.099 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.6 p -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 O-C-N 124.06 0.85 . . . . 71.21 109.794 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -166.47 171.15 41.36 Favored Glycine 1 N--CA 1.396 -4.009 0 C-N-CA 120.393 -0.908 . . . . 71.21 112.306 170.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.9 ttmt -123.89 137.22 54.67 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.123 -1.065 . . . . 74.34 108.123 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.44 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.366 -0.975 . . . . 74.55 108.366 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.8 tttp -75.94 -44.58 39.35 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.12 -1.4 . . . . 65.32 109.386 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -169.54 157.83 7.44 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.632 -0.713 . . . . 74.52 110.269 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -147.45 133.17 18.91 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.598 -0.728 . . . . 71.25 109.437 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -106.08 118.0 35.48 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.506 -0.924 . . . . 72.13 108.506 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 t -68.26 -33.85 75.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.157 -0.474 . . . . 75.31 111.464 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 m -73.57 -49.29 27.07 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.822 0.344 . . . . 71.43 111.534 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 64.4 mttp -82.25 -8.26 59.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.198 0.444 . . . . 72.23 112.198 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 13.4 m120 63.76 22.25 13.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.102 0.778 . . . . 75.41 113.102 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 42.0 p90 -142.37 174.25 10.79 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.544 -0.863 . . . . 75.03 110.804 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.63 -155.29 13.62 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.615 -0.994 . . . . 65.12 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 30.4 m-85 -132.65 163.54 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.404 0.621 . . . . 72.43 112.023 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.8 mt -145.84 138.51 20.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.105 -1.443 . . . . 73.22 107.105 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.07 148.64 35.43 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.761 -1.57 . . . . 74.14 106.761 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.538 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.279 0.2 OUTLIER -72.17 147.58 46.45 Favored 'General case' 0 CA--C 1.47 -2.115 0 C-N-CA 117.464 -1.694 . . . . 73.11 109.971 172.071 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -49.25 -35.15 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.0 1.438 . . . . 74.44 112.443 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -70.01 -0.85 8.25 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.458 0.91 . . . . 74.01 113.458 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 51.52 4.05 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 120.304 -0.95 . . . . 61.21 111.085 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' HA3' ' OE1' ' A' ' 23' ' ' GLN . . . -75.39 -110.55 0.1 Allowed Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.983 -0.627 . . . . 74.52 114.369 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.13 174.55 5.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.981 0.42 . . . . 73.33 112.1 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -102.27 92.87 4.91 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.319 -0.993 . . . . 64.32 108.319 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -116.74 124.45 72.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.633 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.4 p90 -91.19 149.16 21.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.009 -0.541 . . . . 72.03 110.189 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 67' ' ' LEU . 8.8 p -107.63 132.39 55.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 109.335 -0.617 . . . . 75.04 109.335 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -111.93 145.1 40.17 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.077 -1.083 . . . . 71.13 108.077 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 35.9 ttpt -62.54 -22.96 66.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -54.17 -24.07 16.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.34 112.144 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.77 -39.25 70.11 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 122.127 -0.358 . . . . 55.44 110.643 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.56 -36.52 71.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 107.86 -1.163 . . . . 74.25 107.86 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.38 -29.54 70.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.069 -0.969 . . . . 75.43 110.87 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.14 -47.7 9.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.584 0.587 . . . . 75.24 112.584 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -9.87 28.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.019 0.748 . . . . 71.1 113.019 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.48 55.61 29.06 Favored Glycine 0 CA--C 1.498 -1.022 0 O-C-N 123.459 0.475 . . . . 74.43 112.224 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.5 tm? -69.49 141.5 53.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.255 -1.017 . . . . 73.4 108.255 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' N ' HD11 ' A' ' 42' ' ' LEU . 58.7 t-80 -51.75 -60.67 2.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.867 . . . . 72.33 112.334 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -172.51 162.43 5.25 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -124.82 121.08 33.54 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.852 0.834 . . . . 72.14 109.657 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.54 144.85 36.14 Favored 'General case' 0 C--N 1.245 -3.95 0 CA-C-N 113.962 -1.472 . . . . 60.41 108.463 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.65 147.13 53.1 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.605 0.717 . . . . 70.53 112.253 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.21 -16.9 59.41 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.001 -0.999 . . . . 55.34 111.891 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.28 137.47 35.8 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 122.496 0.318 . . . . 74.31 110.659 177.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 9.4 m-20 -88.53 137.48 32.29 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.018 -1.105 . . . . 74.31 108.018 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.65 149.52 23.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 121.704 0.764 . . . . 73.41 110.969 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.1 mt -111.75 137.62 43.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.182 -1.784 . . . . 72.33 106.182 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.1 p90 -152.09 178.87 9.01 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.708 -0.397 . . . . 75.23 110.705 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -114.43 160.52 19.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.843 -2.28 . . . . 74.23 104.843 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 62' ' ' ALA . 18.7 tp -129.81 127.74 40.91 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 113.593 0.96 . . . . 74.41 113.593 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD11 ' A' ' 55' ' ' LEU . 47.0 mt-10 -114.08 134.67 54.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.275 -1.784 . . . . 74.51 107.981 174.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -93.41 134.18 35.91 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.284 0.564 . . . . 72.35 110.818 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 58.4 tptt -102.29 76.9 1.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.11 -1.441 . . . . 73.41 107.11 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 67.71 -70.43 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.647 1.179 . . . . 73.1 110.67 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 -15.56 1.45 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.22 -0.752 . . . . 75.42 111.22 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 54.7 mtpt -84.43 165.04 18.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.57 -0.53 . . . . 75.32 109.57 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -127.94 129.47 46.87 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.619 -0.433 . . . . 53.15 110.499 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.4 p90 -127.65 128.38 45.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 113.167 0.803 . . . . 72.51 113.167 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.48 133.29 43.62 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.264 -1.335 . . . . 73.33 110.688 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.64 164.41 30.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.015 -1.106 . . . . 71.34 108.015 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.71 63.33 2.28 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.733 0.646 . . . . 65.35 110.959 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 38.4 mt -78.46 149.47 33.22 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.775 -0.648 . . . . 64.32 111.937 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -150.81 131.66 14.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.772 -1.936 . . . . 74.23 105.772 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 2.6 pp -80.33 140.57 16.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.366 -1.333 . . . . 74.25 112.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.088 -0.96 . . . . 74.33 109.214 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.507 -0.675 0 N-CA-C 108.574 -0.899 . . . . 74.02 108.574 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.9 91.2 3.46 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.576 -0.527 . . . . 72.31 109.576 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.8 p -115.87 142.56 46.61 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.65 -0.705 . . . . 64.31 110.983 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.35 78.09 0.2 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.035 0.921 . . . . 65.21 111.334 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.45 147.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 114.154 -1.384 . . . . 73.42 109.965 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 73.8 t -92.19 134.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 115.223 -0.899 . . . . 64.21 108.643 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.41 172.73 38.57 Favored Glycine 1 N--CA 1.392 -4.265 0 C-N-CA 120.27 -0.967 . . . . 72.34 112.154 171.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 27.5 ttpp -130.48 132.67 45.77 Favored 'General case' 0 C--N 1.257 -3.42 0 C-N-CA 125.204 1.402 . . . . 75.01 108.412 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.8 115.85 2.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.933 -0.576 . . . . 75.12 110.162 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HD2' ' CB ' ' A' ' 20' ' ' PHE . 66.7 mttm -66.94 -49.43 65.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.413 -0.958 . . . . 73.3 108.413 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -173.78 165.43 4.42 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.246 -1.343 . . . . 74.23 108.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -153.79 121.25 5.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.4 0.438 . . . . 74.43 110.368 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -96.36 98.81 10.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.088 0.471 . . . . 71.04 109.946 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 m -58.93 -35.08 72.51 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.113 -0.949 . . . . 62.31 111.427 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 m -65.32 -31.12 72.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.236 0.541 . . . . 74.21 110.525 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -97.98 -9.01 26.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.1 -0.375 . . . . 73.34 111.997 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.82 23.36 11.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.973 0.509 . . . . 72.2 112.346 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 37.4 p90 -151.06 161.12 43.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.445 0.64 . . . . 72.41 112.539 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -166.95 -162.27 18.18 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.156 -1.578 . . . . 75.1 109.156 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.486 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . 46.9 m-85 -135.71 154.84 51.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.938 0.869 . . . . 75.21 111.711 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.72 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.224 -0.658 . . . . 74.11 109.224 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 14.0 pt-20 -143.54 147.65 34.78 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 105.755 -1.942 . . . . 65.31 105.755 173.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.0 pt20 -80.73 151.3 28.93 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 116.786 -1.966 . . . . 72.52 109.44 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.74 -29.02 24.76 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.251 -1.34 . . . . 71.34 111.913 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -75.71 1.08 15.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.775 -0.648 . . . . 73.12 111.851 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.41 50.87 1.79 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.54 -0.838 . . . . 74.42 111.207 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.81 172.2 54.96 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.639 -0.791 . . . . 64.12 112.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.33 162.96 28.59 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.771 0.656 . . . . 75.41 112.771 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.14 97.67 10.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.398 -0.819 . . . . 72.34 110.604 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.403 HG22 HD13 ' A' ' 55' ' ' LEU . 3.2 p -117.81 134.87 60.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.118 -0.947 . . . . 74.51 109.062 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -90.6 150.15 21.83 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.032 -0.667 . . . . 74.12 111.221 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 67' ' ' LEU . 7.5 p -110.11 125.46 67.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.583 -0.525 . . . . 63.13 109.583 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -108.43 152.93 24.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.298 -1.001 . . . . 73.33 108.298 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.06 -16.04 39.23 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 113.073 0.768 . . . . 74.11 113.073 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -58.76 -26.42 63.99 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.228 0.537 . . . . 54.43 110.03 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.94 -36.44 56.56 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.983 0.42 . . . . 73.41 109.973 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.68 -48.85 84.76 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.091 0 N-CA-C 107.647 -1.242 . . . . 71.13 107.647 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.37 -28.23 58.55 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 124.816 1.246 . . . . 64.12 111.292 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.13 -23.32 67.1 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.458 0.54 . . . . 53.23 112.458 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.44 -24.15 2.29 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.712 0.634 . . . . 72.12 112.712 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.16 48.74 5.57 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.454 -1.059 . . . . 50.03 110.454 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 130.37 41.09 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.435 -1.32 . . . . 75.51 107.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.35 -47.78 75.26 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.128 1.158 . . . . 74.41 114.128 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.4 p -159.06 160.49 35.85 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.53 -0.468 . . . . 74.43 111.064 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.11 142.78 48.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.249 -1.019 . . . . 73.44 108.249 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.86 162.77 40.51 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 123.73 0.812 . . . . 71.54 109.319 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -67.49 153.33 43.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.445 0.641 . . . . 65.24 112.466 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -16.08 59.27 Favored Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.881 -1.054 . . . . 72.35 112.198 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -83.84 124.93 31.46 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.244 0.218 . . . . 72.21 111.122 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 15.4 m-20 -78.33 133.57 37.59 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 107.185 -1.413 . . . . 64.02 107.185 174.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.74 147.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.138 0 CA-C-O 121.913 0.863 . . . . 72.51 110.51 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -109.98 132.28 58.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 N-CA-C 107.002 -1.481 . . . . 73.55 107.002 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -147.62 178.67 8.27 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.764 -0.458 . . . . 72.1 109.764 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -119.67 155.27 32.7 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.671 -1.974 . . . . 74.02 105.671 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 30' ' ' VAL . 26.3 tp -124.4 111.26 15.55 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.452 1.12 . . . . 75.23 112.649 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.74 141.51 45.26 Favored 'General case' 0 C--N 1.268 -2.953 0 CA-C-N 113.062 -1.881 . . . . 62.14 107.425 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 59' ' ' GLN . 33.0 tt0 -87.06 142.14 28.14 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.276 -0.638 . . . . 74.45 109.276 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -90.41 22.31 3.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.298 -1.371 . . . . 73.15 107.298 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 57' ' ' GLU . 29.4 tt0 65.09 87.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 75.14 108.333 -172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.21 -58.41 0.6 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.692 -1.14 . . . . 74.45 111.24 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.1 mmmt -86.19 154.12 21.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.177 -0.305 . . . . 63.13 110.177 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.69 118.11 27.33 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.215 0.206 . . . . 70.44 110.574 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -131.89 140.41 49.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.367 0.603 . . . . 73.21 111.509 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.97 135.14 46.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.675 -1.148 . . . . 64.24 109.527 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 34.8 m -133.96 164.71 33.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.364 -0.835 . . . . 64.15 109.959 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.53 64.23 1.74 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.962 0.789 . . . . 55.35 111.593 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 HG21 ' A' ' 32' ' ' VAL . 28.9 mt -74.67 140.14 44.02 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.671 0.989 . . . . 75.53 113.671 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -143.51 131.35 21.5 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.36 -1.718 . . . . 75.4 106.36 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.9 148.72 4.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.346 -0.942 . . . . 73.34 111.536 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 3.7 ttpm? . . . . . 0 C--O 1.256 1.412 0 CA-C-O 118.758 -0.639 . . . . 73.23 109.498 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 108.356 -0.979 . . . . 71.22 108.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.69 117.09 2.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.144 -1.428 . . . . 73.31 107.144 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.5 p -100.43 140.29 34.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 123.357 0.411 . . . . 74.41 111.812 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 56.5 77.79 0.24 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.774 1.23 . . . . 60.03 110.701 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.3 mt -100.42 148.4 6.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 114.627 -1.17 . . . . 72.32 109.564 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 87.8 t -92.81 132.84 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-N 115.369 -0.832 . . . . 74.13 109.522 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -161.99 163.93 35.08 Favored Glycine 1 N--CA 1.395 -4.087 0 CA-C-N 115.272 -0.877 . . . . 75.41 111.576 171.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -119.28 136.42 54.24 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.898 -1.149 . . . . 74.02 107.898 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.83 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.329 0.585 . . . . 75.45 109.572 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 49.1 tttp -70.18 -47.26 62.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.826 -1.079 . . . . 61.24 108.109 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 68.9 p-90 -173.66 165.75 4.52 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.16 0.984 . . . . 63.15 108.641 175.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.02 132.78 4.31 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.376 0.422 . . . . 74.45 110.596 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -125.39 107.81 11.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.463 -0.569 . . . . 73.33 109.463 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 m -57.55 -33.86 68.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.85 -0.614 . . . . 71.41 110.902 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.9 m -61.44 -33.17 73.28 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 115.951 -0.568 . . . . 73.21 111.219 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -97.62 -8.72 28.27 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 122.021 -0.424 . . . . 72.42 111.049 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 m120 61.26 21.48 11.97 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.784 0.834 . . . . 71.13 110.622 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -137.5 163.62 30.68 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.387 0.675 . . . . 73.3 110.894 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -175.02 -172.55 40.06 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 107.836 -2.106 . . . . 63.34 107.836 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 21.3 m-85 -136.05 162.93 31.52 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 117.749 0.775 . . . . 75.23 111.794 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.5 134.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.669 -1.151 . . . . 75.22 107.924 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.3 pt-20 -135.98 141.79 44.46 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.01 -2.219 . . . . 75.5 105.01 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.8 pt20 -78.53 143.29 36.7 Favored 'General case' 0 CA--C 1.464 -2.353 0 C-N-CA 116.135 -2.226 . . . . 71.53 108.922 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.63 -18.01 4.02 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.793 1.308 . . . . 61.55 112.07 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.36 -0.32 28.53 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.603 -0.726 . . . . 73.43 111.428 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.4 41.91 35.78 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 110.995 -0.842 . . . . 75.34 110.995 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 -132.35 4.26 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.933 -0.651 . . . . 63.44 113.371 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -86.64 152.49 22.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.149 0.426 . . . . 73.33 112.149 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.2 130.25 47.26 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 116.073 -0.512 . . . . 75.25 110.126 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 55' ' ' LEU . 2.7 p -138.66 143.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.823 -0.806 . . . . 74.35 108.823 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 51.5 p90 -93.53 148.99 21.58 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.696 -0.802 . . . . 74.43 111.603 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.498 ' CG2' HD12 ' A' ' 67' ' ' LEU . 7.1 p -105.74 128.85 59.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 CA-C-N 115.75 -0.659 . . . . 73.33 109.316 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -110.02 150.34 28.68 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.015 -0.735 . . . . 74.42 109.015 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.7 -18.82 64.39 Favored 'General case' 0 C--O 1.203 -1.395 0 N-CA-C 113.671 0.989 . . . . 71.4 113.671 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -57.22 -27.5 62.06 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.942 0.401 . . . . 74.52 110.314 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.73 59.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 120.986 0.422 . . . . 75.13 110.38 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.84 -37.77 77.83 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.286 0 N-CA-C 108.292 -1.003 . . . . 73.41 108.292 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.88 -32.58 73.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.053 0.541 . . . . 74.41 110.722 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.96 66.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.35 112.72 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -23.3 2.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.21 0.819 . . . . 61.11 113.21 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 53.93 3.57 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 109.954 -1.258 . . . . 74.12 109.954 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -75.58 127.0 32.11 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.89 -0.655 . . . . 75.41 111.396 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -104.61 -0.4 27.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.816 -0.629 . . . . 72.3 111.391 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 m -123.32 79.3 1.66 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.151 1.167 . . . . 62.33 114.151 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.16 114.1 19.2 Favored 'General case' 0 C--N 1.251 -3.683 0 N-CA-C 108.108 -1.071 . . . . 74.21 108.108 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -151.79 158.19 42.97 Favored 'General case' 1 C--N 1.243 -4.035 0 CA-C-N 113.94 -1.482 . . . . 70.55 107.239 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.12 148.83 49.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.695 0.759 . . . . 74.51 112.344 -174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.29 -18.61 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 CA-C-N 114.82 -1.082 . . . . 63.24 113.993 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -71.03 135.05 47.59 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 117.546 0.673 . . . . 63.41 111.644 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.07 135.11 34.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.426 -1.324 . . . . 75.44 107.426 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.56 145.28 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-O 121.981 0.896 . . . . 72.43 110.989 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.99 130.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.483 -1.673 . . . . 74.31 106.483 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.477 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.3 p90 -146.62 179.62 7.43 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.153 -0.619 . . . . 73.41 110.995 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -120.36 158.29 27.45 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 105.532 -2.025 . . . . 64.44 105.532 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 30' ' ' VAL . 26.1 tp -129.69 129.54 44.36 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.099 1.148 . . . . 74.1 114.099 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD11 ' A' ' 55' ' ' LEU . 5.2 mm-40 -125.63 139.46 53.55 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 113.088 -1.869 . . . . 64.1 109.567 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.94 142.79 32.68 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.825 -1.08 . . . . 75.31 111.688 -174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -90.76 31.92 1.02 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.271 -1.011 . . . . 75.32 108.271 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 62.34 22.72 13.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.197 -0.911 . . . . 70.01 111.715 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.08 -49.08 0.13 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 109.526 -1.43 . . . . 75.31 109.526 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -93.01 164.71 13.17 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.338 -0.431 . . . . 73.22 110.787 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -132.76 119.08 19.84 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.406 -0.59 . . . . 61.4 109.406 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.481 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 44.0 p90 -124.59 133.28 53.32 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.519 0.676 . . . . 71.4 112.423 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.19 134.05 42.75 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.631 -1.168 . . . . 75.23 110.534 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.77 169.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.937 -1.028 . . . . 71.34 109.517 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 53.77 63.06 2.33 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 123.246 0.619 . . . . 53.31 111.384 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.498 HD12 ' CG2' ' A' ' 32' ' ' VAL . 21.9 mt -82.36 135.77 35.12 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.617 0.723 . . . . 72.03 112.869 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -145.95 130.13 17.52 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 114.059 -1.428 . . . . 71.03 107.997 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -80.69 148.79 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 C-N-CA 121.057 -0.257 . . . . 73.5 110.717 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 124.387 1.054 . . . . 75.44 109.152 176.201 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 108.788 -0.819 . . . . 74.43 108.788 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.64 147.77 45.22 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.094 -0.706 . . . . 73.22 109.094 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 p -131.54 153.18 50.11 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.246 0.461 . . . . 71.23 112.246 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 62.68 40.52 10.11 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.022 0.929 . . . . 72.45 111.633 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 mt -75.25 152.94 6.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.772 -0.649 . . . . 75.44 111.229 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 85.9 t -106.83 136.75 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 115.3 -0.863 . . . . 75.32 109.053 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.3 168.73 41.02 Favored Glycine 0 N--CA 1.404 -3.456 0 C-N-CA 119.128 -1.511 . . . . 72.43 113.77 167.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -113.72 136.24 53.07 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 114.411 -0.894 . . . . 72.22 108.969 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.57 107.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.965 -0.754 . . . . 71.51 108.965 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -63.81 -52.99 57.72 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.699 -1.137 . . . . 75.34 109.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 64.4 p-90 -160.64 160.01 31.08 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 108.859 -0.793 . . . . 72.41 108.859 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -157.61 125.31 5.3 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 124.053 0.845 . . . . 73.1 109.272 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.08 115.99 31.06 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 70.2 107.293 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 t -73.0 -25.96 61.17 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.698 0.285 . . . . 74.0 111.261 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 m -68.55 -55.21 12.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.116 0.484 . . . . 71.34 110.356 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.49 -8.49 52.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.498 . . . . 75.42 111.709 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.17 26.17 13.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.194 0.813 . . . . 72.01 113.194 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.83 157.98 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.869 -0.419 . . . . 75.33 109.869 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.96 -174.14 45.56 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.135 -0.786 . . . . 54.01 111.135 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -134.35 159.86 39.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.117 0.567 . . . . 71.15 111.132 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -143.08 135.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 123.737 0.648 . . . . 75.42 109.372 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.84 153.27 42.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.133 -1.432 . . . . 65.54 107.133 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.3 pt20 -84.84 154.69 22.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.382 -1.327 . . . . 73.23 109.386 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.55 -22.41 61.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.159 0.912 . . . . 72.22 113.116 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -77.82 -2.96 39.08 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.763 -0.375 . . . . 72.24 111.771 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.46 51.19 1.23 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 110.256 -1.138 . . . . 61.2 110.256 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -77.14 164.41 52.73 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.365 -0.921 . . . . 71.33 112.128 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.71 155.76 40.03 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 123.806 0.357 . . . . 74.33 111.816 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.09 120.93 25.93 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.83 0.824 . . . . 75.21 111.567 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.471 HG22 HD13 ' A' ' 55' ' ' LEU . 2.7 p -135.9 135.2 50.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.489 -1.232 . . . . 75.34 107.915 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.6 p90 -90.12 150.36 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.43 -0.908 . . . . 70.3 110.84 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.415 ' CG2' HD12 ' A' ' 67' ' ' LEU . 7.3 p -95.29 126.47 47.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-O 121.456 0.646 . . . . 61.21 109.606 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -113.33 148.0 36.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.731 -0.84 . . . . 71.45 108.731 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.72 -21.99 66.88 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.664 0.987 . . . . 72.02 113.664 -173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -54.19 -22.16 10.74 Favored 'General case' 0 C--O 1.208 -1.09 0 C-N-CA 120.627 -0.429 . . . . 37.27 111.315 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -74.21 -42.51 59.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.069 0.461 . . . . 74.02 110.853 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 57.3 t -70.45 -30.31 42.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.51 0 N-CA-C 108.215 -1.031 . . . . 75.02 108.215 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.63 -36.12 65.39 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.036 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.98 24.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.422 0.527 . . . . 73.23 112.422 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.07 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.43 0.53 . . . . 73.25 112.43 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 77.75 62.96 2.28 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 121.454 -0.403 . . . . 72.34 112.224 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.83 130.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.817 -1.549 . . . . 72.14 106.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.45 -49.27 78.24 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.525 0.565 . . . . 74.15 112.525 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -175.09 137.99 0.43 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.097 0.559 . . . . 72.21 110.918 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.82 164.31 12.69 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.195 0.521 . . . . 74.31 110.62 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -169.49 162.83 10.26 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.257 -1.757 . . . . 63.13 106.257 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.5 OUTLIER -75.17 152.84 38.4 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.207 0.527 . . . . 54.13 111.928 -177.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.25 69.81 Favored Glycine 0 C--N 1.306 -1.119 0 CA-C-N 115.386 -0.824 . . . . 72.21 112.478 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -77.42 136.26 38.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 122.503 0.321 . . . . 73.01 111.581 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.56 134.19 33.67 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.227 -1.397 . . . . 72.31 107.227 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.21 147.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-O 121.869 0.842 . . . . 72.23 110.773 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.03 129.34 71.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 106.41 -1.7 . . . . 73.31 106.41 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.5 p90 -147.52 -177.53 5.75 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 120.043 -0.663 . . . . 74.13 110.873 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -124.0 161.81 24.72 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 105.501 -2.037 . . . . 72.4 105.501 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.471 HD13 HG22 ' A' ' 30' ' ' VAL . 23.2 tp -130.18 129.83 43.93 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-O 121.899 0.857 . . . . 71.41 112.946 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.1 137.81 54.83 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.629 -1.623 . . . . 70.02 107.432 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.79 155.77 18.1 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.118 0.961 . . . . 73.0 110.308 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.0 tttp -116.88 24.66 11.07 Favored 'General case' 0 C--N 1.252 -3.643 0 N-CA-C 107.094 -1.447 . . . . 73.51 107.094 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 70.68 -59.99 0.51 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.5 1.52 . . . . 75.33 111.809 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.52 -23.34 36.96 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.098 -0.801 . . . . 62.2 111.098 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.1 mmtt -123.03 164.98 17.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.585 0.231 . . . . 64.23 111.11 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.34 116.42 11.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.192 -1.04 . . . . 71.52 108.192 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p90 -130.39 137.48 49.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.452 0.644 . . . . 73.35 112.442 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 137.52 51.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.666 -1.152 . . . . 51.11 110.181 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 29.0 m -135.42 161.6 38.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 75.04 109.986 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 56.27 63.88 1.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.03 0.831 . . . . 75.03 109.83 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 32.6 mt -79.24 137.43 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.968 0.729 . . . . 75.23 112.968 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.98 135.02 39.19 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-N 114.729 -1.123 . . . . 74.14 109.119 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -72.41 134.19 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 109.408 -0.589 . . . . 74.44 109.408 173.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.307 -1.265 0 O-C-N 123.849 0.718 . . . . 75.21 110.117 179.641 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 120.71 0.29 . . . . 73.12 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.4 116.38 8.85 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.782 -0.822 . . . . 62.53 108.782 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.2 p -107.68 145.6 33.18 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.624 -0.262 . . . . 74.12 111.079 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 58.37 78.39 0.25 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.46 1.104 . . . . 61.3 109.78 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 50.7 mt -108.33 149.53 11.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.314 -1.312 . . . . 71.35 110.245 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 88.5 t -93.26 132.98 35.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.269 -0.878 . . . . 73.31 109.79 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.488 ' HA2' ' CA ' ' A' ' 23' ' ' GLN . . . -158.58 164.89 33.77 Favored Glycine 0 N--CA 1.405 -3.404 0 C-N-CA 120.522 -0.846 . . . . 74.21 111.944 171.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.05 134.31 53.68 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 107.234 -1.395 . . . . 72.34 107.234 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.45 110.41 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.725 -1.213 . . . . 75.02 107.725 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.3 tttp -75.2 -49.88 17.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.286 -1.325 . . . . 75.42 109.36 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -167.72 160.91 13.04 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.618 -0.882 . . . . 73.51 108.618 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -161.39 116.59 2.07 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.738 0.649 . . . . 75.22 110.18 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -92.08 105.76 17.92 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.03 -1.1 . . . . 63.42 108.03 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -53.95 -45.48 71.31 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 124.259 1.024 . . . . 71.5 111.8 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -58.1 -37.44 74.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.131 0.572 . . . . 74.52 111.635 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -99.22 -5.72 29.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.769 -0.372 . . . . 75.34 111.958 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.68 27.33 17.06 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.475 0.484 . . . . 73.43 111.897 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -134.83 152.13 51.5 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.598 -0.519 . . . . 74.3 109.598 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.89 -165.95 33.14 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.826 -0.909 . . . . 70.32 110.826 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 34.8 m-85 -137.26 165.01 27.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.209 0.528 . . . . 73.44 112.023 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -147.28 135.77 15.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.949 -1.13 . . . . 65.45 107.949 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.09 147.34 33.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.02 -2.215 . . . . 72.14 105.02 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.0 pt20 -77.35 144.15 38.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 C-N-CA 116.216 -2.194 . . . . 74.52 109.444 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.02 -29.1 27.5 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.971 1.419 . . . . 73.01 112.471 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.08 -11.77 61.13 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 62.25 111.847 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.89 50.85 0.76 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.42 -0.895 . . . . 72.33 111.199 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.59 171.2 36.07 Favored Glycine 0 C--N 1.318 -0.447 0 N-CA-C 110.602 -0.999 . . . . 75.03 110.602 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.81 147.82 33.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.353 0.577 . . . . 74.22 111.327 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 122.81 18.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.941 -1.027 . . . . 63.02 110.695 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 139.96 49.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -92.64 142.95 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 119.413 -0.915 . . . . 75.14 112.62 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 67' ' ' LEU . 10.8 p -112.83 142.02 26.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.303 -0.862 . . . . 73.35 109.023 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -136.64 162.5 32.97 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.017 -1.105 . . . . 74.15 108.017 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.11 -18.68 59.28 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 112.281 0.474 . . . . 75.51 112.281 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -52.89 -30.2 32.69 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.084 0.469 . . . . 73.15 110.302 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.95 -35.08 57.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.355 -0.384 . . . . 74.12 110.42 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -41.45 89.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.316 0 N-CA-C 107.786 -1.19 . . . . 75.03 107.786 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.07 -36.86 82.93 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.93 -0.577 . . . . 62.24 110.219 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.54 75.66 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.557 0.947 . . . . 74.52 113.557 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.23 -10.79 4.18 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.626 0.973 . . . . 61.43 113.626 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 55.0 5.61 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.21 -0.756 . . . . 45.01 111.21 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' N ' ' A' ' 43' ' ' HIS . 2.4 tm? -71.6 149.82 45.26 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.929 -1.508 . . . . 74.11 106.929 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.56 ' N ' HD11 ' A' ' 42' ' ' LEU . 60.7 m80 -83.04 -60.98 1.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.536 -0.727 . . . . 73.21 111.912 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.5 p -165.87 145.01 6.14 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 122.914 0.485 . . . . 75.42 109.919 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.8 mt -109.9 146.65 34.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.541 0.686 . . . . 74.43 111.669 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.49 153.04 41.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.607 -1.627 . . . . 63.14 106.607 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 155.3 38.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.905 0.383 . . . . 75.1 111.182 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 4.84 79.22 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 121.113 -0.565 . . . . 52.4 112.574 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.43 135.96 34.17 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 122.659 0.384 . . . . 74.11 110.352 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -86.0 120.14 27.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.25 -1.389 . . . . 74.04 107.25 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.37 152.7 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 CA-C-O 121.655 0.741 . . . . 75.44 111.044 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.5 mt -114.47 136.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.028 -1.471 . . . . 75.1 107.028 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -151.19 177.55 10.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.136 -0.32 . . . . 72.41 110.136 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.4 147.7 40.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.54 -1.652 . . . . 72.3 106.54 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 27.3 tp -134.41 133.4 40.49 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.249 1.023 . . . . 73.01 112.056 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -135.71 137.11 41.41 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 113.287 -1.779 . . . . 64.0 107.033 173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.94 138.81 32.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.69 0.757 . . . . 75.12 112.102 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.4 tttm -99.21 72.55 1.86 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 75.34 107.214 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.82 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.548 1.539 . . . . 71.41 109.339 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 -18.4 5.01 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.449 -0.405 . . . . 53.33 112.183 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 8.3 mmpt? -89.19 164.69 14.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.397 -0.594 . . . . 72.01 109.397 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.78 118.54 16.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.803 -0.443 . . . . 63.14 109.803 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -121.93 134.21 54.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.434 0.635 . . . . 73.14 111.976 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.41 131.85 35.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.817 -1.083 . . . . 52.24 109.559 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.0 m -139.64 168.31 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.484 -0.78 . . . . 74.25 110.036 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.73 63.21 1.87 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.956 0.785 . . . . 72.41 109.944 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 34.3 mt -81.41 143.33 32.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.342 -0.844 . . . . 75.3 111.912 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -145.68 129.87 17.57 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.807 -1.923 . . . . 64.41 105.807 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.574 HD12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.68 141.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 118.057 0.389 . . . . 73.2 111.764 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt . . . . . 0 C--N 1.298 -1.652 0 CA-C-N 115.274 -0.875 . . . . 65.22 109.723 176.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 C--O 1.221 -0.436 0 N-CA-C 111.175 0.065 . . . . 75.51 111.175 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.43 135.39 35.64 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.123 -0.325 . . . . 71.23 110.123 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.1 p -120.99 146.12 47.02 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.384 0.513 . . . . 71.43 112.384 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 59.16 78.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.804 1.242 . . . . 64.44 112.266 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 33.4 mt -106.88 147.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.217 -0.901 . . . . 75.01 110.555 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 69.6 t -107.78 135.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.422 -0.808 . . . . 75.4 110.219 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.61 160.93 27.12 Favored Glycine 0 N--CA 1.408 -3.2 0 CA-C-N 115.246 -0.888 . . . . 74.2 112.95 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.2 ttmt -98.88 135.56 40.14 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.782 -0.709 . . . . 73.35 109.483 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.23 109.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.306 -0.998 . . . . 74.23 108.306 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.2 tttp -72.42 -42.22 65.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.371 -1.286 . . . . 74.35 108.954 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -174.79 160.53 2.95 Favored 'General case' 0 CA--C 1.486 -1.518 0 C-N-CA 123.949 0.9 . . . . 72.03 108.821 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -161.72 126.87 3.5 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.978 0.799 . . . . 73.21 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -99.05 118.4 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.711 -1.218 . . . . 73.21 107.711 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -70.04 -23.91 63.18 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.26 0.467 . . . . 62.3 112.26 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 m -86.46 -46.29 10.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.087 0.47 . . . . 75.51 111.216 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.43 -8.68 58.89 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.738 -0.385 . . . . 73.53 111.942 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 60.63 31.36 20.18 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 112.374 0.509 . . . . 70.04 112.374 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.83 153.08 43.09 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.272 -0.422 . . . . 73.55 109.872 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.62 -169.59 39.54 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.68 -0.968 . . . . 62.05 110.68 175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.425 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 53.1 m-85 -140.06 166.62 24.18 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.337 0.655 . . . . 73.34 110.588 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -145.17 133.67 17.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.061 -0.718 . . . . 74.45 109.061 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.44 143.01 31.43 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.488 -1.301 . . . . 72.41 107.488 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.6 pt20 -83.27 156.16 23.25 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 118.035 -1.466 . . . . 63.41 109.26 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.31 -25.06 21.7 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 124.628 1.205 . . . . 72.44 113.554 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -78.41 -0.39 28.98 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 122.256 -0.277 . . . . 71.52 111.591 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 51.48 3.03 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 109.896 -1.282 . . . . 74.51 109.896 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -66.43 -104.77 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 116.651 1.42 . . . . 51.24 116.651 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.69 176.48 7.49 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.301 0.572 . . . . 75.11 111.525 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -116.46 83.32 1.94 Allowed 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 107.816 -1.179 . . . . 62.23 107.816 172.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 HG22 HD13 ' A' ' 55' ' ' LEU . 4.2 p -119.46 129.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 CA-C-N 115.382 -0.827 . . . . 75.21 109.638 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 39.6 p90 -86.23 139.07 31.38 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.289 0.566 . . . . 75.32 111.681 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 67' ' ' LEU . 7.2 p -103.39 119.8 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.289 -0.869 . . . . 74.51 109.81 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -110.24 161.75 15.29 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.952 -1.129 . . . . 65.13 107.952 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.72 -22.31 63.85 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.83 0.678 . . . . 72.53 112.83 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -53.74 -24.58 15.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.178 0.513 . . . . 38.57 111.41 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 64' ' ' ALA . . . -75.33 -39.07 59.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.979 0.418 . . . . 63.1 110.597 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.89 -44.73 88.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 N-CA-C 108.089 -1.078 . . . . 72.41 108.089 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.35 -26.22 67.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.351 0.407 . . . . 70.32 110.634 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.74 66.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.707 0.632 . . . . 71.31 112.707 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.86 -0.59 4.23 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.161 0.8 . . . . 74.12 113.161 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.87 39.57 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 123.251 0.453 . . . . 71.35 112.463 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.43 142.72 51.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.306 -1.739 . . . . 63.41 106.306 178.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.423 ' N ' HD11 ' A' ' 42' ' ' LEU . 40.2 t60 -71.15 -61.51 1.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.637 -0.825 . . . . 75.43 111.829 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -164.37 157.15 17.18 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.077 -0.712 . . . . 63.0 109.077 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.03 153.93 42.72 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.682 0.754 . . . . 44.44 112.425 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.92 172.32 13.86 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.171 -1.377 . . . . 72.2 107.693 173.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.33 156.1 39.9 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.697 0.761 . . . . 75.11 112.607 -177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 -18.5 57.35 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.133 -0.939 . . . . 43.5 112.005 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -82.35 139.38 34.14 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 122.687 0.395 . . . . 64.4 111.657 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 11.1 m-20 -89.12 134.49 33.99 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.274 -1.009 . . . . 73.54 108.274 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.04 152.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.816 0.817 . . . . 75.31 111.142 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.6 mt -116.69 128.92 73.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.631 -1.618 . . . . 75.41 106.631 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.446 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.5 p90 -145.95 -180.0 7.09 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.75 -0.38 . . . . 74.24 110.299 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -119.98 157.23 29.27 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 105.379 -2.082 . . . . 64.24 105.379 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 62' ' ' ALA . 16.2 tp -123.93 128.51 49.54 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 121.581 0.705 . . . . 74.14 111.329 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' HD11 ' A' ' 55' ' ' LEU . 7.7 tp10 -122.85 142.47 50.74 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.43 -1.693 . . . . 74.03 106.43 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.05 143.83 26.01 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.586 -0.846 . . . . 73.44 112.551 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -103.7 35.48 2.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.288 -1.375 . . . . 73.41 107.288 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 63.52 88.81 0.09 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.634 -1.167 . . . . 75.14 109.324 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.82 -47.87 3.62 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.585 -0.817 . . . . 53.53 111.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 73.5 mmtt -83.73 153.11 24.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.519 -0.549 . . . . 74.33 109.519 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -123.82 122.37 37.85 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.829 -0.168 . . . . 73.11 111.183 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.507 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 23.1 p90 -126.49 133.22 51.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.459 0.647 . . . . 73.41 111.777 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -74.39 140.38 44.71 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.736 -1.12 . . . . 72.21 109.709 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -139.5 164.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.469 -0.787 . . . . 71.51 109.314 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.72 63.91 1.56 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.075 0.859 . . . . 70.33 111.147 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 36' ' ' ALA . 24.9 mt -78.98 138.07 37.88 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.611 -1.236 . . . . 75.25 112.929 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -141.92 131.67 24.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.187 -2.153 . . . . 74.23 105.187 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.254 2.3 pp -77.92 146.92 7.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 118.79 -1.164 . . . . 74.13 112.006 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.9 tttt . . . . . 0 C--O 1.262 1.74 0 CA-C-N 115.687 -0.688 . . . . 74.05 109.559 178.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 121.169 0.509 . . . . 73.33 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . . . -161.28 107.57 1.4 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.713 -1.217 . . . . 70.43 107.713 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.503 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 27.7 p -101.0 142.94 31.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.52 0.933 . . . . 64.31 113.52 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 62.75 77.84 0.31 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 124.595 1.158 . . . . 62.5 111.785 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.5 mt -110.02 145.71 16.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.34 -0.845 . . . . 74.13 111.127 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 57.2 t -99.57 137.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.257 -0.883 . . . . 73.41 110.641 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 23' ' ' GLN . . . -172.45 177.99 44.79 Favored Glycine 0 N--CA 1.4 -3.71 0 CA-C-N 115.007 -0.997 . . . . 44.14 112.349 167.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -121.98 141.28 51.49 Favored 'General case' 0 C--N 1.256 -3.467 0 C-N-CA 123.813 0.845 . . . . 72.41 108.978 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.75 111.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 109.045 -0.724 . . . . 74.22 109.045 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 53.4 tttm -72.41 -48.12 43.88 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.393 -1.336 . . . . 73.44 107.393 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.478 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 67.4 p-90 -176.43 160.96 2.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.83 1.252 . . . . 73.21 108.494 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 81.0 t80 -151.35 126.08 9.63 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.943 -0.391 . . . . 73.43 109.943 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.79 101.74 11.56 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.478 -0.934 . . . . 74.12 108.478 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.4 m -63.85 -21.41 66.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.98 -0.554 . . . . 64.43 111.19 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.7 p -65.81 -37.54 86.54 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 123.33 0.652 . . . . 74.41 111.396 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.14 -6.13 22.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.936 -0.574 . . . . 72.25 111.862 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 69.43 22.38 6.48 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.533 0.733 . . . . 75.24 112.226 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -147.59 165.08 31.48 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.169 0.509 . . . . 62.34 111.748 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -167.95 -157.3 10.89 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.999 -1.241 . . . . 71.22 109.999 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' HD1' ' CZ2' ' A' ' 11' ' ' TRP . 46.4 m-85 -137.72 165.75 25.64 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 117.417 0.608 . . . . 75.31 112.168 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -143.92 139.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.09 -1.078 . . . . 72.32 108.09 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 12.4 pt-20 -142.84 144.54 32.55 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.519 -1.66 . . . . 73.14 106.519 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.4 pt20 -86.94 150.33 24.15 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 117.512 -1.675 . . . . 64.02 108.221 174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.59 -14.31 12.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 124.241 0.963 . . . . 75.34 112.597 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -88.64 5.39 43.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.539 -0.301 . . . . 74.05 111.183 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.7 50.97 2.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.691 -1.242 . . . . 63.22 112.259 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.4 55.15 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.359 -0.924 . . . . 72.42 111.399 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.55 162.99 27.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.449 0.537 . . . . 71.24 112.449 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.95 95.55 5.49 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.91 -0.586 . . . . 70.12 110.722 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' CG2' HD13 ' A' ' 55' ' ' LEU . 3.9 p -112.7 130.05 67.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.496 -0.775 . . . . 72.24 109.096 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.7 p90 -90.07 136.62 32.94 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.779 -0.768 . . . . 74.23 110.574 -178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.44 127.14 51.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.753 -0.832 . . . . 74.44 108.753 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -115.96 156.44 26.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.316 -0.624 . . . . 72.31 109.316 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.58 -18.65 12.59 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.631 0.974 . . . . 75.21 113.631 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -61.07 -22.94 65.09 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.22 0.533 . . . . 63.24 110.649 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -77.52 -33.42 54.29 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.433 -0.58 . . . . 62.04 109.433 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.04 -42.64 88.77 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 N-CA-C 107.704 -1.221 . . . . 71.25 107.704 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -53.75 -35.34 61.14 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.915 0.886 . . . . 64.45 110.866 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 -18.51 59.73 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.821 1.045 . . . . 74.12 113.821 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.59 -20.16 2.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.089 . . . . 74.3 113.939 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.12 38.01 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-O 121.689 0.605 . . . . 74.12 111.615 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD21 ' HG ' ' A' ' 45' ' ' LEU . 26.1 tp -64.72 141.31 58.82 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.681 -0.759 . . . . 74.24 110.292 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.22 -57.35 13.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.303 -0.628 . . . . 73.51 109.303 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -175.69 174.96 2.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.173 -1.418 . . . . 74.14 107.173 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.0 mp -111.95 145.19 40.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.094 0.473 . . . . 75.1 110.703 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.81 146.31 45.52 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.224 -0.898 . . . . 71.55 109.012 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.81 154.57 40.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.13 0.491 . . . . 51.34 111.387 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 -26.24 19.25 Favored Glycine 0 C--N 1.303 -1.259 0 C-N-CA 120.687 -0.768 . . . . 62.23 112.188 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 132.22 45.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 123.359 0.664 . . . . 74.22 111.647 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.67 132.91 35.31 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 108.125 -1.065 . . . . 74.32 108.125 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.84 147.27 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.915 0 CA-C-O 121.888 0.851 . . . . 74.1 110.457 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 68.9 mt -117.55 136.9 53.24 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 106.374 -1.713 . . . . 75.31 106.374 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 36.8 p90 -153.11 -178.53 7.0 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.836 -0.346 . . . . 74.01 110.476 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 37.1 m-20 -119.62 156.17 30.91 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.934 -1.876 . . . . 75.24 105.934 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 62' ' ' ALA . 13.6 tp -121.18 116.48 25.02 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-O 122.707 1.241 . . . . 72.33 114.332 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' N ' HD11 ' A' ' 55' ' ' LEU . 7.7 mm-40 -103.51 151.04 23.32 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.813 -1.994 . . . . 74.21 111.288 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -105.76 131.34 53.23 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 114.298 -1.319 . . . . 64.24 111.066 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 86.6 tttt -109.67 78.78 1.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.381 -0.827 . . . . 73.24 109.536 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 60.36 14.12 4.49 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.883 0.849 . . . . 74.54 111.64 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.03 -25.14 3.55 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.328 -0.709 . . . . 62.04 111.328 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.2 mmmt -83.87 164.92 19.16 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.601 -0.889 . . . . 74.14 108.601 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -122.51 119.81 32.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 119.835 -0.126 . . . . 71.02 111.121 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 40.4 p90 -125.22 133.75 52.6 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.549 0.69 . . . . 74.41 112.443 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 137.34 38.23 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.704 -1.135 . . . . 64.1 110.829 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 28.7 m -140.68 168.61 16.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.351 -0.84 . . . . 74.23 109.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.1 t30 54.32 63.43 2.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.079 0.862 . . . . 62.44 110.701 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 36' ' ' ALA . 23.6 mt -74.41 136.1 42.38 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.694 0.998 . . . . 74.43 113.694 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 41.6 mmt180 -122.59 131.17 53.7 Favored 'General case' 0 N--CA 1.405 -2.678 0 N-CA-C 106.177 -1.786 . . . . 64.01 106.177 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.38 131.24 56.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 114.354 1.242 . . . . 73.03 114.354 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.258 1.54 0 CA-C-N 115.209 -0.905 . . . . 72.53 109.345 173.646 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 109.52 -0.548 . . . . 65.5 109.52 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.85 110.29 7.94 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.64 -1.244 . . . . 75.31 107.64 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.5 p -127.18 161.83 27.58 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 60.79 39.85 16.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.0 110.874 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.3 mt -76.79 147.23 7.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.397 -0.819 . . . . 74.43 111.788 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 64.5 t -102.34 136.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.003 -0.999 . . . . 71.53 110.162 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -177.75 160.65 27.32 Favored Glycine 0 N--CA 1.413 -2.849 0 C-N-CA 120.685 -0.769 . . . . 64.42 113.503 168.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -97.63 143.75 27.99 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.661 -0.866 . . . . 64.03 108.661 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.06 107.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.226 -1.027 . . . . 72.31 108.226 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.45 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 65.9 tttp -67.87 -48.35 66.35 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.44 -1.255 . . . . 72.22 109.155 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -166.8 155.55 10.39 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.231 -1.026 . . . . 74.22 108.231 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -160.46 108.43 1.62 Allowed 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.724 0.64 . . . . 72.11 109.67 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -84.97 106.47 16.5 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.735 -1.58 . . . . 63.23 106.735 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 p -62.62 -26.02 68.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.267 0.84 . . . . 63.42 113.267 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -71.49 -32.22 67.99 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.09 0.471 . . . . 72.23 110.081 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.04 -9.8 30.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.004 -0.369 . . . . 70.0 110.004 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 52.37 34.67 15.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.701 0.801 . . . . 75.5 110.074 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.69 156.11 46.99 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.596 -0.52 . . . . 75.44 109.596 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.02 -153.61 17.39 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.296 -0.722 . . . . 63.51 111.296 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.45 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.3 m-85 -137.14 169.18 18.22 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.519 0.728 . . . . 74.52 110.9 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.7 mt -145.61 130.6 12.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 123.505 0.722 . . . . 74.31 109.147 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.34 146.84 32.8 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.52 -0.918 . . . . 74.41 108.52 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.6 pt20 -79.74 148.15 31.61 Favored 'General case' 0 CA--C 1.483 -1.625 0 C-N-CA 118.838 -1.145 . . . . 72.43 108.38 175.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -53.72 -25.32 17.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 124.528 1.143 . . . . 64.1 112.065 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -76.93 -3.94 41.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.191 -0.459 . . . . 61.34 112.138 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.14 50.76 0.76 Allowed Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.393 -1.384 . . . . 61.24 112.542 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.33 150.69 32.08 Favored Glycine 0 C--N 1.313 -0.733 0 C-N-CA 119.753 -1.213 . . . . 43.33 110.167 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.19 163.58 26.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 117.264 0.532 . . . . 74.11 112.262 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.97 105.1 1.54 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-N 115.845 -0.616 . . . . 75.2 111.299 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 55' ' ' LEU . 4.3 p -126.81 123.71 63.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 108.585 -0.894 . . . . 74.12 108.585 172.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 47.2 p90 -87.17 149.73 24.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.041 -0.527 . . . . 74.13 112.397 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.27 126.72 61.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.381 0.61 . . . . 73.41 109.57 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -111.78 156.93 21.17 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.036 -1.468 . . . . 72.43 107.036 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.29 -13.7 61.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.381 -0.928 . . . . 75.4 112.077 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -59.0 -22.54 60.75 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.239 0.542 . . . . 72.11 109.716 171.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -75.51 -38.79 59.18 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.519 -0.549 . . . . 75.02 109.519 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.66 -43.68 96.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.672 0 N-CA-C 107.891 -1.152 . . . . 75.15 107.891 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.15 -37.15 69.14 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.107 0.563 . . . . 64.15 111.623 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.83 -27.45 69.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.22 0.822 . . . . 64.13 113.22 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.55 -14.88 3.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.498 0.925 . . . . 51.24 113.498 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.29 47.74 16.56 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 109.731 -1.347 . . . . 74.2 109.731 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.28 128.95 38.01 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.865 0.866 . . . . 75.31 108.669 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -46.55 -61.55 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.77 0.656 . . . . 71.43 112.77 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 p -178.51 162.98 1.49 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.452 -0.944 . . . . 75.52 108.452 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.9 mt -123.04 149.48 44.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.306 -0.627 . . . . 73.3 109.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.57 149.35 26.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.145 -1.057 . . . . 74.1 108.145 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.0 126.45 27.58 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.472 -0.936 . . . . 72.3 108.472 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.52 -14.91 27.38 Favored Glycine 0 C--N 1.288 -2.094 0 CA-C-N 115.589 -0.732 . . . . 75.34 113.266 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.44 130.04 34.89 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.282 -0.54 . . . . 74.21 111.18 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.86 131.07 34.56 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 107.198 -1.408 . . . . 73.43 107.198 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.1 145.95 31.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-O 121.854 0.835 . . . . 72.21 110.642 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 70.3 mt -113.37 132.67 61.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 107.063 -1.458 . . . . 70.13 107.063 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 34.6 p90 -147.39 -177.01 5.46 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 121.0 0.429 . . . . 61.13 110.968 -175.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -123.78 149.34 45.76 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 105.68 -1.97 . . . . 73.45 105.68 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 30' ' ' VAL . 16.2 tp -114.34 119.91 38.57 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 122.088 0.947 . . . . 75.34 111.473 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -126.25 159.14 33.89 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 113.67 -1.604 . . . . 71.35 107.977 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.31 143.02 26.75 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.368 0.604 . . . . 74.53 111.987 -173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 84.7 tttt -100.86 81.52 2.28 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.245 -1.761 . . . . 63.12 106.245 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 66.82 -68.77 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.724 1.21 . . . . 75.04 110.238 -174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.73 -2.19 1.99 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.577 -0.609 . . . . 72.41 111.577 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.9 mmmt -97.01 165.24 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.15 -0.685 . . . . 72.54 109.15 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -116.35 116.43 27.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 110.14 -0.319 . . . . 63.54 110.14 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -129.99 140.74 50.84 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.493 0.663 . . . . 73.42 111.6 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -72.28 133.55 45.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.552 -1.203 . . . . 64.24 109.227 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 32.5 m -138.3 161.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.69 -0.686 . . . . 73.22 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 59.96 63.23 1.49 Allowed 'General case' 0 C--O 1.216 -0.658 0 O-C-N 124.392 1.057 . . . . 73.14 109.294 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 28.4 mt -80.37 143.61 33.38 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.893 -0.723 . . . . 73.34 112.8 -173.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.07 133.48 41.2 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.187 1.395 . . . . 71.32 107.948 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 69' ' ' ILE . 2.3 mp -82.14 140.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.889 -1.522 . . . . 75.25 106.889 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.258 1.536 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 174.545 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 111.892 0.33 . . . . 74.32 111.892 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.12 117.39 14.56 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.704 -0.622 . . . . 65.32 110.288 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.9 p -102.36 147.31 26.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.377 -0.374 . . . . 73.23 111.539 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 52.27 77.37 0.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.537 1.135 . . . . 75.43 113.059 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 46.6 mt -103.93 148.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.183 -0.917 . . . . 73.33 110.484 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.3 t -91.48 132.72 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 115.242 -0.89 . . . . 64.13 109.134 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.87 167.45 37.95 Favored Glycine 1 N--CA 1.394 -4.123 0 C-N-CA 120.317 -0.945 . . . . 70.44 111.781 171.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -123.04 135.74 54.55 Favored 'General case' 0 C--N 1.261 -3.267 0 N-CA-C 107.569 -1.271 . . . . 74.1 107.569 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.86 116.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.68 0.752 . . . . 74.12 109.16 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 65.4 tttp -75.85 -43.62 44.84 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.03 -1.441 . . . . 71.44 109.109 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -175.02 159.65 2.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 123.917 0.887 . . . . 73.41 109.182 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -163.44 126.85 2.73 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.878 0.736 . . . . 74.05 109.236 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -115.71 122.57 45.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.672 -0.862 . . . . 74.5 108.672 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 m -65.14 -19.15 65.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.087 0.47 . . . . 65.31 110.063 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.6 m -62.28 -34.13 75.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.721 -0.672 . . . . 64.23 110.668 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.36 -10.2 11.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.061 -0.656 . . . . 74.41 111.88 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 54.27 29.66 11.09 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 113.405 0.891 . . . . 63.42 113.405 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -129.8 156.41 44.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 114.672 -1.149 . . . . 75.35 108.534 173.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.44 -172.78 38.54 Favored Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 109.087 -1.605 . . . . 73.44 109.087 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 50.3 m-85 -134.24 165.9 24.03 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 117.036 0.418 . . . . 74.44 111.123 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.6 mt -147.16 136.26 16.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.111 -1.07 . . . . 64.54 108.111 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.39 148.47 34.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.525 -2.028 . . . . 74.53 105.525 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.5 pt20 -74.84 142.5 44.16 Favored 'General case' 0 CA--C 1.473 -2.019 0 C-N-CA 116.655 -2.018 . . . . 75.24 108.68 175.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -49.62 -33.04 14.24 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.122 -1.399 . . . . 75.32 111.594 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -87.75 11.31 15.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.902 0.705 . . . . 64.31 112.902 -173.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.39 51.2 0.67 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.405 -1.379 . . . . 60.31 113.471 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -96.26 157.59 21.51 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 119.774 -1.203 . . . . 74.21 110.989 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -72.06 152.73 42.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.831 0.315 . . . . 73.12 110.522 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 120.79 24.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.19 0.995 . . . . 74.24 111.724 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 55' ' ' LEU . 3.0 p -121.87 139.01 50.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 114.365 -1.289 . . . . 75.23 108.223 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 40.7 p90 -88.15 142.67 27.58 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.428 -0.909 . . . . 74.33 111.45 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 67' ' ' LEU . 13.3 p -110.67 144.21 19.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.605 -0.887 . . . . 74.44 108.605 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -131.66 158.4 41.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.56 -16.44 63.87 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 112.505 0.557 . . . . 75.21 112.505 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -56.67 -26.24 55.87 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.235 0.541 . . . . 70.34 110.357 172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -76.85 -37.71 55.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.117 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.6 t -66.57 -40.6 86.71 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 N-CA-C 107.844 -1.169 . . . . 75.32 107.844 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.26 -32.6 72.42 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.78 0.832 . . . . 63.4 110.755 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.37 82.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.721 0.638 . . . . 71.43 112.721 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.68 -8.79 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.478 0.918 . . . . 71.52 113.478 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.63 58.36 7.83 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.47 -1.052 . . . . 74.22 110.47 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.02 145.46 51.75 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.435 -1.32 . . . . 75.32 107.435 -179.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.468 ' N ' HD11 ' A' ' 42' ' ' LEU . 62.7 t-80 -54.5 -61.7 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.58 0.352 . . . . 73.31 110.981 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -175.62 150.66 1.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.547 -0.538 . . . . 54.41 109.547 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.96 143.84 36.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.261 -0.644 . . . . 75.14 109.261 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.13 160.15 16.0 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.932 -1.136 . . . . 61.2 107.932 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 150.41 45.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.819 0.819 . . . . 74.1 112.374 -176.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.68 -14.73 62.21 Favored Glycine 0 C--N 1.298 -1.569 0 CA-C-N 114.991 -1.004 . . . . 55.01 112.677 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.41 116.65 19.77 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 122.519 -0.4 . . . . 75.11 111.152 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.91 129.92 38.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.998 -1.482 . . . . 71.03 106.998 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 147.83 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-O 122.034 0.921 . . . . 75.44 110.976 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.6 mt -110.03 127.76 66.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.199 -1.778 . . . . 74.42 106.199 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.4 p90 -142.47 176.45 9.0 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.948 -0.701 . . . . 73.43 111.311 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.46 140.39 52.23 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.107 -1.812 . . . . 62.13 106.107 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 30' ' ' VAL . 20.7 tp -121.36 122.06 39.01 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.728 0.775 . . . . 74.5 111.898 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -109.92 166.22 11.1 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.885 -1.507 . . . . 74.41 109.469 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.1 125.72 51.43 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.587 -1.264 . . . . 74.41 107.587 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -126.16 75.16 1.5 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.457 0.54 . . . . 74.31 112.457 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 26.7 tt0 58.12 32.91 22.61 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.857 0.837 . . . . 64.41 111.202 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.37 31.5 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 120.505 -0.855 . . . . 61.14 111.641 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.0 mmtt -96.87 162.04 13.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.803 -0.443 . . . . 74.22 109.803 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.11 112.01 8.91 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.585 -1.265 . . . . 75.15 107.585 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.6 p90 -124.96 135.51 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.418 0.628 . . . . 73.24 111.5 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 123.66 32.75 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.639 -1.164 . . . . 74.14 109.838 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.456 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 18.4 m -137.22 176.29 7.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.588 -0.733 . . . . 60.54 111.62 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.39 40.11 27.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.492 1.12 . . . . 74.32 108.361 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 36.3 mt -62.63 142.07 58.22 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.617 -1.174 . . . . 74.31 113.016 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -143.68 130.39 20.26 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.546 -1.65 . . . . 75.33 106.546 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.23 141.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.567 -0.853 . . . . 75.53 110.891 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.25 1.109 0 O-C-N 123.858 0.724 . . . . 73.03 110.798 178.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 109.522 -0.547 . . . . 74.41 109.522 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.72 129.39 34.96 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.044 -1.095 . . . . 75.41 108.044 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p -101.69 150.32 23.24 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.45 0.469 . . . . 53.21 111.492 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 61.84 76.07 0.38 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.681 0.792 . . . . 74.35 111.319 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 34.1 mt -108.36 150.65 10.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.193 -0.912 . . . . 74.34 110.462 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 93.9 t -96.11 132.46 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 115.629 -0.714 . . . . 65.45 110.182 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.44 171.07 39.04 Favored Glycine 0 N--CA 1.399 -3.819 0 CA-C-N 115.109 -0.95 . . . . 74.31 111.676 170.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -128.35 133.28 48.63 Favored 'General case' 0 C--N 1.26 -3.299 0 C-N-CA 124.472 1.109 . . . . 72.41 108.879 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.91 113.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 116.061 -0.518 . . . . 63.24 109.987 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.506 ' HD2' ' CB ' ' A' ' 20' ' ' PHE . 64.4 mttm -62.58 -49.0 76.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.615 -0.721 . . . . 71.15 109.276 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -175.81 166.67 3.1 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.805 1.242 . . . . 72.23 108.661 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -145.06 140.35 28.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.626 0.579 . . . . 73.4 109.442 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -112.25 121.53 45.18 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.501 -0.926 . . . . 73.43 108.501 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -75.99 -28.94 58.03 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.4 m -69.03 -48.64 62.4 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.975 0.417 . . . . 74.43 111.264 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -95.28 -8.56 35.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.681 0.622 . . . . 74.0 112.681 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 62.43 30.68 17.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.945 0.403 . . . . 71.24 111.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.65 163.41 21.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.128 -0.487 . . . . 62.2 109.939 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.18 -172.47 43.46 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 107.939 -2.064 . . . . 71.34 107.939 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.506 ' CB ' ' HD2' ' A' ' 10' ' ' LYS . 55.8 m-85 -136.82 155.98 49.09 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 118.125 0.963 . . . . 74.34 111.372 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -134.94 140.93 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.499 -0.926 . . . . 74.44 108.499 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 13.8 pt-20 -143.05 147.4 35.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.25 -2.13 . . . . 72.11 105.25 175.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.2 pt20 -79.87 144.45 33.43 Favored 'General case' 0 CA--C 1.483 -1.613 0 C-N-CA 115.305 -2.558 . . . . 72.14 109.315 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.79 -29.21 11.01 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 124.992 1.433 . . . . 62.33 111.357 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.86 4.0 43.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.179 0.807 . . . . 64.13 113.179 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.25 53.62 0.88 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 117.744 -2.17 . . . . 75.11 112.332 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' A' ' 23' ' ' GLN . . . -83.09 -121.91 0.76 Allowed Glycine 0 C--N 1.312 -0.803 0 C-N-CA 120.576 -0.821 . . . . 51.53 114.23 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.95 168.66 15.68 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 122.726 0.41 . . . . 72.53 110.359 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.71 92.19 6.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.186 -0.672 . . . . 54.54 109.186 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.44 132.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.523 -0.762 . . . . 75.21 109.148 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 44.0 p90 -90.09 149.14 22.62 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 118.92 -1.112 . . . . 75.11 110.884 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG21 HD12 ' A' ' 67' ' ' LEU . 8.8 p -105.99 137.12 37.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -125.25 157.17 37.25 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.697 -1.223 . . . . 73.31 107.697 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -62.38 -24.23 67.26 Favored 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 113.022 0.749 . . . . 74.24 113.022 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -52.51 -26.06 12.02 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 120.981 0.419 . . . . 74.04 111.399 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -39.61 61.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.198 0.523 . . . . 73.33 109.823 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.89 -46.34 88.82 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.373 0 CA-C-N 115.06 -0.973 . . . . 64.03 108.404 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.69 -23.79 65.12 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.402 0.439 . . . . 74.02 111.14 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.74 69.16 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.301 0.482 . . . . 70.51 112.301 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.8 -4.8 4.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.229 0.826 . . . . 60.52 113.229 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.05 52.48 44.32 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.295 -0.722 . . . . 71.31 111.295 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.24 125.56 27.27 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.074 -1.825 . . . . 65.11 106.074 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -74.51 -37.79 63.0 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 114.833 1.419 . . . . 75.44 114.833 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -155.63 138.3 15.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.104 -0.638 . . . . 74.12 112.257 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.19 149.3 43.03 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.471 -0.786 . . . . 74.44 109.035 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.46 169.56 22.3 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.42 155.28 36.51 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.58 -0.448 . . . . 71.52 110.966 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.09 1.27 89.67 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.923 -0.656 . . . . 36.84 113.09 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.457 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -86.22 121.08 28.31 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 111.902 0.334 . . . . 74.25 111.902 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -71.78 127.51 32.8 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.144 -1.058 . . . . 74.42 108.144 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.49 147.58 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 CA-C-O 121.976 0.893 . . . . 70.45 110.686 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 71.9 mt -112.69 135.11 53.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 N-CA-C 106.893 -1.521 . . . . 75.52 106.893 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.465 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -150.13 179.28 8.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 121.076 -0.25 . . . . 72.12 110.566 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -114.86 154.35 28.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.035 -1.839 . . . . 73.35 106.035 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 37.1 tp -140.53 136.67 33.13 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.901 0.857 . . . . 75.21 112.755 -176.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -131.54 132.42 44.14 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.226 -1.768 . . . . 74.23 106.226 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.77 116.41 23.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.846 0.832 . . . . 70.12 111.04 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -81.26 79.14 7.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.154 -1.384 . . . . 75.01 109.785 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 57.52 20.62 6.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.061 0.945 . . . . 64.51 112.374 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.16 -30.11 3.56 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.413 -0.675 . . . . 72.05 111.413 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -84.13 164.12 19.38 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.377 -1.342 . . . . 75.54 107.377 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.15 129.04 26.97 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 118.652 0.66 . . . . 73.42 110.784 -176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 6.9 p90 -133.93 133.91 41.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.467 0.651 . . . . 75.21 111.175 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.58 133.37 36.44 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.537 -1.21 . . . . 74.35 110.297 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.508 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 26.9 m -135.24 161.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.976 -1.011 . . . . 75.33 109.29 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 t30 59.63 64.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.848 0.718 . . . . 64.24 110.817 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 21.8 mt -78.14 139.9 39.01 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.976 -1.09 . . . . 73.54 112.132 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 16.6 tpp180 -137.45 130.77 30.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.111 -2.551 . . . . 65.23 104.111 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.58 143.22 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.944 -1.102 . . . . 72.33 113.055 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.914 -1.041 . . . . 75.1 108.945 173.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 26.1 ttt . . . . . 0 C--O 1.223 -0.329 0 CA-C-O 121.277 0.561 . . . . 72.41 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.94 145.2 42.47 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.106 -1.442 . . . . 73.22 107.106 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.415 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 41.5 p -120.49 142.0 49.69 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.137 0.421 . . . . 73.34 112.137 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 55.86 74.54 0.38 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.308 1.043 . . . . 62.44 112.31 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mt -99.58 152.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.643 -1.162 . . . . 74.33 110.818 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.2 t -102.62 135.97 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 115.419 -0.81 . . . . 64.42 109.548 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.14 175.42 47.12 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 115.103 -0.953 . . . . 72.14 111.98 168.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 38.3 ttmt -123.91 143.02 50.62 Favored 'General case' 0 C--N 1.253 -3.627 0 C-N-CA 123.973 0.909 . . . . 74.14 108.801 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.02 109.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.136 -0.69 . . . . 62.42 109.136 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 58.2 tttp -68.53 -49.1 62.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.886 -1.524 . . . . 64.21 106.886 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -169.11 156.18 7.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 114.951 -1.022 . . . . 72.54 108.829 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -157.16 111.39 2.68 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 123.638 0.586 . . . . 71.11 109.668 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -99.49 118.63 36.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.822 -0.626 . . . . 71.42 109.932 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 m -64.36 -22.92 67.11 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.059 -0.973 . . . . 73.04 110.2 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -55.08 -44.99 75.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.537 -0.756 . . . . 64.44 111.212 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.8 mttt -106.21 -6.09 18.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.437 0.532 . . . . 74.14 112.437 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 68.86 22.65 7.11 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.073 0.549 . . . . 73.34 110.928 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.467 ' HB3' ' HD1' ' A' ' 33' ' ' HIS . 36.5 p90 -148.47 166.86 26.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.06 0.457 . . . . 75.21 111.965 176.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.85 -153.06 8.56 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.757 -1.337 . . . . 64.53 109.757 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.522 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.4 m-85 -137.05 167.81 20.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 122.857 0.463 . . . . 75.53 111.419 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 64.0 mt -142.35 138.29 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.573 -0.899 . . . . 72.41 108.573 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -143.18 147.25 34.59 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 106.545 -1.65 . . . . 72.21 106.545 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.1 pt20 -86.29 156.79 20.1 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 117.599 -1.64 . . . . 73.0 108.78 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -53.99 -27.12 29.59 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.232 0.957 . . . . 74.12 112.368 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.41 5.45 17.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.079 0.4 . . . . 64.14 112.079 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.01 51.72 4.09 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.433 -1.365 . . . . 61.45 110.807 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.5 -168.12 32.99 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.877 -0.678 . . . . 75.11 112.459 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.02 144.71 55.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.044 -0.354 . . . . 73.04 110.044 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.29 87.39 7.11 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.494 -0.928 . . . . 73.21 108.494 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 62' ' ' ALA . 3.8 p -100.52 138.41 24.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.441 -1.254 . . . . 74.01 110.055 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.0 p90 -88.98 145.18 25.67 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 119.061 -1.055 . . . . 74.44 110.034 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' CG2' HD12 ' A' ' 67' ' ' LEU . 8.1 p -115.57 136.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 108.748 -0.834 . . . . 74.32 108.748 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' HD1' ' HB3' ' A' ' 18' ' ' PHE . 34.1 t60 -124.67 159.94 29.66 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.136 -0.691 . . . . 74.43 109.136 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.32 -15.69 60.77 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 112.647 0.61 . . . . 74.21 112.647 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.6 m -61.45 -26.93 68.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.963 0.411 . . . . 72.34 110.495 172.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -75.31 -34.9 61.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.7 -0.482 . . . . 71.52 109.7 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.57 -46.29 93.01 Favored 'Isoleucine or valine' 0 C--O 1.181 -2.524 0 N-CA-C 107.721 -1.214 . . . . 75.44 107.721 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.52 -31.24 63.93 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.124 0.97 . . . . 74.35 110.866 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.4 63.84 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.121 0.786 . . . . 74.51 113.121 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.63 -5.62 4.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.654 0.983 . . . . 62.4 113.654 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.09 49.43 75.17 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 111.117 -0.793 . . . . 71.1 111.117 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 43' ' ' HIS . 1.1 tm? -66.86 138.16 57.11 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.154 -1.424 . . . . 65.23 107.154 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.401 ' N ' HD11 ' A' ' 42' ' ' LEU . 29.9 m-70 -65.15 -53.58 42.89 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.0 1.111 . . . . 72.04 114.0 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -165.83 153.84 10.84 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.527 -0.469 . . . . 61.34 110.575 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.6 mt -124.01 143.78 50.22 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.119 -0.697 . . . . 73.23 109.119 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.16 162.38 20.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.132 -1.432 . . . . 62.1 107.132 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.1 153.4 43.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.591 . . . . 73.24 111.501 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.58 84.66 Favored Glycine 0 C--N 1.3 -1.465 0 CA-C-N 115.262 -0.881 . . . . 73.5 112.803 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -93.58 119.08 32.19 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.268 0.47 . . . . 73.25 112.268 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 22.4 m-20 -71.91 136.38 46.87 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.171 -0.612 . . . . 71.41 109.745 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.29 153.41 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-O 121.876 0.846 . . . . 74.31 110.815 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 65.9 mt -115.2 135.36 55.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 N-CA-C 106.58 -1.637 . . . . 75.3 106.58 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -153.06 177.59 10.64 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.947 -0.701 . . . . 74.42 110.624 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 44.5 m-20 -118.93 157.53 27.5 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.013 -1.847 . . . . 75.44 106.013 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 1' ' ' MET . 18.3 tp -134.9 138.18 43.88 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 120.879 0.371 . . . . 75.32 111.883 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -127.56 151.57 48.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.49 -1.3 . . . . 64.14 107.49 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.42 120.82 31.85 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 121.243 0.544 . . . . 71.33 111.018 -175.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 87.0 tttt -90.49 74.31 6.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.528 -0.76 . . . . 73.42 108.956 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 61.14 8.32 1.95 Allowed 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.85 -1.068 . . . . 73.03 113.178 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.53 -24.28 2.49 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.803 -0.919 . . . . 64.21 110.803 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -88.7 162.41 16.29 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.09 -1.078 . . . . 71.45 108.09 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 30' ' ' VAL . . . -120.99 127.73 52.05 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.975 -0.453 . . . . 71.33 111.495 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 36.4 p90 -127.81 132.6 49.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.367 0.603 . . . . 73.22 111.63 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.2 136.8 33.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.147 -0.933 . . . . 63.21 110.755 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 30.6 m -139.64 167.85 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.162 -0.926 . . . . 65.12 109.765 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.08 63.43 2.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.623 0.769 . . . . 62.34 110.472 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.456 HD12 ' CG2' ' A' ' 32' ' ' VAL . 30.1 mt -78.9 141.01 37.99 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.129 -1.029 . . . . 75.33 113.022 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 18.4 tpp180 -141.72 130.58 23.0 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 105.929 -1.878 . . . . 74.25 105.929 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.02 149.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.03 -1.068 . . . . 73.12 111.989 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt . . . . . 0 C--O 1.251 1.17 0 O-C-N 124.049 0.843 . . . . 74.24 110.755 175.555 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 CA--C 1.495 -1.138 0 N-CA-C 109.149 -0.685 . . . . 74.45 109.149 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.23 103.04 4.5 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.327 -0.62 . . . . 74.34 109.327 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 p -100.22 146.0 27.4 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.847 -0.615 . . . . 71.41 111.662 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 t30 54.68 77.18 0.21 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.908 1.283 . . . . 54.41 110.656 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 45.3 mt -103.93 142.84 16.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.422 -0.808 . . . . 74.4 110.416 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 76.4 t -95.96 140.82 16.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.257 -0.883 . . . . 75.13 109.45 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.94 161.87 29.85 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.312 -0.947 . . . . 72.44 113.593 168.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -96.09 137.41 35.19 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.785 -0.821 . . . . 73.4 108.785 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.32 102.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 107.674 -1.232 . . . . 73.43 107.674 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.71 -45.36 92.37 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.499 -1.228 . . . . 72.42 110.417 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -172.53 162.81 5.31 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 124.072 0.949 . . . . 73.25 108.723 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.461 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 88.5 t80 -160.77 116.02 2.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.887 0.742 . . . . 74.33 109.934 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.71 106.28 18.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.374 -0.973 . . . . 64.32 108.374 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 p -59.76 -32.47 70.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.176 0.806 . . . . 72.35 113.176 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 m -76.71 -21.97 54.57 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.204 0.526 . . . . 73.22 110.725 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -101.45 -8.87 21.59 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 119.979 -0.688 . . . . 74.41 110.769 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 91.7 m-20 54.68 29.8 12.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.394 0.678 . . . . 71.31 112.809 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.03 154.32 51.75 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.195 0.598 . . . . 73.0 110.346 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.35 -171.78 39.65 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.787 -1.325 . . . . 72.23 109.787 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -132.39 157.42 44.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.272 0.536 . . . . 74.02 111.297 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -147.02 128.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.482 -0.781 . . . . 75.11 109.23 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.94 148.6 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.308 -0.997 . . . . 74.23 108.308 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 9.9 pt20 -80.41 151.82 29.16 Favored 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 119.567 -0.853 . . . . 74.42 109.971 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.9 -15.22 19.82 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.62 1.2 . . . . 74.53 110.997 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 71.0 m-20 -88.14 6.6 35.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.735 -0.666 . . . . 74.23 110.295 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.81 51.2 2.52 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.988 -1.101 . . . . 74.34 113.111 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.42 41.84 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 119.911 -1.138 . . . . 64.13 111.074 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 157.93 28.47 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.392 0.596 . . . . 75.32 112.055 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.71 90.95 4.63 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.342 0.592 . . . . 71.43 109.984 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 62' ' ' ALA . 5.4 p -106.0 135.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.972 -1.013 . . . . 73.45 108.873 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -91.95 142.84 27.1 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.353 -0.939 . . . . 70.12 110.566 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.44 145.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.535 -0.913 . . . . 70.3 108.535 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 32.8 t60 -135.52 161.37 35.66 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.296 -1.002 . . . . 71.52 108.296 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -68.06 -18.53 64.7 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 112.644 0.609 . . . . 72.5 112.644 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -56.85 -21.99 33.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.28 0.562 . . . . 74.22 110.373 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 65' ' ' VAL . . . -81.14 -34.76 32.25 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.168 -0.469 . . . . 63.23 110.227 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.0 t -64.41 -52.26 57.62 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.424 0 N-CA-C 108.112 -1.07 . . . . 72.42 108.112 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.89 -22.61 64.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 123.436 0.46 . . . . 75.21 112.146 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.42 75.88 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 120.974 -0.29 . . . . 65.45 111.599 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.14 0.6 4.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.802 0.667 . . . . 71.53 112.802 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.08 50.26 65.64 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 111.092 -0.803 . . . . 72.33 111.092 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.8 138.58 58.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.753 -1.573 . . . . 75.02 106.753 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.55 -56.0 19.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.203 0.456 . . . . 71.32 111.968 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.1 p -167.81 152.46 6.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.389 -0.369 . . . . 63.22 110.323 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 90.2 mt -115.11 152.76 31.98 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.825 -0.435 . . . . 73.34 109.825 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.23 163.97 39.29 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.804 -1.554 . . . . 75.24 106.804 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 151.03 39.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.125 -0.63 . . . . 54.02 109.721 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.9 70.69 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.877 -0.678 . . . . 72.41 112.513 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.5 135.41 36.63 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 122.814 -0.227 . . . . 75.43 110.596 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.58 127.78 38.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.749 -1.574 . . . . 72.01 106.749 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.0 153.85 36.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.727 0 CA-C-O 121.485 0.66 . . . . 73.34 111.147 -173.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 67.0 mt -117.92 133.41 64.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 N-CA-C 106.821 -1.548 . . . . 73.11 106.821 177.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.8 p90 -144.76 -178.89 6.25 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.832 -0.432 . . . . 72.43 109.832 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -123.94 143.57 50.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.244 -1.391 . . . . 53.34 107.244 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 62' ' ' ALA . 22.9 tp -117.72 116.88 27.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.445 1.116 . . . . 74.44 112.973 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.94 123.96 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.471 -2.048 . . . . 72.11 105.471 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.57 132.98 36.4 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.783 0.801 . . . . 75.23 111.608 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -102.05 81.09 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.613 -1.176 . . . . 74.31 108.744 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 63.63 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.314 1.046 . . . . 62.23 111.484 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.62 5.35 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.876 -0.89 . . . . 70.25 110.876 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD3' ' H ' ' A' ' 62' ' ' ALA . 16.0 tppt? -110.91 154.73 23.67 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.789 -0.819 . . . . 72.54 108.789 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -134.08 128.63 34.62 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 110.063 -0.347 . . . . 60.12 110.063 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.32 134.54 45.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.35 0.595 . . . . 64.22 110.749 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.97 130.73 35.16 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.798 -1.092 . . . . 72.42 110.898 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 24.1 m -139.39 167.98 19.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.225 -0.898 . . . . 75.42 110.288 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 59.66 63.14 1.57 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.449 1.093 . . . . 74.31 110.056 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 36' ' ' ALA . 23.9 mt -79.47 139.47 37.62 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.932 0.872 . . . . 73.42 113.239 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -139.53 131.79 28.28 Favored 'General case' 0 N--CA 1.41 -2.425 0 C-N-CA 125.822 1.649 . . . . 71.22 107.101 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.8 mt -80.22 138.35 19.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 118.739 -1.185 . . . . 64.34 109.127 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 115.454 -0.794 . . . . 74.4 110.005 -177.163 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.611 -0.144 . . . . 75.43 110.611 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.26 17.26 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.872 -1.899 . . . . 73.45 105.872 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 p -97.09 140.74 31.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.149 1.166 . . . . 75.41 114.149 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 59.01 77.06 0.32 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.705 1.602 . . . . 74.44 110.869 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.4 mt -103.01 150.28 6.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.96 -1.018 . . . . 73.21 110.57 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.5 t -98.84 136.24 30.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.389 -0.823 . . . . 73.23 109.778 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.96 157.2 23.06 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.843 -0.694 . . . . 75.13 113.117 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.7 ttmt -99.69 139.75 34.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 123.231 0.612 . . . . 74.54 110.133 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.18 107.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.709 -0.678 . . . . 75.25 109.326 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -65.7 -46.6 78.4 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.243 -0.89 . . . . 72.11 109.74 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -174.29 161.68 3.5 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 123.736 0.815 . . . . 72.31 109.52 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -154.14 121.77 5.86 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.503 0.502 . . . . 75.2 111.181 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -117.85 106.77 13.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 115.69 -0.686 . . . . 75.2 110.036 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -56.42 -29.61 61.79 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.719 -1.128 . . . . 63.01 111.028 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 m -61.62 -34.57 75.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 65.03 110.614 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.35 -7.26 35.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 74.14 110.18 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.37 22.06 11.97 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.531 1.132 . . . . 74.02 110.983 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -157.2 174.91 14.76 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.493 0.663 . . . . 75.13 111.307 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.41 -164.63 24.43 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 108.834 -1.706 . . . . 70.4 108.834 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -131.95 152.53 51.03 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 117.6 0.7 . . . . 72.45 111.16 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -142.79 134.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 123.522 0.729 . . . . 52.33 109.143 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.99 151.53 38.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.319 -1.363 . . . . 72.24 107.319 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 11.4 pt20 -85.12 151.76 23.89 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.805 -1.558 . . . . 73.55 109.267 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.42 -27.75 57.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 124.282 0.989 . . . . 62.43 111.678 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -76.3 2.51 13.15 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.325 -0.398 . . . . 72.22 111.711 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 51.44 1.53 Allowed Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 119.804 -1.188 . . . . 71.44 111.965 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 170.32 53.28 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 119.758 -1.21 . . . . 72.23 111.047 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.93 154.55 39.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.882 0.341 . . . . 75.04 111.584 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.5 89.17 4.46 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.433 -0.951 . . . . 75.23 108.433 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 136.24 39.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.516 -0.766 . . . . 74.03 109.736 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 53.4 p90 -94.45 139.74 30.73 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.944 -0.702 . . . . 71.31 109.88 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 67' ' ' LEU . 7.4 p -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 109.722 -0.473 . . . . 71.2 109.722 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -98.12 138.61 35.16 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.679 -0.489 . . . . 71.12 109.679 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -57.21 -28.06 62.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.393 1.627 . . . . 73.54 115.393 -173.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 m -54.47 -25.79 27.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 120.624 -0.43 . . . . 72.14 111.244 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.14 -38.86 63.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.53 0.205 . . . . 73.55 110.595 177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.99 -52.64 58.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 108.263 -1.014 . . . . 75.02 108.263 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.91 -22.32 65.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 113.337 0.866 . . . . 72.14 113.337 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.16 -30.83 71.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.995 0.426 . . . . 72.55 110.981 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.98 -7.49 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.459 0.647 . . . . 65.54 110.437 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.59 24.3 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 109.886 -1.286 . . . . 62.5 109.886 -171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.04 130.49 44.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.981 -1.489 . . . . 74.34 106.981 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -53.53 -56.44 17.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.73 1.011 . . . . 74.24 113.73 -172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m -163.94 151.39 12.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 110.351 -0.24 . . . . 71.2 110.351 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -123.59 141.49 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.204 -1.036 . . . . 74.55 108.204 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.22 153.41 33.75 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.031 -0.531 . . . . 74.12 110.229 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.79 134.73 57.09 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.25 -1.018 . . . . 72.3 108.25 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.87 -14.56 49.17 Favored Glycine 0 C--N 1.295 -1.717 0 C-N-CA 120.993 -0.622 . . . . 73.21 111.947 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 134.09 34.09 Favored 'General case' 0 CA--C 1.495 -1.143 0 O-C-N 122.708 -0.289 . . . . 72.21 110.586 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -89.66 136.74 32.86 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.026 -1.472 . . . . 73.31 107.026 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.73 151.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-O 121.918 0.866 . . . . 75.31 111.378 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -113.07 133.32 59.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.918 -1.512 . . . . 74.12 106.918 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 43.5 p90 -149.54 177.48 9.69 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.297 -0.26 . . . . 75.01 110.297 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -115.34 155.56 27.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.349 -1.723 . . . . 71.35 106.349 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -141.03 136.9 32.53 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.772 0.796 . . . . 74.3 111.536 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.21 145.26 27.04 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.661 -1.977 . . . . 72.53 105.661 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.24 128.17 34.58 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 113.699 1.0 . . . . 74.42 113.699 -170.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 64.8 tttp -83.43 70.82 10.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.27 -1.332 . . . . 64.41 109.268 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 55.65 24.46 7.12 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.249 1.02 . . . . 74.52 111.325 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.81 -35.5 1.99 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.306 -0.718 . . . . 75.43 111.306 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 10.9 mptt -84.32 164.79 18.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.84 -0.429 . . . . 74.02 109.84 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.88 113.68 13.16 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.895 -0.409 . . . . 74.32 109.895 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 2.8 p90 -126.88 137.75 53.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.338 0.589 . . . . 72.33 111.569 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.9 35.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.588 -1.187 . . . . 64.04 110.392 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.88 168.08 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.156 -0.929 . . . . 72.05 109.935 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 55.39 63.55 2.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.492 0.717 . . . . 72.0 110.529 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 37.9 mt -81.95 145.93 30.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.274 -0.875 . . . . 74.41 112.461 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -150.53 130.86 13.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.241 -2.133 . . . . 72.23 105.241 174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.38 145.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 C-N-CA 119.545 -0.862 . . . . 73.33 110.148 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.903 -1.147 . . . . 72.42 107.903 174.124 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 110.024 -0.361 . . . . 74.24 110.024 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.3 132.99 28.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.449 -1.315 . . . . 71.41 107.449 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 p -118.58 148.63 42.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 111.983 0.364 . . . . 74.15 111.983 -175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 58.15 76.93 0.31 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.128 0.971 . . . . 71.21 111.435 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mt -108.35 154.41 9.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.983 -1.008 . . . . 70.35 110.51 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.9 t -103.46 129.5 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.665 -0.698 . . . . 63.43 109.505 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.528 ' HA2' ' CA ' ' A' ' 23' ' ' GLN . . . -158.79 171.62 35.48 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 110.658 -0.977 . . . . 63.41 110.658 171.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.8 ttmt -125.94 140.35 52.7 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 108.433 -0.951 . . . . 73.31 108.433 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 73.0 t -57.37 112.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.573 -0.528 . . . . 71.2 109.573 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.4 tttp -79.15 -43.09 24.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.582 -1.19 . . . . 74.3 109.112 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -176.2 160.01 2.14 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 124.139 0.976 . . . . 73.4 109.173 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -155.65 121.99 5.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.498 0.499 . . . . 74.12 110.089 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -105.15 104.18 13.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.733 -0.84 . . . . 75.12 108.733 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 p -63.75 -23.13 67.24 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 123.689 0.795 . . . . 72.43 112.469 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 m -67.84 -28.86 67.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.218 -0.447 . . . . 74.5 110.357 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -110.43 -8.24 14.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.834 -0.346 . . . . 75.43 110.347 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.07 27.2 14.57 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.648 0.779 . . . . 74.43 113.011 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.45 153.72 41.55 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.608 -0.723 . . . . 73.33 109.949 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.22 -168.73 32.47 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.608 -1.397 . . . . 54.23 109.608 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 57.5 m-85 -135.65 164.18 28.44 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.216 0.531 . . . . 74.01 111.597 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.8 mt -144.67 135.23 20.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 114.799 -1.091 . . . . 72.14 108.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.5 146.35 33.32 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.634 -1.987 . . . . 71.5 105.634 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.528 ' CA ' ' HA2' ' A' ' 7' ' ' GLY . 3.4 pt20 -72.17 144.81 48.43 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 117.809 -1.556 . . . . 72.15 109.398 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.81 -25.56 19.99 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.406 -1.27 . . . . 74.42 111.001 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.26 3.27 13.31 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.486 -0.779 . . . . 64.31 112.233 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.85 51.59 3.56 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.184 -1.007 . . . . 72.43 112.204 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.27 -143.5 9.84 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.349 -0.929 . . . . 45.22 113.098 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.38 164.16 13.32 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 110.259 -0.274 . . . . 74.11 110.259 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -101.25 112.53 25.05 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.712 -0.847 . . . . 70.1 108.712 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 55' ' ' LEU . 2.7 p -119.38 138.48 49.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.865 -0.791 . . . . 75.1 108.865 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.2 p90 -90.55 148.16 22.89 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.196 -1.002 . . . . 73.42 110.44 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 67' ' ' LEU . 11.7 p -113.98 142.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 109.078 -0.712 . . . . 74.43 109.078 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -130.12 160.14 34.65 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.426 -0.953 . . . . 74.4 108.426 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.2 -14.73 62.35 Favored 'General case' 0 C--O 1.197 -1.696 0 N-CA-C 111.802 0.297 . . . . 73.02 111.802 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -53.38 -33.32 53.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.702 0.286 . . . . 73.13 110.454 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -37.81 62.29 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.848 0.356 . . . . 73.35 110.894 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.23 -35.0 69.46 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 N-CA-C 108.205 -1.035 . . . . 74.43 108.205 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.2 -35.37 80.85 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.468 -0.787 . . . . 74.1 110.725 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.49 -49.09 12.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.247 0.462 . . . . 64.42 112.247 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.73 -23.27 19.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.492 0.923 . . . . 72.0 113.492 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.93 62.58 3.51 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 111.59 -0.604 . . . . 53.21 111.59 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.8 148.06 24.86 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.906 -1.516 . . . . 73.14 106.906 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -68.42 -60.85 2.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.208 0.458 . . . . 73.51 111.9 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.8 p -163.11 165.22 24.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.023 -0.362 . . . . 74.25 110.023 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.28 137.28 52.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.901 -0.778 . . . . 73.43 108.901 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.64 145.43 22.47 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.065 -0.97 . . . . 70.32 110.051 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -54.87 131.33 44.01 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 124.201 1.0 . . . . 73.02 109.893 -177.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.28 -26.1 8.38 Favored Glycine 0 C--N 1.301 -1.369 0 CA-C-N 115.486 -0.779 . . . . 63.53 111.653 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -80.69 117.51 21.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.676 0.991 . . . . 70.24 113.676 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.3 m-20 -70.4 132.19 45.23 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.431 -1.692 . . . . 73.2 106.431 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -133.26 146.6 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 CA-C-O 121.951 0.882 . . . . 74.14 110.981 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.6 mt -111.68 126.6 69.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 107.027 -1.472 . . . . 74.13 107.027 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.435 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 41.9 p90 -147.83 178.42 8.51 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.808 -0.357 . . . . 73.44 110.634 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -115.12 162.0 17.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.341 -2.096 . . . . 65.41 105.341 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 62' ' ' ALA . 16.4 tp -130.69 128.37 40.75 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.948 0.88 . . . . 72.12 112.841 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' N ' HD11 ' A' ' 55' ' ' LEU . 44.0 mt-10 -116.9 146.48 42.92 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.395 -1.73 . . . . 75.41 108.55 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.63 137.3 33.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.277 0.561 . . . . 65.52 111.873 -172.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -116.94 74.25 0.9 Allowed 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.585 -0.894 . . . . 75.45 108.585 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 65.58 -72.28 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.931 1.292 . . . . 74.22 111.838 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 -1.38 4.79 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.062 -0.815 . . . . 70.14 111.062 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 7.3 mmpt? -104.12 164.97 11.35 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.059 -0.719 . . . . 71.11 109.059 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -129.23 127.22 40.81 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.463 -0.569 . . . . 75.0 109.463 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.9 p90 -122.58 128.7 51.05 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.699 0.761 . . . . 74.11 112.831 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.83 130.98 37.34 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.382 -1.281 . . . . 74.51 110.218 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.9 m -135.36 168.77 22.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.938 -1.028 . . . . 61.0 108.871 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.7 t30 53.18 63.92 2.05 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.724 0.64 . . . . 64.4 111.138 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 44.5 mt -82.47 146.79 29.08 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.538 0.685 . . . . 73.31 112.528 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -148.77 130.72 15.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.016 -2.216 . . . . 75.31 105.016 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.82 148.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.176 -1.01 . . . . 74.3 112.784 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.34 -0.845 . . . . 75.13 109.769 172.507 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 108.473 -0.936 . . . . 61.25 108.473 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -129.56 153.73 47.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.267 0.469 . . . . 50.5 112.267 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 m120 58.07 42.04 23.1 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.985 0.914 . . . . 73.439999999999998 110.739 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 42.1 mt -75.68 150.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.428 -0.806 . . . . 63.109999999999999 112.14 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.8 t -96.43 138.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-N 114.854 -1.067 . . . . 70.439999999999998 109.777 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.71 171.01 43.94 Favored Glycine 0 N--CA 1.403 -3.524 0 C-N-CA 120.808 -0.71 . . . . 73.030000000000001 112.555 168.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -119.5 143.61 47.46 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.742 -0.836 . . . . 71.140000000000001 108.742 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.7 107.77 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.429 -0.952 . . . . 70.319999999999993 108.429 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 64.5 tttp -69.18 -43.07 74.96 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.823 -1.08 . . . . 74.230000000000004 108.57 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -171.85 155.34 3.84 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 114.729 -1.123 . . . . 72.319999999999993 108.346 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -159.99 121.77 3.24 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.624 0.577 . . . . 72.540000000000006 109.557 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -111.21 108.34 17.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.866 -0.42 . . . . 75.409999999999997 109.866 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 p -58.23 -23.64 56.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.215 -0.902 . . . . 45.100000000000001 112.709 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 m -57.46 -36.16 71.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.872 0.469 . . . . 72.349999999999994 110.941 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -114.73 -9.05 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.346 -0.542 . . . . 75.230000000000004 110.346 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 63.52 25.04 14.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.774 0.83 . . . . 73.099999999999994 111.837 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.41 158.34 23.67 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 116.035 -0.53 . . . . 73.409999999999997 109.966 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.51 -167.69 38.87 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.355 -1.098 . . . . 74.030000000000001 110.355 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -134.67 168.69 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.17 0.51 . . . . 73.25 110.981 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.465 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 66.4 mt -140.69 138.69 35.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.3 -0.863 . . . . 64.329999999999998 108.672 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' OE2' ' HG3' ' A' ' 10' ' ' LYS . 11.7 pt-20 -143.03 141.7 31.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.829 -1.545 . . . . 70.329999999999998 106.829 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -83.8 151.17 25.32 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 117.603 -1.639 . . . . 71.430000000000007 108.835 173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.27 -19.75 48.58 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 123.95 0.782 . . . . 72.430000000000007 111.926 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.16 1.14 51.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.157 -0.474 . . . . 70.430000000000007 111.872 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 45.88 1.13 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.579 -1.295 . . . . 65.010000000000005 112.569 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.69 154.67 36.3 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.888 -1.285 . . . . 63.240000000000002 109.888 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.77 169.69 14.95 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.788 0.662 . . . . 51.409999999999997 112.788 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' HE2' ' A' ' 10' ' ' LYS . 3.1 m-20 -70.87 90.44 0.8 Allowed 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.233 -0.894 . . . . 72.239999999999995 112.619 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 55' ' ' LEU . 5.7 p -105.34 123.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.309 -0.997 . . . . 73.340000000000003 108.309 173.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 48.5 p90 -83.5 141.94 31.27 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.058 0.456 . . . . 74.310000000000002 111.539 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 8.9 p -97.96 130.46 46.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.671 -0.695 . . . . 73.510000000000005 109.624 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -109.36 148.41 31.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.557 -0.905 . . . . 75.349999999999994 108.557 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -57.54 -30.14 64.96 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 114.075 1.139 . . . . 64.409999999999997 114.075 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -54.44 -27.8 39.77 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.998 0.363 . . . . 74.129999999999995 111.325 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.26 -39.52 62.95 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.013 0.435 . . . . 54.210000000000001 109.959 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 42' ' ' LEU . 79.1 t -61.97 -50.65 79.23 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.889 0 N-CA-C 108.217 -1.031 . . . . 71.230000000000004 108.217 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.84 -22.63 67.03 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.178 0.924 . . . . 74.450000000000003 111.935 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.66 72.48 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.245 0.545 . . . . 75.519999999999996 110.741 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.89 -13.92 10.68 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.528 -0.76 . . . . 71.340000000000003 110.115 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.28 55.18 22.63 Favored Glycine 0 CA--C 1.486 -1.778 0 N-CA-C 109.743 -1.343 . . . . 51.43 109.743 -173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -64.18 125.99 26.3 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.592 -1.633 . . . . 72.519999999999996 106.592 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -73.81 -34.45 64.61 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 114.042 1.127 . . . . 75.010000000000005 114.042 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -161.4 143.68 12.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.873 0.368 . . . . 70.129999999999995 111.218 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.54 144.5 37.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 109.038 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.18 171.29 20.48 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.533 -1.284 . . . . 74.109999999999999 107.533 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 133.4 51.23 Favored 'General case' 0 N--CA 1.417 -2.095 0 C-N-CA 123.875 0.87 . . . . 75.109999999999999 110.096 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.44 -32.84 5.54 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.615 -0.721 . . . . 41.43 113.51 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -64.0 126.74 28.64 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.741 1.015 . . . . 62.240000000000002 113.741 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.79 133.38 43.25 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 106.389 -1.708 . . . . 72.409999999999997 106.389 169.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 141.44 38.89 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 CA-C-O 122.125 0.964 . . . . 54.539999999999999 110.25 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 54.3 mt -114.92 124.18 71.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 N-CA-C 106.27 -1.752 . . . . 71.109999999999999 106.27 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.36 179.39 7.12 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.609 -0.437 . . . . 74.319999999999993 111.497 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -117.42 158.8 23.84 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 105.649 -1.982 . . . . 64.140000000000001 105.649 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 62' ' ' ALA . 17.2 tp -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 121.864 0.84 . . . . 74.340000000000003 112.577 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.21 157.28 30.59 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.674 -1.603 . . . . 75.329999999999998 108.755 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -100.19 155.22 17.87 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-O 122.082 0.944 . . . . 73.319999999999993 112.9 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.8 tptt -118.78 85.1 2.3 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.308 -1.738 . . . . 75.409999999999997 106.308 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 65.8 -76.04 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.063 0.852 . . . . 75.129999999999995 109.483 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.28 -4.69 3.17 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.378 -0.689 . . . . 70.239999999999995 111.378 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 55.3 mtpt -89.06 165.7 14.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 122.807 0.443 . . . . 60.140000000000001 110.934 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.55 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.97 123.16 40.28 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.757 0.28 . . . . 72.5 111.757 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 41.0 p90 -125.65 132.94 52.36 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.364 0.602 . . . . 73.420000000000002 111.695 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.45 134.99 37.29 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.038 -0.983 . . . . 41.039999999999999 110.446 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.3 m -137.65 165.92 25.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.205 -0.907 . . . . 61.109999999999999 108.864 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.52 64.07 1.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.648 0.593 . . . . 51.039999999999999 111.383 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 32' ' ' VAL . 24.7 mt -80.2 142.67 34.47 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.463 -0.895 . . . . 72.420000000000002 112.443 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 23.0 tpp180 -138.79 131.56 29.22 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.151 -1.796 . . . . 73.439999999999998 106.151 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.34 1.8 pp -90.59 96.56 6.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 116.065 1.876 . . . . 40.399999999999999 116.065 -177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.6 tttp . . . . . 0 C--O 1.259 1.585 0 C-N-CA 125.703 1.601 . . . . 52.240000000000002 113.744 173.762 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 105.582 -2.007 . . . . 64.409999999999997 105.582 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.3 p -108.84 148.98 29.77 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.242 0.83 . . . . 53.32 113.242 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 52.48 76.16 0.2 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.36 -1.291 . . . . 72.299999999999997 112.111 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 36.6 mt -102.76 143.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.653 -1.158 . . . . 74.450000000000003 110.182 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 58.8 t -91.47 133.55 32.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.018 -0.992 . . . . 55.149999999999999 109.522 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.85 172.26 38.84 Favored Glycine 0 N--CA 1.396 -3.984 0 CA-C-N 115.45 -0.795 . . . . 73.349999999999994 112.166 171.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.7 ttmt -123.53 143.06 50.43 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.373 -0.973 . . . . 73.519999999999996 108.373 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.84 111.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 108.39 -0.967 . . . . 71.129999999999995 108.39 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.1 tttp -76.99 -40.57 46.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.549 -1.205 . . . . 72.319999999999993 108.786 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.404 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 68.5 p-90 -177.65 160.58 1.58 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 124.265 1.026 . . . . 75.239999999999995 109.1 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -155.35 134.61 12.36 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.007 0.432 . . . . 73.450000000000003 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -121.71 106.05 10.97 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.757 -0.656 . . . . 72.349999999999994 109.386 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.4 p -61.04 -32.62 72.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.612 -0.722 . . . . 73.329999999999998 112.439 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.0 m -61.88 -28.71 69.7 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.988 0.423 . . . . 64.400000000000006 110.686 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.21 -9.0 18.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.43 -0.508 . . . . 75.409999999999997 111.812 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 63.76 25.99 14.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 120.924 0.392 . . . . 75.230000000000004 110.077 -176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -137.64 165.87 25.31 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.4 0.68 . . . . 62.43 112.318 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.53 44.38 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.507 -1.837 . . . . 53.310000000000002 108.507 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 39.0 m-85 -133.19 160.24 37.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 117.465 0.633 . . . . 74.120000000000005 111.534 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -145.47 130.11 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.092 -0.958 . . . . 72.310000000000002 108.465 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.88 149.65 37.23 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.363 -1.717 . . . . 74.310000000000002 106.363 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -74.87 146.85 41.58 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 117.708 -1.597 . . . . 72.310000000000002 109.24 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.47 -21.09 35.09 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.292 -1.322 . . . . 72.299999999999997 111.0 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.69 5.26 11.55 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.124 -0.944 . . . . 75.099999999999994 111.14 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.54 50.39 2.75 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 111.529 -0.629 . . . . 50.549999999999997 111.529 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.33 172.47 54.62 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.477 -0.868 . . . . 73.209999999999994 112.498 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.75 151.99 43.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.149 -0.525 . . . . 72.349999999999994 110.447 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.26 116.71 20.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.081 0.943 . . . . 74.030000000000001 111.144 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 55' ' ' LEU . 2.5 p -133.17 133.48 58.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.722 -1.127 . . . . 74.5 108.776 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 52.9 p90 -88.91 152.32 21.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 120.251 -0.58 . . . . 64.219999999999999 111.331 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -109.34 128.04 65.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.516 0.674 . . . . 74.430000000000007 109.409 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -109.63 156.73 19.84 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.396 -0.965 . . . . 74.319999999999993 108.396 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -22.48 65.99 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 113.265 0.839 . . . . 74.299999999999997 113.265 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -55.86 -27.41 51.52 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.988 0.423 . . . . 73.030000000000001 110.575 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -76.48 -34.14 58.66 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.912 0.387 . . . . 64.019999999999996 110.169 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 -47.85 78.91 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.625 0 N-CA-C 107.917 -1.142 . . . . 71.129999999999995 107.917 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.24 -22.79 67.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.68 0.622 . . . . 62.530000000000001 112.68 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.19 69.44 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.825 0.305 . . . . 71.040000000000006 111.825 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -21.78 2.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.286 0.565 . . . . 73.109999999999999 112.429 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.85 51.91 5.23 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.483 -1.047 . . . . 43.039999999999999 110.483 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.94 129.19 38.92 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.58 -1.267 . . . . 65.530000000000001 107.58 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -62.44 -39.04 92.05 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.68 0.622 . . . . 65.549999999999997 112.68 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.5 t -171.06 156.56 4.86 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 110.096 -0.335 . . . . 73.310000000000002 110.096 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.4 mt -135.72 132.28 36.68 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.215 -0.661 . . . . 72.439999999999998 109.215 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.88 160.78 34.03 Favored 'General case' 0 C--N 1.266 -3.039 0 C-N-CA 125.547 1.539 . . . . 73.420000000000002 107.023 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 155.12 37.09 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.368 0.877 . . . . 70.109999999999999 113.368 -172.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.37 -19.97 48.85 Favored Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.815 -1.084 . . . . 73.099999999999994 112.02 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -89.4 132.29 35.06 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 122.557 0.343 . . . . 74.129999999999995 111.422 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.6 m-20 -87.32 138.62 31.33 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.465 -0.939 . . . . 75.219999999999999 108.465 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.77 149.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-O 121.807 0.813 . . . . 60.310000000000002 110.893 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 63.2 mt -111.72 135.79 49.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 106.482 -1.673 . . . . 51.039999999999999 106.482 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.52 178.4 8.65 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.8 -0.36 . . . . 75.120000000000005 110.161 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -119.81 154.54 34.12 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 105.077 -2.194 . . . . 74.549999999999997 105.077 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 30' ' ' VAL . 27.4 tp -121.07 130.69 53.87 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 113.324 0.861 . . . . 54.229999999999997 113.324 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -124.6 150.16 46.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.481 -1.69 . . . . 75.319999999999993 111.131 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -100.83 127.09 47.43 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.068 -0.969 . . . . 73.409999999999997 110.251 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.1 tptp -93.76 28.76 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.396 1.078 . . . . 73.5 108.543 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.84 90.86 0.08 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.7 -1.136 . . . . 74.200000000000003 107.981 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.37 -44.78 2.61 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.401 -0.818 . . . . 51.5 111.741 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.7 mmmt -95.95 153.07 17.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.975 -0.38 . . . . 62.009999999999998 109.975 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -126.24 122.6 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.797 -0.446 . . . . 63.030000000000001 109.797 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.7 p90 -130.84 140.31 50.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 111.963 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.34 136.33 44.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.435 -1.257 . . . . 31.140000000000001 109.812 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 m -136.9 163.02 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.362 -0.835 . . . . 63.130000000000003 109.708 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.72 63.56 1.91 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.012 0.82 . . . . 72.140000000000001 111.034 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 32' ' ' VAL . 28.7 mt -75.59 149.56 38.25 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.715 -0.794 . . . . 72.439999999999998 112.336 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 20.1 tpp180 -148.89 130.97 15.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.256 -1.387 . . . . 73.409999999999997 107.256 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.757 ' H ' HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -74.73 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 118.2 0.455 . . . . 62.130000000000003 111.441 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.177 -0.919 . . . . 73.040000000000006 109.83 177.104 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.351 -0.611 . . . . 51.0 109.351 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -95.87 140.51 30.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.675 0.61 . . . . 75.129999999999995 112.411 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 49.51 72.15 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.819 1.044 . . . . 71.129999999999995 113.819 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 57.0 mt -92.66 151.13 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.146 -0.934 . . . . 72.150000000000006 110.081 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 55.9 t -92.28 139.35 18.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.509 -0.768 . . . . 61.350000000000001 110.377 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -174.42 179.13 45.95 Favored Glycine 1 N--CA 1.395 -4.039 0 CA-C-N 115.274 -0.875 . . . . 61.229999999999997 112.239 169.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 37.5 ttmt -132.69 142.76 49.22 Favored 'General case' 0 C--N 1.259 -3.339 0 C-N-CA 124.017 0.927 . . . . 72.329999999999998 108.713 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.36 109.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.667 0.746 . . . . 51.409999999999997 109.072 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 22' ' ' GLU . 59.5 tttp -68.38 -40.73 81.28 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.495 1.518 . . . . 73.219999999999999 108.613 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 69.7 p-90 -177.76 160.51 1.53 Allowed 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.267 1.427 . . . . 75.319999999999993 108.504 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -161.25 133.6 5.96 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.227 0.33 . . . . 73.319999999999993 110.227 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -122.29 103.94 9.09 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.629 -0.714 . . . . 51.329999999999998 109.368 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -57.11 -32.25 66.12 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.294 -0.866 . . . . 62.240000000000002 112.504 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.8 m -60.75 -34.64 74.74 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 112.126 0.417 . . . . 72.530000000000001 112.126 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -101.05 -7.01 23.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.522 -0.471 . . . . 51.520000000000003 111.009 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.9 m120 66.93 21.45 10.35 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.243 1.017 . . . . 73.010000000000005 110.765 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -125.47 152.0 45.52 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.517 0.675 . . . . 61.409999999999997 112.398 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.99 -175.62 38.49 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.528 -1.429 . . . . 41.229999999999997 109.528 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 m-85 -131.45 165.16 24.14 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 117.05 0.425 . . . . 74.319999999999993 110.751 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 65.8 mt -139.44 139.22 39.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.781 -0.822 . . . . 61.100000000000001 108.781 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.2 pt-20 -143.1 144.38 32.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.542 -1.651 . . . . 71.200000000000003 106.542 175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.2 pt20 -84.49 151.91 24.3 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 117.451 -1.7 . . . . 73.439999999999998 109.633 174.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.91 -18.54 23.76 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.925 -1.034 . . . . 62.329999999999998 111.648 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -87.13 -0.93 57.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 73.340000000000003 111.41 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.14 51.02 1.1 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.689 -1.243 . . . . 71.340000000000003 112.782 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.47 150.08 26.67 Favored Glycine 0 C--N 1.318 -0.46 0 C-N-CA 119.948 -1.12 . . . . 75.200000000000003 110.819 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -66.91 171.99 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.572 0.952 . . . . 75.129999999999995 113.572 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.01 99.11 2.65 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.915 -0.584 . . . . 72.0 111.781 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 55' ' ' LEU . 7.1 p -117.71 129.45 74.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.028 -0.73 . . . . 72.430000000000007 109.028 174.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.6 p90 -92.44 142.5 27.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.092 -0.643 . . . . 74.400000000000006 111.345 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.47 122.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-O 121.589 0.709 . . . . 71.349999999999994 109.747 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.19 140.76 31.2 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -76.3 -11.42 59.9 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.917 1.08 . . . . 65.409999999999997 113.917 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -61.59 -21.79 64.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 120.623 -0.431 . . . . 65.239999999999995 109.846 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -71.99 -40.17 68.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.808 0.337 . . . . 34.420000000000002 110.197 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.35 -35.53 73.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.085 0 N-CA-C 108.007 -1.109 . . . . 74.109999999999999 108.007 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -66.28 -30.5 70.94 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.747 -0.66 . . . . 74.450000000000003 111.06 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.79 77.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.617 0.599 . . . . 64.319999999999993 112.617 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 -9.18 6.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.178 0.807 . . . . 75.439999999999998 113.178 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.99 57.71 7.47 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.49 -1.044 . . . . 54.240000000000002 110.49 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.38 131.28 46.78 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.309 -1.367 . . . . 75.329999999999998 107.309 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -50.83 -58.85 4.93 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.65 0.982 . . . . 64.0 113.65 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 p -170.62 147.25 2.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.199 0.444 . . . . 74.5 112.199 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -124.83 148.92 47.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.304 0.573 . . . . 72.340000000000003 110.109 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -166.69 162.13 16.14 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.226 -2.138 . . . . 61.240000000000002 105.226 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -69.1 149.94 48.14 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.907 -0.717 . . . . 61.32 111.295 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.77 -15.36 63.25 Favored Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.334 -0.848 . . . . 73.319999999999993 112.095 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -83.02 121.16 26.65 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 122.556 0.343 . . . . 64.0 111.476 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 m-20 -72.28 135.21 45.92 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.729 -1.212 . . . . 75.25 107.729 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.49 147.33 19.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 121.968 0.889 . . . . 62.399999999999999 111.514 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 60.0 mt -110.67 133.66 55.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 N-CA-C 107.073 -1.455 . . . . 74.120000000000005 107.073 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.1 p90 -148.14 174.78 11.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.187 0.518 . . . . 73.209999999999994 111.405 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.8 146.09 39.45 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.025 -1.472 . . . . 45.420000000000002 107.025 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 56' ' ' GLU . 25.1 tp -129.13 136.9 50.81 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.646 0.736 . . . . 62.310000000000002 111.585 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 55' ' ' LEU . 30.6 tt0 -153.15 143.98 22.82 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.473 -2.047 . . . . 71.299999999999997 105.473 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -85.67 140.65 30.37 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.892 1.071 . . . . 74.340000000000003 113.892 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 84.9 tttt -95.18 80.28 3.57 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.068 -1.827 . . . . 72.409999999999997 106.068 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 64.62 -81.6 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.252 1.021 . . . . 71.450000000000003 110.452 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.33 -6.83 7.96 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.364 -0.694 . . . . 74.120000000000005 111.364 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 9.5 mmpt? -92.49 164.79 13.33 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.293 -0.632 . . . . 71.209999999999994 109.293 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.13 118.53 24.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.774 -0.454 . . . . 62.520000000000003 109.774 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.2 p90 -126.78 136.03 51.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.375 0.607 . . . . 64.400000000000006 112.271 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 132.5 35.2 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.605 -1.18 . . . . 64.420000000000002 110.738 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 m -136.59 177.11 6.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 CA-C-N 115.167 -0.924 . . . . 72.519999999999996 109.337 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.25 63.16 2.35 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.92 0.762 . . . . 74.109999999999999 110.328 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 45.1 mt -81.93 147.46 29.25 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.319 0.859 . . . . 74.140000000000001 113.319 -174.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 22.7 tpp180 -151.33 130.64 12.82 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.315 -2.106 . . . . 73.120000000000005 105.315 175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -93.78 145.9 7.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 113.239 0.829 . . . . 75.530000000000001 113.239 -177.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 58.2 mtpt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 114.986 -1.006 . . . . 72.129999999999995 108.672 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 113.498 0.925 . . . . 71.25 113.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.0 p -141.01 140.95 34.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.478 -1.304 . . . . 72.129999999999995 107.478 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 58.81 74.2 0.45 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 106.833 -1.543 . . . . 65.099999999999994 106.833 -168.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.2 mt -101.47 147.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 113.852 -1.522 . . . . 63.0 111.65 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.4 t -91.27 140.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.502 -1.227 . . . . 72.120000000000005 109.384 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -179.91 161.08 26.59 Favored Glycine 0 N--CA 1.414 -2.785 0 C-N-CA 120.232 -0.985 . . . . 34.0 113.416 167.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 4.8 ttmp? -106.44 139.98 40.07 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.561 -0.903 . . . . 71.530000000000001 108.561 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.54 109.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.483 -0.932 . . . . 64.319999999999993 108.483 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 21' ' ' ILE . 55.2 tttp -67.59 -42.31 82.67 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.592 -1.64 . . . . 74.230000000000004 108.471 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -176.04 160.93 2.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 124.891 1.277 . . . . 71.019999999999996 107.783 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 81.3 t80 -163.35 131.97 3.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.043 0.449 . . . . 75.040000000000006 110.777 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -112.46 105.01 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.045 -1.094 . . . . 73.400000000000006 108.045 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.0 p -61.94 -36.2 80.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.951 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.6 m -63.51 -34.23 77.32 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.843 -0.617 . . . . 71.310000000000002 110.812 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 96.6 mttt -93.62 -8.13 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 62.200000000000003 111.052 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 67.07 23.61 9.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.943 0.897 . . . . 61.310000000000002 112.51 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 46.5 p90 -153.19 168.18 26.84 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 112.883 0.697 . . . . 74.030000000000001 112.883 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -177.66 -154.84 12.78 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 109.923 -1.271 . . . . 71.510000000000005 109.923 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.489 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 35.4 m-85 -140.03 169.48 17.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.513 0.656 . . . . 73.450000000000003 111.24 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 62.9 mt -145.27 140.38 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.163 -1.051 . . . . 73.409999999999997 108.163 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.1 139.68 30.55 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.013 -1.477 . . . . 63.329999999999998 107.013 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.5 pt20 -84.41 146.5 27.63 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 117.765 -1.574 . . . . 74.099999999999994 109.05 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.09 -13.98 20.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 124.632 1.208 . . . . 72.310000000000002 110.627 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 81.4 m-20 -87.34 -5.11 59.02 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.772 -0.649 . . . . 73.329999999999998 110.592 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.98 0.67 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 118.324 -1.893 . . . . 74.430000000000007 113.681 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.2 146.37 19.61 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 119.838 -1.172 . . . . 74.109999999999999 110.428 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.66 -175.86 4.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.293 0.849 . . . . 70.209999999999994 113.293 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.89 99.11 1.01 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.692 -0.685 . . . . 75.140000000000001 111.878 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.33 123.21 59.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.361 -0.978 . . . . 71.400000000000006 108.361 173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.5 p90 -92.41 147.49 22.87 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 119.559 -0.856 . . . . 64.019999999999996 111.16 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -104.0 124.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 109.06 -0.719 . . . . 61.409999999999997 109.06 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -108.71 149.92 28.31 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.412 -0.959 . . . . 74.329999999999998 108.412 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.19 -22.64 61.31 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 113.502 0.927 . . . . 64.349999999999994 113.502 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.2 m -56.32 -23.38 36.64 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 120.388 -0.525 . . . . 74.030000000000001 111.102 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -77.92 -36.22 49.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.871 -0.418 . . . . 74.340000000000003 109.871 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 42' ' ' LEU . 60.8 t -61.9 -49.8 82.73 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.868 0 N-CA-C 107.416 -1.327 . . . . 75.310000000000002 107.416 172.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.93 -33.03 68.38 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.435 1.084 . . . . 72.530000000000001 111.73 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -30.12 68.84 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.998 0.427 . . . . 61.100000000000001 112.135 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.74 0.08 4.87 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.601 -0.44 . . . . 54.200000000000003 111.706 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.05 55.52 27.72 Favored Glycine 0 C--N 1.313 -0.746 0 N-CA-C 110.434 -1.066 . . . . 63.420000000000002 110.434 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -64.94 137.5 57.78 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.728 -1.582 . . . . 63.299999999999997 106.728 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -61.88 -61.14 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.895 0.331 . . . . 72.329999999999998 111.895 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -159.88 151.42 19.92 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.778 -0.453 . . . . 74.329999999999998 109.778 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 88.2 mt -123.87 146.59 48.3 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.545 -0.539 . . . . 60.350000000000001 109.545 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -160.51 162.12 32.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 106.058 -1.83 . . . . 62.119999999999997 106.058 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -68.35 148.86 50.12 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.744 -0.782 . . . . 72.519999999999996 110.627 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.58 -16.85 60.32 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.492 -0.776 . . . . 75.040000000000006 112.484 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -81.34 128.37 33.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 122.789 -0.242 . . . . 73.230000000000004 110.425 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 26.6 m-20 -88.01 138.56 31.35 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.991 -0.744 . . . . 63.130000000000003 108.991 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.64 154.23 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.712 -0.676 . . . . 62.039999999999999 110.656 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 55.2 mt -119.97 131.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.841 -1.54 . . . . 71.140000000000001 106.841 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 45.5 p90 -144.38 -179.98 6.88 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.795 0.331 . . . . 75.409999999999997 111.426 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -117.37 159.88 22.05 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.674 -1.232 . . . . 64.420000000000002 107.674 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.3 tp -136.79 132.95 35.43 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 121.31 0.576 . . . . 62.32 110.958 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.53 145.39 51.47 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.828 -1.078 . . . . 73.530000000000001 108.156 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.86 112.2 20.91 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.45 0.643 . . . . 62.420000000000002 111.955 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -84.11 85.68 7.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.518 -1.29 . . . . 64.219999999999999 107.518 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 66.85 -71.54 0.1 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.562 1.145 . . . . 71.109999999999999 110.703 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 -6.72 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.654 -0.978 . . . . 21.530000000000001 110.654 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -92.09 165.65 13.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.076 0.55 . . . . 63.350000000000001 109.667 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -133.4 125.59 29.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.332 0.253 . . . . 52.340000000000003 110.627 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -136.46 139.88 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.063 0.459 . . . . 74.340000000000003 110.921 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 136.58 39.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.698 -1.137 . . . . 73.439999999999998 111.282 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.4 m -137.24 165.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.266 -0.879 . . . . 64.510000000000005 109.614 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 56.04 65.21 1.5 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.43 0.692 . . . . 75.209999999999994 111.06 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' VAL . 27.9 mt -78.69 140.73 38.32 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.5 -0.88 . . . . 71.040000000000006 113.115 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.599 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 8.4 mpt_? -127.97 135.73 50.33 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.168 -1.79 . . . . 73.109999999999999 106.168 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -78.69 133.08 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 119.576 -0.85 . . . . 61.25 109.641 172.357 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.532 -0.758 . . . . 72.25 109.219 176.123 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 107.769 -1.197 . . . . 71.299999999999997 107.769 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -111.58 147.41 35.51 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.219 -0.446 . . . . 51.409999999999997 110.804 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 m120 59.34 75.87 0.38 Allowed 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.13 0.894 . . . . 74.0 110.977 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 23.9 mt -104.33 146.41 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.535 -0.757 . . . . 72.120000000000005 111.134 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.65 134.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.865 -1.061 . . . . 73.219999999999999 109.819 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 23' ' ' GLN . . . 179.09 163.19 29.7 Favored Glycine 0 CA--C 1.454 -3.774 0 C-N-CA 120.325 -0.94 . . . . 65.109999999999999 113.493 168.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.2 ttmt -101.81 142.27 33.39 Favored 'General case' 0 C--N 1.252 -3.644 0 CA-C-N 114.622 -0.789 . . . . 73.420000000000002 109.241 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.1 108.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.358 -0.979 . . . . 73.239999999999995 108.358 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 57.5 tttp -68.07 -38.84 82.88 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.419 -1.264 . . . . 73.310000000000002 108.19 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 177.78 157.5 0.39 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 125.272 1.429 . . . . 75.329999999999998 108.616 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -146.12 119.52 9.02 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.317 0.58 . . . . 63.100000000000001 110.541 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -88.05 107.11 18.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.893 -1.521 . . . . 74.129999999999995 106.893 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -11.88 60.01 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.107 0.41 . . . . 61.32 112.107 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 m -79.52 -46.47 17.33 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.27 -0.641 . . . . 73.150000000000006 109.27 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -97.41 -7.68 31.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.564 0.579 . . . . 71.299999999999997 112.564 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 66.76 27.67 9.18 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.577 0.584 . . . . 70.010000000000005 112.577 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -122.79 157.68 31.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.89 -0.595 . . . . 63.409999999999997 109.594 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.96 29.57 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.794 -1.323 . . . . 64.329999999999998 109.794 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 60.4 m-85 -141.24 167.64 21.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 117.396 0.598 . . . . 75.019999999999996 110.768 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 59.2 mt -145.4 134.16 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.123 -0.695 . . . . 75.209999999999994 109.123 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -144.11 148.54 35.24 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.949 -1.5 . . . . 64.430000000000007 106.949 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.685 ' HB3' ' HA2' ' A' ' 7' ' ' GLY 0.272 0.0 OUTLIER -91.83 158.8 16.12 Favored 'General case' 0 CA--C 1.462 -2.442 0 C-N-CA 115.245 -2.582 . . . . 71.099999999999994 109.849 172.714 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.15 -15.52 5.76 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 124.301 1.001 . . . . 72.140000000000001 113.027 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 82.4 m-20 -84.36 -2.1 56.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.671 -0.24 . . . . 62.310000000000002 111.313 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.22 50.75 0.7 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.871 -0.68 . . . . 61.25 112.8 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.91 52.13 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.494 -0.86 . . . . 72.340000000000003 113.461 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -74.88 -178.63 3.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.142 0.496 . . . . 73.140000000000001 112.223 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.77 101.3 12.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.898 0.38 . . . . 65.129999999999995 110.598 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 55' ' ' LEU . 6.3 p -128.3 123.76 60.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.411 -0.959 . . . . 73.540000000000006 108.411 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 52.6 p90 -87.69 147.14 25.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 120.119 -0.632 . . . . 52.049999999999997 111.661 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 67' ' ' LEU . 9.2 p -109.28 141.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.0 -0.741 . . . . 73.340000000000003 109.0 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -131.66 155.81 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.235 -0.654 . . . . 72.439999999999998 109.235 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -63.47 -18.44 63.77 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 113.151 0.797 . . . . 72.420000000000002 113.151 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -57.97 -27.18 63.22 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 120.961 0.41 . . . . 73.400000000000006 110.639 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -78.63 -35.77 45.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.833 -0.432 . . . . 62.32 109.833 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 42' ' ' LEU . 71.9 t -61.98 -48.38 88.83 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.308 0 N-CA-C 107.715 -1.216 . . . . 41.340000000000003 107.715 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.84 -33.04 66.39 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.303 1.041 . . . . 74.129999999999995 111.241 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.34 68.32 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.112 0.782 . . . . 53.329999999999998 113.112 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.99 -2.49 4.62 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.595 0.591 . . . . 72.420000000000002 112.595 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.6 52.52 50.45 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 123.65 0.643 . . . . 43.539999999999999 112.969 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -67.65 142.86 56.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.328 -1.73 . . . . 70.420000000000002 106.328 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -64.39 -62.42 1.62 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.6 0.593 . . . . 51.229999999999997 112.6 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.9 m -167.54 162.68 14.47 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.116 -1.068 . . . . 75.109999999999999 108.116 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.68 154.73 45.53 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.729 0.776 . . . . 72.430000000000007 112.006 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 174.97 14.6 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.531 -1.655 . . . . 61.520000000000003 106.531 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 157.8 28.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.28 0.562 . . . . 62.509999999999998 112.225 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.64 14.43 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.584 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -74.56 126.43 30.78 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 112.229 0.455 . . . . 44.520000000000003 112.229 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -81.95 134.46 35.38 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.222 -1.399 . . . . 71.209999999999994 107.222 173.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.88 150.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 CA-C-O 121.926 0.87 . . . . 62.520000000000003 110.463 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 78.4 mt -115.28 131.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 N-CA-C 106.888 -1.523 . . . . 73.099999999999994 106.888 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.48 -178.78 6.34 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.49 -0.559 . . . . 75.140000000000001 109.49 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.76 158.63 28.39 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.236 -1.764 . . . . 65.219999999999999 106.236 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 62' ' ' ALA . 26.9 tp -129.19 123.18 31.4 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.287 1.041 . . . . 63.140000000000001 112.744 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.02 143.78 46.9 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.311 -1.768 . . . . 75.299999999999997 107.561 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.41 141.67 28.35 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.766 -0.774 . . . . 74.400000000000006 110.38 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 tpmt? -86.24 -61.32 1.77 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.966 -1.494 . . . . 71.409999999999997 106.966 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 61' ' ' LYS . 6.5 tp-100 170.46 86.21 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.349 -2.093 . . . . 73.420000000000002 105.349 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.74 -29.94 2.61 Favored Glycine 0 C--N 1.307 -1.078 0 N-CA-C 111.089 -0.804 . . . . 62.399999999999999 111.089 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -92.71 144.75 24.99 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.161 -1.052 . . . . 71.200000000000003 108.161 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -128.71 120.24 26.1 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.968 -0.752 . . . . 34.439999999999998 108.968 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 4.2 p90 -129.16 137.12 50.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.381 0.61 . . . . 75.109999999999999 112.472 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.0 129.15 38.7 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.46 -1.245 . . . . 74.439999999999998 110.224 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.7 166.01 29.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.158 -0.928 . . . . 71.329999999999998 109.047 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.77 63.3 2.09 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.871 0.732 . . . . 73.5 110.604 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CG2' ' A' ' 32' ' ' VAL . 21.4 mt -76.4 133.62 39.86 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 119.219 -0.992 . . . . 70.140000000000001 112.898 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -137.71 131.27 31.11 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 113.899 -1.5 . . . . 72.349999999999994 107.858 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.414 ' O ' HD12 ' A' ' 69' ' ' ILE . 2.4 pp -75.3 146.14 9.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.908 -1.117 . . . . 74.409999999999997 110.634 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HZ3' ' HB3' ' A' ' 70' ' ' LYS . 4.2 ttpm? . . . . . 0 C--O 1.259 1.581 0 CA-C-O 118.115 -0.945 . . . . 72.299999999999997 108.873 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 108.643 -0.873 . . . . 51.329999999999998 108.643 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -111.8 143.31 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.413 -0.812 . . . . 74.409999999999997 112.243 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.1 t30 49.62 75.22 0.17 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.905 1.282 . . . . 74.340000000000003 110.376 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.8 mt -99.43 148.98 5.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.773 -1.103 . . . . 74.540000000000006 111.192 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.3 p -90.35 139.14 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 115.565 -0.743 . . . . 42.439999999999998 109.197 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -164.14 170.49 39.39 Favored Glycine 1 N--CA 1.395 -4.055 0 C-N-CA 120.334 -0.936 . . . . 74.319999999999993 112.102 172.252 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -126.12 138.48 53.68 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 108.533 -0.914 . . . . 64.230000000000004 108.533 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.03 107.53 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 109.135 -0.691 . . . . 70.340000000000003 109.135 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.504 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 27.2 mtpp -65.71 -46.67 78.1 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.149 -0.932 . . . . 45.149999999999999 109.241 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 58.9 p-90 -172.7 160.1 4.46 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 114.894 -1.048 . . . . 71.430000000000007 108.504 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 90.3 t80 -160.5 108.47 1.61 Allowed 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.264 -1.013 . . . . 75.120000000000005 108.264 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 15' ' ' THR . 19.5 t-20 -84.85 106.19 16.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.82 -0.807 . . . . 73.140000000000001 108.82 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 p -64.42 -17.49 63.84 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.487 0.715 . . . . 72.519999999999996 112.648 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 56.5 m -80.56 -43.5 20.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 120.935 0.398 . . . . 73.400000000000006 110.59 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -96.86 -8.15 31.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.9 0.333 . . . . 43.509999999999998 111.9 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 67.68 24.44 8.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.023 0.929 . . . . 65.439999999999998 112.076 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.51 152.6 49.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 122.099 -0.376 . . . . 74.310000000000002 111.241 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -171.67 -168.63 33.5 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 111.178 -0.769 . . . . 73.439999999999998 111.178 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.504 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 40.4 m-85 -135.52 153.77 51.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.009 0.524 . . . . 61.130000000000003 111.529 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -137.23 134.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.718 -0.845 . . . . 73.329999999999998 108.718 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 12.7 pt-20 -143.63 150.62 39.04 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.222 -1.769 . . . . 73.200000000000003 106.222 173.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.715 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.268 0.5 OUTLIER -70.52 144.65 51.26 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 117.981 -1.488 . . . . 71.040000000000006 111.215 174.144 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.8 -39.39 11.77 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.671 -1.604 . . . . 70.049999999999997 112.686 -172.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.02 -9.4 30.16 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.64 0.776 . . . . 70.0 113.011 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 50.54 2.53 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.702 -0.761 . . . . 74.329999999999998 111.222 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.66 -99.66 0.33 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.083 -0.579 . . . . 75.209999999999994 113.179 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.621 0.248 . . . . 74.329999999999998 110.718 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.62 97.77 10.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.936 -0.575 . . . . 72.420000000000002 109.48 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 55' ' ' LEU . 2.6 p -116.4 139.54 42.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.889 -0.596 . . . . 72.420000000000002 109.549 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 50.1 p90 -88.53 145.19 25.87 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.839 -0.744 . . . . 75.420000000000002 111.334 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -95.4 131.28 42.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.384 -0.598 . . . . 52.020000000000003 109.384 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -107.91 146.87 31.78 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.108 -1.441 . . . . 75.310000000000002 107.108 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -68.14 -17.46 64.36 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.684 0.624 . . . . 70.209999999999994 112.684 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.6 t -54.92 -23.85 20.82 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 116.191 -0.459 . . . . 52.109999999999999 110.381 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.592 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -70.62 -41.68 71.91 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.571 0.224 . . . . 74.140000000000001 111.237 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.29 -41.49 83.76 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.837 0 N-CA-C 108.05 -1.093 . . . . 64.219999999999999 108.05 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.65 -24.38 67.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.947 -0.569 . . . . 71.230000000000004 110.889 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.9 45.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.265 0.839 . . . . 61.0 113.265 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.45 -23.37 2.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.813 0.671 . . . . 55.009999999999998 112.813 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.9 62.58 2.21 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.79 -0.641 . . . . 51.520000000000003 112.088 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 142.69 33.71 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.963 -1.866 . . . . 74.099999999999994 105.963 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -58.96 -59.34 5.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 117.737 0.244 . . . . 74.109999999999999 111.59 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 p -162.35 161.23 27.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.211 -0.663 . . . . 61.219999999999999 109.211 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 74.0 mt -124.02 134.28 53.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.859 -1.163 . . . . 61.030000000000001 107.859 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 150.1 34.3 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.08 -0.964 . . . . 74.450000000000003 108.479 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.5 OUTLIER -63.88 151.02 43.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.156 0.799 . . . . 74.230000000000004 113.156 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 -23.2 36.1 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.668 -1.151 . . . . 74.530000000000001 112.763 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.92 136.05 41.42 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 112.506 0.558 . . . . 64.239999999999995 112.506 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -85.97 135.67 33.57 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.665 -1.235 . . . . 53.409999999999997 107.665 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.05 151.58 20.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-O 121.49 0.662 . . . . 61.409999999999997 111.081 -172.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -116.09 134.21 60.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.687 -1.227 . . . . 74.409999999999997 107.687 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.9 p90 -144.86 -178.11 5.86 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.942 -0.392 . . . . 64.409999999999997 109.942 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.36 145.07 49.04 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.818 -1.549 . . . . 64.420000000000002 106.818 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 30' ' ' VAL . 28.3 tp -116.5 109.37 17.18 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 122.374 1.083 . . . . 73.510000000000005 110.578 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -122.06 136.96 54.97 Favored 'General case' 0 C--N 1.258 -3.391 0 N-CA-C 105.07 -2.196 . . . . 74.430000000000007 105.07 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.9 136.9 33.1 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 114.693 1.368 . . . . 73.129999999999995 114.693 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 60.8 tptt -82.47 79.78 8.81 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.774 -1.936 . . . . 71.450000000000003 105.774 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 67.37 -80.0 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.946 0.898 . . . . 65.519999999999996 109.69 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.05 7.3 4.42 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.718 -0.953 . . . . 51.450000000000003 110.718 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -102.45 155.89 17.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.835 -1.543 . . . . 72.040000000000006 106.835 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -117.54 122.05 42.63 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.864 -0.522 . . . . 71.319999999999993 111.107 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -135.53 142.66 45.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.026 0.441 . . . . 73.530000000000001 109.986 178.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.62 33.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.233 -0.894 . . . . 61.100000000000001 109.953 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.592 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.3 m -133.54 169.38 21.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 73.040000000000006 111.019 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 57.2 63.13 1.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.218 0.949 . . . . 54.039999999999999 110.49 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 33.2 mt -81.91 140.29 34.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.299 1.222 . . . . 74.010000000000005 114.299 -172.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -140.28 139.54 35.53 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 125.829 1.651 . . . . 71.040000000000006 106.923 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.42 147.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 117.207 -1.797 . . . . 52.32 110.944 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.254 1.33 0 O-C-N 124.239 0.962 . . . . 71.120000000000005 110.898 179.213 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 107.977 -1.12 . . . . 75.219999999999999 107.977 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.5 p -117.14 140.79 49.09 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 111.378 0.14 . . . . 75.319999999999993 111.378 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.07 76.26 0.37 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.873 0.844 . . . . 63.32 112.022 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 47.1 mt -106.33 148.45 10.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 114.679 -1.146 . . . . 55.340000000000003 110.099 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.6 p -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 O-C-N 124.06 0.85 . . . . 61.509999999999998 109.794 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -166.47 171.15 41.36 Favored Glycine 1 N--CA 1.396 -4.009 0 C-N-CA 120.393 -0.908 . . . . 71.209999999999994 112.306 170.354 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.9 ttmt -123.89 137.22 54.67 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.123 -1.065 . . . . 74.340000000000003 108.123 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.44 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.366 -0.975 . . . . 73.219999999999999 108.366 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.8 tttp -75.94 -44.58 39.35 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.12 -1.4 . . . . 62.229999999999997 109.386 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -169.54 157.83 7.44 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.632 -0.713 . . . . 74.329999999999998 110.269 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -147.45 133.17 18.91 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.598 -0.728 . . . . 61.539999999999999 109.437 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -106.08 118.0 35.48 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.506 -0.924 . . . . 72.129999999999995 108.506 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 t -68.26 -33.85 75.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.157 -0.474 . . . . 61.240000000000002 111.464 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 m -73.57 -49.29 27.07 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.822 0.344 . . . . 71.430000000000007 111.534 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 64.4 mttp -82.25 -8.26 59.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.198 0.444 . . . . 62.020000000000003 112.198 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 13.4 m120 63.76 22.25 13.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.102 0.778 . . . . 75.409999999999997 113.102 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 42.0 p90 -142.37 174.25 10.79 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.544 -0.863 . . . . 71.109999999999999 110.804 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.63 -155.29 13.62 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.615 -0.994 . . . . 65.120000000000005 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 30.4 m-85 -132.65 163.54 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.404 0.621 . . . . 72.430000000000007 112.023 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.8 mt -145.84 138.51 20.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.105 -1.443 . . . . 73.219999999999999 107.105 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.07 148.64 35.43 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.761 -1.57 . . . . 74.140000000000001 106.761 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.735 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.279 0.2 OUTLIER -72.17 147.58 46.45 Favored 'General case' 0 CA--C 1.47 -2.115 0 C-N-CA 117.464 -1.694 . . . . 63.219999999999999 109.971 172.071 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -49.25 -35.15 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.0 1.438 . . . . 74.439999999999998 112.443 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -70.01 -0.85 8.25 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.458 0.91 . . . . 74.010000000000005 113.458 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 51.52 4.05 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 120.304 -0.95 . . . . 54.299999999999997 111.085 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' OE1' ' A' ' 23' ' ' GLN . . . -75.39 -110.55 0.1 Allowed Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.983 -0.627 . . . . 74.519999999999996 114.369 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.13 174.55 5.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.981 0.42 . . . . 64.420000000000002 112.1 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -102.27 92.87 4.91 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.319 -0.993 . . . . 64.319999999999993 108.319 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 55' ' ' LEU . 5.5 p -116.74 124.45 72.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.633 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.4 p90 -91.19 149.16 21.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.009 -0.541 . . . . 72.030000000000001 110.189 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -107.63 132.39 55.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 109.335 -0.617 . . . . 71.510000000000005 109.335 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -111.93 145.1 40.17 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.077 -1.083 . . . . 71.129999999999995 108.077 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 35.9 ttpt -62.54 -22.96 66.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.16 0.8 . . . . 75.310000000000002 113.16 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -54.17 -24.07 16.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 64.430000000000007 112.144 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.77 -39.25 70.11 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 122.127 -0.358 . . . . 52.100000000000001 110.643 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.56 -36.52 71.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 107.86 -1.163 . . . . 73.340000000000003 107.86 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.38 -29.54 70.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.069 -0.969 . . . . 75.430000000000007 110.87 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.14 -47.7 9.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.584 0.587 . . . . 74.150000000000006 112.584 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -9.87 28.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.019 0.748 . . . . 64.230000000000004 113.019 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.48 55.61 29.06 Favored Glycine 0 CA--C 1.498 -1.022 0 O-C-N 123.459 0.475 . . . . 74.430000000000007 112.224 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.5 tm? -69.49 141.5 53.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.255 -1.017 . . . . 73.400000000000006 108.255 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.518 ' N ' HD13 ' A' ' 42' ' ' LEU . 58.7 t-80 -51.75 -60.67 2.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.867 . . . . 72.329999999999998 112.334 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -172.51 162.43 5.25 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 73.439999999999998 108.616 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -124.82 121.08 33.54 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.852 0.834 . . . . 72.140000000000001 109.657 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.54 144.85 36.14 Favored 'General case' 0 C--N 1.245 -3.95 0 CA-C-N 113.962 -1.472 . . . . 60.409999999999997 108.463 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.65 147.13 53.1 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.605 0.717 . . . . 70.530000000000001 112.253 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.21 -16.9 59.41 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.001 -0.999 . . . . 42.450000000000003 111.891 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -81.28 137.47 35.8 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 122.496 0.318 . . . . 73.010000000000005 110.659 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 9.4 m-20 -88.53 137.48 32.29 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.018 -1.105 . . . . 74.310000000000002 108.018 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.65 149.52 23.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 121.704 0.764 . . . . 73.409999999999997 110.969 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.1 mt -111.75 137.62 43.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.182 -1.784 . . . . 72.329999999999998 106.182 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.09 178.87 9.01 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.708 -0.397 . . . . 75.230000000000004 110.705 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -114.43 160.52 19.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.843 -2.28 . . . . 63.409999999999997 104.843 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 18.7 tp -129.81 127.74 40.91 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 113.593 0.96 . . . . 62.530000000000001 113.593 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 55' ' ' LEU . 47.0 mt-10 -114.08 134.67 54.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.275 -1.784 . . . . 74.510000000000005 107.981 174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -93.41 134.18 35.91 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.284 0.564 . . . . 72.349999999999994 110.818 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 58.4 tptt -102.29 76.9 1.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.11 -1.441 . . . . 73.319999999999993 107.11 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 67.71 -70.43 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.647 1.179 . . . . 72.430000000000007 110.67 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 -15.56 1.45 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.22 -0.752 . . . . 75.420000000000002 111.22 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 54.7 mtpt -84.43 165.04 18.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.57 -0.53 . . . . 71.150000000000006 109.57 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -127.94 129.47 46.87 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.619 -0.433 . . . . 53.149999999999999 110.499 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.4 p90 -127.65 128.38 45.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 113.167 0.803 . . . . 71.040000000000006 113.167 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.48 133.29 43.62 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.264 -1.335 . . . . 72.140000000000001 110.688 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.64 164.41 30.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.015 -1.106 . . . . 71.340000000000003 108.015 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.71 63.33 2.28 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.733 0.646 . . . . 65.349999999999994 110.959 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 32' ' ' VAL . 38.4 mt -78.46 149.47 33.22 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.775 -0.648 . . . . 64.319999999999993 111.937 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -150.81 131.66 14.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.772 -1.936 . . . . 64.420000000000002 105.772 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 2.6 pp -80.33 140.57 16.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.366 -1.333 . . . . 73.450000000000003 112.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.088 -0.96 . . . . 74.329999999999998 109.214 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 109.576 -0.527 . . . . 72.310000000000002 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.8 p -115.87 142.56 46.61 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.65 -0.705 . . . . 54.219999999999999 110.983 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 55.35 78.09 0.2 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.035 0.921 . . . . 65.209999999999994 111.334 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.45 147.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 114.154 -1.384 . . . . 64.340000000000003 109.965 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 73.8 t -92.19 134.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 115.223 -0.899 . . . . 54.119999999999997 108.643 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.41 172.73 38.57 Favored Glycine 1 N--CA 1.392 -4.265 0 C-N-CA 120.27 -0.967 . . . . 72.340000000000003 112.154 171.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 27.5 ttpp -130.48 132.67 45.77 Favored 'General case' 0 C--N 1.257 -3.42 0 C-N-CA 125.204 1.402 . . . . 71.109999999999999 108.412 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.8 115.85 2.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.933 -0.576 . . . . 75.120000000000005 110.162 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 66.7 mttm -66.94 -49.43 65.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.413 -0.958 . . . . 73.129999999999995 108.413 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -173.78 165.43 4.42 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.246 -1.343 . . . . 74.230000000000004 108.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 85.5 t80 -153.79 121.25 5.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.4 0.438 . . . . 74.430000000000007 110.368 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -96.36 98.81 10.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.088 0.471 . . . . 71.040000000000006 109.946 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 m -58.93 -35.08 72.51 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.113 -0.949 . . . . 62.310000000000002 111.427 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 m -65.32 -31.12 72.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.236 0.541 . . . . 74.209999999999994 110.525 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -97.98 -9.01 26.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.1 -0.375 . . . . 73.340000000000003 111.997 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.82 23.36 11.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.973 0.509 . . . . 72.099999999999994 112.346 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 37.4 p90 -151.06 161.12 43.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.445 0.64 . . . . 62.32 112.539 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -166.95 -162.27 18.18 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.156 -1.578 . . . . 75.099999999999994 109.156 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 46.9 m-85 -135.71 154.84 51.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.938 0.869 . . . . 75.209999999999994 111.711 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.72 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.224 -0.658 . . . . 74.109999999999999 109.224 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 14.0 pt-20 -143.54 147.65 34.78 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 105.755 -1.942 . . . . 65.310000000000002 105.755 173.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.0 pt20 -80.73 151.3 28.93 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 116.786 -1.966 . . . . 72.010000000000005 109.44 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.74 -29.02 24.76 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.251 -1.34 . . . . 71.340000000000003 111.913 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -75.71 1.08 15.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.775 -0.648 . . . . 73.120000000000005 111.851 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.41 50.87 1.79 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.54 -0.838 . . . . 74.420000000000002 111.207 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.81 172.2 54.96 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.639 -0.791 . . . . 64.120000000000005 112.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.33 162.96 28.59 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.771 0.656 . . . . 50.409999999999997 112.771 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.14 97.67 10.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.398 -0.819 . . . . 45.219999999999999 110.604 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 55' ' ' LEU . 3.2 p -117.81 134.87 60.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.118 -0.947 . . . . 63.520000000000003 109.062 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 54.4 p90 -90.6 150.15 21.83 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.032 -0.667 . . . . 73.530000000000001 111.221 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -110.11 125.46 67.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.583 -0.525 . . . . 43.210000000000001 109.583 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -108.43 152.93 24.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.298 -1.001 . . . . 64.109999999999999 108.298 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.06 -16.04 39.23 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 113.073 0.768 . . . . 74.109999999999999 113.073 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -58.76 -26.42 63.99 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.228 0.537 . . . . 53.439999999999998 110.03 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.94 -36.44 56.56 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.983 0.42 . . . . 71.129999999999995 109.973 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.68 -48.85 84.76 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.091 0 N-CA-C 107.647 -1.242 . . . . 71.129999999999995 107.647 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.37 -28.23 58.55 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 124.816 1.246 . . . . 64.120000000000005 111.292 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.13 -23.32 67.1 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.458 0.54 . . . . 34.310000000000002 112.458 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.44 -24.15 2.29 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.712 0.634 . . . . 70.319999999999993 112.712 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.16 48.74 5.57 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.454 -1.059 . . . . 50.030000000000001 110.454 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 130.37 41.09 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.435 -1.32 . . . . 75.510000000000005 107.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.35 -47.78 75.26 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.128 1.158 . . . . 74.409999999999997 114.128 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.4 p -159.06 160.49 35.85 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.53 -0.468 . . . . 74.430000000000007 111.064 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.11 142.78 48.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.249 -1.019 . . . . 73.0 108.249 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.86 162.77 40.51 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 123.73 0.812 . . . . 71.540000000000006 109.319 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -67.49 153.33 43.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.445 0.641 . . . . 65.010000000000005 112.466 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -16.08 59.27 Favored Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.881 -1.054 . . . . 72.349999999999994 112.198 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -83.84 124.93 31.46 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.244 0.218 . . . . 62.450000000000003 111.122 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 15.4 m-20 -78.33 133.57 37.59 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 107.185 -1.413 . . . . 64.019999999999996 107.185 174.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.74 147.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.138 0 CA-C-O 121.913 0.863 . . . . 62.109999999999999 110.51 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 64.1 mt -109.98 132.28 58.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 N-CA-C 107.002 -1.481 . . . . 73.549999999999997 107.002 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.62 178.67 8.27 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.764 -0.458 . . . . 72.099999999999994 109.764 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -119.67 155.27 32.7 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.671 -1.974 . . . . 72.129999999999995 105.671 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 30' ' ' VAL . 26.3 tp -124.4 111.26 15.55 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.452 1.12 . . . . 75.230000000000004 112.649 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.74 141.51 45.26 Favored 'General case' 0 C--N 1.268 -2.953 0 CA-C-N 113.062 -1.881 . . . . 62.140000000000001 107.425 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -87.06 142.14 28.14 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.276 -0.638 . . . . 74.450000000000003 109.276 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -90.41 22.31 3.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.298 -1.371 . . . . 73.150000000000006 107.298 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 65.09 87.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 75.140000000000001 108.333 -172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.21 -58.41 0.6 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.692 -1.14 . . . . 74.450000000000003 111.24 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.1 mmmt -86.19 154.12 21.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.177 -0.305 . . . . 63.130000000000003 110.177 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.69 118.11 27.33 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.215 0.206 . . . . 70.439999999999998 110.574 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.2 p90 -131.89 140.41 49.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.367 0.603 . . . . 64.040000000000006 111.509 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -71.97 135.14 46.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.675 -1.148 . . . . 64.239999999999995 109.527 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.8 m -133.96 164.71 33.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.364 -0.835 . . . . 62.310000000000002 109.959 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.53 64.23 1.74 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.962 0.789 . . . . 54.32 111.593 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.549 HD11 HG21 ' A' ' 32' ' ' VAL . 28.9 mt -74.67 140.14 44.02 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.671 0.989 . . . . 63.310000000000002 113.671 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 75.5 ttt180 -143.51 131.35 21.5 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.36 -1.718 . . . . 73.129999999999995 106.36 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.9 148.72 4.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.346 -0.942 . . . . 73.340000000000003 111.536 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.556 ' HZ3' ' HB3' ' A' ' 70' ' ' LYS . 3.7 ttpm? . . . . . 0 C--O 1.256 1.412 0 CA-C-O 118.758 -0.639 . . . . 73.230000000000004 109.498 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.434 -1.248 0 N-CA-C 107.144 -1.428 . . . . 64.0 107.144 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.5 p -100.43 140.29 34.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 123.357 0.411 . . . . 63.439999999999998 111.812 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 56.5 77.79 0.24 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.774 1.23 . . . . 60.030000000000001 110.701 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 2' ' ' ALA . 30.3 mt -100.42 148.4 6.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 114.627 -1.17 . . . . 50.409999999999997 109.564 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 87.8 t -92.81 132.84 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-N 115.369 -0.832 . . . . 70.329999999999998 109.522 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -161.99 163.93 35.08 Favored Glycine 1 N--CA 1.395 -4.087 0 CA-C-N 115.272 -0.877 . . . . 65.0 111.576 171.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -119.28 136.42 54.24 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.898 -1.149 . . . . 74.019999999999996 107.898 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.83 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.329 0.585 . . . . 75.450000000000003 109.572 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 49.1 tttp -70.18 -47.26 62.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.826 -1.079 . . . . 61.240000000000002 108.109 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.498 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 68.9 p-90 -173.66 165.75 4.52 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.16 0.984 . . . . 63.149999999999999 108.641 175.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.02 132.78 4.31 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.376 0.422 . . . . 74.450000000000003 110.596 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.39 107.81 11.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.463 -0.569 . . . . 71.109999999999999 109.463 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 m -57.55 -33.86 68.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.85 -0.614 . . . . 63.109999999999999 110.902 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.9 m -61.44 -33.17 73.28 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 115.951 -0.568 . . . . 73.209999999999994 111.219 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -97.62 -8.72 28.27 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 122.021 -0.424 . . . . 54.43 111.049 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 61.26 21.48 11.97 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.784 0.834 . . . . 71.129999999999995 110.622 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -137.5 163.62 30.68 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.387 0.675 . . . . 73.299999999999997 110.894 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -175.02 -172.55 40.06 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 107.836 -2.106 . . . . 50.229999999999997 107.836 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 21.3 m-85 -136.05 162.93 31.52 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 117.749 0.775 . . . . 75.230000000000004 111.794 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.5 134.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.669 -1.151 . . . . 71.299999999999997 107.924 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.3 pt-20 -135.98 141.79 44.46 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.01 -2.219 . . . . 75.5 105.01 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.596 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -78.53 143.29 36.7 Favored 'General case' 0 CA--C 1.464 -2.353 0 C-N-CA 116.135 -2.226 . . . . 65.329999999999998 108.922 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.63 -18.01 4.02 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.793 1.308 . . . . 61.549999999999997 112.07 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.36 -0.32 28.53 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.603 -0.726 . . . . 73.430000000000007 111.428 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.4 41.91 35.78 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 110.995 -0.842 . . . . 75.340000000000003 110.995 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 -132.35 4.26 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.933 -0.651 . . . . 63.439999999999998 113.371 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -86.64 152.49 22.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.149 0.426 . . . . 71.129999999999995 112.149 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.2 130.25 47.26 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 116.073 -0.512 . . . . 75.25 110.126 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -138.66 143.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.823 -0.806 . . . . 60.210000000000001 108.823 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 51.5 p90 -93.53 148.99 21.58 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.696 -0.802 . . . . 65.409999999999997 111.603 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -105.74 128.85 59.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 CA-C-N 115.75 -0.659 . . . . 52.340000000000003 109.316 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -110.02 150.34 28.68 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.015 -0.735 . . . . 73.299999999999997 109.015 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.7 -18.82 64.39 Favored 'General case' 0 C--O 1.203 -1.395 0 N-CA-C 113.671 0.989 . . . . 71.400000000000006 113.671 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -57.22 -27.5 62.06 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.942 0.401 . . . . 74.519999999999996 110.314 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -75.96 -35.73 59.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 120.986 0.422 . . . . 75.129999999999995 110.38 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.84 -37.77 77.83 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.286 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.88 -32.58 73.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.053 0.541 . . . . 70.120000000000005 110.722 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.96 66.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.349999999999994 112.72 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -23.3 2.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.21 0.819 . . . . 61.109999999999999 113.21 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 53.93 3.57 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 109.954 -1.258 . . . . 61.210000000000001 109.954 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -75.58 127.0 32.11 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.89 -0.655 . . . . 35.140000000000001 111.396 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -104.61 -0.4 27.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.816 -0.629 . . . . 72.299999999999997 111.391 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 m -123.32 79.3 1.66 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.151 1.167 . . . . 43.32 114.151 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.16 114.1 19.2 Favored 'General case' 0 C--N 1.251 -3.683 0 N-CA-C 108.108 -1.071 . . . . 60.219999999999999 108.108 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -151.79 158.19 42.97 Favored 'General case' 1 C--N 1.243 -4.035 0 CA-C-N 113.94 -1.482 . . . . 70.549999999999997 107.239 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.12 148.83 49.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.695 0.759 . . . . 74.510000000000005 112.344 -174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.29 -18.61 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 CA-C-N 114.82 -1.082 . . . . 63.240000000000002 113.993 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -71.03 135.05 47.59 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 117.546 0.673 . . . . 52.549999999999997 111.644 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.07 135.11 34.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.426 -1.324 . . . . 73.219999999999999 107.426 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.56 145.28 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-O 121.981 0.896 . . . . 64.319999999999993 110.989 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.99 130.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.483 -1.673 . . . . 73.5 106.483 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.3 p90 -146.62 179.62 7.43 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.153 -0.619 . . . . 73.409999999999997 110.995 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -120.36 158.29 27.45 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 105.532 -2.025 . . . . 64.439999999999998 105.532 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 30' ' ' VAL . 26.1 tp -129.69 129.54 44.36 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.099 1.148 . . . . 74.099999999999994 114.099 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.2 mm-40 -125.63 139.46 53.55 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 113.088 -1.869 . . . . 64.099999999999994 109.567 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.94 142.79 32.68 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.825 -1.08 . . . . 75.310000000000002 111.688 -174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -90.76 31.92 1.02 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.271 -1.011 . . . . 75.319999999999993 108.271 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 62.34 22.72 13.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.197 -0.911 . . . . 52.140000000000001 111.715 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.08 -49.08 0.13 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 109.526 -1.43 . . . . 75.310000000000002 109.526 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -93.01 164.71 13.17 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.338 -0.431 . . . . 72.430000000000007 110.787 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -132.76 119.08 19.84 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.406 -0.59 . . . . 55.520000000000003 109.406 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.489 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 44.0 p90 -124.59 133.28 53.32 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.519 0.676 . . . . 71.400000000000006 112.423 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.19 134.05 42.75 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.631 -1.168 . . . . 33.039999999999999 110.534 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.5 m -133.77 169.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.937 -1.028 . . . . 64.540000000000006 109.517 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 53.77 63.06 2.33 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 123.246 0.619 . . . . 53.310000000000002 111.384 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 32' ' ' VAL . 21.9 mt -82.36 135.77 35.12 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.617 0.723 . . . . 72.030000000000001 112.869 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -145.95 130.13 17.52 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 114.059 -1.428 . . . . 71.030000000000001 107.997 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.759 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -80.69 148.79 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 C-N-CA 121.057 -0.257 . . . . 64.040000000000006 110.717 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 124.387 1.054 . . . . 52.100000000000001 109.152 176.201 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.981 0 N-CA-C 109.094 -0.706 . . . . 73.219999999999999 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 p -131.54 153.18 50.11 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.246 0.461 . . . . 71.230000000000004 112.246 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 62.68 40.52 10.11 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.022 0.929 . . . . 72.450000000000003 111.633 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 mt -75.25 152.94 6.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.772 -0.649 . . . . 53.229999999999997 111.229 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 85.9 t -106.83 136.75 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 115.3 -0.863 . . . . 75.209999999999994 109.053 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.3 168.73 41.02 Favored Glycine 0 N--CA 1.404 -3.456 0 C-N-CA 119.128 -1.511 . . . . 72.430000000000007 113.77 167.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.2 ttmt -113.72 136.24 53.07 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 114.411 -0.894 . . . . 72.219999999999999 108.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.57 107.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.965 -0.754 . . . . 64.310000000000002 108.965 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -63.81 -52.99 57.72 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.699 -1.137 . . . . 65.540000000000006 109.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 64.4 p-90 -160.64 160.01 31.08 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 108.859 -0.793 . . . . 70.299999999999997 108.859 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -157.61 125.31 5.3 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 124.053 0.845 . . . . 73.099999999999994 109.272 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.08 115.99 31.06 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 61.340000000000003 107.293 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 t -73.0 -25.96 61.17 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.698 0.285 . . . . 54.329999999999998 111.261 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 m -68.55 -55.21 12.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.116 0.484 . . . . 64.0 110.356 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.49 -8.49 52.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.498 . . . . 75.420000000000002 111.709 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 89.3 m-20 64.17 26.17 13.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.194 0.813 . . . . 72.010000000000005 113.194 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.83 157.98 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.869 -0.419 . . . . 72.310000000000002 109.869 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.96 -174.14 45.56 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.135 -0.786 . . . . 54.009999999999998 111.135 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 45.7 m-85 -134.35 159.86 39.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.117 0.567 . . . . 65.329999999999998 111.132 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -143.08 135.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 123.737 0.648 . . . . 73.019999999999996 109.372 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.84 153.27 42.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.133 -1.432 . . . . 65.540000000000006 107.133 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.3 pt20 -84.84 154.69 22.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.382 -1.327 . . . . 63.450000000000003 109.386 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.55 -22.41 61.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.159 0.912 . . . . 62.439999999999998 113.116 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -77.82 -2.96 39.08 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.763 -0.375 . . . . 72.239999999999995 111.771 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.46 51.19 1.23 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 110.256 -1.138 . . . . 61.200000000000003 110.256 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -77.14 164.41 52.73 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.365 -0.921 . . . . 71.329999999999998 112.128 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.71 155.76 40.03 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 123.806 0.357 . . . . 74.329999999999998 111.816 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.09 120.93 25.93 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.83 0.824 . . . . 75.209999999999994 111.567 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -135.9 135.2 50.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.489 -1.232 . . . . 63.5 107.915 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.6 p90 -90.12 150.36 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.43 -0.908 . . . . 70.299999999999997 110.84 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 67' ' ' LEU . 7.3 p -95.29 126.47 47.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-O 121.456 0.646 . . . . 55.530000000000001 109.606 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -113.33 148.0 36.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.731 -0.84 . . . . 71.450000000000003 108.731 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' ASN . 86.8 tttt -64.72 -21.99 66.88 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.664 0.987 . . . . 72.019999999999996 113.664 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -54.19 -22.16 10.74 Favored 'General case' 0 C--O 1.208 -1.09 0 C-N-CA 120.627 -0.429 . . . . 33.030000000000001 111.315 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.21 -42.51 59.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.069 0.461 . . . . 53.420000000000002 110.853 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 57.3 t -70.45 -30.31 42.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.51 0 N-CA-C 108.215 -1.031 . . . . 62.509999999999998 108.215 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.63 -36.12 65.39 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.987 -0.551 . . . . 71.200000000000003 110.036 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.98 24.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.422 0.527 . . . . 73.230000000000004 112.422 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.07 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.43 0.53 . . . . 73.25 112.43 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 77.75 62.96 2.28 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 121.454 -0.403 . . . . 72.340000000000003 112.224 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.83 130.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.817 -1.549 . . . . 64.25 106.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.45 -49.27 78.24 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.525 0.565 . . . . 74.150000000000006 112.525 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -175.09 137.99 0.43 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.097 0.559 . . . . 72.209999999999994 110.918 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.82 164.31 12.69 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.195 0.521 . . . . 71.5 110.62 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -169.49 162.83 10.26 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.257 -1.757 . . . . 63.130000000000003 106.257 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -75.17 152.84 38.4 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.207 0.527 . . . . 54.130000000000003 111.928 -177.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.25 69.81 Favored Glycine 0 C--N 1.306 -1.119 0 CA-C-N 115.386 -0.824 . . . . 72.209999999999994 112.478 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -77.42 136.26 38.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 122.503 0.321 . . . . 73.010000000000005 111.581 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.56 134.19 33.67 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.227 -1.397 . . . . 72.310000000000002 107.227 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.21 147.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-O 121.869 0.842 . . . . 72.230000000000004 110.773 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.03 129.34 71.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 106.41 -1.7 . . . . 73.310000000000002 106.41 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -147.52 -177.53 5.75 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 120.043 -0.663 . . . . 74.129999999999995 110.873 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -124.0 161.81 24.72 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 105.501 -2.037 . . . . 72.400000000000006 105.501 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 30' ' ' VAL . 23.2 tp -130.18 129.83 43.93 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-O 121.899 0.857 . . . . 71.409999999999997 112.946 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.1 137.81 54.83 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.629 -1.623 . . . . 64.420000000000002 107.432 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.79 155.77 18.1 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.118 0.961 . . . . 63.509999999999998 110.308 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.0 tttp -116.88 24.66 11.07 Favored 'General case' 0 C--N 1.252 -3.643 0 N-CA-C 107.094 -1.447 . . . . 73.510000000000005 107.094 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 70.68 -59.99 0.51 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.5 1.52 . . . . 75.329999999999998 111.809 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.52 -23.34 36.96 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.098 -0.801 . . . . 32.140000000000001 111.098 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.1 mmtt -123.03 164.98 17.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.585 0.231 . . . . 64.049999999999997 111.11 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.34 116.42 11.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.192 -1.04 . . . . 64.299999999999997 108.192 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p90 -130.39 137.48 49.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.452 0.644 . . . . 73.200000000000003 112.442 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 137.52 51.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.666 -1.152 . . . . 43.43 110.181 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 29.0 m -135.42 161.6 38.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 65.019999999999996 109.986 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 56.27 63.88 1.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.03 0.831 . . . . 75.030000000000001 109.83 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.625 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 32.6 mt -79.24 137.43 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.968 0.729 . . . . 75.230000000000004 112.968 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.98 135.02 39.19 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-N 114.729 -1.123 . . . . 74.140000000000001 109.119 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -72.41 134.19 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 109.408 -0.589 . . . . 72.430000000000007 109.408 173.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.307 -1.265 0 O-C-N 123.849 0.718 . . . . 64.319999999999993 110.117 179.641 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 108.782 -0.822 . . . . 62.530000000000001 108.782 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.2 p -107.68 145.6 33.18 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.624 -0.262 . . . . 73.0 111.079 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 58.37 78.39 0.25 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.46 1.104 . . . . 51.520000000000003 109.78 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 50.7 mt -108.33 149.53 11.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.314 -1.312 . . . . 62.420000000000002 110.245 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 88.5 t -93.26 132.98 35.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.269 -0.878 . . . . 73.310000000000002 109.79 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.58 164.89 33.77 Favored Glycine 0 N--CA 1.405 -3.404 0 C-N-CA 120.522 -0.846 . . . . 74.209999999999994 111.944 171.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.05 134.31 53.68 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 107.234 -1.395 . . . . 72.340000000000003 107.234 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.45 110.41 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.725 -1.213 . . . . 75.019999999999996 107.725 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.3 tttp -75.2 -49.88 17.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.286 -1.325 . . . . 51.030000000000001 109.36 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -167.72 160.91 13.04 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.618 -0.882 . . . . 72.439999999999998 108.618 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -161.39 116.59 2.07 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.738 0.649 . . . . 73.140000000000001 110.18 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.08 105.76 17.92 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.03 -1.1 . . . . 63.420000000000002 108.03 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -53.95 -45.48 71.31 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 124.259 1.024 . . . . 71.5 111.8 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -58.1 -37.44 74.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.131 0.572 . . . . 73.319999999999993 111.635 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -99.22 -5.72 29.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.769 -0.372 . . . . 75.340000000000003 111.958 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 60.68 27.33 17.06 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.475 0.484 . . . . 71.129999999999995 111.897 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -134.83 152.13 51.5 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.598 -0.519 . . . . 74.299999999999997 109.598 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.89 -165.95 33.14 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.826 -0.909 . . . . 70.319999999999993 110.826 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 34.8 m-85 -137.26 165.01 27.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.209 0.528 . . . . 72.109999999999999 112.023 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -147.28 135.77 15.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.949 -1.13 . . . . 65.450000000000003 107.949 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.09 147.34 33.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.02 -2.215 . . . . 72.140000000000001 105.02 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.0 pt20 -77.35 144.15 38.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 C-N-CA 116.216 -2.194 . . . . 74.519999999999996 109.444 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.02 -29.1 27.5 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.971 1.419 . . . . 73.010000000000005 112.471 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.08 -11.77 61.13 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 62.25 111.847 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.89 50.85 0.76 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.42 -0.895 . . . . 72.329999999999998 111.199 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -90.59 171.2 36.07 Favored Glycine 0 C--N 1.318 -0.447 0 N-CA-C 110.602 -0.999 . . . . 75.030000000000001 110.602 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.81 147.82 33.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.353 0.577 . . . . 73.450000000000003 111.327 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 122.81 18.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.941 -1.027 . . . . 63.020000000000003 110.695 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 55' ' ' LEU . 7.3 p -126.01 139.96 49.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.036 -1.098 . . . . 41.420000000000002 108.036 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -92.64 142.95 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 119.413 -0.915 . . . . 75.140000000000001 112.62 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 10.8 p -112.83 142.02 26.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.303 -0.862 . . . . 73.349999999999994 109.023 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -136.64 162.5 32.97 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.017 -1.105 . . . . 74.150000000000006 108.017 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.11 -18.68 59.28 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 112.281 0.474 . . . . 50.299999999999997 112.281 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -52.89 -30.2 32.69 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.084 0.469 . . . . 64.030000000000001 110.302 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.95 -35.08 57.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.355 -0.384 . . . . 54.5 110.42 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -41.45 89.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.316 0 N-CA-C 107.786 -1.19 . . . . 75.030000000000001 107.786 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.07 -36.86 82.93 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.93 -0.577 . . . . 62.240000000000002 110.219 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.54 75.66 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.557 0.947 . . . . 60.409999999999997 113.557 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.23 -10.79 4.18 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.626 0.973 . . . . 55.100000000000001 113.626 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 55.0 5.61 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.21 -0.756 . . . . 45.009999999999998 111.21 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 43' ' ' HIS . 2.4 tm? -71.6 149.82 45.26 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.929 -1.508 . . . . 72.129999999999995 106.929 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.563 ' N ' HD13 ' A' ' 42' ' ' LEU . 60.7 m80 -83.04 -60.98 1.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.536 -0.727 . . . . 73.209999999999994 111.912 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.5 p -165.87 145.01 6.14 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 122.914 0.485 . . . . 75.420000000000002 109.919 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.8 mt -109.9 146.65 34.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.541 0.686 . . . . 72.319999999999993 111.669 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.49 153.04 41.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.607 -1.627 . . . . 63.140000000000001 106.607 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 155.3 38.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.905 0.383 . . . . 75.099999999999994 111.182 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 4.84 79.22 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 121.113 -0.565 . . . . 52.399999999999999 112.574 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -93.43 135.96 34.17 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 122.659 0.384 . . . . 74.109999999999999 110.352 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -86.0 120.14 27.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.25 -1.389 . . . . 74.040000000000006 107.25 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.37 152.7 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 CA-C-O 121.655 0.741 . . . . 62.340000000000003 111.044 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.5 mt -114.47 136.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.028 -1.471 . . . . 72.409999999999997 107.028 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -151.19 177.55 10.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.136 -0.32 . . . . 72.409999999999997 110.136 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.4 147.7 40.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.54 -1.652 . . . . 72.299999999999997 106.54 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 27.3 tp -134.41 133.4 40.49 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.249 1.023 . . . . 45.32 112.056 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -135.71 137.11 41.41 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 113.287 -1.779 . . . . 64.0 107.033 173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -84.94 138.81 32.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.69 0.757 . . . . 75.120000000000005 112.102 -176.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.4 tttm -99.21 72.55 1.86 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 75.340000000000003 107.214 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.82 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.548 1.539 . . . . 71.409999999999997 109.339 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 -18.4 5.01 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.449 -0.405 . . . . 51.399999999999999 112.183 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.3 mmpt? -89.19 164.69 14.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.397 -0.594 . . . . 53.219999999999999 109.397 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.78 118.54 16.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.803 -0.443 . . . . 52.340000000000003 109.803 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -121.93 134.21 54.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.434 0.635 . . . . 73.140000000000001 111.976 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.41 131.85 35.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.817 -1.083 . . . . 52.240000000000002 109.559 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.0 m -139.64 168.31 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.484 -0.78 . . . . 65.230000000000004 110.036 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.73 63.21 1.87 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.956 0.785 . . . . 72.409999999999997 109.944 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 mt -81.41 143.33 32.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.342 -0.844 . . . . 75.299999999999997 111.912 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.3 tpp180 -145.68 129.87 17.57 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.807 -1.923 . . . . 64.409999999999997 105.807 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.83 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.68 141.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 118.057 0.389 . . . . 73.200000000000003 111.764 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt . . . . . 0 C--N 1.298 -1.652 0 CA-C-N 115.274 -0.875 . . . . 62.399999999999999 109.723 176.547 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.123 -0.325 . . . . 71.230000000000004 110.123 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.1 p -120.99 146.12 47.02 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.384 0.513 . . . . 71.430000000000007 112.384 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 59.16 78.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.804 1.242 . . . . 64.439999999999998 112.266 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 33.4 mt -106.88 147.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.217 -0.901 . . . . 72.340000000000003 110.555 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 69.6 t -107.78 135.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.422 -0.808 . . . . 75.400000000000006 110.219 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -178.61 160.93 27.12 Favored Glycine 0 N--CA 1.408 -3.2 0 CA-C-N 115.246 -0.888 . . . . 74.200000000000003 112.95 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.2 ttmt -98.88 135.56 40.14 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.782 -0.709 . . . . 73.349999999999994 109.483 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.23 109.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.306 -0.998 . . . . 74.230000000000004 108.306 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.2 tttp -72.42 -42.22 65.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.371 -1.286 . . . . 70.109999999999999 108.954 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 67.1 p-90 -174.79 160.53 2.95 Favored 'General case' 0 CA--C 1.486 -1.518 0 C-N-CA 123.949 0.9 . . . . 72.030000000000001 108.821 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -161.72 126.87 3.5 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.978 0.799 . . . . 73.209999999999994 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -99.05 118.4 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.711 -1.218 . . . . 73.209999999999994 107.711 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -70.04 -23.91 63.18 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.26 0.467 . . . . 53.32 112.26 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 m -86.46 -46.29 10.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.087 0.47 . . . . 75.510000000000005 111.216 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.43 -8.68 58.89 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.738 -0.385 . . . . 73.530000000000001 111.942 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 60.63 31.36 20.18 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 112.374 0.509 . . . . 70.040000000000006 112.374 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.83 153.08 43.09 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.272 -0.422 . . . . 73.319999999999993 109.872 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.62 -169.59 39.54 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.68 -0.968 . . . . 62.049999999999997 110.68 175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 53.1 m-85 -140.06 166.62 24.18 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.337 0.655 . . . . 72.430000000000007 110.588 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -145.17 133.67 17.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.061 -0.718 . . . . 74.450000000000003 109.061 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.44 143.01 31.43 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.488 -1.301 . . . . 72.409999999999997 107.488 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.6 pt20 -83.27 156.16 23.25 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 118.035 -1.466 . . . . 63.409999999999997 109.26 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.31 -25.06 21.7 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 124.628 1.205 . . . . 72.439999999999998 113.554 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -78.41 -0.39 28.98 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 122.256 -0.277 . . . . 65.219999999999999 111.591 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 51.48 3.03 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 109.896 -1.282 . . . . 74.510000000000005 109.896 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -66.43 -104.77 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 116.651 1.42 . . . . 51.240000000000002 116.651 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.69 176.48 7.49 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.301 0.572 . . . . 75.109999999999999 111.525 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -116.46 83.32 1.94 Allowed 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 107.816 -1.179 . . . . 62.100000000000001 107.816 172.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 55' ' ' LEU . 4.2 p -119.46 129.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 CA-C-N 115.382 -0.827 . . . . 75.209999999999994 109.638 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 39.6 p90 -86.23 139.07 31.38 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.289 0.566 . . . . 75.319999999999993 111.681 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -103.39 119.8 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.289 -0.869 . . . . 72.430000000000007 109.81 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -110.24 161.75 15.29 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.952 -1.129 . . . . 62.340000000000003 107.952 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.72 -22.31 63.85 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.83 0.678 . . . . 72.530000000000001 112.83 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -53.74 -24.58 15.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.178 0.513 . . . . 34.229999999999997 111.41 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.33 -39.07 59.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.979 0.418 . . . . 63.100000000000001 110.597 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.89 -44.73 88.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 N-CA-C 108.089 -1.078 . . . . 72.409999999999997 108.089 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.35 -26.22 67.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.351 0.407 . . . . 64.150000000000006 110.634 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.74 66.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.707 0.632 . . . . 71.310000000000002 112.707 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.86 -0.59 4.23 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.161 0.8 . . . . 74.120000000000005 113.161 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.87 39.57 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 123.251 0.453 . . . . 31.530000000000001 112.463 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.43 142.72 51.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.306 -1.739 . . . . 63.240000000000002 106.306 178.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' N ' HD13 ' A' ' 42' ' ' LEU . 40.2 t60 -71.15 -61.51 1.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.637 -0.825 . . . . 75.430000000000007 111.829 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -164.37 157.15 17.18 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.077 -0.712 . . . . 63.0 109.077 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.03 153.93 42.72 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.682 0.754 . . . . 42.509999999999998 112.425 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.92 172.32 13.86 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.171 -1.377 . . . . 61.329999999999998 107.693 173.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -71.33 156.1 39.9 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.697 0.761 . . . . 70.140000000000001 112.607 -177.087 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 -18.5 57.35 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.133 -0.939 . . . . 43.5 112.005 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -82.35 139.38 34.14 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 122.687 0.395 . . . . 64.400000000000006 111.657 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 11.1 m-20 -89.12 134.49 33.99 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.274 -1.009 . . . . 73.540000000000006 108.274 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.04 152.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.816 0.817 . . . . 74.109999999999999 111.142 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.6 mt -116.69 128.92 73.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.631 -1.618 . . . . 75.409999999999997 106.631 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -145.95 -180.0 7.09 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.75 -0.38 . . . . 71.310000000000002 110.299 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -119.98 157.23 29.27 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 105.379 -2.082 . . . . 64.239999999999995 105.379 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -123.93 128.51 49.54 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 121.581 0.705 . . . . 72.340000000000003 111.329 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -122.85 142.47 50.74 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.43 -1.693 . . . . 73.319999999999993 106.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.05 143.83 26.01 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.586 -0.846 . . . . 73.439999999999998 112.551 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -103.7 35.48 2.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.288 -1.375 . . . . 70.540000000000006 107.288 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 63.52 88.81 0.09 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.634 -1.167 . . . . 75.140000000000001 109.324 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.82 -47.87 3.62 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.585 -0.817 . . . . 53.530000000000001 111.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 73.5 mmtt -83.73 153.11 24.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.519 -0.549 . . . . 74.329999999999998 109.519 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -123.82 122.37 37.85 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.829 -0.168 . . . . 31.309999999999999 111.183 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.515 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 23.1 p90 -126.49 133.22 51.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.459 0.647 . . . . 73.299999999999997 111.777 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -74.39 140.38 44.71 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.736 -1.12 . . . . 52.409999999999997 109.709 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -139.5 164.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.469 -0.787 . . . . 71.510000000000005 109.314 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.72 63.91 1.56 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.075 0.859 . . . . 70.329999999999998 111.147 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.604 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 24.9 mt -78.98 138.07 37.88 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.611 -1.236 . . . . 63.009999999999998 112.929 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -141.92 131.67 24.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.187 -2.153 . . . . 74.230000000000004 105.187 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.254 2.3 pp -77.92 146.92 7.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 118.79 -1.164 . . . . 73.010000000000005 112.006 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.9 tttt . . . . . 0 C--O 1.262 1.74 0 CA-C-N 115.687 -0.688 . . . . 74.049999999999997 109.559 178.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . . . . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 107.713 -1.217 . . . . 52.43 107.713 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 27.7 p -101.0 142.94 31.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.52 0.933 . . . . 64.310000000000002 113.52 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 62.75 77.84 0.31 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 124.595 1.158 . . . . 62.130000000000003 111.785 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.5 mt -110.02 145.71 16.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.34 -0.845 . . . . 74.129999999999995 111.127 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 57.2 t -99.57 137.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.257 -0.883 . . . . 64.319999999999993 110.641 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -172.45 177.99 44.79 Favored Glycine 0 N--CA 1.4 -3.71 0 CA-C-N 115.007 -0.997 . . . . 44.140000000000001 112.349 167.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -121.98 141.28 51.49 Favored 'General case' 0 C--N 1.256 -3.467 0 C-N-CA 123.813 0.845 . . . . 64.430000000000007 108.978 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.75 111.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 109.045 -0.724 . . . . 63.200000000000003 109.045 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 53.4 tttm -72.41 -48.12 43.88 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.393 -1.336 . . . . 71.109999999999999 107.393 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 67.4 p-90 -176.43 160.96 2.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.83 1.252 . . . . 73.209999999999994 108.494 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 81.0 t80 -151.35 126.08 9.63 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.943 -0.391 . . . . 73.430000000000007 109.943 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.79 101.74 11.56 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.478 -0.934 . . . . 74.120000000000005 108.478 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.4 m -63.85 -21.41 66.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.98 -0.554 . . . . 31.41 111.19 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.7 p -65.81 -37.54 86.54 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 123.33 0.652 . . . . 71.150000000000006 111.396 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.7 mttt -103.14 -6.13 22.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.936 -0.574 . . . . 71.519999999999996 111.862 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 69.43 22.38 6.48 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.533 0.733 . . . . 71.310000000000002 112.226 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 48.8 p90 -147.59 165.08 31.48 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.169 0.509 . . . . 62.340000000000003 111.748 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -167.95 -157.3 10.89 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.999 -1.241 . . . . 71.219999999999999 109.999 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.479 ' HD1' ' CZ2' ' A' ' 11' ' ' TRP . 46.4 m-85 -137.72 165.75 25.64 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 117.417 0.608 . . . . 75.310000000000002 112.168 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -143.92 139.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.09 -1.078 . . . . 61.43 108.09 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 12.4 pt-20 -142.84 144.54 32.55 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.519 -1.66 . . . . 73.140000000000001 106.519 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.542 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -86.94 150.33 24.15 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 117.512 -1.675 . . . . 64.019999999999996 108.221 174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.59 -14.31 12.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 124.241 0.963 . . . . 75.340000000000003 112.597 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -88.64 5.39 43.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.539 -0.301 . . . . 73.319999999999993 111.183 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.7 50.97 2.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.691 -1.242 . . . . 53.420000000000002 112.259 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.4 55.15 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.359 -0.924 . . . . 72.420000000000002 111.399 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.55 162.99 27.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.449 0.537 . . . . 63.229999999999997 112.449 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.95 95.55 5.49 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.91 -0.586 . . . . 70.120000000000005 110.722 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.526 HG21 HD13 ' A' ' 55' ' ' LEU . 3.9 p -112.7 130.05 67.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.496 -0.775 . . . . 71.340000000000003 109.096 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.7 p90 -90.07 136.62 32.94 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.779 -0.768 . . . . 73.120000000000005 110.574 -178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -98.44 127.14 51.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.753 -0.832 . . . . 74.439999999999998 108.753 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -115.96 156.44 26.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.316 -0.624 . . . . 60.340000000000003 109.316 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.58 -18.65 12.59 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.631 0.974 . . . . 75.209999999999994 113.631 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -61.07 -22.94 65.09 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.22 0.533 . . . . 53.399999999999999 110.649 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -77.52 -33.42 54.29 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.433 -0.58 . . . . 42.210000000000001 109.433 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.04 -42.64 88.77 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 N-CA-C 107.704 -1.221 . . . . 71.25 107.704 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -53.75 -35.34 61.14 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.915 0.886 . . . . 64.450000000000003 110.866 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 -18.51 59.73 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.821 1.045 . . . . 74.120000000000005 113.821 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.59 -20.16 2.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.089 . . . . 74.019999999999996 113.939 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.12 38.01 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-O 121.689 0.605 . . . . 63.039999999999999 111.615 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD21 ' HG ' ' A' ' 45' ' ' LEU . 26.1 tp -64.72 141.31 58.82 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.681 -0.759 . . . . 62.219999999999999 110.292 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.22 -57.35 13.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.303 -0.628 . . . . 73.510000000000005 109.303 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -175.69 174.96 2.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.173 -1.418 . . . . 74.140000000000001 107.173 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.0 mp -111.95 145.19 40.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.094 0.473 . . . . 74.129999999999995 110.703 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.81 146.31 45.52 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.224 -0.898 . . . . 71.549999999999997 109.012 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.81 154.57 40.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.13 0.491 . . . . 51.340000000000003 111.387 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 -26.24 19.25 Favored Glycine 0 C--N 1.303 -1.259 0 C-N-CA 120.687 -0.768 . . . . 61.549999999999997 112.188 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -69.86 132.22 45.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 123.359 0.664 . . . . 74.219999999999999 111.647 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.67 132.91 35.31 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 108.125 -1.065 . . . . 52.549999999999997 108.125 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.84 147.27 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.915 0 CA-C-O 121.888 0.851 . . . . 71.109999999999999 110.457 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 68.9 mt -117.55 136.9 53.24 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 106.374 -1.713 . . . . 73.519999999999996 106.374 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -153.11 -178.53 7.0 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.836 -0.346 . . . . 74.010000000000005 110.476 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 37.1 m-20 -119.62 156.17 30.91 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.934 -1.876 . . . . 75.239999999999995 105.934 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 13.6 tp -121.18 116.48 25.02 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-O 122.707 1.241 . . . . 64.439999999999998 114.332 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.7 mm-40 -103.51 151.04 23.32 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.813 -1.994 . . . . 74.209999999999994 111.288 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -105.76 131.34 53.23 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 114.298 -1.319 . . . . 64.239999999999995 111.066 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 86.6 tttt -109.67 78.78 1.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.381 -0.827 . . . . 73.019999999999996 109.536 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 60.36 14.12 4.49 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.883 0.849 . . . . 74.540000000000006 111.64 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.03 -25.14 3.55 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.328 -0.709 . . . . 62.039999999999999 111.328 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.2 mmmt -83.87 164.92 19.16 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.601 -0.889 . . . . 73.329999999999998 108.601 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.51 119.81 32.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 119.835 -0.126 . . . . 71.019999999999996 111.121 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 40.4 p90 -125.22 133.75 52.6 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.549 0.69 . . . . 74.409999999999997 112.443 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 137.34 38.23 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.704 -1.135 . . . . 64.099999999999994 110.829 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.7 m -140.68 168.61 16.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.351 -0.84 . . . . 74.150000000000006 109.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.1 t30 54.32 63.43 2.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.079 0.862 . . . . 62.439999999999998 110.701 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.6 mt -74.41 136.1 42.38 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.694 0.998 . . . . 74.430000000000007 113.694 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 41.6 mmt180 -122.59 131.17 53.7 Favored 'General case' 0 N--CA 1.405 -2.678 0 N-CA-C 106.177 -1.786 . . . . 62.219999999999999 106.177 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.38 131.24 56.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 114.354 1.242 . . . . 54.25 114.354 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.258 1.54 0 CA-C-N 115.209 -0.905 . . . . 72.530000000000001 109.345 173.646 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 107.64 -1.244 . . . . 75.310000000000002 107.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.5 p -127.18 161.83 27.58 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.547 0.573 . . . . 74.200000000000003 112.547 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 60.79 39.85 16.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.0 110.874 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.3 mt -76.79 147.23 7.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.397 -0.819 . . . . 74.430000000000007 111.788 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 64.5 t -102.34 136.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.003 -0.999 . . . . 43.43 110.162 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -177.75 160.65 27.32 Favored Glycine 0 N--CA 1.413 -2.849 0 C-N-CA 120.685 -0.769 . . . . 64.420000000000002 113.503 168.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -97.63 143.75 27.99 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.661 -0.866 . . . . 51.020000000000003 108.661 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.06 107.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.226 -1.027 . . . . 64.109999999999999 108.226 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.519 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.9 tttp -67.87 -48.35 66.35 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.44 -1.255 . . . . 72.219999999999999 109.155 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -166.8 155.55 10.39 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.231 -1.026 . . . . 74.219999999999999 108.231 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -160.46 108.43 1.62 Allowed 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.724 0.64 . . . . 71.030000000000001 109.67 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -84.97 106.47 16.5 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.735 -1.58 . . . . 63.229999999999997 106.735 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 p -62.62 -26.02 68.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.267 0.84 . . . . 63.420000000000002 113.267 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -71.49 -32.22 67.99 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.09 0.471 . . . . 72.230000000000004 110.081 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.04 -9.8 30.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.004 -0.369 . . . . 70.0 110.004 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 52.37 34.67 15.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.701 0.801 . . . . 65.140000000000001 110.074 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.69 156.11 46.99 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.596 -0.52 . . . . 72.099999999999994 109.596 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.02 -153.61 17.39 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.296 -0.722 . . . . 63.509999999999998 111.296 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 41.3 m-85 -137.14 169.18 18.22 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.519 0.728 . . . . 74.519999999999996 110.9 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.439 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 61.7 mt -145.61 130.6 12.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 123.505 0.722 . . . . 74.310000000000002 109.147 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.34 146.84 32.8 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.52 -0.918 . . . . 74.409999999999997 108.52 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.6 pt20 -79.74 148.15 31.61 Favored 'General case' 0 CA--C 1.483 -1.625 0 C-N-CA 118.838 -1.145 . . . . 72.430000000000007 108.38 175.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -53.72 -25.32 17.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 124.528 1.143 . . . . 64.099999999999994 112.065 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -76.93 -3.94 41.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.191 -0.459 . . . . 61.340000000000003 112.138 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.14 50.76 0.76 Allowed Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.393 -1.384 . . . . 61.240000000000002 112.542 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.33 150.69 32.08 Favored Glycine 0 C--N 1.313 -0.733 0 C-N-CA 119.753 -1.213 . . . . 43.329999999999998 110.167 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.19 163.58 26.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 117.264 0.532 . . . . 74.109999999999999 112.262 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.97 105.1 1.54 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-N 115.845 -0.616 . . . . 75.200000000000003 111.299 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 55' ' ' LEU . 4.3 p -126.81 123.71 63.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 108.585 -0.894 . . . . 63.119999999999997 108.585 172.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 47.2 p90 -87.17 149.73 24.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.041 -0.527 . . . . 74.129999999999995 112.397 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 67' ' ' LEU . 9.3 p -106.27 126.72 61.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.381 0.61 . . . . 73.409999999999997 109.57 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -111.78 156.93 21.17 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.036 -1.468 . . . . 71.209999999999994 107.036 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.29 -13.7 61.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.381 -0.928 . . . . 75.400000000000006 112.077 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -59.0 -22.54 60.75 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.239 0.542 . . . . 72.109999999999999 109.716 171.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' ALA . . . -75.51 -38.79 59.18 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.519 -0.549 . . . . 73.299999999999997 109.519 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.66 -43.68 96.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.672 0 N-CA-C 107.891 -1.152 . . . . 61.100000000000001 107.891 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.15 -37.15 69.14 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.107 0.563 . . . . 64.150000000000006 111.623 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.83 -27.45 69.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.22 0.822 . . . . 60.240000000000002 113.22 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.55 -14.88 3.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.498 0.925 . . . . 51.240000000000002 113.498 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.29 47.74 16.56 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 109.731 -1.347 . . . . 74.200000000000003 109.731 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.28 128.95 38.01 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.865 0.866 . . . . 75.310000000000002 108.669 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -46.55 -61.55 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.77 0.656 . . . . 71.430000000000007 112.77 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 p -178.51 162.98 1.49 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.452 -0.944 . . . . 75.519999999999996 108.452 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.9 mt -123.04 149.48 44.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.306 -0.627 . . . . 73.299999999999997 109.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.57 149.35 26.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.145 -1.057 . . . . 74.099999999999994 108.145 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.0 126.45 27.58 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.472 -0.936 . . . . 72.299999999999997 108.472 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.52 -14.91 27.38 Favored Glycine 0 C--N 1.288 -2.094 0 CA-C-N 115.589 -0.732 . . . . 75.340000000000003 113.266 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -81.44 130.04 34.89 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.282 -0.54 . . . . 74.209999999999994 111.18 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.86 131.07 34.56 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 107.198 -1.408 . . . . 71.329999999999998 107.198 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.1 145.95 31.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-O 121.854 0.835 . . . . 72.209999999999994 110.642 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 70.3 mt -113.37 132.67 61.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 107.063 -1.458 . . . . 62.310000000000002 107.063 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.39 -177.01 5.46 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 121.0 0.429 . . . . 61.130000000000003 110.968 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -123.78 149.34 45.76 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 105.68 -1.97 . . . . 73.450000000000003 105.68 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -114.34 119.91 38.57 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 122.088 0.947 . . . . 75.340000000000003 111.473 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -126.25 159.14 33.89 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 113.67 -1.604 . . . . 44.020000000000003 107.977 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.31 143.02 26.75 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.368 0.604 . . . . 72.329999999999998 111.987 -173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 84.7 tttt -100.86 81.52 2.28 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.245 -1.761 . . . . 63.119999999999997 106.245 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 66.82 -68.77 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.724 1.21 . . . . 75.040000000000006 110.238 -174.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.73 -2.19 1.99 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.577 -0.609 . . . . 72.409999999999997 111.577 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.9 mmmt -97.01 165.24 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.15 -0.685 . . . . 72.540000000000006 109.15 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -116.35 116.43 27.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 110.14 -0.319 . . . . 62.43 110.14 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -129.99 140.74 50.84 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.493 0.663 . . . . 73.420000000000002 111.6 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -72.28 133.55 45.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.552 -1.203 . . . . 62.399999999999999 109.227 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 32.5 m -138.3 161.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.69 -0.686 . . . . 73.219999999999999 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 59.96 63.23 1.49 Allowed 'General case' 0 C--O 1.216 -0.658 0 O-C-N 124.392 1.057 . . . . 73.140000000000001 109.294 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.442 HD11 HG21 ' A' ' 32' ' ' VAL . 28.4 mt -80.37 143.61 33.38 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.893 -0.723 . . . . 64.549999999999997 112.8 -173.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.07 133.48 41.2 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.187 1.395 . . . . 63.140000000000001 107.948 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' H ' ' A' ' 69' ' ' ILE . 2.3 mp -82.14 140.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.889 -1.522 . . . . 75.25 106.889 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.258 1.536 0 N-CA-C 108.421 -0.955 . . . . 74.120000000000005 108.421 174.545 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.46 0 N-CA-C 110.288 -0.264 . . . . 65.319999999999993 110.288 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.9 p -102.36 147.31 26.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.377 -0.374 . . . . 73.230000000000004 111.539 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 52.27 77.37 0.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.537 1.135 . . . . 75.430000000000007 113.059 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 46.6 mt -103.93 148.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.183 -0.917 . . . . 72.519999999999996 110.484 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.3 t -91.48 132.72 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 115.242 -0.89 . . . . 64.129999999999995 109.134 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.87 167.45 37.95 Favored Glycine 1 N--CA 1.394 -4.123 0 C-N-CA 120.317 -0.945 . . . . 70.439999999999998 111.781 171.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -123.04 135.74 54.55 Favored 'General case' 0 C--N 1.261 -3.267 0 N-CA-C 107.569 -1.271 . . . . 55.43 107.569 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.86 116.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.68 0.752 . . . . 50.439999999999998 109.16 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.4 tttp -75.85 -43.62 44.84 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.03 -1.441 . . . . 65.329999999999998 109.109 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -175.02 159.65 2.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 123.917 0.887 . . . . 73.409999999999997 109.182 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -163.44 126.85 2.73 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.878 0.736 . . . . 74.049999999999997 109.236 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -115.71 122.57 45.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.672 -0.862 . . . . 74.5 108.672 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 m -65.14 -19.15 65.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.087 0.47 . . . . 65.310000000000002 110.063 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.6 m -62.28 -34.13 75.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.721 -0.672 . . . . 64.230000000000004 110.668 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.36 -10.2 11.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.061 -0.656 . . . . 74.319999999999993 111.88 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 54.27 29.66 11.09 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 113.405 0.891 . . . . 63.420000000000002 113.405 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -129.8 156.41 44.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 114.672 -1.149 . . . . 74.319999999999993 108.534 173.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.44 -172.78 38.54 Favored Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 109.087 -1.605 . . . . 73.439999999999998 109.087 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 50.3 m-85 -134.24 165.9 24.03 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 117.036 0.418 . . . . 74.439999999999998 111.123 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.6 mt -147.16 136.26 16.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.111 -1.07 . . . . 54.109999999999999 108.111 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.39 148.47 34.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.525 -2.028 . . . . 74.530000000000001 105.525 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.5 pt20 -74.84 142.5 44.16 Favored 'General case' 0 CA--C 1.473 -2.019 0 C-N-CA 116.655 -2.018 . . . . 74.519999999999996 108.68 175.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -49.62 -33.04 14.24 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.122 -1.399 . . . . 75.319999999999993 111.594 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -87.75 11.31 15.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.902 0.705 . . . . 64.310000000000002 112.902 -173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.39 51.2 0.67 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.405 -1.379 . . . . 60.310000000000002 113.471 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -96.26 157.59 21.51 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 119.774 -1.203 . . . . 62.149999999999999 110.989 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -72.06 152.73 42.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.831 0.315 . . . . 64.219999999999999 110.522 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 120.79 24.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.19 0.995 . . . . 74.239999999999995 111.724 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 55' ' ' LEU . 3.0 p -121.87 139.01 50.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 114.365 -1.289 . . . . 71.109999999999999 108.223 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 40.7 p90 -88.15 142.67 27.58 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.428 -0.909 . . . . 70.340000000000003 111.45 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 67' ' ' LEU . 13.3 p -110.67 144.21 19.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.605 -0.887 . . . . 73.099999999999994 108.605 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -131.66 158.4 41.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.54 -0.911 . . . . 72.430000000000007 108.54 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.56 -16.44 63.87 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 112.505 0.557 . . . . 75.209999999999994 112.505 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -56.67 -26.24 55.87 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.235 0.541 . . . . 70.340000000000003 110.357 172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.85 -37.71 55.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.259 -0.428 . . . . 71.140000000000001 110.117 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.6 t -66.57 -40.6 86.71 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 N-CA-C 107.844 -1.169 . . . . 73.120000000000005 107.844 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.26 -32.6 72.42 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.78 0.832 . . . . 63.399999999999999 110.755 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.37 82.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.721 0.638 . . . . 64.219999999999999 112.721 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.68 -8.79 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.478 0.918 . . . . 41.009999999999998 113.478 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.63 58.36 7.83 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.47 -1.052 . . . . 73.519999999999996 110.47 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.482 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.02 145.46 51.75 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.435 -1.32 . . . . 75.319999999999993 107.435 -179.041 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.482 ' N ' HD13 ' A' ' 42' ' ' LEU . 62.7 t-80 -54.5 -61.7 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.58 0.352 . . . . 73.310000000000002 110.981 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -175.62 150.66 1.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.547 -0.538 . . . . 53.119999999999997 109.547 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.96 143.84 36.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.261 -0.644 . . . . 72.430000000000007 109.261 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.13 160.15 16.0 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.932 -1.136 . . . . 61.200000000000003 107.932 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 150.41 45.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.819 0.819 . . . . 74.099999999999994 112.374 -176.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.68 -14.73 62.21 Favored Glycine 0 C--N 1.298 -1.569 0 CA-C-N 114.991 -1.004 . . . . 55.009999999999998 112.677 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -79.41 116.65 19.77 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 122.519 -0.4 . . . . 75.109999999999999 111.152 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.91 129.92 38.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.998 -1.482 . . . . 71.030000000000001 106.998 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 147.83 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-O 122.034 0.921 . . . . 75.439999999999998 110.976 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.6 mt -110.03 127.76 66.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.199 -1.778 . . . . 71.319999999999993 106.199 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.47 176.45 9.0 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.948 -0.701 . . . . 73.430000000000007 111.311 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.46 140.39 52.23 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.107 -1.812 . . . . 62.130000000000003 106.107 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 30' ' ' VAL . 20.7 tp -121.36 122.06 39.01 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.728 0.775 . . . . 62.439999999999998 111.898 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -109.92 166.22 11.1 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.885 -1.507 . . . . 74.409999999999997 109.469 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.1 125.72 51.43 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.587 -1.264 . . . . 74.409999999999997 107.587 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -126.16 75.16 1.5 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.457 0.54 . . . . 40.299999999999997 112.457 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 59' ' ' GLN . 26.7 tt0 58.12 32.91 22.61 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.857 0.837 . . . . 64.409999999999997 111.202 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.37 31.5 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 120.505 -0.855 . . . . 44.299999999999997 111.641 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.0 mmtt -96.87 162.04 13.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.803 -0.443 . . . . 74.219999999999999 109.803 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.11 112.01 8.91 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.585 -1.265 . . . . 75.150000000000006 107.585 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.6 p90 -124.96 135.51 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.418 0.628 . . . . 65.420000000000002 111.5 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 123.66 32.75 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.639 -1.164 . . . . 74.140000000000001 109.838 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 18.4 m -137.22 176.29 7.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.588 -0.733 . . . . 52.32 111.62 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.39 40.11 27.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.492 1.12 . . . . 74.319999999999993 108.361 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 32' ' ' VAL . 36.3 mt -62.63 142.07 58.22 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.617 -1.174 . . . . 74.140000000000001 113.016 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -143.68 130.39 20.26 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.546 -1.65 . . . . 75.329999999999998 106.546 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.23 141.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.567 -0.853 . . . . 75.530000000000001 110.891 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.25 1.109 0 O-C-N 123.858 0.724 . . . . 73.030000000000001 110.798 178.777 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 108.044 -1.095 . . . . 74.010000000000005 108.044 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p -101.69 150.32 23.24 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.45 0.469 . . . . 53.020000000000003 111.492 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 61.84 76.07 0.38 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.681 0.792 . . . . 74.349999999999994 111.319 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 34.1 mt -108.36 150.65 10.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.193 -0.912 . . . . 70.319999999999993 110.462 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 93.9 t -96.11 132.46 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 115.629 -0.714 . . . . 63.240000000000002 110.182 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.44 171.07 39.04 Favored Glycine 0 N--CA 1.399 -3.819 0 CA-C-N 115.109 -0.95 . . . . 62.119999999999997 111.676 170.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -128.35 133.28 48.63 Favored 'General case' 0 C--N 1.26 -3.299 0 C-N-CA 124.472 1.109 . . . . 71.25 108.879 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.91 113.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 116.061 -0.518 . . . . 62.229999999999997 109.987 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.537 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 64.4 mttm -62.58 -49.0 76.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.615 -0.721 . . . . 34.509999999999998 109.276 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -175.81 166.67 3.1 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.805 1.242 . . . . 72.230000000000004 108.661 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -145.06 140.35 28.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.626 0.579 . . . . 70.340000000000003 109.442 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -112.25 121.53 45.18 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.501 -0.926 . . . . 73.430000000000007 108.501 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -75.99 -28.94 58.03 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.094 0.405 . . . . 74.299999999999997 112.094 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.4 m -69.03 -48.64 62.4 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.975 0.417 . . . . 73.120000000000005 111.264 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -95.28 -8.56 35.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.681 0.622 . . . . 71.109999999999999 112.681 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 62.43 30.68 17.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.945 0.403 . . . . 71.239999999999995 111.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.65 163.41 21.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.128 -0.487 . . . . 62.200000000000003 109.939 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.18 -172.47 43.46 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 107.939 -2.064 . . . . 71.340000000000003 107.939 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 55.8 m-85 -136.82 155.98 49.09 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 118.125 0.963 . . . . 63.219999999999999 111.372 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -134.94 140.93 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.499 -0.926 . . . . 74.439999999999998 108.499 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 13.8 pt-20 -143.05 147.4 35.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.25 -2.13 . . . . 72.109999999999999 105.25 175.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.2 pt20 -79.87 144.45 33.43 Favored 'General case' 0 CA--C 1.483 -1.613 0 C-N-CA 115.305 -2.558 . . . . 72.140000000000001 109.315 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.79 -29.21 11.01 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 124.992 1.433 . . . . 62.329999999999998 111.357 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.86 4.0 43.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.179 0.807 . . . . 64.129999999999995 113.179 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.25 53.62 0.88 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 117.744 -2.17 . . . . 72.0 112.332 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -83.09 -121.91 0.76 Allowed Glycine 0 C--N 1.312 -0.803 0 C-N-CA 120.576 -0.821 . . . . 32.219999999999999 114.23 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.95 168.66 15.68 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 122.726 0.41 . . . . 70.420000000000002 110.359 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.71 92.19 6.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.186 -0.672 . . . . 54.539999999999999 109.186 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.44 132.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.523 -0.762 . . . . 74.519999999999996 109.148 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 44.0 p90 -90.09 149.14 22.62 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 118.92 -1.112 . . . . 75.109999999999999 110.884 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -105.99 137.12 37.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.099 -0.704 . . . . 74.549999999999997 109.099 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -125.25 157.17 37.25 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.697 -1.223 . . . . 53.100000000000001 107.697 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -62.38 -24.23 67.26 Favored 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 113.022 0.749 . . . . 71.0 113.022 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -52.51 -26.06 12.02 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 120.981 0.419 . . . . 53.130000000000003 111.399 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -74.79 -39.61 61.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 109.823 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.89 -46.34 88.82 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.373 0 CA-C-N 115.06 -0.973 . . . . 64.030000000000001 108.404 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.69 -23.79 65.12 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.402 0.439 . . . . 74.019999999999996 111.14 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.74 69.16 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.301 0.482 . . . . 70.510000000000005 112.301 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.8 -4.8 4.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.229 0.826 . . . . 50.100000000000001 113.229 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.05 52.48 44.32 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.295 -0.722 . . . . 71.310000000000002 111.295 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.24 125.56 27.27 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.074 -1.825 . . . . 65.109999999999999 106.074 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -74.51 -37.79 63.0 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 114.833 1.419 . . . . 74.129999999999995 114.833 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -155.63 138.3 15.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.104 -0.638 . . . . 74.120000000000005 112.257 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.19 149.3 43.03 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.471 -0.786 . . . . 74.140000000000001 109.035 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.46 169.56 22.3 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.481 -1.674 . . . . 64.310000000000002 106.481 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -75.42 155.28 36.51 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.58 -0.448 . . . . 71.519999999999996 110.966 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.09 1.27 89.67 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.923 -0.656 . . . . 33.119999999999997 113.09 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -86.22 121.08 28.31 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 111.902 0.334 . . . . 74.25 111.902 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -71.78 127.51 32.8 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.144 -1.058 . . . . 74.420000000000002 108.144 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.49 147.58 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 CA-C-O 121.976 0.893 . . . . 70.450000000000003 110.686 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 71.9 mt -112.69 135.11 53.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 N-CA-C 106.893 -1.521 . . . . 75.200000000000003 106.893 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -150.13 179.28 8.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 121.076 -0.25 . . . . 72.120000000000005 110.566 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -114.86 154.35 28.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.035 -1.839 . . . . 73.349999999999994 106.035 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 62' ' ' ALA . 37.1 tp -140.53 136.67 33.13 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.901 0.857 . . . . 75.209999999999994 112.755 -176.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -131.54 132.42 44.14 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.226 -1.768 . . . . 74.230000000000004 106.226 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.77 116.41 23.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.846 0.832 . . . . 70.120000000000005 111.04 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -81.26 79.14 7.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.154 -1.384 . . . . 75.010000000000005 109.785 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 57.52 20.62 6.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.061 0.945 . . . . 64.510000000000005 112.374 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.16 -30.11 3.56 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.413 -0.675 . . . . 72.049999999999997 111.413 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -84.13 164.12 19.38 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.377 -1.342 . . . . 75.540000000000006 107.377 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -138.15 129.04 26.97 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 118.652 0.66 . . . . 73.420000000000002 110.784 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 6.9 p90 -133.93 133.91 41.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.467 0.651 . . . . 60.229999999999997 111.175 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -79.58 133.37 36.44 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.537 -1.21 . . . . 53.119999999999997 110.297 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 26.9 m -135.24 161.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.976 -1.011 . . . . 74.510000000000005 109.29 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 t30 59.63 64.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.848 0.718 . . . . 64.239999999999995 110.817 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 21.8 mt -78.14 139.9 39.01 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.976 -1.09 . . . . 71.319999999999993 112.132 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 16.6 tpp180 -137.45 130.77 30.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.111 -2.551 . . . . 65.230000000000004 104.111 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.58 143.22 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.944 -1.102 . . . . 72.239999999999995 113.055 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.914 -1.041 . . . . 73.219999999999999 108.945 173.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 107.106 -1.442 . . . . 73.219999999999999 107.106 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.404 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 41.5 p -120.49 142.0 49.69 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.137 0.421 . . . . 73.140000000000001 112.137 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 55.86 74.54 0.38 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.308 1.043 . . . . 62.439999999999998 112.31 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 2' ' ' ALA . 36.6 mt -99.58 152.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.643 -1.162 . . . . 42.229999999999997 110.818 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.2 t -102.62 135.97 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 115.419 -0.81 . . . . 64.420000000000002 109.548 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.14 175.42 47.12 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 115.103 -0.953 . . . . 71.430000000000007 111.98 168.355 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 38.3 ttmt -123.91 143.02 50.62 Favored 'General case' 0 C--N 1.253 -3.627 0 C-N-CA 123.973 0.909 . . . . 63.119999999999997 108.801 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.02 109.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.136 -0.69 . . . . 62.420000000000002 109.136 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.55 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 58.2 tttp -68.53 -49.1 62.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.886 -1.524 . . . . 64.209999999999994 106.886 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -169.11 156.18 7.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 114.951 -1.022 . . . . 70.340000000000003 108.829 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 80.6 t80 -157.16 111.39 2.68 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 123.638 0.586 . . . . 71.109999999999999 109.668 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -99.49 118.63 36.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.822 -0.626 . . . . 71.420000000000002 109.932 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 m -64.36 -22.92 67.11 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.059 -0.973 . . . . 73.040000000000006 110.2 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -55.08 -44.99 75.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.537 -0.756 . . . . 64.439999999999998 111.212 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.8 mttt -106.21 -6.09 18.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.437 0.532 . . . . 63.229999999999997 112.437 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 68.86 22.65 7.11 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.073 0.549 . . . . 73.340000000000003 110.928 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 36.5 p90 -148.47 166.86 26.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.06 0.457 . . . . 75.209999999999994 111.965 176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.85 -153.06 8.56 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.757 -1.337 . . . . 64.530000000000001 109.757 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.4 m-85 -137.05 167.81 20.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 122.857 0.463 . . . . 70.010000000000005 111.419 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 64.0 mt -142.35 138.29 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.573 -0.899 . . . . 72.409999999999997 108.573 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -143.18 147.25 34.59 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 106.545 -1.65 . . . . 70.530000000000001 106.545 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -86.29 156.79 20.1 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 117.599 -1.64 . . . . 73.0 108.78 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -53.99 -27.12 29.59 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.232 0.957 . . . . 74.120000000000005 112.368 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -81.41 5.45 17.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.079 0.4 . . . . 64.140000000000001 112.079 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.01 51.72 4.09 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.433 -1.365 . . . . 61.450000000000003 110.807 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -78.5 -168.12 32.99 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.877 -0.678 . . . . 75.109999999999999 112.459 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.02 144.71 55.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.044 -0.354 . . . . 73.040000000000006 110.044 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.29 87.39 7.11 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.494 -0.928 . . . . 45.329999999999998 108.494 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 55' ' ' LEU . 3.8 p -100.52 138.41 24.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.441 -1.254 . . . . 71.340000000000003 110.055 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.0 p90 -88.98 145.18 25.67 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 119.061 -1.055 . . . . 60.43 110.034 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 67' ' ' LEU . 8.1 p -115.57 136.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 108.748 -0.834 . . . . 73.530000000000001 108.748 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -124.67 159.94 29.66 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.136 -0.691 . . . . 74.430000000000007 109.136 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.32 -15.69 60.77 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 112.647 0.61 . . . . 74.209999999999994 112.647 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.6 m -61.45 -26.93 68.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.963 0.411 . . . . 64.319999999999993 110.495 172.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.31 -34.9 61.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.7 -0.482 . . . . 71.519999999999996 109.7 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.57 -46.29 93.01 Favored 'Isoleucine or valine' 0 C--O 1.181 -2.524 0 N-CA-C 107.721 -1.214 . . . . 75.439999999999998 107.721 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.52 -31.24 63.93 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.124 0.97 . . . . 74.349999999999994 110.866 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.4 63.84 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.121 0.786 . . . . 74.510000000000005 113.121 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.63 -5.62 4.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.654 0.983 . . . . 61.020000000000003 113.654 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.09 49.43 75.17 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 111.117 -0.793 . . . . 71.099999999999994 111.117 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.1 tm? -66.86 138.16 57.11 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.154 -1.424 . . . . 53.32 107.154 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.4 ' N ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-70 -65.15 -53.58 42.89 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.0 1.111 . . . . 72.040000000000006 114.0 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -165.83 153.84 10.84 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.527 -0.469 . . . . 61.340000000000003 110.575 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.6 mt -124.01 143.78 50.22 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.119 -0.697 . . . . 73.230000000000004 109.119 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.16 162.38 20.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.132 -1.432 . . . . 62.100000000000001 107.132 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -69.1 153.4 43.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.591 . . . . 73.239999999999995 111.501 -176.054 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.58 84.66 Favored Glycine 0 C--N 1.3 -1.465 0 CA-C-N 115.262 -0.881 . . . . 64.319999999999993 112.803 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -93.58 119.08 32.19 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.268 0.47 . . . . 73.25 112.268 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 22.4 m-20 -71.91 136.38 46.87 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.171 -0.612 . . . . 71.409999999999997 109.745 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.29 153.41 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-O 121.876 0.846 . . . . 74.310000000000002 110.815 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 65.9 mt -115.2 135.36 55.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 N-CA-C 106.58 -1.637 . . . . 75.299999999999997 106.58 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -153.06 177.59 10.64 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.947 -0.701 . . . . 74.420000000000002 110.624 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 44.5 m-20 -118.93 157.53 27.5 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.013 -1.847 . . . . 75.439999999999998 106.013 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD13 HG21 ' A' ' 30' ' ' VAL . 18.3 tp -134.9 138.18 43.88 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 120.879 0.371 . . . . 71.439999999999998 111.883 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -127.56 151.57 48.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.49 -1.3 . . . . 63.130000000000003 107.49 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.42 120.82 31.85 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 121.243 0.544 . . . . 71.329999999999998 111.018 -175.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 87.0 tttt -90.49 74.31 6.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.528 -0.76 . . . . 73.129999999999995 108.956 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 61.14 8.32 1.95 Allowed 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.85 -1.068 . . . . 73.030000000000001 113.178 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.53 -24.28 2.49 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.803 -0.919 . . . . 64.209999999999994 110.803 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -88.7 162.41 16.29 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.09 -1.078 . . . . 71.450000000000003 108.09 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.452 ' C ' HG23 ' A' ' 30' ' ' VAL . . . -120.99 127.73 52.05 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.975 -0.453 . . . . 71.329999999999998 111.495 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 36.4 p90 -127.81 132.6 49.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.367 0.603 . . . . 50.130000000000003 111.63 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.2 136.8 33.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.147 -0.933 . . . . 63.210000000000001 110.755 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 30.6 m -139.64 167.85 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.162 -0.926 . . . . 65.120000000000005 109.765 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.08 63.43 2.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.623 0.769 . . . . 54.119999999999997 110.472 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.51 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 30.1 mt -78.9 141.01 37.99 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.129 -1.029 . . . . 75.329999999999998 113.022 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 18.4 tpp180 -141.72 130.58 23.0 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 105.929 -1.878 . . . . 73.109999999999999 105.929 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.02 149.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.03 -1.068 . . . . 73.120000000000005 111.989 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt . . . . . 0 C--O 1.251 1.17 0 O-C-N 124.049 0.843 . . . . 74.239999999999995 110.755 175.555 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 109.327 -0.62 . . . . 74.340000000000003 109.327 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 p -100.22 146.0 27.4 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.847 -0.615 . . . . 64.239999999999995 111.662 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 t30 54.68 77.18 0.21 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.908 1.283 . . . . 54.409999999999997 110.656 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 45.3 mt -103.93 142.84 16.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.422 -0.808 . . . . 73.409999999999997 110.416 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 76.4 t -95.96 140.82 16.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.257 -0.883 . . . . 75.129999999999995 109.45 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.94 161.87 29.85 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.312 -0.947 . . . . 55.409999999999997 113.593 168.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -96.09 137.41 35.19 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.785 -0.821 . . . . 72.329999999999998 108.785 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.32 102.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 107.674 -1.232 . . . . 73.430000000000007 107.674 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.71 -45.36 92.37 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.499 -1.228 . . . . 72.420000000000002 110.417 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -172.53 162.81 5.31 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 124.072 0.949 . . . . 73.25 108.723 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 88.5 t80 -160.77 116.02 2.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.887 0.742 . . . . 72.129999999999995 109.934 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.71 106.28 18.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.374 -0.973 . . . . 62.43 108.374 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 p -59.76 -32.47 70.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.176 0.806 . . . . 72.349999999999994 113.176 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 m -76.71 -21.97 54.57 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.204 0.526 . . . . 73.219999999999999 110.725 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -101.45 -8.87 21.59 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 119.979 -0.688 . . . . 74.099999999999994 110.769 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 91.7 m-20 54.68 29.8 12.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.394 0.678 . . . . 71.310000000000002 112.809 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.03 154.32 51.75 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.195 0.598 . . . . 71.239999999999995 110.346 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.35 -171.78 39.65 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.787 -1.325 . . . . 72.230000000000004 109.787 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -132.39 157.42 44.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.272 0.536 . . . . 73.140000000000001 111.297 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 HD13 HG11 ' A' ' 51' ' ' VAL . 59.8 mt -147.02 128.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.482 -0.781 . . . . 74.430000000000007 109.23 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.94 148.6 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.308 -0.997 . . . . 74.230000000000004 108.308 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 9.9 pt20 -80.41 151.82 29.16 Favored 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 119.567 -0.853 . . . . 62.450000000000003 109.971 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.9 -15.22 19.82 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.62 1.2 . . . . 74.530000000000001 110.997 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 71.0 m-20 -88.14 6.6 35.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.735 -0.666 . . . . 74.219999999999999 110.295 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.81 51.2 2.52 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.988 -1.101 . . . . 53.240000000000002 113.111 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.42 41.84 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 119.911 -1.138 . . . . 64.129999999999995 111.074 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 157.93 28.47 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.392 0.596 . . . . 62.240000000000002 112.055 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.71 90.95 4.63 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.342 0.592 . . . . 71.430000000000007 109.984 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 55' ' ' LEU . 5.4 p -106.0 135.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.972 -1.013 . . . . 73.450000000000003 108.873 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -91.95 142.84 27.1 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.353 -0.939 . . . . 63.420000000000002 110.566 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 67' ' ' LEU . 9.7 p -99.44 145.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.535 -0.913 . . . . 62.340000000000003 108.535 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 32.8 t60 -135.52 161.37 35.66 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.296 -1.002 . . . . 71.519999999999996 108.296 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -68.06 -18.53 64.7 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 112.644 0.609 . . . . 60.32 112.644 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -56.85 -21.99 33.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.28 0.562 . . . . 74.219999999999999 110.373 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.626 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -81.14 -34.76 32.25 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.168 -0.469 . . . . 53.100000000000001 110.227 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.0 t -64.41 -52.26 57.62 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.424 0 N-CA-C 108.112 -1.07 . . . . 72.420000000000002 108.112 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.89 -22.61 64.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 123.436 0.46 . . . . 75.209999999999994 112.146 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.42 75.88 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 120.974 -0.29 . . . . 65.450000000000003 111.599 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.14 0.6 4.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.802 0.667 . . . . 64.340000000000003 112.802 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.08 50.26 65.64 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 111.092 -0.803 . . . . 72.329999999999998 111.092 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.8 138.58 58.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.753 -1.573 . . . . 71.340000000000003 106.753 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.55 -56.0 19.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.203 0.456 . . . . 62.299999999999997 111.968 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.1 p -167.81 152.46 6.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.389 -0.369 . . . . 54.210000000000001 110.323 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 90.2 mt -115.11 152.76 31.98 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.825 -0.435 . . . . 65.109999999999999 109.825 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.23 163.97 39.29 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.804 -1.554 . . . . 70.319999999999993 106.804 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 151.03 39.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.125 -0.63 . . . . 54.020000000000003 109.721 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.9 70.69 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.877 -0.678 . . . . 72.409999999999997 112.513 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -79.5 135.41 36.63 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 122.814 -0.227 . . . . 71.040000000000006 110.596 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.58 127.78 38.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.749 -1.574 . . . . 72.010000000000005 106.749 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG11 HD13 ' A' ' 21' ' ' ILE . 14.8 p -134.0 153.85 36.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.727 0 CA-C-O 121.485 0.66 . . . . 73.340000000000003 111.147 -173.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 67.0 mt -117.92 133.41 64.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 N-CA-C 106.821 -1.548 . . . . 63.130000000000003 106.821 177.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.8 p90 -144.76 -178.89 6.25 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.832 -0.432 . . . . 72.430000000000007 109.832 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -123.94 143.57 50.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.244 -1.391 . . . . 53.340000000000003 107.244 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.9 tp -117.72 116.88 27.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.445 1.116 . . . . 73.219999999999999 112.973 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.94 123.96 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.471 -2.048 . . . . 72.109999999999999 105.471 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.57 132.98 36.4 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.783 0.801 . . . . 75.230000000000004 111.608 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -102.05 81.09 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.613 -1.176 . . . . 64.129999999999995 108.744 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 63.63 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.314 1.046 . . . . 61.420000000000002 111.484 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.62 5.35 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.876 -0.89 . . . . 70.25 110.876 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -110.91 154.73 23.67 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.789 -0.819 . . . . 72.540000000000006 108.789 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -134.08 128.63 34.62 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 110.063 -0.347 . . . . 52.229999999999997 110.063 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.32 134.54 45.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.35 0.595 . . . . 64.219999999999999 110.749 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.97 130.73 35.16 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.798 -1.092 . . . . 55.219999999999999 110.898 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 24.1 m -139.39 167.98 19.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.225 -0.898 . . . . 72.129999999999995 110.288 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 59.66 63.14 1.57 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.449 1.093 . . . . 64.120000000000005 110.056 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.626 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.9 mt -79.47 139.47 37.62 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.932 0.872 . . . . 73.420000000000002 113.239 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -139.53 131.79 28.28 Favored 'General case' 0 N--CA 1.41 -2.425 0 C-N-CA 125.822 1.649 . . . . 71.219999999999999 107.101 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.8 mt -80.22 138.35 19.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 118.739 -1.185 . . . . 44.140000000000001 109.127 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 115.454 -0.794 . . . . 74.129999999999995 110.005 -177.163 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 105.872 -1.899 . . . . 72.340000000000003 105.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 p -97.09 140.74 31.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.149 1.166 . . . . 75.409999999999997 114.149 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 59.01 77.06 0.32 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.705 1.602 . . . . 74.439999999999998 110.869 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.4 mt -103.01 150.28 6.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.96 -1.018 . . . . 73.209999999999994 110.57 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.5 t -98.84 136.24 30.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.389 -0.823 . . . . 61.25 109.778 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.96 157.2 23.06 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.843 -0.694 . . . . 75.129999999999995 113.117 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.7 ttmt -99.69 139.75 34.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 123.231 0.612 . . . . 74.299999999999997 110.133 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.18 107.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.709 -0.678 . . . . 61.310000000000002 109.326 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -65.7 -46.6 78.4 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.243 -0.89 . . . . 62.32 109.74 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -174.29 161.68 3.5 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 123.736 0.815 . . . . 72.310000000000002 109.52 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -154.14 121.77 5.86 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.503 0.502 . . . . 75.200000000000003 111.181 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -117.85 106.77 13.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 115.69 -0.686 . . . . 75.200000000000003 110.036 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -56.42 -29.61 61.79 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.719 -1.128 . . . . 63.009999999999998 111.028 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 m -61.62 -34.57 75.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 65.030000000000001 110.614 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.35 -7.26 35.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 55.200000000000003 110.18 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.37 22.06 11.97 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.531 1.132 . . . . 74.019999999999996 110.983 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -157.2 174.91 14.76 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.493 0.663 . . . . 75.129999999999995 111.307 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.41 -164.63 24.43 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 108.834 -1.706 . . . . 70.400000000000006 108.834 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -131.95 152.53 51.03 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 117.6 0.7 . . . . 72.450000000000003 111.16 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -142.79 134.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 123.522 0.729 . . . . 51.219999999999999 109.143 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.99 151.53 38.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.319 -1.363 . . . . 72.239999999999995 107.319 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -85.12 151.76 23.89 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.805 -1.558 . . . . 73.140000000000001 109.267 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.42 -27.75 57.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 124.282 0.989 . . . . 53.240000000000002 111.678 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -76.3 2.51 13.15 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.325 -0.398 . . . . 72.219999999999999 111.711 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 51.44 1.53 Allowed Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 119.804 -1.188 . . . . 71.439999999999998 111.965 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 170.32 53.28 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 119.758 -1.21 . . . . 63.039999999999999 111.047 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.93 154.55 39.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.882 0.341 . . . . 73.510000000000005 111.584 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.5 89.17 4.46 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.433 -0.951 . . . . 75.230000000000004 108.433 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 136.24 39.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.516 -0.766 . . . . 72.099999999999994 109.736 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 53.4 p90 -94.45 139.74 30.73 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.944 -0.702 . . . . 62.030000000000001 109.88 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 67' ' ' LEU . 7.4 p -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 109.722 -0.473 . . . . 71.200000000000003 109.722 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -98.12 138.61 35.16 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.679 -0.489 . . . . 71.120000000000005 109.679 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -57.21 -28.06 62.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.393 1.627 . . . . 53.520000000000003 115.393 -173.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 m -54.47 -25.79 27.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 120.624 -0.43 . . . . 72.109999999999999 111.244 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.14 -38.86 63.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.53 0.205 . . . . 73.549999999999997 110.595 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.99 -52.64 58.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 108.263 -1.014 . . . . 73.239999999999995 108.263 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.91 -22.32 65.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 113.337 0.866 . . . . 62.229999999999997 113.337 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.16 -30.83 71.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.995 0.426 . . . . 72.549999999999997 110.981 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.98 -7.49 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.459 0.647 . . . . 50.329999999999998 110.437 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.59 24.3 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 109.886 -1.286 . . . . 62.5 109.886 -171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.04 130.49 44.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.981 -1.489 . . . . 74.340000000000003 106.981 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -53.53 -56.44 17.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.73 1.011 . . . . 74.239999999999995 113.73 -172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m -163.94 151.39 12.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 110.351 -0.24 . . . . 62.219999999999999 110.351 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -123.59 141.49 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.204 -1.036 . . . . 74.549999999999997 108.204 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.22 153.41 33.75 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.031 -0.531 . . . . 74.120000000000005 110.229 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.79 134.73 57.09 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.25 -1.018 . . . . 72.299999999999997 108.25 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.87 -14.56 49.17 Favored Glycine 0 C--N 1.295 -1.717 0 C-N-CA 120.993 -0.622 . . . . 73.209999999999994 111.947 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -85.41 134.09 34.09 Favored 'General case' 0 CA--C 1.495 -1.143 0 O-C-N 122.708 -0.289 . . . . 62.140000000000001 110.586 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -89.66 136.74 32.86 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.026 -1.472 . . . . 73.310000000000002 107.026 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.73 151.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-O 121.918 0.866 . . . . 71.219999999999999 111.378 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -113.07 133.32 59.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.918 -1.512 . . . . 71.510000000000005 106.918 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 43.5 p90 -149.54 177.48 9.69 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.297 -0.26 . . . . 71.540000000000006 110.297 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -115.34 155.56 27.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.349 -1.723 . . . . 71.010000000000005 106.349 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -141.03 136.9 32.53 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.772 0.796 . . . . 73.310000000000002 111.536 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.21 145.26 27.04 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.661 -1.977 . . . . 72.530000000000001 105.661 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.24 128.17 34.58 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 113.699 1.0 . . . . 74.420000000000002 113.699 -170.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 64.8 tttp -83.43 70.82 10.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.27 -1.332 . . . . 64.409999999999997 109.268 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 55.65 24.46 7.12 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.249 1.02 . . . . 72.349999999999994 111.325 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.81 -35.5 1.99 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.306 -0.718 . . . . 75.430000000000007 111.306 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 10.9 mptt -84.32 164.79 18.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.84 -0.429 . . . . 73.030000000000001 109.84 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.88 113.68 13.16 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.895 -0.409 . . . . 74.319999999999993 109.895 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 2.8 p90 -126.88 137.75 53.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.338 0.589 . . . . 72.329999999999998 111.569 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.9 35.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.588 -1.187 . . . . 44.229999999999997 110.392 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 31.4 m -134.88 168.08 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.156 -0.929 . . . . 52.420000000000002 109.935 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 55.39 63.55 2.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.492 0.717 . . . . 72.0 110.529 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 32' ' ' VAL . 37.9 mt -81.95 145.93 30.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.274 -0.875 . . . . 74.409999999999997 112.461 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -150.53 130.86 13.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.241 -2.133 . . . . 71.049999999999997 105.241 174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.38 145.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 C-N-CA 119.545 -0.862 . . . . 73.329999999999998 110.148 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 87.9 tttt . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.903 -1.147 . . . . 63.229999999999997 107.903 174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 N-CA-C 107.449 -1.315 . . . . 71.409999999999997 107.449 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 p -118.58 148.63 42.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 111.983 0.364 . . . . 74.150000000000006 111.983 -175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 58.15 76.93 0.31 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.128 0.971 . . . . 71.209999999999994 111.435 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mt -108.35 154.41 9.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.983 -1.008 . . . . 54.299999999999997 110.51 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.9 t -103.46 129.5 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.665 -0.698 . . . . 54.200000000000003 109.505 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.79 171.62 35.48 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 110.658 -0.977 . . . . 63.229999999999997 110.658 171.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.8 ttmt -125.94 140.35 52.7 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 108.433 -0.951 . . . . 73.310000000000002 108.433 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 73.0 t -57.37 112.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.573 -0.528 . . . . 61.210000000000001 109.573 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.4 tttp -79.15 -43.09 24.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.582 -1.19 . . . . 43.409999999999997 109.112 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -176.2 160.01 2.14 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 124.139 0.976 . . . . 73.400000000000006 109.173 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 87.6 t80 -155.65 121.99 5.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.498 0.499 . . . . 72.030000000000001 110.089 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -105.15 104.18 13.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.733 -0.84 . . . . 72.150000000000006 108.733 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 p -63.75 -23.13 67.24 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 123.689 0.795 . . . . 72.430000000000007 112.469 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 m -67.84 -28.86 67.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.218 -0.447 . . . . 71.239999999999995 110.357 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -110.43 -8.24 14.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.834 -0.346 . . . . 75.430000000000007 110.347 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.07 27.2 14.57 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.648 0.779 . . . . 74.430000000000007 113.011 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.45 153.72 41.55 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.608 -0.723 . . . . 71.329999999999998 109.949 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.22 -168.73 32.47 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.608 -1.397 . . . . 54.229999999999997 109.608 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 57.5 m-85 -135.65 164.18 28.44 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.216 0.531 . . . . 74.010000000000005 111.597 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.8 mt -144.67 135.23 20.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 114.799 -1.091 . . . . 54.039999999999999 108.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.5 146.35 33.32 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.634 -1.987 . . . . 71.5 105.634 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 3.4 pt20 -72.17 144.81 48.43 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 117.809 -1.556 . . . . 61.119999999999997 109.398 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.81 -25.56 19.99 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.406 -1.27 . . . . 74.420000000000002 111.001 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.26 3.27 13.31 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.486 -0.779 . . . . 64.310000000000002 112.233 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.85 51.59 3.56 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.184 -1.007 . . . . 72.430000000000007 112.204 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -89.27 -143.5 9.84 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.349 -0.929 . . . . 45.219999999999999 113.098 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.38 164.16 13.32 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 110.259 -0.274 . . . . 73.349999999999994 110.259 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -101.25 112.53 25.05 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.712 -0.847 . . . . 63.009999999999998 108.712 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -119.38 138.48 49.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.865 -0.791 . . . . 72.040000000000006 108.865 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.2 p90 -90.55 148.16 22.89 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.196 -1.002 . . . . 62.420000000000002 110.44 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 67' ' ' LEU . 11.7 p -113.98 142.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 109.078 -0.712 . . . . 74.430000000000007 109.078 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -130.12 160.14 34.65 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.426 -0.953 . . . . 74.400000000000006 108.426 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.2 -14.73 62.35 Favored 'General case' 0 C--O 1.197 -1.696 0 N-CA-C 111.802 0.297 . . . . 73.019999999999996 111.802 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -53.38 -33.32 53.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.702 0.286 . . . . 61.43 110.454 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -37.81 62.29 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.848 0.356 . . . . 63.140000000000001 110.894 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.23 -35.0 69.46 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 N-CA-C 108.205 -1.035 . . . . 74.430000000000007 108.205 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.2 -35.37 80.85 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.468 -0.787 . . . . 74.099999999999994 110.725 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.49 -49.09 12.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.247 0.462 . . . . 64.420000000000002 112.247 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.73 -23.27 19.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.492 0.923 . . . . 72.0 113.492 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.93 62.58 3.51 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 111.59 -0.604 . . . . 53.210000000000001 111.59 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.8 148.06 24.86 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.906 -1.516 . . . . 65.099999999999994 106.906 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -68.42 -60.85 2.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.208 0.458 . . . . 73.439999999999998 111.9 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.8 p -163.11 165.22 24.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.023 -0.362 . . . . 74.25 110.023 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.28 137.28 52.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.901 -0.778 . . . . 73.430000000000007 108.901 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.64 145.43 22.47 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.065 -0.97 . . . . 70.319999999999993 110.051 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -54.87 131.33 44.01 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 124.201 1.0 . . . . 73.019999999999996 109.893 -177.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.28 -26.1 8.38 Favored Glycine 0 C--N 1.301 -1.369 0 CA-C-N 115.486 -0.779 . . . . 63.530000000000001 111.653 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -80.69 117.51 21.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.676 0.991 . . . . 70.239999999999995 113.676 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.3 m-20 -70.4 132.19 45.23 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.431 -1.692 . . . . 73.200000000000003 106.431 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -133.26 146.6 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 CA-C-O 121.951 0.882 . . . . 74.140000000000001 110.981 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.6 mt -111.68 126.6 69.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 107.027 -1.472 . . . . 60.009999999999998 107.027 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' HB3' HD23 ' A' ' 67' ' ' LEU . 41.9 p90 -147.83 178.42 8.51 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.808 -0.357 . . . . 61.130000000000003 110.634 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -115.12 162.0 17.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.341 -2.096 . . . . 65.409999999999997 105.341 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 62' ' ' ALA . 16.4 tp -130.69 128.37 40.75 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.948 0.88 . . . . 72.120000000000005 112.841 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 44.0 mt-10 -116.9 146.48 42.92 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.395 -1.73 . . . . 75.409999999999997 108.55 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.63 137.3 33.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.277 0.561 . . . . 63.130000000000003 111.873 -172.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -116.94 74.25 0.9 Allowed 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.585 -0.894 . . . . 72.510000000000005 108.585 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 65.58 -72.28 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.931 1.292 . . . . 72.409999999999997 111.838 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 -1.38 4.79 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.062 -0.815 . . . . 70.140000000000001 111.062 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 7.3 mmpt? -104.12 164.97 11.35 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.059 -0.719 . . . . 71.109999999999999 109.059 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -129.23 127.22 40.81 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.463 -0.569 . . . . 75.0 109.463 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.9 p90 -122.58 128.7 51.05 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.699 0.761 . . . . 73.420000000000002 112.831 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.83 130.98 37.34 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.382 -1.281 . . . . 74.510000000000005 110.218 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.9 m -135.36 168.77 22.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.938 -1.028 . . . . 61.0 108.871 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 57.7 t30 53.18 63.92 2.05 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.724 0.64 . . . . 61.119999999999997 111.138 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 44.5 mt -82.47 146.79 29.08 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.538 0.685 . . . . 73.310000000000002 112.528 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -148.77 130.72 15.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.016 -2.216 . . . . 75.310000000000002 105.016 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.82 148.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.176 -1.01 . . . . 74.299999999999997 112.784 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.34 -0.845 . . . . 73.109999999999999 109.769 172.507 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.404 0.621 . . . . 75.030000000000001 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -162.79 136.59 6.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.473 -0.936 . . . . 61.25 108.473 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -129.56 153.73 47.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.267 0.469 . . . . 50.5 112.267 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 m120 58.07 42.04 23.1 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.985 0.914 . . . . 73.439999999999998 110.739 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 42.1 mt -75.68 150.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.428 -0.806 . . . . 63.109999999999999 112.14 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.8 t -96.43 138.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-N 114.854 -1.067 . . . . 70.439999999999998 109.777 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.71 171.01 43.94 Favored Glycine 0 N--CA 1.403 -3.524 0 C-N-CA 120.808 -0.71 . . . . 73.030000000000001 112.555 168.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -119.5 143.61 47.46 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.742 -0.836 . . . . 71.140000000000001 108.742 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.7 107.77 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.429 -0.952 . . . . 70.319999999999993 108.429 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 64.5 tttp -69.18 -43.07 74.96 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.823 -1.08 . . . . 74.230000000000004 108.57 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -171.85 155.34 3.84 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 114.729 -1.123 . . . . 72.319999999999993 108.346 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -159.99 121.77 3.24 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.624 0.577 . . . . 72.540000000000006 109.557 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -111.21 108.34 17.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.866 -0.42 . . . . 75.409999999999997 109.866 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 p -58.23 -23.64 56.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.215 -0.902 . . . . 45.100000000000001 112.709 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 m -57.46 -36.16 71.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.872 0.469 . . . . 72.349999999999994 110.941 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -114.73 -9.05 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.346 -0.542 . . . . 75.230000000000004 110.346 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 63.52 25.04 14.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.774 0.83 . . . . 73.099999999999994 111.837 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.41 158.34 23.67 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 116.035 -0.53 . . . . 73.409999999999997 109.966 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.51 -167.69 38.87 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.355 -1.098 . . . . 74.030000000000001 110.355 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -134.67 168.69 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.17 0.51 . . . . 73.25 110.981 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.465 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 66.4 mt -140.69 138.69 35.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.3 -0.863 . . . . 64.329999999999998 108.672 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' OE2' ' HG3' ' A' ' 10' ' ' LYS . 11.7 pt-20 -143.03 141.7 31.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.829 -1.545 . . . . 70.329999999999998 106.829 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -83.8 151.17 25.32 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 117.603 -1.639 . . . . 71.430000000000007 108.835 173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.27 -19.75 48.58 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 123.95 0.782 . . . . 72.430000000000007 111.926 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.16 1.14 51.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.157 -0.474 . . . . 70.430000000000007 111.872 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 45.88 1.13 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.579 -1.295 . . . . 65.010000000000005 112.569 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.69 154.67 36.3 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.888 -1.285 . . . . 63.240000000000002 109.888 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.77 169.69 14.95 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.788 0.662 . . . . 51.409999999999997 112.788 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' HE2' ' A' ' 10' ' ' LYS . 3.1 m-20 -70.87 90.44 0.8 Allowed 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.233 -0.894 . . . . 72.239999999999995 112.619 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 55' ' ' LEU . 5.7 p -105.34 123.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.309 -0.997 . . . . 73.340000000000003 108.309 173.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 48.5 p90 -83.5 141.94 31.27 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.058 0.456 . . . . 74.310000000000002 111.539 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 8.9 p -97.96 130.46 46.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.671 -0.695 . . . . 73.510000000000005 109.624 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -109.36 148.41 31.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.557 -0.905 . . . . 75.349999999999994 108.557 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -57.54 -30.14 64.96 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 114.075 1.139 . . . . 64.409999999999997 114.075 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -54.44 -27.8 39.77 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.998 0.363 . . . . 74.129999999999995 111.325 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.26 -39.52 62.95 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.013 0.435 . . . . 54.210000000000001 109.959 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 42' ' ' LEU . 79.1 t -61.97 -50.65 79.23 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.889 0 N-CA-C 108.217 -1.031 . . . . 71.230000000000004 108.217 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.84 -22.63 67.03 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.178 0.924 . . . . 74.450000000000003 111.935 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.66 72.48 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.245 0.545 . . . . 75.519999999999996 110.741 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.89 -13.92 10.68 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.528 -0.76 . . . . 71.340000000000003 110.115 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.28 55.18 22.63 Favored Glycine 0 CA--C 1.486 -1.778 0 N-CA-C 109.743 -1.343 . . . . 51.43 109.743 -173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -64.18 125.99 26.3 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.592 -1.633 . . . . 72.519999999999996 106.592 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -73.81 -34.45 64.61 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 114.042 1.127 . . . . 75.010000000000005 114.042 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -161.4 143.68 12.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.873 0.368 . . . . 70.129999999999995 111.218 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.54 144.5 37.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.544 -0.753 . . . . 65.239999999999995 109.038 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.18 171.29 20.48 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.533 -1.284 . . . . 74.109999999999999 107.533 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 133.4 51.23 Favored 'General case' 0 N--CA 1.417 -2.095 0 C-N-CA 123.875 0.87 . . . . 75.109999999999999 110.096 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.44 -32.84 5.54 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.615 -0.721 . . . . 41.43 113.51 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -64.0 126.74 28.64 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.741 1.015 . . . . 62.240000000000002 113.741 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.79 133.38 43.25 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 106.389 -1.708 . . . . 72.409999999999997 106.389 169.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 141.44 38.89 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 CA-C-O 122.125 0.964 . . . . 54.539999999999999 110.25 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 54.3 mt -114.92 124.18 71.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 N-CA-C 106.27 -1.752 . . . . 71.109999999999999 106.27 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.36 179.39 7.12 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.609 -0.437 . . . . 74.319999999999993 111.497 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -117.42 158.8 23.84 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 105.649 -1.982 . . . . 64.140000000000001 105.649 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 62' ' ' ALA . 17.2 tp -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 121.864 0.84 . . . . 74.340000000000003 112.577 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.21 157.28 30.59 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.674 -1.603 . . . . 75.329999999999998 108.755 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -100.19 155.22 17.87 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-O 122.082 0.944 . . . . 73.319999999999993 112.9 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.8 tptt -118.78 85.1 2.3 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.308 -1.738 . . . . 75.409999999999997 106.308 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 65.8 -76.04 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.063 0.852 . . . . 75.129999999999995 109.483 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.28 -4.69 3.17 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.378 -0.689 . . . . 70.239999999999995 111.378 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 55.3 mtpt -89.06 165.7 14.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 122.807 0.443 . . . . 60.140000000000001 110.934 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.55 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.97 123.16 40.28 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.757 0.28 . . . . 72.5 111.757 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 41.0 p90 -125.65 132.94 52.36 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.364 0.602 . . . . 73.420000000000002 111.695 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.45 134.99 37.29 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.038 -0.983 . . . . 41.039999999999999 110.446 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.3 m -137.65 165.92 25.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.205 -0.907 . . . . 61.109999999999999 108.864 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.52 64.07 1.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.648 0.593 . . . . 51.039999999999999 111.383 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 32' ' ' VAL . 24.7 mt -80.2 142.67 34.47 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.463 -0.895 . . . . 72.420000000000002 112.443 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 23.0 tpp180 -138.79 131.56 29.22 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.151 -1.796 . . . . 73.439999999999998 106.151 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.34 1.8 pp -90.59 96.56 6.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 116.065 1.876 . . . . 40.399999999999999 116.065 -177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.6 tttp . . . . . 0 C--O 1.259 1.585 0 C-N-CA 125.703 1.601 . . . . 52.240000000000002 113.744 173.762 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 122.168 0.985 . . . . 64.099999999999994 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.87 18.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.582 -2.007 . . . . 64.409999999999997 105.582 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.3 p -108.84 148.98 29.77 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.242 0.83 . . . . 53.32 113.242 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 52.48 76.16 0.2 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.36 -1.291 . . . . 72.299999999999997 112.111 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 36.6 mt -102.76 143.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.653 -1.158 . . . . 74.450000000000003 110.182 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 58.8 t -91.47 133.55 32.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.018 -0.992 . . . . 55.149999999999999 109.522 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.85 172.26 38.84 Favored Glycine 0 N--CA 1.396 -3.984 0 CA-C-N 115.45 -0.795 . . . . 73.349999999999994 112.166 171.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.7 ttmt -123.53 143.06 50.43 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.373 -0.973 . . . . 73.519999999999996 108.373 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.84 111.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 108.39 -0.967 . . . . 71.129999999999995 108.39 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.1 tttp -76.99 -40.57 46.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.549 -1.205 . . . . 72.319999999999993 108.786 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.404 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 68.5 p-90 -177.65 160.58 1.58 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 124.265 1.026 . . . . 75.239999999999995 109.1 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -155.35 134.61 12.36 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.007 0.432 . . . . 73.450000000000003 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -121.71 106.05 10.97 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.757 -0.656 . . . . 72.349999999999994 109.386 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.4 p -61.04 -32.62 72.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.612 -0.722 . . . . 73.329999999999998 112.439 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.0 m -61.88 -28.71 69.7 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.988 0.423 . . . . 64.400000000000006 110.686 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.21 -9.0 18.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.43 -0.508 . . . . 75.409999999999997 111.812 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 63.76 25.99 14.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 120.924 0.392 . . . . 75.230000000000004 110.077 -176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -137.64 165.87 25.31 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.4 0.68 . . . . 62.43 112.318 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.53 44.38 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.507 -1.837 . . . . 53.310000000000002 108.507 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 39.0 m-85 -133.19 160.24 37.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 117.465 0.633 . . . . 74.120000000000005 111.534 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -145.47 130.11 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.092 -0.958 . . . . 72.310000000000002 108.465 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.88 149.65 37.23 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.363 -1.717 . . . . 74.310000000000002 106.363 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -74.87 146.85 41.58 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 117.708 -1.597 . . . . 72.310000000000002 109.24 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.47 -21.09 35.09 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.292 -1.322 . . . . 72.299999999999997 111.0 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.69 5.26 11.55 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.124 -0.944 . . . . 75.099999999999994 111.14 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.54 50.39 2.75 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 111.529 -0.629 . . . . 50.549999999999997 111.529 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.33 172.47 54.62 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.477 -0.868 . . . . 73.209999999999994 112.498 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.75 151.99 43.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.149 -0.525 . . . . 72.349999999999994 110.447 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.26 116.71 20.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.081 0.943 . . . . 74.030000000000001 111.144 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 55' ' ' LEU . 2.5 p -133.17 133.48 58.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.722 -1.127 . . . . 74.5 108.776 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 52.9 p90 -88.91 152.32 21.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 120.251 -0.58 . . . . 64.219999999999999 111.331 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -109.34 128.04 65.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.516 0.674 . . . . 74.430000000000007 109.409 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -109.63 156.73 19.84 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.396 -0.965 . . . . 74.319999999999993 108.396 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -22.48 65.99 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 113.265 0.839 . . . . 74.299999999999997 113.265 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -55.86 -27.41 51.52 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.988 0.423 . . . . 73.030000000000001 110.575 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -76.48 -34.14 58.66 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.912 0.387 . . . . 64.019999999999996 110.169 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 -47.85 78.91 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.625 0 N-CA-C 107.917 -1.142 . . . . 71.129999999999995 107.917 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.24 -22.79 67.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.68 0.622 . . . . 62.530000000000001 112.68 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.19 69.44 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.825 0.305 . . . . 71.040000000000006 111.825 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -21.78 2.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.286 0.565 . . . . 73.109999999999999 112.429 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.85 51.91 5.23 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.483 -1.047 . . . . 43.039999999999999 110.483 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.94 129.19 38.92 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.58 -1.267 . . . . 65.530000000000001 107.58 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -62.44 -39.04 92.05 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.68 0.622 . . . . 65.549999999999997 112.68 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.5 t -171.06 156.56 4.86 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 110.096 -0.335 . . . . 73.310000000000002 110.096 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.4 mt -135.72 132.28 36.68 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.215 -0.661 . . . . 72.439999999999998 109.215 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.88 160.78 34.03 Favored 'General case' 0 C--N 1.266 -3.039 0 C-N-CA 125.547 1.539 . . . . 73.420000000000002 107.023 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 155.12 37.09 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.368 0.877 . . . . 70.109999999999999 113.368 -172.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.37 -19.97 48.85 Favored Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.815 -1.084 . . . . 73.099999999999994 112.02 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -89.4 132.29 35.06 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 122.557 0.343 . . . . 74.129999999999995 111.422 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.6 m-20 -87.32 138.62 31.33 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.465 -0.939 . . . . 75.219999999999999 108.465 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.77 149.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-O 121.807 0.813 . . . . 60.310000000000002 110.893 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 63.2 mt -111.72 135.79 49.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 106.482 -1.673 . . . . 51.039999999999999 106.482 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.52 178.4 8.65 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.8 -0.36 . . . . 75.120000000000005 110.161 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -119.81 154.54 34.12 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 105.077 -2.194 . . . . 74.549999999999997 105.077 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 30' ' ' VAL . 27.4 tp -121.07 130.69 53.87 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 113.324 0.861 . . . . 54.229999999999997 113.324 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -124.6 150.16 46.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.481 -1.69 . . . . 75.319999999999993 111.131 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -100.83 127.09 47.43 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.068 -0.969 . . . . 73.409999999999997 110.251 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.1 tptp -93.76 28.76 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.396 1.078 . . . . 73.5 108.543 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.84 90.86 0.08 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.7 -1.136 . . . . 74.200000000000003 107.981 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.37 -44.78 2.61 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.401 -0.818 . . . . 51.5 111.741 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.7 mmmt -95.95 153.07 17.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.975 -0.38 . . . . 62.009999999999998 109.975 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -126.24 122.6 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.797 -0.446 . . . . 63.030000000000001 109.797 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.7 p90 -130.84 140.31 50.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 111.963 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.34 136.33 44.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.435 -1.257 . . . . 31.140000000000001 109.812 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 m -136.9 163.02 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.362 -0.835 . . . . 63.130000000000003 109.708 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.72 63.56 1.91 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.012 0.82 . . . . 72.140000000000001 111.034 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 32' ' ' VAL . 28.7 mt -75.59 149.56 38.25 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.715 -0.794 . . . . 72.439999999999998 112.336 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 20.1 tpp180 -148.89 130.97 15.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.256 -1.387 . . . . 73.409999999999997 107.256 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.757 ' H ' HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -74.73 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 118.2 0.455 . . . . 62.130000000000003 111.441 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.177 -0.919 . . . . 73.040000000000006 109.83 177.104 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 25.8 ttt . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.426 0.155 . . . . 74.219999999999999 111.031 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -96.5 119.67 35.41 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.351 -0.611 . . . . 51.0 109.351 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -95.87 140.51 30.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.675 0.61 . . . . 75.129999999999995 112.411 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 49.51 72.15 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.819 1.044 . . . . 71.129999999999995 113.819 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 57.0 mt -92.66 151.13 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.146 -0.934 . . . . 72.150000000000006 110.081 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 55.9 t -92.28 139.35 18.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.509 -0.768 . . . . 61.350000000000001 110.377 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -174.42 179.13 45.95 Favored Glycine 1 N--CA 1.395 -4.039 0 CA-C-N 115.274 -0.875 . . . . 61.229999999999997 112.239 169.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 37.5 ttmt -132.69 142.76 49.22 Favored 'General case' 0 C--N 1.259 -3.339 0 C-N-CA 124.017 0.927 . . . . 72.329999999999998 108.713 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.36 109.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.667 0.746 . . . . 51.409999999999997 109.072 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 22' ' ' GLU . 59.5 tttp -68.38 -40.73 81.28 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.495 1.518 . . . . 73.219999999999999 108.613 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 69.7 p-90 -177.76 160.51 1.53 Allowed 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.267 1.427 . . . . 75.319999999999993 108.504 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -161.25 133.6 5.96 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.227 0.33 . . . . 73.319999999999993 110.227 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -122.29 103.94 9.09 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.629 -0.714 . . . . 51.329999999999998 109.368 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -57.11 -32.25 66.12 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.294 -0.866 . . . . 62.240000000000002 112.504 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.8 m -60.75 -34.64 74.74 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 112.126 0.417 . . . . 72.530000000000001 112.126 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -101.05 -7.01 23.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.522 -0.471 . . . . 51.520000000000003 111.009 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.9 m120 66.93 21.45 10.35 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.243 1.017 . . . . 73.010000000000005 110.765 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -125.47 152.0 45.52 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.517 0.675 . . . . 61.409999999999997 112.398 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.99 -175.62 38.49 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.528 -1.429 . . . . 41.229999999999997 109.528 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 m-85 -131.45 165.16 24.14 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 117.05 0.425 . . . . 74.319999999999993 110.751 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 65.8 mt -139.44 139.22 39.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.781 -0.822 . . . . 61.100000000000001 108.781 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.2 pt-20 -143.1 144.38 32.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.542 -1.651 . . . . 71.200000000000003 106.542 175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.2 pt20 -84.49 151.91 24.3 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 117.451 -1.7 . . . . 73.439999999999998 109.633 174.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.91 -18.54 23.76 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.925 -1.034 . . . . 62.329999999999998 111.648 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -87.13 -0.93 57.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 73.340000000000003 111.41 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.14 51.02 1.1 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.689 -1.243 . . . . 71.340000000000003 112.782 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.47 150.08 26.67 Favored Glycine 0 C--N 1.318 -0.46 0 C-N-CA 119.948 -1.12 . . . . 75.200000000000003 110.819 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -66.91 171.99 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.572 0.952 . . . . 75.129999999999995 113.572 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.01 99.11 2.65 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.915 -0.584 . . . . 72.0 111.781 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 55' ' ' LEU . 7.1 p -117.71 129.45 74.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.028 -0.73 . . . . 72.430000000000007 109.028 174.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.6 p90 -92.44 142.5 27.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.092 -0.643 . . . . 74.400000000000006 111.345 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.47 122.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-O 121.589 0.709 . . . . 71.349999999999994 109.747 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.19 140.76 31.2 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -76.3 -11.42 59.9 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.917 1.08 . . . . 65.409999999999997 113.917 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -61.59 -21.79 64.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 120.623 -0.431 . . . . 65.239999999999995 109.846 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -71.99 -40.17 68.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.808 0.337 . . . . 34.420000000000002 110.197 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.35 -35.53 73.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.085 0 N-CA-C 108.007 -1.109 . . . . 74.109999999999999 108.007 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -66.28 -30.5 70.94 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.747 -0.66 . . . . 74.450000000000003 111.06 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.79 77.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.617 0.599 . . . . 64.319999999999993 112.617 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 -9.18 6.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.178 0.807 . . . . 75.439999999999998 113.178 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.99 57.71 7.47 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.49 -1.044 . . . . 54.240000000000002 110.49 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.38 131.28 46.78 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.309 -1.367 . . . . 75.329999999999998 107.309 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -50.83 -58.85 4.93 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.65 0.982 . . . . 64.0 113.65 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 p -170.62 147.25 2.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.199 0.444 . . . . 74.5 112.199 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -124.83 148.92 47.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.304 0.573 . . . . 72.340000000000003 110.109 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -166.69 162.13 16.14 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.226 -2.138 . . . . 61.240000000000002 105.226 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -69.1 149.94 48.14 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.907 -0.717 . . . . 61.32 111.295 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.77 -15.36 63.25 Favored Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.334 -0.848 . . . . 73.319999999999993 112.095 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -83.02 121.16 26.65 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 122.556 0.343 . . . . 64.0 111.476 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 m-20 -72.28 135.21 45.92 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.729 -1.212 . . . . 75.25 107.729 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.49 147.33 19.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 121.968 0.889 . . . . 62.399999999999999 111.514 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 60.0 mt -110.67 133.66 55.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 N-CA-C 107.073 -1.455 . . . . 74.120000000000005 107.073 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.1 p90 -148.14 174.78 11.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.187 0.518 . . . . 73.209999999999994 111.405 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.8 146.09 39.45 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.025 -1.472 . . . . 45.420000000000002 107.025 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 56' ' ' GLU . 25.1 tp -129.13 136.9 50.81 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.646 0.736 . . . . 62.310000000000002 111.585 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 55' ' ' LEU . 30.6 tt0 -153.15 143.98 22.82 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.473 -2.047 . . . . 71.299999999999997 105.473 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -85.67 140.65 30.37 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.892 1.071 . . . . 74.340000000000003 113.892 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 84.9 tttt -95.18 80.28 3.57 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.068 -1.827 . . . . 72.409999999999997 106.068 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 64.62 -81.6 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.252 1.021 . . . . 71.450000000000003 110.452 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.33 -6.83 7.96 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.364 -0.694 . . . . 74.120000000000005 111.364 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 9.5 mmpt? -92.49 164.79 13.33 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.293 -0.632 . . . . 71.209999999999994 109.293 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.13 118.53 24.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.774 -0.454 . . . . 62.520000000000003 109.774 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.2 p90 -126.78 136.03 51.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.375 0.607 . . . . 64.400000000000006 112.271 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 132.5 35.2 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.605 -1.18 . . . . 64.420000000000002 110.738 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 m -136.59 177.11 6.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 CA-C-N 115.167 -0.924 . . . . 72.519999999999996 109.337 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.25 63.16 2.35 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.92 0.762 . . . . 74.109999999999999 110.328 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 45.1 mt -81.93 147.46 29.25 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.319 0.859 . . . . 74.140000000000001 113.319 -174.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 22.7 tpp180 -151.33 130.64 12.82 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.315 -2.106 . . . . 73.120000000000005 105.315 175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -93.78 145.9 7.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 113.239 0.829 . . . . 75.530000000000001 113.239 -177.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 58.2 mtpt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 114.986 -1.006 . . . . 72.129999999999995 108.672 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 108.589 -0.893 . . . . 73.230000000000004 108.589 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.02 89.67 3.06 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.498 0.925 . . . . 71.25 113.498 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.0 p -141.01 140.95 34.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.478 -1.304 . . . . 72.129999999999995 107.478 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 58.81 74.2 0.45 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 106.833 -1.543 . . . . 65.099999999999994 106.833 -168.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.2 mt -101.47 147.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 113.852 -1.522 . . . . 63.0 111.65 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.4 t -91.27 140.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.502 -1.227 . . . . 72.120000000000005 109.384 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -179.91 161.08 26.59 Favored Glycine 0 N--CA 1.414 -2.785 0 C-N-CA 120.232 -0.985 . . . . 34.0 113.416 167.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 4.8 ttmp? -106.44 139.98 40.07 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.561 -0.903 . . . . 71.530000000000001 108.561 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.54 109.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.483 -0.932 . . . . 64.319999999999993 108.483 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 21' ' ' ILE . 55.2 tttp -67.59 -42.31 82.67 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.592 -1.64 . . . . 74.230000000000004 108.471 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -176.04 160.93 2.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 124.891 1.277 . . . . 71.019999999999996 107.783 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 81.3 t80 -163.35 131.97 3.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.043 0.449 . . . . 75.040000000000006 110.777 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -112.46 105.01 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.045 -1.094 . . . . 73.400000000000006 108.045 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.0 p -61.94 -36.2 80.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.951 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.6 m -63.51 -34.23 77.32 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.843 -0.617 . . . . 71.310000000000002 110.812 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 96.6 mttt -93.62 -8.13 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 62.200000000000003 111.052 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 67.07 23.61 9.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.943 0.897 . . . . 61.310000000000002 112.51 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 46.5 p90 -153.19 168.18 26.84 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 112.883 0.697 . . . . 74.030000000000001 112.883 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -177.66 -154.84 12.78 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 109.923 -1.271 . . . . 71.510000000000005 109.923 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.489 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 35.4 m-85 -140.03 169.48 17.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.513 0.656 . . . . 73.450000000000003 111.24 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 62.9 mt -145.27 140.38 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.163 -1.051 . . . . 73.409999999999997 108.163 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.1 139.68 30.55 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.013 -1.477 . . . . 63.329999999999998 107.013 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.5 pt20 -84.41 146.5 27.63 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 117.765 -1.574 . . . . 74.099999999999994 109.05 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.09 -13.98 20.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 124.632 1.208 . . . . 72.310000000000002 110.627 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 81.4 m-20 -87.34 -5.11 59.02 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.772 -0.649 . . . . 73.329999999999998 110.592 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.98 0.67 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 118.324 -1.893 . . . . 74.430000000000007 113.681 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.2 146.37 19.61 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 119.838 -1.172 . . . . 74.109999999999999 110.428 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.66 -175.86 4.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.293 0.849 . . . . 70.209999999999994 113.293 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.89 99.11 1.01 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.692 -0.685 . . . . 75.140000000000001 111.878 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.33 123.21 59.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.361 -0.978 . . . . 71.400000000000006 108.361 173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.5 p90 -92.41 147.49 22.87 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 119.559 -0.856 . . . . 64.019999999999996 111.16 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -104.0 124.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 109.06 -0.719 . . . . 61.409999999999997 109.06 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -108.71 149.92 28.31 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.412 -0.959 . . . . 74.329999999999998 108.412 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.19 -22.64 61.31 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 113.502 0.927 . . . . 64.349999999999994 113.502 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.2 m -56.32 -23.38 36.64 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 120.388 -0.525 . . . . 74.030000000000001 111.102 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -77.92 -36.22 49.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.871 -0.418 . . . . 74.340000000000003 109.871 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 42' ' ' LEU . 60.8 t -61.9 -49.8 82.73 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.868 0 N-CA-C 107.416 -1.327 . . . . 75.310000000000002 107.416 172.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.93 -33.03 68.38 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.435 1.084 . . . . 72.530000000000001 111.73 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -30.12 68.84 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.998 0.427 . . . . 61.100000000000001 112.135 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.74 0.08 4.87 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.601 -0.44 . . . . 54.200000000000003 111.706 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.05 55.52 27.72 Favored Glycine 0 C--N 1.313 -0.746 0 N-CA-C 110.434 -1.066 . . . . 63.420000000000002 110.434 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -64.94 137.5 57.78 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.728 -1.582 . . . . 63.299999999999997 106.728 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -61.88 -61.14 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.895 0.331 . . . . 72.329999999999998 111.895 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -159.88 151.42 19.92 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.778 -0.453 . . . . 74.329999999999998 109.778 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 88.2 mt -123.87 146.59 48.3 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.545 -0.539 . . . . 60.350000000000001 109.545 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -160.51 162.12 32.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 106.058 -1.83 . . . . 62.119999999999997 106.058 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -68.35 148.86 50.12 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.744 -0.782 . . . . 72.519999999999996 110.627 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.58 -16.85 60.32 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.492 -0.776 . . . . 75.040000000000006 112.484 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -81.34 128.37 33.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 122.789 -0.242 . . . . 73.230000000000004 110.425 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 26.6 m-20 -88.01 138.56 31.35 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.991 -0.744 . . . . 63.130000000000003 108.991 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.64 154.23 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.712 -0.676 . . . . 62.039999999999999 110.656 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 55.2 mt -119.97 131.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.841 -1.54 . . . . 71.140000000000001 106.841 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 45.5 p90 -144.38 -179.98 6.88 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.795 0.331 . . . . 75.409999999999997 111.426 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -117.37 159.88 22.05 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.674 -1.232 . . . . 64.420000000000002 107.674 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.3 tp -136.79 132.95 35.43 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 121.31 0.576 . . . . 62.32 110.958 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.53 145.39 51.47 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.828 -1.078 . . . . 73.530000000000001 108.156 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.86 112.2 20.91 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.45 0.643 . . . . 62.420000000000002 111.955 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -84.11 85.68 7.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.518 -1.29 . . . . 64.219999999999999 107.518 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 66.85 -71.54 0.1 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.562 1.145 . . . . 71.109999999999999 110.703 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 -6.72 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.654 -0.978 . . . . 21.530000000000001 110.654 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -92.09 165.65 13.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.076 0.55 . . . . 63.350000000000001 109.667 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -133.4 125.59 29.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.332 0.253 . . . . 52.340000000000003 110.627 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -136.46 139.88 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.063 0.459 . . . . 74.340000000000003 110.921 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 136.58 39.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.698 -1.137 . . . . 73.439999999999998 111.282 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.4 m -137.24 165.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.266 -0.879 . . . . 64.510000000000005 109.614 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 56.04 65.21 1.5 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.43 0.692 . . . . 75.209999999999994 111.06 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' VAL . 27.9 mt -78.69 140.73 38.32 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.5 -0.88 . . . . 71.040000000000006 113.115 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.599 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 8.4 mpt_? -127.97 135.73 50.33 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.168 -1.79 . . . . 73.109999999999999 106.168 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -78.69 133.08 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 119.576 -0.85 . . . . 61.25 109.641 172.357 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.532 -0.758 . . . . 72.25 109.219 176.123 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.844 0.354 . . . . 63.140000000000001 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.52 109.98 9.63 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.769 -1.197 . . . . 71.299999999999997 107.769 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -111.58 147.41 35.51 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.219 -0.446 . . . . 51.409999999999997 110.804 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 m120 59.34 75.87 0.38 Allowed 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.13 0.894 . . . . 74.0 110.977 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 23.9 mt -104.33 146.41 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.535 -0.757 . . . . 72.120000000000005 111.134 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.65 134.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.865 -1.061 . . . . 73.219999999999999 109.819 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 23' ' ' GLN . . . 179.09 163.19 29.7 Favored Glycine 0 CA--C 1.454 -3.774 0 C-N-CA 120.325 -0.94 . . . . 65.109999999999999 113.493 168.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.2 ttmt -101.81 142.27 33.39 Favored 'General case' 0 C--N 1.252 -3.644 0 CA-C-N 114.622 -0.789 . . . . 73.420000000000002 109.241 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.1 108.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.358 -0.979 . . . . 73.239999999999995 108.358 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 57.5 tttp -68.07 -38.84 82.88 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.419 -1.264 . . . . 73.310000000000002 108.19 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 177.78 157.5 0.39 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 125.272 1.429 . . . . 75.329999999999998 108.616 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -146.12 119.52 9.02 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.317 0.58 . . . . 63.100000000000001 110.541 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -88.05 107.11 18.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.893 -1.521 . . . . 74.129999999999995 106.893 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -11.88 60.01 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.107 0.41 . . . . 61.32 112.107 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 m -79.52 -46.47 17.33 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.27 -0.641 . . . . 73.150000000000006 109.27 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -97.41 -7.68 31.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.564 0.579 . . . . 71.299999999999997 112.564 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 66.76 27.67 9.18 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.577 0.584 . . . . 70.010000000000005 112.577 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -122.79 157.68 31.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.89 -0.595 . . . . 63.409999999999997 109.594 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.96 29.57 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.794 -1.323 . . . . 64.329999999999998 109.794 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 60.4 m-85 -141.24 167.64 21.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 117.396 0.598 . . . . 75.019999999999996 110.768 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 59.2 mt -145.4 134.16 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.123 -0.695 . . . . 75.209999999999994 109.123 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -144.11 148.54 35.24 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.949 -1.5 . . . . 64.430000000000007 106.949 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.685 ' HB3' ' HA2' ' A' ' 7' ' ' GLY 0.272 0.0 OUTLIER -91.83 158.8 16.12 Favored 'General case' 0 CA--C 1.462 -2.442 0 C-N-CA 115.245 -2.582 . . . . 71.099999999999994 109.849 172.714 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.15 -15.52 5.76 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 124.301 1.001 . . . . 72.140000000000001 113.027 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 82.4 m-20 -84.36 -2.1 56.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.671 -0.24 . . . . 62.310000000000002 111.313 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.22 50.75 0.7 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.871 -0.68 . . . . 61.25 112.8 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.91 52.13 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.494 -0.86 . . . . 72.340000000000003 113.461 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -74.88 -178.63 3.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.142 0.496 . . . . 73.140000000000001 112.223 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.77 101.3 12.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.898 0.38 . . . . 65.129999999999995 110.598 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 55' ' ' LEU . 6.3 p -128.3 123.76 60.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.411 -0.959 . . . . 73.540000000000006 108.411 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 52.6 p90 -87.69 147.14 25.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 120.119 -0.632 . . . . 52.049999999999997 111.661 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 67' ' ' LEU . 9.2 p -109.28 141.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.0 -0.741 . . . . 73.340000000000003 109.0 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -131.66 155.81 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.235 -0.654 . . . . 72.439999999999998 109.235 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -63.47 -18.44 63.77 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 113.151 0.797 . . . . 72.420000000000002 113.151 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -57.97 -27.18 63.22 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 120.961 0.41 . . . . 73.400000000000006 110.639 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -78.63 -35.77 45.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.833 -0.432 . . . . 62.32 109.833 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 42' ' ' LEU . 71.9 t -61.98 -48.38 88.83 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.308 0 N-CA-C 107.715 -1.216 . . . . 41.340000000000003 107.715 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.84 -33.04 66.39 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.303 1.041 . . . . 74.129999999999995 111.241 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.34 68.32 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.112 0.782 . . . . 53.329999999999998 113.112 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.99 -2.49 4.62 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.595 0.591 . . . . 72.420000000000002 112.595 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.6 52.52 50.45 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 123.65 0.643 . . . . 43.539999999999999 112.969 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -67.65 142.86 56.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.328 -1.73 . . . . 70.420000000000002 106.328 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -64.39 -62.42 1.62 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.6 0.593 . . . . 51.229999999999997 112.6 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.9 m -167.54 162.68 14.47 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.116 -1.068 . . . . 75.109999999999999 108.116 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.68 154.73 45.53 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.729 0.776 . . . . 72.430000000000007 112.006 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 174.97 14.6 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.531 -1.655 . . . . 61.520000000000003 106.531 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 157.8 28.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.28 0.562 . . . . 62.509999999999998 112.225 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.64 14.43 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.584 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -74.56 126.43 30.78 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 112.229 0.455 . . . . 44.520000000000003 112.229 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -81.95 134.46 35.38 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.222 -1.399 . . . . 71.209999999999994 107.222 173.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.88 150.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 CA-C-O 121.926 0.87 . . . . 62.520000000000003 110.463 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 78.4 mt -115.28 131.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 N-CA-C 106.888 -1.523 . . . . 73.099999999999994 106.888 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.48 -178.78 6.34 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.49 -0.559 . . . . 75.140000000000001 109.49 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.76 158.63 28.39 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.236 -1.764 . . . . 65.219999999999999 106.236 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 62' ' ' ALA . 26.9 tp -129.19 123.18 31.4 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.287 1.041 . . . . 63.140000000000001 112.744 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.02 143.78 46.9 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.311 -1.768 . . . . 75.299999999999997 107.561 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.41 141.67 28.35 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.766 -0.774 . . . . 74.400000000000006 110.38 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 tpmt? -86.24 -61.32 1.77 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.966 -1.494 . . . . 71.409999999999997 106.966 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 61' ' ' LYS . 6.5 tp-100 170.46 86.21 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.349 -2.093 . . . . 73.420000000000002 105.349 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.74 -29.94 2.61 Favored Glycine 0 C--N 1.307 -1.078 0 N-CA-C 111.089 -0.804 . . . . 62.399999999999999 111.089 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -92.71 144.75 24.99 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.161 -1.052 . . . . 71.200000000000003 108.161 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -128.71 120.24 26.1 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.968 -0.752 . . . . 34.439999999999998 108.968 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 4.2 p90 -129.16 137.12 50.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.381 0.61 . . . . 75.109999999999999 112.472 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.0 129.15 38.7 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.46 -1.245 . . . . 74.439999999999998 110.224 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.7 166.01 29.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.158 -0.928 . . . . 71.329999999999998 109.047 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.77 63.3 2.09 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.871 0.732 . . . . 73.5 110.604 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CG2' ' A' ' 32' ' ' VAL . 21.4 mt -76.4 133.62 39.86 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 119.219 -0.992 . . . . 70.140000000000001 112.898 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -137.71 131.27 31.11 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 113.899 -1.5 . . . . 72.349999999999994 107.858 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.414 ' O ' HD12 ' A' ' 69' ' ' ILE . 2.4 pp -75.3 146.14 9.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.908 -1.117 . . . . 74.409999999999997 110.634 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HZ3' ' HB3' ' A' ' 70' ' ' LYS . 4.2 ttpm? . . . . . 0 C--O 1.259 1.581 0 CA-C-O 118.115 -0.945 . . . . 72.299999999999997 108.873 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 109.923 -0.399 . . . . 73.140000000000001 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.14 98.85 3.46 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.643 -0.873 . . . . 51.329999999999998 108.643 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -111.8 143.31 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.413 -0.812 . . . . 74.409999999999997 112.243 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.1 t30 49.62 75.22 0.17 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.905 1.282 . . . . 74.340000000000003 110.376 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.8 mt -99.43 148.98 5.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.773 -1.103 . . . . 74.540000000000006 111.192 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.3 p -90.35 139.14 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 115.565 -0.743 . . . . 42.439999999999998 109.197 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -164.14 170.49 39.39 Favored Glycine 1 N--CA 1.395 -4.055 0 C-N-CA 120.334 -0.936 . . . . 74.319999999999993 112.102 172.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -126.12 138.48 53.68 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 108.533 -0.914 . . . . 64.230000000000004 108.533 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.03 107.53 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 109.135 -0.691 . . . . 70.340000000000003 109.135 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.504 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 27.2 mtpp -65.71 -46.67 78.1 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.149 -0.932 . . . . 45.149999999999999 109.241 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 58.9 p-90 -172.7 160.1 4.46 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 114.894 -1.048 . . . . 71.430000000000007 108.504 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 90.3 t80 -160.5 108.47 1.61 Allowed 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.264 -1.013 . . . . 75.120000000000005 108.264 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 15' ' ' THR . 19.5 t-20 -84.85 106.19 16.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.82 -0.807 . . . . 73.140000000000001 108.82 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 p -64.42 -17.49 63.84 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.487 0.715 . . . . 72.519999999999996 112.648 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 56.5 m -80.56 -43.5 20.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 120.935 0.398 . . . . 73.400000000000006 110.59 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -96.86 -8.15 31.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.9 0.333 . . . . 43.509999999999998 111.9 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 67.68 24.44 8.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.023 0.929 . . . . 65.439999999999998 112.076 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.51 152.6 49.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 122.099 -0.376 . . . . 74.310000000000002 111.241 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -171.67 -168.63 33.5 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 111.178 -0.769 . . . . 73.439999999999998 111.178 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.504 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 40.4 m-85 -135.52 153.77 51.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.009 0.524 . . . . 61.130000000000003 111.529 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -137.23 134.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.718 -0.845 . . . . 73.329999999999998 108.718 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 12.7 pt-20 -143.63 150.62 39.04 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.222 -1.769 . . . . 73.200000000000003 106.222 173.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.715 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.268 0.5 OUTLIER -70.52 144.65 51.26 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 117.981 -1.488 . . . . 71.040000000000006 111.215 174.144 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.8 -39.39 11.77 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.671 -1.604 . . . . 70.049999999999997 112.686 -172.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.02 -9.4 30.16 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.64 0.776 . . . . 70.0 113.011 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 50.54 2.53 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.702 -0.761 . . . . 74.329999999999998 111.222 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.66 -99.66 0.33 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.083 -0.579 . . . . 75.209999999999994 113.179 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.621 0.248 . . . . 74.329999999999998 110.718 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.62 97.77 10.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.936 -0.575 . . . . 72.420000000000002 109.48 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 55' ' ' LEU . 2.6 p -116.4 139.54 42.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.889 -0.596 . . . . 72.420000000000002 109.549 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 50.1 p90 -88.53 145.19 25.87 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.839 -0.744 . . . . 75.420000000000002 111.334 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -95.4 131.28 42.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.384 -0.598 . . . . 52.020000000000003 109.384 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -107.91 146.87 31.78 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.108 -1.441 . . . . 75.310000000000002 107.108 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -68.14 -17.46 64.36 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.684 0.624 . . . . 70.209999999999994 112.684 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.6 t -54.92 -23.85 20.82 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 116.191 -0.459 . . . . 52.109999999999999 110.381 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.592 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -70.62 -41.68 71.91 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.571 0.224 . . . . 74.140000000000001 111.237 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.29 -41.49 83.76 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.837 0 N-CA-C 108.05 -1.093 . . . . 64.219999999999999 108.05 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.65 -24.38 67.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.947 -0.569 . . . . 71.230000000000004 110.889 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.9 45.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.265 0.839 . . . . 61.0 113.265 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.45 -23.37 2.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.813 0.671 . . . . 55.009999999999998 112.813 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.9 62.58 2.21 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.79 -0.641 . . . . 51.520000000000003 112.088 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 142.69 33.71 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.963 -1.866 . . . . 74.099999999999994 105.963 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -58.96 -59.34 5.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 117.737 0.244 . . . . 74.109999999999999 111.59 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 p -162.35 161.23 27.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.211 -0.663 . . . . 61.219999999999999 109.211 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 74.0 mt -124.02 134.28 53.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.859 -1.163 . . . . 61.030000000000001 107.859 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 150.1 34.3 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.08 -0.964 . . . . 74.450000000000003 108.479 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.5 OUTLIER -63.88 151.02 43.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.156 0.799 . . . . 74.230000000000004 113.156 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 -23.2 36.1 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.668 -1.151 . . . . 74.530000000000001 112.763 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -74.92 136.05 41.42 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 112.506 0.558 . . . . 64.239999999999995 112.506 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -85.97 135.67 33.57 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.665 -1.235 . . . . 53.409999999999997 107.665 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.05 151.58 20.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-O 121.49 0.662 . . . . 61.409999999999997 111.081 -172.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -116.09 134.21 60.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.687 -1.227 . . . . 74.409999999999997 107.687 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.9 p90 -144.86 -178.11 5.86 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.942 -0.392 . . . . 64.409999999999997 109.942 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.36 145.07 49.04 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.818 -1.549 . . . . 64.420000000000002 106.818 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 30' ' ' VAL . 28.3 tp -116.5 109.37 17.18 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 122.374 1.083 . . . . 73.510000000000005 110.578 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -122.06 136.96 54.97 Favored 'General case' 0 C--N 1.258 -3.391 0 N-CA-C 105.07 -2.196 . . . . 74.430000000000007 105.07 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.9 136.9 33.1 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 114.693 1.368 . . . . 73.129999999999995 114.693 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 60.8 tptt -82.47 79.78 8.81 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.774 -1.936 . . . . 71.450000000000003 105.774 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 67.37 -80.0 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.946 0.898 . . . . 65.519999999999996 109.69 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.05 7.3 4.42 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.718 -0.953 . . . . 51.450000000000003 110.718 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -102.45 155.89 17.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.835 -1.543 . . . . 72.040000000000006 106.835 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -117.54 122.05 42.63 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.864 -0.522 . . . . 71.319999999999993 111.107 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -135.53 142.66 45.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.026 0.441 . . . . 73.530000000000001 109.986 178.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.62 33.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.233 -0.894 . . . . 61.100000000000001 109.953 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.592 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.3 m -133.54 169.38 21.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 73.040000000000006 111.019 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 57.2 63.13 1.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.218 0.949 . . . . 54.039999999999999 110.49 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 33.2 mt -81.91 140.29 34.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.299 1.222 . . . . 74.010000000000005 114.299 -172.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -140.28 139.54 35.53 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 125.829 1.651 . . . . 71.040000000000006 106.923 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.42 147.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 117.207 -1.797 . . . . 52.32 110.944 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.254 1.33 0 O-C-N 124.239 0.962 . . . . 71.120000000000005 110.898 179.213 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtm . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.943 -0.762 . . . . 62.340000000000003 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -127.99 134.98 49.3 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.977 -1.12 . . . . 75.219999999999999 107.977 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.5 p -117.14 140.79 49.09 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 111.378 0.14 . . . . 75.319999999999993 111.378 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 60.07 76.26 0.37 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.873 0.844 . . . . 63.32 112.022 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 47.1 mt -106.33 148.45 10.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 114.679 -1.146 . . . . 55.340000000000003 110.099 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.6 p -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 O-C-N 124.06 0.85 . . . . 61.509999999999998 109.794 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -166.47 171.15 41.36 Favored Glycine 1 N--CA 1.396 -4.009 0 C-N-CA 120.393 -0.908 . . . . 71.209999999999994 112.306 170.354 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.9 ttmt -123.89 137.22 54.67 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.123 -1.065 . . . . 74.340000000000003 108.123 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.44 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.366 -0.975 . . . . 73.219999999999999 108.366 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.8 tttp -75.94 -44.58 39.35 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.12 -1.4 . . . . 62.229999999999997 109.386 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -169.54 157.83 7.44 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.632 -0.713 . . . . 74.329999999999998 110.269 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -147.45 133.17 18.91 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.598 -0.728 . . . . 61.539999999999999 109.437 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -106.08 118.0 35.48 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.506 -0.924 . . . . 72.129999999999995 108.506 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 t -68.26 -33.85 75.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.157 -0.474 . . . . 61.240000000000002 111.464 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 m -73.57 -49.29 27.07 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.822 0.344 . . . . 71.430000000000007 111.534 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 64.4 mttp -82.25 -8.26 59.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.198 0.444 . . . . 62.020000000000003 112.198 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 13.4 m120 63.76 22.25 13.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.102 0.778 . . . . 75.409999999999997 113.102 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 42.0 p90 -142.37 174.25 10.79 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.544 -0.863 . . . . 71.109999999999999 110.804 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.63 -155.29 13.62 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.615 -0.994 . . . . 65.120000000000005 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 30.4 m-85 -132.65 163.54 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.404 0.621 . . . . 72.430000000000007 112.023 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.8 mt -145.84 138.51 20.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.105 -1.443 . . . . 73.219999999999999 107.105 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.07 148.64 35.43 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.761 -1.57 . . . . 74.140000000000001 106.761 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.735 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.279 0.2 OUTLIER -72.17 147.58 46.45 Favored 'General case' 0 CA--C 1.47 -2.115 0 C-N-CA 117.464 -1.694 . . . . 63.219999999999999 109.971 172.071 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -49.25 -35.15 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.0 1.438 . . . . 74.439999999999998 112.443 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -70.01 -0.85 8.25 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.458 0.91 . . . . 74.010000000000005 113.458 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 51.52 4.05 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 120.304 -0.95 . . . . 54.299999999999997 111.085 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' OE1' ' A' ' 23' ' ' GLN . . . -75.39 -110.55 0.1 Allowed Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.983 -0.627 . . . . 74.519999999999996 114.369 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.13 174.55 5.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.981 0.42 . . . . 64.420000000000002 112.1 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -102.27 92.87 4.91 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.319 -0.993 . . . . 64.319999999999993 108.319 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 55' ' ' LEU . 5.5 p -116.74 124.45 72.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.633 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.4 p90 -91.19 149.16 21.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.009 -0.541 . . . . 72.030000000000001 110.189 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -107.63 132.39 55.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 109.335 -0.617 . . . . 71.510000000000005 109.335 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -111.93 145.1 40.17 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.077 -1.083 . . . . 71.129999999999995 108.077 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 35.9 ttpt -62.54 -22.96 66.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.16 0.8 . . . . 75.310000000000002 113.16 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -54.17 -24.07 16.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 64.430000000000007 112.144 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.77 -39.25 70.11 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 122.127 -0.358 . . . . 52.100000000000001 110.643 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.56 -36.52 71.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 107.86 -1.163 . . . . 73.340000000000003 107.86 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.38 -29.54 70.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.069 -0.969 . . . . 75.430000000000007 110.87 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.14 -47.7 9.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.584 0.587 . . . . 74.150000000000006 112.584 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -9.87 28.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.019 0.748 . . . . 64.230000000000004 113.019 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.48 55.61 29.06 Favored Glycine 0 CA--C 1.498 -1.022 0 O-C-N 123.459 0.475 . . . . 74.430000000000007 112.224 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.5 tm? -69.49 141.5 53.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.255 -1.017 . . . . 73.400000000000006 108.255 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.518 ' N ' HD13 ' A' ' 42' ' ' LEU . 58.7 t-80 -51.75 -60.67 2.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.867 . . . . 72.329999999999998 112.334 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -172.51 162.43 5.25 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 73.439999999999998 108.616 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -124.82 121.08 33.54 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.852 0.834 . . . . 72.140000000000001 109.657 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.54 144.85 36.14 Favored 'General case' 0 C--N 1.245 -3.95 0 CA-C-N 113.962 -1.472 . . . . 60.409999999999997 108.463 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.65 147.13 53.1 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.605 0.717 . . . . 70.530000000000001 112.253 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.21 -16.9 59.41 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.001 -0.999 . . . . 42.450000000000003 111.891 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -81.28 137.47 35.8 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 122.496 0.318 . . . . 73.010000000000005 110.659 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 9.4 m-20 -88.53 137.48 32.29 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.018 -1.105 . . . . 74.310000000000002 108.018 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.65 149.52 23.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 121.704 0.764 . . . . 73.409999999999997 110.969 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.1 mt -111.75 137.62 43.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.182 -1.784 . . . . 72.329999999999998 106.182 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.09 178.87 9.01 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.708 -0.397 . . . . 75.230000000000004 110.705 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -114.43 160.52 19.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.843 -2.28 . . . . 63.409999999999997 104.843 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 18.7 tp -129.81 127.74 40.91 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 113.593 0.96 . . . . 62.530000000000001 113.593 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 55' ' ' LEU . 47.0 mt-10 -114.08 134.67 54.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.275 -1.784 . . . . 74.510000000000005 107.981 174.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -93.41 134.18 35.91 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.284 0.564 . . . . 72.349999999999994 110.818 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 58.4 tptt -102.29 76.9 1.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.11 -1.441 . . . . 73.319999999999993 107.11 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 67.71 -70.43 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.647 1.179 . . . . 72.430000000000007 110.67 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 -15.56 1.45 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.22 -0.752 . . . . 75.420000000000002 111.22 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 54.7 mtpt -84.43 165.04 18.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.57 -0.53 . . . . 71.150000000000006 109.57 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -127.94 129.47 46.87 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.619 -0.433 . . . . 53.149999999999999 110.499 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.4 p90 -127.65 128.38 45.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 113.167 0.803 . . . . 71.040000000000006 113.167 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.48 133.29 43.62 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.264 -1.335 . . . . 72.140000000000001 110.688 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.64 164.41 30.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.015 -1.106 . . . . 71.340000000000003 108.015 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.71 63.33 2.28 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.733 0.646 . . . . 65.349999999999994 110.959 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 32' ' ' VAL . 38.4 mt -78.46 149.47 33.22 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.775 -0.648 . . . . 64.319999999999993 111.937 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -150.81 131.66 14.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.772 -1.936 . . . . 64.420000000000002 105.772 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 2.6 pp -80.33 140.57 16.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.366 -1.333 . . . . 73.450000000000003 112.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.088 -0.96 . . . . 74.329999999999998 109.214 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.507 -0.675 0 N-CA-C 108.574 -0.899 . . . . 74.019999999999996 108.574 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.9 91.2 3.46 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.576 -0.527 . . . . 72.310000000000002 109.576 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.8 p -115.87 142.56 46.61 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.65 -0.705 . . . . 54.219999999999999 110.983 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 55.35 78.09 0.2 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.035 0.921 . . . . 65.209999999999994 111.334 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.45 147.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 114.154 -1.384 . . . . 64.340000000000003 109.965 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 73.8 t -92.19 134.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 115.223 -0.899 . . . . 54.119999999999997 108.643 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.41 172.73 38.57 Favored Glycine 1 N--CA 1.392 -4.265 0 C-N-CA 120.27 -0.967 . . . . 72.340000000000003 112.154 171.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 27.5 ttpp -130.48 132.67 45.77 Favored 'General case' 0 C--N 1.257 -3.42 0 C-N-CA 125.204 1.402 . . . . 71.109999999999999 108.412 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.8 115.85 2.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.933 -0.576 . . . . 75.120000000000005 110.162 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 66.7 mttm -66.94 -49.43 65.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.413 -0.958 . . . . 73.129999999999995 108.413 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -173.78 165.43 4.42 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.246 -1.343 . . . . 74.230000000000004 108.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 85.5 t80 -153.79 121.25 5.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.4 0.438 . . . . 74.430000000000007 110.368 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -96.36 98.81 10.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.088 0.471 . . . . 71.040000000000006 109.946 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 m -58.93 -35.08 72.51 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.113 -0.949 . . . . 62.310000000000002 111.427 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 m -65.32 -31.12 72.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.236 0.541 . . . . 74.209999999999994 110.525 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -97.98 -9.01 26.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.1 -0.375 . . . . 73.340000000000003 111.997 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.82 23.36 11.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.973 0.509 . . . . 72.099999999999994 112.346 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 37.4 p90 -151.06 161.12 43.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.445 0.64 . . . . 62.32 112.539 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -166.95 -162.27 18.18 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.156 -1.578 . . . . 75.099999999999994 109.156 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 46.9 m-85 -135.71 154.84 51.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.938 0.869 . . . . 75.209999999999994 111.711 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.72 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.224 -0.658 . . . . 74.109999999999999 109.224 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 14.0 pt-20 -143.54 147.65 34.78 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 105.755 -1.942 . . . . 65.310000000000002 105.755 173.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.0 pt20 -80.73 151.3 28.93 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 116.786 -1.966 . . . . 72.010000000000005 109.44 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.74 -29.02 24.76 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.251 -1.34 . . . . 71.340000000000003 111.913 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -75.71 1.08 15.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.775 -0.648 . . . . 73.120000000000005 111.851 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.41 50.87 1.79 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.54 -0.838 . . . . 74.420000000000002 111.207 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.81 172.2 54.96 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.639 -0.791 . . . . 64.120000000000005 112.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.33 162.96 28.59 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.771 0.656 . . . . 50.409999999999997 112.771 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.14 97.67 10.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.398 -0.819 . . . . 45.219999999999999 110.604 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 55' ' ' LEU . 3.2 p -117.81 134.87 60.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.118 -0.947 . . . . 63.520000000000003 109.062 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 54.4 p90 -90.6 150.15 21.83 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.032 -0.667 . . . . 73.530000000000001 111.221 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -110.11 125.46 67.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.583 -0.525 . . . . 43.210000000000001 109.583 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -108.43 152.93 24.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.298 -1.001 . . . . 64.109999999999999 108.298 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.06 -16.04 39.23 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 113.073 0.768 . . . . 74.109999999999999 113.073 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -58.76 -26.42 63.99 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.228 0.537 . . . . 53.439999999999998 110.03 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.94 -36.44 56.56 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.983 0.42 . . . . 71.129999999999995 109.973 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.68 -48.85 84.76 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.091 0 N-CA-C 107.647 -1.242 . . . . 71.129999999999995 107.647 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.37 -28.23 58.55 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 124.816 1.246 . . . . 64.120000000000005 111.292 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.13 -23.32 67.1 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.458 0.54 . . . . 34.310000000000002 112.458 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.44 -24.15 2.29 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.712 0.634 . . . . 70.319999999999993 112.712 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.16 48.74 5.57 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.454 -1.059 . . . . 50.030000000000001 110.454 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 130.37 41.09 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.435 -1.32 . . . . 75.510000000000005 107.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.35 -47.78 75.26 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.128 1.158 . . . . 74.409999999999997 114.128 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.4 p -159.06 160.49 35.85 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.53 -0.468 . . . . 74.430000000000007 111.064 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.11 142.78 48.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.249 -1.019 . . . . 73.0 108.249 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.86 162.77 40.51 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 123.73 0.812 . . . . 71.540000000000006 109.319 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -67.49 153.33 43.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.445 0.641 . . . . 65.010000000000005 112.466 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -16.08 59.27 Favored Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.881 -1.054 . . . . 72.349999999999994 112.198 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -83.84 124.93 31.46 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.244 0.218 . . . . 62.450000000000003 111.122 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 15.4 m-20 -78.33 133.57 37.59 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 107.185 -1.413 . . . . 64.019999999999996 107.185 174.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.74 147.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.138 0 CA-C-O 121.913 0.863 . . . . 62.109999999999999 110.51 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 64.1 mt -109.98 132.28 58.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 N-CA-C 107.002 -1.481 . . . . 73.549999999999997 107.002 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.62 178.67 8.27 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.764 -0.458 . . . . 72.099999999999994 109.764 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -119.67 155.27 32.7 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.671 -1.974 . . . . 72.129999999999995 105.671 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 30' ' ' VAL . 26.3 tp -124.4 111.26 15.55 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.452 1.12 . . . . 75.230000000000004 112.649 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.74 141.51 45.26 Favored 'General case' 0 C--N 1.268 -2.953 0 CA-C-N 113.062 -1.881 . . . . 62.140000000000001 107.425 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -87.06 142.14 28.14 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.276 -0.638 . . . . 74.450000000000003 109.276 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -90.41 22.31 3.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.298 -1.371 . . . . 73.150000000000006 107.298 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 65.09 87.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 75.140000000000001 108.333 -172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.21 -58.41 0.6 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.692 -1.14 . . . . 74.450000000000003 111.24 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.1 mmmt -86.19 154.12 21.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.177 -0.305 . . . . 63.130000000000003 110.177 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.69 118.11 27.33 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.215 0.206 . . . . 70.439999999999998 110.574 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.2 p90 -131.89 140.41 49.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.367 0.603 . . . . 64.040000000000006 111.509 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -71.97 135.14 46.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.675 -1.148 . . . . 64.239999999999995 109.527 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.8 m -133.96 164.71 33.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.364 -0.835 . . . . 62.310000000000002 109.959 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.53 64.23 1.74 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.962 0.789 . . . . 54.32 111.593 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.549 HD11 HG21 ' A' ' 32' ' ' VAL . 28.9 mt -74.67 140.14 44.02 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.671 0.989 . . . . 63.310000000000002 113.671 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 75.5 ttt180 -143.51 131.35 21.5 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.36 -1.718 . . . . 73.129999999999995 106.36 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.9 148.72 4.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.346 -0.942 . . . . 73.340000000000003 111.536 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.556 ' HZ3' ' HB3' ' A' ' 70' ' ' LYS . 3.7 ttpm? . . . . . 0 C--O 1.256 1.412 0 CA-C-O 118.758 -0.639 . . . . 73.230000000000004 109.498 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 108.356 -0.979 . . . . 64.129999999999995 108.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -161.69 117.09 2.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.144 -1.428 . . . . 64.0 107.144 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.5 p -100.43 140.29 34.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 123.357 0.411 . . . . 63.439999999999998 111.812 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 56.5 77.79 0.24 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.774 1.23 . . . . 60.030000000000001 110.701 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 2' ' ' ALA . 30.3 mt -100.42 148.4 6.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 114.627 -1.17 . . . . 50.409999999999997 109.564 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 87.8 t -92.81 132.84 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-N 115.369 -0.832 . . . . 70.329999999999998 109.522 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -161.99 163.93 35.08 Favored Glycine 1 N--CA 1.395 -4.087 0 CA-C-N 115.272 -0.877 . . . . 65.0 111.576 171.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -119.28 136.42 54.24 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.898 -1.149 . . . . 74.019999999999996 107.898 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.83 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.329 0.585 . . . . 75.450000000000003 109.572 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 49.1 tttp -70.18 -47.26 62.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.826 -1.079 . . . . 61.240000000000002 108.109 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.498 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 68.9 p-90 -173.66 165.75 4.52 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.16 0.984 . . . . 63.149999999999999 108.641 175.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.02 132.78 4.31 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.376 0.422 . . . . 74.450000000000003 110.596 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -125.39 107.81 11.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.463 -0.569 . . . . 71.109999999999999 109.463 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 m -57.55 -33.86 68.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.85 -0.614 . . . . 63.109999999999999 110.902 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.9 m -61.44 -33.17 73.28 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 115.951 -0.568 . . . . 73.209999999999994 111.219 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -97.62 -8.72 28.27 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 122.021 -0.424 . . . . 54.43 111.049 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 61.26 21.48 11.97 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.784 0.834 . . . . 71.129999999999995 110.622 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -137.5 163.62 30.68 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.387 0.675 . . . . 73.299999999999997 110.894 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -175.02 -172.55 40.06 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 107.836 -2.106 . . . . 50.229999999999997 107.836 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 21.3 m-85 -136.05 162.93 31.52 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 117.749 0.775 . . . . 75.230000000000004 111.794 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.5 134.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.669 -1.151 . . . . 71.299999999999997 107.924 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.3 pt-20 -135.98 141.79 44.46 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.01 -2.219 . . . . 75.5 105.01 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.596 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -78.53 143.29 36.7 Favored 'General case' 0 CA--C 1.464 -2.353 0 C-N-CA 116.135 -2.226 . . . . 65.329999999999998 108.922 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.63 -18.01 4.02 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.793 1.308 . . . . 61.549999999999997 112.07 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.36 -0.32 28.53 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.603 -0.726 . . . . 73.430000000000007 111.428 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.4 41.91 35.78 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 110.995 -0.842 . . . . 75.340000000000003 110.995 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 -132.35 4.26 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.933 -0.651 . . . . 63.439999999999998 113.371 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -86.64 152.49 22.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.149 0.426 . . . . 71.129999999999995 112.149 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.2 130.25 47.26 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 116.073 -0.512 . . . . 75.25 110.126 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -138.66 143.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.823 -0.806 . . . . 60.210000000000001 108.823 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 51.5 p90 -93.53 148.99 21.58 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.696 -0.802 . . . . 65.409999999999997 111.603 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -105.74 128.85 59.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 CA-C-N 115.75 -0.659 . . . . 52.340000000000003 109.316 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -110.02 150.34 28.68 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.015 -0.735 . . . . 73.299999999999997 109.015 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.7 -18.82 64.39 Favored 'General case' 0 C--O 1.203 -1.395 0 N-CA-C 113.671 0.989 . . . . 71.400000000000006 113.671 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -57.22 -27.5 62.06 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.942 0.401 . . . . 74.519999999999996 110.314 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -75.96 -35.73 59.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 120.986 0.422 . . . . 75.129999999999995 110.38 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.84 -37.77 77.83 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.286 0 N-CA-C 108.292 -1.003 . . . . 73.409999999999997 108.292 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.88 -32.58 73.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.053 0.541 . . . . 70.120000000000005 110.722 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.96 66.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.349999999999994 112.72 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -23.3 2.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.21 0.819 . . . . 61.109999999999999 113.21 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 53.93 3.57 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 109.954 -1.258 . . . . 61.210000000000001 109.954 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -75.58 127.0 32.11 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.89 -0.655 . . . . 35.140000000000001 111.396 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -104.61 -0.4 27.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.816 -0.629 . . . . 72.299999999999997 111.391 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 m -123.32 79.3 1.66 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.151 1.167 . . . . 43.32 114.151 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.16 114.1 19.2 Favored 'General case' 0 C--N 1.251 -3.683 0 N-CA-C 108.108 -1.071 . . . . 60.219999999999999 108.108 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -151.79 158.19 42.97 Favored 'General case' 1 C--N 1.243 -4.035 0 CA-C-N 113.94 -1.482 . . . . 70.549999999999997 107.239 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.12 148.83 49.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.695 0.759 . . . . 74.510000000000005 112.344 -174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.29 -18.61 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 CA-C-N 114.82 -1.082 . . . . 63.240000000000002 113.993 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -71.03 135.05 47.59 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 117.546 0.673 . . . . 52.549999999999997 111.644 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.07 135.11 34.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.426 -1.324 . . . . 73.219999999999999 107.426 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.56 145.28 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-O 121.981 0.896 . . . . 64.319999999999993 110.989 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.99 130.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.483 -1.673 . . . . 73.5 106.483 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.3 p90 -146.62 179.62 7.43 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.153 -0.619 . . . . 73.409999999999997 110.995 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -120.36 158.29 27.45 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 105.532 -2.025 . . . . 64.439999999999998 105.532 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 30' ' ' VAL . 26.1 tp -129.69 129.54 44.36 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.099 1.148 . . . . 74.099999999999994 114.099 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.2 mm-40 -125.63 139.46 53.55 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 113.088 -1.869 . . . . 64.099999999999994 109.567 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.94 142.79 32.68 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.825 -1.08 . . . . 75.310000000000002 111.688 -174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -90.76 31.92 1.02 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.271 -1.011 . . . . 75.319999999999993 108.271 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 62.34 22.72 13.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.197 -0.911 . . . . 52.140000000000001 111.715 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.08 -49.08 0.13 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 109.526 -1.43 . . . . 75.310000000000002 109.526 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -93.01 164.71 13.17 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.338 -0.431 . . . . 72.430000000000007 110.787 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -132.76 119.08 19.84 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.406 -0.59 . . . . 55.520000000000003 109.406 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.489 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 44.0 p90 -124.59 133.28 53.32 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.519 0.676 . . . . 71.400000000000006 112.423 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.19 134.05 42.75 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.631 -1.168 . . . . 33.039999999999999 110.534 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.5 m -133.77 169.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.937 -1.028 . . . . 64.540000000000006 109.517 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 53.77 63.06 2.33 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 123.246 0.619 . . . . 53.310000000000002 111.384 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 32' ' ' VAL . 21.9 mt -82.36 135.77 35.12 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.617 0.723 . . . . 72.030000000000001 112.869 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -145.95 130.13 17.52 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 114.059 -1.428 . . . . 71.030000000000001 107.997 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.759 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -80.69 148.79 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 C-N-CA 121.057 -0.257 . . . . 64.040000000000006 110.717 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 124.387 1.054 . . . . 52.100000000000001 109.152 176.201 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 108.788 -0.819 . . . . 72.239999999999995 108.788 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.64 147.77 45.22 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.094 -0.706 . . . . 73.219999999999999 109.094 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 p -131.54 153.18 50.11 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.246 0.461 . . . . 71.230000000000004 112.246 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 62.68 40.52 10.11 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.022 0.929 . . . . 72.450000000000003 111.633 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 mt -75.25 152.94 6.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.772 -0.649 . . . . 53.229999999999997 111.229 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 85.9 t -106.83 136.75 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 115.3 -0.863 . . . . 75.209999999999994 109.053 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.3 168.73 41.02 Favored Glycine 0 N--CA 1.404 -3.456 0 C-N-CA 119.128 -1.511 . . . . 72.430000000000007 113.77 167.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.2 ttmt -113.72 136.24 53.07 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 114.411 -0.894 . . . . 72.219999999999999 108.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.57 107.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.965 -0.754 . . . . 64.310000000000002 108.965 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -63.81 -52.99 57.72 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.699 -1.137 . . . . 65.540000000000006 109.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 64.4 p-90 -160.64 160.01 31.08 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 108.859 -0.793 . . . . 70.299999999999997 108.859 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -157.61 125.31 5.3 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 124.053 0.845 . . . . 73.099999999999994 109.272 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.08 115.99 31.06 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 61.340000000000003 107.293 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 t -73.0 -25.96 61.17 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.698 0.285 . . . . 54.329999999999998 111.261 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 m -68.55 -55.21 12.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.116 0.484 . . . . 64.0 110.356 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.49 -8.49 52.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.498 . . . . 75.420000000000002 111.709 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 89.3 m-20 64.17 26.17 13.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.194 0.813 . . . . 72.010000000000005 113.194 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.83 157.98 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.869 -0.419 . . . . 72.310000000000002 109.869 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.96 -174.14 45.56 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.135 -0.786 . . . . 54.009999999999998 111.135 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 45.7 m-85 -134.35 159.86 39.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.117 0.567 . . . . 65.329999999999998 111.132 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -143.08 135.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 123.737 0.648 . . . . 73.019999999999996 109.372 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.84 153.27 42.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.133 -1.432 . . . . 65.540000000000006 107.133 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.3 pt20 -84.84 154.69 22.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.382 -1.327 . . . . 63.450000000000003 109.386 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.55 -22.41 61.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.159 0.912 . . . . 62.439999999999998 113.116 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -77.82 -2.96 39.08 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.763 -0.375 . . . . 72.239999999999995 111.771 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.46 51.19 1.23 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 110.256 -1.138 . . . . 61.200000000000003 110.256 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -77.14 164.41 52.73 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.365 -0.921 . . . . 71.329999999999998 112.128 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.71 155.76 40.03 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 123.806 0.357 . . . . 74.329999999999998 111.816 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.09 120.93 25.93 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.83 0.824 . . . . 75.209999999999994 111.567 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -135.9 135.2 50.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.489 -1.232 . . . . 63.5 107.915 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.6 p90 -90.12 150.36 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.43 -0.908 . . . . 70.299999999999997 110.84 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 67' ' ' LEU . 7.3 p -95.29 126.47 47.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-O 121.456 0.646 . . . . 55.530000000000001 109.606 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -113.33 148.0 36.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.731 -0.84 . . . . 71.450000000000003 108.731 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' ASN . 86.8 tttt -64.72 -21.99 66.88 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.664 0.987 . . . . 72.019999999999996 113.664 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -54.19 -22.16 10.74 Favored 'General case' 0 C--O 1.208 -1.09 0 C-N-CA 120.627 -0.429 . . . . 33.030000000000001 111.315 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.21 -42.51 59.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.069 0.461 . . . . 53.420000000000002 110.853 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 57.3 t -70.45 -30.31 42.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.51 0 N-CA-C 108.215 -1.031 . . . . 62.509999999999998 108.215 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.63 -36.12 65.39 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.987 -0.551 . . . . 71.200000000000003 110.036 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.98 24.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.422 0.527 . . . . 73.230000000000004 112.422 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.07 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.43 0.53 . . . . 73.25 112.43 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 77.75 62.96 2.28 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 121.454 -0.403 . . . . 72.340000000000003 112.224 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.83 130.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.817 -1.549 . . . . 64.25 106.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.45 -49.27 78.24 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.525 0.565 . . . . 74.150000000000006 112.525 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -175.09 137.99 0.43 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.097 0.559 . . . . 72.209999999999994 110.918 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.82 164.31 12.69 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.195 0.521 . . . . 71.5 110.62 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -169.49 162.83 10.26 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.257 -1.757 . . . . 63.130000000000003 106.257 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -75.17 152.84 38.4 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.207 0.527 . . . . 54.130000000000003 111.928 -177.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.25 69.81 Favored Glycine 0 C--N 1.306 -1.119 0 CA-C-N 115.386 -0.824 . . . . 72.209999999999994 112.478 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -77.42 136.26 38.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 122.503 0.321 . . . . 73.010000000000005 111.581 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.56 134.19 33.67 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.227 -1.397 . . . . 72.310000000000002 107.227 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.21 147.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-O 121.869 0.842 . . . . 72.230000000000004 110.773 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.03 129.34 71.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 106.41 -1.7 . . . . 73.310000000000002 106.41 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -147.52 -177.53 5.75 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 120.043 -0.663 . . . . 74.129999999999995 110.873 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -124.0 161.81 24.72 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 105.501 -2.037 . . . . 72.400000000000006 105.501 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 30' ' ' VAL . 23.2 tp -130.18 129.83 43.93 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-O 121.899 0.857 . . . . 71.409999999999997 112.946 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.1 137.81 54.83 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.629 -1.623 . . . . 64.420000000000002 107.432 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.79 155.77 18.1 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.118 0.961 . . . . 63.509999999999998 110.308 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.0 tttp -116.88 24.66 11.07 Favored 'General case' 0 C--N 1.252 -3.643 0 N-CA-C 107.094 -1.447 . . . . 73.510000000000005 107.094 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 70.68 -59.99 0.51 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.5 1.52 . . . . 75.329999999999998 111.809 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.52 -23.34 36.96 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.098 -0.801 . . . . 32.140000000000001 111.098 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.1 mmtt -123.03 164.98 17.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.585 0.231 . . . . 64.049999999999997 111.11 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.34 116.42 11.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.192 -1.04 . . . . 64.299999999999997 108.192 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p90 -130.39 137.48 49.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.452 0.644 . . . . 73.200000000000003 112.442 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 137.52 51.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.666 -1.152 . . . . 43.43 110.181 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 29.0 m -135.42 161.6 38.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 65.019999999999996 109.986 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 56.27 63.88 1.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.03 0.831 . . . . 75.030000000000001 109.83 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.625 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 32.6 mt -79.24 137.43 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.968 0.729 . . . . 75.230000000000004 112.968 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.98 135.02 39.19 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-N 114.729 -1.123 . . . . 74.140000000000001 109.119 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -72.41 134.19 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 109.408 -0.589 . . . . 72.430000000000007 109.408 173.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.307 -1.265 0 O-C-N 123.849 0.718 . . . . 64.319999999999993 110.117 179.641 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 120.71 0.29 . . . . 73.120000000000005 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -143.4 116.38 8.85 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.782 -0.822 . . . . 62.530000000000001 108.782 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.2 p -107.68 145.6 33.18 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.624 -0.262 . . . . 73.0 111.079 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 58.37 78.39 0.25 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.46 1.104 . . . . 51.520000000000003 109.78 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 50.7 mt -108.33 149.53 11.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.314 -1.312 . . . . 62.420000000000002 110.245 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 88.5 t -93.26 132.98 35.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.269 -0.878 . . . . 73.310000000000002 109.79 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.58 164.89 33.77 Favored Glycine 0 N--CA 1.405 -3.404 0 C-N-CA 120.522 -0.846 . . . . 74.209999999999994 111.944 171.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.05 134.31 53.68 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 107.234 -1.395 . . . . 72.340000000000003 107.234 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.45 110.41 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.725 -1.213 . . . . 75.019999999999996 107.725 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.3 tttp -75.2 -49.88 17.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.286 -1.325 . . . . 51.030000000000001 109.36 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -167.72 160.91 13.04 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.618 -0.882 . . . . 72.439999999999998 108.618 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -161.39 116.59 2.07 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.738 0.649 . . . . 73.140000000000001 110.18 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.08 105.76 17.92 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.03 -1.1 . . . . 63.420000000000002 108.03 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -53.95 -45.48 71.31 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 124.259 1.024 . . . . 71.5 111.8 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -58.1 -37.44 74.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.131 0.572 . . . . 73.319999999999993 111.635 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -99.22 -5.72 29.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.769 -0.372 . . . . 75.340000000000003 111.958 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 60.68 27.33 17.06 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.475 0.484 . . . . 71.129999999999995 111.897 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -134.83 152.13 51.5 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.598 -0.519 . . . . 74.299999999999997 109.598 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.89 -165.95 33.14 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.826 -0.909 . . . . 70.319999999999993 110.826 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 34.8 m-85 -137.26 165.01 27.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.209 0.528 . . . . 72.109999999999999 112.023 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -147.28 135.77 15.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.949 -1.13 . . . . 65.450000000000003 107.949 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.09 147.34 33.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.02 -2.215 . . . . 72.140000000000001 105.02 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.0 pt20 -77.35 144.15 38.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 C-N-CA 116.216 -2.194 . . . . 74.519999999999996 109.444 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.02 -29.1 27.5 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.971 1.419 . . . . 73.010000000000005 112.471 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.08 -11.77 61.13 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 62.25 111.847 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.89 50.85 0.76 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.42 -0.895 . . . . 72.329999999999998 111.199 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -90.59 171.2 36.07 Favored Glycine 0 C--N 1.318 -0.447 0 N-CA-C 110.602 -0.999 . . . . 75.030000000000001 110.602 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.81 147.82 33.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.353 0.577 . . . . 73.450000000000003 111.327 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 122.81 18.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.941 -1.027 . . . . 63.020000000000003 110.695 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 55' ' ' LEU . 7.3 p -126.01 139.96 49.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.036 -1.098 . . . . 41.420000000000002 108.036 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -92.64 142.95 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 119.413 -0.915 . . . . 75.140000000000001 112.62 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 10.8 p -112.83 142.02 26.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.303 -0.862 . . . . 73.349999999999994 109.023 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -136.64 162.5 32.97 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.017 -1.105 . . . . 74.150000000000006 108.017 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.11 -18.68 59.28 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 112.281 0.474 . . . . 50.299999999999997 112.281 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -52.89 -30.2 32.69 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.084 0.469 . . . . 64.030000000000001 110.302 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.95 -35.08 57.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.355 -0.384 . . . . 54.5 110.42 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -41.45 89.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.316 0 N-CA-C 107.786 -1.19 . . . . 75.030000000000001 107.786 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.07 -36.86 82.93 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.93 -0.577 . . . . 62.240000000000002 110.219 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.54 75.66 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.557 0.947 . . . . 60.409999999999997 113.557 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.23 -10.79 4.18 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.626 0.973 . . . . 55.100000000000001 113.626 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 55.0 5.61 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.21 -0.756 . . . . 45.009999999999998 111.21 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 43' ' ' HIS . 2.4 tm? -71.6 149.82 45.26 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.929 -1.508 . . . . 72.129999999999995 106.929 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.563 ' N ' HD13 ' A' ' 42' ' ' LEU . 60.7 m80 -83.04 -60.98 1.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.536 -0.727 . . . . 73.209999999999994 111.912 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.5 p -165.87 145.01 6.14 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 122.914 0.485 . . . . 75.420000000000002 109.919 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.8 mt -109.9 146.65 34.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.541 0.686 . . . . 72.319999999999993 111.669 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.49 153.04 41.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.607 -1.627 . . . . 63.140000000000001 106.607 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 155.3 38.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.905 0.383 . . . . 75.099999999999994 111.182 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 4.84 79.22 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 121.113 -0.565 . . . . 52.399999999999999 112.574 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -93.43 135.96 34.17 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 122.659 0.384 . . . . 74.109999999999999 110.352 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -86.0 120.14 27.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.25 -1.389 . . . . 74.040000000000006 107.25 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.37 152.7 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 CA-C-O 121.655 0.741 . . . . 62.340000000000003 111.044 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.5 mt -114.47 136.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.028 -1.471 . . . . 72.409999999999997 107.028 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -151.19 177.55 10.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.136 -0.32 . . . . 72.409999999999997 110.136 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.4 147.7 40.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.54 -1.652 . . . . 72.299999999999997 106.54 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 27.3 tp -134.41 133.4 40.49 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.249 1.023 . . . . 45.32 112.056 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -135.71 137.11 41.41 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 113.287 -1.779 . . . . 64.0 107.033 173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -84.94 138.81 32.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.69 0.757 . . . . 75.120000000000005 112.102 -176.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.4 tttm -99.21 72.55 1.86 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 75.340000000000003 107.214 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.82 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.548 1.539 . . . . 71.409999999999997 109.339 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 -18.4 5.01 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.449 -0.405 . . . . 51.399999999999999 112.183 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.3 mmpt? -89.19 164.69 14.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.397 -0.594 . . . . 53.219999999999999 109.397 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.78 118.54 16.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.803 -0.443 . . . . 52.340000000000003 109.803 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -121.93 134.21 54.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.434 0.635 . . . . 73.140000000000001 111.976 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.41 131.85 35.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.817 -1.083 . . . . 52.240000000000002 109.559 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.0 m -139.64 168.31 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.484 -0.78 . . . . 65.230000000000004 110.036 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.73 63.21 1.87 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.956 0.785 . . . . 72.409999999999997 109.944 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 mt -81.41 143.33 32.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.342 -0.844 . . . . 75.299999999999997 111.912 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.3 tpp180 -145.68 129.87 17.57 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.807 -1.923 . . . . 64.409999999999997 105.807 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.83 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.68 141.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 118.057 0.389 . . . . 73.200000000000003 111.764 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt . . . . . 0 C--N 1.298 -1.652 0 CA-C-N 115.274 -0.875 . . . . 62.399999999999999 109.723 176.547 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 C--O 1.221 -0.436 0 N-CA-C 111.175 0.065 . . . . 75.510000000000005 111.175 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.43 135.39 35.64 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.123 -0.325 . . . . 71.230000000000004 110.123 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.1 p -120.99 146.12 47.02 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.384 0.513 . . . . 71.430000000000007 112.384 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 59.16 78.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.804 1.242 . . . . 64.439999999999998 112.266 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 33.4 mt -106.88 147.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.217 -0.901 . . . . 72.340000000000003 110.555 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 69.6 t -107.78 135.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.422 -0.808 . . . . 75.400000000000006 110.219 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -178.61 160.93 27.12 Favored Glycine 0 N--CA 1.408 -3.2 0 CA-C-N 115.246 -0.888 . . . . 74.200000000000003 112.95 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.2 ttmt -98.88 135.56 40.14 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.782 -0.709 . . . . 73.349999999999994 109.483 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.23 109.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.306 -0.998 . . . . 74.230000000000004 108.306 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.2 tttp -72.42 -42.22 65.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.371 -1.286 . . . . 70.109999999999999 108.954 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 67.1 p-90 -174.79 160.53 2.95 Favored 'General case' 0 CA--C 1.486 -1.518 0 C-N-CA 123.949 0.9 . . . . 72.030000000000001 108.821 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -161.72 126.87 3.5 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.978 0.799 . . . . 73.209999999999994 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -99.05 118.4 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.711 -1.218 . . . . 73.209999999999994 107.711 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -70.04 -23.91 63.18 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.26 0.467 . . . . 53.32 112.26 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 m -86.46 -46.29 10.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.087 0.47 . . . . 75.510000000000005 111.216 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.43 -8.68 58.89 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.738 -0.385 . . . . 73.530000000000001 111.942 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 60.63 31.36 20.18 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 112.374 0.509 . . . . 70.040000000000006 112.374 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.83 153.08 43.09 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.272 -0.422 . . . . 73.319999999999993 109.872 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.62 -169.59 39.54 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.68 -0.968 . . . . 62.049999999999997 110.68 175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 53.1 m-85 -140.06 166.62 24.18 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.337 0.655 . . . . 72.430000000000007 110.588 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -145.17 133.67 17.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.061 -0.718 . . . . 74.450000000000003 109.061 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.44 143.01 31.43 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.488 -1.301 . . . . 72.409999999999997 107.488 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.6 pt20 -83.27 156.16 23.25 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 118.035 -1.466 . . . . 63.409999999999997 109.26 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.31 -25.06 21.7 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 124.628 1.205 . . . . 72.439999999999998 113.554 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -78.41 -0.39 28.98 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 122.256 -0.277 . . . . 65.219999999999999 111.591 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 51.48 3.03 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 109.896 -1.282 . . . . 74.510000000000005 109.896 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -66.43 -104.77 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 116.651 1.42 . . . . 51.240000000000002 116.651 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.69 176.48 7.49 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.301 0.572 . . . . 75.109999999999999 111.525 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -116.46 83.32 1.94 Allowed 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 107.816 -1.179 . . . . 62.100000000000001 107.816 172.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 55' ' ' LEU . 4.2 p -119.46 129.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 CA-C-N 115.382 -0.827 . . . . 75.209999999999994 109.638 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 39.6 p90 -86.23 139.07 31.38 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.289 0.566 . . . . 75.319999999999993 111.681 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -103.39 119.8 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.289 -0.869 . . . . 72.430000000000007 109.81 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -110.24 161.75 15.29 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.952 -1.129 . . . . 62.340000000000003 107.952 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.72 -22.31 63.85 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.83 0.678 . . . . 72.530000000000001 112.83 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -53.74 -24.58 15.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.178 0.513 . . . . 34.229999999999997 111.41 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.33 -39.07 59.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.979 0.418 . . . . 63.100000000000001 110.597 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.89 -44.73 88.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 N-CA-C 108.089 -1.078 . . . . 72.409999999999997 108.089 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.35 -26.22 67.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.351 0.407 . . . . 64.150000000000006 110.634 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.74 66.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.707 0.632 . . . . 71.310000000000002 112.707 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.86 -0.59 4.23 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.161 0.8 . . . . 74.120000000000005 113.161 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.87 39.57 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 123.251 0.453 . . . . 31.530000000000001 112.463 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.43 142.72 51.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.306 -1.739 . . . . 63.240000000000002 106.306 178.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' N ' HD13 ' A' ' 42' ' ' LEU . 40.2 t60 -71.15 -61.51 1.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.637 -0.825 . . . . 75.430000000000007 111.829 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -164.37 157.15 17.18 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.077 -0.712 . . . . 63.0 109.077 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.03 153.93 42.72 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.682 0.754 . . . . 42.509999999999998 112.425 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.92 172.32 13.86 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.171 -1.377 . . . . 61.329999999999998 107.693 173.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -71.33 156.1 39.9 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.697 0.761 . . . . 70.140000000000001 112.607 -177.087 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 -18.5 57.35 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.133 -0.939 . . . . 43.5 112.005 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -82.35 139.38 34.14 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 122.687 0.395 . . . . 64.400000000000006 111.657 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 11.1 m-20 -89.12 134.49 33.99 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.274 -1.009 . . . . 73.540000000000006 108.274 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.04 152.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.816 0.817 . . . . 74.109999999999999 111.142 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.6 mt -116.69 128.92 73.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.631 -1.618 . . . . 75.409999999999997 106.631 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -145.95 -180.0 7.09 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.75 -0.38 . . . . 71.310000000000002 110.299 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -119.98 157.23 29.27 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 105.379 -2.082 . . . . 64.239999999999995 105.379 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -123.93 128.51 49.54 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 121.581 0.705 . . . . 72.340000000000003 111.329 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -122.85 142.47 50.74 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.43 -1.693 . . . . 73.319999999999993 106.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.05 143.83 26.01 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.586 -0.846 . . . . 73.439999999999998 112.551 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -103.7 35.48 2.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.288 -1.375 . . . . 70.540000000000006 107.288 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 63.52 88.81 0.09 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.634 -1.167 . . . . 75.140000000000001 109.324 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.82 -47.87 3.62 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.585 -0.817 . . . . 53.530000000000001 111.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 73.5 mmtt -83.73 153.11 24.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.519 -0.549 . . . . 74.329999999999998 109.519 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -123.82 122.37 37.85 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.829 -0.168 . . . . 31.309999999999999 111.183 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.515 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 23.1 p90 -126.49 133.22 51.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.459 0.647 . . . . 73.299999999999997 111.777 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -74.39 140.38 44.71 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.736 -1.12 . . . . 52.409999999999997 109.709 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -139.5 164.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.469 -0.787 . . . . 71.510000000000005 109.314 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.72 63.91 1.56 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.075 0.859 . . . . 70.329999999999998 111.147 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.604 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 24.9 mt -78.98 138.07 37.88 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.611 -1.236 . . . . 63.009999999999998 112.929 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -141.92 131.67 24.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.187 -2.153 . . . . 74.230000000000004 105.187 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.254 2.3 pp -77.92 146.92 7.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 118.79 -1.164 . . . . 73.010000000000005 112.006 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.9 tttt . . . . . 0 C--O 1.262 1.74 0 CA-C-N 115.687 -0.688 . . . . 74.049999999999997 109.559 178.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 121.169 0.509 . . . . 73.329999999999998 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . . . -161.28 107.57 1.4 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.713 -1.217 . . . . 52.43 107.713 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 27.7 p -101.0 142.94 31.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.52 0.933 . . . . 64.310000000000002 113.52 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 62.75 77.84 0.31 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 124.595 1.158 . . . . 62.130000000000003 111.785 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.5 mt -110.02 145.71 16.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.34 -0.845 . . . . 74.129999999999995 111.127 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 57.2 t -99.57 137.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.257 -0.883 . . . . 64.319999999999993 110.641 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -172.45 177.99 44.79 Favored Glycine 0 N--CA 1.4 -3.71 0 CA-C-N 115.007 -0.997 . . . . 44.140000000000001 112.349 167.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -121.98 141.28 51.49 Favored 'General case' 0 C--N 1.256 -3.467 0 C-N-CA 123.813 0.845 . . . . 64.430000000000007 108.978 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.75 111.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 109.045 -0.724 . . . . 63.200000000000003 109.045 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 53.4 tttm -72.41 -48.12 43.88 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.393 -1.336 . . . . 71.109999999999999 107.393 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 67.4 p-90 -176.43 160.96 2.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.83 1.252 . . . . 73.209999999999994 108.494 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 81.0 t80 -151.35 126.08 9.63 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.943 -0.391 . . . . 73.430000000000007 109.943 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.79 101.74 11.56 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.478 -0.934 . . . . 74.120000000000005 108.478 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.4 m -63.85 -21.41 66.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.98 -0.554 . . . . 31.41 111.19 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.7 p -65.81 -37.54 86.54 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 123.33 0.652 . . . . 71.150000000000006 111.396 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.7 mttt -103.14 -6.13 22.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.936 -0.574 . . . . 71.519999999999996 111.862 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 69.43 22.38 6.48 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.533 0.733 . . . . 71.310000000000002 112.226 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 48.8 p90 -147.59 165.08 31.48 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.169 0.509 . . . . 62.340000000000003 111.748 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -167.95 -157.3 10.89 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.999 -1.241 . . . . 71.219999999999999 109.999 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' HD1' ' CZ2' ' A' ' 11' ' ' TRP . 46.4 m-85 -137.72 165.75 25.64 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 117.417 0.608 . . . . 75.310000000000002 112.168 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -143.92 139.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.09 -1.078 . . . . 61.43 108.09 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 12.4 pt-20 -142.84 144.54 32.55 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.519 -1.66 . . . . 73.140000000000001 106.519 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.542 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -86.94 150.33 24.15 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 117.512 -1.675 . . . . 64.019999999999996 108.221 174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.59 -14.31 12.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 124.241 0.963 . . . . 75.340000000000003 112.597 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -88.64 5.39 43.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.539 -0.301 . . . . 73.319999999999993 111.183 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.7 50.97 2.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.691 -1.242 . . . . 53.420000000000002 112.259 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.4 55.15 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.359 -0.924 . . . . 72.420000000000002 111.399 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.55 162.99 27.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.449 0.537 . . . . 63.229999999999997 112.449 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.95 95.55 5.49 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.91 -0.586 . . . . 70.120000000000005 110.722 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.526 HG21 HD13 ' A' ' 55' ' ' LEU . 3.9 p -112.7 130.05 67.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.496 -0.775 . . . . 71.340000000000003 109.096 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.7 p90 -90.07 136.62 32.94 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.779 -0.768 . . . . 73.120000000000005 110.574 -178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -98.44 127.14 51.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.753 -0.832 . . . . 74.439999999999998 108.753 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -115.96 156.44 26.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.316 -0.624 . . . . 60.340000000000003 109.316 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.58 -18.65 12.59 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.631 0.974 . . . . 75.209999999999994 113.631 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -61.07 -22.94 65.09 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.22 0.533 . . . . 53.399999999999999 110.649 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -77.52 -33.42 54.29 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.433 -0.58 . . . . 42.210000000000001 109.433 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.04 -42.64 88.77 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 N-CA-C 107.704 -1.221 . . . . 71.25 107.704 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -53.75 -35.34 61.14 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.915 0.886 . . . . 64.450000000000003 110.866 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 -18.51 59.73 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.821 1.045 . . . . 74.120000000000005 113.821 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.59 -20.16 2.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.089 . . . . 74.019999999999996 113.939 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.12 38.01 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-O 121.689 0.605 . . . . 63.039999999999999 111.615 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD21 ' HG ' ' A' ' 45' ' ' LEU . 26.1 tp -64.72 141.31 58.82 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.681 -0.759 . . . . 62.219999999999999 110.292 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.22 -57.35 13.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.303 -0.628 . . . . 73.510000000000005 109.303 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -175.69 174.96 2.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.173 -1.418 . . . . 74.140000000000001 107.173 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.0 mp -111.95 145.19 40.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.094 0.473 . . . . 74.129999999999995 110.703 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.81 146.31 45.52 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.224 -0.898 . . . . 71.549999999999997 109.012 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.81 154.57 40.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.13 0.491 . . . . 51.340000000000003 111.387 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 -26.24 19.25 Favored Glycine 0 C--N 1.303 -1.259 0 C-N-CA 120.687 -0.768 . . . . 61.549999999999997 112.188 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -69.86 132.22 45.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 123.359 0.664 . . . . 74.219999999999999 111.647 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.67 132.91 35.31 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 108.125 -1.065 . . . . 52.549999999999997 108.125 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.84 147.27 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.915 0 CA-C-O 121.888 0.851 . . . . 71.109999999999999 110.457 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 68.9 mt -117.55 136.9 53.24 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 106.374 -1.713 . . . . 73.519999999999996 106.374 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -153.11 -178.53 7.0 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.836 -0.346 . . . . 74.010000000000005 110.476 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 37.1 m-20 -119.62 156.17 30.91 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.934 -1.876 . . . . 75.239999999999995 105.934 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 13.6 tp -121.18 116.48 25.02 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-O 122.707 1.241 . . . . 64.439999999999998 114.332 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.7 mm-40 -103.51 151.04 23.32 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.813 -1.994 . . . . 74.209999999999994 111.288 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -105.76 131.34 53.23 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 114.298 -1.319 . . . . 64.239999999999995 111.066 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 86.6 tttt -109.67 78.78 1.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.381 -0.827 . . . . 73.019999999999996 109.536 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 60.36 14.12 4.49 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.883 0.849 . . . . 74.540000000000006 111.64 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.03 -25.14 3.55 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.328 -0.709 . . . . 62.039999999999999 111.328 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.2 mmmt -83.87 164.92 19.16 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.601 -0.889 . . . . 73.329999999999998 108.601 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.51 119.81 32.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 119.835 -0.126 . . . . 71.019999999999996 111.121 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 40.4 p90 -125.22 133.75 52.6 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.549 0.69 . . . . 74.409999999999997 112.443 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 137.34 38.23 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.704 -1.135 . . . . 64.099999999999994 110.829 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.7 m -140.68 168.61 16.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.351 -0.84 . . . . 74.150000000000006 109.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.1 t30 54.32 63.43 2.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.079 0.862 . . . . 62.439999999999998 110.701 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.6 mt -74.41 136.1 42.38 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.694 0.998 . . . . 74.430000000000007 113.694 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 41.6 mmt180 -122.59 131.17 53.7 Favored 'General case' 0 N--CA 1.405 -2.678 0 N-CA-C 106.177 -1.786 . . . . 62.219999999999999 106.177 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.38 131.24 56.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 114.354 1.242 . . . . 54.25 114.354 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.258 1.54 0 CA-C-N 115.209 -0.905 . . . . 72.530000000000001 109.345 173.646 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 109.52 -0.548 . . . . 63.009999999999998 109.52 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.85 110.29 7.94 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.64 -1.244 . . . . 75.310000000000002 107.64 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.5 p -127.18 161.83 27.58 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.547 0.573 . . . . 74.200000000000003 112.547 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 60.79 39.85 16.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.0 110.874 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.3 mt -76.79 147.23 7.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.397 -0.819 . . . . 74.430000000000007 111.788 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 64.5 t -102.34 136.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.003 -0.999 . . . . 43.43 110.162 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -177.75 160.65 27.32 Favored Glycine 0 N--CA 1.413 -2.849 0 C-N-CA 120.685 -0.769 . . . . 64.420000000000002 113.503 168.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -97.63 143.75 27.99 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.661 -0.866 . . . . 51.020000000000003 108.661 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.06 107.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.226 -1.027 . . . . 64.109999999999999 108.226 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.519 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.9 tttp -67.87 -48.35 66.35 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.44 -1.255 . . . . 72.219999999999999 109.155 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -166.8 155.55 10.39 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.231 -1.026 . . . . 74.219999999999999 108.231 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -160.46 108.43 1.62 Allowed 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.724 0.64 . . . . 71.030000000000001 109.67 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -84.97 106.47 16.5 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.735 -1.58 . . . . 63.229999999999997 106.735 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 p -62.62 -26.02 68.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.267 0.84 . . . . 63.420000000000002 113.267 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -71.49 -32.22 67.99 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.09 0.471 . . . . 72.230000000000004 110.081 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.04 -9.8 30.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.004 -0.369 . . . . 70.0 110.004 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 52.37 34.67 15.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.701 0.801 . . . . 65.140000000000001 110.074 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.69 156.11 46.99 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.596 -0.52 . . . . 72.099999999999994 109.596 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.02 -153.61 17.39 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.296 -0.722 . . . . 63.509999999999998 111.296 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 41.3 m-85 -137.14 169.18 18.22 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.519 0.728 . . . . 74.519999999999996 110.9 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.439 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 61.7 mt -145.61 130.6 12.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 123.505 0.722 . . . . 74.310000000000002 109.147 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.34 146.84 32.8 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.52 -0.918 . . . . 74.409999999999997 108.52 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.6 pt20 -79.74 148.15 31.61 Favored 'General case' 0 CA--C 1.483 -1.625 0 C-N-CA 118.838 -1.145 . . . . 72.430000000000007 108.38 175.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -53.72 -25.32 17.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 124.528 1.143 . . . . 64.099999999999994 112.065 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -76.93 -3.94 41.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.191 -0.459 . . . . 61.340000000000003 112.138 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.14 50.76 0.76 Allowed Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.393 -1.384 . . . . 61.240000000000002 112.542 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.33 150.69 32.08 Favored Glycine 0 C--N 1.313 -0.733 0 C-N-CA 119.753 -1.213 . . . . 43.329999999999998 110.167 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.19 163.58 26.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 117.264 0.532 . . . . 74.109999999999999 112.262 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.97 105.1 1.54 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-N 115.845 -0.616 . . . . 75.200000000000003 111.299 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 55' ' ' LEU . 4.3 p -126.81 123.71 63.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 108.585 -0.894 . . . . 63.119999999999997 108.585 172.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 47.2 p90 -87.17 149.73 24.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.041 -0.527 . . . . 74.129999999999995 112.397 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 67' ' ' LEU . 9.3 p -106.27 126.72 61.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.381 0.61 . . . . 73.409999999999997 109.57 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -111.78 156.93 21.17 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.036 -1.468 . . . . 71.209999999999994 107.036 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.29 -13.7 61.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.381 -0.928 . . . . 75.400000000000006 112.077 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -59.0 -22.54 60.75 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.239 0.542 . . . . 72.109999999999999 109.716 171.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' ALA . . . -75.51 -38.79 59.18 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.519 -0.549 . . . . 73.299999999999997 109.519 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.66 -43.68 96.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.672 0 N-CA-C 107.891 -1.152 . . . . 61.100000000000001 107.891 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.15 -37.15 69.14 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.107 0.563 . . . . 64.150000000000006 111.623 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.83 -27.45 69.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.22 0.822 . . . . 60.240000000000002 113.22 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.55 -14.88 3.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.498 0.925 . . . . 51.240000000000002 113.498 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.29 47.74 16.56 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 109.731 -1.347 . . . . 74.200000000000003 109.731 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.28 128.95 38.01 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.865 0.866 . . . . 75.310000000000002 108.669 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -46.55 -61.55 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.77 0.656 . . . . 71.430000000000007 112.77 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 p -178.51 162.98 1.49 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.452 -0.944 . . . . 75.519999999999996 108.452 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.9 mt -123.04 149.48 44.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.306 -0.627 . . . . 73.299999999999997 109.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.57 149.35 26.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.145 -1.057 . . . . 74.099999999999994 108.145 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.0 126.45 27.58 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.472 -0.936 . . . . 72.299999999999997 108.472 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.52 -14.91 27.38 Favored Glycine 0 C--N 1.288 -2.094 0 CA-C-N 115.589 -0.732 . . . . 75.340000000000003 113.266 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -81.44 130.04 34.89 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.282 -0.54 . . . . 74.209999999999994 111.18 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.86 131.07 34.56 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 107.198 -1.408 . . . . 71.329999999999998 107.198 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.1 145.95 31.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-O 121.854 0.835 . . . . 72.209999999999994 110.642 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 70.3 mt -113.37 132.67 61.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 107.063 -1.458 . . . . 62.310000000000002 107.063 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.39 -177.01 5.46 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 121.0 0.429 . . . . 61.130000000000003 110.968 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -123.78 149.34 45.76 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 105.68 -1.97 . . . . 73.450000000000003 105.68 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -114.34 119.91 38.57 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 122.088 0.947 . . . . 75.340000000000003 111.473 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -126.25 159.14 33.89 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 113.67 -1.604 . . . . 44.020000000000003 107.977 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.31 143.02 26.75 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.368 0.604 . . . . 72.329999999999998 111.987 -173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 84.7 tttt -100.86 81.52 2.28 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.245 -1.761 . . . . 63.119999999999997 106.245 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 66.82 -68.77 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.724 1.21 . . . . 75.040000000000006 110.238 -174.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.73 -2.19 1.99 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.577 -0.609 . . . . 72.409999999999997 111.577 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.9 mmmt -97.01 165.24 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.15 -0.685 . . . . 72.540000000000006 109.15 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -116.35 116.43 27.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 110.14 -0.319 . . . . 62.43 110.14 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -129.99 140.74 50.84 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.493 0.663 . . . . 73.420000000000002 111.6 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -72.28 133.55 45.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.552 -1.203 . . . . 62.399999999999999 109.227 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 32.5 m -138.3 161.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.69 -0.686 . . . . 73.219999999999999 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 59.96 63.23 1.49 Allowed 'General case' 0 C--O 1.216 -0.658 0 O-C-N 124.392 1.057 . . . . 73.140000000000001 109.294 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.442 HD11 HG21 ' A' ' 32' ' ' VAL . 28.4 mt -80.37 143.61 33.38 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.893 -0.723 . . . . 64.549999999999997 112.8 -173.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.07 133.48 41.2 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.187 1.395 . . . . 63.140000000000001 107.948 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' H ' ' A' ' 69' ' ' ILE . 2.3 mp -82.14 140.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.889 -1.522 . . . . 75.25 106.889 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.258 1.536 0 N-CA-C 108.421 -0.955 . . . . 74.120000000000005 108.421 174.545 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 111.892 0.33 . . . . 74.319999999999993 111.892 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.12 117.39 14.56 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.704 -0.622 . . . . 65.319999999999993 110.288 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.9 p -102.36 147.31 26.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.377 -0.374 . . . . 73.230000000000004 111.539 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 52.27 77.37 0.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.537 1.135 . . . . 75.430000000000007 113.059 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 46.6 mt -103.93 148.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.183 -0.917 . . . . 72.519999999999996 110.484 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.3 t -91.48 132.72 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 115.242 -0.89 . . . . 64.129999999999995 109.134 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.87 167.45 37.95 Favored Glycine 1 N--CA 1.394 -4.123 0 C-N-CA 120.317 -0.945 . . . . 70.439999999999998 111.781 171.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -123.04 135.74 54.55 Favored 'General case' 0 C--N 1.261 -3.267 0 N-CA-C 107.569 -1.271 . . . . 55.43 107.569 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.86 116.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.68 0.752 . . . . 50.439999999999998 109.16 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.4 tttp -75.85 -43.62 44.84 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.03 -1.441 . . . . 65.329999999999998 109.109 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -175.02 159.65 2.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 123.917 0.887 . . . . 73.409999999999997 109.182 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -163.44 126.85 2.73 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.878 0.736 . . . . 74.049999999999997 109.236 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -115.71 122.57 45.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.672 -0.862 . . . . 74.5 108.672 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 m -65.14 -19.15 65.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.087 0.47 . . . . 65.310000000000002 110.063 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.6 m -62.28 -34.13 75.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.721 -0.672 . . . . 64.230000000000004 110.668 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.36 -10.2 11.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.061 -0.656 . . . . 74.319999999999993 111.88 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 54.27 29.66 11.09 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 113.405 0.891 . . . . 63.420000000000002 113.405 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -129.8 156.41 44.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 114.672 -1.149 . . . . 74.319999999999993 108.534 173.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.44 -172.78 38.54 Favored Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 109.087 -1.605 . . . . 73.439999999999998 109.087 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 50.3 m-85 -134.24 165.9 24.03 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 117.036 0.418 . . . . 74.439999999999998 111.123 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.6 mt -147.16 136.26 16.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.111 -1.07 . . . . 54.109999999999999 108.111 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.39 148.47 34.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.525 -2.028 . . . . 74.530000000000001 105.525 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.5 pt20 -74.84 142.5 44.16 Favored 'General case' 0 CA--C 1.473 -2.019 0 C-N-CA 116.655 -2.018 . . . . 74.519999999999996 108.68 175.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -49.62 -33.04 14.24 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.122 -1.399 . . . . 75.319999999999993 111.594 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -87.75 11.31 15.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.902 0.705 . . . . 64.310000000000002 112.902 -173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.39 51.2 0.67 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.405 -1.379 . . . . 60.310000000000002 113.471 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -96.26 157.59 21.51 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 119.774 -1.203 . . . . 62.149999999999999 110.989 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -72.06 152.73 42.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.831 0.315 . . . . 64.219999999999999 110.522 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 120.79 24.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.19 0.995 . . . . 74.239999999999995 111.724 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 55' ' ' LEU . 3.0 p -121.87 139.01 50.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 114.365 -1.289 . . . . 71.109999999999999 108.223 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 40.7 p90 -88.15 142.67 27.58 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.428 -0.909 . . . . 70.340000000000003 111.45 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 67' ' ' LEU . 13.3 p -110.67 144.21 19.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.605 -0.887 . . . . 73.099999999999994 108.605 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -131.66 158.4 41.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.54 -0.911 . . . . 72.430000000000007 108.54 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.56 -16.44 63.87 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 112.505 0.557 . . . . 75.209999999999994 112.505 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -56.67 -26.24 55.87 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.235 0.541 . . . . 70.340000000000003 110.357 172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.85 -37.71 55.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.259 -0.428 . . . . 71.140000000000001 110.117 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.6 t -66.57 -40.6 86.71 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 N-CA-C 107.844 -1.169 . . . . 73.120000000000005 107.844 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.26 -32.6 72.42 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.78 0.832 . . . . 63.399999999999999 110.755 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.37 82.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.721 0.638 . . . . 64.219999999999999 112.721 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.68 -8.79 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.478 0.918 . . . . 41.009999999999998 113.478 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.63 58.36 7.83 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.47 -1.052 . . . . 73.519999999999996 110.47 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.482 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.02 145.46 51.75 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.435 -1.32 . . . . 75.319999999999993 107.435 -179.041 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.482 ' N ' HD13 ' A' ' 42' ' ' LEU . 62.7 t-80 -54.5 -61.7 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.58 0.352 . . . . 73.310000000000002 110.981 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -175.62 150.66 1.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.547 -0.538 . . . . 53.119999999999997 109.547 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.96 143.84 36.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.261 -0.644 . . . . 72.430000000000007 109.261 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.13 160.15 16.0 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.932 -1.136 . . . . 61.200000000000003 107.932 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 150.41 45.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.819 0.819 . . . . 74.099999999999994 112.374 -176.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.68 -14.73 62.21 Favored Glycine 0 C--N 1.298 -1.569 0 CA-C-N 114.991 -1.004 . . . . 55.009999999999998 112.677 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -79.41 116.65 19.77 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 122.519 -0.4 . . . . 75.109999999999999 111.152 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.91 129.92 38.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.998 -1.482 . . . . 71.030000000000001 106.998 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 147.83 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-O 122.034 0.921 . . . . 75.439999999999998 110.976 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.6 mt -110.03 127.76 66.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.199 -1.778 . . . . 71.319999999999993 106.199 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.47 176.45 9.0 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.948 -0.701 . . . . 73.430000000000007 111.311 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.46 140.39 52.23 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.107 -1.812 . . . . 62.130000000000003 106.107 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 30' ' ' VAL . 20.7 tp -121.36 122.06 39.01 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.728 0.775 . . . . 62.439999999999998 111.898 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -109.92 166.22 11.1 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.885 -1.507 . . . . 74.409999999999997 109.469 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.1 125.72 51.43 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.587 -1.264 . . . . 74.409999999999997 107.587 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -126.16 75.16 1.5 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.457 0.54 . . . . 40.299999999999997 112.457 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 59' ' ' GLN . 26.7 tt0 58.12 32.91 22.61 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.857 0.837 . . . . 64.409999999999997 111.202 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.37 31.5 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 120.505 -0.855 . . . . 44.299999999999997 111.641 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.0 mmtt -96.87 162.04 13.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.803 -0.443 . . . . 74.219999999999999 109.803 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.11 112.01 8.91 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.585 -1.265 . . . . 75.150000000000006 107.585 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.6 p90 -124.96 135.51 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.418 0.628 . . . . 65.420000000000002 111.5 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 123.66 32.75 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.639 -1.164 . . . . 74.140000000000001 109.838 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 18.4 m -137.22 176.29 7.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.588 -0.733 . . . . 52.32 111.62 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.39 40.11 27.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.492 1.12 . . . . 74.319999999999993 108.361 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 32' ' ' VAL . 36.3 mt -62.63 142.07 58.22 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.617 -1.174 . . . . 74.140000000000001 113.016 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -143.68 130.39 20.26 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.546 -1.65 . . . . 75.329999999999998 106.546 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.23 141.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.567 -0.853 . . . . 75.530000000000001 110.891 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.25 1.109 0 O-C-N 123.858 0.724 . . . . 73.030000000000001 110.798 178.777 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 109.522 -0.547 . . . . 74.409999999999997 109.522 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.72 129.39 34.96 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.044 -1.095 . . . . 74.010000000000005 108.044 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p -101.69 150.32 23.24 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.45 0.469 . . . . 53.020000000000003 111.492 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 61.84 76.07 0.38 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.681 0.792 . . . . 74.349999999999994 111.319 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 34.1 mt -108.36 150.65 10.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.193 -0.912 . . . . 70.319999999999993 110.462 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 93.9 t -96.11 132.46 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 115.629 -0.714 . . . . 63.240000000000002 110.182 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.44 171.07 39.04 Favored Glycine 0 N--CA 1.399 -3.819 0 CA-C-N 115.109 -0.95 . . . . 62.119999999999997 111.676 170.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -128.35 133.28 48.63 Favored 'General case' 0 C--N 1.26 -3.299 0 C-N-CA 124.472 1.109 . . . . 71.25 108.879 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.91 113.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 116.061 -0.518 . . . . 62.229999999999997 109.987 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 64.4 mttm -62.58 -49.0 76.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.615 -0.721 . . . . 34.509999999999998 109.276 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -175.81 166.67 3.1 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.805 1.242 . . . . 72.230000000000004 108.661 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -145.06 140.35 28.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.626 0.579 . . . . 70.340000000000003 109.442 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -112.25 121.53 45.18 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.501 -0.926 . . . . 73.430000000000007 108.501 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -75.99 -28.94 58.03 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.094 0.405 . . . . 74.299999999999997 112.094 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.4 m -69.03 -48.64 62.4 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.975 0.417 . . . . 73.120000000000005 111.264 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -95.28 -8.56 35.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.681 0.622 . . . . 71.109999999999999 112.681 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 62.43 30.68 17.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.945 0.403 . . . . 71.239999999999995 111.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.65 163.41 21.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.128 -0.487 . . . . 62.200000000000003 109.939 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.18 -172.47 43.46 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 107.939 -2.064 . . . . 71.340000000000003 107.939 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 55.8 m-85 -136.82 155.98 49.09 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 118.125 0.963 . . . . 63.219999999999999 111.372 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -134.94 140.93 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.499 -0.926 . . . . 74.439999999999998 108.499 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 13.8 pt-20 -143.05 147.4 35.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.25 -2.13 . . . . 72.109999999999999 105.25 175.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.2 pt20 -79.87 144.45 33.43 Favored 'General case' 0 CA--C 1.483 -1.613 0 C-N-CA 115.305 -2.558 . . . . 72.140000000000001 109.315 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.79 -29.21 11.01 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 124.992 1.433 . . . . 62.329999999999998 111.357 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.86 4.0 43.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.179 0.807 . . . . 64.129999999999995 113.179 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.25 53.62 0.88 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 117.744 -2.17 . . . . 72.0 112.332 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -83.09 -121.91 0.76 Allowed Glycine 0 C--N 1.312 -0.803 0 C-N-CA 120.576 -0.821 . . . . 32.219999999999999 114.23 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.95 168.66 15.68 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 122.726 0.41 . . . . 70.420000000000002 110.359 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.71 92.19 6.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.186 -0.672 . . . . 54.539999999999999 109.186 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.44 132.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.523 -0.762 . . . . 74.519999999999996 109.148 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 44.0 p90 -90.09 149.14 22.62 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 118.92 -1.112 . . . . 75.109999999999999 110.884 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -105.99 137.12 37.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.099 -0.704 . . . . 74.549999999999997 109.099 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -125.25 157.17 37.25 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.697 -1.223 . . . . 53.100000000000001 107.697 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -62.38 -24.23 67.26 Favored 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 113.022 0.749 . . . . 71.0 113.022 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -52.51 -26.06 12.02 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 120.981 0.419 . . . . 53.130000000000003 111.399 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -74.79 -39.61 61.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 109.823 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.89 -46.34 88.82 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.373 0 CA-C-N 115.06 -0.973 . . . . 64.030000000000001 108.404 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.69 -23.79 65.12 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.402 0.439 . . . . 74.019999999999996 111.14 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.74 69.16 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.301 0.482 . . . . 70.510000000000005 112.301 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.8 -4.8 4.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.229 0.826 . . . . 50.100000000000001 113.229 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.05 52.48 44.32 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.295 -0.722 . . . . 71.310000000000002 111.295 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.24 125.56 27.27 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.074 -1.825 . . . . 65.109999999999999 106.074 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -74.51 -37.79 63.0 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 114.833 1.419 . . . . 74.129999999999995 114.833 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -155.63 138.3 15.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.104 -0.638 . . . . 74.120000000000005 112.257 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.19 149.3 43.03 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.471 -0.786 . . . . 74.140000000000001 109.035 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.46 169.56 22.3 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.481 -1.674 . . . . 64.310000000000002 106.481 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -75.42 155.28 36.51 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.58 -0.448 . . . . 71.519999999999996 110.966 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.09 1.27 89.67 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.923 -0.656 . . . . 33.119999999999997 113.09 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -86.22 121.08 28.31 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 111.902 0.334 . . . . 74.25 111.902 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -71.78 127.51 32.8 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.144 -1.058 . . . . 74.420000000000002 108.144 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.49 147.58 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 CA-C-O 121.976 0.893 . . . . 70.450000000000003 110.686 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 71.9 mt -112.69 135.11 53.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 N-CA-C 106.893 -1.521 . . . . 75.200000000000003 106.893 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -150.13 179.28 8.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 121.076 -0.25 . . . . 72.120000000000005 110.566 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -114.86 154.35 28.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.035 -1.839 . . . . 73.349999999999994 106.035 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 62' ' ' ALA . 37.1 tp -140.53 136.67 33.13 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.901 0.857 . . . . 75.209999999999994 112.755 -176.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -131.54 132.42 44.14 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.226 -1.768 . . . . 74.230000000000004 106.226 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.77 116.41 23.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.846 0.832 . . . . 70.120000000000005 111.04 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -81.26 79.14 7.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.154 -1.384 . . . . 75.010000000000005 109.785 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 57.52 20.62 6.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.061 0.945 . . . . 64.510000000000005 112.374 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.16 -30.11 3.56 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.413 -0.675 . . . . 72.049999999999997 111.413 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -84.13 164.12 19.38 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.377 -1.342 . . . . 75.540000000000006 107.377 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -138.15 129.04 26.97 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 118.652 0.66 . . . . 73.420000000000002 110.784 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 6.9 p90 -133.93 133.91 41.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.467 0.651 . . . . 60.229999999999997 111.175 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -79.58 133.37 36.44 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.537 -1.21 . . . . 53.119999999999997 110.297 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 26.9 m -135.24 161.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.976 -1.011 . . . . 74.510000000000005 109.29 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 t30 59.63 64.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.848 0.718 . . . . 64.239999999999995 110.817 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 21.8 mt -78.14 139.9 39.01 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.976 -1.09 . . . . 71.319999999999993 112.132 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 16.6 tpp180 -137.45 130.77 30.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.111 -2.551 . . . . 65.230000000000004 104.111 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.58 143.22 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.944 -1.102 . . . . 72.239999999999995 113.055 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.914 -1.041 . . . . 73.219999999999999 108.945 173.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 26.1 ttt . . . . . 0 C--O 1.223 -0.329 0 CA-C-O 121.277 0.561 . . . . 55.539999999999999 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -114.94 145.2 42.47 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.106 -1.442 . . . . 73.219999999999999 107.106 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.404 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 41.5 p -120.49 142.0 49.69 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.137 0.421 . . . . 73.140000000000001 112.137 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 55.86 74.54 0.38 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.308 1.043 . . . . 62.439999999999998 112.31 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 2' ' ' ALA . 36.6 mt -99.58 152.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.643 -1.162 . . . . 42.229999999999997 110.818 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.2 t -102.62 135.97 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 115.419 -0.81 . . . . 64.420000000000002 109.548 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.14 175.42 47.12 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 115.103 -0.953 . . . . 71.430000000000007 111.98 168.355 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 38.3 ttmt -123.91 143.02 50.62 Favored 'General case' 0 C--N 1.253 -3.627 0 C-N-CA 123.973 0.909 . . . . 63.119999999999997 108.801 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.02 109.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.136 -0.69 . . . . 62.420000000000002 109.136 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.55 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 58.2 tttp -68.53 -49.1 62.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.886 -1.524 . . . . 64.209999999999994 106.886 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -169.11 156.18 7.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 114.951 -1.022 . . . . 70.340000000000003 108.829 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 80.6 t80 -157.16 111.39 2.68 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 123.638 0.586 . . . . 71.109999999999999 109.668 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -99.49 118.63 36.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.822 -0.626 . . . . 71.420000000000002 109.932 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 m -64.36 -22.92 67.11 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.059 -0.973 . . . . 73.040000000000006 110.2 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -55.08 -44.99 75.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.537 -0.756 . . . . 64.439999999999998 111.212 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.8 mttt -106.21 -6.09 18.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.437 0.532 . . . . 63.229999999999997 112.437 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 68.86 22.65 7.11 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.073 0.549 . . . . 73.340000000000003 110.928 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 36.5 p90 -148.47 166.86 26.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.06 0.457 . . . . 75.209999999999994 111.965 176.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.85 -153.06 8.56 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.757 -1.337 . . . . 64.530000000000001 109.757 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.4 m-85 -137.05 167.81 20.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 122.857 0.463 . . . . 70.010000000000005 111.419 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 64.0 mt -142.35 138.29 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.573 -0.899 . . . . 72.409999999999997 108.573 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -143.18 147.25 34.59 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 106.545 -1.65 . . . . 70.530000000000001 106.545 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -86.29 156.79 20.1 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 117.599 -1.64 . . . . 73.0 108.78 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -53.99 -27.12 29.59 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.232 0.957 . . . . 74.120000000000005 112.368 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -81.41 5.45 17.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.079 0.4 . . . . 64.140000000000001 112.079 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.01 51.72 4.09 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.433 -1.365 . . . . 61.450000000000003 110.807 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -78.5 -168.12 32.99 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.877 -0.678 . . . . 75.109999999999999 112.459 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.02 144.71 55.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.044 -0.354 . . . . 73.040000000000006 110.044 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.29 87.39 7.11 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.494 -0.928 . . . . 45.329999999999998 108.494 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 55' ' ' LEU . 3.8 p -100.52 138.41 24.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.441 -1.254 . . . . 71.340000000000003 110.055 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.0 p90 -88.98 145.18 25.67 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 119.061 -1.055 . . . . 60.43 110.034 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 67' ' ' LEU . 8.1 p -115.57 136.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 108.748 -0.834 . . . . 73.530000000000001 108.748 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -124.67 159.94 29.66 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.136 -0.691 . . . . 74.430000000000007 109.136 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.32 -15.69 60.77 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 112.647 0.61 . . . . 74.209999999999994 112.647 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.6 m -61.45 -26.93 68.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.963 0.411 . . . . 64.319999999999993 110.495 172.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.31 -34.9 61.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.7 -0.482 . . . . 71.519999999999996 109.7 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.57 -46.29 93.01 Favored 'Isoleucine or valine' 0 C--O 1.181 -2.524 0 N-CA-C 107.721 -1.214 . . . . 75.439999999999998 107.721 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.52 -31.24 63.93 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.124 0.97 . . . . 74.349999999999994 110.866 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.4 63.84 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.121 0.786 . . . . 74.510000000000005 113.121 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.63 -5.62 4.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.654 0.983 . . . . 61.020000000000003 113.654 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.09 49.43 75.17 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 111.117 -0.793 . . . . 71.099999999999994 111.117 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.1 tm? -66.86 138.16 57.11 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.154 -1.424 . . . . 53.32 107.154 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.4 ' N ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-70 -65.15 -53.58 42.89 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.0 1.111 . . . . 72.040000000000006 114.0 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -165.83 153.84 10.84 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.527 -0.469 . . . . 61.340000000000003 110.575 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.6 mt -124.01 143.78 50.22 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.119 -0.697 . . . . 73.230000000000004 109.119 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.16 162.38 20.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.132 -1.432 . . . . 62.100000000000001 107.132 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -69.1 153.4 43.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.591 . . . . 73.239999999999995 111.501 -176.054 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.58 84.66 Favored Glycine 0 C--N 1.3 -1.465 0 CA-C-N 115.262 -0.881 . . . . 64.319999999999993 112.803 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -93.58 119.08 32.19 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.268 0.47 . . . . 73.25 112.268 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 22.4 m-20 -71.91 136.38 46.87 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.171 -0.612 . . . . 71.409999999999997 109.745 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.29 153.41 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-O 121.876 0.846 . . . . 74.310000000000002 110.815 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 65.9 mt -115.2 135.36 55.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 N-CA-C 106.58 -1.637 . . . . 75.299999999999997 106.58 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -153.06 177.59 10.64 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.947 -0.701 . . . . 74.420000000000002 110.624 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 44.5 m-20 -118.93 157.53 27.5 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.013 -1.847 . . . . 75.439999999999998 106.013 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 1' ' ' MET . 18.3 tp -134.9 138.18 43.88 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 120.879 0.371 . . . . 71.439999999999998 111.883 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -127.56 151.57 48.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.49 -1.3 . . . . 63.130000000000003 107.49 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.42 120.82 31.85 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 121.243 0.544 . . . . 71.329999999999998 111.018 -175.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 87.0 tttt -90.49 74.31 6.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.528 -0.76 . . . . 73.129999999999995 108.956 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 61.14 8.32 1.95 Allowed 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.85 -1.068 . . . . 73.030000000000001 113.178 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.53 -24.28 2.49 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.803 -0.919 . . . . 64.209999999999994 110.803 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -88.7 162.41 16.29 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.09 -1.078 . . . . 71.450000000000003 108.09 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.452 ' C ' HG23 ' A' ' 30' ' ' VAL . . . -120.99 127.73 52.05 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.975 -0.453 . . . . 71.329999999999998 111.495 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 36.4 p90 -127.81 132.6 49.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.367 0.603 . . . . 50.130000000000003 111.63 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.2 136.8 33.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.147 -0.933 . . . . 63.210000000000001 110.755 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 30.6 m -139.64 167.85 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.162 -0.926 . . . . 65.120000000000005 109.765 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.08 63.43 2.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.623 0.769 . . . . 54.119999999999997 110.472 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.51 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 30.1 mt -78.9 141.01 37.99 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.129 -1.029 . . . . 75.329999999999998 113.022 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 18.4 tpp180 -141.72 130.58 23.0 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 105.929 -1.878 . . . . 73.109999999999999 105.929 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.02 149.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.03 -1.068 . . . . 73.120000000000005 111.989 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt . . . . . 0 C--O 1.251 1.17 0 O-C-N 124.049 0.843 . . . . 74.239999999999995 110.755 175.555 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 CA--C 1.495 -1.138 0 N-CA-C 109.149 -0.685 . . . . 74.450000000000003 109.149 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.23 103.04 4.5 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.327 -0.62 . . . . 74.340000000000003 109.327 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 p -100.22 146.0 27.4 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.847 -0.615 . . . . 64.239999999999995 111.662 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 t30 54.68 77.18 0.21 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.908 1.283 . . . . 54.409999999999997 110.656 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 45.3 mt -103.93 142.84 16.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.422 -0.808 . . . . 73.409999999999997 110.416 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 76.4 t -95.96 140.82 16.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.257 -0.883 . . . . 75.129999999999995 109.45 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.94 161.87 29.85 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.312 -0.947 . . . . 55.409999999999997 113.593 168.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -96.09 137.41 35.19 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.785 -0.821 . . . . 72.329999999999998 108.785 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.32 102.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 107.674 -1.232 . . . . 73.430000000000007 107.674 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.71 -45.36 92.37 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.499 -1.228 . . . . 72.420000000000002 110.417 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -172.53 162.81 5.31 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 124.072 0.949 . . . . 73.25 108.723 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 88.5 t80 -160.77 116.02 2.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.887 0.742 . . . . 72.129999999999995 109.934 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.71 106.28 18.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.374 -0.973 . . . . 62.43 108.374 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 p -59.76 -32.47 70.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.176 0.806 . . . . 72.349999999999994 113.176 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 m -76.71 -21.97 54.57 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.204 0.526 . . . . 73.219999999999999 110.725 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -101.45 -8.87 21.59 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 119.979 -0.688 . . . . 74.099999999999994 110.769 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 91.7 m-20 54.68 29.8 12.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.394 0.678 . . . . 71.310000000000002 112.809 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.03 154.32 51.75 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.195 0.598 . . . . 71.239999999999995 110.346 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.35 -171.78 39.65 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.787 -1.325 . . . . 72.230000000000004 109.787 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -132.39 157.42 44.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.272 0.536 . . . . 73.140000000000001 111.297 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 HD13 HG11 ' A' ' 51' ' ' VAL . 59.8 mt -147.02 128.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.482 -0.781 . . . . 74.430000000000007 109.23 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.94 148.6 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.308 -0.997 . . . . 74.230000000000004 108.308 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 9.9 pt20 -80.41 151.82 29.16 Favored 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 119.567 -0.853 . . . . 62.450000000000003 109.971 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.9 -15.22 19.82 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.62 1.2 . . . . 74.530000000000001 110.997 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 71.0 m-20 -88.14 6.6 35.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.735 -0.666 . . . . 74.219999999999999 110.295 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.81 51.2 2.52 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.988 -1.101 . . . . 53.240000000000002 113.111 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.42 41.84 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 119.911 -1.138 . . . . 64.129999999999995 111.074 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 157.93 28.47 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.392 0.596 . . . . 62.240000000000002 112.055 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.71 90.95 4.63 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.342 0.592 . . . . 71.430000000000007 109.984 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 55' ' ' LEU . 5.4 p -106.0 135.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.972 -1.013 . . . . 73.450000000000003 108.873 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -91.95 142.84 27.1 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.353 -0.939 . . . . 63.420000000000002 110.566 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 67' ' ' LEU . 9.7 p -99.44 145.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.535 -0.913 . . . . 62.340000000000003 108.535 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 32.8 t60 -135.52 161.37 35.66 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.296 -1.002 . . . . 71.519999999999996 108.296 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -68.06 -18.53 64.7 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 112.644 0.609 . . . . 60.32 112.644 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -56.85 -21.99 33.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.28 0.562 . . . . 74.219999999999999 110.373 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.626 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -81.14 -34.76 32.25 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.168 -0.469 . . . . 53.100000000000001 110.227 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.0 t -64.41 -52.26 57.62 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.424 0 N-CA-C 108.112 -1.07 . . . . 72.420000000000002 108.112 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.89 -22.61 64.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 123.436 0.46 . . . . 75.209999999999994 112.146 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.42 75.88 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 120.974 -0.29 . . . . 65.450000000000003 111.599 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.14 0.6 4.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.802 0.667 . . . . 64.340000000000003 112.802 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.08 50.26 65.64 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 111.092 -0.803 . . . . 72.329999999999998 111.092 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.8 138.58 58.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.753 -1.573 . . . . 71.340000000000003 106.753 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.55 -56.0 19.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.203 0.456 . . . . 62.299999999999997 111.968 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.1 p -167.81 152.46 6.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.389 -0.369 . . . . 54.210000000000001 110.323 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 90.2 mt -115.11 152.76 31.98 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.825 -0.435 . . . . 65.109999999999999 109.825 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.23 163.97 39.29 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.804 -1.554 . . . . 70.319999999999993 106.804 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 151.03 39.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.125 -0.63 . . . . 54.020000000000003 109.721 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.9 70.69 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.877 -0.678 . . . . 72.409999999999997 112.513 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -79.5 135.41 36.63 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 122.814 -0.227 . . . . 71.040000000000006 110.596 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.58 127.78 38.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.749 -1.574 . . . . 72.010000000000005 106.749 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG11 HD13 ' A' ' 21' ' ' ILE . 14.8 p -134.0 153.85 36.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.727 0 CA-C-O 121.485 0.66 . . . . 73.340000000000003 111.147 -173.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 67.0 mt -117.92 133.41 64.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 N-CA-C 106.821 -1.548 . . . . 63.130000000000003 106.821 177.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.8 p90 -144.76 -178.89 6.25 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.832 -0.432 . . . . 72.430000000000007 109.832 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -123.94 143.57 50.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.244 -1.391 . . . . 53.340000000000003 107.244 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.9 tp -117.72 116.88 27.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.445 1.116 . . . . 73.219999999999999 112.973 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.94 123.96 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.471 -2.048 . . . . 72.109999999999999 105.471 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.57 132.98 36.4 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.783 0.801 . . . . 75.230000000000004 111.608 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -102.05 81.09 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.613 -1.176 . . . . 64.129999999999995 108.744 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 63.63 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.314 1.046 . . . . 61.420000000000002 111.484 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.62 5.35 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.876 -0.89 . . . . 70.25 110.876 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -110.91 154.73 23.67 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.789 -0.819 . . . . 72.540000000000006 108.789 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -134.08 128.63 34.62 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 110.063 -0.347 . . . . 52.229999999999997 110.063 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.32 134.54 45.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.35 0.595 . . . . 64.219999999999999 110.749 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.97 130.73 35.16 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.798 -1.092 . . . . 55.219999999999999 110.898 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 24.1 m -139.39 167.98 19.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.225 -0.898 . . . . 72.129999999999995 110.288 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 59.66 63.14 1.57 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.449 1.093 . . . . 64.120000000000005 110.056 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.626 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.9 mt -79.47 139.47 37.62 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.932 0.872 . . . . 73.420000000000002 113.239 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -139.53 131.79 28.28 Favored 'General case' 0 N--CA 1.41 -2.425 0 C-N-CA 125.822 1.649 . . . . 71.219999999999999 107.101 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.8 mt -80.22 138.35 19.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 118.739 -1.185 . . . . 44.140000000000001 109.127 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 115.454 -0.794 . . . . 74.129999999999995 110.005 -177.163 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.611 -0.144 . . . . 75.430000000000007 110.611 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.26 17.26 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.872 -1.899 . . . . 72.340000000000003 105.872 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 p -97.09 140.74 31.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.149 1.166 . . . . 75.409999999999997 114.149 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 59.01 77.06 0.32 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.705 1.602 . . . . 74.439999999999998 110.869 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.4 mt -103.01 150.28 6.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.96 -1.018 . . . . 73.209999999999994 110.57 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.5 t -98.84 136.24 30.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.389 -0.823 . . . . 61.25 109.778 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.96 157.2 23.06 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.843 -0.694 . . . . 75.129999999999995 113.117 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.7 ttmt -99.69 139.75 34.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 123.231 0.612 . . . . 74.299999999999997 110.133 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.18 107.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.709 -0.678 . . . . 61.310000000000002 109.326 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -65.7 -46.6 78.4 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.243 -0.89 . . . . 62.32 109.74 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -174.29 161.68 3.5 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 123.736 0.815 . . . . 72.310000000000002 109.52 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -154.14 121.77 5.86 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.503 0.502 . . . . 75.200000000000003 111.181 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -117.85 106.77 13.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 115.69 -0.686 . . . . 75.200000000000003 110.036 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -56.42 -29.61 61.79 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.719 -1.128 . . . . 63.009999999999998 111.028 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 m -61.62 -34.57 75.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 65.030000000000001 110.614 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.35 -7.26 35.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 55.200000000000003 110.18 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.37 22.06 11.97 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.531 1.132 . . . . 74.019999999999996 110.983 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -157.2 174.91 14.76 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.493 0.663 . . . . 75.129999999999995 111.307 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.41 -164.63 24.43 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 108.834 -1.706 . . . . 70.400000000000006 108.834 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -131.95 152.53 51.03 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 117.6 0.7 . . . . 72.450000000000003 111.16 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -142.79 134.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 123.522 0.729 . . . . 51.219999999999999 109.143 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.99 151.53 38.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.319 -1.363 . . . . 72.239999999999995 107.319 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -85.12 151.76 23.89 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.805 -1.558 . . . . 73.140000000000001 109.267 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.42 -27.75 57.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 124.282 0.989 . . . . 53.240000000000002 111.678 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -76.3 2.51 13.15 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.325 -0.398 . . . . 72.219999999999999 111.711 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 51.44 1.53 Allowed Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 119.804 -1.188 . . . . 71.439999999999998 111.965 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 170.32 53.28 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 119.758 -1.21 . . . . 63.039999999999999 111.047 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.93 154.55 39.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.882 0.341 . . . . 73.510000000000005 111.584 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.5 89.17 4.46 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.433 -0.951 . . . . 75.230000000000004 108.433 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 136.24 39.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.516 -0.766 . . . . 72.099999999999994 109.736 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 53.4 p90 -94.45 139.74 30.73 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.944 -0.702 . . . . 62.030000000000001 109.88 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 67' ' ' LEU . 7.4 p -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 109.722 -0.473 . . . . 71.200000000000003 109.722 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -98.12 138.61 35.16 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.679 -0.489 . . . . 71.120000000000005 109.679 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -57.21 -28.06 62.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.393 1.627 . . . . 53.520000000000003 115.393 -173.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 m -54.47 -25.79 27.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 120.624 -0.43 . . . . 72.109999999999999 111.244 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.14 -38.86 63.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.53 0.205 . . . . 73.549999999999997 110.595 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.99 -52.64 58.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 108.263 -1.014 . . . . 73.239999999999995 108.263 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.91 -22.32 65.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 113.337 0.866 . . . . 62.229999999999997 113.337 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.16 -30.83 71.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.995 0.426 . . . . 72.549999999999997 110.981 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.98 -7.49 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.459 0.647 . . . . 50.329999999999998 110.437 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.59 24.3 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 109.886 -1.286 . . . . 62.5 109.886 -171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.04 130.49 44.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.981 -1.489 . . . . 74.340000000000003 106.981 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -53.53 -56.44 17.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.73 1.011 . . . . 74.239999999999995 113.73 -172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m -163.94 151.39 12.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 110.351 -0.24 . . . . 62.219999999999999 110.351 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -123.59 141.49 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.204 -1.036 . . . . 74.549999999999997 108.204 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.22 153.41 33.75 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.031 -0.531 . . . . 74.120000000000005 110.229 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.79 134.73 57.09 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.25 -1.018 . . . . 72.299999999999997 108.25 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.87 -14.56 49.17 Favored Glycine 0 C--N 1.295 -1.717 0 C-N-CA 120.993 -0.622 . . . . 73.209999999999994 111.947 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -85.41 134.09 34.09 Favored 'General case' 0 CA--C 1.495 -1.143 0 O-C-N 122.708 -0.289 . . . . 62.140000000000001 110.586 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -89.66 136.74 32.86 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.026 -1.472 . . . . 73.310000000000002 107.026 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.73 151.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-O 121.918 0.866 . . . . 71.219999999999999 111.378 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -113.07 133.32 59.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.918 -1.512 . . . . 71.510000000000005 106.918 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 43.5 p90 -149.54 177.48 9.69 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.297 -0.26 . . . . 71.540000000000006 110.297 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -115.34 155.56 27.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.349 -1.723 . . . . 71.010000000000005 106.349 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -141.03 136.9 32.53 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.772 0.796 . . . . 73.310000000000002 111.536 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.21 145.26 27.04 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.661 -1.977 . . . . 72.530000000000001 105.661 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.24 128.17 34.58 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 113.699 1.0 . . . . 74.420000000000002 113.699 -170.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 64.8 tttp -83.43 70.82 10.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.27 -1.332 . . . . 64.409999999999997 109.268 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 55.65 24.46 7.12 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.249 1.02 . . . . 72.349999999999994 111.325 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.81 -35.5 1.99 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.306 -0.718 . . . . 75.430000000000007 111.306 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 10.9 mptt -84.32 164.79 18.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.84 -0.429 . . . . 73.030000000000001 109.84 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.88 113.68 13.16 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.895 -0.409 . . . . 74.319999999999993 109.895 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 2.8 p90 -126.88 137.75 53.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.338 0.589 . . . . 72.329999999999998 111.569 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.9 35.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.588 -1.187 . . . . 44.229999999999997 110.392 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 31.4 m -134.88 168.08 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.156 -0.929 . . . . 52.420000000000002 109.935 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 55.39 63.55 2.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.492 0.717 . . . . 72.0 110.529 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 32' ' ' VAL . 37.9 mt -81.95 145.93 30.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.274 -0.875 . . . . 74.409999999999997 112.461 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -150.53 130.86 13.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.241 -2.133 . . . . 71.049999999999997 105.241 174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.38 145.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 C-N-CA 119.545 -0.862 . . . . 73.329999999999998 110.148 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 87.9 tttt . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.903 -1.147 . . . . 63.229999999999997 107.903 174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 110.024 -0.361 . . . . 74.239999999999995 110.024 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.3 132.99 28.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.449 -1.315 . . . . 71.409999999999997 107.449 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 p -118.58 148.63 42.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 111.983 0.364 . . . . 74.150000000000006 111.983 -175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 58.15 76.93 0.31 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.128 0.971 . . . . 71.209999999999994 111.435 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mt -108.35 154.41 9.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.983 -1.008 . . . . 54.299999999999997 110.51 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.9 t -103.46 129.5 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.665 -0.698 . . . . 54.200000000000003 109.505 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.79 171.62 35.48 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 110.658 -0.977 . . . . 63.229999999999997 110.658 171.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.8 ttmt -125.94 140.35 52.7 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 108.433 -0.951 . . . . 73.310000000000002 108.433 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 73.0 t -57.37 112.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.573 -0.528 . . . . 61.210000000000001 109.573 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.4 tttp -79.15 -43.09 24.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.582 -1.19 . . . . 43.409999999999997 109.112 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -176.2 160.01 2.14 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 124.139 0.976 . . . . 73.400000000000006 109.173 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 87.6 t80 -155.65 121.99 5.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.498 0.499 . . . . 72.030000000000001 110.089 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -105.15 104.18 13.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.733 -0.84 . . . . 72.150000000000006 108.733 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 p -63.75 -23.13 67.24 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 123.689 0.795 . . . . 72.430000000000007 112.469 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 m -67.84 -28.86 67.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.218 -0.447 . . . . 71.239999999999995 110.357 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -110.43 -8.24 14.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.834 -0.346 . . . . 75.430000000000007 110.347 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.07 27.2 14.57 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.648 0.779 . . . . 74.430000000000007 113.011 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.45 153.72 41.55 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.608 -0.723 . . . . 71.329999999999998 109.949 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.22 -168.73 32.47 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.608 -1.397 . . . . 54.229999999999997 109.608 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 57.5 m-85 -135.65 164.18 28.44 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.216 0.531 . . . . 74.010000000000005 111.597 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.8 mt -144.67 135.23 20.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 114.799 -1.091 . . . . 54.039999999999999 108.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.5 146.35 33.32 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.634 -1.987 . . . . 71.5 105.634 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 3.4 pt20 -72.17 144.81 48.43 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 117.809 -1.556 . . . . 61.119999999999997 109.398 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.81 -25.56 19.99 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.406 -1.27 . . . . 74.420000000000002 111.001 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.26 3.27 13.31 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.486 -0.779 . . . . 64.310000000000002 112.233 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.85 51.59 3.56 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.184 -1.007 . . . . 72.430000000000007 112.204 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -89.27 -143.5 9.84 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.349 -0.929 . . . . 45.219999999999999 113.098 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.38 164.16 13.32 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 110.259 -0.274 . . . . 73.349999999999994 110.259 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -101.25 112.53 25.05 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.712 -0.847 . . . . 63.009999999999998 108.712 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -119.38 138.48 49.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.865 -0.791 . . . . 72.040000000000006 108.865 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.2 p90 -90.55 148.16 22.89 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.196 -1.002 . . . . 62.420000000000002 110.44 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 67' ' ' LEU . 11.7 p -113.98 142.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 109.078 -0.712 . . . . 74.430000000000007 109.078 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -130.12 160.14 34.65 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.426 -0.953 . . . . 74.400000000000006 108.426 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.2 -14.73 62.35 Favored 'General case' 0 C--O 1.197 -1.696 0 N-CA-C 111.802 0.297 . . . . 73.019999999999996 111.802 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -53.38 -33.32 53.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.702 0.286 . . . . 61.43 110.454 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -37.81 62.29 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.848 0.356 . . . . 63.140000000000001 110.894 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.23 -35.0 69.46 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 N-CA-C 108.205 -1.035 . . . . 74.430000000000007 108.205 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.2 -35.37 80.85 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.468 -0.787 . . . . 74.099999999999994 110.725 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.49 -49.09 12.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.247 0.462 . . . . 64.420000000000002 112.247 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.73 -23.27 19.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.492 0.923 . . . . 72.0 113.492 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.93 62.58 3.51 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 111.59 -0.604 . . . . 53.210000000000001 111.59 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.8 148.06 24.86 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.906 -1.516 . . . . 65.099999999999994 106.906 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -68.42 -60.85 2.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.208 0.458 . . . . 73.439999999999998 111.9 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.8 p -163.11 165.22 24.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.023 -0.362 . . . . 74.25 110.023 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.28 137.28 52.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.901 -0.778 . . . . 73.430000000000007 108.901 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.64 145.43 22.47 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.065 -0.97 . . . . 70.319999999999993 110.051 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -54.87 131.33 44.01 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 124.201 1.0 . . . . 73.019999999999996 109.893 -177.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.28 -26.1 8.38 Favored Glycine 0 C--N 1.301 -1.369 0 CA-C-N 115.486 -0.779 . . . . 63.530000000000001 111.653 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -80.69 117.51 21.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.676 0.991 . . . . 70.239999999999995 113.676 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.3 m-20 -70.4 132.19 45.23 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.431 -1.692 . . . . 73.200000000000003 106.431 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -133.26 146.6 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 CA-C-O 121.951 0.882 . . . . 74.140000000000001 110.981 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.6 mt -111.68 126.6 69.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 107.027 -1.472 . . . . 60.009999999999998 107.027 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' HB3' HD23 ' A' ' 67' ' ' LEU . 41.9 p90 -147.83 178.42 8.51 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.808 -0.357 . . . . 61.130000000000003 110.634 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -115.12 162.0 17.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.341 -2.096 . . . . 65.409999999999997 105.341 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 62' ' ' ALA . 16.4 tp -130.69 128.37 40.75 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.948 0.88 . . . . 72.120000000000005 112.841 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 44.0 mt-10 -116.9 146.48 42.92 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.395 -1.73 . . . . 75.409999999999997 108.55 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.63 137.3 33.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.277 0.561 . . . . 63.130000000000003 111.873 -172.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -116.94 74.25 0.9 Allowed 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.585 -0.894 . . . . 72.510000000000005 108.585 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 65.58 -72.28 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.931 1.292 . . . . 72.409999999999997 111.838 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 -1.38 4.79 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.062 -0.815 . . . . 70.140000000000001 111.062 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 7.3 mmpt? -104.12 164.97 11.35 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.059 -0.719 . . . . 71.109999999999999 109.059 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -129.23 127.22 40.81 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.463 -0.569 . . . . 75.0 109.463 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.9 p90 -122.58 128.7 51.05 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.699 0.761 . . . . 73.420000000000002 112.831 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.83 130.98 37.34 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.382 -1.281 . . . . 74.510000000000005 110.218 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.9 m -135.36 168.77 22.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.938 -1.028 . . . . 61.0 108.871 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 57.7 t30 53.18 63.92 2.05 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.724 0.64 . . . . 61.119999999999997 111.138 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 44.5 mt -82.47 146.79 29.08 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.538 0.685 . . . . 73.310000000000002 112.528 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -148.77 130.72 15.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.016 -2.216 . . . . 75.310000000000002 105.016 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.82 148.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.176 -1.01 . . . . 74.299999999999997 112.784 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.34 -0.845 . . . . 73.109999999999999 109.769 172.507 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 108.473 -0.936 . . . . 61.25 108.473 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -129.56 153.73 47.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.267 0.469 . . . . 50.5 112.267 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 m120 58.07 42.04 23.1 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.985 0.914 . . . . 73.44 110.739 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 42.1 mt -75.68 150.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.428 -0.806 . . . . 63.11 112.14 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.8 t -96.43 138.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-N 114.854 -1.067 . . . . 70.44 109.777 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.71 171.01 43.94 Favored Glycine 0 N--CA 1.403 -3.524 0 C-N-CA 120.808 -0.71 . . . . 73.03 112.555 168.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -119.5 143.61 47.46 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.742 -0.836 . . . . 71.14 108.742 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.7 107.77 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.429 -0.952 . . . . 70.32 108.429 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 64.5 tttp -69.18 -43.07 74.96 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.823 -1.08 . . . . 74.23 108.57 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -171.85 155.34 3.84 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 114.729 -1.123 . . . . 72.32 108.346 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -159.99 121.77 3.24 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.624 0.577 . . . . 72.54 109.557 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -111.21 108.34 17.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.866 -0.42 . . . . 75.41 109.866 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 p -58.23 -23.64 56.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.215 -0.902 . . . . 45.1 112.709 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 m -57.46 -36.16 71.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.872 0.469 . . . . 72.35 110.941 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -114.73 -9.05 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.346 -0.542 . . . . 75.23 110.346 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 63.52 25.04 14.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.774 0.83 . . . . 73.1 111.837 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.41 158.34 23.67 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 116.035 -0.53 . . . . 73.41 109.966 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.51 -167.69 38.87 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.355 -1.098 . . . . 74.03 110.355 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -134.67 168.69 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.17 0.51 . . . . 73.25 110.981 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.465 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 66.4 mt -140.69 138.69 35.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.3 -0.863 . . . . 64.33 108.672 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' OE2' ' HG3' ' A' ' 10' ' ' LYS . 11.7 pt-20 -143.03 141.7 31.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.829 -1.545 . . . . 70.33 106.829 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -83.8 151.17 25.32 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 117.603 -1.639 . . . . 71.43 108.835 173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.27 -19.75 48.58 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 123.95 0.782 . . . . 72.43 111.926 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.16 1.14 51.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.157 -0.474 . . . . 70.43 111.872 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 45.88 1.13 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.579 -1.295 . . . . 65.01 112.569 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.69 154.67 36.3 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.888 -1.285 . . . . 63.24 109.888 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.77 169.69 14.95 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.788 0.662 . . . . 51.41 112.788 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' HE2' ' A' ' 10' ' ' LYS . 3.1 m-20 -70.87 90.44 0.8 Allowed 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.233 -0.894 . . . . 72.24 112.619 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 55' ' ' LEU . 5.7 p -105.34 123.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.309 -0.997 . . . . 73.34 108.309 173.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 48.5 p90 -83.5 141.94 31.27 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.058 0.456 . . . . 74.31 111.539 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 8.9 p -97.96 130.46 46.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.671 -0.695 . . . . 73.51 109.624 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 35' ' ' SER . 83.9 t60 -109.36 148.41 31.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.557 -0.905 . . . . 75.35 108.557 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -57.54 -30.14 64.96 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 114.075 1.139 . . . . 64.41 114.075 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.418 ' H ' ' CD2' ' A' ' 33' ' ' HIS . 39.4 t -54.44 -27.8 39.77 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.998 0.363 . . . . 74.13 111.325 174.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.26 -39.52 62.95 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.013 0.435 . . . . 54.21 109.959 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 42' ' ' LEU . 79.1 t -61.97 -50.65 79.23 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.889 0 N-CA-C 108.217 -1.031 . . . . 71.23 108.217 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.84 -22.63 67.03 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.178 0.924 . . . . 74.45 111.935 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.66 72.48 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.245 0.545 . . . . 75.52 110.741 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.89 -13.92 10.68 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.528 -0.76 . . . . 71.34 110.115 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.28 55.18 22.63 Favored Glycine 0 CA--C 1.486 -1.778 0 N-CA-C 109.743 -1.343 . . . . 51.43 109.743 -173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -64.18 125.99 26.3 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.592 -1.633 . . . . 72.52 106.592 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -73.81 -34.45 64.61 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 114.042 1.127 . . . . 75.01 114.042 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -161.4 143.68 12.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.873 0.368 . . . . 70.13 111.218 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.54 144.5 37.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.544 -0.753 . . . . 65.24 109.038 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.18 171.29 20.48 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.533 -1.284 . . . . 74.11 107.533 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 133.4 51.23 Favored 'General case' 0 N--CA 1.417 -2.095 0 C-N-CA 123.875 0.87 . . . . 75.11 110.096 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.44 -32.84 5.54 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.615 -0.721 . . . . 41.43 113.51 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.0 126.74 28.64 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.741 1.015 . . . . 62.24 113.741 -178.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.79 133.38 43.25 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 106.389 -1.708 . . . . 72.41 106.389 169.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 141.44 38.89 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 CA-C-O 122.125 0.964 . . . . 54.54 110.25 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 54.3 mt -114.92 124.18 71.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 N-CA-C 106.27 -1.752 . . . . 71.11 106.27 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.36 179.39 7.12 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.609 -0.437 . . . . 74.32 111.497 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -117.42 158.8 23.84 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 105.649 -1.982 . . . . 64.14 105.649 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 62' ' ' ALA . 17.2 tp -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 121.864 0.84 . . . . 74.34 112.577 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.21 157.28 30.59 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.674 -1.603 . . . . 75.33 108.755 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -100.19 155.22 17.87 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-O 122.082 0.944 . . . . 73.32 112.9 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.8 tptt -118.78 85.1 2.3 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.308 -1.738 . . . . 75.41 106.308 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 65.8 -76.04 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.063 0.852 . . . . 75.13 109.483 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.28 -4.69 3.17 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.378 -0.689 . . . . 70.24 111.378 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 55.3 mtpt -89.06 165.7 14.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 122.807 0.443 . . . . 60.14 110.934 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.55 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.97 123.16 40.28 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.757 0.28 . . . . 72.5 111.757 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 41.0 p90 -125.65 132.94 52.36 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.364 0.602 . . . . 73.42 111.695 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.45 134.99 37.29 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.038 -0.983 . . . . 41.04 110.446 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.3 m -137.65 165.92 25.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.205 -0.907 . . . . 61.11 108.864 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.52 64.07 1.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.648 0.593 . . . . 51.04 111.383 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 32' ' ' VAL . 24.7 mt -80.2 142.67 34.47 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.463 -0.895 . . . . 72.42 112.443 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 23.0 tpp180 -138.79 131.56 29.22 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.151 -1.796 . . . . 73.44 106.151 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.34 1.8 pp -90.59 96.56 6.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 116.065 1.876 . . . . 40.4 116.065 -177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.6 tttp . . . . . 0 C--O 1.259 1.585 0 C-N-CA 125.703 1.601 . . . . 52.24 113.744 173.762 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 105.582 -2.007 . . . . 64.41 105.582 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.3 p -108.84 148.98 29.77 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.242 0.83 . . . . 53.32 113.242 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 52.48 76.16 0.2 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.36 -1.291 . . . . 72.3 112.111 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 36.6 mt -102.76 143.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.653 -1.158 . . . . 74.45 110.182 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 58.8 t -91.47 133.55 32.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.018 -0.992 . . . . 55.15 109.522 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.85 172.26 38.84 Favored Glycine 0 N--CA 1.396 -3.984 0 CA-C-N 115.45 -0.795 . . . . 73.35 112.166 171.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.7 ttmt -123.53 143.06 50.43 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.373 -0.973 . . . . 73.52 108.373 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.84 111.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 108.39 -0.967 . . . . 71.13 108.39 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.1 tttp -76.99 -40.57 46.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.549 -1.205 . . . . 72.32 108.786 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.404 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 68.5 p-90 -177.65 160.58 1.58 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 124.265 1.026 . . . . 75.24 109.1 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -155.35 134.61 12.36 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.007 0.432 . . . . 73.45 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.71 106.05 10.97 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.757 -0.656 . . . . 72.35 109.386 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.4 p -61.04 -32.62 72.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.612 -0.722 . . . . 73.33 112.439 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.0 m -61.88 -28.71 69.7 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.988 0.423 . . . . 64.4 110.686 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.21 -9.0 18.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.43 -0.508 . . . . 75.41 111.812 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 17' ' ' ASN . 0.7 OUTLIER 63.76 25.99 14.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 120.924 0.392 . . . . 75.23 110.077 -176.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -137.64 165.87 25.31 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.4 0.68 . . . . 62.43 112.318 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.53 44.38 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.507 -1.837 . . . . 53.31 108.507 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 39.0 m-85 -133.19 160.24 37.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 117.465 0.633 . . . . 74.12 111.534 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -145.47 130.11 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.092 -0.958 . . . . 72.31 108.465 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.88 149.65 37.23 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.363 -1.717 . . . . 74.31 106.363 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -74.87 146.85 41.58 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 117.708 -1.597 . . . . 72.31 109.24 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.47 -21.09 35.09 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.292 -1.322 . . . . 72.3 111.0 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.69 5.26 11.55 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.124 -0.944 . . . . 75.1 111.14 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.54 50.39 2.75 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 111.529 -0.629 . . . . 50.55 111.529 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.33 172.47 54.62 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.477 -0.868 . . . . 73.21 112.498 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.75 151.99 43.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.149 -0.525 . . . . 72.35 110.447 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.26 116.71 20.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.081 0.943 . . . . 74.03 111.144 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 55' ' ' LEU . 2.5 p -133.17 133.48 58.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.722 -1.127 . . . . 74.5 108.776 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 52.9 p90 -88.91 152.32 21.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 120.251 -0.58 . . . . 64.22 111.331 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -109.34 128.04 65.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.516 0.674 . . . . 74.43 109.409 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -109.63 156.73 19.84 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.396 -0.965 . . . . 74.32 108.396 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -22.48 65.99 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 113.265 0.839 . . . . 74.3 113.265 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -55.86 -27.41 51.52 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.988 0.423 . . . . 73.03 110.575 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -76.48 -34.14 58.66 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.912 0.387 . . . . 64.02 110.169 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 -47.85 78.91 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.625 0 N-CA-C 107.917 -1.142 . . . . 71.13 107.917 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.24 -22.79 67.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.68 0.622 . . . . 62.53 112.68 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.19 69.44 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.825 0.305 . . . . 71.04 111.825 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -21.78 2.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.286 0.565 . . . . 73.11 112.429 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.85 51.91 5.23 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.483 -1.047 . . . . 43.04 110.483 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.94 129.19 38.92 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.58 -1.267 . . . . 65.53 107.58 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -62.44 -39.04 92.05 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.68 0.622 . . . . 65.55 112.68 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.5 t -171.06 156.56 4.86 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 110.096 -0.335 . . . . 73.31 110.096 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.4 mt -135.72 132.28 36.68 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.215 -0.661 . . . . 72.44 109.215 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.88 160.78 34.03 Favored 'General case' 0 C--N 1.266 -3.039 0 C-N-CA 125.547 1.539 . . . . 73.42 107.023 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 155.12 37.09 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.368 0.877 . . . . 70.11 113.368 -172.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.37 -19.97 48.85 Favored Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.815 -1.084 . . . . 73.1 112.02 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.471 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -89.4 132.29 35.06 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 122.557 0.343 . . . . 74.13 111.422 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.6 m-20 -87.32 138.62 31.33 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.465 -0.939 . . . . 75.22 108.465 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.77 149.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-O 121.807 0.813 . . . . 60.31 110.893 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 63.2 mt -111.72 135.79 49.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 106.482 -1.673 . . . . 51.04 106.482 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.52 178.4 8.65 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.8 -0.36 . . . . 75.12 110.161 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -119.81 154.54 34.12 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 105.077 -2.194 . . . . 74.55 105.077 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 30' ' ' VAL . 27.4 tp -121.07 130.69 53.87 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 113.324 0.861 . . . . 54.23 113.324 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -124.6 150.16 46.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.481 -1.69 . . . . 75.32 111.131 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -100.83 127.09 47.43 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.068 -0.969 . . . . 73.41 110.251 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.1 tptp -93.76 28.76 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.396 1.078 . . . . 73.5 108.543 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.84 90.86 0.08 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.7 -1.136 . . . . 74.2 107.981 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.37 -44.78 2.61 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.401 -0.818 . . . . 51.5 111.741 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.7 mmmt -95.95 153.07 17.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.975 -0.38 . . . . 62.01 109.975 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -126.24 122.6 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.797 -0.446 . . . . 63.03 109.797 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.7 p90 -130.84 140.31 50.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 72.13 111.963 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.34 136.33 44.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.435 -1.257 . . . . 31.14 109.812 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 m -136.9 163.02 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.708 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.72 63.56 1.91 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.012 0.82 . . . . 72.14 111.034 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 32' ' ' VAL . 28.7 mt -75.59 149.56 38.25 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.715 -0.794 . . . . 72.44 112.336 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 20.1 tpp180 -148.89 130.97 15.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -74.73 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 118.2 0.455 . . . . 62.13 111.441 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.177 -0.919 . . . . 73.04 109.83 177.104 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 109.351 -0.611 . . . . 51.0 109.351 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -95.87 140.51 30.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.675 0.61 . . . . 75.13 112.411 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 49.51 72.15 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.819 1.044 . . . . 71.13 113.819 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 57.0 mt -92.66 151.13 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.146 -0.934 . . . . 72.15 110.081 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 55.9 t -92.28 139.35 18.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.509 -0.768 . . . . 61.35 110.377 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -174.42 179.13 45.95 Favored Glycine 1 N--CA 1.395 -4.039 0 CA-C-N 115.274 -0.875 . . . . 61.23 112.239 169.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 37.5 ttmt -132.69 142.76 49.22 Favored 'General case' 0 C--N 1.259 -3.339 0 C-N-CA 124.017 0.927 . . . . 72.33 108.713 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.36 109.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.667 0.746 . . . . 51.41 109.072 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 22' ' ' GLU . 59.5 tttp -68.38 -40.73 81.28 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.495 1.518 . . . . 73.22 108.613 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 69.7 p-90 -177.76 160.51 1.53 Allowed 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.267 1.427 . . . . 75.32 108.504 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -161.25 133.6 5.96 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.227 0.33 . . . . 73.32 110.227 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -122.29 103.94 9.09 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.629 -0.714 . . . . 51.33 109.368 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -57.11 -32.25 66.12 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.294 -0.866 . . . . 62.24 112.504 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.8 m -60.75 -34.64 74.74 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 112.126 0.417 . . . . 72.53 112.126 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -101.05 -7.01 23.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.522 -0.471 . . . . 51.52 111.009 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.9 m120 66.93 21.45 10.35 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.243 1.017 . . . . 73.01 110.765 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -125.47 152.0 45.52 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.517 0.675 . . . . 61.41 112.398 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.99 -175.62 38.49 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.528 -1.429 . . . . 41.23 109.528 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 m-85 -131.45 165.16 24.14 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 117.05 0.425 . . . . 74.32 110.751 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 65.8 mt -139.44 139.22 39.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.781 -0.822 . . . . 61.1 108.781 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.2 pt-20 -143.1 144.38 32.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.542 -1.651 . . . . 71.2 106.542 175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.2 pt20 -84.49 151.91 24.3 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 117.451 -1.7 . . . . 73.44 109.633 174.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.91 -18.54 23.76 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.925 -1.034 . . . . 62.33 111.648 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -87.13 -0.93 57.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 73.34 111.41 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.14 51.02 1.1 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.689 -1.243 . . . . 71.34 112.782 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.47 150.08 26.67 Favored Glycine 0 C--N 1.318 -0.46 0 C-N-CA 119.948 -1.12 . . . . 75.2 110.819 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -66.91 171.99 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.572 0.952 . . . . 75.13 113.572 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.01 99.11 2.65 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.915 -0.584 . . . . 72.0 111.781 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 55' ' ' LEU . 7.1 p -117.71 129.45 74.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.028 -0.73 . . . . 72.43 109.028 174.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.6 p90 -92.44 142.5 27.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.092 -0.643 . . . . 74.4 111.345 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.47 122.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-O 121.589 0.709 . . . . 71.35 109.747 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.19 140.76 31.2 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.212 -1.033 . . . . 72.22 108.212 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -76.3 -11.42 59.9 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.917 1.08 . . . . 65.41 113.917 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -61.59 -21.79 64.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 120.623 -0.431 . . . . 65.24 109.846 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -71.99 -40.17 68.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.808 0.337 . . . . 34.42 110.197 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.35 -35.53 73.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.085 0 N-CA-C 108.007 -1.109 . . . . 74.11 108.007 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -66.28 -30.5 70.94 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.747 -0.66 . . . . 74.45 111.06 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.79 77.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.617 0.599 . . . . 64.32 112.617 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 -9.18 6.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.178 0.807 . . . . 75.44 113.178 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.99 57.71 7.47 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.49 -1.044 . . . . 54.24 110.49 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.38 131.28 46.78 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -50.83 -58.85 4.93 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.65 0.982 . . . . 64.0 113.65 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 p -170.62 147.25 2.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.199 0.444 . . . . 74.5 112.199 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -124.83 148.92 47.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.304 0.573 . . . . 72.34 110.109 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -166.69 162.13 16.14 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.226 -2.138 . . . . 61.24 105.226 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -69.1 149.94 48.14 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.907 -0.717 . . . . 61.32 111.295 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.77 -15.36 63.25 Favored Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.334 -0.848 . . . . 73.32 112.095 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -83.02 121.16 26.65 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 122.556 0.343 . . . . 64.0 111.476 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 m-20 -72.28 135.21 45.92 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.729 -1.212 . . . . 75.25 107.729 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.49 147.33 19.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 121.968 0.889 . . . . 62.4 111.514 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 60.0 mt -110.67 133.66 55.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 N-CA-C 107.073 -1.455 . . . . 74.12 107.073 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.1 p90 -148.14 174.78 11.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.187 0.518 . . . . 73.21 111.405 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.8 146.09 39.45 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.025 -1.472 . . . . 45.42 107.025 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 56' ' ' GLU . 25.1 tp -129.13 136.9 50.81 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.646 0.736 . . . . 62.31 111.585 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 55' ' ' LEU . 30.6 tt0 -153.15 143.98 22.82 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.473 -2.047 . . . . 71.3 105.473 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -85.67 140.65 30.37 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.892 1.071 . . . . 74.34 113.892 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 84.9 tttt -95.18 80.28 3.57 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.068 -1.827 . . . . 72.41 106.068 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 64.62 -81.6 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.252 1.021 . . . . 71.45 110.452 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.33 -6.83 7.96 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.364 -0.694 . . . . 74.12 111.364 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 9.5 mmpt? -92.49 164.79 13.33 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.293 -0.632 . . . . 71.21 109.293 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.13 118.53 24.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.774 -0.454 . . . . 62.52 109.774 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.2 p90 -126.78 136.03 51.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.375 0.607 . . . . 64.4 112.271 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 132.5 35.2 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.605 -1.18 . . . . 64.42 110.738 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 m -136.59 177.11 6.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 CA-C-N 115.167 -0.924 . . . . 72.52 109.337 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.25 63.16 2.35 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.92 0.762 . . . . 74.11 110.328 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 45.1 mt -81.93 147.46 29.25 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.319 0.859 . . . . 74.14 113.319 -174.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 22.7 tpp180 -151.33 130.64 12.82 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.315 -2.106 . . . . 73.12 105.315 175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -93.78 145.9 7.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 113.239 0.829 . . . . 75.53 113.239 -177.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 58.2 mtpt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 114.986 -1.006 . . . . 72.13 108.672 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 113.498 0.925 . . . . 71.25 113.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.0 p -141.01 140.95 34.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.478 -1.304 . . . . 72.13 107.478 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 58.81 74.2 0.45 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 106.833 -1.543 . . . . 65.1 106.833 -168.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.2 mt -101.47 147.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 113.852 -1.522 . . . . 63.0 111.65 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.4 t -91.27 140.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.502 -1.227 . . . . 72.12 109.384 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -179.91 161.08 26.59 Favored Glycine 0 N--CA 1.414 -2.785 0 C-N-CA 120.232 -0.985 . . . . 34.0 113.416 167.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 4.8 ttmp? -106.44 139.98 40.07 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.561 -0.903 . . . . 71.53 108.561 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.54 109.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.483 -0.932 . . . . 64.32 108.483 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 21' ' ' ILE . 55.2 tttp -67.59 -42.31 82.67 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.592 -1.64 . . . . 74.23 108.471 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -176.04 160.93 2.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 124.891 1.277 . . . . 71.02 107.783 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 81.3 t80 -163.35 131.97 3.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.043 0.449 . . . . 75.04 110.777 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -112.46 105.01 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.045 -1.094 . . . . 73.4 108.045 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.0 p -61.94 -36.2 80.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.951 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.6 m -63.51 -34.23 77.32 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.843 -0.617 . . . . 71.31 110.812 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 96.6 mttt -93.62 -8.13 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 62.2 111.052 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 m120 67.07 23.61 9.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.943 0.897 . . . . 61.31 112.51 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 46.5 p90 -153.19 168.18 26.84 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 112.883 0.697 . . . . 74.03 112.883 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -177.66 -154.84 12.78 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 109.923 -1.271 . . . . 71.51 109.923 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.489 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 35.4 m-85 -140.03 169.48 17.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.513 0.656 . . . . 73.45 111.24 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 62.9 mt -145.27 140.38 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.163 -1.051 . . . . 73.41 108.163 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.1 139.68 30.55 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.013 -1.477 . . . . 63.33 107.013 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.5 pt20 -84.41 146.5 27.63 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 117.765 -1.574 . . . . 74.1 109.05 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.09 -13.98 20.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 124.632 1.208 . . . . 72.31 110.627 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 14.1 m120 -87.34 -5.11 59.02 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.772 -0.649 . . . . 73.33 110.592 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.98 0.67 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 118.324 -1.893 . . . . 74.43 113.681 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.2 146.37 19.61 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 119.838 -1.172 . . . . 74.11 110.428 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.66 -175.86 4.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.293 0.849 . . . . 70.21 113.293 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.89 99.11 1.01 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.692 -0.685 . . . . 75.14 111.878 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.33 123.21 59.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.361 -0.978 . . . . 71.4 108.361 173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.5 p90 -92.41 147.49 22.87 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 119.559 -0.856 . . . . 64.02 111.16 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -104.0 124.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 109.06 -0.719 . . . . 61.41 109.06 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -108.71 149.92 28.31 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.412 -0.959 . . . . 74.33 108.412 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.19 -22.64 61.31 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 113.502 0.927 . . . . 64.35 113.502 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.2 m -56.32 -23.38 36.64 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 120.388 -0.525 . . . . 74.03 111.102 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -77.92 -36.22 49.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.871 -0.418 . . . . 74.34 109.871 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 42' ' ' LEU . 60.8 t -61.9 -49.8 82.73 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.868 0 N-CA-C 107.416 -1.327 . . . . 75.31 107.416 172.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.93 -33.03 68.38 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.435 1.084 . . . . 72.53 111.73 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -30.12 68.84 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.998 0.427 . . . . 61.1 112.135 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.74 0.08 4.87 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.601 -0.44 . . . . 54.2 111.706 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.05 55.52 27.72 Favored Glycine 0 C--N 1.313 -0.746 0 N-CA-C 110.434 -1.066 . . . . 63.42 110.434 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -64.94 137.5 57.78 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.728 -1.582 . . . . 63.3 106.728 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -61.88 -61.14 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.895 0.331 . . . . 72.33 111.895 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -159.88 151.42 19.92 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.778 -0.453 . . . . 74.33 109.778 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 88.2 mt -123.87 146.59 48.3 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.545 -0.539 . . . . 60.35 109.545 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -160.51 162.12 32.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 106.058 -1.83 . . . . 62.12 106.058 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -68.35 148.86 50.12 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.744 -0.782 . . . . 72.52 110.627 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.58 -16.85 60.32 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.492 -0.776 . . . . 75.04 112.484 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.34 128.37 33.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 122.789 -0.242 . . . . 73.23 110.425 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 26.6 m-20 -88.01 138.56 31.35 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.991 -0.744 . . . . 63.13 108.991 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.64 154.23 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.712 -0.676 . . . . 62.04 110.656 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 55.2 mt -119.97 131.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.841 -1.54 . . . . 71.14 106.841 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 45.5 p90 -144.38 -179.98 6.88 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.795 0.331 . . . . 75.41 111.426 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -117.37 159.88 22.05 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.674 -1.232 . . . . 64.42 107.674 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.3 tp -136.79 132.95 35.43 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 121.31 0.576 . . . . 62.32 110.958 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.53 145.39 51.47 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.828 -1.078 . . . . 73.53 108.156 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.86 112.2 20.91 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.45 0.643 . . . . 62.42 111.955 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -84.11 85.68 7.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.518 -1.29 . . . . 64.22 107.518 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 66.85 -71.54 0.1 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.562 1.145 . . . . 71.11 110.703 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 -6.72 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.654 -0.978 . . . . 21.53 110.654 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -92.09 165.65 13.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.076 0.55 . . . . 63.35 109.667 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -133.4 125.59 29.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.332 0.253 . . . . 52.34 110.627 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -136.46 139.88 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.063 0.459 . . . . 74.34 110.921 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 136.58 39.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.698 -1.137 . . . . 73.44 111.282 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.4 m -137.24 165.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.266 -0.879 . . . . 64.51 109.614 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 56.04 65.21 1.5 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.43 0.692 . . . . 75.21 111.06 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' VAL . 27.9 mt -78.69 140.73 38.32 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.5 -0.88 . . . . 71.04 113.115 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.599 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 8.4 mpt_? -127.97 135.73 50.33 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.168 -1.79 . . . . 73.11 106.168 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -78.69 133.08 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 119.576 -0.85 . . . . 61.25 109.641 172.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.532 -0.758 . . . . 72.25 109.219 176.123 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 107.769 -1.197 . . . . 71.3 107.769 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -111.58 147.41 35.51 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.219 -0.446 . . . . 51.41 110.804 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 m120 59.34 75.87 0.38 Allowed 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.13 0.894 . . . . 74.0 110.977 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 23.9 mt -104.33 146.41 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.535 -0.757 . . . . 72.12 111.134 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.65 134.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.865 -1.061 . . . . 73.22 109.819 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 23' ' ' GLN . . . 179.09 163.19 29.7 Favored Glycine 0 CA--C 1.454 -3.774 0 C-N-CA 120.325 -0.94 . . . . 65.11 113.493 168.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.2 ttmt -101.81 142.27 33.39 Favored 'General case' 0 C--N 1.252 -3.644 0 CA-C-N 114.622 -0.789 . . . . 73.42 109.241 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.1 108.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.358 -0.979 . . . . 73.24 108.358 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.554 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 57.5 tttp -68.07 -38.84 82.88 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.419 -1.264 . . . . 73.31 108.19 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 177.78 157.5 0.39 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 125.272 1.429 . . . . 75.33 108.616 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -146.12 119.52 9.02 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.317 0.58 . . . . 63.1 110.541 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -88.05 107.11 18.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.893 -1.521 . . . . 74.13 106.893 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -11.88 60.01 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.107 0.41 . . . . 61.32 112.107 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 m -79.52 -46.47 17.33 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.27 -0.641 . . . . 73.15 109.27 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -97.41 -7.68 31.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.564 0.579 . . . . 71.3 112.564 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 66.76 27.67 9.18 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.577 0.584 . . . . 70.01 112.577 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -122.79 157.68 31.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.89 -0.595 . . . . 63.41 109.594 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.96 29.57 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.794 -1.323 . . . . 64.33 109.794 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 60.4 m-85 -141.24 167.64 21.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 117.396 0.598 . . . . 75.02 110.768 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 59.2 mt -145.4 134.16 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.123 -0.695 . . . . 75.21 109.123 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -144.11 148.54 35.24 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.949 -1.5 . . . . 64.43 106.949 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.685 ' HB3' ' HA2' ' A' ' 7' ' ' GLY 0.272 0.0 OUTLIER -91.83 158.8 16.12 Favored 'General case' 0 CA--C 1.462 -2.442 0 C-N-CA 115.245 -2.582 . . . . 71.1 109.849 172.714 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.15 -15.52 5.76 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 124.301 1.001 . . . . 72.14 113.027 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 13.5 m120 -84.36 -2.1 56.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.671 -0.24 . . . . 62.31 111.313 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.22 50.75 0.7 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.871 -0.68 . . . . 61.25 112.8 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.91 52.13 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.494 -0.86 . . . . 72.34 113.461 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -74.88 -178.63 3.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.142 0.496 . . . . 73.14 112.223 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.77 101.3 12.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.898 0.38 . . . . 65.13 110.598 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 55' ' ' LEU . 6.3 p -128.3 123.76 60.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.411 -0.959 . . . . 73.54 108.411 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 52.6 p90 -87.69 147.14 25.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 120.119 -0.632 . . . . 52.05 111.661 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 67' ' ' LEU . 9.2 p -109.28 141.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.0 -0.741 . . . . 73.34 109.0 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -131.66 155.81 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.235 -0.654 . . . . 72.44 109.235 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -63.47 -18.44 63.77 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 113.151 0.797 . . . . 72.42 113.151 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -57.97 -27.18 63.22 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 120.961 0.41 . . . . 73.4 110.639 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -78.63 -35.77 45.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.833 -0.432 . . . . 62.32 109.833 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 42' ' ' LEU . 71.9 t -61.98 -48.38 88.83 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.308 0 N-CA-C 107.715 -1.216 . . . . 41.34 107.715 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.84 -33.04 66.39 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.303 1.041 . . . . 74.13 111.241 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.34 68.32 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.112 0.782 . . . . 53.33 113.112 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.99 -2.49 4.62 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.6 52.52 50.45 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 123.65 0.643 . . . . 43.54 112.969 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -67.65 142.86 56.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.328 -1.73 . . . . 70.42 106.328 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -64.39 -62.42 1.62 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.6 0.593 . . . . 51.23 112.6 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.9 m -167.54 162.68 14.47 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.116 -1.068 . . . . 75.11 108.116 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.68 154.73 45.53 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.729 0.776 . . . . 72.43 112.006 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 174.97 14.6 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.531 -1.655 . . . . 61.52 106.531 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 157.8 28.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.28 0.562 . . . . 62.51 112.225 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.64 14.43 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.584 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.56 126.43 30.78 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 112.229 0.455 . . . . 44.52 112.229 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -81.95 134.46 35.38 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.222 -1.399 . . . . 71.21 107.222 173.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.88 150.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 CA-C-O 121.926 0.87 . . . . 62.52 110.463 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 78.4 mt -115.28 131.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 N-CA-C 106.888 -1.523 . . . . 73.1 106.888 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.48 -178.78 6.34 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.49 -0.559 . . . . 75.14 109.49 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.76 158.63 28.39 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.236 -1.764 . . . . 65.22 106.236 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 62' ' ' ALA . 26.9 tp -129.19 123.18 31.4 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.287 1.041 . . . . 63.14 112.744 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.02 143.78 46.9 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.311 -1.768 . . . . 75.3 107.561 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.41 141.67 28.35 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.766 -0.774 . . . . 74.4 110.38 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 tpmt? -86.24 -61.32 1.77 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.966 -1.494 . . . . 71.41 106.966 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 61' ' ' LYS . 6.5 tp-100 170.46 86.21 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.349 -2.093 . . . . 73.42 105.349 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.74 -29.94 2.61 Favored Glycine 0 C--N 1.307 -1.078 0 N-CA-C 111.089 -0.804 . . . . 62.4 111.089 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -92.71 144.75 24.99 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.161 -1.052 . . . . 71.2 108.161 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -128.71 120.24 26.1 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.968 -0.752 . . . . 34.44 108.968 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 4.2 p90 -129.16 137.12 50.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.381 0.61 . . . . 75.11 112.472 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.0 129.15 38.7 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.46 -1.245 . . . . 74.44 110.224 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.7 166.01 29.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.158 -0.928 . . . . 71.33 109.047 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.77 63.3 2.09 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.871 0.732 . . . . 73.5 110.604 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CG2' ' A' ' 32' ' ' VAL . 21.4 mt -76.4 133.62 39.86 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 119.219 -0.992 . . . . 70.14 112.898 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -137.71 131.27 31.11 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 113.899 -1.5 . . . . 72.35 107.858 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.414 ' O ' HD12 ' A' ' 69' ' ' ILE . 2.4 pp -75.3 146.14 9.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.908 -1.117 . . . . 74.41 110.634 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 4.2 ttpm? . . . . . 0 C--O 1.259 1.581 0 CA-C-O 118.115 -0.945 . . . . 72.3 108.873 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 108.643 -0.873 . . . . 51.33 108.643 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -111.8 143.31 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.413 -0.812 . . . . 74.41 112.243 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.1 t30 49.62 75.22 0.17 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.905 1.282 . . . . 74.34 110.376 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.8 mt -99.43 148.98 5.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.773 -1.103 . . . . 74.54 111.192 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.3 p -90.35 139.14 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 115.565 -0.743 . . . . 42.44 109.197 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -164.14 170.49 39.39 Favored Glycine 1 N--CA 1.395 -4.055 0 C-N-CA 120.334 -0.936 . . . . 74.32 112.102 172.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -126.12 138.48 53.68 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 108.533 -0.914 . . . . 64.23 108.533 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.03 107.53 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 109.135 -0.691 . . . . 70.34 109.135 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.504 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 27.2 mtpp -65.71 -46.67 78.1 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.149 -0.932 . . . . 45.15 109.241 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 58.9 p-90 -172.7 160.1 4.46 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 114.894 -1.048 . . . . 71.43 108.504 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 90.3 t80 -160.5 108.47 1.61 Allowed 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.264 -1.013 . . . . 75.12 108.264 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 15' ' ' THR . 19.5 t-20 -84.85 106.19 16.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.82 -0.807 . . . . 73.14 108.82 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 p -64.42 -17.49 63.84 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.487 0.715 . . . . 72.52 112.648 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 56.5 m -80.56 -43.5 20.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 120.935 0.398 . . . . 73.4 110.59 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 16' ' ' LYS . 11.0 mmpt? -96.86 -8.15 31.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.9 0.333 . . . . 43.51 111.9 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 67.68 24.44 8.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.023 0.929 . . . . 65.44 112.076 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.51 152.6 49.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 122.099 -0.376 . . . . 74.31 111.241 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -171.67 -168.63 33.5 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 111.178 -0.769 . . . . 73.44 111.178 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.504 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 40.4 m-85 -135.52 153.77 51.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.009 0.524 . . . . 61.13 111.529 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -137.23 134.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.718 -0.845 . . . . 73.33 108.718 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 12.7 pt-20 -143.63 150.62 39.04 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.222 -1.769 . . . . 73.2 106.222 173.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.715 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.268 0.5 OUTLIER -70.52 144.65 51.26 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 117.981 -1.488 . . . . 71.04 111.215 174.144 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.8 -39.39 11.77 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.671 -1.604 . . . . 70.05 112.686 -172.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.02 -9.4 30.16 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.64 0.776 . . . . 70.0 113.011 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 50.54 2.53 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.702 -0.761 . . . . 74.33 111.222 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.66 -99.66 0.33 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.083 -0.579 . . . . 75.21 113.179 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.621 0.248 . . . . 74.33 110.718 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.62 97.77 10.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.936 -0.575 . . . . 72.42 109.48 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 55' ' ' LEU . 2.6 p -116.4 139.54 42.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.889 -0.596 . . . . 72.42 109.549 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 50.1 p90 -88.53 145.19 25.87 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.839 -0.744 . . . . 75.42 111.334 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -95.4 131.28 42.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.384 -0.598 . . . . 52.02 109.384 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -107.91 146.87 31.78 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.108 -1.441 . . . . 75.31 107.108 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -68.14 -17.46 64.36 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.684 0.624 . . . . 70.21 112.684 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.6 t -54.92 -23.85 20.82 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 116.191 -0.459 . . . . 52.11 110.381 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.592 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -70.62 -41.68 71.91 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.571 0.224 . . . . 74.14 111.237 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.29 -41.49 83.76 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.837 0 N-CA-C 108.05 -1.093 . . . . 64.22 108.05 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.65 -24.38 67.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.947 -0.569 . . . . 71.23 110.889 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.9 45.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.265 0.839 . . . . 61.0 113.265 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.45 -23.37 2.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.813 0.671 . . . . 55.01 112.813 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.9 62.58 2.21 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.79 -0.641 . . . . 51.52 112.088 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 142.69 33.71 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.963 -1.866 . . . . 74.1 105.963 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -58.96 -59.34 5.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 117.737 0.244 . . . . 74.11 111.59 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 p -162.35 161.23 27.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.211 -0.663 . . . . 61.22 109.211 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 74.0 mt -124.02 134.28 53.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.859 -1.163 . . . . 61.03 107.859 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 150.1 34.3 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.08 -0.964 . . . . 74.45 108.479 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.5 OUTLIER -63.88 151.02 43.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.156 0.799 . . . . 74.23 113.156 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 -23.2 36.1 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.668 -1.151 . . . . 74.53 112.763 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.574 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.92 136.05 41.42 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 112.506 0.558 . . . . 64.24 112.506 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -85.97 135.67 33.57 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.665 -1.235 . . . . 53.41 107.665 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.05 151.58 20.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-O 121.49 0.662 . . . . 61.41 111.081 -172.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -116.09 134.21 60.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.9 p90 -144.86 -178.11 5.86 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.942 -0.392 . . . . 64.41 109.942 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.36 145.07 49.04 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.818 -1.549 . . . . 64.42 106.818 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 30' ' ' VAL . 28.3 tp -116.5 109.37 17.18 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 122.374 1.083 . . . . 73.51 110.578 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -122.06 136.96 54.97 Favored 'General case' 0 C--N 1.258 -3.391 0 N-CA-C 105.07 -2.196 . . . . 74.43 105.07 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.9 136.9 33.1 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 114.693 1.368 . . . . 73.13 114.693 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 60.8 tptt -82.47 79.78 8.81 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.774 -1.936 . . . . 71.45 105.774 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 67.37 -80.0 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.946 0.898 . . . . 65.52 109.69 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.05 7.3 4.42 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.718 -0.953 . . . . 51.45 110.718 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -102.45 155.89 17.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.835 -1.543 . . . . 72.04 106.835 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -117.54 122.05 42.63 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.864 -0.522 . . . . 71.32 111.107 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -135.53 142.66 45.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.026 0.441 . . . . 73.53 109.986 178.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.62 33.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.233 -0.894 . . . . 61.1 109.953 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.592 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.3 m -133.54 169.38 21.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 73.04 111.019 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 57.2 63.13 1.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.218 0.949 . . . . 54.04 110.49 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 33.2 mt -81.91 140.29 34.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.299 1.222 . . . . 74.01 114.299 -172.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -140.28 139.54 35.53 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 125.829 1.651 . . . . 71.04 106.923 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.42 147.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 117.207 -1.797 . . . . 52.32 110.944 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.254 1.33 0 O-C-N 124.239 0.962 . . . . 71.12 110.898 179.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 107.977 -1.12 . . . . 75.22 107.977 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.5 p -117.14 140.79 49.09 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 111.378 0.14 . . . . 75.32 111.378 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 76.26 0.37 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.873 0.844 . . . . 63.32 112.022 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 47.1 mt -106.33 148.45 10.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 114.679 -1.146 . . . . 55.34 110.099 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.6 p -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 O-C-N 124.06 0.85 . . . . 61.51 109.794 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -166.47 171.15 41.36 Favored Glycine 1 N--CA 1.396 -4.009 0 C-N-CA 120.393 -0.908 . . . . 71.21 112.306 170.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.9 ttmt -123.89 137.22 54.67 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.123 -1.065 . . . . 74.34 108.123 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.44 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.366 -0.975 . . . . 73.22 108.366 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.8 tttp -75.94 -44.58 39.35 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.12 -1.4 . . . . 62.23 109.386 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -169.54 157.83 7.44 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.632 -0.713 . . . . 74.33 110.269 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -147.45 133.17 18.91 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.598 -0.728 . . . . 61.54 109.437 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -106.08 118.0 35.48 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.506 -0.924 . . . . 72.13 108.506 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 t -68.26 -33.85 75.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.157 -0.474 . . . . 61.24 111.464 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 m -73.57 -49.29 27.07 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.822 0.344 . . . . 71.43 111.534 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 64.4 mttp -82.25 -8.26 59.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.198 0.444 . . . . 62.02 112.198 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 13.4 m120 63.76 22.25 13.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.102 0.778 . . . . 75.41 113.102 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 42.0 p90 -142.37 174.25 10.79 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.544 -0.863 . . . . 71.11 110.804 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.63 -155.29 13.62 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.615 -0.994 . . . . 65.12 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 30.4 m-85 -132.65 163.54 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.404 0.621 . . . . 72.43 112.023 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.8 mt -145.84 138.51 20.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.105 -1.443 . . . . 73.22 107.105 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.07 148.64 35.43 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.761 -1.57 . . . . 74.14 106.761 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.735 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.279 0.2 OUTLIER -72.17 147.58 46.45 Favored 'General case' 0 CA--C 1.47 -2.115 0 C-N-CA 117.464 -1.694 . . . . 63.22 109.971 172.071 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -49.25 -35.15 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.0 1.438 . . . . 74.44 112.443 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -70.01 -0.85 8.25 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.458 0.91 . . . . 74.01 113.458 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 51.52 4.05 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 120.304 -0.95 . . . . 54.3 111.085 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' OE1' ' A' ' 23' ' ' GLN . . . -75.39 -110.55 0.1 Allowed Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.983 -0.627 . . . . 74.52 114.369 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.13 174.55 5.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.981 0.42 . . . . 64.42 112.1 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -102.27 92.87 4.91 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.319 -0.993 . . . . 64.32 108.319 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 55' ' ' LEU . 5.5 p -116.74 124.45 72.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.633 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.4 p90 -91.19 149.16 21.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.009 -0.541 . . . . 72.03 110.189 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -107.63 132.39 55.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 109.335 -0.617 . . . . 71.51 109.335 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -111.93 145.1 40.17 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.077 -1.083 . . . . 71.13 108.077 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 35.9 ttpt -62.54 -22.96 66.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -54.17 -24.07 16.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 64.43 112.144 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.77 -39.25 70.11 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 122.127 -0.358 . . . . 52.1 110.643 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.56 -36.52 71.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 107.86 -1.163 . . . . 73.34 107.86 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.38 -29.54 70.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.069 -0.969 . . . . 75.43 110.87 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.14 -47.7 9.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.584 0.587 . . . . 74.15 112.584 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -9.87 28.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.019 0.748 . . . . 64.23 113.019 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.48 55.61 29.06 Favored Glycine 0 CA--C 1.498 -1.022 0 O-C-N 123.459 0.475 . . . . 74.43 112.224 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.5 tm? -69.49 141.5 53.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.255 -1.017 . . . . 73.4 108.255 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.518 ' N ' HD13 ' A' ' 42' ' ' LEU . 58.7 t-80 -51.75 -60.67 2.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.867 . . . . 72.33 112.334 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -172.51 162.43 5.25 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -124.82 121.08 33.54 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.852 0.834 . . . . 72.14 109.657 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.54 144.85 36.14 Favored 'General case' 0 C--N 1.245 -3.95 0 CA-C-N 113.962 -1.472 . . . . 60.41 108.463 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.65 147.13 53.1 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.605 0.717 . . . . 70.53 112.253 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.21 -16.9 59.41 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.001 -0.999 . . . . 42.45 111.891 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.28 137.47 35.8 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 122.496 0.318 . . . . 73.01 110.659 177.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 9.4 m-20 -88.53 137.48 32.29 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.018 -1.105 . . . . 74.31 108.018 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.65 149.52 23.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 121.704 0.764 . . . . 73.41 110.969 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.1 mt -111.75 137.62 43.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.182 -1.784 . . . . 72.33 106.182 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.09 178.87 9.01 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.708 -0.397 . . . . 75.23 110.705 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -114.43 160.52 19.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.843 -2.28 . . . . 63.41 104.843 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 18.7 tp -129.81 127.74 40.91 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 113.593 0.96 . . . . 62.53 113.593 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 55' ' ' LEU . 47.0 mt-10 -114.08 134.67 54.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.275 -1.784 . . . . 74.51 107.981 174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -93.41 134.18 35.91 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.284 0.564 . . . . 72.35 110.818 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 58.4 tptt -102.29 76.9 1.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.11 -1.441 . . . . 73.32 107.11 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 67.71 -70.43 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.647 1.179 . . . . 72.43 110.67 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 -15.56 1.45 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.22 -0.752 . . . . 75.42 111.22 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 54.7 mtpt -84.43 165.04 18.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.57 -0.53 . . . . 71.15 109.57 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -127.94 129.47 46.87 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.619 -0.433 . . . . 53.15 110.499 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.4 p90 -127.65 128.38 45.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 113.167 0.803 . . . . 71.04 113.167 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.48 133.29 43.62 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.264 -1.335 . . . . 72.14 110.688 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.64 164.41 30.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.015 -1.106 . . . . 71.34 108.015 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.71 63.33 2.28 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.733 0.646 . . . . 65.35 110.959 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 32' ' ' VAL . 38.4 mt -78.46 149.47 33.22 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.775 -0.648 . . . . 64.32 111.937 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -150.81 131.66 14.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.772 -1.936 . . . . 64.42 105.772 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 2.6 pp -80.33 140.57 16.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.366 -1.333 . . . . 73.45 112.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.088 -0.96 . . . . 74.33 109.214 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 109.576 -0.527 . . . . 72.31 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.8 p -115.87 142.56 46.61 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.65 -0.705 . . . . 54.22 110.983 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.35 78.09 0.2 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.035 0.921 . . . . 65.21 111.334 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.45 147.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 114.154 -1.384 . . . . 64.34 109.965 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 73.8 t -92.19 134.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 115.223 -0.899 . . . . 54.12 108.643 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.41 172.73 38.57 Favored Glycine 1 N--CA 1.392 -4.265 0 C-N-CA 120.27 -0.967 . . . . 72.34 112.154 171.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 27.5 ttpp -130.48 132.67 45.77 Favored 'General case' 0 C--N 1.257 -3.42 0 C-N-CA 125.204 1.402 . . . . 71.11 108.412 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.8 115.85 2.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.933 -0.576 . . . . 75.12 110.162 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 66.7 mttm -66.94 -49.43 65.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.413 -0.958 . . . . 73.13 108.413 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -173.78 165.43 4.42 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.246 -1.343 . . . . 74.23 108.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 85.5 t80 -153.79 121.25 5.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.4 0.438 . . . . 74.43 110.368 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -96.36 98.81 10.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.088 0.471 . . . . 71.04 109.946 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 m -58.93 -35.08 72.51 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.113 -0.949 . . . . 62.31 111.427 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 m -65.32 -31.12 72.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.236 0.541 . . . . 74.21 110.525 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -97.98 -9.01 26.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.1 -0.375 . . . . 73.34 111.997 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.82 23.36 11.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.973 0.509 . . . . 72.1 112.346 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 37.4 p90 -151.06 161.12 43.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.445 0.64 . . . . 62.32 112.539 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -166.95 -162.27 18.18 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.156 -1.578 . . . . 75.1 109.156 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 46.9 m-85 -135.71 154.84 51.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.938 0.869 . . . . 75.21 111.711 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.72 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.224 -0.658 . . . . 74.11 109.224 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 14.0 pt-20 -143.54 147.65 34.78 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 105.755 -1.942 . . . . 65.31 105.755 173.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.0 pt20 -80.73 151.3 28.93 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 116.786 -1.966 . . . . 72.01 109.44 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.74 -29.02 24.76 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.251 -1.34 . . . . 71.34 111.913 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -75.71 1.08 15.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.775 -0.648 . . . . 73.12 111.851 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.41 50.87 1.79 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.54 -0.838 . . . . 74.42 111.207 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.81 172.2 54.96 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.639 -0.791 . . . . 64.12 112.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.33 162.96 28.59 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.771 0.656 . . . . 50.41 112.771 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.14 97.67 10.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.398 -0.819 . . . . 45.22 110.604 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 55' ' ' LEU . 3.2 p -117.81 134.87 60.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.118 -0.947 . . . . 63.52 109.062 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 54.4 p90 -90.6 150.15 21.83 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.032 -0.667 . . . . 73.53 111.221 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -110.11 125.46 67.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.583 -0.525 . . . . 43.21 109.583 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -108.43 152.93 24.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.298 -1.001 . . . . 64.11 108.298 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.06 -16.04 39.23 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 113.073 0.768 . . . . 74.11 113.073 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -58.76 -26.42 63.99 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.228 0.537 . . . . 53.44 110.03 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.94 -36.44 56.56 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.983 0.42 . . . . 71.13 109.973 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.68 -48.85 84.76 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.091 0 N-CA-C 107.647 -1.242 . . . . 71.13 107.647 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.37 -28.23 58.55 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 124.816 1.246 . . . . 64.12 111.292 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.13 -23.32 67.1 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.458 0.54 . . . . 34.31 112.458 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.44 -24.15 2.29 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.712 0.634 . . . . 70.32 112.712 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.16 48.74 5.57 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.454 -1.059 . . . . 50.03 110.454 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 130.37 41.09 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.435 -1.32 . . . . 75.51 107.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.35 -47.78 75.26 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.128 1.158 . . . . 74.41 114.128 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.4 p -159.06 160.49 35.85 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.53 -0.468 . . . . 74.43 111.064 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.11 142.78 48.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.249 -1.019 . . . . 73.0 108.249 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.86 162.77 40.51 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 123.73 0.812 . . . . 71.54 109.319 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -67.49 153.33 43.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.445 0.641 . . . . 65.01 112.466 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -16.08 59.27 Favored Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.881 -1.054 . . . . 72.35 112.198 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -83.84 124.93 31.46 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.244 0.218 . . . . 62.45 111.122 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 15.4 m-20 -78.33 133.57 37.59 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 107.185 -1.413 . . . . 64.02 107.185 174.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.74 147.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.138 0 CA-C-O 121.913 0.863 . . . . 62.11 110.51 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 64.1 mt -109.98 132.28 58.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 N-CA-C 107.002 -1.481 . . . . 73.55 107.002 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.62 178.67 8.27 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.764 -0.458 . . . . 72.1 109.764 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -119.67 155.27 32.7 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.671 -1.974 . . . . 72.13 105.671 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 30' ' ' VAL . 26.3 tp -124.4 111.26 15.55 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.452 1.12 . . . . 75.23 112.649 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.74 141.51 45.26 Favored 'General case' 0 C--N 1.268 -2.953 0 CA-C-N 113.062 -1.881 . . . . 62.14 107.425 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -87.06 142.14 28.14 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.276 -0.638 . . . . 74.45 109.276 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -90.41 22.31 3.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.298 -1.371 . . . . 73.15 107.298 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 65.09 87.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 75.14 108.333 -172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.21 -58.41 0.6 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.692 -1.14 . . . . 74.45 111.24 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.1 mmmt -86.19 154.12 21.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.177 -0.305 . . . . 63.13 110.177 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.69 118.11 27.33 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.215 0.206 . . . . 70.44 110.574 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.2 p90 -131.89 140.41 49.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.367 0.603 . . . . 64.04 111.509 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -71.97 135.14 46.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.675 -1.148 . . . . 64.24 109.527 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.8 m -133.96 164.71 33.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.364 -0.835 . . . . 62.31 109.959 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.53 64.23 1.74 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.962 0.789 . . . . 54.32 111.593 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.549 HD11 HG21 ' A' ' 32' ' ' VAL . 28.9 mt -74.67 140.14 44.02 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.671 0.989 . . . . 63.31 113.671 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 75.5 ttt180 -143.51 131.35 21.5 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.36 -1.718 . . . . 73.13 106.36 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.9 148.72 4.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.346 -0.942 . . . . 73.34 111.536 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.556 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 3.7 ttpm? . . . . . 0 C--O 1.256 1.412 0 CA-C-O 118.758 -0.639 . . . . 73.23 109.498 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.434 -1.248 0 N-CA-C 107.144 -1.428 . . . . 64.0 107.144 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.5 p -100.43 140.29 34.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 123.357 0.411 . . . . 63.44 111.812 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 56.5 77.79 0.24 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.774 1.23 . . . . 60.03 110.701 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 2' ' ' ALA . 30.3 mt -100.42 148.4 6.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 114.627 -1.17 . . . . 50.41 109.564 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 87.8 t -92.81 132.84 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-N 115.369 -0.832 . . . . 70.33 109.522 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -161.99 163.93 35.08 Favored Glycine 1 N--CA 1.395 -4.087 0 CA-C-N 115.272 -0.877 . . . . 65.0 111.576 171.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -119.28 136.42 54.24 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.898 -1.149 . . . . 74.02 107.898 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.83 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.329 0.585 . . . . 75.45 109.572 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 49.1 tttp -70.18 -47.26 62.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.826 -1.079 . . . . 61.24 108.109 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.498 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 68.9 p-90 -173.66 165.75 4.52 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.16 0.984 . . . . 63.15 108.641 175.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.02 132.78 4.31 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.376 0.422 . . . . 74.45 110.596 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -125.39 107.81 11.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.463 -0.569 . . . . 71.11 109.463 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 m -57.55 -33.86 68.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.85 -0.614 . . . . 63.11 110.902 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.9 m -61.44 -33.17 73.28 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 115.951 -0.568 . . . . 73.21 111.219 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -97.62 -8.72 28.27 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 122.021 -0.424 . . . . 54.43 111.049 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 m120 61.26 21.48 11.97 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.784 0.834 . . . . 71.13 110.622 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -137.5 163.62 30.68 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.387 0.675 . . . . 73.3 110.894 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -175.02 -172.55 40.06 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 107.836 -2.106 . . . . 50.23 107.836 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 21.3 m-85 -136.05 162.93 31.52 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 117.749 0.775 . . . . 75.23 111.794 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.5 134.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.669 -1.151 . . . . 71.3 107.924 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.3 pt-20 -135.98 141.79 44.46 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.01 -2.219 . . . . 75.5 105.01 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.596 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -78.53 143.29 36.7 Favored 'General case' 0 CA--C 1.464 -2.353 0 C-N-CA 116.135 -2.226 . . . . 65.33 108.922 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.63 -18.01 4.02 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.793 1.308 . . . . 61.55 112.07 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.36 -0.32 28.53 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.603 -0.726 . . . . 73.43 111.428 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.4 41.91 35.78 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 110.995 -0.842 . . . . 75.34 110.995 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 -132.35 4.26 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.933 -0.651 . . . . 63.44 113.371 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -86.64 152.49 22.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.149 0.426 . . . . 71.13 112.149 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.2 130.25 47.26 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 116.073 -0.512 . . . . 75.25 110.126 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -138.66 143.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.823 -0.806 . . . . 60.21 108.823 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 51.5 p90 -93.53 148.99 21.58 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.696 -0.802 . . . . 65.41 111.603 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -105.74 128.85 59.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 CA-C-N 115.75 -0.659 . . . . 52.34 109.316 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -110.02 150.34 28.68 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.015 -0.735 . . . . 73.3 109.015 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.7 -18.82 64.39 Favored 'General case' 0 C--O 1.203 -1.395 0 N-CA-C 113.671 0.989 . . . . 71.4 113.671 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -57.22 -27.5 62.06 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.942 0.401 . . . . 74.52 110.314 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -75.96 -35.73 59.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 120.986 0.422 . . . . 75.13 110.38 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.84 -37.77 77.83 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.286 0 N-CA-C 108.292 -1.003 . . . . 73.41 108.292 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.88 -32.58 73.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.053 0.541 . . . . 70.12 110.722 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.96 66.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.35 112.72 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -23.3 2.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.21 0.819 . . . . 61.11 113.21 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 53.93 3.57 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 109.954 -1.258 . . . . 61.21 109.954 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -75.58 127.0 32.11 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.89 -0.655 . . . . 35.14 111.396 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -104.61 -0.4 27.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.816 -0.629 . . . . 72.3 111.391 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 m -123.32 79.3 1.66 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.151 1.167 . . . . 43.32 114.151 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.16 114.1 19.2 Favored 'General case' 0 C--N 1.251 -3.683 0 N-CA-C 108.108 -1.071 . . . . 60.22 108.108 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -151.79 158.19 42.97 Favored 'General case' 1 C--N 1.243 -4.035 0 CA-C-N 113.94 -1.482 . . . . 70.55 107.239 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.12 148.83 49.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.695 0.759 . . . . 74.51 112.344 -174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.29 -18.61 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 CA-C-N 114.82 -1.082 . . . . 63.24 113.993 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -71.03 135.05 47.59 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 117.546 0.673 . . . . 52.55 111.644 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.07 135.11 34.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.426 -1.324 . . . . 73.22 107.426 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.56 145.28 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-O 121.981 0.896 . . . . 64.32 110.989 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.99 130.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.483 -1.673 . . . . 73.5 106.483 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.3 p90 -146.62 179.62 7.43 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.153 -0.619 . . . . 73.41 110.995 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -120.36 158.29 27.45 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 105.532 -2.025 . . . . 64.44 105.532 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 30' ' ' VAL . 26.1 tp -129.69 129.54 44.36 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.099 1.148 . . . . 74.1 114.099 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.2 mm-40 -125.63 139.46 53.55 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 113.088 -1.869 . . . . 64.1 109.567 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.94 142.79 32.68 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.825 -1.08 . . . . 75.31 111.688 -174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -90.76 31.92 1.02 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.271 -1.011 . . . . 75.32 108.271 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 62.34 22.72 13.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.197 -0.911 . . . . 52.14 111.715 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.08 -49.08 0.13 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 109.526 -1.43 . . . . 75.31 109.526 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -93.01 164.71 13.17 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.338 -0.431 . . . . 72.43 110.787 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -132.76 119.08 19.84 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.406 -0.59 . . . . 55.52 109.406 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.489 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 44.0 p90 -124.59 133.28 53.32 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.519 0.676 . . . . 71.4 112.423 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.19 134.05 42.75 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.631 -1.168 . . . . 33.04 110.534 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.5 m -133.77 169.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.937 -1.028 . . . . 64.54 109.517 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 53.77 63.06 2.33 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 123.246 0.619 . . . . 53.31 111.384 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 32' ' ' VAL . 21.9 mt -82.36 135.77 35.12 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.617 0.723 . . . . 72.03 112.869 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -145.95 130.13 17.52 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 114.059 -1.428 . . . . 71.03 107.997 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.759 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -80.69 148.79 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 C-N-CA 121.057 -0.257 . . . . 64.04 110.717 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 124.387 1.054 . . . . 52.1 109.152 176.201 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.981 0 N-CA-C 109.094 -0.706 . . . . 73.22 109.094 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 p -131.54 153.18 50.11 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.246 0.461 . . . . 71.23 112.246 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 62.68 40.52 10.11 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.022 0.929 . . . . 72.45 111.633 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 mt -75.25 152.94 6.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.772 -0.649 . . . . 53.23 111.229 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 85.9 t -106.83 136.75 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 115.3 -0.863 . . . . 75.21 109.053 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.3 168.73 41.02 Favored Glycine 0 N--CA 1.404 -3.456 0 C-N-CA 119.128 -1.511 . . . . 72.43 113.77 167.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.2 ttmt -113.72 136.24 53.07 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 114.411 -0.894 . . . . 72.22 108.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.57 107.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.965 -0.754 . . . . 64.31 108.965 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -63.81 -52.99 57.72 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.699 -1.137 . . . . 65.54 109.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 64.4 p-90 -160.64 160.01 31.08 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 108.859 -0.793 . . . . 70.3 108.859 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -157.61 125.31 5.3 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 124.053 0.845 . . . . 73.1 109.272 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.08 115.99 31.06 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 61.34 107.293 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 t -73.0 -25.96 61.17 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.698 0.285 . . . . 54.33 111.261 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 m -68.55 -55.21 12.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.116 0.484 . . . . 64.0 110.356 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.49 -8.49 52.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.498 . . . . 75.42 111.709 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 14.4 m120 64.17 26.17 13.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.194 0.813 . . . . 72.01 113.194 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.83 157.98 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.869 -0.419 . . . . 72.31 109.869 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.96 -174.14 45.56 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.135 -0.786 . . . . 54.01 111.135 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 45.7 m-85 -134.35 159.86 39.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.117 0.567 . . . . 65.33 111.132 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -143.08 135.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 123.737 0.648 . . . . 73.02 109.372 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.84 153.27 42.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.133 -1.432 . . . . 65.54 107.133 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.3 pt20 -84.84 154.69 22.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.382 -1.327 . . . . 63.45 109.386 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.55 -22.41 61.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.159 0.912 . . . . 62.44 113.116 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -77.82 -2.96 39.08 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.763 -0.375 . . . . 72.24 111.771 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.46 51.19 1.23 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 110.256 -1.138 . . . . 61.2 110.256 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -77.14 164.41 52.73 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.365 -0.921 . . . . 71.33 112.128 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.71 155.76 40.03 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 123.806 0.357 . . . . 74.33 111.816 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.09 120.93 25.93 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.83 0.824 . . . . 75.21 111.567 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -135.9 135.2 50.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.489 -1.232 . . . . 63.5 107.915 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.6 p90 -90.12 150.36 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.43 -0.908 . . . . 70.3 110.84 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 67' ' ' LEU . 7.3 p -95.29 126.47 47.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-O 121.456 0.646 . . . . 55.53 109.606 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -113.33 148.0 36.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.731 -0.84 . . . . 71.45 108.731 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' ASN . 86.8 tttt -64.72 -21.99 66.88 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.664 0.987 . . . . 72.02 113.664 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -54.19 -22.16 10.74 Favored 'General case' 0 C--O 1.208 -1.09 0 C-N-CA 120.627 -0.429 . . . . 33.03 111.315 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.21 -42.51 59.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.069 0.461 . . . . 53.42 110.853 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 57.3 t -70.45 -30.31 42.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.51 0 N-CA-C 108.215 -1.031 . . . . 62.51 108.215 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.63 -36.12 65.39 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.987 -0.551 . . . . 71.2 110.036 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.98 24.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.422 0.527 . . . . 73.23 112.422 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.07 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.43 0.53 . . . . 73.25 112.43 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 77.75 62.96 2.28 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 121.454 -0.403 . . . . 72.34 112.224 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.83 130.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.817 -1.549 . . . . 64.25 106.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.45 -49.27 78.24 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.525 0.565 . . . . 74.15 112.525 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -175.09 137.99 0.43 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.097 0.559 . . . . 72.21 110.918 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.82 164.31 12.69 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.195 0.521 . . . . 71.5 110.62 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -169.49 162.83 10.26 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.257 -1.757 . . . . 63.13 106.257 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -75.17 152.84 38.4 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.207 0.527 . . . . 54.13 111.928 -177.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.25 69.81 Favored Glycine 0 C--N 1.306 -1.119 0 CA-C-N 115.386 -0.824 . . . . 72.21 112.478 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.517 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -77.42 136.26 38.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 122.503 0.321 . . . . 73.01 111.581 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.56 134.19 33.67 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.227 -1.397 . . . . 72.31 107.227 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.21 147.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-O 121.869 0.842 . . . . 72.23 110.773 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.03 129.34 71.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 106.41 -1.7 . . . . 73.31 106.41 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -147.52 -177.53 5.75 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 120.043 -0.663 . . . . 74.13 110.873 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -124.0 161.81 24.72 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 105.501 -2.037 . . . . 72.4 105.501 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 30' ' ' VAL . 23.2 tp -130.18 129.83 43.93 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-O 121.899 0.857 . . . . 71.41 112.946 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.1 137.81 54.83 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.629 -1.623 . . . . 64.42 107.432 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.79 155.77 18.1 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.118 0.961 . . . . 63.51 110.308 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.0 tttp -116.88 24.66 11.07 Favored 'General case' 0 C--N 1.252 -3.643 0 N-CA-C 107.094 -1.447 . . . . 73.51 107.094 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 70.68 -59.99 0.51 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.5 1.52 . . . . 75.33 111.809 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.52 -23.34 36.96 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.098 -0.801 . . . . 32.14 111.098 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.1 mmtt -123.03 164.98 17.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.585 0.231 . . . . 64.05 111.11 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.34 116.42 11.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.192 -1.04 . . . . 64.3 108.192 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p90 -130.39 137.48 49.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.452 0.644 . . . . 73.2 112.442 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 137.52 51.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.666 -1.152 . . . . 43.43 110.181 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 29.0 m -135.42 161.6 38.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 65.02 109.986 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 56.27 63.88 1.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.03 0.831 . . . . 75.03 109.83 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.625 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 32.6 mt -79.24 137.43 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.968 0.729 . . . . 75.23 112.968 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.98 135.02 39.19 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-N 114.729 -1.123 . . . . 74.14 109.119 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -72.41 134.19 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 109.408 -0.589 . . . . 72.43 109.408 173.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.307 -1.265 0 O-C-N 123.849 0.718 . . . . 64.32 110.117 179.641 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 108.782 -0.822 . . . . 62.53 108.782 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.2 p -107.68 145.6 33.18 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.624 -0.262 . . . . 73.0 111.079 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 58.37 78.39 0.25 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.46 1.104 . . . . 51.52 109.78 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 50.7 mt -108.33 149.53 11.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.314 -1.312 . . . . 62.42 110.245 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 88.5 t -93.26 132.98 35.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.269 -0.878 . . . . 73.31 109.79 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.58 164.89 33.77 Favored Glycine 0 N--CA 1.405 -3.404 0 C-N-CA 120.522 -0.846 . . . . 74.21 111.944 171.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.05 134.31 53.68 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 107.234 -1.395 . . . . 72.34 107.234 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.45 110.41 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.725 -1.213 . . . . 75.02 107.725 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.3 tttp -75.2 -49.88 17.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.286 -1.325 . . . . 51.03 109.36 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -167.72 160.91 13.04 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.618 -0.882 . . . . 72.44 108.618 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -161.39 116.59 2.07 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.738 0.649 . . . . 73.14 110.18 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -92.08 105.76 17.92 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.03 -1.1 . . . . 63.42 108.03 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -53.95 -45.48 71.31 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 124.259 1.024 . . . . 71.5 111.8 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -58.1 -37.44 74.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.131 0.572 . . . . 73.32 111.635 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -99.22 -5.72 29.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.769 -0.372 . . . . 75.34 111.958 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.68 27.33 17.06 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.475 0.484 . . . . 71.13 111.897 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -134.83 152.13 51.5 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.598 -0.519 . . . . 74.3 109.598 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.89 -165.95 33.14 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.826 -0.909 . . . . 70.32 110.826 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 34.8 m-85 -137.26 165.01 27.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.209 0.528 . . . . 72.11 112.023 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -147.28 135.77 15.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.949 -1.13 . . . . 65.45 107.949 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.09 147.34 33.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.02 -2.215 . . . . 72.14 105.02 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.0 pt20 -77.35 144.15 38.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 C-N-CA 116.216 -2.194 . . . . 74.52 109.444 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.02 -29.1 27.5 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.971 1.419 . . . . 73.01 112.471 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.08 -11.77 61.13 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 62.25 111.847 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.89 50.85 0.76 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.42 -0.895 . . . . 72.33 111.199 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -90.59 171.2 36.07 Favored Glycine 0 C--N 1.318 -0.447 0 N-CA-C 110.602 -0.999 . . . . 75.03 110.602 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.81 147.82 33.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.353 0.577 . . . . 73.45 111.327 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 122.81 18.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.941 -1.027 . . . . 63.02 110.695 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 55' ' ' LEU . 7.3 p -126.01 139.96 49.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.036 -1.098 . . . . 41.42 108.036 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -92.64 142.95 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 119.413 -0.915 . . . . 75.14 112.62 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 10.8 p -112.83 142.02 26.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.303 -0.862 . . . . 73.35 109.023 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -136.64 162.5 32.97 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.017 -1.105 . . . . 74.15 108.017 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.11 -18.68 59.28 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 112.281 0.474 . . . . 50.3 112.281 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -52.89 -30.2 32.69 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.084 0.469 . . . . 64.03 110.302 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.95 -35.08 57.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.355 -0.384 . . . . 54.5 110.42 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -41.45 89.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.316 0 N-CA-C 107.786 -1.19 . . . . 75.03 107.786 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.07 -36.86 82.93 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.93 -0.577 . . . . 62.24 110.219 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.54 75.66 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.557 0.947 . . . . 60.41 113.557 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.23 -10.79 4.18 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.626 0.973 . . . . 55.1 113.626 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 55.0 5.61 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.21 -0.756 . . . . 45.01 111.21 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 43' ' ' HIS . 2.4 tm? -71.6 149.82 45.26 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.929 -1.508 . . . . 72.13 106.929 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.563 ' N ' HD13 ' A' ' 42' ' ' LEU . 60.7 m80 -83.04 -60.98 1.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.536 -0.727 . . . . 73.21 111.912 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.5 p -165.87 145.01 6.14 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 122.914 0.485 . . . . 75.42 109.919 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.8 mt -109.9 146.65 34.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.541 0.686 . . . . 72.32 111.669 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.49 153.04 41.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.607 -1.627 . . . . 63.14 106.607 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 155.3 38.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.905 0.383 . . . . 75.1 111.182 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 4.84 79.22 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 121.113 -0.565 . . . . 52.4 112.574 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.43 135.96 34.17 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 122.659 0.384 . . . . 74.11 110.352 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -86.0 120.14 27.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.25 -1.389 . . . . 74.04 107.25 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.37 152.7 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 CA-C-O 121.655 0.741 . . . . 62.34 111.044 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.5 mt -114.47 136.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.028 -1.471 . . . . 72.41 107.028 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -151.19 177.55 10.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.136 -0.32 . . . . 72.41 110.136 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.4 147.7 40.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.54 -1.652 . . . . 72.3 106.54 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 27.3 tp -134.41 133.4 40.49 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.249 1.023 . . . . 45.32 112.056 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -135.71 137.11 41.41 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 113.287 -1.779 . . . . 64.0 107.033 173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -84.94 138.81 32.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.69 0.757 . . . . 75.12 112.102 -176.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.4 tttm -99.21 72.55 1.86 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 75.34 107.214 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.82 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.548 1.539 . . . . 71.41 109.339 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 -18.4 5.01 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.449 -0.405 . . . . 51.4 112.183 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 8.3 mmpt? -89.19 164.69 14.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.397 -0.594 . . . . 53.22 109.397 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.78 118.54 16.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.803 -0.443 . . . . 52.34 109.803 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -121.93 134.21 54.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.434 0.635 . . . . 73.14 111.976 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.41 131.85 35.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.817 -1.083 . . . . 52.24 109.559 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.0 m -139.64 168.31 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.484 -0.78 . . . . 65.23 110.036 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.73 63.21 1.87 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.956 0.785 . . . . 72.41 109.944 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 mt -81.41 143.33 32.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.342 -0.844 . . . . 75.3 111.912 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.3 tpp180 -145.68 129.87 17.57 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.807 -1.923 . . . . 64.41 105.807 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.83 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.68 141.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 118.057 0.389 . . . . 73.2 111.764 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt . . . . . 0 C--N 1.298 -1.652 0 CA-C-N 115.274 -0.875 . . . . 62.4 109.723 176.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.123 -0.325 . . . . 71.23 110.123 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.1 p -120.99 146.12 47.02 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.384 0.513 . . . . 71.43 112.384 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 59.16 78.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.804 1.242 . . . . 64.44 112.266 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 33.4 mt -106.88 147.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.555 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 69.6 t -107.78 135.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.422 -0.808 . . . . 75.4 110.219 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -178.61 160.93 27.12 Favored Glycine 0 N--CA 1.408 -3.2 0 CA-C-N 115.246 -0.888 . . . . 74.2 112.95 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.2 ttmt -98.88 135.56 40.14 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.782 -0.709 . . . . 73.35 109.483 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.23 109.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.306 -0.998 . . . . 74.23 108.306 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.2 tttp -72.42 -42.22 65.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.371 -1.286 . . . . 70.11 108.954 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 67.1 p-90 -174.79 160.53 2.95 Favored 'General case' 0 CA--C 1.486 -1.518 0 C-N-CA 123.949 0.9 . . . . 72.03 108.821 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -161.72 126.87 3.5 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.978 0.799 . . . . 73.21 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -99.05 118.4 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.711 -1.218 . . . . 73.21 107.711 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -70.04 -23.91 63.18 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.26 0.467 . . . . 53.32 112.26 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 m -86.46 -46.29 10.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.087 0.47 . . . . 75.51 111.216 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.43 -8.68 58.89 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.738 -0.385 . . . . 73.53 111.942 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 60.63 31.36 20.18 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 112.374 0.509 . . . . 70.04 112.374 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.83 153.08 43.09 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.272 -0.422 . . . . 73.32 109.872 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.62 -169.59 39.54 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.68 -0.968 . . . . 62.05 110.68 175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 53.1 m-85 -140.06 166.62 24.18 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.337 0.655 . . . . 72.43 110.588 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -145.17 133.67 17.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.061 -0.718 . . . . 74.45 109.061 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.44 143.01 31.43 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.488 -1.301 . . . . 72.41 107.488 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.6 pt20 -83.27 156.16 23.25 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 118.035 -1.466 . . . . 63.41 109.26 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.31 -25.06 21.7 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 124.628 1.205 . . . . 72.44 113.554 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -78.41 -0.39 28.98 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 122.256 -0.277 . . . . 65.22 111.591 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 51.48 3.03 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 109.896 -1.282 . . . . 74.51 109.896 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -66.43 -104.77 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 116.651 1.42 . . . . 51.24 116.651 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.69 176.48 7.49 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.301 0.572 . . . . 75.11 111.525 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -116.46 83.32 1.94 Allowed 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 107.816 -1.179 . . . . 62.1 107.816 172.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 55' ' ' LEU . 4.2 p -119.46 129.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 CA-C-N 115.382 -0.827 . . . . 75.21 109.638 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 39.6 p90 -86.23 139.07 31.38 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.289 0.566 . . . . 75.32 111.681 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -103.39 119.8 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.289 -0.869 . . . . 72.43 109.81 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -110.24 161.75 15.29 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.952 -1.129 . . . . 62.34 107.952 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.72 -22.31 63.85 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.83 0.678 . . . . 72.53 112.83 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -53.74 -24.58 15.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.178 0.513 . . . . 34.23 111.41 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.33 -39.07 59.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.979 0.418 . . . . 63.1 110.597 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.89 -44.73 88.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 N-CA-C 108.089 -1.078 . . . . 72.41 108.089 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.35 -26.22 67.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.351 0.407 . . . . 64.15 110.634 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.74 66.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.707 0.632 . . . . 71.31 112.707 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.86 -0.59 4.23 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.161 0.8 . . . . 74.12 113.161 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.87 39.57 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 123.251 0.453 . . . . 31.53 112.463 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.43 142.72 51.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.306 -1.739 . . . . 63.24 106.306 178.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' N ' HD13 ' A' ' 42' ' ' LEU . 40.2 t60 -71.15 -61.51 1.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.637 -0.825 . . . . 75.43 111.829 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -164.37 157.15 17.18 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.077 -0.712 . . . . 63.0 109.077 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.03 153.93 42.72 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.682 0.754 . . . . 42.51 112.425 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.92 172.32 13.86 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.171 -1.377 . . . . 61.33 107.693 173.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -71.33 156.1 39.9 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.697 0.761 . . . . 70.14 112.607 -177.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 -18.5 57.35 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.133 -0.939 . . . . 43.5 112.005 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -82.35 139.38 34.14 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 122.687 0.395 . . . . 64.4 111.657 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 11.1 m-20 -89.12 134.49 33.99 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.274 -1.009 . . . . 73.54 108.274 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.04 152.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.816 0.817 . . . . 74.11 111.142 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.6 mt -116.69 128.92 73.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.631 -1.618 . . . . 75.41 106.631 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -145.95 -180.0 7.09 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.75 -0.38 . . . . 71.31 110.299 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -119.98 157.23 29.27 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 105.379 -2.082 . . . . 64.24 105.379 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -123.93 128.51 49.54 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 121.581 0.705 . . . . 72.34 111.329 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -122.85 142.47 50.74 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.43 -1.693 . . . . 73.32 106.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.05 143.83 26.01 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.586 -0.846 . . . . 73.44 112.551 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -103.7 35.48 2.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.288 -1.375 . . . . 70.54 107.288 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 63.52 88.81 0.09 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.634 -1.167 . . . . 75.14 109.324 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.82 -47.87 3.62 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.585 -0.817 . . . . 53.53 111.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 73.5 mmtt -83.73 153.11 24.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.519 -0.549 . . . . 74.33 109.519 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -123.82 122.37 37.85 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.829 -0.168 . . . . 31.31 111.183 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.515 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 23.1 p90 -126.49 133.22 51.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.459 0.647 . . . . 73.3 111.777 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -74.39 140.38 44.71 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.736 -1.12 . . . . 52.41 109.709 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -139.5 164.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.469 -0.787 . . . . 71.51 109.314 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.72 63.91 1.56 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.075 0.859 . . . . 70.33 111.147 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.604 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 24.9 mt -78.98 138.07 37.88 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.611 -1.236 . . . . 63.01 112.929 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -141.92 131.67 24.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.187 -2.153 . . . . 74.23 105.187 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.254 2.3 pp -77.92 146.92 7.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 118.79 -1.164 . . . . 73.01 112.006 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.9 tttt . . . . . 0 C--O 1.262 1.74 0 CA-C-N 115.687 -0.688 . . . . 74.05 109.559 178.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . . . . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 107.713 -1.217 . . . . 52.43 107.713 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 27.7 p -101.0 142.94 31.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.52 0.933 . . . . 64.31 113.52 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 62.75 77.84 0.31 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 124.595 1.158 . . . . 62.13 111.785 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.5 mt -110.02 145.71 16.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.34 -0.845 . . . . 74.13 111.127 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 57.2 t -99.57 137.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.257 -0.883 . . . . 64.32 110.641 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -172.45 177.99 44.79 Favored Glycine 0 N--CA 1.4 -3.71 0 CA-C-N 115.007 -0.997 . . . . 44.14 112.349 167.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -121.98 141.28 51.49 Favored 'General case' 0 C--N 1.256 -3.467 0 C-N-CA 123.813 0.845 . . . . 64.43 108.978 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.75 111.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 109.045 -0.724 . . . . 63.2 109.045 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 53.4 tttm -72.41 -48.12 43.88 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.393 -1.336 . . . . 71.11 107.393 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 67.4 p-90 -176.43 160.96 2.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.83 1.252 . . . . 73.21 108.494 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 81.0 t80 -151.35 126.08 9.63 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.943 -0.391 . . . . 73.43 109.943 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.79 101.74 11.56 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.478 -0.934 . . . . 74.12 108.478 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.4 m -63.85 -21.41 66.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.98 -0.554 . . . . 31.41 111.19 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.7 p -65.81 -37.54 86.54 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 123.33 0.652 . . . . 71.15 111.396 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.7 mttt -103.14 -6.13 22.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.936 -0.574 . . . . 71.52 111.862 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 69.43 22.38 6.48 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.533 0.733 . . . . 71.31 112.226 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 48.8 p90 -147.59 165.08 31.48 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.169 0.509 . . . . 62.34 111.748 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -167.95 -157.3 10.89 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.999 -1.241 . . . . 71.22 109.999 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.479 ' HD1' ' CZ2' ' A' ' 11' ' ' TRP . 46.4 m-85 -137.72 165.75 25.64 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 117.417 0.608 . . . . 75.31 112.168 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -143.92 139.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.09 -1.078 . . . . 61.43 108.09 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 12.4 pt-20 -142.84 144.54 32.55 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.519 -1.66 . . . . 73.14 106.519 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.542 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -86.94 150.33 24.15 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 117.512 -1.675 . . . . 64.02 108.221 174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.59 -14.31 12.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 124.241 0.963 . . . . 75.34 112.597 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -88.64 5.39 43.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.539 -0.301 . . . . 73.32 111.183 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.7 50.97 2.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.691 -1.242 . . . . 53.42 112.259 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.4 55.15 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.359 -0.924 . . . . 72.42 111.399 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.55 162.99 27.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.449 0.537 . . . . 63.23 112.449 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.95 95.55 5.49 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.91 -0.586 . . . . 70.12 110.722 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.526 HG21 HD13 ' A' ' 55' ' ' LEU . 3.9 p -112.7 130.05 67.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.496 -0.775 . . . . 71.34 109.096 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.7 p90 -90.07 136.62 32.94 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.779 -0.768 . . . . 73.12 110.574 -178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -98.44 127.14 51.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.753 -0.832 . . . . 74.44 108.753 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -115.96 156.44 26.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.316 -0.624 . . . . 60.34 109.316 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.58 -18.65 12.59 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.631 0.974 . . . . 75.21 113.631 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -61.07 -22.94 65.09 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.22 0.533 . . . . 53.4 110.649 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -77.52 -33.42 54.29 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.433 -0.58 . . . . 42.21 109.433 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.04 -42.64 88.77 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 N-CA-C 107.704 -1.221 . . . . 71.25 107.704 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -53.75 -35.34 61.14 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.915 0.886 . . . . 64.45 110.866 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 -18.51 59.73 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.821 1.045 . . . . 74.12 113.821 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.59 -20.16 2.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.089 . . . . 74.02 113.939 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.12 38.01 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-O 121.689 0.605 . . . . 63.04 111.615 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD21 ' HG ' ' A' ' 45' ' ' LEU . 26.1 tp -64.72 141.31 58.82 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.681 -0.759 . . . . 62.22 110.292 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.22 -57.35 13.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.303 -0.628 . . . . 73.51 109.303 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -175.69 174.96 2.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.173 -1.418 . . . . 74.14 107.173 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.0 mp -111.95 145.19 40.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.094 0.473 . . . . 74.13 110.703 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.81 146.31 45.52 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.224 -0.898 . . . . 71.55 109.012 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.81 154.57 40.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.13 0.491 . . . . 51.34 111.387 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 -26.24 19.25 Favored Glycine 0 C--N 1.303 -1.259 0 C-N-CA 120.687 -0.768 . . . . 61.55 112.188 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 132.22 45.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 123.359 0.664 . . . . 74.22 111.647 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.67 132.91 35.31 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 108.125 -1.065 . . . . 52.55 108.125 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.84 147.27 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.915 0 CA-C-O 121.888 0.851 . . . . 71.11 110.457 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 68.9 mt -117.55 136.9 53.24 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 106.374 -1.713 . . . . 73.52 106.374 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -153.11 -178.53 7.0 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.836 -0.346 . . . . 74.01 110.476 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 37.1 m-20 -119.62 156.17 30.91 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.934 -1.876 . . . . 75.24 105.934 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 13.6 tp -121.18 116.48 25.02 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-O 122.707 1.241 . . . . 64.44 114.332 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.7 mm-40 -103.51 151.04 23.32 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.813 -1.994 . . . . 74.21 111.288 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -105.76 131.34 53.23 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 114.298 -1.319 . . . . 64.24 111.066 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 86.6 tttt -109.67 78.78 1.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.381 -0.827 . . . . 73.02 109.536 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 60.36 14.12 4.49 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.883 0.849 . . . . 74.54 111.64 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.03 -25.14 3.55 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.328 -0.709 . . . . 62.04 111.328 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.2 mmmt -83.87 164.92 19.16 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.601 -0.889 . . . . 73.33 108.601 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.51 119.81 32.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 119.835 -0.126 . . . . 71.02 111.121 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 40.4 p90 -125.22 133.75 52.6 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.549 0.69 . . . . 74.41 112.443 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 137.34 38.23 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.704 -1.135 . . . . 64.1 110.829 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.7 m -140.68 168.61 16.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.351 -0.84 . . . . 74.15 109.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.1 t30 54.32 63.43 2.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.079 0.862 . . . . 62.44 110.701 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.6 mt -74.41 136.1 42.38 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.694 0.998 . . . . 74.43 113.694 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 41.6 mmt180 -122.59 131.17 53.7 Favored 'General case' 0 N--CA 1.405 -2.678 0 N-CA-C 106.177 -1.786 . . . . 62.22 106.177 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.38 131.24 56.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 114.354 1.242 . . . . 54.25 114.354 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.258 1.54 0 CA-C-N 115.209 -0.905 . . . . 72.53 109.345 173.646 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.777 0 N-CA-C 107.64 -1.244 . . . . 75.31 107.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.5 p -127.18 161.83 27.58 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 60.79 39.85 16.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.0 110.874 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.3 mt -76.79 147.23 7.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.397 -0.819 . . . . 74.43 111.788 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 64.5 t -102.34 136.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.003 -0.999 . . . . 43.43 110.162 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -177.75 160.65 27.32 Favored Glycine 0 N--CA 1.413 -2.849 0 C-N-CA 120.685 -0.769 . . . . 64.42 113.503 168.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -97.63 143.75 27.99 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.661 -0.866 . . . . 51.02 108.661 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.06 107.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.226 -1.027 . . . . 64.11 108.226 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.519 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.9 tttp -67.87 -48.35 66.35 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.44 -1.255 . . . . 72.22 109.155 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -166.8 155.55 10.39 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.231 -1.026 . . . . 74.22 108.231 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -160.46 108.43 1.62 Allowed 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.724 0.64 . . . . 71.03 109.67 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -84.97 106.47 16.5 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.735 -1.58 . . . . 63.23 106.735 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 p -62.62 -26.02 68.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.267 0.84 . . . . 63.42 113.267 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -71.49 -32.22 67.99 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.09 0.471 . . . . 72.23 110.081 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.04 -9.8 30.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.004 -0.369 . . . . 70.0 110.004 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 52.37 34.67 15.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.701 0.801 . . . . 65.14 110.074 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.69 156.11 46.99 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.596 -0.52 . . . . 72.1 109.596 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.02 -153.61 17.39 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.296 -0.722 . . . . 63.51 111.296 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 41.3 m-85 -137.14 169.18 18.22 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.519 0.728 . . . . 74.52 110.9 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.439 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 61.7 mt -145.61 130.6 12.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 123.505 0.722 . . . . 74.31 109.147 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.34 146.84 32.8 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.52 -0.918 . . . . 74.41 108.52 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.6 pt20 -79.74 148.15 31.61 Favored 'General case' 0 CA--C 1.483 -1.625 0 C-N-CA 118.838 -1.145 . . . . 72.43 108.38 175.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -53.72 -25.32 17.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 124.528 1.143 . . . . 64.1 112.065 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -76.93 -3.94 41.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.191 -0.459 . . . . 61.34 112.138 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.14 50.76 0.76 Allowed Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.393 -1.384 . . . . 61.24 112.542 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.33 150.69 32.08 Favored Glycine 0 C--N 1.313 -0.733 0 C-N-CA 119.753 -1.213 . . . . 43.33 110.167 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.19 163.58 26.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 117.264 0.532 . . . . 74.11 112.262 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.97 105.1 1.54 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-N 115.845 -0.616 . . . . 75.2 111.299 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 55' ' ' LEU . 4.3 p -126.81 123.71 63.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 108.585 -0.894 . . . . 63.12 108.585 172.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 47.2 p90 -87.17 149.73 24.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.041 -0.527 . . . . 74.13 112.397 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 67' ' ' LEU . 9.3 p -106.27 126.72 61.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.381 0.61 . . . . 73.41 109.57 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -111.78 156.93 21.17 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.036 -1.468 . . . . 71.21 107.036 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.29 -13.7 61.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.381 -0.928 . . . . 75.4 112.077 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -59.0 -22.54 60.75 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.239 0.542 . . . . 72.11 109.716 171.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' ALA . . . -75.51 -38.79 59.18 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.519 -0.549 . . . . 73.3 109.519 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.66 -43.68 96.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.672 0 N-CA-C 107.891 -1.152 . . . . 61.1 107.891 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.15 -37.15 69.14 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.107 0.563 . . . . 64.15 111.623 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.83 -27.45 69.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.22 0.822 . . . . 60.24 113.22 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.55 -14.88 3.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.498 0.925 . . . . 51.24 113.498 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.29 47.74 16.56 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 109.731 -1.347 . . . . 74.2 109.731 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.28 128.95 38.01 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.865 0.866 . . . . 75.31 108.669 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -46.55 -61.55 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.77 0.656 . . . . 71.43 112.77 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 p -178.51 162.98 1.49 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.452 -0.944 . . . . 75.52 108.452 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.9 mt -123.04 149.48 44.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.306 -0.627 . . . . 73.3 109.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.57 149.35 26.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.145 -1.057 . . . . 74.1 108.145 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.0 126.45 27.58 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.472 -0.936 . . . . 72.3 108.472 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.52 -14.91 27.38 Favored Glycine 0 C--N 1.288 -2.094 0 CA-C-N 115.589 -0.732 . . . . 75.34 113.266 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.44 130.04 34.89 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.282 -0.54 . . . . 74.21 111.18 176.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.86 131.07 34.56 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 107.198 -1.408 . . . . 71.33 107.198 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.1 145.95 31.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-O 121.854 0.835 . . . . 72.21 110.642 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 70.3 mt -113.37 132.67 61.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 107.063 -1.458 . . . . 62.31 107.063 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.39 -177.01 5.46 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 121.0 0.429 . . . . 61.13 110.968 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -123.78 149.34 45.76 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 105.68 -1.97 . . . . 73.45 105.68 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -114.34 119.91 38.57 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 122.088 0.947 . . . . 75.34 111.473 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -126.25 159.14 33.89 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 113.67 -1.604 . . . . 44.02 107.977 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.31 143.02 26.75 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.368 0.604 . . . . 72.33 111.987 -173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 84.7 tttt -100.86 81.52 2.28 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.245 -1.761 . . . . 63.12 106.245 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 66.82 -68.77 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.724 1.21 . . . . 75.04 110.238 -174.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.73 -2.19 1.99 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.577 -0.609 . . . . 72.41 111.577 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.9 mmmt -97.01 165.24 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.15 -0.685 . . . . 72.54 109.15 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -116.35 116.43 27.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 110.14 -0.319 . . . . 62.43 110.14 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -129.99 140.74 50.84 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.493 0.663 . . . . 73.42 111.6 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -72.28 133.55 45.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.552 -1.203 . . . . 62.4 109.227 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 32.5 m -138.3 161.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.69 -0.686 . . . . 73.22 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 59.96 63.23 1.49 Allowed 'General case' 0 C--O 1.216 -0.658 0 O-C-N 124.392 1.057 . . . . 73.14 109.294 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.442 HD11 HG21 ' A' ' 32' ' ' VAL . 28.4 mt -80.37 143.61 33.38 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.893 -0.723 . . . . 64.55 112.8 -173.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.07 133.48 41.2 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.187 1.395 . . . . 63.14 107.948 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' H ' ' A' ' 69' ' ' ILE . 2.3 mp -82.14 140.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.889 -1.522 . . . . 75.25 106.889 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.258 1.536 0 N-CA-C 108.421 -0.955 . . . . 74.12 108.421 174.545 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.46 0 N-CA-C 110.288 -0.264 . . . . 65.32 110.288 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.9 p -102.36 147.31 26.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.377 -0.374 . . . . 73.23 111.539 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 52.27 77.37 0.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.537 1.135 . . . . 75.43 113.059 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 46.6 mt -103.93 148.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.183 -0.917 . . . . 72.52 110.484 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.3 t -91.48 132.72 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 115.242 -0.89 . . . . 64.13 109.134 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.87 167.45 37.95 Favored Glycine 1 N--CA 1.394 -4.123 0 C-N-CA 120.317 -0.945 . . . . 70.44 111.781 171.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -123.04 135.74 54.55 Favored 'General case' 0 C--N 1.261 -3.267 0 N-CA-C 107.569 -1.271 . . . . 55.43 107.569 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.86 116.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.68 0.752 . . . . 50.44 109.16 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.4 tttp -75.85 -43.62 44.84 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.03 -1.441 . . . . 65.33 109.109 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -175.02 159.65 2.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 123.917 0.887 . . . . 73.41 109.182 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -163.44 126.85 2.73 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.878 0.736 . . . . 74.05 109.236 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -115.71 122.57 45.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.672 -0.862 . . . . 74.5 108.672 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 m -65.14 -19.15 65.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.087 0.47 . . . . 65.31 110.063 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.6 m -62.28 -34.13 75.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.721 -0.672 . . . . 64.23 110.668 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.36 -10.2 11.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.061 -0.656 . . . . 74.32 111.88 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 54.27 29.66 11.09 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 113.405 0.891 . . . . 63.42 113.405 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -129.8 156.41 44.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 114.672 -1.149 . . . . 74.32 108.534 173.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.44 -172.78 38.54 Favored Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 109.087 -1.605 . . . . 73.44 109.087 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 50.3 m-85 -134.24 165.9 24.03 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 117.036 0.418 . . . . 74.44 111.123 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.6 mt -147.16 136.26 16.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.111 -1.07 . . . . 54.11 108.111 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.39 148.47 34.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.525 -2.028 . . . . 74.53 105.525 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.5 pt20 -74.84 142.5 44.16 Favored 'General case' 0 CA--C 1.473 -2.019 0 C-N-CA 116.655 -2.018 . . . . 74.52 108.68 175.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -49.62 -33.04 14.24 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.122 -1.399 . . . . 75.32 111.594 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -87.75 11.31 15.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.902 0.705 . . . . 64.31 112.902 -173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.39 51.2 0.67 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.405 -1.379 . . . . 60.31 113.471 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -96.26 157.59 21.51 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 119.774 -1.203 . . . . 62.15 110.989 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -72.06 152.73 42.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.831 0.315 . . . . 64.22 110.522 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 120.79 24.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.19 0.995 . . . . 74.24 111.724 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 55' ' ' LEU . 3.0 p -121.87 139.01 50.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 114.365 -1.289 . . . . 71.11 108.223 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 40.7 p90 -88.15 142.67 27.58 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.428 -0.909 . . . . 70.34 111.45 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 67' ' ' LEU . 13.3 p -110.67 144.21 19.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.605 -0.887 . . . . 73.1 108.605 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -131.66 158.4 41.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.56 -16.44 63.87 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 112.505 0.557 . . . . 75.21 112.505 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -56.67 -26.24 55.87 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.235 0.541 . . . . 70.34 110.357 172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.85 -37.71 55.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.117 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.6 t -66.57 -40.6 86.71 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 N-CA-C 107.844 -1.169 . . . . 73.12 107.844 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.26 -32.6 72.42 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.78 0.832 . . . . 63.4 110.755 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.37 82.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.721 0.638 . . . . 64.22 112.721 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.68 -8.79 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.478 0.918 . . . . 41.01 113.478 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.63 58.36 7.83 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.47 -1.052 . . . . 73.52 110.47 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.482 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.02 145.46 51.75 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.435 -1.32 . . . . 75.32 107.435 -179.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.482 ' N ' HD13 ' A' ' 42' ' ' LEU . 62.7 t-80 -54.5 -61.7 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.58 0.352 . . . . 73.31 110.981 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -175.62 150.66 1.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.547 -0.538 . . . . 53.12 109.547 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.96 143.84 36.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.261 -0.644 . . . . 72.43 109.261 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.13 160.15 16.0 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.932 -1.136 . . . . 61.2 107.932 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 150.41 45.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.819 0.819 . . . . 74.1 112.374 -176.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.68 -14.73 62.21 Favored Glycine 0 C--N 1.298 -1.569 0 CA-C-N 114.991 -1.004 . . . . 55.01 112.677 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.557 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.41 116.65 19.77 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 122.519 -0.4 . . . . 75.11 111.152 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.91 129.92 38.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.998 -1.482 . . . . 71.03 106.998 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 147.83 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-O 122.034 0.921 . . . . 75.44 110.976 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.6 mt -110.03 127.76 66.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.199 -1.778 . . . . 71.32 106.199 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.47 176.45 9.0 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.948 -0.701 . . . . 73.43 111.311 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.46 140.39 52.23 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.107 -1.812 . . . . 62.13 106.107 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 30' ' ' VAL . 20.7 tp -121.36 122.06 39.01 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.728 0.775 . . . . 62.44 111.898 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -109.92 166.22 11.1 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.885 -1.507 . . . . 74.41 109.469 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.1 125.72 51.43 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.587 -1.264 . . . . 74.41 107.587 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -126.16 75.16 1.5 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.457 0.54 . . . . 40.3 112.457 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 26.7 tt0 58.12 32.91 22.61 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.857 0.837 . . . . 64.41 111.202 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.37 31.5 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 120.505 -0.855 . . . . 44.3 111.641 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.0 mmtt -96.87 162.04 13.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.803 -0.443 . . . . 74.22 109.803 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.11 112.01 8.91 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.585 -1.265 . . . . 75.15 107.585 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.6 p90 -124.96 135.51 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.418 0.628 . . . . 65.42 111.5 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 123.66 32.75 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.639 -1.164 . . . . 74.14 109.838 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 18.4 m -137.22 176.29 7.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.588 -0.733 . . . . 52.32 111.62 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.39 40.11 27.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.492 1.12 . . . . 74.32 108.361 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 32' ' ' VAL . 36.3 mt -62.63 142.07 58.22 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.617 -1.174 . . . . 74.14 113.016 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -143.68 130.39 20.26 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.546 -1.65 . . . . 75.33 106.546 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.23 141.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.567 -0.853 . . . . 75.53 110.891 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.25 1.109 0 O-C-N 123.858 0.724 . . . . 73.03 110.798 178.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p -101.69 150.32 23.24 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.45 0.469 . . . . 53.02 111.492 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 61.84 76.07 0.38 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.681 0.792 . . . . 74.35 111.319 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 34.1 mt -108.36 150.65 10.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.193 -0.912 . . . . 70.32 110.462 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 93.9 t -96.11 132.46 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 115.629 -0.714 . . . . 63.24 110.182 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.44 171.07 39.04 Favored Glycine 0 N--CA 1.399 -3.819 0 CA-C-N 115.109 -0.95 . . . . 62.12 111.676 170.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -128.35 133.28 48.63 Favored 'General case' 0 C--N 1.26 -3.299 0 C-N-CA 124.472 1.109 . . . . 71.25 108.879 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.91 113.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 116.061 -0.518 . . . . 62.23 109.987 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.537 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 64.4 mttm -62.58 -49.0 76.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.615 -0.721 . . . . 34.51 109.276 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -175.81 166.67 3.1 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.805 1.242 . . . . 72.23 108.661 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -145.06 140.35 28.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.626 0.579 . . . . 70.34 109.442 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -112.25 121.53 45.18 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.501 -0.926 . . . . 73.43 108.501 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -75.99 -28.94 58.03 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.4 m -69.03 -48.64 62.4 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.975 0.417 . . . . 73.12 111.264 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -95.28 -8.56 35.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.681 0.622 . . . . 71.11 112.681 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 62.43 30.68 17.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.945 0.403 . . . . 71.24 111.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.65 163.41 21.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.128 -0.487 . . . . 62.2 109.939 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.18 -172.47 43.46 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 107.939 -2.064 . . . . 71.34 107.939 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 55.8 m-85 -136.82 155.98 49.09 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 118.125 0.963 . . . . 63.22 111.372 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -134.94 140.93 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.499 -0.926 . . . . 74.44 108.499 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 13.8 pt-20 -143.05 147.4 35.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.25 -2.13 . . . . 72.11 105.25 175.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.2 pt20 -79.87 144.45 33.43 Favored 'General case' 0 CA--C 1.483 -1.613 0 C-N-CA 115.305 -2.558 . . . . 72.14 109.315 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.79 -29.21 11.01 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 124.992 1.433 . . . . 62.33 111.357 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.86 4.0 43.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.179 0.807 . . . . 64.13 113.179 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.25 53.62 0.88 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 117.744 -2.17 . . . . 72.0 112.332 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -83.09 -121.91 0.76 Allowed Glycine 0 C--N 1.312 -0.803 0 C-N-CA 120.576 -0.821 . . . . 32.22 114.23 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.95 168.66 15.68 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 122.726 0.41 . . . . 70.42 110.359 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.71 92.19 6.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.186 -0.672 . . . . 54.54 109.186 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.44 132.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.523 -0.762 . . . . 74.52 109.148 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 44.0 p90 -90.09 149.14 22.62 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 118.92 -1.112 . . . . 75.11 110.884 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -105.99 137.12 37.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -125.25 157.17 37.25 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.697 -1.223 . . . . 53.1 107.697 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -62.38 -24.23 67.26 Favored 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 113.022 0.749 . . . . 71.0 113.022 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -52.51 -26.06 12.02 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 120.981 0.419 . . . . 53.13 111.399 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -74.79 -39.61 61.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.198 0.523 . . . . 73.33 109.823 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.89 -46.34 88.82 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.373 0 CA-C-N 115.06 -0.973 . . . . 64.03 108.404 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.69 -23.79 65.12 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.402 0.439 . . . . 74.02 111.14 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.74 69.16 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.301 0.482 . . . . 70.51 112.301 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.8 -4.8 4.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.229 0.826 . . . . 50.1 113.229 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.05 52.48 44.32 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.295 -0.722 . . . . 71.31 111.295 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.24 125.56 27.27 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.074 -1.825 . . . . 65.11 106.074 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -74.51 -37.79 63.0 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 114.833 1.419 . . . . 74.13 114.833 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -155.63 138.3 15.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.104 -0.638 . . . . 74.12 112.257 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.19 149.3 43.03 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.471 -0.786 . . . . 74.14 109.035 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.46 169.56 22.3 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -75.42 155.28 36.51 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.58 -0.448 . . . . 71.52 110.966 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.09 1.27 89.67 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.923 -0.656 . . . . 33.12 113.09 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.461 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -86.22 121.08 28.31 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 111.902 0.334 . . . . 74.25 111.902 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -71.78 127.51 32.8 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.144 -1.058 . . . . 74.42 108.144 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.49 147.58 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 CA-C-O 121.976 0.893 . . . . 70.45 110.686 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 71.9 mt -112.69 135.11 53.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 N-CA-C 106.893 -1.521 . . . . 75.2 106.893 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -150.13 179.28 8.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 121.076 -0.25 . . . . 72.12 110.566 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -114.86 154.35 28.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.035 -1.839 . . . . 73.35 106.035 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 62' ' ' ALA . 37.1 tp -140.53 136.67 33.13 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.901 0.857 . . . . 75.21 112.755 -176.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -131.54 132.42 44.14 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.226 -1.768 . . . . 74.23 106.226 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.77 116.41 23.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.846 0.832 . . . . 70.12 111.04 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -81.26 79.14 7.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.154 -1.384 . . . . 75.01 109.785 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 57.52 20.62 6.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.061 0.945 . . . . 64.51 112.374 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.16 -30.11 3.56 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.413 -0.675 . . . . 72.05 111.413 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 1.4 tpmt? -84.13 164.12 19.38 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.377 -1.342 . . . . 75.54 107.377 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -138.15 129.04 26.97 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 118.652 0.66 . . . . 73.42 110.784 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 6.9 p90 -133.93 133.91 41.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.467 0.651 . . . . 60.23 111.175 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -79.58 133.37 36.44 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.537 -1.21 . . . . 53.12 110.297 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 26.9 m -135.24 161.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.976 -1.011 . . . . 74.51 109.29 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 t30 59.63 64.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.848 0.718 . . . . 64.24 110.817 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 21.8 mt -78.14 139.9 39.01 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.976 -1.09 . . . . 71.32 112.132 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 16.6 tpp180 -137.45 130.77 30.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.111 -2.551 . . . . 65.23 104.111 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.58 143.22 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.944 -1.102 . . . . 72.24 113.055 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.914 -1.041 . . . . 73.22 108.945 173.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 107.106 -1.442 . . . . 73.22 107.106 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.404 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 41.5 p -120.49 142.0 49.69 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.137 0.421 . . . . 73.14 112.137 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 55.86 74.54 0.38 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.308 1.043 . . . . 62.44 112.31 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 2' ' ' ALA . 36.6 mt -99.58 152.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.643 -1.162 . . . . 42.23 110.818 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.2 t -102.62 135.97 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 115.419 -0.81 . . . . 64.42 109.548 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.14 175.42 47.12 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 115.103 -0.953 . . . . 71.43 111.98 168.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 38.3 ttmt -123.91 143.02 50.62 Favored 'General case' 0 C--N 1.253 -3.627 0 C-N-CA 123.973 0.909 . . . . 63.12 108.801 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.02 109.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.136 -0.69 . . . . 62.42 109.136 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.55 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 58.2 tttp -68.53 -49.1 62.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.886 -1.524 . . . . 64.21 106.886 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -169.11 156.18 7.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 114.951 -1.022 . . . . 70.34 108.829 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 80.6 t80 -157.16 111.39 2.68 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 123.638 0.586 . . . . 71.11 109.668 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -99.49 118.63 36.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.822 -0.626 . . . . 71.42 109.932 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 m -64.36 -22.92 67.11 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.059 -0.973 . . . . 73.04 110.2 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -55.08 -44.99 75.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.537 -0.756 . . . . 64.44 111.212 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.8 mttt -106.21 -6.09 18.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.437 0.532 . . . . 63.23 112.437 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 68.86 22.65 7.11 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.073 0.549 . . . . 73.34 110.928 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 36.5 p90 -148.47 166.86 26.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.06 0.457 . . . . 75.21 111.965 176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.85 -153.06 8.56 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.757 -1.337 . . . . 64.53 109.757 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.4 m-85 -137.05 167.81 20.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 122.857 0.463 . . . . 70.01 111.419 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 64.0 mt -142.35 138.29 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.573 -0.899 . . . . 72.41 108.573 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -143.18 147.25 34.59 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 106.545 -1.65 . . . . 70.53 106.545 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -86.29 156.79 20.1 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 117.599 -1.64 . . . . 73.0 108.78 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -53.99 -27.12 29.59 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.232 0.957 . . . . 74.12 112.368 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.41 5.45 17.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.079 0.4 . . . . 64.14 112.079 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.01 51.72 4.09 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.433 -1.365 . . . . 61.45 110.807 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -78.5 -168.12 32.99 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.877 -0.678 . . . . 75.11 112.459 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.02 144.71 55.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.044 -0.354 . . . . 73.04 110.044 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.29 87.39 7.11 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.494 -0.928 . . . . 45.33 108.494 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 55' ' ' LEU . 3.8 p -100.52 138.41 24.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.441 -1.254 . . . . 71.34 110.055 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.0 p90 -88.98 145.18 25.67 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 119.061 -1.055 . . . . 60.43 110.034 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 67' ' ' LEU . 8.1 p -115.57 136.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 108.748 -0.834 . . . . 73.53 108.748 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -124.67 159.94 29.66 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.136 -0.691 . . . . 74.43 109.136 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.32 -15.69 60.77 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 112.647 0.61 . . . . 74.21 112.647 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.6 m -61.45 -26.93 68.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.963 0.411 . . . . 64.32 110.495 172.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.31 -34.9 61.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.7 -0.482 . . . . 71.52 109.7 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.57 -46.29 93.01 Favored 'Isoleucine or valine' 0 C--O 1.181 -2.524 0 N-CA-C 107.721 -1.214 . . . . 75.44 107.721 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.52 -31.24 63.93 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.124 0.97 . . . . 74.35 110.866 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.4 63.84 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.121 0.786 . . . . 74.51 113.121 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.63 -5.62 4.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.654 0.983 . . . . 61.02 113.654 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.09 49.43 75.17 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 111.117 -0.793 . . . . 71.1 111.117 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.1 tm? -66.86 138.16 57.11 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.154 -1.424 . . . . 53.32 107.154 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.4 ' N ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-70 -65.15 -53.58 42.89 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.0 1.111 . . . . 72.04 114.0 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -165.83 153.84 10.84 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.527 -0.469 . . . . 61.34 110.575 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.6 mt -124.01 143.78 50.22 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.119 -0.697 . . . . 73.23 109.119 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.16 162.38 20.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.132 -1.432 . . . . 62.1 107.132 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -69.1 153.4 43.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.591 . . . . 73.24 111.501 -176.054 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.58 84.66 Favored Glycine 0 C--N 1.3 -1.465 0 CA-C-N 115.262 -0.881 . . . . 64.32 112.803 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -93.58 119.08 32.19 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.268 0.47 . . . . 73.25 112.268 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 22.4 m-20 -71.91 136.38 46.87 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.171 -0.612 . . . . 71.41 109.745 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.29 153.41 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-O 121.876 0.846 . . . . 74.31 110.815 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 65.9 mt -115.2 135.36 55.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 N-CA-C 106.58 -1.637 . . . . 75.3 106.58 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -153.06 177.59 10.64 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.947 -0.701 . . . . 74.42 110.624 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 44.5 m-20 -118.93 157.53 27.5 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.013 -1.847 . . . . 75.44 106.013 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD13 HG21 ' A' ' 30' ' ' VAL . 18.3 tp -134.9 138.18 43.88 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 120.879 0.371 . . . . 71.44 111.883 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -127.56 151.57 48.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.49 -1.3 . . . . 63.13 107.49 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.42 120.82 31.85 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 121.243 0.544 . . . . 71.33 111.018 -175.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 87.0 tttt -90.49 74.31 6.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.528 -0.76 . . . . 73.13 108.956 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 61.14 8.32 1.95 Allowed 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.85 -1.068 . . . . 73.03 113.178 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.53 -24.28 2.49 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.803 -0.919 . . . . 64.21 110.803 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -88.7 162.41 16.29 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.09 -1.078 . . . . 71.45 108.09 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.452 ' C ' HG23 ' A' ' 30' ' ' VAL . . . -120.99 127.73 52.05 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.975 -0.453 . . . . 71.33 111.495 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 36.4 p90 -127.81 132.6 49.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.367 0.603 . . . . 50.13 111.63 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.2 136.8 33.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.147 -0.933 . . . . 63.21 110.755 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 30.6 m -139.64 167.85 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.162 -0.926 . . . . 65.12 109.765 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.08 63.43 2.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.623 0.769 . . . . 54.12 110.472 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 32' ' ' VAL . 30.1 mt -78.9 141.01 37.99 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.129 -1.029 . . . . 75.33 113.022 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 18.4 tpp180 -141.72 130.58 23.0 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 105.929 -1.878 . . . . 73.11 105.929 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.02 149.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.03 -1.068 . . . . 73.12 111.989 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt . . . . . 0 C--O 1.251 1.17 0 O-C-N 124.049 0.843 . . . . 74.24 110.755 175.555 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 109.327 -0.62 . . . . 74.34 109.327 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 p -100.22 146.0 27.4 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.847 -0.615 . . . . 64.24 111.662 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 t30 54.68 77.18 0.21 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.908 1.283 . . . . 54.41 110.656 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 45.3 mt -103.93 142.84 16.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.422 -0.808 . . . . 73.41 110.416 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 76.4 t -95.96 140.82 16.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.257 -0.883 . . . . 75.13 109.45 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.94 161.87 29.85 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.312 -0.947 . . . . 55.41 113.593 168.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -96.09 137.41 35.19 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.785 -0.821 . . . . 72.33 108.785 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.32 102.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 107.674 -1.232 . . . . 73.43 107.674 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.71 -45.36 92.37 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.499 -1.228 . . . . 72.42 110.417 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -172.53 162.81 5.31 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 124.072 0.949 . . . . 73.25 108.723 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 88.5 t80 -160.77 116.02 2.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.887 0.742 . . . . 72.13 109.934 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.71 106.28 18.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.374 -0.973 . . . . 62.43 108.374 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 p -59.76 -32.47 70.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.176 0.806 . . . . 72.35 113.176 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 m -76.71 -21.97 54.57 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.204 0.526 . . . . 73.22 110.725 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -101.45 -8.87 21.59 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 119.979 -0.688 . . . . 74.1 110.769 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 91.7 m-20 54.68 29.8 12.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.394 0.678 . . . . 71.31 112.809 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.03 154.32 51.75 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.195 0.598 . . . . 71.24 110.346 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.35 -171.78 39.65 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.787 -1.325 . . . . 72.23 109.787 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -132.39 157.42 44.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.272 0.536 . . . . 73.14 111.297 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 HD13 HG11 ' A' ' 51' ' ' VAL . 59.8 mt -147.02 128.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.482 -0.781 . . . . 74.43 109.23 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.94 148.6 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.308 -0.997 . . . . 74.23 108.308 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 9.9 pt20 -80.41 151.82 29.16 Favored 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 119.567 -0.853 . . . . 62.45 109.971 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.9 -15.22 19.82 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.62 1.2 . . . . 74.53 110.997 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 71.0 m-20 -88.14 6.6 35.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.735 -0.666 . . . . 74.22 110.295 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.81 51.2 2.52 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.988 -1.101 . . . . 53.24 113.111 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.42 41.84 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 119.911 -1.138 . . . . 64.13 111.074 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 157.93 28.47 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.392 0.596 . . . . 62.24 112.055 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.71 90.95 4.63 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.342 0.592 . . . . 71.43 109.984 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 55' ' ' LEU . 5.4 p -106.0 135.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.972 -1.013 . . . . 73.45 108.873 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -91.95 142.84 27.1 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.353 -0.939 . . . . 63.42 110.566 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 67' ' ' LEU . 9.7 p -99.44 145.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.535 -0.913 . . . . 62.34 108.535 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 32.8 t60 -135.52 161.37 35.66 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.296 -1.002 . . . . 71.52 108.296 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -68.06 -18.53 64.7 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 112.644 0.609 . . . . 60.32 112.644 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -56.85 -21.99 33.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.28 0.562 . . . . 74.22 110.373 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.626 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -81.14 -34.76 32.25 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.168 -0.469 . . . . 53.1 110.227 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.0 t -64.41 -52.26 57.62 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.424 0 N-CA-C 108.112 -1.07 . . . . 72.42 108.112 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.89 -22.61 64.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 123.436 0.46 . . . . 75.21 112.146 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.42 75.88 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 120.974 -0.29 . . . . 65.45 111.599 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.14 0.6 4.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.802 0.667 . . . . 64.34 112.802 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.08 50.26 65.64 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 111.092 -0.803 . . . . 72.33 111.092 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.8 138.58 58.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.753 -1.573 . . . . 71.34 106.753 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.55 -56.0 19.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.203 0.456 . . . . 62.3 111.968 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.1 p -167.81 152.46 6.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.389 -0.369 . . . . 54.21 110.323 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 90.2 mt -115.11 152.76 31.98 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.825 -0.435 . . . . 65.11 109.825 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.23 163.97 39.29 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.804 -1.554 . . . . 70.32 106.804 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 151.03 39.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.125 -0.63 . . . . 54.02 109.721 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.9 70.69 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.877 -0.678 . . . . 72.41 112.513 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.5 135.41 36.63 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 122.814 -0.227 . . . . 71.04 110.596 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.58 127.78 38.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.749 -1.574 . . . . 72.01 106.749 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG11 HD13 ' A' ' 21' ' ' ILE . 14.8 p -134.0 153.85 36.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.727 0 CA-C-O 121.485 0.66 . . . . 73.34 111.147 -173.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 67.0 mt -117.92 133.41 64.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 N-CA-C 106.821 -1.548 . . . . 63.13 106.821 177.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.8 p90 -144.76 -178.89 6.25 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.832 -0.432 . . . . 72.43 109.832 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -123.94 143.57 50.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.244 -1.391 . . . . 53.34 107.244 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.9 tp -117.72 116.88 27.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.445 1.116 . . . . 73.22 112.973 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.94 123.96 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.471 -2.048 . . . . 72.11 105.471 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.57 132.98 36.4 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.783 0.801 . . . . 75.23 111.608 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -102.05 81.09 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.613 -1.176 . . . . 64.13 108.744 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 63.63 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.314 1.046 . . . . 61.42 111.484 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.62 5.35 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.876 -0.89 . . . . 70.25 110.876 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -110.91 154.73 23.67 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.789 -0.819 . . . . 72.54 108.789 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -134.08 128.63 34.62 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 110.063 -0.347 . . . . 52.23 110.063 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.32 134.54 45.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.35 0.595 . . . . 64.22 110.749 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.97 130.73 35.16 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.798 -1.092 . . . . 55.22 110.898 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 24.1 m -139.39 167.98 19.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.225 -0.898 . . . . 72.13 110.288 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 59.66 63.14 1.57 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.449 1.093 . . . . 64.12 110.056 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.626 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.9 mt -79.47 139.47 37.62 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.932 0.872 . . . . 73.42 113.239 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -139.53 131.79 28.28 Favored 'General case' 0 N--CA 1.41 -2.425 0 C-N-CA 125.822 1.649 . . . . 71.22 107.101 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.8 mt -80.22 138.35 19.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 118.739 -1.185 . . . . 44.14 109.127 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 115.454 -0.794 . . . . 74.13 110.005 -177.163 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 105.872 -1.899 . . . . 72.34 105.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 p -97.09 140.74 31.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.149 1.166 . . . . 75.41 114.149 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 59.01 77.06 0.32 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.705 1.602 . . . . 74.44 110.869 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.4 mt -103.01 150.28 6.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.96 -1.018 . . . . 73.21 110.57 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.5 t -98.84 136.24 30.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.389 -0.823 . . . . 61.25 109.778 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.96 157.2 23.06 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.843 -0.694 . . . . 75.13 113.117 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.7 ttmt -99.69 139.75 34.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 123.231 0.612 . . . . 74.3 110.133 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.18 107.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.709 -0.678 . . . . 61.31 109.326 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -65.7 -46.6 78.4 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.243 -0.89 . . . . 62.32 109.74 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -174.29 161.68 3.5 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 123.736 0.815 . . . . 72.31 109.52 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -154.14 121.77 5.86 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.503 0.502 . . . . 75.2 111.181 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -117.85 106.77 13.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 115.69 -0.686 . . . . 75.2 110.036 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -56.42 -29.61 61.79 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.719 -1.128 . . . . 63.01 111.028 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 m -61.62 -34.57 75.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 65.03 110.614 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.35 -7.26 35.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 55.2 110.18 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.37 22.06 11.97 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.531 1.132 . . . . 74.02 110.983 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -157.2 174.91 14.76 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.493 0.663 . . . . 75.13 111.307 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.41 -164.63 24.43 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 108.834 -1.706 . . . . 70.4 108.834 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -131.95 152.53 51.03 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 117.6 0.7 . . . . 72.45 111.16 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -142.79 134.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 123.522 0.729 . . . . 51.22 109.143 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.99 151.53 38.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.319 -1.363 . . . . 72.24 107.319 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -85.12 151.76 23.89 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.805 -1.558 . . . . 73.14 109.267 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.42 -27.75 57.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 124.282 0.989 . . . . 53.24 111.678 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -76.3 2.51 13.15 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.325 -0.398 . . . . 72.22 111.711 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 51.44 1.53 Allowed Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 119.804 -1.188 . . . . 71.44 111.965 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 170.32 53.28 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 119.758 -1.21 . . . . 63.04 111.047 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.93 154.55 39.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.882 0.341 . . . . 73.51 111.584 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.5 89.17 4.46 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.433 -0.951 . . . . 75.23 108.433 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 136.24 39.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.516 -0.766 . . . . 72.1 109.736 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 53.4 p90 -94.45 139.74 30.73 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.944 -0.702 . . . . 62.03 109.88 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 67' ' ' LEU . 7.4 p -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 109.722 -0.473 . . . . 71.2 109.722 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -98.12 138.61 35.16 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.679 -0.489 . . . . 71.12 109.679 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -57.21 -28.06 62.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.393 1.627 . . . . 53.52 115.393 -173.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 m -54.47 -25.79 27.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 120.624 -0.43 . . . . 72.11 111.244 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.14 -38.86 63.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.53 0.205 . . . . 73.55 110.595 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.99 -52.64 58.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 108.263 -1.014 . . . . 73.24 108.263 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.91 -22.32 65.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 113.337 0.866 . . . . 62.23 113.337 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.16 -30.83 71.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.995 0.426 . . . . 72.55 110.981 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.98 -7.49 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.459 0.647 . . . . 50.33 110.437 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.59 24.3 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 109.886 -1.286 . . . . 62.5 109.886 -171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.04 130.49 44.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.981 -1.489 . . . . 74.34 106.981 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -53.53 -56.44 17.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.73 1.011 . . . . 74.24 113.73 -172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m -163.94 151.39 12.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 110.351 -0.24 . . . . 62.22 110.351 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -123.59 141.49 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.204 -1.036 . . . . 74.55 108.204 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.22 153.41 33.75 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.031 -0.531 . . . . 74.12 110.229 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.79 134.73 57.09 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.25 -1.018 . . . . 72.3 108.25 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.87 -14.56 49.17 Favored Glycine 0 C--N 1.295 -1.717 0 C-N-CA 120.993 -0.622 . . . . 73.21 111.947 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 134.09 34.09 Favored 'General case' 0 CA--C 1.495 -1.143 0 O-C-N 122.708 -0.289 . . . . 62.14 110.586 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -89.66 136.74 32.86 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.026 -1.472 . . . . 73.31 107.026 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.73 151.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-O 121.918 0.866 . . . . 71.22 111.378 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -113.07 133.32 59.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.918 -1.512 . . . . 71.51 106.918 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 43.5 p90 -149.54 177.48 9.69 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.297 -0.26 . . . . 71.54 110.297 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -115.34 155.56 27.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.349 -1.723 . . . . 71.01 106.349 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -141.03 136.9 32.53 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.772 0.796 . . . . 73.31 111.536 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.21 145.26 27.04 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.661 -1.977 . . . . 72.53 105.661 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.24 128.17 34.58 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 113.699 1.0 . . . . 74.42 113.699 -170.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 64.8 tttp -83.43 70.82 10.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.27 -1.332 . . . . 64.41 109.268 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 55.65 24.46 7.12 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.249 1.02 . . . . 72.35 111.325 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.81 -35.5 1.99 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.306 -0.718 . . . . 75.43 111.306 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 10.9 mptt -84.32 164.79 18.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.84 -0.429 . . . . 73.03 109.84 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.88 113.68 13.16 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.895 -0.409 . . . . 74.32 109.895 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 2.8 p90 -126.88 137.75 53.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.338 0.589 . . . . 72.33 111.569 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.9 35.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.588 -1.187 . . . . 44.23 110.392 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 31.4 m -134.88 168.08 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.156 -0.929 . . . . 52.42 109.935 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 55.39 63.55 2.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.492 0.717 . . . . 72.0 110.529 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 32' ' ' VAL . 37.9 mt -81.95 145.93 30.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.274 -0.875 . . . . 74.41 112.461 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -150.53 130.86 13.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.241 -2.133 . . . . 71.05 105.241 174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.38 145.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 C-N-CA 119.545 -0.862 . . . . 73.33 110.148 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 87.9 tttt . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.903 -1.147 . . . . 63.23 107.903 174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 N-CA-C 107.449 -1.315 . . . . 71.41 107.449 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 p -118.58 148.63 42.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 111.983 0.364 . . . . 74.15 111.983 -175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 58.15 76.93 0.31 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.128 0.971 . . . . 71.21 111.435 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mt -108.35 154.41 9.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.983 -1.008 . . . . 54.3 110.51 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.9 t -103.46 129.5 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.665 -0.698 . . . . 54.2 109.505 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.79 171.62 35.48 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 110.658 -0.977 . . . . 63.23 110.658 171.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.8 ttmt -125.94 140.35 52.7 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 108.433 -0.951 . . . . 73.31 108.433 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 73.0 t -57.37 112.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.573 -0.528 . . . . 61.21 109.573 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.4 tttp -79.15 -43.09 24.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.582 -1.19 . . . . 43.41 109.112 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -176.2 160.01 2.14 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 124.139 0.976 . . . . 73.4 109.173 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 87.6 t80 -155.65 121.99 5.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.498 0.499 . . . . 72.03 110.089 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -105.15 104.18 13.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.733 -0.84 . . . . 72.15 108.733 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 p -63.75 -23.13 67.24 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 123.689 0.795 . . . . 72.43 112.469 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 m -67.84 -28.86 67.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.218 -0.447 . . . . 71.24 110.357 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -110.43 -8.24 14.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.834 -0.346 . . . . 75.43 110.347 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.07 27.2 14.57 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.648 0.779 . . . . 74.43 113.011 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.45 153.72 41.55 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.949 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.22 -168.73 32.47 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.608 -1.397 . . . . 54.23 109.608 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 57.5 m-85 -135.65 164.18 28.44 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.216 0.531 . . . . 74.01 111.597 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.8 mt -144.67 135.23 20.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 114.799 -1.091 . . . . 54.04 108.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.5 146.35 33.32 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.634 -1.987 . . . . 71.5 105.634 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 3.4 pt20 -72.17 144.81 48.43 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 117.809 -1.556 . . . . 61.12 109.398 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.81 -25.56 19.99 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.406 -1.27 . . . . 74.42 111.001 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.26 3.27 13.31 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.486 -0.779 . . . . 64.31 112.233 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.85 51.59 3.56 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.184 -1.007 . . . . 72.43 112.204 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -89.27 -143.5 9.84 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.349 -0.929 . . . . 45.22 113.098 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.38 164.16 13.32 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 110.259 -0.274 . . . . 73.35 110.259 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -101.25 112.53 25.05 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.712 -0.847 . . . . 63.01 108.712 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -119.38 138.48 49.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.865 -0.791 . . . . 72.04 108.865 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.2 p90 -90.55 148.16 22.89 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.196 -1.002 . . . . 62.42 110.44 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 67' ' ' LEU . 11.7 p -113.98 142.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 109.078 -0.712 . . . . 74.43 109.078 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -130.12 160.14 34.65 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.426 -0.953 . . . . 74.4 108.426 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.2 -14.73 62.35 Favored 'General case' 0 C--O 1.197 -1.696 0 N-CA-C 111.802 0.297 . . . . 73.02 111.802 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -53.38 -33.32 53.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.702 0.286 . . . . 61.43 110.454 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -37.81 62.29 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.848 0.356 . . . . 63.14 110.894 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.23 -35.0 69.46 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 N-CA-C 108.205 -1.035 . . . . 74.43 108.205 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.2 -35.37 80.85 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.468 -0.787 . . . . 74.1 110.725 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.49 -49.09 12.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.247 0.462 . . . . 64.42 112.247 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.73 -23.27 19.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.492 0.923 . . . . 72.0 113.492 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.93 62.58 3.51 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 111.59 -0.604 . . . . 53.21 111.59 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.8 148.06 24.86 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.906 -1.516 . . . . 65.1 106.906 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -68.42 -60.85 2.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.208 0.458 . . . . 73.44 111.9 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.8 p -163.11 165.22 24.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.023 -0.362 . . . . 74.25 110.023 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.28 137.28 52.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.901 -0.778 . . . . 73.43 108.901 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.64 145.43 22.47 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.065 -0.97 . . . . 70.32 110.051 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -54.87 131.33 44.01 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 124.201 1.0 . . . . 73.02 109.893 -177.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.28 -26.1 8.38 Favored Glycine 0 C--N 1.301 -1.369 0 CA-C-N 115.486 -0.779 . . . . 63.53 111.653 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.486 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -80.69 117.51 21.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.676 0.991 . . . . 70.24 113.676 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.3 m-20 -70.4 132.19 45.23 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.431 -1.692 . . . . 73.2 106.431 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -133.26 146.6 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 CA-C-O 121.951 0.882 . . . . 74.14 110.981 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.6 mt -111.68 126.6 69.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 107.027 -1.472 . . . . 60.01 107.027 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' HB3' HD23 ' A' ' 67' ' ' LEU . 41.9 p90 -147.83 178.42 8.51 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.808 -0.357 . . . . 61.13 110.634 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -115.12 162.0 17.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.341 -2.096 . . . . 65.41 105.341 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 62' ' ' ALA . 16.4 tp -130.69 128.37 40.75 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.948 0.88 . . . . 72.12 112.841 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 44.0 mt-10 -116.9 146.48 42.92 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.395 -1.73 . . . . 75.41 108.55 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.63 137.3 33.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.277 0.561 . . . . 63.13 111.873 -172.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -116.94 74.25 0.9 Allowed 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.585 -0.894 . . . . 72.51 108.585 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 65.58 -72.28 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.931 1.292 . . . . 72.41 111.838 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 -1.38 4.79 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.062 -0.815 . . . . 70.14 111.062 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 7.3 mmpt? -104.12 164.97 11.35 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.059 -0.719 . . . . 71.11 109.059 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -129.23 127.22 40.81 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.463 -0.569 . . . . 75.0 109.463 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.9 p90 -122.58 128.7 51.05 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.699 0.761 . . . . 73.42 112.831 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.83 130.98 37.34 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.382 -1.281 . . . . 74.51 110.218 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.9 m -135.36 168.77 22.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.938 -1.028 . . . . 61.0 108.871 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 57.7 t30 53.18 63.92 2.05 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.724 0.64 . . . . 61.12 111.138 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 44.5 mt -82.47 146.79 29.08 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.538 0.685 . . . . 73.31 112.528 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -148.77 130.72 15.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.016 -2.216 . . . . 75.31 105.016 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.82 148.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.176 -1.01 . . . . 74.3 112.784 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.34 -0.845 . . . . 73.11 109.769 172.507 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.404 0.621 . . . . 75.03 111.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -162.79 136.59 6.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.473 -0.936 . . . . 61.25 108.473 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -129.56 153.73 47.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.267 0.469 . . . . 50.5 112.267 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.8 m120 58.07 42.04 23.1 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.985 0.914 . . . . 73.44 110.739 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 42.1 mt -75.68 150.46 6.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.428 -0.806 . . . . 63.11 112.14 -175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.8 t -96.43 138.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 CA-C-N 114.854 -1.067 . . . . 70.44 109.777 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.71 171.01 43.94 Favored Glycine 0 N--CA 1.403 -3.524 0 C-N-CA 120.808 -0.71 . . . . 73.03 112.555 168.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -119.5 143.61 47.46 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.742 -0.836 . . . . 71.14 108.742 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.7 107.77 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.429 -0.952 . . . . 70.32 108.429 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 64.5 tttp -69.18 -43.07 74.96 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.823 -1.08 . . . . 74.23 108.57 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -171.85 155.34 3.84 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 114.729 -1.123 . . . . 72.32 108.346 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -159.99 121.77 3.24 Favored 'General case' 0 C--N 1.289 -2.024 0 O-C-N 123.624 0.577 . . . . 72.54 109.557 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -111.21 108.34 17.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.866 -0.42 . . . . 75.41 109.866 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 p -58.23 -23.64 56.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.215 -0.902 . . . . 45.1 112.709 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.1 m -57.46 -36.16 71.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.872 0.469 . . . . 72.35 110.941 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -114.73 -9.05 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.346 -0.542 . . . . 75.23 110.346 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 63.52 25.04 14.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.774 0.83 . . . . 73.1 111.837 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -116.41 158.34 23.67 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-N 116.035 -0.53 . . . . 73.41 109.966 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.51 -167.69 38.87 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.355 -1.098 . . . . 74.03 110.355 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -134.67 168.69 18.55 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.17 0.51 . . . . 73.25 110.981 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.465 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 66.4 mt -140.69 138.69 35.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.3 -0.863 . . . . 64.33 108.672 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' OE2' ' HG3' ' A' ' 10' ' ' LYS . 11.7 pt-20 -143.03 141.7 31.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.829 -1.545 . . . . 70.33 106.829 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -83.8 151.17 25.32 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 117.603 -1.639 . . . . 71.43 108.835 173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.27 -19.75 48.58 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 123.95 0.782 . . . . 72.43 111.926 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -86.16 1.14 51.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.157 -0.474 . . . . 70.43 111.872 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.14 45.88 1.13 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.579 -1.295 . . . . 65.01 112.569 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.69 154.67 36.3 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.888 -1.285 . . . . 63.24 109.888 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.77 169.69 14.95 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.788 0.662 . . . . 51.41 112.788 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' OD2' ' HE2' ' A' ' 10' ' ' LYS . 3.1 m-20 -70.87 90.44 0.8 Allowed 'General case' 0 CA--C 1.496 -1.125 0 CA-C-N 115.233 -0.894 . . . . 72.24 112.619 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 55' ' ' LEU . 5.7 p -105.34 123.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.309 -0.997 . . . . 73.34 108.309 173.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 48.5 p90 -83.5 141.94 31.27 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.058 0.456 . . . . 74.31 111.539 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 8.9 p -97.96 130.46 46.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 115.671 -0.695 . . . . 73.51 109.624 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 35' ' ' SER . 83.9 t60 -109.36 148.41 31.13 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.557 -0.905 . . . . 75.35 108.557 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -57.54 -30.14 64.96 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 114.075 1.139 . . . . 64.41 114.075 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.418 ' H ' ' CD2' ' A' ' 33' ' ' HIS . 39.4 t -54.44 -27.8 39.77 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.998 0.363 . . . . 74.13 111.325 174.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.26 -39.52 62.95 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.013 0.435 . . . . 54.21 109.959 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 42' ' ' LEU . 79.1 t -61.97 -50.65 79.23 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.889 0 N-CA-C 108.217 -1.031 . . . . 71.23 108.217 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -64.84 -22.63 67.03 Favored 'General case' 0 CA--C 1.5 -0.951 0 O-C-N 124.178 0.924 . . . . 74.45 111.935 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.66 72.48 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.245 0.545 . . . . 75.52 110.741 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.89 -13.92 10.68 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.528 -0.76 . . . . 71.34 110.115 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.28 55.18 22.63 Favored Glycine 0 CA--C 1.486 -1.778 0 N-CA-C 109.743 -1.343 . . . . 51.43 109.743 -173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -64.18 125.99 26.3 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.592 -1.633 . . . . 72.52 106.592 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -73.81 -34.45 64.61 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 114.042 1.127 . . . . 75.01 114.042 -170.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -161.4 143.68 12.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.873 0.368 . . . . 70.13 111.218 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.8 mt -139.54 144.5 37.89 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.544 -0.753 . . . . 65.24 109.038 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.18 171.29 20.48 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.533 -1.284 . . . . 74.11 107.533 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.85 133.4 51.23 Favored 'General case' 0 N--CA 1.417 -2.095 0 C-N-CA 123.875 0.87 . . . . 75.11 110.096 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.44 -32.84 5.54 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.615 -0.721 . . . . 41.43 113.51 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -64.0 126.74 28.64 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.741 1.015 . . . . 62.24 113.741 -178.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.79 133.38 43.25 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 106.389 -1.708 . . . . 72.41 106.389 169.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 141.44 38.89 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 CA-C-O 122.125 0.964 . . . . 54.54 110.25 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 54.3 mt -114.92 124.18 71.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 N-CA-C 106.27 -1.752 . . . . 71.11 106.27 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -143.36 179.39 7.12 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.609 -0.437 . . . . 74.32 111.497 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -117.42 158.8 23.84 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 105.649 -1.982 . . . . 64.14 105.649 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 62' ' ' ALA . 17.2 tp -132.91 125.32 29.63 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 121.864 0.84 . . . . 74.34 112.577 -175.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -121.21 157.28 30.59 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 113.674 -1.603 . . . . 75.33 108.755 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -100.19 155.22 17.87 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-O 122.082 0.944 . . . . 73.32 112.9 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 57.8 tptt -118.78 85.1 2.3 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.308 -1.738 . . . . 75.41 106.308 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 65.8 -76.04 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.063 0.852 . . . . 75.13 109.483 -172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.28 -4.69 3.17 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 111.378 -0.689 . . . . 70.24 111.378 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 55.3 mtpt -89.06 165.7 14.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 122.807 0.443 . . . . 60.14 110.934 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.55 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.97 123.16 40.28 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 111.757 0.28 . . . . 72.5 111.757 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 41.0 p90 -125.65 132.94 52.36 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.364 0.602 . . . . 73.42 111.695 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.45 134.99 37.29 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.038 -0.983 . . . . 41.04 110.446 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.3 m -137.65 165.92 25.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.205 -0.907 . . . . 61.11 108.864 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 56.52 64.07 1.79 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.648 0.593 . . . . 51.04 111.383 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 32' ' ' VAL . 24.7 mt -80.2 142.67 34.47 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.463 -0.895 . . . . 72.42 112.443 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 23.0 tpp180 -138.79 131.56 29.22 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.151 -1.796 . . . . 73.44 106.151 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.34 1.8 pp -90.59 96.56 6.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 116.065 1.876 . . . . 40.4 116.065 -177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.6 tttp . . . . . 0 C--O 1.259 1.585 0 C-N-CA 125.703 1.601 . . . . 52.24 113.744 173.762 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 122.168 0.985 . . . . 64.1 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.87 18.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.582 -2.007 . . . . 64.41 105.582 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.3 p -108.84 148.98 29.77 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.242 0.83 . . . . 53.32 113.242 -173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 52.48 76.16 0.2 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.36 -1.291 . . . . 72.3 112.111 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 36.6 mt -102.76 143.43 15.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.653 -1.158 . . . . 74.45 110.182 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 58.8 t -91.47 133.55 32.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 115.018 -0.992 . . . . 55.15 109.522 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.85 172.26 38.84 Favored Glycine 0 N--CA 1.396 -3.984 0 CA-C-N 115.45 -0.795 . . . . 73.35 112.166 171.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.7 ttmt -123.53 143.06 50.43 Favored 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.373 -0.973 . . . . 73.52 108.373 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.84 111.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 108.39 -0.967 . . . . 71.13 108.39 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.1 tttp -76.99 -40.57 46.28 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.549 -1.205 . . . . 72.32 108.786 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.404 ' CZ2' ' HD1' ' A' ' 20' ' ' PHE . 68.5 p-90 -177.65 160.58 1.58 Allowed 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 124.265 1.026 . . . . 75.24 109.1 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -155.35 134.61 12.36 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.007 0.432 . . . . 73.45 110.155 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -121.71 106.05 10.97 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.757 -0.656 . . . . 72.35 109.386 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.4 p -61.04 -32.62 72.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.612 -0.722 . . . . 73.33 112.439 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.0 m -61.88 -28.71 69.7 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.988 0.423 . . . . 64.4 110.686 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -104.21 -9.0 18.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.43 -0.508 . . . . 75.41 111.812 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 17' ' ' ASN . 0.7 OUTLIER 63.76 25.99 14.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 120.924 0.392 . . . . 75.23 110.077 -176.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -137.64 165.87 25.31 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 123.4 0.68 . . . . 62.43 112.318 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.53 44.38 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.507 -1.837 . . . . 53.31 108.507 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.53 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 39.0 m-85 -133.19 160.24 37.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 117.465 0.633 . . . . 74.12 111.534 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.8 mt -145.47 130.11 12.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.092 -0.958 . . . . 72.31 108.465 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.88 149.65 37.23 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.363 -1.717 . . . . 74.31 106.363 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -74.87 146.85 41.58 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 117.708 -1.597 . . . . 72.31 109.24 176.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.47 -21.09 35.09 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.292 -1.322 . . . . 72.3 111.0 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.69 5.26 11.55 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.124 -0.944 . . . . 75.1 111.14 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.54 50.39 2.75 Favored Glycine 0 CA--C 1.498 -1.017 0 N-CA-C 111.529 -0.629 . . . . 50.55 111.529 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -80.33 172.47 54.62 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.477 -0.868 . . . . 73.21 112.498 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -71.75 151.99 43.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.149 -0.525 . . . . 72.35 110.447 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -80.26 116.71 20.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.081 0.943 . . . . 74.03 111.144 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 55' ' ' LEU . 2.5 p -133.17 133.48 58.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 114.722 -1.127 . . . . 74.5 108.776 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 52.9 p90 -88.91 152.32 21.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 120.251 -0.58 . . . . 64.22 111.331 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.547 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -109.34 128.04 65.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-O 121.516 0.674 . . . . 74.43 109.409 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -109.63 156.73 19.84 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.396 -0.965 . . . . 74.32 108.396 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -62.23 -22.48 65.99 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 113.265 0.839 . . . . 74.3 113.265 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -55.86 -27.41 51.52 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.988 0.423 . . . . 73.03 110.575 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -76.48 -34.14 58.66 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.912 0.387 . . . . 64.02 110.169 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.56 -47.85 78.91 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.625 0 N-CA-C 107.917 -1.142 . . . . 71.13 107.917 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.24 -22.79 67.07 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.68 0.622 . . . . 62.53 112.68 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.19 69.44 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.825 0.305 . . . . 71.04 111.825 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -21.78 2.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.286 0.565 . . . . 73.11 112.429 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.85 51.91 5.23 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.483 -1.047 . . . . 43.04 110.483 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.94 129.19 38.92 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.58 -1.267 . . . . 65.53 107.58 -178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -62.44 -39.04 92.05 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.68 0.622 . . . . 65.55 112.68 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.5 t -171.06 156.56 4.86 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 110.096 -0.335 . . . . 73.31 110.096 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.4 mt -135.72 132.28 36.68 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.215 -0.661 . . . . 72.44 109.215 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.88 160.78 34.03 Favored 'General case' 0 C--N 1.266 -3.039 0 C-N-CA 125.547 1.539 . . . . 73.42 107.023 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.75 155.12 37.09 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.368 0.877 . . . . 70.11 113.368 -172.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.37 -19.97 48.85 Favored Glycine 0 C--N 1.313 -0.695 0 CA-C-N 114.815 -1.084 . . . . 73.1 112.02 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.471 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -89.4 132.29 35.06 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 122.557 0.343 . . . . 74.13 111.422 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.6 m-20 -87.32 138.62 31.33 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.465 -0.939 . . . . 75.22 108.465 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.77 149.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-O 121.807 0.813 . . . . 60.31 110.893 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 63.2 mt -111.72 135.79 49.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 N-CA-C 106.482 -1.673 . . . . 51.04 106.482 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -148.52 178.4 8.65 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.8 -0.36 . . . . 75.12 110.161 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -119.81 154.54 34.12 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 105.077 -2.194 . . . . 74.55 105.077 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 30' ' ' VAL . 27.4 tp -121.07 130.69 53.87 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 113.324 0.861 . . . . 54.23 113.324 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -124.6 150.16 46.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.481 -1.69 . . . . 75.32 111.131 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -100.83 127.09 47.43 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.068 -0.969 . . . . 73.41 110.251 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 28.1 tptp -93.76 28.76 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.396 1.078 . . . . 73.5 108.543 -177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.84 90.86 0.08 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.7 -1.136 . . . . 74.2 107.981 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.37 -44.78 2.61 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.401 -0.818 . . . . 51.5 111.741 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.7 mmmt -95.95 153.07 17.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.975 -0.38 . . . . 62.01 109.975 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -126.24 122.6 36.01 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.797 -0.446 . . . . 63.03 109.797 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.427 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.7 p90 -130.84 140.31 50.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 72.13 111.963 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.34 136.33 44.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.435 -1.257 . . . . 31.14 109.812 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 m -136.9 163.02 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.708 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.72 63.56 1.91 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.012 0.82 . . . . 72.14 111.034 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 32' ' ' VAL . 28.7 mt -75.59 149.56 38.25 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.715 -0.794 . . . . 72.44 112.336 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 20.1 tpp180 -148.89 130.97 15.37 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.757 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -74.73 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 118.2 0.455 . . . . 62.13 111.441 177.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.177 -0.919 . . . . 73.04 109.83 177.104 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 25.8 ttt . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.426 0.155 . . . . 74.22 111.031 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -96.5 119.67 35.41 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.351 -0.611 . . . . 51.0 109.351 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.0 p -95.87 140.51 30.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.675 0.61 . . . . 75.13 112.411 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 49.51 72.15 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.819 1.044 . . . . 71.13 113.819 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 57.0 mt -92.66 151.13 3.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-N 115.146 -0.934 . . . . 72.15 110.081 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 55.9 t -92.28 139.35 18.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.509 -0.768 . . . . 61.35 110.377 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -174.42 179.13 45.95 Favored Glycine 1 N--CA 1.395 -4.039 0 CA-C-N 115.274 -0.875 . . . . 61.23 112.239 169.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 37.5 ttmt -132.69 142.76 49.22 Favored 'General case' 0 C--N 1.259 -3.339 0 C-N-CA 124.017 0.927 . . . . 72.33 108.713 176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.36 109.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.667 0.746 . . . . 51.41 109.072 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 22' ' ' GLU . 59.5 tttp -68.38 -40.73 81.28 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 125.495 1.518 . . . . 73.22 108.613 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 69.7 p-90 -177.76 160.51 1.53 Allowed 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 125.267 1.427 . . . . 75.32 108.504 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -161.25 133.6 5.96 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.227 0.33 . . . . 73.32 110.227 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -122.29 103.94 9.09 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.629 -0.714 . . . . 51.33 109.368 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 m -57.11 -32.25 66.12 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.294 -0.866 . . . . 62.24 112.504 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.8 m -60.75 -34.64 74.74 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 112.126 0.417 . . . . 72.53 112.126 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -101.05 -7.01 23.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.522 -0.471 . . . . 51.52 111.009 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.9 m120 66.93 21.45 10.35 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.243 1.017 . . . . 73.01 110.765 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -125.47 152.0 45.52 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.517 0.675 . . . . 61.41 112.398 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.99 -175.62 38.49 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.528 -1.429 . . . . 41.23 109.528 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 m-85 -131.45 165.16 24.14 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 117.05 0.425 . . . . 74.32 110.751 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 65.8 mt -139.44 139.22 39.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.781 -0.822 . . . . 61.1 108.781 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.2 pt-20 -143.1 144.38 32.21 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.542 -1.651 . . . . 71.2 106.542 175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.2 pt20 -84.49 151.91 24.3 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 117.451 -1.7 . . . . 73.44 109.633 174.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.91 -18.54 23.76 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.925 -1.034 . . . . 62.33 111.648 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -87.13 -0.93 57.45 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 73.34 111.41 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.14 51.02 1.1 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.689 -1.243 . . . . 71.34 112.782 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.47 150.08 26.67 Favored Glycine 0 C--N 1.318 -0.46 0 C-N-CA 119.948 -1.12 . . . . 75.2 110.819 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -66.91 171.99 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.572 0.952 . . . . 75.13 113.572 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.01 99.11 2.65 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 115.915 -0.584 . . . . 72.0 111.781 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 55' ' ' LEU . 7.1 p -117.71 129.45 74.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.028 -0.73 . . . . 72.43 109.028 174.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.6 p90 -92.44 142.5 27.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.092 -0.643 . . . . 74.4 111.345 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.47 122.97 45.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-O 121.589 0.709 . . . . 71.35 109.747 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.19 140.76 31.2 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.212 -1.033 . . . . 72.22 108.212 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -76.3 -11.42 59.9 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.917 1.08 . . . . 65.41 113.917 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -61.59 -21.79 64.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 120.623 -0.431 . . . . 65.24 109.846 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -71.99 -40.17 68.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.808 0.337 . . . . 34.42 110.197 175.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.35 -35.53 73.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.085 0 N-CA-C 108.007 -1.109 . . . . 74.11 108.007 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -66.28 -30.5 70.94 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.747 -0.66 . . . . 74.45 111.06 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.79 77.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.617 0.599 . . . . 64.32 112.617 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.29 -9.18 6.4 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.178 0.807 . . . . 75.44 113.178 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.99 57.71 7.47 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.49 -1.044 . . . . 54.24 110.49 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -64.38 131.28 46.78 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -50.83 -58.85 4.93 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 113.65 0.982 . . . . 64.0 113.65 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 p -170.62 147.25 2.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.199 0.444 . . . . 74.5 112.199 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.7 mt -124.83 148.92 47.95 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.304 0.573 . . . . 72.34 110.109 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -166.69 162.13 16.14 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.226 -2.138 . . . . 61.24 105.226 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -69.1 149.94 48.14 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.907 -0.717 . . . . 61.32 111.295 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.77 -15.36 63.25 Favored Glycine 0 C--N 1.3 -1.447 0 CA-C-N 115.334 -0.848 . . . . 73.32 112.095 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -83.02 121.16 26.65 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 122.556 0.343 . . . . 64.0 111.476 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 m-20 -72.28 135.21 45.92 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.729 -1.212 . . . . 75.25 107.729 174.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.49 147.33 19.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 121.968 0.889 . . . . 62.4 111.514 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 60.0 mt -110.67 133.66 55.41 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 N-CA-C 107.073 -1.455 . . . . 74.12 107.073 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 42.1 p90 -148.14 174.78 11.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.187 0.518 . . . . 73.21 111.405 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.8 146.09 39.45 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.025 -1.472 . . . . 45.42 107.025 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 56' ' ' GLU . 25.1 tp -129.13 136.9 50.81 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.646 0.736 . . . . 62.31 111.585 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.484 ' H ' HD12 ' A' ' 55' ' ' LEU . 30.6 tt0 -153.15 143.98 22.82 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 105.473 -2.047 . . . . 71.3 105.473 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -85.67 140.65 30.37 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 113.892 1.071 . . . . 74.34 113.892 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 84.9 tttt -95.18 80.28 3.57 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.068 -1.827 . . . . 72.41 106.068 175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 64.62 -81.6 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.252 1.021 . . . . 71.45 110.452 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.33 -6.83 7.96 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.364 -0.694 . . . . 74.12 111.364 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 9.5 mmpt? -92.49 164.79 13.33 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.293 -0.632 . . . . 71.21 109.293 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.13 118.53 24.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.774 -0.454 . . . . 62.52 109.774 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 6.2 p90 -126.78 136.03 51.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.375 0.607 . . . . 64.4 112.271 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.47 132.5 35.2 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.605 -1.18 . . . . 64.42 110.738 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 35.7 m -136.59 177.11 6.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 CA-C-N 115.167 -0.924 . . . . 72.52 109.337 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.25 63.16 2.35 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.92 0.762 . . . . 74.11 110.328 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 45.1 mt -81.93 147.46 29.25 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.319 0.859 . . . . 74.14 113.319 -174.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 22.7 tpp180 -151.33 130.64 12.82 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 105.315 -2.106 . . . . 73.12 105.315 175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -93.78 145.9 7.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 113.239 0.829 . . . . 75.53 113.239 -177.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 58.2 mtpt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 114.986 -1.006 . . . . 72.13 108.672 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 108.589 -0.893 . . . . 73.23 108.589 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.02 89.67 3.06 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.498 0.925 . . . . 71.25 113.498 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.0 p -141.01 140.95 34.39 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.478 -1.304 . . . . 72.13 107.478 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 58.81 74.2 0.45 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 106.833 -1.543 . . . . 65.1 106.833 -168.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.2 mt -101.47 147.19 8.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 113.852 -1.522 . . . . 63.0 111.65 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.4 t -91.27 140.59 15.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 CA-C-N 114.502 -1.227 . . . . 72.12 109.384 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -179.91 161.08 26.59 Favored Glycine 0 N--CA 1.414 -2.785 0 C-N-CA 120.232 -0.985 . . . . 34.0 113.416 167.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 4.8 ttmp? -106.44 139.98 40.07 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 108.561 -0.903 . . . . 71.53 108.561 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.54 109.03 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.483 -0.932 . . . . 64.32 108.483 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 21' ' ' ILE . 55.2 tttp -67.59 -42.31 82.67 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.592 -1.64 . . . . 74.23 108.471 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -176.04 160.93 2.34 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 124.891 1.277 . . . . 71.02 107.783 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 81.3 t80 -163.35 131.97 3.87 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.043 0.449 . . . . 75.04 110.777 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -112.46 105.01 13.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.045 -1.094 . . . . 73.4 108.045 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.0 p -61.94 -36.2 80.71 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.951 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.6 m -63.51 -34.23 77.32 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.843 -0.617 . . . . 71.31 110.812 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 96.6 mttt -93.62 -8.13 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 62.2 111.052 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 m120 67.07 23.61 9.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.943 0.897 . . . . 61.31 112.51 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 46.5 p90 -153.19 168.18 26.84 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 112.883 0.697 . . . . 74.03 112.883 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -177.66 -154.84 12.78 Favored Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 109.923 -1.271 . . . . 71.51 109.923 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.489 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 35.4 m-85 -140.03 169.48 17.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.513 0.656 . . . . 73.45 111.24 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 62.9 mt -145.27 140.38 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.163 -1.051 . . . . 73.41 108.163 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -143.1 139.68 30.55 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.013 -1.477 . . . . 63.33 107.013 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 10.5 pt20 -84.41 146.5 27.63 Favored 'General case' 0 CA--C 1.459 -2.529 0 C-N-CA 117.765 -1.574 . . . . 74.1 109.05 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.09 -13.98 20.89 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 124.632 1.208 . . . . 72.31 110.627 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 14.1 m120 -87.34 -5.11 59.02 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.772 -0.649 . . . . 73.33 110.592 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.98 0.67 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 118.324 -1.893 . . . . 74.43 113.681 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.2 146.37 19.61 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 119.838 -1.172 . . . . 74.11 110.428 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -77.66 -175.86 4.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.293 0.849 . . . . 70.21 113.293 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.89 99.11 1.01 Allowed 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.692 -0.685 . . . . 75.14 111.878 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.33 123.21 59.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.361 -0.978 . . . . 71.4 108.361 173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.5 p90 -92.41 147.49 22.87 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 119.559 -0.856 . . . . 64.02 111.16 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -104.0 124.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 109.06 -0.719 . . . . 61.41 109.06 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -108.71 149.92 28.31 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.412 -0.959 . . . . 74.33 108.412 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.19 -22.64 61.31 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 113.502 0.927 . . . . 64.35 113.502 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.2 m -56.32 -23.38 36.64 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 120.388 -0.525 . . . . 74.03 111.102 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -77.92 -36.22 49.68 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.871 -0.418 . . . . 74.34 109.871 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 42' ' ' LEU . 60.8 t -61.9 -49.8 82.73 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.868 0 N-CA-C 107.416 -1.327 . . . . 75.31 107.416 172.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.93 -33.03 68.38 Favored 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.435 1.084 . . . . 72.53 111.73 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -30.12 68.84 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.998 0.427 . . . . 61.1 112.135 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.74 0.08 4.87 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.601 -0.44 . . . . 54.2 111.706 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.05 55.52 27.72 Favored Glycine 0 C--N 1.313 -0.746 0 N-CA-C 110.434 -1.066 . . . . 63.42 110.434 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -64.94 137.5 57.78 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 106.728 -1.582 . . . . 63.3 106.728 -179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -61.88 -61.14 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.895 0.331 . . . . 72.33 111.895 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -159.88 151.42 19.92 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.778 -0.453 . . . . 74.33 109.778 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 88.2 mt -123.87 146.59 48.3 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.545 -0.539 . . . . 60.35 109.545 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -160.51 162.12 32.95 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 106.058 -1.83 . . . . 62.12 106.058 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -68.35 148.86 50.12 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.744 -0.782 . . . . 72.52 110.627 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.58 -16.85 60.32 Favored Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.492 -0.776 . . . . 75.04 112.484 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.34 128.37 33.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 O-C-N 122.789 -0.242 . . . . 73.23 110.425 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 26.6 m-20 -88.01 138.56 31.35 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.991 -0.744 . . . . 63.13 108.991 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.64 154.23 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 CA-C-N 115.712 -0.676 . . . . 62.04 110.656 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 55.2 mt -119.97 131.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.841 -1.54 . . . . 71.14 106.841 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 45.5 p90 -144.38 -179.98 6.88 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 120.795 0.331 . . . . 75.41 111.426 -176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -117.37 159.88 22.05 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 107.674 -1.232 . . . . 64.42 107.674 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.3 tp -136.79 132.95 35.43 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-O 121.31 0.576 . . . . 62.32 110.958 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.53 145.39 51.47 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.828 -1.078 . . . . 73.53 108.156 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -85.86 112.2 20.91 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.45 0.643 . . . . 62.42 111.955 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -84.11 85.68 7.31 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.518 -1.29 . . . . 64.22 107.518 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 66.85 -71.54 0.1 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.562 1.145 . . . . 71.11 110.703 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 -6.72 0.79 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.654 -0.978 . . . . 21.53 110.654 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -92.09 165.65 13.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.076 0.55 . . . . 63.35 109.667 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -133.4 125.59 29.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.332 0.253 . . . . 52.34 110.627 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -136.46 139.88 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.063 0.459 . . . . 74.34 110.921 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 136.58 39.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.698 -1.137 . . . . 73.44 111.282 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.4 m -137.24 165.07 28.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.266 -0.879 . . . . 64.51 109.614 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 56.04 65.21 1.5 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.43 0.692 . . . . 75.21 111.06 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 32' ' ' VAL . 27.9 mt -78.69 140.73 38.32 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.5 -0.88 . . . . 71.04 113.115 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.599 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 8.4 mpt_? -127.97 135.73 50.33 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 106.168 -1.79 . . . . 73.11 106.168 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.783 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -78.69 133.08 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 119.576 -0.85 . . . . 61.25 109.641 172.357 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.532 -0.758 . . . . 72.25 109.219 176.123 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 CA--C 1.504 -0.797 0 CA-C-O 120.844 0.354 . . . . 63.14 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.52 109.98 9.63 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.769 -1.197 . . . . 71.3 107.769 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -111.58 147.41 35.51 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.219 -0.446 . . . . 51.41 110.804 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 m120 59.34 75.87 0.38 Allowed 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.13 0.894 . . . . 74.0 110.977 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 23.9 mt -104.33 146.41 11.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.535 -0.757 . . . . 72.12 111.134 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.3 t -105.65 134.24 47.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.865 -1.061 . . . . 73.22 109.819 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 23' ' ' GLN . . . 179.09 163.19 29.7 Favored Glycine 0 CA--C 1.454 -3.774 0 C-N-CA 120.325 -0.94 . . . . 65.11 113.493 168.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.2 ttmt -101.81 142.27 33.39 Favored 'General case' 0 C--N 1.252 -3.644 0 CA-C-N 114.622 -0.789 . . . . 73.42 109.241 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.1 108.86 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 108.358 -0.979 . . . . 73.24 108.358 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.554 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 57.5 tttp -68.07 -38.84 82.88 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.419 -1.264 . . . . 73.31 108.19 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 177.78 157.5 0.39 Allowed 'General case' 0 CA--C 1.496 -1.098 0 C-N-CA 125.272 1.429 . . . . 75.33 108.616 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -146.12 119.52 9.02 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.317 0.58 . . . . 63.1 110.541 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -88.05 107.11 18.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.893 -1.521 . . . . 74.13 106.893 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.0 m -79.05 -11.88 60.01 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.107 0.41 . . . . 61.32 112.107 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 m -79.52 -46.47 17.33 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 109.27 -0.641 . . . . 73.15 109.27 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -97.41 -7.68 31.17 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.564 0.579 . . . . 71.3 112.564 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 66.76 27.67 9.18 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.577 0.584 . . . . 70.01 112.577 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -122.79 157.68 31.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.89 -0.595 . . . . 63.41 109.594 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.96 29.57 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.794 -1.323 . . . . 64.33 109.794 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 60.4 m-85 -141.24 167.64 21.69 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 117.396 0.598 . . . . 75.02 110.768 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 59.2 mt -145.4 134.16 17.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.123 -0.695 . . . . 75.21 109.123 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -144.11 148.54 35.24 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.949 -1.5 . . . . 64.43 106.949 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.685 ' HB3' ' HA2' ' A' ' 7' ' ' GLY 0.272 0.0 OUTLIER -91.83 158.8 16.12 Favored 'General case' 0 CA--C 1.462 -2.442 0 C-N-CA 115.245 -2.582 . . . . 71.1 109.849 172.714 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.15 -15.52 5.76 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 124.301 1.001 . . . . 72.14 113.027 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 13.5 m120 -84.36 -2.1 56.56 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.671 -0.24 . . . . 62.31 111.313 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.22 50.75 0.7 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.871 -0.68 . . . . 61.25 112.8 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.47 150.91 52.13 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.494 -0.86 . . . . 72.34 113.461 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -74.88 -178.63 3.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.142 0.496 . . . . 73.14 112.223 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.77 101.3 12.68 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.898 0.38 . . . . 65.13 110.598 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 55' ' ' LEU . 6.3 p -128.3 123.76 60.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.411 -0.959 . . . . 73.54 108.411 173.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 52.6 p90 -87.69 147.14 25.36 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 120.119 -0.632 . . . . 52.05 111.661 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 67' ' ' LEU . 9.2 p -109.28 141.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.0 -0.741 . . . . 73.34 109.0 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -131.66 155.81 46.95 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.235 -0.654 . . . . 72.44 109.235 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -63.47 -18.44 63.77 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 113.151 0.797 . . . . 72.42 113.151 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 t -57.97 -27.18 63.22 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 120.961 0.41 . . . . 73.4 110.639 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -78.63 -35.77 45.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.833 -0.432 . . . . 62.32 109.833 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 42' ' ' LEU . 71.9 t -61.98 -48.38 88.83 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.308 0 N-CA-C 107.715 -1.216 . . . . 41.34 107.715 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -56.84 -33.04 66.39 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.303 1.041 . . . . 74.13 111.241 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.34 68.32 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.112 0.782 . . . . 53.33 113.112 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.99 -2.49 4.62 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.6 52.52 50.45 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 123.65 0.643 . . . . 43.54 112.969 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.424 ' HB3' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -67.65 142.86 56.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.328 -1.73 . . . . 70.42 106.328 178.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -64.39 -62.42 1.62 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.6 0.593 . . . . 51.23 112.6 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.9 m -167.54 162.68 14.47 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.116 -1.068 . . . . 75.11 108.116 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.68 154.73 45.53 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.729 0.776 . . . . 72.43 112.006 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 174.97 14.6 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.531 -1.655 . . . . 61.52 106.531 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.46 157.8 28.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.28 0.562 . . . . 62.51 112.225 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.64 14.43 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.584 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.56 126.43 30.78 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 112.229 0.455 . . . . 44.52 112.229 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -81.95 134.46 35.38 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.222 -1.399 . . . . 71.21 107.222 173.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.88 150.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 CA-C-O 121.926 0.87 . . . . 62.52 110.463 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 78.4 mt -115.28 131.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 N-CA-C 106.888 -1.523 . . . . 73.1 106.888 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.48 -178.78 6.34 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.49 -0.559 . . . . 75.14 109.49 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.76 158.63 28.39 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.236 -1.764 . . . . 65.22 106.236 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 62' ' ' ALA . 26.9 tp -129.19 123.18 31.4 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 122.287 1.041 . . . . 63.14 112.744 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.02 143.78 46.9 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 113.311 -1.768 . . . . 75.3 107.561 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.41 141.67 28.35 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.766 -0.774 . . . . 74.4 110.38 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 tpmt? -86.24 -61.32 1.77 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.966 -1.494 . . . . 71.41 106.966 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 61' ' ' LYS . 6.5 tp-100 170.46 86.21 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 105.349 -2.093 . . . . 73.42 105.349 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.74 -29.94 2.61 Favored Glycine 0 C--N 1.307 -1.078 0 N-CA-C 111.089 -0.804 . . . . 62.4 111.089 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -92.71 144.75 24.99 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 108.161 -1.052 . . . . 71.2 108.161 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -128.71 120.24 26.1 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.968 -0.752 . . . . 34.44 108.968 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 4.2 p90 -129.16 137.12 50.98 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.381 0.61 . . . . 75.11 112.472 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.0 129.15 38.7 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.46 -1.245 . . . . 74.44 110.224 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.7 166.01 29.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.158 -0.928 . . . . 71.33 109.047 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.77 63.3 2.09 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.871 0.732 . . . . 73.5 110.604 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CG2' ' A' ' 32' ' ' VAL . 21.4 mt -76.4 133.62 39.86 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 119.219 -0.992 . . . . 70.14 112.898 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -137.71 131.27 31.11 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 113.899 -1.5 . . . . 72.35 107.858 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.414 ' O ' HD12 ' A' ' 69' ' ' ILE . 2.4 pp -75.3 146.14 9.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.908 -1.117 . . . . 74.41 110.634 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.661 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 4.2 ttpm? . . . . . 0 C--O 1.259 1.581 0 CA-C-O 118.115 -0.945 . . . . 72.3 108.873 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 109.923 -0.399 . . . . 73.14 109.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.14 98.85 3.46 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.643 -0.873 . . . . 51.33 108.643 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -111.8 143.31 42.95 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.413 -0.812 . . . . 74.41 112.243 -174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.1 t30 49.62 75.22 0.17 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.905 1.282 . . . . 74.34 110.376 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.8 mt -99.43 148.98 5.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.773 -1.103 . . . . 74.54 111.192 -175.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.3 p -90.35 139.14 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-N 115.565 -0.743 . . . . 42.44 109.197 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -164.14 170.49 39.39 Favored Glycine 1 N--CA 1.395 -4.055 0 C-N-CA 120.334 -0.936 . . . . 74.32 112.102 172.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -126.12 138.48 53.68 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 108.533 -0.914 . . . . 64.23 108.533 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.03 107.53 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 109.135 -0.691 . . . . 70.34 109.135 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.504 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 27.2 mtpp -65.71 -46.67 78.1 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.149 -0.932 . . . . 45.15 109.241 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 58.9 p-90 -172.7 160.1 4.46 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 114.894 -1.048 . . . . 71.43 108.504 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 90.3 t80 -160.5 108.47 1.61 Allowed 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.264 -1.013 . . . . 75.12 108.264 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.408 ' OD1' ' HB ' ' A' ' 15' ' ' THR . 19.5 t-20 -84.85 106.19 16.19 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 108.82 -0.807 . . . . 73.14 108.82 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 p -64.42 -17.49 63.84 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.487 0.715 . . . . 72.52 112.648 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.408 ' HB ' ' OD1' ' A' ' 13' ' ' ASN . 56.5 m -80.56 -43.5 20.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 120.935 0.398 . . . . 73.4 110.59 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 16' ' ' LYS . 11.0 mmpt? -96.86 -8.15 31.66 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.9 0.333 . . . . 43.51 111.9 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 67.68 24.44 8.42 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.023 0.929 . . . . 65.44 112.076 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.51 152.6 49.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 122.099 -0.376 . . . . 74.31 111.241 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -171.67 -168.63 33.5 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 111.178 -0.769 . . . . 73.44 111.178 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.504 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 40.4 m-85 -135.52 153.77 51.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.009 0.524 . . . . 61.13 111.529 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -137.23 134.05 47.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.718 -0.845 . . . . 73.33 108.718 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 12.7 pt-20 -143.63 150.62 39.04 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.222 -1.769 . . . . 73.2 106.222 173.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.715 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.268 0.5 OUTLIER -70.52 144.65 51.26 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 117.981 -1.488 . . . . 71.04 111.215 174.144 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.8 -39.39 11.77 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.671 -1.604 . . . . 70.05 112.686 -172.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.02 -9.4 30.16 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.64 0.776 . . . . 70.0 113.011 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.49 50.54 2.53 Favored Glycine 0 CA--C 1.501 -0.817 0 C-N-CA 120.702 -0.761 . . . . 74.33 111.222 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.66 -99.66 0.33 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.083 -0.579 . . . . 75.21 113.179 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -121.76 143.15 49.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.621 0.248 . . . . 74.33 110.718 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -94.62 97.77 10.34 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.936 -0.575 . . . . 72.42 109.48 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 55' ' ' LEU . 2.6 p -116.4 139.54 42.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.889 -0.596 . . . . 72.42 109.549 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 50.1 p90 -88.53 145.19 25.87 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.839 -0.744 . . . . 75.42 111.334 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -95.4 131.28 42.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 109.384 -0.598 . . . . 52.02 109.384 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -107.91 146.87 31.78 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.108 -1.441 . . . . 75.31 107.108 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -68.14 -17.46 64.36 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.684 0.624 . . . . 70.21 112.684 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.6 t -54.92 -23.85 20.82 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 116.191 -0.459 . . . . 52.11 110.381 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.592 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -70.62 -41.68 71.91 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 120.571 0.224 . . . . 74.14 111.237 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.29 -41.49 83.76 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.837 0 N-CA-C 108.05 -1.093 . . . . 64.22 108.05 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.65 -24.38 67.01 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.947 -0.569 . . . . 71.23 110.889 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.9 45.88 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.265 0.839 . . . . 61.0 113.265 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.45 -23.37 2.64 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.813 0.671 . . . . 55.01 112.813 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.9 62.58 2.21 Favored Glycine 0 C--N 1.307 -1.035 0 CA-C-N 115.79 -0.641 . . . . 51.52 112.088 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.66 142.69 33.71 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 105.963 -1.866 . . . . 74.1 105.963 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -58.96 -59.34 5.62 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 117.737 0.244 . . . . 74.11 111.59 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 p -162.35 161.23 27.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.211 -0.663 . . . . 61.22 109.211 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 74.0 mt -124.02 134.28 53.47 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 107.859 -1.163 . . . . 61.03 107.859 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 150.1 34.3 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.08 -0.964 . . . . 74.45 108.479 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 11' ' ' TRP . 0.5 OUTLIER -63.88 151.02 43.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.156 0.799 . . . . 74.23 113.156 -175.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.47 -23.2 36.1 Favored Glycine 0 C--N 1.309 -0.963 0 CA-C-N 114.668 -1.151 . . . . 74.53 112.763 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.574 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -74.92 136.05 41.42 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 112.506 0.558 . . . . 64.24 112.506 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -85.97 135.67 33.57 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.665 -1.235 . . . . 53.41 107.665 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.05 151.58 20.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-O 121.49 0.662 . . . . 61.41 111.081 -172.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -116.09 134.21 60.16 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.9 p90 -144.86 -178.11 5.86 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.942 -0.392 . . . . 64.41 109.942 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.36 145.07 49.04 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.818 -1.549 . . . . 64.42 106.818 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 30' ' ' VAL . 28.3 tp -116.5 109.37 17.18 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-O 122.374 1.083 . . . . 73.51 110.578 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -122.06 136.96 54.97 Favored 'General case' 0 C--N 1.258 -3.391 0 N-CA-C 105.07 -2.196 . . . . 74.43 105.07 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.9 136.9 33.1 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 114.693 1.368 . . . . 73.13 114.693 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 60.8 tptt -82.47 79.78 8.81 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.774 -1.936 . . . . 71.45 105.774 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 67.37 -80.0 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.946 0.898 . . . . 65.52 109.69 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.05 7.3 4.42 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.718 -0.953 . . . . 51.45 110.718 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -102.45 155.89 17.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.835 -1.543 . . . . 72.04 106.835 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -117.54 122.05 42.63 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.864 -0.522 . . . . 71.32 111.107 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -135.53 142.66 45.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.026 0.441 . . . . 73.53 109.986 178.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.47 127.62 33.0 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.233 -0.894 . . . . 61.1 109.953 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.592 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.3 m -133.54 169.38 21.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.124 -0.944 . . . . 73.04 111.019 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.8 t30 57.2 63.13 1.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.218 0.949 . . . . 54.04 110.49 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 33.2 mt -81.91 140.29 34.16 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.299 1.222 . . . . 74.01 114.299 -172.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -140.28 139.54 35.53 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 125.829 1.651 . . . . 71.04 106.923 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.42 147.9 5.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 117.207 -1.797 . . . . 52.32 110.944 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.254 1.33 0 O-C-N 124.239 0.962 . . . . 71.12 110.898 179.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtm . . . . . 0 CA--C 1.504 -0.79 0 N-CA-C 108.943 -0.762 . . . . 62.34 108.943 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -127.99 134.98 49.3 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.977 -1.12 . . . . 75.22 107.977 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.5 p -117.14 140.79 49.09 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 111.378 0.14 . . . . 75.32 111.378 -176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.07 76.26 0.37 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.873 0.844 . . . . 63.32 112.022 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 47.1 mt -106.33 148.45 10.71 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 114.679 -1.146 . . . . 55.34 110.099 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 7.6 p -90.94 139.24 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 O-C-N 124.06 0.85 . . . . 61.51 109.794 176.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -166.47 171.15 41.36 Favored Glycine 1 N--CA 1.396 -4.009 0 C-N-CA 120.393 -0.908 . . . . 71.21 112.306 170.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.9 ttmt -123.89 137.22 54.67 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.123 -1.065 . . . . 74.34 108.123 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.44 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 108.366 -0.975 . . . . 73.22 108.366 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.8 tttp -75.94 -44.58 39.35 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.12 -1.4 . . . . 62.23 109.386 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -169.54 157.83 7.44 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 115.632 -0.713 . . . . 74.33 110.269 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -147.45 133.17 18.91 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.598 -0.728 . . . . 61.54 109.437 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -106.08 118.0 35.48 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.506 -0.924 . . . . 72.13 108.506 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 t -68.26 -33.85 75.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.157 -0.474 . . . . 61.24 111.464 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.4 m -73.57 -49.29 27.07 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.822 0.344 . . . . 71.43 111.534 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 64.4 mttp -82.25 -8.26 59.64 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.198 0.444 . . . . 62.02 112.198 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 13.4 m120 63.76 22.25 13.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.102 0.778 . . . . 75.41 113.102 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 42.0 p90 -142.37 174.25 10.79 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.544 -0.863 . . . . 71.11 110.804 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.63 -155.29 13.62 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.615 -0.994 . . . . 65.12 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 30.4 m-85 -132.65 163.54 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.404 0.621 . . . . 72.43 112.023 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.8 mt -145.84 138.51 20.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.105 -1.443 . . . . 73.22 107.105 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -144.07 148.64 35.43 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.761 -1.57 . . . . 74.14 106.761 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.735 ' HA ' ' HA2' ' A' ' 7' ' ' GLY 0.279 0.2 OUTLIER -72.17 147.58 46.45 Favored 'General case' 0 CA--C 1.47 -2.115 0 C-N-CA 117.464 -1.694 . . . . 63.22 109.971 172.071 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -49.25 -35.15 16.79 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 125.0 1.438 . . . . 74.44 112.443 -171.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -70.01 -0.85 8.25 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.458 0.91 . . . . 74.01 113.458 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 51.52 4.05 Favored Glycine 0 CA--C 1.496 -1.139 0 C-N-CA 120.304 -0.95 . . . . 54.3 111.085 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' OE1' ' A' ' 23' ' ' GLN . . . -75.39 -110.55 0.1 Allowed Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.983 -0.627 . . . . 74.52 114.369 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.13 174.55 5.83 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.981 0.42 . . . . 64.42 112.1 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -102.27 92.87 4.91 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.319 -0.993 . . . . 64.32 108.319 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 55' ' ' LEU . 5.5 p -116.74 124.45 72.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.633 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 51.4 p90 -91.19 149.16 21.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.009 -0.541 . . . . 72.03 110.189 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -107.63 132.39 55.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 109.335 -0.617 . . . . 71.51 109.335 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -111.93 145.1 40.17 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.077 -1.083 . . . . 71.13 108.077 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 35.9 ttpt -62.54 -22.96 66.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.16 0.8 . . . . 75.31 113.16 -172.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.7 m -54.17 -24.07 16.73 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 64.43 112.144 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.77 -39.25 70.11 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 122.127 -0.358 . . . . 52.1 110.643 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -69.56 -36.52 71.41 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.843 0 N-CA-C 107.86 -1.163 . . . . 73.34 107.86 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.38 -29.54 70.26 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.069 -0.969 . . . . 75.43 110.87 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.14 -47.7 9.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.584 0.587 . . . . 74.15 112.584 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -9.87 28.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.019 0.748 . . . . 64.23 113.019 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.48 55.61 29.06 Favored Glycine 0 CA--C 1.498 -1.022 0 O-C-N 123.459 0.475 . . . . 74.43 112.224 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.5 tm? -69.49 141.5 53.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 108.255 -1.017 . . . . 73.4 108.255 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.518 ' N ' HD13 ' A' ' 42' ' ' LEU . 58.7 t-80 -51.75 -60.67 2.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.869 0.867 . . . . 72.33 112.334 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -172.51 162.43 5.25 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.6 mt -124.82 121.08 33.54 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.852 0.834 . . . . 72.14 109.657 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.54 144.85 36.14 Favored 'General case' 0 C--N 1.245 -3.95 0 CA-C-N 113.962 -1.472 . . . . 60.41 108.463 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.65 147.13 53.1 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.605 0.717 . . . . 70.53 112.253 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.21 -16.9 59.41 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.001 -0.999 . . . . 42.45 111.891 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.28 137.47 35.8 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 122.496 0.318 . . . . 73.01 110.659 177.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 9.4 m-20 -88.53 137.48 32.29 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.018 -1.105 . . . . 74.31 108.018 177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 p -138.65 149.52 23.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 121.704 0.764 . . . . 73.41 110.969 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.1 mt -111.75 137.62 43.67 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.182 -1.784 . . . . 72.33 106.182 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.09 178.87 9.01 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.708 -0.397 . . . . 75.23 110.705 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -114.43 160.52 19.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.843 -2.28 . . . . 63.41 104.843 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 18.7 tp -129.81 127.74 40.91 Favored 'General case' 0 C--N 1.275 -2.632 0 N-CA-C 113.593 0.96 . . . . 62.53 113.593 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 55' ' ' LEU . 47.0 mt-10 -114.08 134.67 54.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.275 -1.784 . . . . 74.51 107.981 174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -93.41 134.18 35.91 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.284 0.564 . . . . 72.35 110.818 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 58.4 tptt -102.29 76.9 1.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.11 -1.441 . . . . 73.32 107.11 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 67.71 -70.43 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.647 1.179 . . . . 72.43 110.67 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 -15.56 1.45 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.22 -0.752 . . . . 75.42 111.22 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 54.7 mtpt -84.43 165.04 18.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.57 -0.53 . . . . 71.15 109.57 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -127.94 129.47 46.87 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.619 -0.433 . . . . 53.15 110.499 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.4 p90 -127.65 128.38 45.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 113.167 0.803 . . . . 71.04 113.167 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.48 133.29 43.62 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.264 -1.335 . . . . 72.14 110.688 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.64 164.41 30.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.015 -1.106 . . . . 71.34 108.015 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.1 t30 52.71 63.33 2.28 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.733 0.646 . . . . 65.35 110.959 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 32' ' ' VAL . 38.4 mt -78.46 149.47 33.22 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.775 -0.648 . . . . 64.32 111.937 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -150.81 131.66 14.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.772 -1.936 . . . . 64.42 105.772 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 2.6 pp -80.33 140.57 16.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.366 -1.333 . . . . 73.45 112.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.088 -0.96 . . . . 74.33 109.214 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.507 -0.675 0 N-CA-C 108.574 -0.899 . . . . 74.02 108.574 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.9 91.2 3.46 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.576 -0.527 . . . . 72.31 109.576 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.8 p -115.87 142.56 46.61 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.65 -0.705 . . . . 54.22 110.983 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.35 78.09 0.2 Allowed 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.035 0.921 . . . . 65.21 111.334 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.45 147.22 7.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 114.154 -1.384 . . . . 64.34 109.965 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 73.8 t -92.19 134.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.269 0 CA-C-N 115.223 -0.899 . . . . 54.12 108.643 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -162.41 172.73 38.57 Favored Glycine 1 N--CA 1.392 -4.265 0 C-N-CA 120.27 -0.967 . . . . 72.34 112.154 171.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 27.5 ttpp -130.48 132.67 45.77 Favored 'General case' 0 C--N 1.257 -3.42 0 C-N-CA 125.204 1.402 . . . . 71.11 108.412 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -61.8 115.85 2.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.933 -0.576 . . . . 75.12 110.162 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 66.7 mttm -66.94 -49.43 65.53 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.413 -0.958 . . . . 73.13 108.413 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -173.78 165.43 4.42 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.246 -1.343 . . . . 74.23 108.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 85.5 t80 -153.79 121.25 5.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 123.4 0.438 . . . . 74.43 110.368 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -96.36 98.81 10.56 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.088 0.471 . . . . 71.04 109.946 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 m -58.93 -35.08 72.51 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.113 -0.949 . . . . 62.31 111.427 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.4 m -65.32 -31.12 72.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.236 0.541 . . . . 74.21 110.525 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -97.98 -9.01 26.83 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.1 -0.375 . . . . 73.34 111.997 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.82 23.36 11.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.973 0.509 . . . . 72.1 112.346 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 37.4 p90 -151.06 161.12 43.33 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.445 0.64 . . . . 62.32 112.539 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -166.95 -162.27 18.18 Favored Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 109.156 -1.578 . . . . 75.1 109.156 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 46.9 m-85 -135.71 154.84 51.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.938 0.869 . . . . 75.21 111.711 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.72 140.73 44.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.224 -0.658 . . . . 74.11 109.224 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 14.0 pt-20 -143.54 147.65 34.78 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 105.755 -1.942 . . . . 65.31 105.755 173.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.595 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.0 pt20 -80.73 151.3 28.93 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 116.786 -1.966 . . . . 72.01 109.44 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.74 -29.02 24.76 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.251 -1.34 . . . . 71.34 111.913 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -75.71 1.08 15.6 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.775 -0.648 . . . . 73.12 111.851 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.41 50.87 1.79 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.54 -0.838 . . . . 74.42 111.207 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.81 172.2 54.96 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.639 -0.791 . . . . 64.12 112.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.33 162.96 28.59 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.771 0.656 . . . . 50.41 112.771 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.14 97.67 10.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.398 -0.819 . . . . 45.22 110.604 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.493 HG21 HD13 ' A' ' 55' ' ' LEU . 3.2 p -117.81 134.87 60.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 115.118 -0.947 . . . . 63.52 109.062 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 54.4 p90 -90.6 150.15 21.83 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.032 -0.667 . . . . 73.53 111.221 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -110.11 125.46 67.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 109.583 -0.525 . . . . 43.21 109.583 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -108.43 152.93 24.02 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.298 -1.001 . . . . 64.11 108.298 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.06 -16.04 39.23 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 113.073 0.768 . . . . 74.11 113.073 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.5 t -58.76 -26.42 63.99 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.228 0.537 . . . . 53.44 110.03 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.94 -36.44 56.56 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.983 0.42 . . . . 71.13 109.973 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.68 -48.85 84.76 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.091 0 N-CA-C 107.647 -1.242 . . . . 71.13 107.647 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -56.37 -28.23 58.55 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 124.816 1.246 . . . . 64.12 111.292 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.13 -23.32 67.1 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.458 0.54 . . . . 34.31 112.458 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.44 -24.15 2.29 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.712 0.634 . . . . 70.32 112.712 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.16 48.74 5.57 Favored Glycine 0 C--N 1.31 -0.905 0 N-CA-C 110.454 -1.059 . . . . 50.03 110.454 -175.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.49 130.37 41.09 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.435 -1.32 . . . . 75.51 107.435 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.35 -47.78 75.26 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.128 1.158 . . . . 74.41 114.128 -174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.4 p -159.06 160.49 35.85 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.53 -0.468 . . . . 74.43 111.064 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.11 142.78 48.89 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.249 -1.019 . . . . 73.0 108.249 175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.86 162.77 40.51 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 123.73 0.812 . . . . 71.54 109.319 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -67.49 153.33 43.93 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.445 0.641 . . . . 65.01 112.466 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.91 -16.08 59.27 Favored Glycine 0 C--N 1.305 -1.154 0 CA-C-N 114.881 -1.054 . . . . 72.35 112.198 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -83.84 124.93 31.46 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 122.244 0.218 . . . . 62.45 111.122 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 15.4 m-20 -78.33 133.57 37.59 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 107.185 -1.413 . . . . 64.02 107.185 174.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.74 147.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.138 0 CA-C-O 121.913 0.863 . . . . 62.11 110.51 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 64.1 mt -109.98 132.28 58.66 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 N-CA-C 107.002 -1.481 . . . . 73.55 107.002 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.62 178.67 8.27 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.764 -0.458 . . . . 72.1 109.764 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -119.67 155.27 32.7 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.671 -1.974 . . . . 72.13 105.671 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.493 HD13 HG21 ' A' ' 30' ' ' VAL . 26.3 tp -124.4 111.26 15.55 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.452 1.12 . . . . 75.23 112.649 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.74 141.51 45.26 Favored 'General case' 0 C--N 1.268 -2.953 0 CA-C-N 113.062 -1.881 . . . . 62.14 107.425 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -87.06 142.14 28.14 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.276 -0.638 . . . . 74.45 109.276 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -90.41 22.31 3.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.298 -1.371 . . . . 73.15 107.298 -179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 65.09 87.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 75.14 108.333 -172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.21 -58.41 0.6 Allowed Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 114.692 -1.14 . . . . 74.45 111.24 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.1 mmmt -86.19 154.12 21.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.177 -0.305 . . . . 63.13 110.177 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.69 118.11 27.33 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 122.215 0.206 . . . . 70.44 110.574 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.4 ' HB3' ' CE2' ' A' ' 31' ' ' PHE . 1.2 p90 -131.89 140.41 49.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.367 0.603 . . . . 64.04 111.509 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -71.97 135.14 46.33 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.675 -1.148 . . . . 64.24 109.527 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 34.8 m -133.96 164.71 33.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.364 -0.835 . . . . 62.31 109.959 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.53 64.23 1.74 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.962 0.789 . . . . 54.32 111.593 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.549 HD11 HG21 ' A' ' 32' ' ' VAL . 28.9 mt -74.67 140.14 44.02 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.671 0.989 . . . . 63.31 113.671 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 75.5 ttt180 -143.51 131.35 21.5 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 106.36 -1.718 . . . . 73.13 106.36 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.9 148.72 4.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.346 -0.942 . . . . 73.34 111.536 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.556 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 3.7 ttpm? . . . . . 0 C--O 1.256 1.412 0 CA-C-O 118.758 -0.639 . . . . 73.23 109.498 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 CA--C 1.497 -1.061 0 N-CA-C 108.356 -0.979 . . . . 64.13 108.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -161.69 117.09 2.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.144 -1.428 . . . . 64.0 107.144 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.5 p -100.43 140.29 34.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 123.357 0.411 . . . . 63.44 111.812 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 56.5 77.79 0.24 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.774 1.23 . . . . 60.03 110.701 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 2' ' ' ALA . 30.3 mt -100.42 148.4 6.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 114.627 -1.17 . . . . 50.41 109.564 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 87.8 t -92.81 132.84 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-N 115.369 -0.832 . . . . 70.33 109.522 176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -161.99 163.93 35.08 Favored Glycine 1 N--CA 1.395 -4.087 0 CA-C-N 115.272 -0.877 . . . . 65.0 111.576 171.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -119.28 136.42 54.24 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.898 -1.149 . . . . 74.02 107.898 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.83 103.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.329 0.585 . . . . 75.45 109.572 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 49.1 tttp -70.18 -47.26 62.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.826 -1.079 . . . . 61.24 108.109 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.498 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 68.9 p-90 -173.66 165.75 4.52 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.16 0.984 . . . . 63.15 108.641 175.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -163.02 132.78 4.31 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.376 0.422 . . . . 74.45 110.596 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -125.39 107.81 11.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.463 -0.569 . . . . 71.11 109.463 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 m -57.55 -33.86 68.55 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.85 -0.614 . . . . 63.11 110.902 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.9 m -61.44 -33.17 73.28 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 115.951 -0.568 . . . . 73.21 111.219 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -97.62 -8.72 28.27 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 122.021 -0.424 . . . . 54.43 111.049 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.2 m120 61.26 21.48 11.97 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.784 0.834 . . . . 71.13 110.622 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -137.5 163.62 30.68 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 123.387 0.675 . . . . 73.3 110.894 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -175.02 -172.55 40.06 Favored Glycine 0 N--CA 1.409 -3.158 0 N-CA-C 107.836 -2.106 . . . . 50.23 107.836 177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 21.3 m-85 -136.05 162.93 31.52 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 117.749 0.775 . . . . 75.23 111.794 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.5 134.51 29.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.669 -1.151 . . . . 71.3 107.924 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 10' ' ' LYS . 12.3 pt-20 -135.98 141.79 44.46 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.01 -2.219 . . . . 75.5 105.01 176.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.596 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.8 pt20 -78.53 143.29 36.7 Favored 'General case' 0 CA--C 1.464 -2.353 0 C-N-CA 116.135 -2.226 . . . . 65.33 108.922 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -54.63 -18.01 4.02 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.793 1.308 . . . . 61.55 112.07 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.36 -0.32 28.53 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.603 -0.726 . . . . 73.43 111.428 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.4 41.91 35.78 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 110.995 -0.842 . . . . 75.34 110.995 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 -132.35 4.26 Favored Glycine 0 N--CA 1.44 -1.033 0 C-N-CA 120.933 -0.651 . . . . 63.44 113.371 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -86.64 152.49 22.53 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.149 0.426 . . . . 71.13 112.149 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.2 130.25 47.26 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 116.073 -0.512 . . . . 75.25 110.126 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -138.66 143.22 32.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 108.823 -0.806 . . . . 60.21 108.823 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 51.5 p90 -93.53 148.99 21.58 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 119.696 -0.802 . . . . 65.41 111.603 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 67' ' ' LEU . 7.1 p -105.74 128.85 59.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 CA-C-N 115.75 -0.659 . . . . 52.34 109.316 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -110.02 150.34 28.68 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 109.015 -0.735 . . . . 73.3 109.015 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.7 -18.82 64.39 Favored 'General case' 0 C--O 1.203 -1.395 0 N-CA-C 113.671 0.989 . . . . 71.4 113.671 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -57.22 -27.5 62.06 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.942 0.401 . . . . 74.52 110.314 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -75.96 -35.73 59.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 120.986 0.422 . . . . 75.13 110.38 176.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.84 -37.77 77.83 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.286 0 N-CA-C 108.292 -1.003 . . . . 73.41 108.292 174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -62.88 -32.58 73.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.053 0.541 . . . . 70.12 110.722 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.1 -30.96 66.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.35 112.72 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.85 -23.3 2.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.21 0.819 . . . . 61.11 113.21 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 53.93 3.57 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 109.954 -1.258 . . . . 61.21 109.954 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 tp -75.58 127.0 32.11 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.89 -0.655 . . . . 35.14 111.396 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -104.61 -0.4 27.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.816 -0.629 . . . . 72.3 111.391 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.9 m -123.32 79.3 1.66 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.151 1.167 . . . . 43.32 114.151 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.16 114.1 19.2 Favored 'General case' 0 C--N 1.251 -3.683 0 N-CA-C 108.108 -1.071 . . . . 60.22 108.108 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -151.79 158.19 42.97 Favored 'General case' 1 C--N 1.243 -4.035 0 CA-C-N 113.94 -1.482 . . . . 70.55 107.239 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.12 148.83 49.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 121.695 0.759 . . . . 74.51 112.344 -174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.29 -18.61 27.48 Favored Glycine 0 C--N 1.294 -1.798 0 CA-C-N 114.82 -1.082 . . . . 63.24 113.993 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -71.03 135.05 47.59 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 117.546 0.673 . . . . 52.55 111.644 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -85.07 135.11 34.14 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.426 -1.324 . . . . 73.22 107.426 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.56 145.28 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-O 121.981 0.896 . . . . 64.32 110.989 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.5 mt -107.99 130.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 106.483 -1.673 . . . . 73.5 106.483 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 39.3 p90 -146.62 179.62 7.43 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 120.153 -0.619 . . . . 73.41 110.995 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -120.36 158.29 27.45 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 105.532 -2.025 . . . . 64.44 105.532 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 30' ' ' VAL . 26.1 tp -129.69 129.54 44.36 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.099 1.148 . . . . 74.1 114.099 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.2 mm-40 -125.63 139.46 53.55 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-N 113.088 -1.869 . . . . 64.1 109.567 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.94 142.79 32.68 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.825 -1.08 . . . . 75.31 111.688 -174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -90.76 31.92 1.02 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.271 -1.011 . . . . 75.32 108.271 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 62.34 22.72 13.4 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.197 -0.911 . . . . 52.14 111.715 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.08 -49.08 0.13 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 109.526 -1.43 . . . . 75.31 109.526 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 74.5 mmtt -93.01 164.71 13.17 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.338 -0.431 . . . . 72.43 110.787 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -132.76 119.08 19.84 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.406 -0.59 . . . . 55.52 109.406 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.489 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 44.0 p90 -124.59 133.28 53.32 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.519 0.676 . . . . 71.4 112.423 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.19 134.05 42.75 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.631 -1.168 . . . . 33.04 110.534 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 27.5 m -133.77 169.37 21.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 114.937 -1.028 . . . . 64.54 109.517 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 53.77 63.06 2.33 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 123.246 0.619 . . . . 53.31 111.384 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 32' ' ' VAL . 21.9 mt -82.36 135.77 35.12 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.617 0.723 . . . . 72.03 112.869 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -145.95 130.13 17.52 Favored 'General case' 0 N--CA 1.4 -2.951 0 CA-C-N 114.059 -1.428 . . . . 71.03 107.997 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.759 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -80.69 148.79 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 C-N-CA 121.057 -0.257 . . . . 64.04 110.717 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 124.387 1.054 . . . . 52.1 109.152 176.201 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 108.788 -0.819 . . . . 72.24 108.788 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.64 147.77 45.22 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.094 -0.706 . . . . 73.22 109.094 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 p -131.54 153.18 50.11 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.246 0.461 . . . . 71.23 112.246 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 62.68 40.52 10.11 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.022 0.929 . . . . 72.45 111.633 174.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 mt -75.25 152.94 6.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.772 -0.649 . . . . 53.23 111.229 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 85.9 t -106.83 136.75 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 115.3 -0.863 . . . . 75.21 109.053 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.3 168.73 41.02 Favored Glycine 0 N--CA 1.404 -3.456 0 C-N-CA 119.128 -1.511 . . . . 72.43 113.77 167.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.2 ttmt -113.72 136.24 53.07 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 114.411 -0.894 . . . . 72.22 108.969 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.57 107.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.965 -0.754 . . . . 64.31 108.965 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -63.81 -52.99 57.72 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.699 -1.137 . . . . 65.54 109.883 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 64.4 p-90 -160.64 160.01 31.08 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 108.859 -0.793 . . . . 70.3 108.859 174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -157.61 125.31 5.3 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 124.053 0.845 . . . . 73.1 109.272 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.08 115.99 31.06 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.293 -1.373 . . . . 61.34 107.293 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 t -73.0 -25.96 61.17 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.698 0.285 . . . . 54.33 111.261 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 m -68.55 -55.21 12.43 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.116 0.484 . . . . 64.0 110.356 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.49 -8.49 52.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.103 -0.498 . . . . 75.42 111.709 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 34' ' ' LYS . 14.4 m120 64.17 26.17 13.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.194 0.813 . . . . 72.01 113.194 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -114.83 157.98 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.869 -0.419 . . . . 72.31 109.869 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.96 -174.14 45.56 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.135 -0.786 . . . . 54.01 111.135 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 31' ' ' PHE . 45.7 m-85 -134.35 159.86 39.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.117 0.567 . . . . 65.33 111.132 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 62.5 mt -143.08 135.9 25.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 123.737 0.648 . . . . 73.02 109.372 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.84 153.27 42.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 107.133 -1.432 . . . . 65.54 107.133 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.3 pt20 -84.84 154.69 22.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.382 -1.327 . . . . 63.45 109.386 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.55 -22.41 61.65 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.159 0.912 . . . . 62.44 113.116 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -77.82 -2.96 39.08 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.763 -0.375 . . . . 72.24 111.771 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.46 51.19 1.23 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 110.256 -1.138 . . . . 61.2 110.256 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -77.14 164.41 52.73 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.365 -0.921 . . . . 71.33 112.128 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.71 155.76 40.03 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 123.806 0.357 . . . . 74.33 111.816 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.09 120.93 25.93 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.83 0.824 . . . . 75.21 111.567 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -135.9 135.2 50.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 114.489 -1.232 . . . . 63.5 107.915 174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.6 p90 -90.12 150.36 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 119.43 -0.908 . . . . 70.3 110.84 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 67' ' ' LEU . 7.3 p -95.29 126.47 47.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-O 121.456 0.646 . . . . 55.53 109.606 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -113.33 148.0 36.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.731 -0.84 . . . . 71.45 108.731 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' ASN . 86.8 tttt -64.72 -21.99 66.88 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.664 0.987 . . . . 72.02 113.664 -173.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -54.19 -22.16 10.74 Favored 'General case' 0 C--O 1.208 -1.09 0 C-N-CA 120.627 -0.429 . . . . 33.03 111.315 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.21 -42.51 59.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.069 0.461 . . . . 53.42 110.853 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 57.3 t -70.45 -30.31 42.34 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.51 0 N-CA-C 108.215 -1.031 . . . . 62.51 108.215 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.63 -36.12 65.39 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.987 -0.551 . . . . 71.2 110.036 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.35 -49.98 24.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.422 0.527 . . . . 73.23 112.422 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.07 15.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.43 0.53 . . . . 73.25 112.43 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 37' ' ' VAL . . . 77.75 62.96 2.28 Favored Glycine 0 CA--C 1.493 -1.325 0 C-N-CA 121.454 -0.403 . . . . 72.34 112.224 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.83 130.02 39.08 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 106.817 -1.549 . . . . 64.25 106.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -60.45 -49.27 78.24 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.525 0.565 . . . . 74.15 112.525 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.4 p -175.09 137.99 0.43 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.097 0.559 . . . . 72.21 110.918 -175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.82 164.31 12.69 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.195 0.521 . . . . 71.5 110.62 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -169.49 162.83 10.26 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.257 -1.757 . . . . 63.13 106.257 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -75.17 152.84 38.4 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.207 0.527 . . . . 54.13 111.928 -177.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.42 -12.25 69.81 Favored Glycine 0 C--N 1.306 -1.119 0 CA-C-N 115.386 -0.824 . . . . 72.21 112.478 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.517 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -77.42 136.26 38.38 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 122.503 0.321 . . . . 73.01 111.581 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -86.56 134.19 33.67 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.227 -1.397 . . . . 72.31 107.227 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.21 147.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.434 0 CA-C-O 121.869 0.842 . . . . 72.23 110.773 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.03 129.34 71.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 106.41 -1.7 . . . . 73.31 106.41 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -147.52 -177.53 5.75 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 120.043 -0.663 . . . . 74.13 110.873 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -124.0 161.81 24.72 Favored 'General case' 0 N--CA 1.41 -2.433 0 N-CA-C 105.501 -2.037 . . . . 72.4 105.501 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 30' ' ' VAL . 23.2 tp -130.18 129.83 43.93 Favored 'General case' 0 C--N 1.268 -2.942 0 CA-C-O 121.899 0.857 . . . . 71.41 112.946 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.1 137.81 54.83 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.629 -1.623 . . . . 64.42 107.432 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.79 155.77 18.1 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.118 0.961 . . . . 63.51 110.308 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 52.0 tttp -116.88 24.66 11.07 Favored 'General case' 0 C--N 1.252 -3.643 0 N-CA-C 107.094 -1.447 . . . . 73.51 107.094 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 70.68 -59.99 0.51 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.5 1.52 . . . . 75.33 111.809 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.52 -23.34 36.96 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 111.098 -0.801 . . . . 32.14 111.098 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.1 mmtt -123.03 164.98 17.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.585 0.231 . . . . 64.05 111.11 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.34 116.42 11.04 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.192 -1.04 . . . . 64.3 108.192 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 21.9 p90 -130.39 137.48 49.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.452 0.644 . . . . 73.2 112.442 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 137.52 51.59 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.666 -1.152 . . . . 43.43 110.181 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.651 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 29.0 m -135.42 161.6 38.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 65.02 109.986 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 56.27 63.88 1.86 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.03 0.831 . . . . 75.03 109.83 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.625 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 32.6 mt -79.24 137.43 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.968 0.729 . . . . 75.23 112.968 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.98 135.02 39.19 Favored 'General case' 0 N--CA 1.405 -2.688 0 CA-C-N 114.729 -1.123 . . . . 74.14 109.119 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -72.41 134.19 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 N-CA-C 109.408 -0.589 . . . . 72.43 109.408 173.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.307 -1.265 0 O-C-N 123.849 0.718 . . . . 64.32 110.117 179.641 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 120.71 0.29 . . . . 73.12 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -143.4 116.38 8.85 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.782 -0.822 . . . . 62.53 108.782 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.2 p -107.68 145.6 33.18 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.624 -0.262 . . . . 73.0 111.079 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 58.37 78.39 0.25 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.46 1.104 . . . . 51.52 109.78 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 50.7 mt -108.33 149.53 11.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 114.314 -1.312 . . . . 62.42 110.245 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 88.5 t -93.26 132.98 35.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.269 -0.878 . . . . 73.31 109.79 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.58 164.89 33.77 Favored Glycine 0 N--CA 1.405 -3.404 0 C-N-CA 120.522 -0.846 . . . . 74.21 111.944 171.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -112.05 134.31 53.68 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 107.234 -1.395 . . . . 72.34 107.234 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.45 110.41 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 107.725 -1.213 . . . . 75.02 107.725 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.3 tttp -75.2 -49.88 17.99 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.286 -1.325 . . . . 51.03 109.36 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -167.72 160.91 13.04 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.618 -0.882 . . . . 72.44 108.618 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -161.39 116.59 2.07 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 123.738 0.649 . . . . 73.14 110.18 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -92.08 105.76 17.92 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.03 -1.1 . . . . 63.42 108.03 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -53.95 -45.48 71.31 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 124.259 1.024 . . . . 71.5 111.8 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -58.1 -37.44 74.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.131 0.572 . . . . 73.32 111.635 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -99.22 -5.72 29.43 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.769 -0.372 . . . . 75.34 111.958 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.68 27.33 17.06 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.475 0.484 . . . . 71.13 111.897 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -134.83 152.13 51.5 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.598 -0.519 . . . . 74.3 109.598 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.89 -165.95 33.14 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.826 -0.909 . . . . 70.32 110.826 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 34.8 m-85 -137.26 165.01 27.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.209 0.528 . . . . 72.11 112.023 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.0 mt -147.28 135.77 15.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.949 -1.13 . . . . 65.45 107.949 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.09 147.34 33.64 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.02 -2.215 . . . . 72.14 105.02 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.0 pt20 -77.35 144.15 38.22 Favored 'General case' 0 CA--C 1.473 -2.012 0 C-N-CA 116.216 -2.194 . . . . 74.52 109.444 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -53.02 -29.1 27.5 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 124.971 1.419 . . . . 73.01 112.471 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.08 -11.77 61.13 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 62.25 111.847 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.89 50.85 0.76 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.42 -0.895 . . . . 72.33 111.199 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -90.59 171.2 36.07 Favored Glycine 0 C--N 1.318 -0.447 0 N-CA-C 110.602 -0.999 . . . . 75.03 110.602 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.81 147.82 33.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.353 0.577 . . . . 73.45 111.327 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.56 122.81 18.81 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.941 -1.027 . . . . 63.02 110.695 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 55' ' ' LEU . 7.3 p -126.01 139.96 49.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.036 -1.098 . . . . 41.42 108.036 174.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -92.64 142.95 26.81 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 119.413 -0.915 . . . . 75.14 112.62 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG21 HD11 ' A' ' 67' ' ' LEU . 10.8 p -112.83 142.02 26.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.303 -0.862 . . . . 73.35 109.023 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -136.64 162.5 32.97 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.017 -1.105 . . . . 74.15 108.017 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.11 -18.68 59.28 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 112.281 0.474 . . . . 50.3 112.281 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.8 m -52.89 -30.2 32.69 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.084 0.469 . . . . 64.03 110.302 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.95 -35.08 57.53 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.355 -0.384 . . . . 54.5 110.42 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.95 -41.45 89.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.316 0 N-CA-C 107.786 -1.19 . . . . 75.03 107.786 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.07 -36.86 82.93 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.93 -0.577 . . . . 62.24 110.219 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.04 -33.54 75.66 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.557 0.947 . . . . 60.41 113.557 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.23 -10.79 4.18 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.626 0.973 . . . . 55.1 113.626 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.75 55.0 5.61 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.21 -0.756 . . . . 45.01 111.21 -175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 43' ' ' HIS . 2.4 tm? -71.6 149.82 45.26 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.929 -1.508 . . . . 72.13 106.929 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.563 ' N ' HD13 ' A' ' 42' ' ' LEU . 60.7 m80 -83.04 -60.98 1.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.536 -0.727 . . . . 73.21 111.912 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.5 p -165.87 145.01 6.14 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 122.914 0.485 . . . . 75.42 109.919 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.8 mt -109.9 146.65 34.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.541 0.686 . . . . 72.32 111.669 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.49 153.04 41.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.607 -1.627 . . . . 63.14 106.607 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.51 155.3 38.1 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.905 0.383 . . . . 75.1 111.182 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 4.84 79.22 Favored Glycine 0 C--N 1.318 -0.453 0 C-N-CA 121.113 -0.565 . . . . 52.4 112.574 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.43 135.96 34.17 Favored 'General case' 0 CA--C 1.487 -1.462 0 C-N-CA 122.659 0.384 . . . . 74.11 110.352 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -86.0 120.14 27.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.25 -1.389 . . . . 74.04 107.25 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.37 152.7 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 CA-C-O 121.655 0.741 . . . . 62.34 111.044 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 68.5 mt -114.47 136.03 52.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.028 -1.471 . . . . 72.41 107.028 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.6 p90 -151.19 177.55 10.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.136 -0.32 . . . . 72.41 110.136 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.4 147.7 40.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.54 -1.652 . . . . 72.3 106.54 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 27.3 tp -134.41 133.4 40.49 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.249 1.023 . . . . 45.32 112.056 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -135.71 137.11 41.41 Favored 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 113.287 -1.779 . . . . 64.0 107.033 173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.4 OUTLIER -84.94 138.81 32.27 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.69 0.757 . . . . 75.12 112.102 -176.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 65.4 tttm -99.21 72.55 1.86 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.214 -1.402 . . . . 75.34 107.214 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.82 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.548 1.539 . . . . 71.41 109.339 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 -18.4 5.01 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.449 -0.405 . . . . 51.4 112.183 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 8.3 mmpt? -89.19 164.69 14.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.397 -0.594 . . . . 53.22 109.397 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.78 118.54 16.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.803 -0.443 . . . . 52.34 109.803 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -121.93 134.21 54.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.434 0.635 . . . . 73.14 111.976 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.41 131.85 35.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.817 -1.083 . . . . 52.24 109.559 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 17.0 m -139.64 168.31 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.484 -0.78 . . . . 65.23 110.036 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.73 63.21 1.87 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.956 0.785 . . . . 72.41 109.944 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 mt -81.41 143.33 32.21 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.342 -0.844 . . . . 75.3 111.912 -174.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 19.3 tpp180 -145.68 129.87 17.57 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.807 -1.923 . . . . 64.41 105.807 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.83 HD13 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.68 141.13 15.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-N 118.057 0.389 . . . . 73.2 111.764 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt . . . . . 0 C--N 1.298 -1.652 0 CA-C-N 115.274 -0.875 . . . . 62.4 109.723 176.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 C--O 1.221 -0.436 0 N-CA-C 111.175 0.065 . . . . 75.51 111.175 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.43 135.39 35.64 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.123 -0.325 . . . . 71.23 110.123 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.1 p -120.99 146.12 47.02 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.384 0.513 . . . . 71.43 112.384 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 59.16 78.8 0.25 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.804 1.242 . . . . 64.44 112.266 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 33.4 mt -106.88 147.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.217 -0.901 . . . . 72.34 110.555 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 69.6 t -107.78 135.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.422 -0.808 . . . . 75.4 110.219 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -178.61 160.93 27.12 Favored Glycine 0 N--CA 1.408 -3.2 0 CA-C-N 115.246 -0.888 . . . . 74.2 112.95 170.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.2 ttmt -98.88 135.56 40.14 Favored 'General case' 0 C--N 1.266 -3.049 0 CA-C-N 114.782 -0.709 . . . . 73.35 109.483 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.23 109.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.306 -0.998 . . . . 74.23 108.306 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.2 tttp -72.42 -42.22 65.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.371 -1.286 . . . . 70.11 108.954 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 47' ' ' GLU . 67.1 p-90 -174.79 160.53 2.95 Favored 'General case' 0 CA--C 1.486 -1.518 0 C-N-CA 123.949 0.9 . . . . 72.03 108.821 172.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -161.72 126.87 3.5 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 123.978 0.799 . . . . 73.21 109.519 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -99.05 118.4 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.711 -1.218 . . . . 73.21 107.711 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -70.04 -23.91 63.18 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.26 0.467 . . . . 53.32 112.26 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 m -86.46 -46.29 10.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.087 0.47 . . . . 75.51 111.216 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.43 -8.68 58.89 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.738 -0.385 . . . . 73.53 111.942 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.3 m120 60.63 31.36 20.18 Favored 'General case' 0 C--O 1.25 1.122 0 N-CA-C 112.374 0.509 . . . . 70.04 112.374 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.83 153.08 43.09 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.272 -0.422 . . . . 73.32 109.872 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.62 -169.59 39.54 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.68 -0.968 . . . . 62.05 110.68 175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 53.1 m-85 -140.06 166.62 24.18 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.337 0.655 . . . . 72.43 110.588 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -145.17 133.67 17.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.061 -0.718 . . . . 74.45 109.061 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -143.44 143.01 31.43 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.488 -1.301 . . . . 72.41 107.488 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.6 pt20 -83.27 156.16 23.25 Favored 'General case' 0 CA--C 1.481 -1.691 0 C-N-CA 118.035 -1.466 . . . . 63.41 109.26 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.31 -25.06 21.7 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 124.628 1.205 . . . . 72.44 113.554 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -78.41 -0.39 28.98 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 122.256 -0.277 . . . . 65.22 111.591 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 51.48 3.03 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 109.896 -1.282 . . . . 74.51 109.896 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -66.43 -104.77 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 116.651 1.42 . . . . 51.24 116.651 -172.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -127.69 176.48 7.49 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.301 0.572 . . . . 75.11 111.525 -171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -116.46 83.32 1.94 Allowed 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 107.816 -1.179 . . . . 62.1 107.816 172.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 55' ' ' LEU . 4.2 p -119.46 129.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 CA-C-N 115.382 -0.827 . . . . 75.21 109.638 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 39.6 p90 -86.23 139.07 31.38 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.289 0.566 . . . . 75.32 111.681 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 67' ' ' LEU . 7.2 p -103.39 119.8 52.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.289 -0.869 . . . . 72.43 109.81 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -110.24 161.75 15.29 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.952 -1.129 . . . . 62.34 107.952 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.72 -22.31 63.85 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 112.83 0.678 . . . . 72.53 112.83 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -53.74 -24.58 15.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.178 0.513 . . . . 34.23 111.41 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.33 -39.07 59.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 120.979 0.418 . . . . 63.1 110.597 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.7 t -66.89 -44.73 88.65 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 N-CA-C 108.089 -1.078 . . . . 72.41 108.089 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.35 -26.22 67.68 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 123.351 0.407 . . . . 64.15 110.634 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.69 -30.74 66.01 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 112.707 0.632 . . . . 71.31 112.707 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.86 -0.59 4.23 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.161 0.8 . . . . 74.12 113.161 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.87 39.57 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 123.251 0.453 . . . . 31.53 112.463 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.43 142.72 51.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.306 -1.739 . . . . 63.24 106.306 178.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' N ' HD13 ' A' ' 42' ' ' LEU . 40.2 t60 -71.15 -61.51 1.74 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.637 -0.825 . . . . 75.43 111.829 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.9 m -164.37 157.15 17.18 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.077 -0.712 . . . . 63.0 109.077 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.9 mt -144.03 153.93 42.72 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.682 0.754 . . . . 42.51 112.425 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.92 172.32 13.86 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.171 -1.377 . . . . 61.33 107.693 173.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -71.33 156.1 39.9 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.697 0.761 . . . . 70.14 112.607 -177.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 -18.5 57.35 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.133 -0.939 . . . . 43.5 112.005 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -82.35 139.38 34.14 Favored 'General case' 0 C--O 1.207 -1.142 0 C-N-CA 122.687 0.395 . . . . 64.4 111.657 -179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 11.1 m-20 -89.12 134.49 33.99 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.274 -1.009 . . . . 73.54 108.274 175.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.04 152.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-O 121.816 0.817 . . . . 74.11 111.142 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 55.6 mt -116.69 128.92 73.93 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.631 -1.618 . . . . 75.41 106.631 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -145.95 -180.0 7.09 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.75 -0.38 . . . . 71.31 110.299 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -119.98 157.23 29.27 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 105.379 -2.082 . . . . 64.24 105.379 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -123.93 128.51 49.54 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 121.581 0.705 . . . . 72.34 111.329 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -122.85 142.47 50.74 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.43 -1.693 . . . . 73.32 106.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.05 143.83 26.01 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.586 -0.846 . . . . 73.44 112.551 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -103.7 35.48 2.61 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.288 -1.375 . . . . 70.54 107.288 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 63.52 88.81 0.09 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.634 -1.167 . . . . 75.14 109.324 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.82 -47.87 3.62 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.585 -0.817 . . . . 53.53 111.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 73.5 mmtt -83.73 153.11 24.34 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.519 -0.549 . . . . 74.33 109.519 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -123.82 122.37 37.85 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.829 -0.168 . . . . 31.31 111.183 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.515 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 23.1 p90 -126.49 133.22 51.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.459 0.647 . . . . 73.3 111.777 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -74.39 140.38 44.71 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.736 -1.12 . . . . 52.41 109.709 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 27.3 m -139.5 164.57 24.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.469 -0.787 . . . . 71.51 109.314 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.7 t30 58.72 63.91 1.56 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.075 0.859 . . . . 70.33 111.147 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.604 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 24.9 mt -78.98 138.07 37.88 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.611 -1.236 . . . . 63.01 112.929 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -141.92 131.67 24.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.187 -2.153 . . . . 74.23 105.187 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.254 2.3 pp -77.92 146.92 7.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 118.79 -1.164 . . . . 73.01 112.006 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.9 tttt . . . . . 0 C--O 1.262 1.74 0 CA-C-N 115.687 -0.688 . . . . 74.05 109.559 178.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 121.169 0.509 . . . . 73.33 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . . . -161.28 107.57 1.4 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.713 -1.217 . . . . 52.43 107.713 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 27.7 p -101.0 142.94 31.76 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.52 0.933 . . . . 64.31 113.52 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 62.75 77.84 0.31 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 124.595 1.158 . . . . 62.13 111.785 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.5 mt -110.02 145.71 16.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.34 -0.845 . . . . 74.13 111.127 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 57.2 t -99.57 137.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.257 -0.883 . . . . 64.32 110.641 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -172.45 177.99 44.79 Favored Glycine 0 N--CA 1.4 -3.71 0 CA-C-N 115.007 -0.997 . . . . 44.14 112.349 167.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -121.98 141.28 51.49 Favored 'General case' 0 C--N 1.256 -3.467 0 C-N-CA 123.813 0.845 . . . . 64.43 108.978 177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -59.75 111.97 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 N-CA-C 109.045 -0.724 . . . . 63.2 109.045 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 53.4 tttm -72.41 -48.12 43.88 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.393 -1.336 . . . . 71.11 107.393 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CZ3' ' HA2' ' A' ' 19' ' ' GLY . 67.4 p-90 -176.43 160.96 2.15 Favored 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.83 1.252 . . . . 73.21 108.494 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 81.0 t80 -151.35 126.08 9.63 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.943 -0.391 . . . . 73.43 109.943 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -103.79 101.74 11.56 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.478 -0.934 . . . . 74.12 108.478 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.4 m -63.85 -21.41 66.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.98 -0.554 . . . . 31.41 111.19 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.7 p -65.81 -37.54 86.54 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 123.33 0.652 . . . . 71.15 111.396 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.7 mttt -103.14 -6.13 22.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.936 -0.574 . . . . 71.52 111.862 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 m120 69.43 22.38 6.48 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.533 0.733 . . . . 71.31 112.226 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 48.8 p90 -147.59 165.08 31.48 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.169 0.509 . . . . 62.34 111.748 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 11' ' ' TRP . . . -167.95 -157.3 10.89 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.999 -1.241 . . . . 71.22 109.999 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' HD1' ' CZ2' ' A' ' 11' ' ' TRP . 46.4 m-85 -137.72 165.75 25.64 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 117.417 0.608 . . . . 75.31 112.168 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -143.92 139.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.09 -1.078 . . . . 61.43 108.09 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 12.4 pt-20 -142.84 144.54 32.55 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 106.519 -1.66 . . . . 73.14 106.519 174.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.542 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -86.94 150.33 24.15 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 117.512 -1.675 . . . . 64.02 108.221 174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.59 -14.31 12.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 124.241 0.963 . . . . 75.34 112.597 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -88.64 5.39 43.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.539 -0.301 . . . . 73.32 111.183 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.7 50.97 2.4 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.691 -1.242 . . . . 53.42 112.259 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.58 171.4 55.15 Favored Glycine 0 C--N 1.316 -0.532 0 C-N-CA 120.359 -0.924 . . . . 72.42 111.399 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.55 162.99 27.82 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.449 0.537 . . . . 63.23 112.449 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.95 95.55 5.49 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 115.91 -0.586 . . . . 70.12 110.722 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.526 HG21 HD13 ' A' ' 55' ' ' LEU . 3.9 p -112.7 130.05 67.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 CA-C-N 115.496 -0.775 . . . . 71.34 109.096 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 54.7 p90 -90.07 136.62 32.94 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 119.779 -0.768 . . . . 73.12 110.574 -178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 67' ' ' LEU . 7.5 p -98.44 127.14 51.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.753 -0.832 . . . . 74.44 108.753 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -115.96 156.44 26.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.316 -0.624 . . . . 60.34 109.316 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -56.58 -18.65 12.59 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 113.631 0.974 . . . . 75.21 113.631 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 m -61.07 -22.94 65.09 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.22 0.533 . . . . 53.4 110.649 171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -77.52 -33.42 54.29 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.433 -0.58 . . . . 42.21 109.433 175.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.04 -42.64 88.77 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 N-CA-C 107.704 -1.221 . . . . 71.25 107.704 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -53.75 -35.34 61.14 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.915 0.886 . . . . 64.45 110.866 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 -18.51 59.73 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.821 1.045 . . . . 74.12 113.821 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.59 -20.16 2.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.089 . . . . 74.02 113.939 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.12 38.01 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-O 121.689 0.605 . . . . 63.04 111.615 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD21 ' HG ' ' A' ' 45' ' ' LEU . 26.1 tp -64.72 141.31 58.82 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.681 -0.759 . . . . 62.22 110.292 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.22 -57.35 13.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.303 -0.628 . . . . 73.51 109.303 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -175.69 174.96 2.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.173 -1.418 . . . . 74.14 107.173 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.0 mp -111.95 145.19 40.02 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.094 0.473 . . . . 74.13 110.703 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.81 146.31 45.52 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 115.224 -0.898 . . . . 71.55 109.012 174.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.81 154.57 40.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.13 0.491 . . . . 51.34 111.387 -174.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 -26.24 19.25 Favored Glycine 0 C--N 1.303 -1.259 0 C-N-CA 120.687 -0.768 . . . . 61.55 112.188 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.86 132.22 45.67 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 123.359 0.664 . . . . 74.22 111.647 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -81.67 132.91 35.31 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 108.125 -1.065 . . . . 52.55 108.125 174.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.84 147.27 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.915 0 CA-C-O 121.888 0.851 . . . . 71.11 110.457 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 68' ' ' ARG . 68.9 mt -117.55 136.9 53.24 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.002 0 N-CA-C 106.374 -1.713 . . . . 73.52 106.374 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -153.11 -178.53 7.0 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.836 -0.346 . . . . 74.01 110.476 -175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 37.1 m-20 -119.62 156.17 30.91 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.934 -1.876 . . . . 75.24 105.934 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD11 ' HB1' ' A' ' 62' ' ' ALA . 13.6 tp -121.18 116.48 25.02 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-O 122.707 1.241 . . . . 64.44 114.332 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.7 mm-40 -103.51 151.04 23.32 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 112.813 -1.994 . . . . 74.21 111.288 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -105.76 131.34 53.23 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 114.298 -1.319 . . . . 64.24 111.066 -171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 86.6 tttt -109.67 78.78 1.15 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.381 -0.827 . . . . 73.02 109.536 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 60.36 14.12 4.49 Favored 'General case' 0 CA--C 1.572 1.823 0 CA-C-O 121.883 0.849 . . . . 74.54 111.64 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.03 -25.14 3.55 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.328 -0.709 . . . . 62.04 111.328 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 32.2 mmmt -83.87 164.92 19.16 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.601 -0.889 . . . . 73.33 108.601 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -122.51 119.81 32.01 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 119.835 -0.126 . . . . 71.02 111.121 -174.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 40.4 p90 -125.22 133.75 52.6 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.549 0.69 . . . . 74.41 112.443 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 137.34 38.23 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.704 -1.135 . . . . 64.1 110.829 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.7 m -140.68 168.61 16.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.351 -0.84 . . . . 74.15 109.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.1 t30 54.32 63.43 2.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.079 0.862 . . . . 62.44 110.701 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.6 mt -74.41 136.1 42.38 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.694 0.998 . . . . 74.43 113.694 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 41.6 mmt180 -122.59 131.17 53.7 Favored 'General case' 0 N--CA 1.405 -2.678 0 N-CA-C 106.177 -1.786 . . . . 62.22 106.177 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.38 131.24 56.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 114.354 1.242 . . . . 54.25 114.354 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.258 1.54 0 CA-C-N 115.209 -0.905 . . . . 72.53 109.345 173.646 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 109.52 -0.548 . . . . 63.01 109.52 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.85 110.29 7.94 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.64 -1.244 . . . . 75.31 107.64 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.5 p -127.18 161.83 27.58 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 60.79 39.85 16.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.857 0.863 . . . . 74.0 110.874 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 37.3 mt -76.79 147.23 7.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.397 -0.819 . . . . 74.43 111.788 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 64.5 t -102.34 136.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.003 -0.999 . . . . 43.43 110.162 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -177.75 160.65 27.32 Favored Glycine 0 N--CA 1.413 -2.849 0 C-N-CA 120.685 -0.769 . . . . 64.42 113.503 168.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -97.63 143.75 27.99 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.661 -0.866 . . . . 51.02 108.661 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.06 107.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.226 -1.027 . . . . 64.11 108.226 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.519 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.9 tttp -67.87 -48.35 66.35 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.44 -1.255 . . . . 72.22 109.155 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -166.8 155.55 10.39 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.231 -1.026 . . . . 74.22 108.231 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -160.46 108.43 1.62 Allowed 'General case' 0 C--N 1.289 -2.057 0 O-C-N 123.724 0.64 . . . . 71.03 109.67 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -84.97 106.47 16.5 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.735 -1.58 . . . . 63.23 106.735 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 p -62.62 -26.02 68.4 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.267 0.84 . . . . 63.42 113.267 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.4 m -71.49 -32.22 67.99 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.09 0.471 . . . . 72.23 110.081 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -96.04 -9.8 30.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.004 -0.369 . . . . 70.0 110.004 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 52.37 34.67 15.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.701 0.801 . . . . 65.14 110.074 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -139.69 156.11 46.99 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.596 -0.52 . . . . 72.1 109.596 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.02 -153.61 17.39 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.296 -0.722 . . . . 63.51 111.296 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.519 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 41.3 m-85 -137.14 169.18 18.22 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.519 0.728 . . . . 74.52 110.9 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.439 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 61.7 mt -145.61 130.6 12.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 123.505 0.722 . . . . 74.31 109.147 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.34 146.84 32.8 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.52 -0.918 . . . . 74.41 108.52 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.6 pt20 -79.74 148.15 31.61 Favored 'General case' 0 CA--C 1.483 -1.625 0 C-N-CA 118.838 -1.145 . . . . 72.43 108.38 175.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -53.72 -25.32 17.96 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 124.528 1.143 . . . . 64.1 112.065 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -76.93 -3.94 41.34 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.191 -0.459 . . . . 61.34 112.138 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.14 50.76 0.76 Allowed Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 119.393 -1.384 . . . . 61.24 112.542 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.33 150.69 32.08 Favored Glycine 0 C--N 1.313 -0.733 0 C-N-CA 119.753 -1.213 . . . . 43.33 110.167 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.19 163.58 26.07 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 117.264 0.532 . . . . 74.11 112.262 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -66.97 105.1 1.54 Allowed 'General case' 0 C--O 1.247 0.961 0 CA-C-N 115.845 -0.616 . . . . 75.2 111.299 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 55' ' ' LEU . 4.3 p -126.81 123.71 63.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 108.585 -0.894 . . . . 63.12 108.585 172.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 63' ' ' TYR . 47.2 p90 -87.17 149.73 24.43 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.041 -0.527 . . . . 74.13 112.397 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 67' ' ' LEU . 9.3 p -106.27 126.72 61.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.381 0.61 . . . . 73.41 109.57 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -111.78 156.93 21.17 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.036 -1.468 . . . . 71.21 107.036 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.29 -13.7 61.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.381 -0.928 . . . . 75.4 112.077 -173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -59.0 -22.54 60.75 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.239 0.542 . . . . 72.11 109.716 171.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' ALA . . . -75.51 -38.79 59.18 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.519 -0.549 . . . . 73.3 109.519 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.66 -43.68 96.63 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.672 0 N-CA-C 107.891 -1.152 . . . . 61.1 107.891 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.15 -37.15 69.14 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 123.107 0.563 . . . . 64.15 111.623 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.83 -27.45 69.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.22 0.822 . . . . 60.24 113.22 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.55 -14.88 3.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.498 0.925 . . . . 51.24 113.498 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.29 47.74 16.56 Favored Glycine 0 C--N 1.297 -1.621 0 N-CA-C 109.731 -1.347 . . . . 74.2 109.731 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.28 128.95 38.01 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.865 0.866 . . . . 75.31 108.669 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -46.55 -61.55 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.77 0.656 . . . . 71.43 112.77 -177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 p -178.51 162.98 1.49 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.452 -0.944 . . . . 75.52 108.452 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.9 mt -123.04 149.48 44.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.306 -0.627 . . . . 73.3 109.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -154.57 149.35 26.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.145 -1.057 . . . . 74.1 108.145 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.0 126.45 27.58 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.472 -0.936 . . . . 72.3 108.472 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.52 -14.91 27.38 Favored Glycine 0 C--N 1.288 -2.094 0 CA-C-N 115.589 -0.732 . . . . 75.34 113.266 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -81.44 130.04 34.89 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.282 -0.54 . . . . 74.21 111.18 176.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.86 131.07 34.56 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 107.198 -1.408 . . . . 71.33 107.198 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.1 145.95 31.22 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-O 121.854 0.835 . . . . 72.21 110.642 -175.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 70.3 mt -113.37 132.67 61.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 107.063 -1.458 . . . . 62.31 107.063 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.39 -177.01 5.46 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 121.0 0.429 . . . . 61.13 110.968 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -123.78 149.34 45.76 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 105.68 -1.97 . . . . 73.45 105.68 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 30' ' ' VAL . 16.2 tp -114.34 119.91 38.57 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 122.088 0.947 . . . . 75.34 111.473 -177.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -126.25 159.14 33.89 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 113.67 -1.604 . . . . 44.02 107.977 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.31 143.02 26.75 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.368 0.604 . . . . 72.33 111.987 -173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 84.7 tttt -100.86 81.52 2.28 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.245 -1.761 . . . . 63.12 106.245 174.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 66.82 -68.77 0.14 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.724 1.21 . . . . 75.04 110.238 -174.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.73 -2.19 1.99 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.577 -0.609 . . . . 72.41 111.577 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 31.9 mmmt -97.01 165.24 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.15 -0.685 . . . . 72.54 109.15 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -116.35 116.43 27.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 110.14 -0.319 . . . . 62.43 110.14 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -129.99 140.74 50.84 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.493 0.663 . . . . 73.42 111.6 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -72.28 133.55 45.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.552 -1.203 . . . . 62.4 109.227 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 32.5 m -138.3 161.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.69 -0.686 . . . . 73.22 109.439 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 59.96 63.23 1.49 Allowed 'General case' 0 C--O 1.216 -0.658 0 O-C-N 124.392 1.057 . . . . 73.14 109.294 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.442 HD11 HG21 ' A' ' 32' ' ' VAL . 28.4 mt -80.37 143.61 33.38 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.893 -0.723 . . . . 64.55 112.8 -173.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.07 133.48 41.2 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 125.187 1.395 . . . . 63.14 107.948 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' H ' ' A' ' 69' ' ' ILE . 2.3 mp -82.14 140.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 106.889 -1.522 . . . . 75.25 106.889 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.258 1.536 0 N-CA-C 108.421 -0.955 . . . . 74.12 108.421 174.545 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 111.892 0.33 . . . . 74.32 111.892 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.12 117.39 14.56 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.704 -0.622 . . . . 65.32 110.288 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.9 p -102.36 147.31 26.86 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.377 -0.374 . . . . 73.23 111.539 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 52.27 77.37 0.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.537 1.135 . . . . 75.43 113.059 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 46.6 mt -103.93 148.58 8.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.183 -0.917 . . . . 72.52 110.484 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 79.3 t -91.48 132.72 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 115.242 -0.89 . . . . 64.13 109.134 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.87 167.45 37.95 Favored Glycine 1 N--CA 1.394 -4.123 0 C-N-CA 120.317 -0.945 . . . . 70.44 111.781 171.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -123.04 135.74 54.55 Favored 'General case' 0 C--N 1.261 -3.267 0 N-CA-C 107.569 -1.271 . . . . 55.43 107.569 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.86 116.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.68 0.752 . . . . 50.44 109.16 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 65.4 tttp -75.85 -43.62 44.84 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.03 -1.441 . . . . 65.33 109.109 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -175.02 159.65 2.66 Favored 'General case' 0 CA--C 1.488 -1.414 0 C-N-CA 123.917 0.887 . . . . 73.41 109.182 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -163.44 126.85 2.73 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.878 0.736 . . . . 74.05 109.236 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -115.71 122.57 45.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.672 -0.862 . . . . 74.5 108.672 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 m -65.14 -19.15 65.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.087 0.47 . . . . 65.31 110.063 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.6 m -62.28 -34.13 75.97 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.721 -0.672 . . . . 64.23 110.668 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.36 -10.2 11.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.061 -0.656 . . . . 74.32 111.88 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 54.27 29.66 11.09 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 113.405 0.891 . . . . 63.42 113.405 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -129.8 156.41 44.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 114.672 -1.149 . . . . 74.32 108.534 173.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.44 -172.78 38.54 Favored Glycine 0 N--CA 1.406 -3.335 0 N-CA-C 109.087 -1.605 . . . . 73.44 109.087 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.472 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 50.3 m-85 -134.24 165.9 24.03 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 117.036 0.418 . . . . 74.44 111.123 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.6 mt -147.16 136.26 16.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.111 -1.07 . . . . 54.11 108.111 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -144.39 148.47 34.71 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 105.525 -2.028 . . . . 74.53 105.525 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.648 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.5 pt20 -74.84 142.5 44.16 Favored 'General case' 0 CA--C 1.473 -2.019 0 C-N-CA 116.655 -2.018 . . . . 74.52 108.68 175.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -49.62 -33.04 14.24 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.122 -1.399 . . . . 75.32 111.594 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -87.75 11.31 15.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.902 0.705 . . . . 64.31 112.902 -173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.39 51.2 0.67 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.405 -1.379 . . . . 60.31 113.471 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -96.26 157.59 21.51 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 119.774 -1.203 . . . . 62.15 110.989 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -72.06 152.73 42.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.831 0.315 . . . . 64.22 110.522 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 120.79 24.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.19 0.995 . . . . 74.24 111.724 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 HD13 ' A' ' 55' ' ' LEU . 3.0 p -121.87 139.01 50.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 114.365 -1.289 . . . . 71.11 108.223 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 40.7 p90 -88.15 142.67 27.58 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.428 -0.909 . . . . 70.34 111.45 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 67' ' ' LEU . 13.3 p -110.67 144.21 19.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.605 -0.887 . . . . 73.1 108.605 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -131.66 158.4 41.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.56 -16.44 63.87 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 112.505 0.557 . . . . 75.21 112.505 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -56.67 -26.24 55.87 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.235 0.541 . . . . 70.34 110.357 172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -76.85 -37.71 55.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.117 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.6 t -66.57 -40.6 86.71 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 N-CA-C 107.844 -1.169 . . . . 73.12 107.844 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.26 -32.6 72.42 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.78 0.832 . . . . 63.4 110.755 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.37 82.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.721 0.638 . . . . 64.22 112.721 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.68 -8.79 5.61 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.478 0.918 . . . . 41.01 113.478 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.63 58.36 7.83 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.47 -1.052 . . . . 73.52 110.47 -175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.482 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -70.02 145.46 51.75 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.435 -1.32 . . . . 75.32 107.435 -179.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.482 ' N ' HD13 ' A' ' 42' ' ' LEU . 62.7 t-80 -54.5 -61.7 2.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.58 0.352 . . . . 73.31 110.981 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.8 p -175.62 150.66 1.09 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.547 -0.538 . . . . 53.12 109.547 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -107.96 143.84 36.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.261 -0.644 . . . . 72.43 109.261 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.13 160.15 16.0 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.932 -1.136 . . . . 61.2 107.932 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 150.41 45.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.819 0.819 . . . . 74.1 112.374 -176.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.68 -14.73 62.21 Favored Glycine 0 C--N 1.298 -1.569 0 CA-C-N 114.991 -1.004 . . . . 55.01 112.677 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.557 ' HA ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -79.41 116.65 19.77 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 122.519 -0.4 . . . . 75.11 111.152 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.91 129.92 38.49 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.998 -1.482 . . . . 71.03 106.998 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 147.83 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-O 122.034 0.921 . . . . 75.44 110.976 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 57.6 mt -110.03 127.76 66.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.199 -1.778 . . . . 71.32 106.199 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -142.47 176.45 9.0 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.948 -0.701 . . . . 73.43 111.311 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -121.46 140.39 52.23 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.107 -1.812 . . . . 62.13 106.107 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 30' ' ' VAL . 20.7 tp -121.36 122.06 39.01 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.728 0.775 . . . . 62.44 111.898 -174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -109.92 166.22 11.1 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.885 -1.507 . . . . 74.41 109.469 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.1 125.72 51.43 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.587 -1.264 . . . . 74.41 107.587 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 87.8 tttt -126.16 75.16 1.5 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.457 0.54 . . . . 40.3 112.457 -176.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 26.7 tt0 58.12 32.91 22.61 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 121.857 0.837 . . . . 64.41 111.202 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.96 -8.37 31.5 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 120.505 -0.855 . . . . 44.3 111.641 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 75.0 mmtt -96.87 162.04 13.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.803 -0.443 . . . . 74.22 109.803 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.11 112.01 8.91 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.585 -1.265 . . . . 75.15 107.585 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.6 p90 -124.96 135.51 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.418 0.628 . . . . 65.42 111.5 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.69 123.66 32.75 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.639 -1.164 . . . . 74.14 109.838 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 18.4 m -137.22 176.29 7.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.588 -0.733 . . . . 52.32 111.62 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.39 40.11 27.69 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.492 1.12 . . . . 74.32 108.361 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 32' ' ' VAL . 36.3 mt -62.63 142.07 58.22 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.617 -1.174 . . . . 74.14 113.016 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -143.68 130.39 20.26 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 106.546 -1.65 . . . . 75.33 106.546 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.23 141.01 16.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.567 -0.853 . . . . 75.53 110.891 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.25 1.109 0 O-C-N 123.858 0.724 . . . . 73.03 110.798 178.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 109.522 -0.547 . . . . 74.41 109.522 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.72 129.39 34.96 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p -101.69 150.32 23.24 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.45 0.469 . . . . 53.02 111.492 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 61.84 76.07 0.38 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.681 0.792 . . . . 74.35 111.319 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 34.1 mt -108.36 150.65 10.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.193 -0.912 . . . . 70.32 110.462 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 93.9 t -96.11 132.46 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 CA-C-N 115.629 -0.714 . . . . 63.24 110.182 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -163.44 171.07 39.04 Favored Glycine 0 N--CA 1.399 -3.819 0 CA-C-N 115.109 -0.95 . . . . 62.12 111.676 170.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -128.35 133.28 48.63 Favored 'General case' 0 C--N 1.26 -3.299 0 C-N-CA 124.472 1.109 . . . . 71.25 108.879 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.91 113.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 116.061 -0.518 . . . . 62.23 109.987 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' HD2' ' HB3' ' A' ' 20' ' ' PHE . 64.4 mttm -62.58 -49.0 76.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.615 -0.721 . . . . 34.51 109.276 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -175.81 166.67 3.1 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.805 1.242 . . . . 72.23 108.661 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -145.06 140.35 28.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.626 0.579 . . . . 70.34 109.442 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -112.25 121.53 45.18 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.501 -0.926 . . . . 73.43 108.501 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -75.99 -28.94 58.03 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.4 m -69.03 -48.64 62.4 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 120.975 0.417 . . . . 73.12 111.264 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -95.28 -8.56 35.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.681 0.622 . . . . 71.11 112.681 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 62.43 30.68 17.31 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.945 0.403 . . . . 71.24 111.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -123.65 163.41 21.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.128 -0.487 . . . . 62.2 109.939 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.18 -172.47 43.46 Favored Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 107.939 -2.064 . . . . 71.34 107.939 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.537 ' HB3' ' HD2' ' A' ' 10' ' ' LYS . 55.8 m-85 -136.82 155.98 49.09 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 118.125 0.963 . . . . 63.22 111.372 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -134.94 140.93 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.499 -0.926 . . . . 74.44 108.499 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 13.8 pt-20 -143.05 147.4 35.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.25 -2.13 . . . . 72.11 105.25 175.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.618 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 10.2 pt20 -79.87 144.45 33.43 Favored 'General case' 0 CA--C 1.483 -1.613 0 C-N-CA 115.305 -2.558 . . . . 72.14 109.315 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -50.79 -29.21 11.01 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 124.992 1.433 . . . . 62.33 111.357 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -86.86 4.0 43.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.179 0.807 . . . . 64.13 113.179 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.25 53.62 0.88 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 117.744 -2.17 . . . . 72.0 112.332 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -83.09 -121.91 0.76 Allowed Glycine 0 C--N 1.312 -0.803 0 C-N-CA 120.576 -0.821 . . . . 32.22 114.23 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.95 168.66 15.68 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 122.726 0.41 . . . . 70.42 110.359 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.71 92.19 6.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.186 -0.672 . . . . 54.54 109.186 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.44 132.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.523 -0.762 . . . . 74.52 109.148 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 44.0 p90 -90.09 149.14 22.62 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 118.92 -1.112 . . . . 75.11 110.884 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 67' ' ' LEU . 8.8 p -105.99 137.12 37.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -125.25 157.17 37.25 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.697 -1.223 . . . . 53.1 107.697 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -62.38 -24.23 67.26 Favored 'General case' 0 C--O 1.197 -1.679 0 N-CA-C 113.022 0.749 . . . . 71.0 113.022 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 m -52.51 -26.06 12.02 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 120.981 0.419 . . . . 53.13 111.399 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -74.79 -39.61 61.63 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.198 0.523 . . . . 73.33 109.823 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.89 -46.34 88.82 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.373 0 CA-C-N 115.06 -0.973 . . . . 64.03 108.404 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.69 -23.79 65.12 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.402 0.439 . . . . 74.02 111.14 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.74 69.16 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.301 0.482 . . . . 70.51 112.301 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.8 -4.8 4.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.229 0.826 . . . . 50.1 113.229 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.05 52.48 44.32 Favored Glycine 0 C--N 1.307 -1.064 0 N-CA-C 111.295 -0.722 . . . . 71.31 111.295 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.24 125.56 27.27 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.074 -1.825 . . . . 65.11 106.074 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -74.51 -37.79 63.0 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 114.833 1.419 . . . . 74.13 114.833 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -155.63 138.3 15.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 120.104 -0.638 . . . . 74.12 112.257 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.19 149.3 43.03 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.471 -0.786 . . . . 74.14 109.035 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.46 169.56 22.3 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.481 -1.674 . . . . 64.31 106.481 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -75.42 155.28 36.51 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.58 -0.448 . . . . 71.52 110.966 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.09 1.27 89.67 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.923 -0.656 . . . . 33.12 113.09 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.461 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -86.22 121.08 28.31 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 111.902 0.334 . . . . 74.25 111.902 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -71.78 127.51 32.8 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.144 -1.058 . . . . 74.42 108.144 171.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.49 147.58 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.95 0 CA-C-O 121.976 0.893 . . . . 70.45 110.686 -174.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 71.9 mt -112.69 135.11 53.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 N-CA-C 106.893 -1.521 . . . . 75.2 106.893 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 40.7 p90 -150.13 179.28 8.21 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 121.076 -0.25 . . . . 72.12 110.566 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -114.86 154.35 28.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.035 -1.839 . . . . 73.35 106.035 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 62' ' ' ALA . 37.1 tp -140.53 136.67 33.13 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.901 0.857 . . . . 75.21 112.755 -176.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -131.54 132.42 44.14 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.226 -1.768 . . . . 74.23 106.226 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.77 116.41 23.25 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.846 0.832 . . . . 70.12 111.04 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -81.26 79.14 7.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.154 -1.384 . . . . 75.01 109.785 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 57.52 20.62 6.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.061 0.945 . . . . 64.51 112.374 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.16 -30.11 3.56 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.413 -0.675 . . . . 72.05 111.413 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 61' ' ' LYS . 1.4 tpmt? -84.13 164.12 19.38 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.377 -1.342 . . . . 75.54 107.377 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -138.15 129.04 26.97 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 118.652 0.66 . . . . 73.42 110.784 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 6.9 p90 -133.93 133.91 41.97 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.467 0.651 . . . . 60.23 111.175 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' ALA . . . -79.58 133.37 36.44 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.537 -1.21 . . . . 53.12 110.297 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 26.9 m -135.24 161.77 39.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.976 -1.011 . . . . 74.51 109.29 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.8 t30 59.63 64.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.848 0.718 . . . . 64.24 110.817 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 21.8 mt -78.14 139.9 39.01 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.976 -1.09 . . . . 71.32 112.132 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 16.6 tpp180 -137.45 130.77 30.96 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 104.111 -2.551 . . . . 65.23 104.111 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -95.58 143.22 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.944 -1.102 . . . . 72.24 113.055 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.914 -1.041 . . . . 73.22 108.945 173.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 26.1 ttt . . . . . 0 C--O 1.223 -0.329 0 CA-C-O 121.277 0.561 . . . . 55.54 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 5' ' ' ILE . . . -114.94 145.2 42.47 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.106 -1.442 . . . . 73.22 107.106 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.404 ' HA ' ' OD1' ' A' ' 54' ' ' ASP . 41.5 p -120.49 142.0 49.69 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.137 0.421 . . . . 73.14 112.137 -175.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 55.86 74.54 0.38 Allowed 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.308 1.043 . . . . 62.44 112.31 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 2' ' ' ALA . 36.6 mt -99.58 152.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.643 -1.162 . . . . 42.23 110.818 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.2 t -102.62 135.97 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 115.419 -0.81 . . . . 64.42 109.548 176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.14 175.42 47.12 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 115.103 -0.953 . . . . 71.43 111.98 168.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 38.3 ttmt -123.91 143.02 50.62 Favored 'General case' 0 C--N 1.253 -3.627 0 C-N-CA 123.973 0.909 . . . . 63.12 108.801 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -58.02 109.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 109.136 -0.69 . . . . 62.42 109.136 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.55 ' HD3' ' CB ' ' A' ' 20' ' ' PHE . 58.2 tttp -68.53 -49.1 62.13 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 106.886 -1.524 . . . . 64.21 106.886 -177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -169.11 156.18 7.01 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 114.951 -1.022 . . . . 70.34 108.829 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 80.6 t80 -157.16 111.39 2.68 Favored 'General case' 0 C--N 1.288 -2.069 0 O-C-N 123.638 0.586 . . . . 71.11 109.668 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -99.49 118.63 36.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.822 -0.626 . . . . 71.42 109.932 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.8 m -64.36 -22.92 67.11 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.059 -0.973 . . . . 73.04 110.2 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -55.08 -44.99 75.37 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.537 -0.756 . . . . 64.44 111.212 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 98.8 mttt -106.21 -6.09 18.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.437 0.532 . . . . 63.23 112.437 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.2 m120 68.86 22.65 7.11 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.073 0.549 . . . . 73.34 110.928 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 16' ' ' LYS . 36.5 p90 -148.47 166.86 26.91 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.06 0.457 . . . . 75.21 111.965 176.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.85 -153.06 8.56 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 109.757 -1.337 . . . . 64.53 109.757 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' CB ' ' HD3' ' A' ' 10' ' ' LYS . 41.4 m-85 -137.05 167.81 20.8 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 122.857 0.463 . . . . 70.01 111.419 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 64.0 mt -142.35 138.29 29.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.573 -0.899 . . . . 72.41 108.573 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -143.18 147.25 34.59 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 106.545 -1.65 . . . . 70.53 106.545 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.1 pt20 -86.29 156.79 20.1 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 117.599 -1.64 . . . . 73.0 108.78 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -53.99 -27.12 29.59 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.232 0.957 . . . . 74.12 112.368 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.41 5.45 17.54 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.079 0.4 . . . . 64.14 112.079 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.01 51.72 4.09 Favored Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.433 -1.365 . . . . 61.45 110.807 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -78.5 -168.12 32.99 Favored Glycine 0 C--O 1.25 1.102 0 C-N-CA 120.877 -0.678 . . . . 75.11 112.459 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -68.02 144.71 55.01 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.044 -0.354 . . . . 73.04 110.044 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.29 87.39 7.11 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.494 -0.928 . . . . 45.33 108.494 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 55' ' ' LEU . 3.8 p -100.52 138.41 24.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.441 -1.254 . . . . 71.34 110.055 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.0 p90 -88.98 145.18 25.67 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 119.061 -1.055 . . . . 60.43 110.034 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 67' ' ' LEU . 8.1 p -115.57 136.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 108.748 -0.834 . . . . 73.53 108.748 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -124.67 159.94 29.66 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 109.136 -0.691 . . . . 74.43 109.136 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.32 -15.69 60.77 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 112.647 0.61 . . . . 74.21 112.647 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.6 m -61.45 -26.93 68.2 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.963 0.411 . . . . 64.32 110.495 172.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -75.31 -34.9 61.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.7 -0.482 . . . . 71.52 109.7 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.57 -46.29 93.01 Favored 'Isoleucine or valine' 0 C--O 1.181 -2.524 0 N-CA-C 107.721 -1.214 . . . . 75.44 107.721 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -56.52 -31.24 63.93 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.124 0.97 . . . . 74.35 110.866 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -27.4 63.84 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.121 0.786 . . . . 74.51 113.121 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.63 -5.62 4.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.654 0.983 . . . . 61.02 113.654 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.09 49.43 75.17 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 111.117 -0.793 . . . . 71.1 111.117 -175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 43' ' ' HIS . 1.1 tm? -66.86 138.16 57.11 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.154 -1.424 . . . . 53.32 107.154 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.4 ' N ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-70 -65.15 -53.58 42.89 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.0 1.111 . . . . 72.04 114.0 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -165.83 153.84 10.84 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.527 -0.469 . . . . 61.34 110.575 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.6 mt -124.01 143.78 50.22 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.119 -0.697 . . . . 73.23 109.119 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.16 162.38 20.05 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.132 -1.432 . . . . 62.1 107.132 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -69.1 153.4 43.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.34 0.591 . . . . 73.24 111.501 -176.054 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.58 84.66 Favored Glycine 0 C--N 1.3 -1.465 0 CA-C-N 115.262 -0.881 . . . . 64.32 112.803 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.483 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -93.58 119.08 32.19 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 112.268 0.47 . . . . 73.25 112.268 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 22.4 m-20 -71.91 136.38 46.87 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.171 -0.612 . . . . 71.41 109.745 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.29 153.41 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-O 121.876 0.846 . . . . 74.31 110.815 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 68' ' ' ARG . 65.9 mt -115.2 135.36 55.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 N-CA-C 106.58 -1.637 . . . . 75.3 106.58 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -153.06 177.59 10.64 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.947 -0.701 . . . . 74.42 110.624 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' OD1' ' HA ' ' A' ' 3' ' ' THR . 44.5 m-20 -118.93 157.53 27.5 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.013 -1.847 . . . . 75.44 106.013 173.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 1' ' ' MET . 18.3 tp -134.9 138.18 43.88 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-O 120.879 0.371 . . . . 71.44 111.883 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -127.56 151.57 48.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.49 -1.3 . . . . 63.13 107.49 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -90.42 120.82 31.85 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 121.243 0.544 . . . . 71.33 111.018 -175.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 87.0 tttt -90.49 74.31 6.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.528 -0.76 . . . . 73.13 108.956 178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 61.14 8.32 1.95 Allowed 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.85 -1.068 . . . . 73.03 113.178 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.53 -24.28 2.49 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.803 -0.919 . . . . 64.21 110.803 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -88.7 162.41 16.29 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.09 -1.078 . . . . 71.45 108.09 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.452 ' C ' HG23 ' A' ' 30' ' ' VAL . . . -120.99 127.73 52.05 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.975 -0.453 . . . . 71.33 111.495 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 36.4 p90 -127.81 132.6 49.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.367 0.603 . . . . 50.13 111.63 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.2 136.8 33.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.147 -0.933 . . . . 63.21 110.755 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 30.6 m -139.64 167.85 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.162 -0.926 . . . . 65.12 109.765 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.08 63.43 2.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.623 0.769 . . . . 54.12 110.472 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 32' ' ' VAL . 30.1 mt -78.9 141.01 37.99 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.129 -1.029 . . . . 75.33 113.022 -175.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 18.4 tpp180 -141.72 130.58 23.0 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 105.929 -1.878 . . . . 73.11 105.929 175.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.02 149.05 4.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 C-N-CA 119.03 -1.068 . . . . 73.12 111.989 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt . . . . . 0 C--O 1.251 1.17 0 O-C-N 124.049 0.843 . . . . 74.24 110.755 175.555 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 CA--C 1.495 -1.138 0 N-CA-C 109.149 -0.685 . . . . 74.45 109.149 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.23 103.04 4.5 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.327 -0.62 . . . . 74.34 109.327 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 p -100.22 146.0 27.4 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.847 -0.615 . . . . 64.24 111.662 -177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 t30 54.68 77.18 0.21 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.908 1.283 . . . . 54.41 110.656 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 45.3 mt -103.93 142.84 16.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.422 -0.808 . . . . 73.41 110.416 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 76.4 t -95.96 140.82 16.37 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.257 -0.883 . . . . 75.13 109.45 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -176.94 161.87 29.85 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.312 -0.947 . . . . 55.41 113.593 168.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -96.09 137.41 35.19 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.785 -0.821 . . . . 72.33 108.785 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.32 102.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 107.674 -1.232 . . . . 73.43 107.674 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -59.71 -45.36 92.37 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.499 -1.228 . . . . 72.42 110.417 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.5 p-90 -172.53 162.81 5.31 Favored 'General case' 0 CA--C 1.495 -1.165 0 C-N-CA 124.072 0.949 . . . . 73.25 108.723 174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 88.5 t80 -160.77 116.02 2.2 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.887 0.742 . . . . 72.13 109.934 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -93.71 106.28 18.26 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.374 -0.973 . . . . 62.43 108.374 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 p -59.76 -32.47 70.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.176 0.806 . . . . 72.35 113.176 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 m -76.71 -21.97 54.57 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.204 0.526 . . . . 73.22 110.725 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -101.45 -8.87 21.59 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 119.979 -0.688 . . . . 74.1 110.769 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' HIS . 91.7 m-20 54.68 29.8 12.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.394 0.678 . . . . 71.31 112.809 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -135.03 154.32 51.75 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.195 0.598 . . . . 71.24 110.346 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.35 -171.78 39.65 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.787 -1.325 . . . . 72.23 109.787 177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -132.39 157.42 44.57 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 117.272 0.536 . . . . 73.14 111.297 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 HD13 HG11 ' A' ' 51' ' ' VAL . 59.8 mt -147.02 128.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.482 -0.781 . . . . 74.43 109.23 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.94 148.6 34.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.308 -0.997 . . . . 74.23 108.308 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 9.9 pt20 -80.41 151.82 29.16 Favored 'General case' 0 CA--C 1.478 -1.821 0 C-N-CA 119.567 -0.853 . . . . 62.45 109.971 175.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.9 -15.22 19.82 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 124.62 1.2 . . . . 74.53 110.997 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 71.0 m-20 -88.14 6.6 35.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.735 -0.666 . . . . 74.22 110.295 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.81 51.2 2.52 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.988 -1.101 . . . . 53.24 113.111 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.9 163.42 41.84 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 119.911 -1.138 . . . . 64.13 111.074 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.58 157.93 28.47 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.392 0.596 . . . . 62.24 112.055 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.71 90.95 4.63 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.342 0.592 . . . . 71.43 109.984 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 HD13 ' A' ' 55' ' ' LEU . 5.4 p -106.0 135.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 114.972 -1.013 . . . . 73.45 108.873 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -91.95 142.84 27.1 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 119.353 -0.939 . . . . 63.42 110.566 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.474 HG21 HD11 ' A' ' 67' ' ' LEU . 9.7 p -99.44 145.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.535 -0.913 . . . . 62.34 108.535 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 32.8 t60 -135.52 161.37 35.66 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.296 -1.002 . . . . 71.52 108.296 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -68.06 -18.53 64.7 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 112.644 0.609 . . . . 60.32 112.644 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -56.85 -21.99 33.33 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.28 0.562 . . . . 74.22 110.373 170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.626 ' HB1' ' HG ' ' A' ' 67' ' ' LEU . . . -81.14 -34.76 32.25 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.168 -0.469 . . . . 53.1 110.227 175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.0 t -64.41 -52.26 57.62 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.424 0 N-CA-C 108.112 -1.07 . . . . 72.42 108.112 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.89 -22.61 64.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 123.436 0.46 . . . . 75.21 112.146 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.42 75.88 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 120.974 -0.29 . . . . 65.45 111.599 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.14 0.6 4.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.802 0.667 . . . . 64.34 112.802 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.08 50.26 65.64 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 111.092 -0.803 . . . . 72.33 111.092 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.8 138.58 58.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.753 -1.573 . . . . 71.34 106.753 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.55 -56.0 19.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.203 0.456 . . . . 62.3 111.968 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.1 p -167.81 152.46 6.67 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.389 -0.369 . . . . 54.21 110.323 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 12' ' ' TYR . 90.2 mt -115.11 152.76 31.98 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.825 -0.435 . . . . 65.11 109.825 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -154.23 163.97 39.29 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.804 -1.554 . . . . 70.32 106.804 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.87 151.03 39.01 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 120.125 -0.63 . . . . 54.02 109.721 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.78 -9.9 70.69 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.877 -0.678 . . . . 72.41 112.513 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.5 135.41 36.63 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 122.814 -0.227 . . . . 71.04 110.596 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.58 127.78 38.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 106.749 -1.574 . . . . 72.01 106.749 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG11 HD13 ' A' ' 21' ' ' ILE . 14.8 p -134.0 153.85 36.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.727 0 CA-C-O 121.485 0.66 . . . . 73.34 111.147 -173.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.651 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 67.0 mt -117.92 133.41 64.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 N-CA-C 106.821 -1.548 . . . . 63.13 106.821 177.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 38.8 p90 -144.76 -178.89 6.25 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.832 -0.432 . . . . 72.43 109.832 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -123.94 143.57 50.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.244 -1.391 . . . . 53.34 107.244 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 62' ' ' ALA . 22.9 tp -117.72 116.88 27.92 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 122.445 1.116 . . . . 73.22 112.973 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.94 123.96 48.82 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 105.471 -2.048 . . . . 72.11 105.471 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.57 132.98 36.4 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.783 0.801 . . . . 75.23 111.608 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -102.05 81.09 2.06 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.613 -1.176 . . . . 64.13 108.744 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 63.63 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.314 1.046 . . . . 61.42 111.484 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.62 5.35 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 110.876 -0.89 . . . . 70.25 110.876 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -110.91 154.73 23.67 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 108.789 -0.819 . . . . 72.54 108.789 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -134.08 128.63 34.62 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 110.063 -0.347 . . . . 52.23 110.063 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -132.32 134.54 45.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.35 0.595 . . . . 64.22 110.749 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.97 130.73 35.16 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.798 -1.092 . . . . 55.22 110.898 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 24.1 m -139.39 167.98 19.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.225 -0.898 . . . . 72.13 110.288 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 59.66 63.14 1.57 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.449 1.093 . . . . 64.12 110.056 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.626 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 23.9 mt -79.47 139.47 37.62 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.932 0.872 . . . . 73.42 113.239 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -139.53 131.79 28.28 Favored 'General case' 0 N--CA 1.41 -2.425 0 C-N-CA 125.822 1.649 . . . . 71.22 107.101 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.8 mt -80.22 138.35 19.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 118.739 -1.185 . . . . 44.14 109.127 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 115.454 -0.794 . . . . 74.13 110.005 -177.163 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 110.611 -0.144 . . . . 75.43 110.611 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.09 105.26 17.26 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.872 -1.899 . . . . 72.34 105.872 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 p -97.09 140.74 31.16 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.149 1.166 . . . . 75.41 114.149 -172.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 59.01 77.06 0.32 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.705 1.602 . . . . 74.44 110.869 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.4 mt -103.01 150.28 6.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-N 114.96 -1.018 . . . . 73.21 110.57 -178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.56 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 77.5 t -98.84 136.24 30.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.389 -0.823 . . . . 61.25 109.778 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -175.96 157.2 23.06 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.843 -0.694 . . . . 75.13 113.117 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 37.7 ttmt -99.69 139.75 34.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 123.231 0.612 . . . . 74.3 110.133 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.18 107.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.709 -0.678 . . . . 61.31 109.326 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -65.7 -46.6 78.4 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.243 -0.89 . . . . 62.32 109.74 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -174.29 161.68 3.5 Favored 'General case' 0 CA--C 1.497 -1.072 0 C-N-CA 123.736 0.815 . . . . 72.31 109.52 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -154.14 121.77 5.86 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.503 0.502 . . . . 75.2 111.181 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -117.85 106.77 13.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 115.69 -0.686 . . . . 75.2 110.036 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -56.42 -29.61 61.79 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.719 -1.128 . . . . 63.01 111.028 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 m -61.62 -34.57 75.88 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 65.03 110.614 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.35 -7.26 35.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 55.2 110.18 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m120 65.37 22.06 11.97 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.531 1.132 . . . . 74.02 110.983 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -157.2 174.91 14.76 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.493 0.663 . . . . 75.13 111.307 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.41 -164.63 24.43 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 108.834 -1.706 . . . . 70.4 108.834 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -131.95 152.53 51.03 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 117.6 0.7 . . . . 72.45 111.16 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -142.79 134.02 24.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 123.522 0.729 . . . . 51.22 109.143 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.99 151.53 38.73 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.319 -1.363 . . . . 72.24 107.319 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.59 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 11.4 pt20 -85.12 151.76 23.89 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.805 -1.558 . . . . 73.14 109.267 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.42 -27.75 57.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 124.282 0.989 . . . . 53.24 111.678 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -76.3 2.51 13.15 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.325 -0.398 . . . . 72.22 111.711 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.69 51.44 1.53 Allowed Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 119.804 -1.188 . . . . 71.44 111.965 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.48 170.32 53.28 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 119.758 -1.21 . . . . 63.04 111.047 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.93 154.55 39.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.882 0.341 . . . . 73.51 111.584 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -78.5 89.17 4.46 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.433 -0.951 . . . . 75.23 108.433 174.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.86 136.24 39.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.516 -0.766 . . . . 72.1 109.736 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 53.4 p90 -94.45 139.74 30.73 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.944 -0.702 . . . . 62.03 109.88 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 67' ' ' LEU . 7.4 p -93.63 122.69 45.32 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 109.722 -0.473 . . . . 71.2 109.722 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -98.12 138.61 35.16 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.679 -0.489 . . . . 71.12 109.679 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -57.21 -28.06 62.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.393 1.627 . . . . 53.52 115.393 -173.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 m -54.47 -25.79 27.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 120.624 -0.43 . . . . 72.11 111.244 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.14 -38.86 63.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.53 0.205 . . . . 73.55 110.595 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.99 -52.64 58.87 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 108.263 -1.014 . . . . 73.24 108.263 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.91 -22.32 65.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 113.337 0.866 . . . . 62.23 113.337 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.16 -30.83 71.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.995 0.426 . . . . 72.55 110.981 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.98 -7.49 8.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.459 0.647 . . . . 50.33 110.437 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.58 56.59 24.3 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 109.886 -1.286 . . . . 62.5 109.886 -171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.04 130.49 44.23 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.981 -1.489 . . . . 74.34 106.981 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -53.53 -56.44 17.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.73 1.011 . . . . 74.24 113.73 -172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m -163.94 151.39 12.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 110.351 -0.24 . . . . 62.22 110.351 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -123.59 141.49 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.204 -1.036 . . . . 74.55 108.204 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.22 153.41 33.75 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.031 -0.531 . . . . 74.12 110.229 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.79 134.73 57.09 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 108.25 -1.018 . . . . 72.3 108.25 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.87 -14.56 49.17 Favored Glycine 0 C--N 1.295 -1.717 0 C-N-CA 120.993 -0.622 . . . . 73.21 111.947 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.41 134.09 34.09 Favored 'General case' 0 CA--C 1.495 -1.143 0 O-C-N 122.708 -0.289 . . . . 62.14 110.586 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 10.6 m-20 -89.66 136.74 32.86 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.026 -1.472 . . . . 73.31 107.026 173.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.73 151.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-O 121.918 0.866 . . . . 71.22 111.378 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 65.1 mt -113.07 133.32 59.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.918 -1.512 . . . . 71.51 106.918 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . 43.5 p90 -149.54 177.48 9.69 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.297 -0.26 . . . . 71.54 110.297 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -115.34 155.56 27.12 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.349 -1.723 . . . . 71.01 106.349 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -141.03 136.9 32.53 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.772 0.796 . . . . 73.31 111.536 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.21 145.26 27.04 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.661 -1.977 . . . . 72.53 105.661 174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -85.24 128.17 34.58 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 113.699 1.0 . . . . 74.42 113.699 -170.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 61' ' ' LYS . 64.8 tttp -83.43 70.82 10.27 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 114.27 -1.332 . . . . 64.41 109.268 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 55.65 24.46 7.12 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.249 1.02 . . . . 72.35 111.325 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.81 -35.5 1.99 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.306 -0.718 . . . . 75.43 111.306 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 58' ' ' LYS . 10.9 mptt -84.32 164.79 18.77 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.84 -0.429 . . . . 73.03 109.84 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.88 113.68 13.16 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.895 -0.409 . . . . 74.32 109.895 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 2.8 p90 -126.88 137.75 53.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.338 0.589 . . . . 72.33 111.569 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.9 35.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.588 -1.187 . . . . 44.23 110.392 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 31.4 m -134.88 168.08 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.156 -0.929 . . . . 52.42 109.935 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 62.9 t30 55.39 63.55 2.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.492 0.717 . . . . 72.0 110.529 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 32' ' ' VAL . 37.9 mt -81.95 145.93 30.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.274 -0.875 . . . . 74.41 112.461 -174.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -150.53 130.86 13.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 105.241 -2.133 . . . . 71.05 105.241 174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.38 145.24 8.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 C-N-CA 119.545 -0.862 . . . . 73.33 110.148 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 50' ' ' ASP . 87.9 tttt . . . . . 0 C--N 1.293 -1.858 0 N-CA-C 107.903 -1.147 . . . . 63.23 107.903 174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 110.024 -0.361 . . . . 74.24 110.024 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.3 132.99 28.9 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.449 -1.315 . . . . 71.41 107.449 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 p -118.58 148.63 42.47 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 111.983 0.364 . . . . 74.15 111.983 -175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 58.15 76.93 0.31 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 124.128 0.971 . . . . 71.21 111.435 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mt -108.35 154.41 9.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.983 -1.008 . . . . 54.3 110.51 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 23' ' ' GLN . 72.9 t -103.46 129.5 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 CA-C-N 115.665 -0.698 . . . . 54.2 109.505 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 23' ' ' GLN . . . -158.79 171.62 35.48 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 110.658 -0.977 . . . . 63.23 110.658 171.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 50' ' ' ASP . 39.8 ttmt -125.94 140.35 52.7 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 108.433 -0.951 . . . . 73.31 108.433 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 73.0 t -57.37 112.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 109.573 -0.528 . . . . 61.21 109.573 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD3' ' HB3' ' A' ' 20' ' ' PHE . 66.4 tttp -79.15 -43.09 24.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.582 -1.19 . . . . 43.41 109.112 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -176.2 160.01 2.14 Favored 'General case' 0 CA--C 1.494 -1.18 0 C-N-CA 124.139 0.976 . . . . 73.4 109.173 172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 87.6 t80 -155.65 121.99 5.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 123.498 0.499 . . . . 72.03 110.089 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -105.15 104.18 13.86 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.733 -0.84 . . . . 72.15 108.733 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.4 p -63.75 -23.13 67.24 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 123.689 0.795 . . . . 72.43 112.469 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.1 m -67.84 -28.86 67.91 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.218 -0.447 . . . . 71.24 110.357 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -110.43 -8.24 14.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.834 -0.346 . . . . 75.43 110.347 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 58.07 27.2 14.57 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.648 0.779 . . . . 74.43 113.011 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.45 153.72 41.55 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.608 -0.723 . . . . 71.33 109.949 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 12' ' ' TYR . . . -170.22 -168.73 32.47 Favored Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 109.608 -1.397 . . . . 54.23 109.608 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 57.5 m-85 -135.65 164.18 28.44 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.216 0.531 . . . . 74.01 111.597 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.8 mt -144.67 135.23 20.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 114.799 -1.091 . . . . 54.04 108.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -143.5 146.35 33.32 Favored 'General case' 0 CA--C 1.491 -1.313 0 N-CA-C 105.634 -1.987 . . . . 71.5 105.634 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.665 ' HA ' ' HA2' ' A' ' 7' ' ' GLY . 3.4 pt20 -72.17 144.81 48.43 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 117.809 -1.556 . . . . 61.12 109.398 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.81 -25.56 19.99 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 114.406 -1.27 . . . . 74.42 111.001 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.26 3.27 13.31 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.486 -0.779 . . . . 64.31 112.233 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.85 51.59 3.56 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.184 -1.007 . . . . 72.43 112.204 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 23' ' ' GLN . . . -89.27 -143.5 9.84 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.349 -0.929 . . . . 45.22 113.098 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.38 164.16 13.32 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 110.259 -0.274 . . . . 73.35 110.259 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -101.25 112.53 25.05 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.712 -0.847 . . . . 63.01 108.712 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 55' ' ' LEU . 2.7 p -119.38 138.48 49.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.865 -0.791 . . . . 72.04 108.865 177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 38.2 p90 -90.55 148.16 22.89 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 119.196 -1.002 . . . . 62.42 110.44 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 67' ' ' LEU . 11.7 p -113.98 142.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 109.078 -0.712 . . . . 74.43 109.078 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -130.12 160.14 34.65 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 108.426 -0.953 . . . . 74.4 108.426 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -66.2 -14.73 62.35 Favored 'General case' 0 C--O 1.197 -1.696 0 N-CA-C 111.802 0.297 . . . . 73.02 111.802 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -53.38 -33.32 53.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 120.702 0.286 . . . . 61.43 110.454 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . . . -74.79 -37.81 62.29 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-O 120.848 0.356 . . . . 63.14 110.894 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.23 -35.0 69.46 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.845 0 N-CA-C 108.205 -1.035 . . . . 74.43 108.205 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.2 -35.37 80.85 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.468 -0.787 . . . . 74.1 110.725 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.49 -49.09 12.8 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.247 0.462 . . . . 64.42 112.247 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.73 -23.27 19.82 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.492 0.923 . . . . 72.0 113.492 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.93 62.58 3.51 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 111.59 -0.604 . . . . 53.21 111.59 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.8 148.06 24.86 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.906 -1.516 . . . . 65.1 106.906 -177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -68.42 -60.85 2.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 118.208 0.458 . . . . 73.44 111.9 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.8 p -163.11 165.22 24.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 110.023 -0.362 . . . . 74.25 110.023 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.28 137.28 52.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.901 -0.778 . . . . 73.43 108.901 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.64 145.43 22.47 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.065 -0.97 . . . . 70.32 110.051 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -54.87 131.33 44.01 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 124.201 1.0 . . . . 73.02 109.893 -177.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 117.28 -26.1 8.38 Favored Glycine 0 C--N 1.301 -1.369 0 CA-C-N 115.486 -0.779 . . . . 63.53 111.653 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.486 HE21 ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -80.69 117.51 21.43 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 113.676 0.991 . . . . 70.24 113.676 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 7.3 m-20 -70.4 132.19 45.23 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.431 -1.692 . . . . 73.2 106.431 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -133.26 146.6 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.803 0 CA-C-O 121.951 0.882 . . . . 74.14 110.981 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.6 mt -111.68 126.6 69.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 107.027 -1.472 . . . . 60.01 107.027 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' HB3' HD23 ' A' ' 67' ' ' LEU . 41.9 p90 -147.83 178.42 8.51 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.808 -0.357 . . . . 61.13 110.634 -177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -115.12 162.0 17.62 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.341 -2.096 . . . . 65.41 105.341 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 62' ' ' ALA . 16.4 tp -130.69 128.37 40.75 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.948 0.88 . . . . 72.12 112.841 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 44.0 mt-10 -116.9 146.48 42.92 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.395 -1.73 . . . . 75.41 108.55 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -93.63 137.3 33.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 121.277 0.561 . . . . 63.13 111.873 -172.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -116.94 74.25 0.9 Allowed 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 108.585 -0.894 . . . . 72.51 108.585 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 65.58 -72.28 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.931 1.292 . . . . 72.41 111.838 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 -1.38 4.79 Favored Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 111.062 -0.815 . . . . 70.14 111.062 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 7.3 mmpt? -104.12 164.97 11.35 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 109.059 -0.719 . . . . 71.11 109.059 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.59 ' HB1' HD11 ' A' ' 55' ' ' LEU . . . -129.23 127.22 40.81 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.463 -0.569 . . . . 75.0 109.463 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 31' ' ' PHE . 40.9 p90 -122.58 128.7 51.05 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.699 0.761 . . . . 73.42 112.831 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.83 130.98 37.34 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.382 -1.281 . . . . 74.51 110.218 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 28.9 m -135.36 168.77 22.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.938 -1.028 . . . . 61.0 108.871 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' PHE . 57.7 t30 53.18 63.92 2.05 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.724 0.64 . . . . 61.12 111.138 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 36' ' ' ALA . 44.5 mt -82.47 146.79 29.08 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.538 0.685 . . . . 73.31 112.528 -175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -148.77 130.72 15.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.016 -2.216 . . . . 75.31 105.016 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.82 148.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.176 -1.01 . . . . 74.3 112.784 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.34 -0.845 . . . . 73.11 109.769 172.507 . . . . . . . . 0 0 . 1 stop_ save_